Clustering O 0 0.008083759807050228
of O 0 5.3251606004778296e-05
missense O 0 0.017241347581148148
mutations O 0 0.001103886985220015
in O 0 0.00010422942432342097
the O 0 0.0008725283551029861
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9970064759254456
telangiectasia I-Disease 1 0.9998841285705566
gene O 0 0.0011207894422113895
in O 0 4.798324516741559e-05
a O 0 0.00046620811917819083
sporadic B-Disease 0 0.04458465427160263
T I-Disease 1 0.9999140501022339
- I-Disease 0 0.08266915380954742
cell I-Disease 0 0.05673821270465851
leukaemia I-Disease 1 0.9999986886978149
. O 0 0.0009542061015963554

Ataxia B-Disease 1 0.9999990463256836
- I-Disease 1 0.9962211847305298
telangiectasia I-Disease 1 0.9999741315841675
( O 0 0.002969913650304079
A B-Disease 1 0.998610258102417
- I-Disease 1 0.9939123392105103
T I-Disease 1 0.9999097585678101
) O 0 7.91967031545937e-05
is O 0 6.281566311372444e-05
a O 0 0.0004019632178824395
recessive B-Disease 1 0.9794822335243225
multi I-Disease 1 0.9960864782333374
- I-Disease 1 0.9949894547462463
system I-Disease 1 0.9605608582496643
disorder I-Disease 1 0.9999998807907104
caused O 0 0.037007350474596024
by O 0 4.573924888973124e-05
mutations O 0 0.0006241975352168083
in O 0 3.53283467120491e-05
the O 0 0.00011318492761347443
ATM O 0 0.013340533711016178
gene O 0 0.0012143307831138372
at O 0 0.0010268002515658736
11q22 O 0 0.0863441675901413
- O 0 0.009319393895566463
q23 O 0 0.05731895565986633
( O 0 0.0010445748921483755
ref O 0 0.21004442870616913
. O 0 0.00015230303688440472
3 O 0 0.000605027365963906
) O 0 0.00015612103743478656
. O 0 0.00017259179730899632

The O 0 0.0007232849020510912
risk O 0 0.032019056379795074
of O 0 0.00025709051988087595
cancer B-Disease 1 1.0
, O 0 0.0002199189766542986
especially O 0 0.001634633750654757
lymphoid B-Disease 1 0.9998021721839905
neoplasias I-Disease 1 0.9925512075424194
, O 0 0.00012848082405980676
is O 0 0.00018353659834247082
substantially O 0 0.010246445424854755
elevated O 1 0.9505889415740967
in O 0 0.00023722214973531663
A B-Disease 1 0.9992146492004395
- I-Disease 1 0.9998494386672974
T I-Disease 1 0.9999995231628418
patients O 1 0.999991774559021
and O 0 0.00014322149218060076
has O 0 0.000391502893762663
long O 0 0.0010741706937551498
been O 0 0.00013956338807474822
associated O 0 0.0001758947764756158
with O 0 0.00015762193652335554
chromosomal O 1 0.9987058639526367
instability O 1 0.9892633557319641
. O 0 0.0010128944413736463

By O 0 0.0002497139503248036
analysing O 0 0.10369578748941422
tumour B-Disease 1 0.9999997615814209
DNA O 0 0.0021454961970448494
from O 0 0.00017182546434924006
patients O 1 0.9998772144317627
with O 0 0.00010239100811304525
sporadic B-Disease 0 0.06258304417133331
T I-Disease 1 0.9998527765274048
- I-Disease 0 0.008151489309966564
cell I-Disease 0 0.005326204467564821
prolymphocytic I-Disease 1 0.9973857998847961
leukaemia I-Disease 1 0.9999996423721313
( O 0 0.005913092289119959
T B-Disease 1 0.9999463558197021
- I-Disease 0 0.24635513126850128
PLL I-Disease 1 0.9993022680282593
) O 0 0.00016237216186709702
, O 0 5.84083391004242e-05
a O 0 0.00040668685687705874
rare O 0 0.010687029920518398
clonal B-Disease 1 0.9783850908279419
malignancy I-Disease 1 0.9998847246170044
with O 0 4.969059591530822e-05
similarities O 0 0.00035285562626086175
to O 0 3.479557562968694e-05
a O 0 0.0005605122423730791
mature B-Disease 1 0.9932969212532043
T I-Disease 1 0.9999697208404541
- I-Disease 0 0.019596649333834648
cell I-Disease 0 0.016462862491607666
leukaemia I-Disease 1 0.9999980926513672
seen O 0 0.0012942706234753132
in O 0 0.0002618525759316981
A B-Disease 1 0.9939835667610168
- I-Disease 1 0.9973143935203552
T I-Disease 1 0.9999809265136719
, O 0 0.00018220199854113162
we O 0 8.538003748981282e-05
demonstrate O 0 0.000970791035797447
a O 0 0.000188837613677606
high O 0 0.00047049822751432657
frequency O 0 5.085484735900536e-05
of O 0 1.4214375369192567e-05
ATM O 0 0.016665514558553696
mutations O 0 0.0020018124487251043
in O 0 0.0009751776233315468
T B-Disease 1 0.9998140931129456
- I-Disease 0 0.07900108397006989
PLL I-Disease 1 0.9978848099708557
. O 0 0.0008011299651116133

In O 0 0.000562701839953661
marked O 0 0.001219309982843697
contrast O 0 0.0006310834432952106
to O 0 2.903001404774841e-05
the O 0 6.869131175335497e-05
ATM O 0 0.01185906957834959
mutation O 0 0.0011294310679659247
pattern O 0 0.001792266732081771
in O 0 0.0004015045997221023
A B-Disease 1 0.9984299540519714
- I-Disease 1 0.9951860308647156
T I-Disease 1 0.9999511241912842
, O 0 0.00011618914140854031
the O 0 5.283813152345829e-05
most O 0 6.586118252016604e-05
frequent O 0 0.001142409280873835
nucleotide O 0 0.00017041913815774024
changes O 0 0.0001340575108770281
in O 0 9.074604895431548e-05
this O 0 0.00025112071307376027
leukaemia B-Disease 1 0.9999996423721313
were O 0 0.00015883885498624295
missense O 0 0.01900738663971424
mutations O 0 0.0029540995601564646
. O 0 0.0003192224248778075

These O 0 0.00013239600230008364
clustered O 0 0.001854719128459692
in O 0 0.00010135778575204313
the O 0 0.00011150816135341302
region O 0 0.000652599090244621
corresponding O 0 0.00013879289326723665
to O 0 3.054181797779165e-05
the O 0 0.00010956687037833035
kinase O 0 0.0068116202019155025
domain O 0 0.0004675883101299405
, O 0 8.599614375270903e-05
which O 0 2.6147792596020736e-05
is O 0 6.196114554768428e-05
highly O 0 0.00038125357241369784
conserved O 0 0.00014387631381396204
in O 0 0.00012453587260097265
ATM O 0 0.02220591902732849
- O 0 0.0028552168514579535
related O 0 0.0002542405272834003
proteins O 0 4.945403998135589e-05
in O 0 0.0001549565204186365
mouse O 0 0.00569077767431736
, O 0 0.00012190413690404966
yeast O 0 0.0019360053120180964
and O 0 0.00014274947170633823
Drosophila O 0 0.004345904570072889
. O 0 0.0003965924261137843

The O 0 0.0002436107024550438
resulting O 0 0.0005641991156153381
amino O 0 0.0004615607613231987
- O 0 0.003275833558291197
acid O 0 0.002862510969862342
substitutions O 0 0.0004843624192290008
are O 0 1.4890519196342211e-05
predicted O 0 0.0009684861288405955
to O 0 4.6544388169422746e-05
interfere O 0 0.004665111657232046
with O 0 0.00019186346617061645
ATP O 1 0.993160605430603
binding O 0 0.0006821936112828553
or O 0 0.00029677082784473896
substrate O 0 0.006375372875481844
recognition O 0 0.00311020715162158
. O 0 0.0005345226963981986

Two O 0 2.0511268303380348e-05
of O 0 9.679799404693767e-06
seventeen O 0 0.004847249016165733
mutated O 0 0.16610947251319885
T B-Disease 1 0.999744713306427
- I-Disease 0 0.023994719609618187
PLL I-Disease 1 0.9804617166519165
samples O 0 0.0004229850019328296
had O 0 0.0001646399323362857
a O 0 0.00014793477021157742
previously O 0 0.0008383268723264337
reported O 0 0.003486099885776639
A B-Disease 1 0.9762727618217468
- I-Disease 1 0.9744369387626648
T I-Disease 1 0.999874472618103
allele O 0 0.008074283599853516
. O 0 0.0005154754617251456

In O 0 0.0005669689271599054
contrast O 0 0.0021080984733998775
, O 0 0.00015746839926578104
no O 0 0.00014669653319288045
mutations O 0 0.0006612718570977449
were O 0 2.22034959733719e-05
detected O 0 0.0020621283911168575
in O 0 3.781734631047584e-05
the O 0 0.00013935381139162928
p53 O 0 0.007992726750671864
gene O 0 0.0010606221621856093
, O 0 8.425563282798976e-05
suggesting O 0 0.0009527988731861115
that O 0 2.9834420274710283e-05
this O 0 0.00019932695431634784
tumour B-Disease 1 0.9999998807907104
suppressor O 0 0.07513014227151871
is O 0 0.00017812466830946505
not O 0 5.352541120373644e-05
frequently O 0 0.0003779119870159775
altered O 0 0.0008176297415047884
in O 0 6.63021783111617e-05
this O 0 0.000284553476376459
leukaemia B-Disease 1 0.9999997615814209
. O 0 0.0008373843738809228

Occasional O 0 0.02082826755940914
missense O 0 0.03215485066175461
mutations O 0 0.0020026739221066236
in O 0 0.00014536645903717726
ATM O 0 0.006998226046562195
were O 0 1.9026339941774495e-05
also O 0 6.150462286313996e-05
found O 0 0.00012180583144072443
in O 0 0.00038538884837180376
tumour B-Disease 1 0.9999998807907104
DNA O 0 0.0016784884501248598
from O 0 0.0001699415734037757
patients O 1 0.9998869895935059
with O 0 0.00012864364543929696
B B-Disease 1 0.9759233593940735
- I-Disease 0 0.004564265720546246
cell I-Disease 0 0.0020679295994341373
non I-Disease 0 0.008255131542682648
- I-Disease 1 0.9988346695899963
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999905824661255
( O 0 0.0022719891276210546
B B-Disease 1 0.9484755396842957
- I-Disease 0 0.009532056748867035
NHL I-Disease 0 0.028272973373532295
) O 0 7.467783871106803e-05
and O 0 2.9266398996696807e-05
a O 0 0.0009454145911149681
B B-Disease 1 0.9416671991348267
- I-Disease 0 0.008354478515684605
NHL I-Disease 0 0.03844217583537102
cell O 0 0.0027788192965090275
line O 0 0.0016928118420764804
. O 0 0.00032879202626645565

The O 0 0.00028690387262031436
evidence O 0 8.451764733763412e-05
of O 0 3.591097083699424e-06
a O 0 9.221530490322039e-05
significant O 0 0.00012368257739581168
proportion O 0 0.00013403974298853427
of O 0 2.3871070879977196e-05
loss O 0 0.03296248987317085
- O 0 0.0019332310184836388
of O 0 2.4710743673495017e-05
- O 0 0.003312047803774476
function O 0 0.0006482561584562063
mutations O 0 0.00072450254810974
and O 0 4.816382715944201e-05
a O 0 0.0002606057678349316
complete O 0 0.0007946428959257901
absence O 0 0.0011010079178959131
of O 0 7.188174095063005e-06
the O 0 0.00013624494022224098
normal O 0 0.002248006407171488
copy O 0 0.0005775754107162356
of O 0 1.7105699953390285e-05
ATM O 0 0.010338264517486095
in O 0 6.1029622884234414e-05
the O 0 4.955535405315459e-05
majority O 0 9.159368346445262e-05
of O 0 5.6074328313115984e-05
mutated O 1 0.9418529868125916
tumours B-Disease 1 0.9999994039535522
establishes O 1 0.7295565009117126
somatic O 0 0.025797652080655098
inactivation O 0 0.03826535865664482
of O 0 8.429710760538e-06
this O 0 3.1400533771375194e-05
gene O 0 0.00038013793528079987
in O 0 3.605391248129308e-05
the O 0 0.00014994488446973264
pathogenesis O 1 0.9995614886283875
of O 0 8.655228157294914e-05
sporadic B-Disease 0 0.3447871804237366
T I-Disease 1 0.9999593496322632
- I-Disease 1 0.5187221765518188
PLL I-Disease 1 0.9995457530021667
and O 0 0.00015838803665246814
suggests O 0 0.0009039280703291297
that O 0 3.5155662772012874e-05
ATM O 0 0.004443390294909477
acts O 0 0.0001297502894885838
as O 0 0.0001422025088686496
a O 0 0.0033643206115812063
tumour B-Disease 1 0.9999996423721313
suppressor O 0 0.09885317832231522
. O 0 0.00048456352669745684

As O 0 0.0004740151052828878
constitutional O 0 0.0006389794289134443
DNA O 0 0.0011956333182752132
was O 0 0.00036442987038753927
not O 0 3.1534491427009925e-05
available O 0 3.376046151970513e-05
, O 0 3.558660682756454e-05
a O 0 0.00036961777368560433
putative O 0 0.19649630784988403
hereditary O 1 0.9996380805969238
predisposition O 1 0.9998767375946045
to O 0 0.0018096959684044123
T B-Disease 1 0.9999678134918213
- I-Disease 0 0.08400805294513702
PLL I-Disease 1 0.9985916018486023
will O 0 0.0001025442179525271
require O 0 0.0002872681652661413
further O 0 0.00022732715297024697
investigation O 0 0.0029351527336984873
. O 0 9.593128925189376e-05
. O 0 0.00020135176600888371

Myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999997615814209
protein O 0 0.006821285933256149
kinase O 0 0.021805455908179283
is O 0 0.00025636254576966166
involved O 0 0.00030409908504225314
in O 0 3.232400194974616e-05
the O 0 3.067187935812399e-05
modulation O 0 0.0004956409684382379
of O 0 6.17300020167022e-06
the O 0 0.0003379248082637787
Ca2 O 1 0.9644136428833008
+ O 0 0.0829191654920578
homeostasis O 1 0.9956651329994202
in O 0 0.0009232452139258385
skeletal O 1 0.9999651908874512
muscle O 1 0.9998459815979004
cells O 0 0.009306921623647213
. O 0 0.0004059834172949195

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.5427156090736389
DM B-Disease 1 1.0
) O 0 0.0005721047054976225
, O 0 4.28238527092617e-05
the O 0 4.0767678001429886e-05
most O 0 0.0002819029032252729
prevalent O 1 0.9984890222549438
muscular B-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
in O 0 0.0009513325057923794
adults O 0 0.017062796279788017
, O 0 0.00013151197344996035
is O 0 0.00023314496502280235
caused O 0 0.003396793268620968
by O 0 8.030381286516786e-05
( O 0 0.001617642235942185
CTG O 1 0.9980584979057312
) O 0 0.0008172632660716772
n O 0 0.00476008141413331
- O 0 0.005173234734684229
repeat O 0 0.004594576545059681
expansion O 0 0.0005806686822324991
in O 0 3.0500017601298168e-05
a O 0 0.00010486737301107496
gene O 0 0.00015962400357238948
encoding O 0 4.787920988746919e-05
a O 0 8.445979619864374e-05
protein O 0 0.0006376088713295758
kinase O 0 0.01875639706850052
( O 0 0.0018227093387395144
DM B-Disease 1 0.999995231628418
protein O 0 0.002424925798550248
kinase O 0 0.021602772176265717
; O 0 0.0004888206603936851
DMPK O 1 0.9951790571212769
) O 0 0.00016633953782729805
and O 0 4.888835610472597e-05
involves O 0 0.0010669032344594598
changes O 0 0.0002649997768457979
in O 0 0.00020246912026777864
cytoarchitecture O 1 0.7241610884666443
and O 0 0.00016746453184168786
ion O 0 0.015268626622855663
homeostasis O 1 0.9984392523765564
. O 0 0.0008630418451502919

To O 0 0.0002665761858224869
obtain O 0 0.0007461612112820148
clues O 0 0.0012838031398132443
to O 0 2.7950105504714884e-05
the O 0 5.851426249137148e-05
normal O 0 0.0013293529627844691
biological O 0 0.0007316092378459871
role O 0 0.0007148156873881817
of O 0 4.514392639975995e-05
DMPK O 1 0.9941655397415161
in O 0 0.00019991814042441547
cellular O 0 0.006397425662726164
ion O 0 0.02217710204422474
homeostasis O 1 0.9989404082298279
, O 0 0.00024408615718130022
we O 0 5.628186772810295e-05
have O 0 1.4299324902822264e-05
compared O 0 0.0001569853484397754
the O 0 0.00015218400221783668
resting O 1 0.9892592430114746
[ O 0 0.029323270544409752
Ca2 O 1 0.9460932016372681
+ O 0 0.3959827125072479
] O 0 0.020255684852600098
i O 0 0.0014345591189339757
, O 0 4.4690405047731474e-05
the O 0 2.3639702703803778e-05
amplitude O 0 0.000214042782317847
and O 0 4.770070518134162e-05
shape O 0 0.0020587709732353687
of O 0 3.133209247607738e-05
depolarization O 0 0.17945228517055511
- O 0 0.019449735060334206
induced O 1 0.981130838394165
Ca2 O 1 0.9222912788391113
+ O 0 0.13535992801189423
transients O 0 0.09217528253793716
, O 0 0.00012172038987046108
and O 0 2.415597191429697e-05
the O 0 2.3328808310907334e-05
content O 0 6.881482840981334e-05
of O 0 3.748664676095359e-05
ATP O 1 0.9966892600059509
- O 0 0.002517548855394125
driven O 0 0.0005919385002925992
ion O 0 0.0029740764293819666
pumps O 0 0.011446140706539154
in O 0 0.00020988588221371174
cultured O 0 0.2682555913925171
skeletal O 1 0.9999411106109619
muscle O 1 0.9969047904014587
cells O 0 0.0008722375496290624
of O 0 1.059895566868363e-05
wild O 0 0.0005371002480387688
- O 0 0.0029663355089724064
type O 0 0.0021764172706753016
and O 0 0.0002846576680894941
DMPK O 1 0.9996778964996338
[ O 0 0.027995048090815544
- O 0 0.02544163353741169
/ O 0 0.07924199849367142
- O 0 0.007580791600048542
] O 0 0.00971178337931633
knockout O 0 0.03257692605257034
mice O 0 0.011685214005410671
. O 0 0.00030453779618255794

In O 0 0.00032041341182775795
vitro O 0 0.004828415811061859
- O 0 0.006807328201830387
differentiated O 0 0.07985018938779831
DMPK O 1 0.9991466999053955
[ O 0 0.03562779352068901
- O 0 0.038922470062971115
/ O 0 0.112351194024086
- O 0 0.00902630016207695
] O 0 0.008022725582122803
myotubes O 0 0.03071749210357666
exhibit O 0 0.0006965508800931275
a O 0 0.00015997262380551547
higher O 0 0.0008412623428739607
resting O 1 0.9927603006362915
[ O 0 0.024530606344342232
Ca2 O 1 0.8651977777481079
+ O 0 0.07475980371236801
] O 0 0.011447949334979057
i O 0 0.0008160753059200943
than O 0 4.809906386071816e-05
do O 0 0.00022560812067240477
wild O 0 0.0005911130574531853
- O 0 0.007216501049697399
type O 0 0.009217552840709686
myotubes O 1 0.920301616191864
because O 0 0.00019489099213387817
of O 0 6.708743512717774e-06
an O 0 0.00020009242871310562
altered O 0 0.0023214633110910654
open O 0 0.00036499486304819584
probability O 0 2.370128277107142e-05
of O 0 5.267438154987758e-06
voltage O 0 0.0018398137763142586
- O 0 0.002385674510151148
dependent O 0 0.002319497289136052
l O 0 0.0699494406580925
- O 0 0.004151835106313229
type O 0 0.00648054014891386
Ca2 O 0 0.23664982616901398
+ O 0 0.023460127413272858
and O 0 0.0004835150029975921
Na O 1 0.7735162973403931
+ O 0 0.016025597229599953
channels O 0 0.0005057758535258472
. O 0 0.0003148684627376497

The O 0 0.000806913711130619
mutant O 0 0.010586538352072239
myotubes O 0 0.16711266338825226
exhibit O 0 0.0017108609899878502
smaller O 0 0.00011719840404111892
and O 0 8.250857354141772e-05
slower O 0 0.004881913308054209
Ca2 O 0 0.27768343687057495
+ O 0 0.02135409228503704
responses O 0 0.00046813947847113013
upon O 0 0.0003033855464309454
triggering O 0 0.0035254161339253187
by O 0 0.00010134579497389495
acetylcholine O 1 0.5908129215240479
or O 0 0.0004714380484074354
high O 0 0.0025134803727269173
external O 0 0.005623826757073402
K O 1 0.7740756869316101
+ O 0 0.04246125370264053
. O 0 0.0004350437375251204

In O 0 0.0005998544511385262
addition O 0 0.0003606125246733427
, O 0 8.324092777911574e-05
we O 0 4.540081135928631e-05
observed O 0 7.493792509194463e-05
that O 0 9.533782758808229e-06
these O 0 4.208431710139848e-05
Ca2 O 1 0.9574967622756958
+ O 1 0.5383952856063843
transients O 1 0.6399468779563904
partially O 0 0.024394406005740166
result O 0 0.0003178249462507665
from O 0 2.2102050934336148e-05
an O 0 3.556965020834468e-05
influx O 0 0.00023285616771318018
of O 0 1.42831331686466e-05
extracellular O 0 0.015715261921286583
Ca2 O 0 0.25895875692367554
+ O 0 0.012419609352946281
through O 0 0.00012226957187522203
the O 0 0.0002804691903293133
l O 0 0.10638350248336792
- O 0 0.006448847707360983
type O 0 0.007989551872015
Ca2 O 0 0.11368626356124878
+ O 0 0.024546802043914795
channel O 0 0.001866803620941937
. O 0 0.00031386769842356443

Neither O 0 0.00615482684224844
the O 0 7.99143745098263e-05
content O 0 0.00021706083498429507
nor O 0 0.0007300322176888585
the O 0 1.9331950170453638e-05
activity O 0 8.185052865883335e-05
of O 0 4.253349470673129e-05
Na O 1 0.9974008798599243
+ O 1 0.5002180933952332
/ O 0 0.12360339611768723
K O 0 0.07257086038589478
+ O 0 0.02890569157898426
ATPase O 0 0.06937585771083832
and O 0 0.0007510310388170183
sarcoplasmic O 1 0.9958531856536865
reticulum O 1 0.9904966354370117
Ca2 O 1 0.8920618295669556
+ O 0 0.08380401879549026
- O 0 0.010391843505203724
ATPase O 0 0.03773823007941246
are O 0 3.626072793849744e-05
affected O 0 0.001742459600791335
by O 0 0.00012041838635923341
DMPK O 1 0.9990116357803345
absence O 0 0.010312250815331936
. O 0 0.0004612819175235927

In O 0 0.0005270617548376322
conclusion O 0 0.0010720014106482267
, O 0 6.795430090278387e-05
our O 0 9.931161184795201e-05
data O 0 7.785558409523219e-05
suggest O 0 0.0005763387307524681
that O 0 0.00015094663831405342
DMPK O 1 0.9955627918243408
is O 0 0.00023899109510239214
involved O 0 0.00043133675353601575
in O 0 0.00011020006058970466
modulating O 0 0.0427425242960453
the O 0 0.00012065056944265962
initial O 0 0.0004999645170755684
events O 0 3.667543933261186e-05
of O 0 1.1771208846766967e-05
excitation O 0 0.017002929002046585
- O 0 0.004770814906805754
contraction O 0 0.008116657845675945
coupling O 0 0.0023263718467205763
in O 0 0.0005606610793620348
skeletal O 1 0.9999970197677612
muscle O 1 0.9999583959579468
. O 0 0.0003163111105095595
. O 0 0.00030077973497100174

Constitutional O 0 0.020040862262248993
RB1 O 1 0.999946117401123
- O 0 0.020491808652877808
gene O 0 0.0018383765127509832
mutations O 0 0.001657365239225328
in O 0 0.00043650768930092454
patients O 1 0.999975323677063
with O 0 0.00013122822565492243
isolated O 0 0.026333361864089966
unilateral B-Disease 0 0.36341890692710876
retinoblastoma I-Disease 1 0.9999607801437378
. O 0 0.0012304718839004636

In O 0 0.0005167333292774856
most O 0 0.0005997401312924922
patients O 1 0.999826967716217
with O 0 0.00011130972416140139
isolated O 0 0.028074203059077263
unilateral B-Disease 1 0.9797303676605225
retinoblastoma I-Disease 1 0.9999988079071045
, O 0 0.0015241926303133368
tumor B-Disease 1 0.9999856948852539
development O 0 0.0016389935044571757
is O 0 0.00022213510237634182
initiated O 0 0.002514461288228631
by O 0 3.629864295362495e-05
somatic O 0 0.015249029733240604
inactivation O 0 0.03530589118599892
of O 0 8.134880772558972e-06
both O 0 4.500556315178983e-05
alleles O 0 0.0003957735898438841
of O 0 1.2420495295373257e-05
the O 0 0.001222886610776186
RB1 O 1 0.9999681711196899
gene O 0 0.004697756376117468
. O 0 0.00034353864612057805

However O 0 0.0007606789586134255
, O 0 4.0000701119424775e-05
some O 0 5.240696282271529e-06
of O 0 6.309030140982941e-06
these O 0 9.584624785929918e-05
patients O 1 0.9999948740005493
can O 0 0.00037181301740929484
transmit O 0 0.03714096173644066
retinoblastoma B-Disease 1 0.9999802112579346
predisposition O 1 0.9948817491531372
to O 0 5.650633465847932e-05
their O 0 3.534391362336464e-05
offspring O 0 0.0015071879606693983
. O 0 0.0002959170378744602

To O 0 0.00019944329687859863
determine O 0 0.00021866090537514538
the O 0 4.139472730457783e-05
frequency O 0 0.0001297787530347705
and O 0 4.669180270866491e-05
nature O 0 0.0005097650573588908
of O 0 2.6375697416369803e-05
constitutional O 0 0.005461232271045446
RB1 O 1 0.9999909400939941
- O 0 0.014673441648483276
gene O 0 0.0018626153469085693
mutations O 0 0.0013653249479830265
in O 0 0.0003570344706531614
patients O 1 0.9999607801437378
with O 0 0.00014912303595338017
isolated O 0 0.045551300048828125
unilateral B-Disease 1 0.9739963412284851
retinoblastoma I-Disease 1 0.9999825954437256
, O 0 0.00017122423741966486
we O 0 4.546220225165598e-05
analyzed O 0 0.0004708870255853981
DNA O 0 0.0002559473505243659
from O 0 6.820840644650161e-05
peripheral O 1 0.9997932314872742
blood O 1 0.9300410151481628
and O 0 0.00012673280434682965
from O 0 0.0004314749676268548
tumor B-Disease 1 0.9999998807907104
tissue O 1 0.9997370839118958
. O 0 0.0004839323228225112

The O 0 0.00017309264512732625
analysis O 0 0.00017597227997612208
of O 0 0.00011781344073824584
tumors B-Disease 1 0.9999990463256836
from O 0 0.00029561109840869904
54 O 0 0.007177446037530899
( O 0 0.0006757471710443497
71 O 0 0.0056142378598451614
% O 0 4.0310500480700284e-05
) O 0 3.3140284358523786e-05
of O 0 1.3165144991944544e-05
76 O 0 0.022673076018691063
informative O 0 0.1904604285955429
patients O 1 0.9999879598617554
showed O 0 0.00109356630127877
loss O 0 0.0009456524276174605
of O 0 9.808117283682805e-06
constitutional O 0 0.001941504655405879
heterozygosity O 1 0.9992932081222534
( O 0 0.006473449058830738
LOH O 1 0.9999983310699463
) O 0 0.00043873448157683015
at O 0 0.0012379762483760715
intragenic O 0 0.48720481991767883
loci O 0 0.014875084161758423
. O 0 0.000339914346113801

Three O 0 7.864490908104926e-05
of O 0 2.7073301680502482e-05
13 O 0 0.004044869914650917
uninformative O 1 0.9998834133148193
patients O 1 0.9999916553497314
had O 0 0.0005645915516652167
constitutional O 0 0.00039551957161165774
deletions O 0 0.003737143473699689
. O 0 0.0003237832570448518

For O 0 0.0003671911545097828
39 O 0 0.0012859581038355827
randomly O 0 0.0002690330147743225
selected O 0 0.0015510943485423923
tumors B-Disease 1 0.9999954700469971
, O 0 0.0008196684066206217
SSCP O 1 0.9997283816337585
, O 0 0.0010425221407786012
hetero O 1 0.9987030029296875
- O 0 0.018491331487894058
duplex O 0 0.05894400179386139
analysis O 0 0.0002576986444182694
, O 0 0.00010026955715147778
sequencing O 0 0.0007173218764364719
, O 0 0.00019036377489101142
and O 0 0.00015203199291136116
Southern O 0 0.004287658724933863
blot O 1 0.9731146097183228
analysis O 0 0.00021773864864371717
were O 0 1.1306909073027782e-05
used O 0 5.292416244628839e-05
to O 0 4.304909452912398e-05
identify O 0 0.0012837052345275879
mutations O 0 0.0019433089764788747
. O 0 0.00032224965980276465

Mutations O 0 0.0030885348096489906
were O 0 4.9166075768880546e-05
detected O 0 0.003232676535844803
in O 0 0.00014565090532414615
21 O 0 0.0015290012815967202
( O 0 0.00043882857426069677
91 O 0 0.007397756911814213
% O 0 4.051880750921555e-05
) O 0 3.521149847074412e-05
of O 0 1.760312807164155e-05
23 O 0 0.009965630248188972
tumors B-Disease 1 1.0
with O 0 0.0016961479559540749
LOH O 1 0.9999998807907104
. O 0 0.0008534810040146112

In O 0 0.0009921570308506489
6 O 0 0.0023841995280236006
( O 0 0.0003815766249317676
38 O 0 0.000847507209982723
% O 0 3.3169755624840036e-05
) O 0 3.088396988459863e-05
of O 0 1.6680918633937836e-05
16 O 0 0.004675200674682856
tumors B-Disease 1 0.9999998807907104
without O 0 0.005070915911346674
LOH O 1 0.9999997615814209
, O 0 0.00010478781041456386
one O 0 7.378127338597551e-05
mutation O 0 0.0011468528537079692
was O 0 0.0010601826943457127
detected O 0 0.005083146970719099
, O 0 0.0001031003484968096
and O 0 7.175015343818814e-05
in O 0 0.00023194191453512758
9 O 0 0.0023410178255289793
( O 0 0.0003842424775939435
56 O 0 0.0013919139746576548
% O 0 2.652502189448569e-05
) O 0 2.269344258820638e-05
of O 0 7.218240625661565e-06
the O 0 0.001165766385383904
tumors B-Disease 1 1.0
without O 0 0.008397461846470833
LOH O 1 0.9999997615814209
, O 0 0.00018638154142536223
both O 0 8.310782868647948e-05
mutations O 0 0.0008390772272832692
were O 0 2.6399453417980112e-05
found O 0 0.00022297371469903737
. O 0 0.0002325772657059133

Thus O 0 0.0009689262369647622
, O 0 6.993242277530953e-05
a O 0 7.045656093396246e-05
total O 0 2.2399541194317862e-05
of O 0 8.02791055320995e-06
45 O 0 0.0004706056497525424
mutations O 0 0.0007804697379469872
were O 0 2.6227182388538495e-05
identified O 0 0.00048686671652831137
in O 0 0.00035745740751735866
tumors B-Disease 1 0.9999915361404419
of O 0 5.377262277761474e-05
36 O 0 0.006787716411054134
patients O 1 0.9999924898147583
. O 0 0.00044475094182416797

Thirty O 0 0.009778324514627457
- O 0 0.0017639464931562543
nine O 0 3.350911720190197e-05
of O 0 5.2799609875364695e-06
the O 0 0.00017557607498019934
mutations O 0 0.0032509907614439726
- O 0 0.001959898043423891
including O 0 3.24112297676038e-05
34 O 0 0.0005266798543743789
small O 0 0.00013579061487689614
mutations O 0 0.001035327441059053
, O 0 9.247136767953634e-05
2 O 0 0.00025717189419083297
large O 0 0.00016375705308746547
structural O 1 0.9562866687774658
alterations O 0 0.023762544617056847
, O 0 0.00015579922182951123
and O 0 0.00022378047287929803
hypermethylation O 1 0.9937252402305603
in O 0 0.0005351568106561899
3 O 0 0.006773314438760281
tumors O 1 0.9999997615814209
- O 0 0.0033786797430366278
were O 0 1.036993671732489e-05
not O 0 3.283629848738201e-05
detected O 0 0.0008057127706706524
in O 0 1.2689499271800742e-05
the O 0 2.803103780024685e-05
corresponding O 0 0.0007225676672533154
peripheral O 1 0.9999773502349854
blood O 1 0.9980819225311279
DNA O 0 0.002572081284597516
. O 0 0.000311680807499215

In O 0 0.0010675120865926147
6 O 0 0.0027323721442371607
( O 0 0.000560678425244987
17 O 0 0.0010243937140330672
% O 0 3.2472366001456976e-05
) O 0 3.0427043384406716e-05
of O 0 5.141916517459322e-06
the O 0 0.00030899132252670825
36 O 0 0.006710575427860022
patients O 1 0.9999592304229736
, O 0 0.00010156830830965191
a O 0 0.0003105512587353587
mutation O 0 0.001859675394371152
was O 0 0.0007876168237999082
detected O 0 0.0028834983240813017
in O 0 5.078932372271083e-05
constitutional O 0 0.0004662212450057268
DNA O 0 0.001583887031301856
, O 0 0.00011302897473797202
and O 0 6.372477218974382e-05
1 O 0 0.00020404548558872193
of O 0 5.033257821196457e-06
these O 0 2.6933574190479703e-05
mutations O 0 0.0015098359435796738
is O 0 0.00021308106079231948
known O 0 0.00026393847656436265
to O 0 2.861112807295285e-05
be O 0 3.090748214162886e-05
associated O 0 7.779324369039387e-05
with O 0 3.7204514228506014e-05
reduced O 0 0.008374698460102081
expressivity O 1 0.9991201758384705
. O 0 0.0007646311423741281

The O 0 0.0002636628341861069
presence O 0 0.00013200069952290505
of O 0 7.501744676119415e-06
a O 0 0.0002870286407414824
constitutional O 0 0.0006294039776548743
mutation O 0 0.001963059650734067
was O 0 0.0005839535151608288
not O 0 4.874660226050764e-05
associated O 0 6.081275932956487e-05
with O 0 1.064083608071087e-05
an O 0 0.00010815326095325872
early O 0 0.0006178286275826395
age O 0 0.001059647649526596
at O 0 0.002769841579720378
treatment O 1 0.999931812286377
. O 0 0.0005597880808636546

In O 0 0.0006093487609177828
1 O 0 0.002611390547826886
patient O 1 0.9991567134857178
, O 0 0.00040980588528327644
somatic O 0 0.0567401759326458
mosaicism O 1 0.9990474581718445
was O 0 0.0016498789191246033
demonstrated O 0 0.001560447970405221
by O 0 2.010780190175865e-05
molecular O 0 0.0006378382677212358
analysis O 0 5.9575835621217266e-05
of O 0 9.133173080044799e-06
DNA O 0 0.0005891888868063688
and O 0 3.8304067857097834e-05
RNA O 0 0.0011180617148056626
from O 0 0.00018206305685453117
peripheral O 1 0.9999215602874756
blood O 1 0.9966894388198853
. O 0 0.0005825099069625139

In O 0 0.0009286387357860804
2 O 0 0.0030743523966521025
patients O 1 0.9997612833976746
without O 0 8.33179583423771e-05
a O 0 0.00022702041314914823
detectable O 0 0.010713398456573486
mutation O 0 0.001016315771266818
in O 0 0.00018775749776978046
peripheral O 1 0.9999903440475464
blood O 1 0.9993775486946106
, O 0 0.0010526783298701048
mosaicism O 1 0.9991263747215271
was O 0 0.0017040043603628874
suggested O 0 0.0008905490394681692
because O 0 0.00011603325401665643
1 O 0 5.553069058805704e-05
of O 0 3.6363492199598113e-06
the O 0 0.0005036763614043593
patients O 1 0.9999997615814209
showed O 1 0.7953349947929382
multifocal O 1 0.9999998807907104
tumors B-Disease 1 0.9999997615814209
and O 0 0.00013558476348407567
the O 0 6.240054062800482e-05
other O 0 2.5800076400628313e-05
later O 0 0.000289697025436908
developed O 0 0.003164544003084302
bilateral B-Disease 0 0.23355476558208466
retinoblastoma I-Disease 1 0.9999842643737793
. O 0 0.0007180427201092243

In O 0 0.0004900808562524617
conclusion O 0 0.0014581214636564255
, O 0 0.00010479040793143213
our O 0 0.00024761949316598475
results O 0 0.00035787836532108486
emphasize O 0 0.002398398006334901
that O 0 2.25862895604223e-05
the O 0 9.759499516803771e-05
manifestation O 0 0.427717387676239
and O 0 0.0004113315080758184
transmissibility O 0 0.3071557581424713
of O 0 0.00017797271721065044
retinoblastoma B-Disease 1 0.999745786190033
depend O 0 0.0013380253221839666
on O 0 9.287400462199003e-05
the O 0 7.575355266453698e-05
nature O 0 0.00038088724249973893
of O 0 6.264161584113026e-06
the O 0 9.235363540938124e-05
first O 0 0.00022367338533513248
mutation O 0 0.0010368499206379056
, O 0 5.692603735951707e-05
its O 0 6.886314076837152e-05
time O 0 0.00010819306771736592
in O 0 0.00013164371193852276
development O 0 0.0021440957207232714
, O 0 0.00016823226178530604
and O 0 5.607229468296282e-05
the O 0 6.465976184699684e-05
number O 0 1.843144309532363e-05
and O 0 4.893630466540344e-05
types O 0 0.00023655494442209601
of O 0 2.0801433493033983e-05
cells O 0 0.0016068101394921541
that O 0 2.456980109855067e-05
are O 0 1.5294746845029294e-05
affected O 0 0.0026222688611596823
. O 0 9.481394226895645e-05
. O 0 0.0002420232049189508

Hereditary B-Disease 1 0.9999861717224121
deficiency I-Disease 1 0.9999990463256836
of I-Disease 0 4.373637057142332e-05
the I-Disease 0 0.00022195007477421314
fifth I-Disease 0 0.0015298605430871248
component I-Disease 0 0.0012646567774936557
of I-Disease 0 8.184886610251851e-06
complement I-Disease 0 0.001554197515361011
in O 0 0.00028557865880429745
man O 0 0.004210683051496744
. O 0 0.00034198438515886664

I O 0 0.05538276210427284
. O 0 0.0005224271444603801

Clinical O 1 0.9999632835388184
, O 0 0.0010088625131174922
immunochemical O 1 0.9743794202804565
, O 0 0.00021529030345845968
and O 0 0.00010561793897068128
family O 0 0.00047495748731307685
studies O 0 0.000994552276097238
. O 0 0.00023822326329536736

The O 0 0.00022653304040431976
first O 0 0.0001332163519691676
recognized O 0 0.0016192988259717822
human O 0 0.0027433843351900578
kindred O 1 0.9989997744560242
with O 0 0.0011049227323383093
hereditary B-Disease 1 0.9999918937683105
deficiency I-Disease 1 0.9999997615814209
of I-Disease 0 2.1054394892416894e-05
the I-Disease 0 0.00010697474499465898
fifth I-Disease 0 0.0011510617332533002
component I-Disease 0 0.0009972578845918179
of I-Disease 0 1.3457872228173073e-05
complement I-Disease 0 0.004955947864800692
( O 0 0.0019089344423264265
C5 O 1 0.9990482926368713
) O 0 0.0003184995730407536
is O 0 0.0002289480617037043
described O 0 0.0022779684513807297
. O 0 0.00036684636143036187

The O 0 0.001011441694572568
proband O 0 0.05764160677790642
, O 0 0.00011112307402072474
a O 0 0.00027571801911108196
20 O 0 0.0005118727567605674
- O 0 0.0018753329059109092
year O 0 0.0006906743510626256
- O 0 0.002828379161655903
old O 0 0.0014896874781697989
black O 0 0.004363626707345247
female O 0 0.0026254383847117424
with O 0 0.031539395451545715
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.010856961831450462
age O 0 0.0011466097785159945
11 O 0 0.0007578929653391242
, O 0 0.00020345005032140762
lacked O 0 0.4619671702384949
serum O 1 0.9997342228889465
hemolytic O 1 0.9999920129776001
complement O 0 0.0031753124203532934
activity O 0 0.0004793310072273016
, O 0 9.340974793303758e-05
even O 0 0.00026941337273456156
during O 0 0.0027074788231402636
remission O 1 0.9996933937072754
. O 0 0.00047881025238893926

C5 O 1 0.9968953132629395
was O 0 0.006100348196923733
undetectable O 1 0.9715914726257324
in O 0 0.00021422879945021123
her O 0 0.0012957180151715875
serum O 1 0.7334755063056946
by O 0 3.744148853002116e-05
both O 0 0.0002091164351440966
immunodiffusion O 1 0.992570698261261
and O 0 0.0010578844230622053
hemolytic O 1 0.9999969005584717
assays O 0 0.006707249209284782
. O 0 0.0006141031044535339

Other O 0 0.00010620015382301062
complement O 0 0.000851387856528163
components O 0 0.0005485493456944823
were O 0 2.4239372578449547e-05
normal O 0 0.0013902884675189853
during O 0 0.0021691136062145233
remission O 1 0.9996191263198853
of O 0 0.0003697781648952514
lupus O 1 1.0
, O 0 0.0008057986851781607
but O 0 0.0008580064750276506
C1 O 1 0.9999836683273315
, O 0 0.0007209334871731699
C4 O 1 0.9986646175384521
, O 0 0.0010528123239055276
C2 O 1 0.9999829530715942
, O 0 0.000255193212069571
and O 0 0.00024919642601162195
C3 O 1 0.9997321963310242
levels O 0 0.0074022565968334675
fell O 0 0.01484648883342743
during O 0 0.0034025136847049
exacerbations O 1 0.9998654127120972
. O 0 0.0010030422126874328

A O 0 0.005975150968879461
younger O 0 0.0032095874194055796
half O 0 0.0006605013040825725
- O 0 0.008366231806576252
sister O 0 0.002502917777746916
, O 0 0.00013437606685329229
who O 0 0.0002603333559818566
had O 0 0.0002882209373638034
no O 0 0.00033215712755918503
underlying O 1 0.9998601675033569
disease O 1 1.0
, O 0 0.00032737822039052844
was O 0 0.0007525280234403908
also O 0 8.458681986667216e-05
found O 0 6.492877582786605e-05
to O 0 3.386677781236358e-05
lack O 0 0.003866675542667508
immunochemically O 1 0.9917928576469421
detectable O 1 0.6098089218139648
C5 O 1 0.998073935508728
. O 0 0.0006736025679856539

By O 0 0.001524487161077559
hemolytic O 1 0.999988317489624
assay O 0 0.026026256382465363
, O 0 0.0005706234369426966
she O 0 0.001603779150173068
exhibited O 0 0.011408187448978424
1 O 0 0.0023229250218719244
- O 0 0.002296469174325466
2 O 0 0.00012525089550763369
% O 0 4.43647741121822e-06
of O 0 2.4913692868722137e-06
the O 0 0.0001381051988573745
normal O 0 0.01054939441382885
serum O 1 0.9981738328933716
C5 O 1 0.9973610043525696
level O 0 0.0041311816312372684
and O 0 0.0001267627812922001
normal O 0 0.0019287309842184186
concentrations O 0 0.0013979078503325582
of O 0 4.743258159578545e-06
other O 0 1.807199078029953e-05
complement O 0 0.0016996801132336259
components O 0 0.002228513592854142
. O 0 0.00044988648733124137

C5 O 1 0.992948055267334
levels O 0 0.0027958520222455263
of O 0 1.4997032849350944e-05
other O 0 4.828592864214443e-05
family O 0 0.00037556671304628253
members O 0 6.054922778275795e-05
were O 0 2.1296333216014318e-05
either O 0 0.00016013270942494273
normal O 0 0.0011322350474074483
or O 0 0.00011674175766529515
approximately O 0 0.0002537987311370671
half O 0 0.0002952736394945532
- O 0 0.0036787327844649553
normal O 0 0.0015330981696024537
, O 0 9.989753743866459e-05
consistent O 0 0.0032437085174024105
with O 0 0.0003719250380527228
autosomal O 1 0.9994403719902039
codominant O 1 0.9876524209976196
inheritance O 0 0.000794661114923656
of O 0 5.808795776829356e-06
the O 0 9.148744720732793e-05
gene O 0 0.0017930892063304782
determining O 0 0.015881450846791267
C5 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.001312138861976564

Normal O 1 0.6590456366539001
hemolytic O 1 0.9999985694885254
titers O 1 0.987093985080719
were O 0 7.317768904613331e-05
restored O 0 0.001016146270558238
to O 0 1.7214426407008432e-05
both O 0 6.437206320697442e-05
homozygous O 0 0.012786653824150562
C5 B-Disease 1 0.9999923706054688
- I-Disease 1 0.9923264980316162
deficient I-Disease 1 0.9999990463256836
( O 0 0.004547514021396637
C5D B-Disease 1 0.9999785423278809
) O 0 0.0008581627043895423
sera O 0 0.01992478407919407
by O 0 1.2723477084364276e-05
addition O 0 3.226213084417395e-05
of O 0 6.998897333687637e-06
highly O 0 0.002252562902867794
purified O 0 0.03419021889567375
human O 0 0.003310461761429906
C5 O 1 0.9988549947738647
. O 0 0.0006334178033284843

In O 0 0.00048777618212625384
specific O 0 0.0012264917604625225
C5 O 1 0.9990911483764648
titrations O 1 0.9896048307418823
, O 0 0.00045924700680188835
however O 0 0.00021878498955629766
, O 0 9.285815031034872e-05
it O 0 8.860869274940342e-05
was O 0 0.0006329691386781633
noted O 0 0.0003789200563915074
that O 0 2.4407725504715927e-05
when O 0 6.368176400428638e-05
limited O 0 0.00017165319877676666
amounts O 0 9.434720413992181e-05
of O 0 4.486428952077404e-05
C5 O 1 0.9969601631164551
were O 0 7.21690958016552e-05
assayed O 0 0.0036675729788839817
in O 0 3.5748314985539764e-05
the O 0 3.3768414141377434e-05
presence O 0 0.00013934425078332424
of O 0 1.4492664377030451e-05
low O 0 0.005190209951251745
dilutions O 0 0.2881676256656647
of O 0 4.1051145672099665e-05
either O 0 0.002238713437691331
C5D B-Disease 1 0.9999812841415405
serum O 1 0.9911166429519653
, O 0 0.00029284608899615705
curving O 0 0.006485233083367348
rather O 0 8.009762677829713e-05
than O 0 4.8162080929614604e-05
linear O 0 0.005513492505997419
dose O 1 0.9652868509292603
- O 0 0.005851855035871267
response O 0 0.0009956619469448924
plots O 0 0.00047909325803630054
were O 0 3.6609610106097534e-05
consistently O 0 0.0034890531096607447
obtained O 0 0.0002833331236615777
, O 0 7.649989129276946e-05
suggesting O 0 0.0007631861371919513
some O 0 1.7619757272768766e-05
inhibitory O 0 0.00204989081248641
effect O 0 0.0012452874798327684
. O 0 0.00031059037428349257

Further O 0 0.0008627019124105573
studies O 0 0.00048683254863135517
suggested O 0 0.0006073765689507127
that O 0 3.393560473341495e-05
low O 0 0.0023378191981464624
dilutions O 0 0.12447047233581543
of O 0 0.00011963108408963308
C5D B-Disease 1 0.9999700784683228
serum O 1 0.7025884985923767
contain O 0 0.00016920361667871475
a O 0 0.0003198518243152648
factor O 0 0.0018438866827636957
( O 0 0.0003861927834805101
or O 0 0.0002476313093211502
factors O 0 0.0006199131021276116
) O 0 0.00021091058442834765
interfering O 0 0.006466439459472895
at O 0 0.0003796712844632566
some O 0 2.258443782920949e-05
step O 0 0.0010276942048221827
in O 0 5.9576173953246325e-05
the O 0 0.0005400267546065152
hemolytic O 1 0.9999946355819702
assay O 0 0.008168362081050873
of O 0 0.00011321775673422962
C5 O 1 0.9994114637374878
, O 0 0.00010807345825014636
rather O 0 6.348300667013973e-05
than O 0 2.3146560124587268e-05
a O 0 0.00025038051535375416
true O 0 0.0028280054684728384
C5 O 1 0.9991430044174194
inhibitor O 1 0.5834811329841614
or O 0 0.0008524936274625361
inactivator O 1 0.6355675458908081
. O 0 0.0004799764137715101

Of O 0 0.0002481456031091511
clinical O 1 0.9998733997344971
interest O 0 0.00014611259393859655
are O 0 2.4543924155295826e-05
( O 0 0.0001786328648449853
a O 0 0.0003130811091978103
) O 0 4.571213139570318e-05
the O 0 2.8616343115572818e-05
documentation O 0 0.0005714251310564578
of O 0 8.035360951907933e-05
membranous O 1 0.9999970197677612
glomerulonephritis B-Disease 1 1.0
, O 0 0.018519187346100807
vasculitis B-Disease 1 1.0
, O 0 0.0016660126857459545
and O 0 0.008732376620173454
arthritis B-Disease 1 1.0
in O 0 0.00013487284013535827
an O 0 8.037123188842088e-05
individual O 0 0.0005224455962888896
lacking O 1 0.9944266080856323
C5 O 1 0.9998770952224731
( O 0 0.0004220715200062841
and O 0 6.295364437391981e-05
its O 0 0.00018854971858672798
biologic O 0 0.13135990500450134
functions O 0 0.00034187923301942647
) O 0 0.00018724153051152825
, O 0 0.00011650156375253573
and O 0 0.0001497925550211221
( O 0 0.0006889431388117373
b O 0 0.00824094470590353
) O 0 4.4937332859262824e-05
a O 0 0.00011639461445156485
remarkable O 0 0.003598290728405118
propensity O 1 0.8210170865058899
to O 0 0.0010575399501249194
bacterial B-Disease 1 0.9999990463256836
infections I-Disease 1 1.0
in O 0 0.00035458538332022727
the O 0 0.0005612987442873418
proband O 1 0.9718272686004639
, O 0 0.00024320455850102007
even O 0 0.0001503218081779778
during O 0 0.0002333653683308512
periods O 0 0.00015915089170448482
of O 0 1.3618404409498908e-05
low O 0 0.005044064484536648
- O 0 0.004516840912401676
dose O 0 0.020230555906891823
or O 0 0.0001968234428204596
alternate O 0 0.000819081615190953
- O 0 0.00495372898876667
day O 0 0.003160497173666954
corticosteroid O 1 0.9999974966049194
therapy O 1 0.9999494552612305
. O 0 0.0005001737736165524

Other O 0 9.369807958137244e-05
observations O 0 0.0005944243748672307
indicate O 0 0.0005089129554107785
that O 0 4.026016540592536e-05
the O 0 0.00039066796307452023
C5D B-Disease 1 0.999941349029541
state O 0 0.00014842591190245003
is O 0 0.00010922450746875256
compatible O 0 0.0006885338807478547
with O 0 6.151717389002442e-05
normal O 0 0.0059402696788311005
coagulation O 0 0.4495307505130768
function O 0 0.0007591198082081974
and O 0 4.746859849547036e-05
the O 0 5.36024417669978e-05
capacity O 0 0.0007599623640999198
to O 0 0.00011879827070515603
mount O 0 0.09715746343135834
a O 0 0.0022365087643265724
neutrophilic O 1 0.9999750852584839
leukocytosis O 1 0.9998548030853271
during O 0 0.018297819420695305
pyogenic B-Disease 1 0.9999651908874512
infection I-Disease 1 0.9999904632568359
. O 0 0.00032988813472911716
. O 0 0.00030189272365532815

Susceptibility O 1 0.9911357164382935
to O 0 0.0037878286093473434
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.0037951406557112932
twins O 0 0.02616029977798462
: O 0 0.00010993986506946385
the O 0 3.828989792964421e-05
role O 0 0.00033199216704815626
of O 0 1.1248059308854863e-05
genes O 0 0.00045289896661415696
, O 0 0.0009643408702686429
HLA O 1 0.9999532699584961
, O 0 0.000161423537065275
and O 0 4.344315311755054e-05
the O 0 0.00011834229371743277
environment O 0 0.003756709164008498
. O 0 0.00039990938967093825

OBJECTIVE O 0 0.0475117489695549
To O 0 0.00015737442299723625
determine O 0 0.0001907016703626141
the O 0 5.0952377932844684e-05
relative O 0 0.0003403037553653121
effects O 0 0.0018007579492405057
of O 0 2.304651752638165e-05
genetic O 0 0.0018289308063685894
and O 0 0.00010749039211077616
environmental O 0 0.002581780543550849
factors O 0 0.00016986916307359934
in O 0 0.00013812877296004444
susceptibility O 1 0.9972530007362366
to O 0 0.0034552435390651226
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.011343351565301418
AS B-Disease 1 0.6294023394584656
) O 0 0.00032117494265548885
. O 0 0.00022923860524315387

METHODS O 0 0.01658700965344906
Twins O 0 0.02385309524834156
with O 0 0.00015582954802084714
AS B-Disease 0 0.007155826780945063
were O 0 2.8199361622682773e-05
identified O 0 0.00016294073429889977
from O 0 1.2485622391977813e-05
the O 0 9.994338324759156e-05
Royal O 0 0.00757304672151804
National O 1 0.6725858449935913
Hospital O 1 0.9999997615814209
for O 0 0.007392838131636381
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 0.004591762088239193
. O 0 0.00041266807238571346

Clinical O 1 0.9999485015869141
and O 0 0.0011941395932808518
radiographic O 1 0.9999213218688965
examinations O 0 0.4552980661392212
were O 0 2.996478542627301e-05
performed O 0 0.00036040067789144814
to O 0 4.7883091610856354e-05
establish O 0 0.003668369259685278
diagnoses O 1 0.9999934434890747
, O 0 0.0004080886428710073
and O 0 0.0018039148999378085
disease O 1 1.0
severity O 1 0.9998561143875122
was O 0 0.0016997875645756721
assessed O 0 0.004414828959852457
using O 0 4.9141985073219985e-05
a O 0 0.00016404775669798255
combination O 0 0.0008440031670033932
of O 0 1.29916807054542e-05
validated O 0 0.0038161519914865494
scoring O 0 0.0002567289920989424
systems O 0 0.009416213259100914
. O 0 0.00040492479456588626

HLA O 1 0.9944170713424683
typing O 0 0.017169151455163956
for O 0 0.0011888676090165973
HLA O 1 0.9996652603149414
- O 0 0.011817924678325653
B27 O 0 0.036831412464380264
, O 0 0.001094958046451211
HLA O 1 0.9992380142211914
- O 0 0.007764685899019241
B60 O 0 0.020048415288329124
, O 0 0.0001646028831601143
and O 0 0.0006532416446134448
HLA O 1 0.9999711513519287
- O 0 0.16935601830482483
DR1 O 1 0.9992891550064087
was O 0 0.0012385410955175757
performed O 0 0.0003911846433766186
by O 0 2.209631747973617e-05
polymerase O 0 0.002878750441595912
chain O 0 0.0021483744494616985
reaction O 0 0.00038682049489580095
with O 0 3.178469341946766e-05
sequence O 0 0.0001014598019537516
- O 0 0.0015430304920300841
specific O 0 0.0001770051894709468
primers O 0 0.016516756266355515
, O 0 0.00020425765251275152
and O 0 0.0002322479704162106
zygosity O 1 0.8237805962562561
was O 0 0.0009040606673806906
assessed O 0 0.004044772125780582
using O 0 0.0001530376321170479
microsatellite O 0 0.04790052771568298
markers O 0 0.009179944172501564
. O 0 0.00038132898043841124

Genetic O 0 0.006341526284813881
and O 0 0.00016537027840968221
environmental O 0 0.002878714818507433
variance O 0 0.00027479714481160045
components O 0 0.0007247988251037896
were O 0 3.3986583730438724e-05
assessed O 0 0.003493435913696885
with O 0 3.8866972317919135e-05
the O 0 0.00028386033955030143
program O 0 0.01615382544696331
Mx O 1 0.9957377910614014
, O 0 7.861790800234303e-05
using O 0 3.2699805160518736e-05
data O 0 6.022553861839697e-05
from O 0 3.04932109429501e-05
this O 0 2.5087118046940304e-05
and O 0 5.143392627360299e-05
previous O 0 0.0002437066286802292
studies O 0 0.00022648446611128747
of O 0 2.4350300009245984e-05
twins O 0 0.007789029739797115
with O 0 0.00010361305612605065
AS B-Disease 0 0.027613749727606773
. O 0 0.00044468248961493373

RESULTS O 0 0.0030354417394846678
Six O 0 8.320988854393363e-05
of O 0 1.3431330444291234e-05
8 O 0 0.0020060597453266382
monozygotic O 1 0.9792735576629639
( O 0 0.003925752360373735
MZ O 1 0.9998863935470581
) O 0 0.0008808583952486515
twin O 0 0.007673220243304968
pairs O 0 0.000630960101261735
were O 0 0.00039592149551026523
disease O 1 0.9999991655349731
concordant O 1 0.7720153331756592
, O 0 0.0002708432439249009
compared O 0 0.00043463337351568043
with O 0 3.2471190934302285e-05
4 O 0 0.00019275149679742754
of O 0 9.647819751990028e-06
15 O 0 0.0008679520105943084
B27 O 0 0.045340750366449356
- O 0 0.005583289545029402
positive O 0 0.0034398327115923166
dizygotic O 1 0.967184841632843
( O 0 0.0027492139488458633
DZ O 1 0.9987284541130066
) O 0 0.000945494684856385
twin O 0 0.009279720485210419
pairs O 0 0.0010731397196650505
( O 0 0.0009036249830387533
27 O 0 0.0022398566361516714
% O 0 7.995308988029137e-05
) O 0 0.00011371525033609942
and O 0 5.3574338380713016e-05
4 O 0 0.0002615975390654057
of O 0 1.841310404415708e-05
32 O 0 0.003974705934524536
DZ O 1 0.9985553622245789
twin O 0 0.011711860075592995
pairs O 0 0.00044539416558109224
overall O 0 0.0039001875557005405
( O 0 0.0006013625534251332
12 O 0 0.0008001533569768071
. O 0 8.895927749108523e-05
5 O 0 0.00038676976691931486
% O 0 6.357837992254645e-05
) O 0 0.00018270895816385746
. O 0 0.0002893994387704879

Nonsignificant O 1 0.9560542106628418
increases O 0 0.0020491748582571745
in O 0 8.188815991161391e-05
similarity O 0 0.00032121475669555366
with O 0 3.7695928767789155e-05
regard O 0 0.0008690670947544277
to O 0 9.788859460968524e-05
age O 0 0.001536868279799819
at O 0 0.034285061061382294
disease O 1 1.0
onset O 1 0.9999397993087769
and O 0 5.2646446420112625e-05
all O 0 5.957729626970831e-06
of O 0 1.290187083213823e-05
the O 0 0.0020702159963548183
disease O 1 1.0
severity O 1 0.9998109936714172
scores O 0 0.0011166458716616035
assessed O 0 0.0034959837794303894
were O 0 1.4091418961470481e-05
noted O 0 0.00044117195648141205
in O 0 0.0007940075010992587
disease O 1 0.9999998807907104
- O 0 0.2191060483455658
concordant O 1 0.9859269857406616
MZ O 1 0.9998706579208374
twins O 0 0.013055354356765747
compared O 0 0.0005881203687749803
with O 0 0.0002585659094620496
concordant O 1 0.986586332321167
DZ O 1 0.9999185800552368
twins O 0 0.03973861783742905
. O 0 0.0004488875565584749

HLA O 1 0.9997931122779846
- O 0 0.02874538116157055
B27 O 0 0.03753130882978439
and O 0 0.00020987547759432346
B60 O 0 0.019471336156129837
were O 0 1.9731152860913426e-05
associated O 0 8.514376531820744e-05
with O 0 4.0816150431055576e-05
the O 0 0.0011028816225007176
disease O 1 0.9999998807907104
in O 0 0.0005791365401819348
probands O 1 0.9877107739448547
, O 0 0.00013335782568901777
and O 0 2.5289828045060858e-05
the O 0 3.8360507460311055e-05
rate O 0 0.00011502305278554559
of O 0 9.469440556131303e-05
disease O 1 0.9999991655349731
concordance O 0 0.0103864511474967
was O 0 0.0009622968500480056
significantly O 0 0.002729416359215975
increased O 0 0.0003748440067283809
among O 0 0.0004842421622015536
DZ O 1 0.9998345375061035
twin O 0 0.011849350295960903
pairs O 0 0.0002671453694347292
in O 0 5.824719846714288e-05
which O 0 3.1956322345649824e-05
the O 0 0.0003437300038058311
co O 0 0.1259763240814209
- O 0 0.009401858784258366
twin O 0 0.006553933024406433
was O 0 0.0003857139381580055
positive O 0 0.0002411686145933345
for O 0 5.266266452963464e-05
both O 0 0.00013003281492274255
B27 O 0 0.08632302284240723
and O 0 0.0006782282725907862
DR1 O 1 0.9998834133148193
. O 0 0.0009254986071027815

Additive O 0 0.01488085649907589
genetic O 0 0.003219399368390441
effects O 0 0.002650225767865777
were O 0 2.8154436222393997e-05
estimated O 0 0.00024215062148869038
to O 0 7.047282269923016e-05
contribute O 0 0.004464122466742992
97 O 0 0.0038537797518074512
% O 0 1.2350075849099085e-05
of O 0 3.5264883990748785e-06
the O 0 4.394205825519748e-05
population O 0 3.500104867271148e-05
variance O 0 0.0003475288103800267
. O 0 0.0003657365741673857

CONCLUSION O 0 0.02719779498875141
Susceptibility O 1 0.8296346664428711
to O 0 0.00018580273899715394
AS B-Disease 0 0.005916972644627094
is O 0 0.00017614888201933354
largely O 0 0.00031153816962614655
genetically O 0 0.0007292017107829452
determined O 0 0.0011990942293778062
, O 0 7.53784115659073e-05
and O 0 3.438581552472897e-05
the O 0 9.697317000245675e-05
environmental O 0 0.004657534416764975
trigger O 0 0.003310393774881959
for O 0 0.00015094663831405342
the O 0 0.0010128587018698454
disease O 1 0.9999997615814209
is O 0 0.0005170732620172203
probably O 0 0.0012561535695567727
ubiquitous O 0 0.012519043870270252
. O 0 0.00042138848220929503

HLA O 1 0.999841570854187
- O 0 0.022636575624346733
B27 O 0 0.023106666281819344
accounts O 0 9.569108806317672e-05
for O 0 6.172377470647916e-05
a O 0 0.000242603084188886
minority O 0 0.00018736171477939934
of O 0 4.331393029133324e-06
the O 0 0.00010101467341883108
overall O 0 0.00302169774658978
genetic O 0 0.0038010748103260994
susceptibility O 0 0.13207875192165375
to O 0 0.00023301829060073942
AS B-Disease 0 0.013555694371461868
. O 0 0.0003104482311755419

Cell O 0 0.010683738626539707
cycle O 0 0.0035813285503536463
- O 0 0.0032142254058271646
dependent O 0 0.0018492919625714421
colocalization O 0 0.038611654192209244
of O 0 0.00010889098484767601
BARD1 O 1 0.9973764419555664
and O 0 0.0005400152294896543
BRCA1 O 1 0.9900907278060913
proteins O 0 4.787519355886616e-05
in O 0 3.424526221351698e-05
discrete O 0 0.0010808140505105257
nuclear O 0 0.0038265190087258816
domains O 0 0.0025940085761249065
. O 0 0.0004110212903469801

Germ O 1 0.9996806383132935
- O 0 0.009662638418376446
line O 0 0.0007402622140944004
mutations O 0 0.00021079074940644205
of O 0 6.012410267430823e-06
the O 0 0.00046148686669766903
BRCA1 O 1 0.9999085664749146
gene O 0 0.005250995047390461
predispose O 0 0.31374391913414
women O 0 0.00027302472153678536
to O 0 4.047362017445266e-05
early O 0 0.0007592399488203228
- O 1 0.9549273252487183
onset O 1 0.9999982118606567
breast B-Disease 1 1.0
and I-Disease 1 0.9886994957923889
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.00012993428390473127
compromising O 0 0.045959897339344025
the O 0 0.0001520570949651301
genes O 0 0.00045020956895314157
presumptive O 0 0.3808770775794983
function O 0 0.0003614101151470095
as O 0 0.0001387658849125728
a O 0 0.001870040432550013
tumor B-Disease 1 0.9999791383743286
suppressor O 0 0.06377948075532913
. O 0 0.0003868472413159907

Although O 0 0.0005639406153932214
the O 0 9.55705254455097e-05
biochemical O 0 0.006570552475750446
properties O 0 0.0008425194537267089
of O 0 9.27576984395273e-05
BRCA1 O 1 0.9997426867485046
polypeptides O 0 0.006734713912010193
are O 0 2.724086334637832e-05
not O 0 0.0001151202741311863
understood O 0 0.0026855922769755125
, O 0 5.078593676444143e-05
their O 0 1.7373178707202896e-05
expression O 0 0.0006739768432453275
pattern O 0 0.0029960647225379944
and O 0 0.00013108478742651641
subcellular O 0 0.009319476783275604
localization O 0 0.007605578284710646
suggest O 0 0.0004353513359092176
a O 0 0.0001493320451118052
role O 0 0.0008887528674677014
in O 0 0.00018534145783632994
cell O 0 0.0038818095345050097
- O 0 0.002543484326452017
cycle O 0 0.0009724192786961794
regulation O 0 0.001213810290209949
. O 0 0.00034324306761845946

When O 0 0.0030451903585344553
resting O 0 0.22792676091194153
cells O 0 0.0021726058330386877
are O 0 3.527851731632836e-05
induced O 0 0.04096578061580658
to O 0 0.00017004173423629254
proliferate O 0 0.015913259238004684
, O 0 6.365389708662406e-05
the O 0 0.00010394317359896377
steady O 0 0.006458092946559191
- O 0 0.0013939901255071163
state O 0 4.709889253717847e-05
levels O 0 0.0006306145223788917
of O 0 3.3646461815806106e-05
BRCA1 O 1 0.998362123966217
increase O 0 0.0005178336286917329
in O 0 0.0003017200797330588
late O 0 0.00479973666369915
G1 O 1 0.9921610951423645
and O 0 5.4520034609595314e-05
reach O 0 0.00012189181870780885
a O 0 7.352582179009914e-05
maximum O 0 0.0003059611772187054
during O 0 0.0018613303545862436
S O 1 0.7804843783378601
phase O 0 0.011854696087539196
. O 0 0.0002563171146903187

Moreover O 0 0.007348089944571257
, O 0 0.0002284056245116517
in O 0 0.0003063496551476419
S O 1 0.726929247379303
phase O 0 0.011722930707037449
cells O 0 0.0030954843387007713
, O 0 0.0004904252709820867
BRCA1 O 1 0.998296320438385
polypeptides O 0 0.005299841053783894
are O 0 6.987083907006308e-05
hyperphosphorylated O 0 0.24814824759960175
and O 0 0.00012714750482700765
accumulate O 0 0.005111468955874443
into O 0 7.328746869461611e-05
discrete O 0 0.0023816705215722322
subnuclear O 0 0.3653465211391449
foci O 0 0.10141697525978088
termed O 0 0.1550351083278656
" O 0 0.004057682119309902
BRCA1 O 1 0.997247040271759
nuclear O 0 0.012141082435846329
dots O 0 0.03612523153424263
. O 0 0.00043077708687633276

" O 0 0.01349987555295229
BRCA1 O 1 0.999784529209137
associates O 1 0.956894040107727
in O 0 0.00024641602067276835
vivo O 0 0.0033923438750207424
with O 0 2.4788772861938924e-05
a O 0 0.00040748840547166765
structurally O 0 0.06343385577201843
related O 0 0.0007198810344561934
protein O 0 0.0011443437542766333
termed O 1 0.7813952565193176
BARD1 O 1 0.9986914992332458
. O 0 0.0007961762603372335

Here O 0 0.0006716615171171725
we O 0 9.560736361891031e-05
show O 0 0.00010716750693973154
that O 0 1.0906998795690015e-05
the O 0 6.35809192317538e-05
steady O 0 0.006844215095043182
- O 0 0.001630159909836948
state O 0 6.977535667829216e-05
levels O 0 0.0010584460105746984
of O 0 5.0757949793478474e-05
BARD1 O 1 0.999104917049408
, O 0 0.00022192108735907823
unlike O 0 0.0004091007576789707
those O 0 2.5633504264988005e-05
of O 0 8.824079850455746e-05
BRCA1 O 1 0.9999160766601562
, O 0 0.0003096731670666486
remain O 0 0.0004126507556065917
relatively O 0 0.00025513555738143623
constant O 0 0.0003881162265315652
during O 0 0.0009388268226757646
cell O 0 0.003362856339663267
cycle O 0 0.00420839199796319
progression O 1 0.9844150543212891
. O 0 0.0005272411508485675

However O 0 0.0009690477163530886
, O 0 0.00035396614111959934
immunostaining O 1 0.8005053997039795
revealed O 0 0.006009340286254883
that O 0 0.00013372990360949188
BARD1 O 1 0.9970613121986389
resides O 0 0.007470639422535896
within O 0 0.00030472135404124856
BRCA1 O 1 0.9979149699211121
nuclear O 0 0.010344707407057285
dots O 0 0.027059728279709816
during O 0 0.0029914421029388905
S O 0 0.11846549063920975
phase O 0 0.0013543415116146207
of O 0 5.832337592437398e-06
the O 0 0.00013058401236776263
cell O 0 0.002994332928210497
cycle O 0 0.0009736180072650313
, O 0 7.247350731631741e-05
but O 0 5.456861254060641e-05
not O 0 3.734691927093081e-05
during O 0 0.000361618644092232
the O 0 0.00045957393012940884
G1 O 1 0.9983223080635071
phase O 0 0.012314564548432827
. O 0 0.00042569098877720535

Nevertheless O 0 0.018915114924311638
, O 0 0.001130449352785945
BARD1 O 1 0.976355791091919
polypeptides O 0 0.0049373311921954155
are O 0 2.1352872863644734e-05
found O 0 9.760374086908996e-05
exclusively O 0 0.00014371149882208556
in O 0 4.027879549539648e-05
the O 0 3.966520671383478e-05
nuclear O 0 0.0005116332904435694
fractions O 0 9.274248441215605e-05
of O 0 7.663767064514104e-06
both O 0 0.00046483249752782285
G1 O 1 0.9982771873474121
- O 0 0.0060600400902330875
and O 0 0.00031779403798282146
S O 1 0.9224483370780945
- O 0 0.004464512690901756
phase O 0 0.007268879096955061
cells O 0 0.0024890820495784283
. O 0 0.00018256023759022355

Therefore O 0 0.0017335278680548072
, O 0 0.00045362047967500985
progression O 1 0.5487583875656128
to O 0 0.00046590378042310476
S O 1 0.907090425491333
phase O 0 0.008612648583948612
is O 0 0.00017817392654251307
accompanied O 0 0.00030082851299084723
by O 0 8.793146662355866e-06
the O 0 3.856422335957177e-05
aggregation O 0 0.0008259985479526222
of O 0 2.2968273697188124e-05
nuclear O 0 0.008269473910331726
BARD1 O 1 0.9720879793167114
polypeptides O 0 0.00300605152733624
into O 0 0.00043432440725155175
BRCA1 O 1 0.9982207417488098
nuclear O 0 0.01177537813782692
dots O 0 0.034417085349559784
. O 0 0.00043665498378686607

This O 0 0.0001799663732526824
cell O 0 0.0024587835650891066
cycle O 0 0.00216845003888011
- O 0 0.002137043746188283
dependent O 0 0.001273270696401596
colocalization O 0 0.03132706135511398
of O 0 6.746525468770415e-05
BARD1 O 1 0.999406099319458
and O 0 0.0007062651566229761
BRCA1 O 1 0.9991649389266968
indicates O 0 0.0011001501698046923
a O 0 0.00011006218119291589
role O 0 0.0005978716653771698
for O 0 0.000273691926850006
BARD1 O 1 0.9957113265991211
in O 0 0.000627095636446029
BRCA1 O 1 0.9998511075973511
- O 0 0.037230268120765686
mediated O 1 0.8057737350463867
tumor B-Disease 1 0.999983549118042
suppression O 0 0.02831396833062172
. O 0 0.0004665702290367335

Ethnic O 0 0.00033023583819158375
differences O 0 0.0005447480943985283
in O 0 9.705319826025516e-05
the O 0 0.000452700856840238
HFE O 1 0.9981921315193176
codon O 0 0.01705419458448887
282 O 0 0.05746699124574661
( O 0 0.004275802057236433
Cys O 1 0.9999843835830688
/ O 1 0.9937025308609009
Tyr O 1 0.9992285966873169
) O 0 0.00031527000828646123
polymorphism O 0 0.001822093385271728
. O 0 0.0002475468209013343

Recent O 0 0.001321180141530931
studies O 0 0.00024651430430822074
have O 0 1.6618345398455858e-05
shown O 0 0.00021590084361378103
that O 0 0.0003025473852176219
hereditary B-Disease 1 0.9999992847442627
hemochromatosis I-Disease 1 1.0
( O 0 0.4174706041812897
HH B-Disease 1 0.9999998807907104
) O 0 0.0007455876329913735
is O 0 0.00023594472440890968
likely O 0 0.00031714027863927186
to O 0 2.7074593162979e-05
be O 0 5.8008507039630786e-05
caused O 0 0.00197428441606462
by O 0 4.666847598855384e-05
homozygosity O 0 0.07896079868078232
for O 0 0.00013010027760174125
a O 0 0.0007529419381171465
Cys282Tyr O 1 0.5920743942260742
mutation O 0 0.0006961433682590723
in O 0 5.257345037534833e-05
the O 0 0.0003493724507279694
HFE O 1 0.999535083770752
gene O 0 0.003036340931430459
located O 0 0.00126941769849509
4 O 0 0.0007796037243679166
. O 0 0.00021052906231489033

5 O 0 0.003918914590030909
Mb O 1 0.6238078474998474
telomeric O 1 0.6036918759346008
to O 0 0.000825989933218807
HLA O 1 0.9995443224906921
- O 0 0.006127225235104561
A O 0 0.0028390963561832905
. O 0 0.00032253487734124064

Population O 0 0.00014230275701265782
studies O 0 0.00016584194963797927
of O 0 5.372352916310774e-06
this O 0 3.280324744991958e-05
polymorphism O 0 0.0011541905114427209
are O 0 2.5089293558266945e-05
facilitated O 0 0.004155245143920183
by O 0 2.3255995984072797e-05
the O 0 8.18016123957932e-05
fact O 0 0.000190433842362836
that O 0 2.3207870981423184e-05
the O 0 0.00017414403555449098
Cys282Tyr O 1 0.8802683353424072
mutation O 0 0.0011161949951201677
creates O 0 0.0012352560879662633
a O 0 0.0005914416979067028
Rsal O 0 0.16109029948711395
restriction O 0 0.0010622431291267276
site O 0 0.0019641791004687548
. O 0 0.00022914221335668117

We O 0 0.0003075583081226796
have O 0 2.4066663172561675e-05
studied O 0 0.0001417936000507325
the O 0 6.386420864146203e-05
codon O 0 0.004778541158884764
282 O 0 0.04102974757552147
( O 0 0.004378963261842728
Cys O 1 0.9999706745147705
/ O 1 0.9945594668388367
Tyr O 1 0.9993484616279602
) O 0 0.00035099813248962164
polymorphism O 0 0.0007775389240123332
in O 0 2.930678783741314e-05
different O 0 3.698639829963213e-06
ethnic O 0 2.646094981173519e-05
groups O 0 4.6365410526050255e-05
. O 0 0.00029921013629063964

In O 0 0.0004995705094188452
agreement O 0 0.0006908511277288198
with O 0 2.5724453735165298e-05
previous O 0 0.00020480839884839952
observations O 0 0.0006458723219111562
the O 0 0.0004886431852355599
Tyr O 1 0.9997575879096985
allele O 0 0.009187688119709492
appeared O 0 0.001084464485757053
to O 0 3.479411680018529e-05
be O 0 5.840031735715456e-05
rare O 0 0.002169310813769698
or O 0 0.00048354591126553714
absent O 0 0.008446672931313515
in O 0 0.0003990997211076319
Asiatic O 1 0.9476398229598999
( O 0 0.0008399831713177264
Indian O 0 0.0006489349179901183
, O 0 0.00011103694123448804
Chinese O 0 0.00031838356517255306
) O 0 0.00012118416634621099
populations O 0 0.0002890723990276456
. O 0 0.0002198757865699008

The O 0 0.00039992350502870977
highest O 0 0.003838815027847886
allele O 0 0.0030396319925785065
frequency O 0 0.0007341340533457696
( O 0 0.0007046227692626417
7 O 0 0.0009306396823376417
. O 0 6.993942952249199e-05
5 O 0 0.00030943204183131456
% O 0 4.547512435237877e-05
) O 0 0.00011747968528652564
was O 0 0.00048066064482554793
found O 0 0.00010355180711485445
in O 0 9.423948358744383e-05
Swedes O 0 0.005236151162534952
. O 0 0.000307186390273273

Saamis O 1 0.8314906358718872
( O 0 0.0008472015615552664
2 O 0 0.0006162495701573789
% O 0 5.287431849865243e-05
) O 0 0.00012734481424558908
and O 0 0.00026316128787584603
Mordvinians O 1 0.9808422327041626
( O 0 0.0006838353001512587
1 O 0 0.0011490893084555864
. O 0 9.701127419248223e-05
8 O 0 0.000453769025625661
% O 0 6.0972903156653047e-05
) O 0 0.00017895817290991545
had O 0 0.0005772188305854797
significantly O 0 0.003547652391716838
lower O 0 0.000838451087474823
frequencies O 0 3.6269339034333825e-05
of O 0 8.168308340827934e-06
the O 0 0.0005749691626988351
Tyr O 1 0.9982607960700989
allele O 0 0.013451457023620605
. O 0 0.0005273969727568328

Comparisons O 0 0.0009490533266216516
with O 0 5.959777263342403e-05
allele O 0 0.001512375078164041
frequencies O 0 0.00010127729910891503
based O 0 9.848406625678763e-05
on O 0 0.0002778584894258529
prevalence O 1 0.9106339812278748
estimates O 0 0.0007562436512671411
of O 0 0.00020508568559307605
HH B-Disease 1 0.9999995231628418
showed O 0 0.0024759701918810606
some O 0 4.6875527914380655e-05
disagreements O 0 0.0034717395901679993
with O 0 5.8358673413749784e-05
the O 0 0.00030423252610489726
RFLP O 1 0.9353128671646118
data O 0 0.0001608685270184651
, O 0 0.00012743602565024048
particularly O 0 0.0006167558021843433
in O 0 0.00019870985124725848
Finns O 0 0.020599331706762314
. O 0 0.00048002987750805914

The O 0 0.0007789221126586199
newly O 0 0.005939497612416744
described O 0 0.013647389598190784
HFE O 1 0.9994376301765442
marker O 0 0.023097559809684753
provides O 0 0.0017669103108346462
a O 0 0.000232518941629678
new O 0 0.00012875224638264626
approach O 0 0.000987360836006701
to O 0 2.467283047735691e-05
the O 0 6.960536120459437e-05
screening O 0 0.0045995404943823814
of O 0 0.00019680372497532517
HH B-Disease 1 0.9999996423721313
as O 0 0.00035886300611309707
well O 0 0.0001171977273770608
as O 0 0.00010349415970267728
studies O 0 0.00014663138426840305
of O 0 5.352092102839379e-06
the O 0 0.00013350197696126997
relationship O 0 0.0022687821183353662
between O 0 0.00015392347995657474
the O 0 0.001082422910258174
HFE O 1 0.9999881982803345
Tyr O 1 0.9995031356811523
allele O 0 0.006200842559337616
and O 0 9.97406750684604e-05
different O 0 0.00012507199426181614
disorders O 1 0.9999998807907104
including O 0 0.007340783253312111
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9984221458435059
dominant I-Disease 1 0.9948351383209229
neurohypophyseal I-Disease 1 0.999997615814209
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
associated O 0 0.0008566059404984117
with O 0 2.8264301363378763e-05
a O 0 0.00031723282882012427
missense O 0 0.005997020751237869
mutation O 0 0.0007556068594567478
encoding O 0 0.000919862650334835
Gly23 O 1 0.9786010980606079
- O 0 0.015378476120531559
- O 0 0.01032930240035057
> O 0 0.02231631614267826
Val O 1 0.9624205827713013
in O 0 0.0004727201594505459
neurophysin O 1 0.9940980672836304
II O 1 0.9953226447105408
. O 0 0.0006132854032330215

Autosomal B-Disease 1 0.9955757856369019
dominant I-Disease 1 0.9455817937850952
neurohypophyseal I-Disease 1 0.9999877214431763
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
( O 0 0.0038903853856027126
ADNDI B-Disease 1 0.9995741248130798
) O 0 0.00016181125829461962
is O 0 0.000162046097102575
an O 0 0.0012339354725554585
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.18794582784175873
by O 0 0.00015982000331860036
progressive O 1 0.9996260404586792
degeneration O 1 0.9999996423721313
of O 0 3.886356353177689e-05
the O 0 0.0004364964261185378
magnocellular O 1 0.9894864559173584
neurons O 0 0.004474553279578686
of O 0 1.367536788166035e-05
the O 0 0.00034472858533263206
hypothalamus O 1 0.9808217883110046
leading O 0 0.00209081475622952
to O 0 0.00012597674503922462
decreased O 0 0.0074147190898656845
ability O 0 0.0007627651793882251
to O 0 1.891067950055003e-05
produce O 0 3.999787804787047e-05
the O 0 0.000140169431688264
hormone O 0 0.44192835688591003
arginine O 0 0.08182870596647263
vasopressin O 1 0.9632309675216675
( O 0 0.0036031014751642942
AVP O 1 0.9999566078186035
) O 0 0.0005431534955278039
. O 0 0.00031352913356386125

Affected O 0 0.010498225688934326
individuals O 0 0.00015527776849921793
are O 0 2.384897379670292e-05
not O 0 0.0003221012884750962
symptomatic O 1 0.9999747276306152
at O 0 0.0014926474541425705
birth O 0 0.0012998768361285329
, O 0 0.0001019218543660827
but O 0 0.00011872795585077256
usually O 0 0.000570931879337877
develop O 1 0.9995496869087219
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999945163726807
at O 0 0.0026066231075674295
1 O 0 0.0020187487825751305
- O 0 0.004448004066944122
6 O 0 0.0015535480342805386
yr O 1 0.6625895500183105
of O 0 2.739527371886652e-05
age O 0 0.0011184322647750378
. O 0 0.0003213170566596091

The O 0 0.000416024646256119
genetic O 0 0.0010237118694931269
locus O 0 0.0032584425061941147
of O 0 1.950195110111963e-05
the O 0 0.0009238392231054604
disease O 1 0.9999996423721313
is O 0 0.0003259661898482591
the O 0 0.0005694314604625106
AVP O 1 0.9999938011169434
- O 0 0.0312032513320446
neurophysin O 1 0.9374808669090271
II O 1 0.995427131652832
( O 0 0.0021401785779744387
NPII O 1 0.9989593029022217
) O 0 0.00034365852479822934
gene O 0 0.0008755014277994633
, O 0 7.148837175918743e-05
and O 0 7.454009755747393e-05
mutations O 0 0.001026590820401907
that O 0 9.949027298716828e-05
cause O 1 0.9391077160835266
ADNDI B-Disease 1 0.9997758269309998
have O 0 0.00011448469740571454
been O 0 0.0001491927105234936
found O 0 7.12153923814185e-05
in O 0 2.5360783183714375e-05
both O 0 1.8979406377184205e-05
the O 0 3.996447776444256e-05
signal O 0 0.0004838725726585835
peptide O 0 0.0003312495246063918
of O 0 5.244171006779652e-06
the O 0 0.00022828631335869431
prepro O 1 0.9945947527885437
- O 0 0.08473975956439972
AVP O 1 0.9999252557754517
- O 0 0.019235923886299133
NPII O 1 0.9403069615364075
precursor O 0 0.007643989287316799
and O 0 6.941425817785785e-05
within O 0 0.0002612884563859552
NPII O 1 0.9960989952087402
itself O 0 0.004827957134693861
. O 0 0.0003367773024365306

An O 0 0.001696313265711069
affected O 0 0.017413994297385216
girl O 0 0.033830367028713226
who O 0 0.0006673192256130278
presented O 0 0.0010625649010762572
at O 0 0.0010070743737742305
9 O 0 0.0012194877490401268
months O 0 0.00040684023406356573
of O 0 1.1054302376578562e-05
age O 0 0.0006265410338528454
and O 0 0.00012997182784602046
her O 0 0.0013783782487735152
similarly O 0 0.00671997107565403
affected O 0 0.017172377556562424
younger O 0 0.009522099047899246
brother O 0 0.004697210621088743
and O 0 0.0002872525656130165
father O 0 0.0015391435008496046
were O 0 1.7446165657020174e-05
all O 0 1.4345163435791619e-05
found O 0 8.377381163882092e-05
to O 0 1.2804716789105441e-05
have O 0 1.161053114628885e-05
a O 0 0.00014466622087638825
novel O 0 0.0012209410779178143
missense O 0 0.01199833583086729
mutation O 0 0.002186643425375223
( O 0 0.0007252341019921005
G1758 O 0 0.16406811773777008
- O 0 0.021918145939707756
- O 0 0.01773844286799431
> O 0 0.04284839332103729
T O 1 0.8547431230545044
) O 0 3.491637107799761e-05
encoding O 0 3.4370346838841215e-05
the O 0 1.5829047697479837e-05
amino O 0 9.278424113290384e-05
acid O 0 0.002278387313708663
substitution O 0 0.0010393101256340742
Gly23 O 1 0.9722813367843628
- O 0 0.01320410706102848
- O 0 0.009647510014474392
> O 0 0.020342040807008743
Val O 1 0.8897421956062317
within O 0 0.00046366776223294437
NPII O 1 0.9823562502861023
. O 0 0.0008143545710481703

The O 0 0.0006131100235506892
mutation O 0 0.002812647493556142
was O 0 0.0010224670404568315
confirmed O 0 0.0005396465421654284
by O 0 1.1443103176134173e-05
restriction O 0 0.00039878307143226266
endonuclease O 0 0.03626440092921257
analysis O 0 0.0006286545540206134
. O 0 0.0003822720318567008

A O 0 0.023367989808321
T1 O 1 0.9994451403617859
- O 0 0.003876087022945285
weighted O 0 0.00048232392873615026
magnetic O 0 0.0008885242859832942
resonance O 0 0.005465139169245958
imaging O 0 0.0480441115796566
of O 0 1.039724793372443e-05
the O 0 0.00021194799046497792
fathers O 0 0.005942516960203648
pituitary O 1 0.9998276233673096
gland O 1 0.9989283680915833
demonstrates O 0 0.008200101554393768
an O 0 0.0004196204827167094
attenuated O 1 0.9886301755905151
posterior O 1 0.9996432065963745
pituitary O 1 0.9999589920043945
bright O 1 0.983805775642395
spot O 0 0.011500990949571133
. O 0 0.00040644925320520997

This O 0 0.00027911883080378175
mutation O 0 0.003093278966844082
may O 0 0.0004665046581067145
be O 0 2.445819518470671e-05
valuable O 0 0.0006626688991673291
for O 0 8.347064431291074e-05
developing O 0 0.0017728691454976797
models O 0 0.00021390916663222015
of O 0 5.19612840435002e-05
dominantly B-Disease 1 0.9994064569473267
inherited I-Disease 1 0.9999877214431763
neurodegeneration I-Disease 1 0.9999998807907104
, O 0 0.0004055907775182277
as O 0 9.975969442166388e-05
the O 0 7.761082088109106e-05
early O 0 0.00034500594483688474
age O 0 0.0002554110833443701
of O 0 4.538470602710731e-05
onset O 1 0.9999648332595825
of O 0 0.0003424955066293478
symptoms O 1 0.9999998807907104
suggests O 0 0.0019553673919290304
that O 0 2.5236484361812472e-05
this O 0 3.603032746468671e-05
mutation O 0 0.001783813931979239
may O 0 0.0004949264694005251
be O 0 3.833586015389301e-05
particularly O 0 0.0004830760008189827
deleterious O 0 0.011262398213148117
to O 0 4.686738975578919e-05
the O 0 0.0003104322822764516
magnocellular O 1 0.9989845156669617
neuron O 1 0.9890670776367188
. O 0 0.00021526751515921205
. O 0 0.00024149168166331947

Frequent O 0 0.014315469190478325
inactivation O 0 0.06913471221923828
of O 0 0.00030009032343514264
PTEN O 1 0.9999940395355225
/ O 1 0.9861246943473816
MMAC1 O 1 0.9966995120048523
in O 0 0.0005815880722366273
primary O 1 0.9999434947967529
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0008772300207056105

Sporadic B-Disease 1 0.9991544485092163
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.0004899823106825352
the O 0 5.468780000228435e-05
most O 0 0.00017305072105955333
common O 0 0.0041128830052912235
male B-Disease 0 0.17816603183746338
cancer I-Disease 1 0.9999998807907104
in O 0 0.00013466902601066977
the O 0 0.00019758418784476817
Western O 0 0.001653379062190652
world O 0 0.0009096736903302372
, O 0 0.0001907016703626141
yet O 0 0.00016876551671884954
many O 0 6.186425707710441e-06
of O 0 4.846391220780788e-06
the O 0 0.00011669746891129762
major O 0 0.0021606681402772665
genetic O 0 0.0010618236847221851
events O 0 0.00014217729039955884
involved O 0 0.00038308740477077663
in O 0 5.7633624237496406e-05
the O 0 0.00011109298066003248
progression O 0 0.03207404538989067
of O 0 8.089067705441266e-06
this O 0 7.885201193857938e-05
often O 0 0.0032311989925801754
fatal O 1 0.9999998807907104
cancer B-Disease 1 1.0
remain O 0 0.000786305929068476
to O 0 3.420873690629378e-05
be O 0 8.369141141884029e-05
elucidated O 0 0.05681954696774483
. O 0 0.00027657579630613327

Numerous O 0 0.0037332861684262753
cytogenetic O 1 0.9891961812973022
and O 0 0.0008452269248664379
allelotype O 1 0.9776061773300171
studies O 0 0.0009947132784873247
have O 0 0.00010557322821114212
reported O 0 0.0016408319352194667
frequent O 0 0.002592730801552534
loss O 0 0.0024304790422320366
of O 0 3.562735946616158e-05
heterozygosity O 1 0.9835866093635559
on O 0 0.0005330609274096787
chromosomal O 0 0.042281124740839005
arm O 1 0.9807378649711609
10q O 0 0.07710497081279755
in O 0 0.0005879317759536207
sporadic B-Disease 1 0.9995726943016052
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0010129304137080908

Deletion O 0 0.02420910820364952
mapping O 0 0.007935685105621815
studies O 0 0.0009547334047965705
have O 0 8.649451774545014e-05
unambiguously O 0 0.012695890851318836
identified O 0 0.00036074095987714827
a O 0 0.00014879065565764904
region O 0 0.00037307609454728663
of O 0 2.3004886315902695e-05
chromosome O 0 0.004411401227116585
10q23 O 0 0.0253400057554245
to O 0 3.8816222513560206e-05
be O 0 1.8587626982480288e-05
the O 0 3.7093483115313575e-05
minimal O 0 0.002051166957244277
area O 0 0.0005119044799357653
of O 0 1.772012001310941e-05
loss O 0 0.023148223757743835
. O 0 0.0005709656979888678

A O 0 0.0030824874993413687
new O 0 0.001049074693582952
tumor B-Disease 1 0.9999667406082153
suppressor O 0 0.03911476209759712
gene O 0 0.0021912259981036186
, O 0 0.0011548458132892847
PTEN O 1 0.9999860525131226
/ O 1 0.991089940071106
MMAC1 O 1 0.9977572560310364
, O 0 0.0004971852758899331
was O 0 0.0018631359562277794
isolated O 0 0.014134442433714867
recently O 0 0.0037987118121236563
at O 0 0.0002670078829396516
this O 0 1.7373444279655814e-05
region O 0 0.00028668949380517006
of O 0 1.8467513655195944e-05
chromosome O 0 0.004436199087649584
10q23 O 0 0.0479254350066185
and O 0 9.983867494156584e-05
found O 0 9.790791955310851e-05
to O 0 2.3710415916866623e-05
be O 0 3.9040409319568425e-05
inactivated O 0 0.00910660345107317
by O 0 1.0471600035089068e-05
mutation O 0 0.0003371886850800365
in O 0 9.172208228847012e-05
three O 0 0.002186086028814316
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.008567791432142258
lines O 0 0.0012573879212141037
. O 0 0.00026001507649198174

We O 0 0.0006014729151502252
screened O 0 0.006842322647571564
80 O 0 0.021418873220682144
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999992847442627
by O 0 9.645165846450254e-05
microsatellite O 0 0.024289283901453018
analysis O 0 0.00030091084772720933
and O 0 0.00010420756734674796
found O 0 0.0003212174924556166
chromosome O 0 0.0020682543981820345
10q23 O 0 0.015408064238727093
to O 0 5.2887782658217475e-05
be O 0 3.817319156951271e-05
deleted O 0 0.0008624630863778293
in O 0 8.081174019025639e-05
23 O 0 0.001270381617359817
cases O 0 0.0014700782485306263
. O 0 0.0003978802706114948

We O 0 0.0009293730254285038
then O 0 0.00027304451214149594
proceeded O 0 0.0005720867193304002
with O 0 7.296080184460152e-06
sequence O 0 1.272797817364335e-05
analysis O 0 2.5750323402462527e-05
of O 0 4.767525751958601e-06
the O 0 0.0002026651636697352
entire O 0 0.039845842868089676
PTEN O 1 0.999984860420227
/ O 1 0.9824512600898743
MMAC1 O 1 0.984918475151062
coding O 0 0.016726898029446602
region O 0 0.0023473238106817007
and O 0 0.00015295781486202031
tested O 0 0.006310970056802034
for O 0 0.0001288542989641428
homozygous O 0 0.002717699157074094
deletion O 0 0.002520923037081957
with O 0 6.26270702923648e-05
new O 0 0.0005723427748307586
intragenic O 1 0.9642265439033508
markers O 0 0.003645221469923854
in O 0 3.890939842676744e-05
these O 0 1.699123822618276e-05
23 O 0 0.0010121563682332635
cases O 0 0.0006343016866594553
with O 0 0.00010341365123167634
10q23 O 0 0.15047241747379303
loss O 0 0.0039801509119570255
of O 0 6.990050314925611e-05
heterozygosity O 1 0.991576611995697
. O 0 0.0007410548278130591

The O 0 0.00022803372121416032
identification O 0 0.00011909782915608957
of O 0 4.57957594335312e-06
the O 0 8.011014870135114e-05
second O 0 0.0005482458509504795
mutational O 0 0.08977077156305313
event O 0 0.0008894237689673901
in O 0 0.0001334592088824138
10 O 0 0.00034324111766181886
( O 0 0.00024899738491512835
43 O 0 0.0009456127299927175
% O 0 0.00010450618719914928
) O 0 0.0013010062975808978
tumors B-Disease 1 0.9999998807907104
establishes O 1 0.999392032623291
PTEN O 1 0.9999971389770508
/ O 1 0.9948091506958008
MMAC1 O 1 0.988373875617981
as O 0 0.00013315121759660542
a O 0 0.000280899228528142
main O 0 0.0013912208378314972
inactivation O 0 0.04528055340051651
target O 0 0.00019361833983566612
of O 0 1.5432044165208936e-05
10q O 0 0.0378023236989975
loss O 0 0.004337568301707506
in O 0 0.0005248639499768615
sporadic B-Disease 1 0.9996986389160156
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0003895185946021229
. O 0 0.00022571851150132716

Risk O 0 0.4192228317260742
reversals O 0 0.01435061451047659
in O 0 0.00010249503975501284
predictive O 0 0.013821084052324295
testing O 0 0.02076701819896698
for O 0 0.0050591942854225636
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0011074244976043701

The O 0 0.0001523108803667128
first O 0 0.0001143564804806374
predictive O 0 0.008939860388636589
testing O 0 0.007767817471176386
for O 0 0.0030895480886101723
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.003931011538952589
HD B-Disease 1 0.9978281855583191
) O 0 0.0002678556484170258
was O 0 0.00036606096546165645
based O 0 3.123126589343883e-05
on O 0 2.592002783785574e-05
analysis O 0 5.3118823416298255e-05
of O 0 2.227142067567911e-05
linked O 0 0.0148111367598176
polymorphic O 0 0.057198382914066315
DNA O 0 0.002837562933564186
markers O 0 0.003001333447173238
to O 0 3.3945314498851076e-05
estimate O 0 0.0003019186551682651
the O 0 4.45419573225081e-05
likelihood O 0 0.0011608497006818652
of O 0 1.3079870768706314e-05
inheriting O 0 0.043150629848241806
the O 0 0.00014733633724972606
mutation O 0 0.0015867023030295968
for O 0 0.00046130651026032865
HD B-Disease 1 0.9926209449768066
. O 0 0.00045851783943362534

Limits O 0 0.0008234013221226633
to O 0 4.093909956282005e-05
accuracy O 0 0.0004287545452825725
included O 0 4.8546844482189044e-05
recombination O 0 0.0006682696985080838
between O 0 4.6746696170885116e-05
the O 0 0.0001456734025850892
DNA O 0 0.001888763508759439
markers O 0 0.002613992430269718
and O 0 4.009511030744761e-05
the O 0 0.00011250573152210563
mutation O 0 0.0022391725797206163
, O 0 0.0002736794122029096
pedigree O 0 0.036372262984514236
structure O 0 0.003238449804484844
, O 0 0.00016996037447825074
and O 0 0.00010498693882254884
whether O 0 0.0003605785022955388
DNA O 0 0.0005363198579289019
samples O 0 0.00013050631969235837
were O 0 1.12587486000848e-05
available O 0 8.356414036825299e-05
from O 0 3.843546437565237e-05
family O 0 0.00028559716884046793
members O 0 9.821734420256689e-05
. O 0 0.0002726613311097026

With O 0 9.949027298716828e-05
direct O 0 0.00021069955255370587
tests O 0 0.0006776067893952131
for O 0 6.460883741965517e-05
the O 0 0.0004223500145599246
HD B-Disease 1 0.9941784143447876
mutation O 0 0.002630725735798478
, O 0 0.00011387073755031452
we O 0 6.981961632845923e-05
have O 0 3.4021733881672844e-05
assessed O 0 0.0025571463629603386
the O 0 2.97743063129019e-05
accuracy O 0 0.00028154512983746827
of O 0 9.052761924976949e-06
results O 0 0.0003923169570043683
obtained O 0 0.00016128983406815678
by O 0 3.960676986025646e-05
linkage O 0 0.02781493403017521
approaches O 0 0.00711103156208992
when O 0 0.0003654363099485636
requested O 0 0.0010714856907725334
to O 0 5.23111957591027e-05
do O 0 0.0001266014005523175
so O 0 4.3802825530292466e-05
by O 0 1.0931145880022086e-05
the O 0 0.00010393881530035287
test O 0 0.001377283362671733
individuals O 0 0.00020099918765481561
. O 0 0.00031576547189615667

For O 0 0.00038791188853792846
six O 0 0.00010729675705078989
such O 0 1.952893944690004e-05
individuals O 0 0.0001468073605792597
, O 0 0.00011110092600574717
there O 0 6.1018276028335094e-05
was O 0 0.0005148877389729023
significant O 0 0.0005270522087812424
disparity O 0 0.013485082425177097
between O 0 7.3648763645906e-05
the O 0 0.00018276333867106587
tests O 0 0.0028092097491025925
. O 0 0.0002523639996070415

Three O 0 0.0002842883113771677
went O 0 0.0006118754390627146
from O 0 4.3488951632753015e-05
a O 0 0.0006008810014463961
decreased O 0 0.09532002359628677
risk O 0 0.02251284196972847
to O 0 3.8490412407554686e-05
an O 0 0.00010997740173479542
increased O 0 0.0013403407065197825
risk O 1 0.5577563643455505
, O 0 0.0001354838314000517
while O 0 8.570551290176809e-05
in O 0 3.729594754986465e-05
another O 0 0.00011736615124391392
three O 0 2.3662661988055333e-05
the O 0 0.0001494028401793912
risk O 1 0.861711323261261
was O 0 0.00207970361225307
decreased O 0 0.021356910467147827
. O 0 0.0005564828752540052

Knowledge O 0 0.0016968392301350832
of O 0 1.5701732991146855e-05
the O 0 0.00014897067740093917
potential O 0 0.001375971594825387
reasons O 0 0.0006099077872931957
for O 0 5.538847472053021e-05
these O 0 1.3968592611490749e-05
changes O 0 0.00022839472512714565
in O 0 0.00011702440679073334
results O 0 0.0004714190145023167
and O 0 5.105135278427042e-05
impact O 0 0.0004870941338595003
of O 0 6.098959602240939e-06
these O 0 4.396930307848379e-05
risk O 1 0.7930420637130737
reversals O 0 0.04078733175992966
on O 0 0.00032120433752425015
both O 0 0.0006449511856772006
patients O 1 0.9999923706054688
and O 0 0.00010914057929767296
the O 0 0.0003460761799942702
counseling O 1 0.9959047436714172
team O 0 0.0014745380030944943
can O 0 6.860365101601928e-05
assist O 0 0.001094986218959093
in O 0 4.721842924482189e-05
the O 0 5.5090116802603006e-05
development O 0 0.0005123352748341858
of O 0 1.4385371287062299e-05
strategies O 0 0.004850649740546942
for O 0 0.00019070494454354048
the O 0 0.0006467275670729578
prevention O 1 0.9996042847633362
and O 0 0.0002222232287749648
, O 0 0.00012461711594369262
where O 0 0.00012368035095278174
necessary O 0 0.0007452153949998319
, O 0 0.00019245674775447696
management O 0 0.010963733308017254
of O 0 1.714525387797039e-05
a O 0 0.001207763678394258
risk O 0 0.49135929346084595
reversal O 0 0.007382446434348822
in O 0 4.266649921191856e-05
any O 0 6.985637446632609e-05
predictive O 0 0.021516289561986923
testing O 0 0.010635237209498882
program O 0 0.0028673941269516945
. O 0 8.667783549753949e-05
. O 0 0.00020856704213656485

A O 0 0.005116101820021868
novel O 0 0.0020579698029905558
common O 0 0.0023076150100678205
missense O 0 0.026750367134809494
mutation O 0 0.0028199083171784878
G301C O 0 0.015297000296413898
in O 0 6.126894004410133e-05
the O 0 0.00021370490139815956
N O 0 0.018846750259399414
- O 0 0.006185675505548716
acetylgalactosamine O 0 0.06674456596374512
- O 0 0.003616423811763525
6 O 0 0.0016877328744158149
- O 0 0.0087705934420228
sulfate O 1 0.9977397918701172
sulfatase O 1 0.9976505637168884
gene O 0 0.002471943385899067
in O 0 0.0004996031639166176
mucopolysaccharidosis B-Disease 1 0.9935218691825867
IVA I-Disease 1 0.9994896650314331
. O 0 0.0010903551010414958

Mucopolysaccharidosis B-Disease 1 0.9960829019546509
IVA I-Disease 1 0.9994551539421082
( O 0 0.004731235560029745
MPS B-Disease 1 0.996625542640686
IVA I-Disease 1 0.999992847442627
) O 0 0.0002609729999676347
is O 0 0.00010524896060815081
an O 0 0.0002852333418559283
autosomal B-Disease 1 0.9998853206634521
recessive I-Disease 1 0.999984622001648
lysosomal I-Disease 1 0.9999979734420776
storage I-Disease 1 0.9999092817306519
disorder I-Disease 1 1.0
caused O 0 0.02953859604895115
by O 0 4.037539838463999e-05
a O 0 0.0009196671308018267
genetic B-Disease 1 0.9184051752090454
defect I-Disease 1 0.9998971223831177
in O 0 0.000541833636816591
N O 0 0.02039019949734211
- O 0 0.00772472657263279
acetylgalactosamine O 0 0.08712845295667648
- O 0 0.0033081655856221914
6 O 0 0.0015839459374547005
- O 0 0.011158425360918045
sulfate O 1 0.9986867308616638
sulfatase O 1 0.9995330572128296
( O 0 0.003634347813203931
GALNS O 1 0.9979580640792847
) O 0 0.000491297454573214
. O 0 0.00027972200768999755

In O 0 0.0005539379199035466
previous O 0 0.000590053154155612
studies O 0 0.0010130897862836719
, O 0 0.00012021439761156216
we O 0 8.595826511736959e-05
have O 0 2.1731650122092105e-05
found O 0 4.9399368435842916e-05
two O 0 1.3195550309319515e-05
common O 0 0.0009926571510732174
mutations O 0 0.0021115276031196117
in O 0 0.0004184700082987547
Caucasians O 1 0.9331345558166504
and O 0 0.00019636865181382746
Japanese O 0 0.0015391052002087235
, O 0 0.0002508905017748475
respectively O 0 0.0008651241660118103
. O 0 0.00033315582550130785

To O 0 0.0005044308491051197
characterize O 0 0.03230319172143936
the O 0 0.0006280784728005528
mutational O 1 0.6951326131820679
spectrum O 0 0.005266651976853609
in O 0 5.913163477089256e-05
various O 0 1.0909962838923093e-05
ethnic O 0 4.479699055082165e-05
groups O 0 3.465731788310222e-05
, O 0 0.00012585801596287638
mutations O 0 0.0007097881170921028
in O 0 6.6796550527215e-05
the O 0 0.0002816959749907255
GALNS O 1 0.9938381314277649
gene O 0 0.0007356614805757999
in O 0 0.00014105139416642487
Colombian O 0 0.017491674050688744
MPS B-Disease 1 0.9990730285644531
IVA I-Disease 1 0.9999997615814209
patients O 1 0.9999979734420776
were O 0 0.0001302199234487489
investigated O 0 0.017698118463158607
, O 0 0.00019634752243291587
and O 0 0.00015946045459713787
genetic O 0 0.001918315072543919
backgrounds O 0 0.0015669073909521103
were O 0 5.5866377806523815e-05
extensively O 0 0.0034661630634218454
analyzed O 0 0.0010272489162161946
to O 0 4.6672481403220445e-05
identify O 0 0.0006603414076380432
racial O 0 0.0008430937305092812
origin O 0 4.711416841018945e-05
, O 0 6.327160372165963e-05
based O 0 4.1253802919527516e-05
on O 0 9.524900087853894e-05
mitochondrial O 0 0.002047428395599127
DNA O 0 0.001491375151090324
( O 0 0.00033949135104194283
mtDNA O 0 0.0010545087279751897
) O 0 0.00019871286349371076
lineages O 0 0.0013739836867898703
. O 0 0.00032628022017888725

Three O 0 0.00034918132587336004
novel O 0 0.0025563156232237816
missense O 0 0.030582020059227943
mutations O 0 0.005142791196703911
never O 0 0.002895878627896309
identified O 0 0.0008162712911143899
previously O 0 0.0003918056609109044
in O 0 4.258435365045443e-05
other O 0 1.981567038455978e-05
populations O 0 0.00025516035384498537
and O 0 0.00011096189700765535
found O 0 0.00019594785408116877
in O 0 7.460501365130767e-05
16 O 0 0.00022320555581245571
out O 0 1.6972711819107644e-05
of O 0 1.1626396371866576e-05
19 O 0 0.0022370684891939163
Colombian O 0 0.01940345950424671
MPS B-Disease 1 0.9896466135978699
IVA I-Disease 1 0.9999662637710571
unrelated O 0 0.010102649219334126
alleles O 0 0.0015909896465018392
account O 0 0.00015499492292292416
for O 0 0.00025361732696183026
84 O 0 0.012319274246692657
. O 0 0.00036488889600150287

2 O 0 0.0009833956137299538
% O 0 1.8800737962010317e-05
of O 0 6.100373411754845e-06
the O 0 0.00014604473835788667
alleles O 0 0.0015778180677443743
in O 0 7.419154280796647e-05
this O 0 4.296116821933538e-05
study O 0 0.0014131022617220879
. O 0 0.000279780913842842

The O 0 0.0012726220302283764
G301C O 0 0.04577116668224335
and O 0 0.0003016326518263668
S162F O 0 0.030476799234747887
mutations O 0 0.000579618092160672
account O 0 8.394311589654535e-05
for O 0 0.0002042703126790002
68 O 0 0.00588188273832202
. O 0 0.0003053145483136177

4 O 0 0.0016193550545722246
% O 0 6.339111860143021e-05
and O 0 0.00010063777881441638
10 O 0 0.00044156532385386527
. O 0 0.000274944439297542

5 O 0 0.0008217819849960506
% O 0 2.576329279690981e-05
of O 0 1.8776350771076977e-05
mutations O 0 0.0028671070467680693
, O 0 0.00027537517598830163
respectively O 0 0.0008507646271027625
, O 0 0.00015199142217170447
whereas O 0 0.0005330906133167446
the O 0 0.0001109437071136199
remaining O 0 0.0005608855281025171
F69V O 1 0.9954317808151245
is O 0 0.0002202011673944071
limited O 0 0.00025257343077100813
to O 0 1.8926539269159548e-05
a O 0 9.896994743030518e-05
single O 0 0.00022971075668465346
allele O 0 0.005084844306111336
. O 0 0.0003991792327724397

The O 0 0.0005707268137484789
skewed O 0 0.011622476391494274
prevalence O 0 0.1402151882648468
of O 0 3.169839328620583e-05
G301C O 0 0.027312656864523888
in O 0 9.150490222964436e-05
only O 0 0.00012218320625834167
Colombian O 0 0.029934050515294075
patients O 1 0.9999791383743286
and O 0 0.0002054636279353872
haplotype O 0 0.020703643560409546
analysis O 0 0.0001074069004971534
by O 0 1.1593835552048404e-05
restriction O 0 0.0002657051372807473
fragment O 0 0.0011422819225117564
length O 0 0.0002652255352586508
polymorphisms O 0 0.0010880142217501998
in O 0 7.061731594149023e-05
the O 0 0.0002981775323860347
GALNS O 1 0.9992725253105164
gene O 0 0.0017482666298747063
suggest O 0 0.00046646417467854917
that O 0 5.858260556124151e-05
G301C O 0 0.019833529368042946
originated O 0 0.0003826607426162809
from O 0 2.601559208414983e-05
a O 0 0.0002298882172908634
common O 0 0.001393927726894617
ancestor O 0 0.0023456348571926355
. O 0 0.00040782615542411804

Investigation O 0 0.005404413212090731
of O 0 1.2314816558500752e-05
the O 0 0.00014341923815663904
genetic O 0 0.0013310416834428906
background O 0 0.0004269021737854928
by O 0 2.2383526811609045e-05
means O 0 0.0002106744359480217
of O 0 1.4972339158703107e-05
mtDNA O 0 0.0009834002703428268
lineages O 0 0.0008900401298888028
indicate O 0 0.00036276501487009227
that O 0 2.145132930309046e-05
all O 0 2.4610839318484068e-05
our O 0 0.001972045749425888
patients O 1 0.9999735355377197
are O 0 2.000093081733212e-05
probably O 0 0.0002736141614150256
of O 0 5.684635198122123e-06
native O 0 0.00018615899898577482
American O 0 0.0008649782394059002
descent O 0 0.006657521240413189

Low O 0 0.0019176515052095056
frequency O 0 0.0001584458805155009
of O 0 7.350346277235076e-05
BRCA1 O 1 0.9997828602790833
germline O 1 0.8568813800811768
mutations O 0 0.0005367742851376534
in O 0 4.03421072405763e-05
45 O 0 0.00048343808157369494
German O 1 0.9959415793418884
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0009153220453299582
. O 0 0.00034793224767781794

In O 0 0.00018092920072376728
this O 0 1.7512860722490586e-05
study O 0 0.0002006568101933226
we O 0 4.6563516661990434e-05
investigated O 0 0.0021050788927823305
45 O 0 0.0004097108030691743
German O 1 0.9954445362091064
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0004430857370607555
for O 0 0.00029532460030168295
germline O 1 0.6906955242156982
mutations O 0 0.0007594885537400842
in O 0 5.9717127442127094e-05
the O 0 0.00044630488264374435
BRCA1 O 1 0.9998425245285034
gene O 0 0.003957571927458048
. O 0 0.00037955818697810173

We O 0 0.0004631469491869211
identified O 0 0.00036307013942860067
four O 0 8.734509901842102e-05
germline O 0 0.09964114427566528
mutations O 0 0.0006198959890753031
in O 0 9.178140317089856e-05
three O 0 0.0007833081763237715
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00010110130097018555
and O 0 2.0284880520193838e-05
in O 0 5.5371732742059976e-05
one O 0 0.0010487755062058568
breast B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.001726919086650014
. O 0 5.392318416852504e-05
among O 0 1.728321694827173e-05
these O 0 4.710522262030281e-06
were O 0 1.5736062778159976e-05
one O 0 0.0001748036447679624
frameshift O 1 0.9418691396713257
mutation O 0 0.0016844647470861673
, O 0 8.91349627636373e-05
one O 0 0.00011932814959436655
nonsense O 0 0.012634736485779285
mutation O 0 0.001833030954003334
, O 0 7.425821240758523e-05
one O 0 6.500448944279924e-05
novel O 0 0.0012084185145795345
splice O 0 0.028590530157089233
site O 0 0.0031549164559692144
mutation O 0 0.0012863585725426674
, O 0 7.460864435415715e-05
and O 0 4.790232196683064e-05
one O 0 0.0001277145929634571
missense O 0 0.014952794648706913
mutation O 0 0.003233463503420353
. O 0 0.0003484391199890524

The O 0 0.0007900252821855247
missense O 0 0.017524845898151398
mutation O 0 0.002187575912103057
was O 0 0.0008663482149131596
also O 0 0.00011968745093327016
found O 0 0.00010645575821399689
in O 0 8.779217750998214e-05
2 O 0 0.0008839882211759686
. O 0 0.00022907952370587736

8 O 0 0.001177564263343811
% O 0 1.8605805962579325e-05
of O 0 6.141713583929231e-06
the O 0 0.0001203855499625206
general O 0 0.0006821390707045794
population O 0 5.141631845617667e-05
, O 0 0.00010997508798027411
suggesting O 0 0.001039103139191866
that O 0 1.518788394605508e-05
it O 0 3.8607198803219944e-05
is O 0 0.00024046098405960947
not O 0 0.0006069309310987592
disease O 1 0.9999991655349731
associated O 0 0.0009664010722190142
. O 0 0.00033694348530843854

The O 0 0.0003311210311949253
average O 0 0.001097745494917035
age O 0 0.0006391871720552444
of O 0 0.0002376828488195315
disease O 1 1.0
onset O 1 0.9999794960021973
in O 0 0.00016840222815517336
those O 0 6.101205144659616e-05
families O 0 0.0004945784457959235
harbouring O 1 0.9981735944747925
causative O 1 0.9651986360549927
mutations O 0 0.002580199623480439
was O 0 0.0006459446158260107
between O 0 0.00012578074529301375
32 O 0 0.0012393401702865958
. O 0 0.00035314238630235195

3 O 0 0.0015741623938083649
and O 0 0.00020000222139060497
37 O 0 0.002299018669873476
. O 0 0.0003705850394908339

4 O 0 0.0023111780174076557
years O 0 0.0005398561479523778
, O 0 0.00011735966108972207
whereas O 0 0.0006614502635784447
the O 0 0.00014832220040261745
family O 0 0.0012035879772156477
harbouring O 1 0.9574651718139648
the O 0 0.00044695462565869093
missense O 0 0.025838470086455345
mutation O 0 0.0019124281825497746
had O 0 0.0002332474832655862
an O 0 8.828531281324103e-05
average O 0 0.0009216119069606066
age O 0 0.00028692983323708177
of O 0 3.644619937404059e-05
onset O 1 0.9990134239196777
of O 0 8.39537606225349e-05
51 O 0 0.007844647392630577
. O 0 0.0005309620173648

2 O 0 0.0023689258377999067
years O 0 0.0007564476691186428
. O 0 0.0002583682944532484

These O 0 9.929162479238585e-05
findings O 0 0.001641575712710619
show O 0 0.000373852119082585
that O 0 0.0002182874159188941
BRCA1 O 1 0.9997791647911072
is O 0 0.0008834766922518611
implicated O 0 0.03320916369557381
in O 0 2.694217982934788e-05
a O 0 3.480871964711696e-05
small O 0 1.853093817771878e-05
fraction O 0 0.00031415841658599675
of O 0 0.00022139103384688497
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0006068025249987841
suggesting O 0 0.0012776562944054604
the O 0 5.909657556912862e-05
involvement O 0 0.001529234228655696
of O 0 7.726458534307312e-06
another O 0 0.0006212048465386033
susceptibility O 1 0.8874298334121704
gene O 0 0.004163637757301331
( O 0 0.0011072377674281597
s O 0 0.05096722021698952
) O 0 0.0009313306654803455

Paternal O 0 0.01722491905093193
transmission O 0 0.019337665289640427
of O 0 0.0011544197332113981
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.004791984334588051

We O 0 0.0005639840383082628
report O 0 0.0003465389017947018
a O 0 0.00016812674584798515
rare O 0 0.001270507462322712
case O 0 0.0002849666925612837
of O 0 2.8310434572631493e-05
paternally O 1 0.9991503953933716
transmitted O 1 0.9998996257781982
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9023758769035339
DM B-Disease 1 1.0
) O 0 0.0014411844313144684
. O 0 0.00038905846304260194

The O 0 0.0008607315830886364
proband O 0 0.0546264573931694
is O 0 0.00018901466683018953
a O 0 0.0002984565799124539
23 O 0 0.0009237251942977309
year O 0 0.0004436161834746599
old O 0 0.001987715717405081
, O 0 0.0008341605425812304
mentally B-Disease 1 0.9999996423721313
retarded I-Disease 1 0.9999878406524658
male O 0 0.0039044562727212906
who O 0 0.014570810832083225
suffers O 1 1.0
severe O 1 0.9999998807907104
muscular B-Disease 1 1.0
weakness I-Disease 1 0.9999927282333374
. O 0 0.0015179081819951534

He O 0 0.0025269046891480684
presented O 0 0.0012615227606147528
with O 0 0.0008105324814096093
respiratory O 1 1.0
and O 0 0.0006092404364608228
feeding O 0 0.050349894911050797
difficulties O 0 0.3379859924316406
at O 0 0.0021966665517538786
birth O 0 0.0025001622270792723
. O 0 0.00033062390866689384

His O 0 0.0012428326299414039
two O 0 0.000290635391138494
sibs O 1 0.9998738765716553
suffer O 1 0.9998481273651123
from O 0 0.0004497102927416563
childhood O 1 0.9999600648880005
onset O 1 0.9999995231628418
DM B-Disease 1 1.0
. O 0 0.0017145704478025436

Their O 0 0.0002529688645154238
late O 0 0.0018152411794289947
father O 0 0.0013157054781913757
had O 0 0.00016775108815636486
the O 0 6.0144382587168366e-05
adult O 0 0.0012424716260284185
type O 0 0.004086573142558336
of O 0 0.00035163399297744036
DM B-Disease 1 1.0
, O 0 0.0005232738913036883
with O 0 0.0002399740624241531
onset O 1 0.9996458292007446
around O 0 0.00032359655597247183
30 O 0 0.0008242217008955777
years O 0 0.0004342010652180761
. O 0 0.00022404137416742742

Only O 0 0.00015617940516676754
six O 0 6.478869181592017e-05
other O 0 1.4078000276640523e-05
cases O 0 0.00019423721823841333
of O 0 1.0752731213869993e-05
paternal O 0 0.009453331120312214
transmission O 0 0.027817774564027786
of O 0 0.0009366245358251035
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.0003999970795121044
been O 0 0.000383311475161463
reported O 0 0.0019893585704267025
recently O 0 0.003794641001150012
. O 0 0.0002766599354799837

We O 0 0.0006025754264555871
review O 0 0.0007177424849942327
the O 0 0.00010010933328885585
sex O 0 0.0008770774002186954
related O 0 0.0007875514565967023
effects O 0 0.0019382215104997158
on O 0 0.0001699014101177454
transmission O 0 0.008628573268651962
of O 0 0.0006169024854898453
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.002598605817183852

Decreased O 0 0.12583395838737488
fertility O 0 0.03902043402194977
of O 0 1.4191986338119023e-05
males O 0 0.0005095245433039963
with O 0 0.00012927815259899944
adult O 0 0.40923792123794556
onset O 1 0.9999992847442627
DM B-Disease 1 1.0
and O 0 0.000534875609446317
contraction O 0 0.006830557249486446
of O 0 1.0798500625242013e-05
the O 0 0.00018320613889954984
repeat O 0 0.009326488710939884
upon O 0 0.0005295363371260464
male O 0 0.002020321087911725
transmission O 0 0.00950651429593563
contribute O 0 0.002578104380518198
to O 0 3.0478558983304538e-05
the O 0 5.027189399697818e-05
almost O 0 0.00033715556492097676
absent O 0 0.003997606225311756
occurrence O 0 0.0014056090731173754
of O 0 1.4166036635288037e-05
paternal O 0 0.007029173895716667
transmission O 0 0.041686564683914185
of O 0 0.0009717034408822656
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.002081155776977539

Also O 0 0.00043345417361706495
the O 0 6.934022530913353e-05
fathers O 0 0.0002792535233311355
of O 0 7.27005499356892e-06
the O 0 0.0003249214787501842
reported O 0 0.015419180504977703
congenitally O 1 0.9993672966957092
affected O 0 0.01560751162469387
children O 0 0.001292031374759972
showed O 0 0.001298160757869482
, O 0 7.548955909442157e-05
on O 0 9.716051863506436e-05
average O 0 0.0011314685689285398
, O 0 0.00033640392939560115
shorter O 0 0.018872348591685295
CTG O 1 0.9969651103019714
repeat O 0 0.014783080667257309
lengths O 0 0.0018732649041339755
and O 0 6.0223701439099386e-05
hence O 0 0.0007071697036735713
less O 0 0.002388415625318885
severe O 1 0.9999998807907104
clinical O 1 1.0
symptoms O 1 0.999998927116394
than O 0 6.528247467940673e-05
the O 0 8.335737220477313e-05
mothers O 0 0.0024167955853044987
of O 0 1.0467546417203266e-05
children O 0 0.0013099375646561384
with O 0 0.00231741601601243
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00226155505515635

We O 0 0.0004944106913171709
conclude O 0 0.0020207958295941353
that O 0 1.9463344870018773e-05
paternal O 0 0.0026770744007080793
transmission O 0 0.012434379197657108
of O 0 0.0006944331689737737
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.0020958262030035257
rare O 0 0.003198745660483837
and O 0 0.00013436697190627456
preferentially O 0 0.00555418198928237
occurs O 0 0.000467650213977322
with O 0 0.00013911511632613838
onset O 1 0.9994691014289856
of O 0 0.0006557706510648131
DM B-Disease 1 1.0
past O 0 0.0016722566215321422
30 O 0 0.0005536539247259498
years O 0 0.00017463073891121894
in O 0 4.463001459953375e-05
the O 0 0.0001385825889883563
father O 0 0.0024318359792232513
. O 0 0.00016715328092686832
. O 0 0.00026050242013297975

The O 0 0.004652229603379965
RB1 O 1 0.9995487332344055
gene O 0 0.002940530190244317
mutation O 0 0.0007559028454124928
in O 0 5.3973853937350214e-05
a O 0 0.00038473104359582067
child O 0 0.003193539334461093
with O 0 0.0005305199301801622
ectopic B-Disease 1 0.9999953508377075
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9999951124191284
. O 0 0.001527255866676569

The O 0 0.0037701264955103397
RB1 O 1 0.9996758699417114
gene O 0 0.004354274831712246
mutation O 0 0.0026467256247997284
was O 0 0.0010706776520237327
investigated O 0 0.003865094156935811
in O 0 4.822794289793819e-05
a O 0 0.00040549374534748495
child O 0 0.0029484631959348917
with O 0 0.0005507113528437912
ectopic B-Disease 1 0.9999969005584717
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9999682903289795
using O 0 0.00029888853896409273
DNA O 0 0.0007051259162835777
obtained O 0 0.00010290096543030813
from O 0 1.4132748219708446e-05
both O 0 2.64219670498278e-05
the O 0 0.00026456807972863317
pineal B-Disease 1 0.999496579170227
and I-Disease 0 0.0016515086172148585
retinal I-Disease 1 0.9999994039535522
tumours I-Disease 1 0.9999974966049194
of O 0 4.11877226724755e-05
the O 0 0.0007601043325848877
patient O 1 0.9999580383300781
. O 0 0.00046277977526187897

A O 0 0.005864567589014769
nonsense O 0 0.014425110071897507
mutation O 0 0.0012997027952224016
in O 0 0.00016441592015326023
exon O 0 0.03064989112317562
17 O 0 0.0021092200186103582
( O 0 0.00038165447767823935
codon O 0 0.005976175889372826
556 O 0 0.03588511422276497
) O 0 6.260515510803089e-05
of O 0 1.0335164915886708e-05
the O 0 0.0011138076661154628
RB1 O 1 0.9999704360961914
gene O 0 0.00450787553563714
was O 0 0.0010093249147757888
found O 0 0.00010410506365587935
to O 0 2.558612141001504e-05
be O 0 3.686107083922252e-05
present O 0 0.0001437874452676624
homozygously O 0 0.040388163179159164
in O 0 5.2858747949358076e-05
both O 0 4.76103596156463e-05
the O 0 0.00030353193869814277
retinal B-Disease 1 0.9998983144760132
and I-Disease 0 0.00012243491073604673
the I-Disease 0 0.0009057472343556583
pineal I-Disease 1 0.9999768733978271
tumours I-Disease 1 0.9999991655349731
. O 0 0.0009232060401700437

The O 0 0.00025104935048148036
same O 0 0.00012329402670729905
mutation O 0 0.0015068313805386424
was O 0 0.0007213623030111194
present O 0 0.00030697384499944746
heterozygously O 0 0.0975358635187149
in O 0 9.195143502438441e-05
the O 0 0.00010452293645357713
DNA O 0 0.0005482343840412796
from O 0 1.832684029068332e-05
the O 0 4.154500493314117e-05
constitutional O 0 0.00032603516592644155
cells O 0 0.0005140831344760954
of O 0 8.986196007754188e-06
the O 0 0.0005669553647749126
patient O 1 0.9999774694442749
, O 0 0.00037071420229040086
proving O 1 0.564647376537323
it O 0 6.653983291471377e-05
to O 0 1.716282349661924e-05
be O 0 1.2543110642582178e-05
of O 0 1.6844807760207914e-05
germline O 0 0.2746574282646179
origin O 0 0.00011247181828366593
. O 0 0.00030527234775945544

The O 0 0.0004114913463126868
initial O 0 0.002108961110934615
mutation O 0 0.002292432589456439
was O 0 0.0008080481784418225
shown O 0 0.0003318997914902866
to O 0 3.883503450197168e-05
have O 0 3.2252133678412065e-05
occurred O 0 0.0003743091074284166
in O 0 3.502462641336024e-05
the O 0 0.0001356570573989302
paternally O 0 0.059475693851709366
derived O 0 0.003999101929366589
RB1 O 1 0.9994097948074341
allele O 0 0.015192430466413498
. O 0 0.0006815341184847057

The O 0 0.0009455290273763239
mutation O 0 0.0024985834024846554
is O 0 0.00019259295368101448
in O 0 5.480082836584188e-05
an O 0 0.00010247334284940735
area O 0 0.00043588518747128546
of O 0 7.0701421464036684e-06
the O 0 7.856994488975033e-05
gene O 0 0.0003331081534270197
that O 0 9.49527293414576e-06
encodes O 0 0.0001896987814689055
the O 0 4.633340722648427e-05
protein O 0 0.0006729891174472868
- O 0 0.0019703111611306667
binding O 0 0.00039922870928421617
region O 0 0.0012374528450891376
known O 0 0.0003882861346937716
as O 0 0.00014366136747412384
the O 0 0.00035837001632899046
pocket O 0 0.09260182827711105
region O 0 0.0017217202112078667
and O 0 0.00012803285790141672
has O 0 0.000474175758427009
been O 0 0.00024980062153190374
detected O 0 0.001993778860196471
in O 0 2.931019480456598e-05
other O 0 1.624187279958278e-05
cases O 0 0.00044627388706430793
of O 0 8.30973731353879e-05
retinoblastoma B-Disease 1 0.9999964237213135
. O 0 0.00029340051696635783
. O 0 0.0002862874243874103

Low O 0 0.0048721544444561005
levels O 0 0.0009631866123527288
of O 0 2.075379597954452e-05
beta O 0 0.016430120915174484
hexosaminidase O 0 0.10440193116664886
A O 0 0.0012957000872120261
in O 0 0.00014084507711231709
healthy O 0 0.019655125215649605
individuals O 0 9.32798720896244e-05
with O 0 0.00015372266352642328
apparent O 1 0.9932426810264587
deficiency O 1 0.9999997615814209
of O 0 1.3892190509068314e-05
this O 0 5.028637679060921e-05
enzyme O 0 0.003403306473046541
. O 0 0.0003506945795379579

Appreciable O 0 0.05148262158036232
beta O 0 0.019061265513300896
hexosaminidase O 0 0.07105443626642227
A O 0 0.003875608090311289
( O 0 0.000663001264911145
hex O 0 0.015222650952637196
A O 0 0.002688608132302761
) O 0 9.958852751879022e-05
activity O 0 0.00016427942318841815
has O 0 0.00015915663971100003
been O 0 0.0001071114165824838
detected O 0 0.0013558140490204096
in O 0 0.00010237567767035216
cultured O 1 0.9899689555168152
skin O 1 1.0
fibroblasts O 1 0.9996576309204102
and O 0 0.009227365255355835
melanoma B-Disease 1 1.0
tissue O 1 0.9997552037239075
from O 0 0.0001833344140322879
healthy O 0 0.14851932227611542
individuals O 0 0.0002255291910842061
previously O 0 0.001250036875717342
reported O 0 0.0018196860328316689
as O 0 0.00025585514958947897
having O 0 0.005845935083925724
deficiency B-Disease 1 0.9999967813491821
of I-Disease 0 5.875553688383661e-05
hex I-Disease 0 0.01769041083753109
A I-Disease 0 0.001812801114283502
activity O 0 0.0004413067363202572
indistinguishable O 0 0.0034486691001802683
from O 0 1.560202508699149e-05
that O 0 9.462037269258872e-06
of O 0 2.9227410777821206e-05
patients O 1 0.9999990463256836
with O 0 0.001664081821218133
Tay B-Disease 1 1.0
- I-Disease 1 0.9999425411224365
Sachs I-Disease 1 0.9999988079071045
disease I-Disease 1 1.0
( O 0 0.00451877573505044
TSD B-Disease 1 0.9999593496322632
) O 0 0.0006887615891173482
. O 0 0.0002941354759968817

Identification O 0 0.0016074259765446186
and O 0 0.0001425500522600487
quantitation O 0 0.0317714549601078
of O 0 5.176385093363933e-05
hex O 0 0.01950785703957081
A O 0 0.0028005808126181364
, O 0 0.00017376700998283923
amounting O 0 0.004554145969450474
to O 0 9.208841220242903e-05
3 O 0 0.0006938318838365376
. O 0 0.0002022541593760252

5 O 0 0.0014938048552721739
% O 0 0.00014942049165256321
- O 0 0.005103095434606075
6 O 0 0.001505016814917326
. O 0 0.0002942195860669017

9 O 0 0.0013576217461377382
% O 0 1.0411377843411174e-05
of O 0 4.085283308086218e-06
total O 0 0.00016005057841539383
beta O 0 0.015106864273548126
hexosaminidase O 0 0.061923522502183914
activity O 0 0.0004047688562422991
, O 0 0.00010347146599087864
has O 0 0.00013916444731876254
been O 0 4.987703505321406e-05
obtained O 0 4.2910924094030634e-05
by O 0 1.645221891521942e-05
cellulose O 0 0.06566841155290604
acetate O 0 0.13272497057914734
gel O 1 0.9939253926277161
electrophoresis O 0 0.0558713860809803
, O 0 0.0005913233617320657
DEAE O 1 0.9957755208015442
- O 0 0.005015422124415636
cellulose O 0 0.0204680934548378
ion O 0 0.006482296623289585
- O 0 0.00289713591337204
exchange O 0 0.0009121265611611307
chromatography O 0 0.11485316604375839
, O 0 0.0009824319276958704
radial O 1 0.998325765132904
immunodiffusion O 1 0.9827513098716736
, O 0 0.00031461636535823345
and O 0 0.00023825826065149158
radioimmunoassay O 1 0.8652371168136597
. O 0 0.0005861558602191508

Previous O 0 0.0026791526470333338
family O 0 0.0009442524751648307
studies O 0 0.0011210477678105235
suggested O 0 0.0008536836830899119
that O 0 1.5051881746330764e-05
these O 0 8.858461114868987e-06
individuals O 0 0.00016018554742913693
may O 0 0.0008679520105943084
be O 0 0.0001133584082708694
compound O 0 0.009528026916086674
heterozygotes O 0 0.03989342972636223
for O 0 5.705152216251008e-05
the O 0 0.0001095511979656294
common O 0 0.0027721449732780457
mutant O 0 0.0283663272857666
TSD B-Disease 1 0.9994206428527832
gene O 0 0.002046003472059965
and O 0 6.234694592421874e-05
a O 0 0.00047165725845843554
rare O 0 0.006891530007123947
( O 0 0.000824895512778312
allelic O 0 0.05562227964401245
) O 0 0.00027754020993597806
mutant O 0 0.0032777972519397736
gene O 0 0.001839701784774661
. O 0 0.00029763110796920955

Thus O 0 0.0006481013842858374
, O 0 7.236743113026023e-05
the O 0 6.55831754556857e-05
postulated O 0 0.006807521916925907
rate O 0 0.0003561158082447946
mutant O 0 0.005051279440522194
gene O 0 0.002405177801847458
appears O 0 0.002049411181360483
to O 0 3.8679874705849215e-05
code O 0 9.376117668580264e-05
for O 0 3.410020872252062e-05
the O 0 3.53350187651813e-05
expression O 0 0.00011101038398919627
of O 0 8.370965588255785e-06
low O 0 0.0007964831893332303
amounts O 0 0.00010097614722326398
of O 0 2.065054104605224e-05
hex O 0 0.017869096249341965
A O 0 0.004018330946564674
. O 0 0.0003538541204761714

Heterozygotes O 0 0.2490437775850296
for O 0 0.00011671460379147902
the O 0 0.0001492001028964296
rare O 0 0.007197609171271324
mutant O 0 0.008732269518077374
may O 0 0.0007701361901126802
be O 0 5.7157445553457364e-05
indistinguishable O 0 0.004805032629519701
from O 0 0.00010956644837278873
heterozygotes O 0 0.030201345682144165
for O 0 5.607229468296282e-05
the O 0 0.0001604659337317571
common O 0 0.007881795056164265
TSD B-Disease 1 0.9999642372131348
mutant O 0 0.016119934618473053
. O 0 0.00041766001959331334

However O 0 0.0007517775520682335
, O 0 7.506873953389004e-05
direct O 0 0.00021773118351120502
visualization O 0 0.022771725431084633
and O 0 0.0002522155991755426
quantitation O 0 0.044215600937604904
of O 0 4.331036325311288e-05
hex O 0 0.013759760186076164
A O 0 0.0009516557329334319
by O 0 1.3904198567615822e-05
the O 0 4.7711306251585484e-05
methods O 0 0.0005588545463979244
described O 0 0.003015575697645545
may O 0 0.0008647688664495945
prevent O 0 0.002866477007046342
false O 0 0.0013634628849104047
- O 0 0.011001979932188988
positive O 0 0.005297873169183731
prenatal O 1 0.9999821186065674
diagnosis O 1 0.9999978542327881
of O 0 0.00020626644254662097
TSD B-Disease 1 0.9999866485595703
in O 0 0.0008093358483165503
fetuses O 0 0.025427494198083878
having O 0 0.00034352552029304206
the O 0 9.074293484445661e-05
incomplete O 0 0.0062660472467541695
hex B-Disease 0 0.04040894657373428
A I-Disease 0 0.02580047957599163
deficiency I-Disease 1 0.9999973773956299
of O 0 2.3266999050974846e-05
the O 0 0.0002009202289627865
type O 0 0.006353841628879309
described O 0 0.0014572788495570421
in O 0 4.408635868458077e-05
the O 0 5.779934144811705e-05
four O 0 0.00011278759484412149
healthy O 0 0.032676540315151215
individuals O 0 0.0006621317588724196

The O 0 0.0017787623219192028
tumor B-Disease 1 0.999804675579071
suppressor O 0 0.07465425878763199
gene O 0 0.007961991243064404
Smad4 O 1 0.9962332844734192
/ O 1 0.7632445096969604
Dpc4 O 0 0.2980727255344391
is O 0 0.00019950872228946537
required O 0 0.00023345014778897166
for O 0 0.00023418315686285496
gastrulation O 1 0.993061363697052
and O 0 0.0001939511130331084
later O 0 0.00037060008617118
for O 0 0.0003866372280754149
anterior O 1 0.9999042749404907
development O 0 0.000737421796657145
of O 0 9.741158464748878e-06
the O 0 0.00018199067562818527
mouse O 0 0.009104602038860321
embryo O 0 0.005603044293820858
. O 0 0.00037406833143904805

Mutations O 0 0.002002195455133915
in O 0 9.038858115673065e-05
the O 0 0.000609667447861284
SMAD4 O 1 0.9999490976333618
/ O 1 0.998761773109436
DPC4 O 1 0.9999336004257202
tumor B-Disease 1 0.9999707937240601
suppressor O 0 0.044780563563108444
gene O 0 0.0010143461404368281
, O 0 4.216236629872583e-05
a O 0 0.0001262629812117666
key O 0 0.0006487302016466856
signal O 0 0.001237797667272389
transducer O 0 0.015335863456130028
in O 0 0.0001188593523693271
most O 0 0.00037229876033961773
TGFbeta O 1 0.998348593711853
- O 0 0.01197883952409029
related O 0 0.0020148809999227524
pathways O 0 0.014317946508526802
, O 0 0.00010518224007682875
are O 0 9.114832209888846e-06
involved O 0 0.000223809081944637
in O 0 4.0975890442496166e-05
50 O 0 8.357162732863799e-05
% O 0 1.6746207620599307e-05
of O 0 0.00013050744018983096
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999996423721313
. O 0 0.0007298663258552551

Homozygous O 0 0.028942851349711418
Smad4 O 1 0.689534068107605
mutant O 0 0.02257595956325531
mice O 0 0.04032355174422264
die O 0 0.4618602693080902
before O 0 0.00040536950109526515
day O 0 0.0004966103006154299
7 O 0 0.0007370566017925739
. O 0 0.00019745425379369408

5 O 0 0.0006442969315685332
of O 0 3.7651308957720175e-05
embryogenesis O 0 0.11075443774461746
. O 0 0.0007909265113994479

Mutant O 0 0.010464354418218136
embryos O 0 0.0006251645972952247
have O 0 4.567213181871921e-05
reduced O 0 0.0007446169038303196
size O 0 0.0003376032691448927
, O 0 0.00031215063063427806
fail O 0 0.022910229861736298
to O 0 0.00015488635108340532
gastrulate O 0 0.4914165735244751
or O 0 0.00027021911228075624
express O 0 0.001627009711228311
a O 0 0.0006710846209898591
mesodermal O 1 0.9696683883666992
marker O 0 0.01769980974495411
, O 0 0.00011979854753008112
and O 0 6.081049650674686e-05
show O 0 0.0006680799997411668
abnormal O 1 0.6043809652328491
visceral O 1 0.9900845289230347
endoderm O 1 0.9980497360229492
development O 0 0.004629335831850767
. O 0 0.00041519603109918535

Growth B-Disease 1 0.8692816495895386
retardation I-Disease 1 0.9999736547470093
of O 0 3.1729057809570804e-05
the O 0 0.0004637384554371238
Smad4 O 1 0.9993011951446533
- O 0 0.08902356773614883
deficient O 1 0.9987610578536987
embryos O 0 0.000748422637116164
results O 0 0.00022487064416054636
from O 0 5.0965249101864174e-05
reduced O 0 0.0033843526616692543
cell O 0 0.0036306458059698343
proliferation O 0 0.0049388473853468895
rather O 0 7.707668555667624e-05
than O 0 2.8068863684893586e-05
increased O 0 0.00048577034613117576
apoptosis O 0 0.004930432885885239
. O 0 0.00026437570340931416

Aggregation O 0 0.0030525836627930403
of O 0 5.815944678033702e-05
mutant O 0 0.015087218023836613
Smad4 O 1 0.993100643157959
ES O 1 0.5236450433731079
cells O 0 0.000698887393809855
with O 0 3.736843791557476e-05
wild O 0 0.0005655386485159397
- O 0 0.004673311021178961
type O 0 0.0056353420950472355
tetraploid O 0 0.08532899618148804
morulae O 1 0.8860544562339783
rescues O 0 0.05563772842288017
the O 0 0.0008762145298533142
gastrulation B-Disease 1 0.9993294477462769
defect I-Disease 1 0.999170184135437
. O 0 0.0006982742343097925

These O 0 0.00010057051258627325
results O 0 0.0005675852880813181
indicate O 0 0.0005824047257192433
that O 0 0.00011200433800695464
Smad4 O 1 0.9621276259422302
is O 0 0.0003424853493925184
initially O 0 0.0007006560335867107
required O 0 0.00016628277080599219
for O 0 4.1646475438028574e-05
the O 0 3.9875048969406635e-05
differentiation O 0 0.0005887722945772111
of O 0 8.060782420216128e-06
the O 0 0.0002983837330248207
visceral O 1 0.9957221746444702
endoderm O 1 0.9983349442481995
and O 0 8.651795360492542e-05
that O 0 2.907567613874562e-05
the O 0 0.00031844794284552336
gastrulation B-Disease 1 0.9994194507598877
defect I-Disease 1 0.9947038292884827
in O 0 0.00012472423259168863
the O 0 0.0004535705375019461
epiblast O 1 0.9995915293693542
is O 0 0.0007859934703446925
secondary O 0 0.00846862606704235
and O 0 0.00013738095003645867
non O 0 0.004216328263282776
- O 0 0.005131218582391739
cell O 0 0.0012498795986175537
autonomous O 0 0.0007566606509499252
. O 0 0.0002796275948639959

Rescued O 0 0.03940166160464287
embryos O 0 0.0019353926181793213
show O 0 0.002868202980607748
severe O 1 0.9999821186065674
anterior O 1 0.9999921321868896
truncations O 1 0.9282957911491394
, O 0 0.0005191927775740623
indicating O 0 0.0015235396567732096
a O 0 0.00017378789198119193
second O 0 8.804125536698848e-05
important O 0 0.00012995349243283272
role O 0 0.0008991177892312407
for O 0 0.00028469430981203914
Smad4 O 1 0.9933342933654785
in O 0 0.0007295520044863224
anterior O 1 0.999985933303833
patterning O 1 0.9892528653144836
during O 0 0.0042032781057059765
embryogenesis O 0 0.48963579535484314
. O 0 0.0007469274569302797

Prevalence O 1 0.5252686738967896
of O 0 8.190252992790192e-05
p16 O 0 0.3775886595249176
and O 0 0.0005404904950410128
CDK4 O 1 0.9976664781570435
germline O 1 0.6141058802604675
mutations O 0 0.0008518178947269917
in O 0 0.0001740648440318182
48 O 0 0.01616516150534153
melanoma B-Disease 1 1.0
- O 1 0.6410008072853088
prone O 1 0.688262939453125
families O 0 0.00032586490851826966
in O 0 0.00023842368682380766
France O 0 0.0035878499038517475
. O 0 0.0004426239465828985

The O 0 0.0007553098257631063
French O 0 0.02278558351099491
Familial B-Disease 1 0.9999997615814209
Melanoma I-Disease 1 1.0
Study O 0 0.0081944540143013
Group O 0 0.0007389392121694982
. O 0 0.00024310231674462557

Germline O 1 0.9248194098472595
mutations O 0 0.0019016258884221315
in O 0 9.016192052513361e-05
the O 0 0.0002805231779348105
p16 O 0 0.35068395733833313
and O 0 0.0006965479115024209
CDK4 O 1 0.992244303226471
genes O 0 0.00024753878824412823
have O 0 4.282973532099277e-05
been O 0 0.00014311335689853877
reported O 0 0.000499343906994909
in O 0 1.4297728739620652e-05
a O 0 9.152129496214911e-05
subset O 0 0.001239423407241702
of O 0 0.00022837641881778836
melanoma B-Disease 1 1.0
pedigrees O 0 0.06085769832134247
, O 0 0.00018325923883821815
but O 0 7.212753553176299e-05
their O 0 6.670297443633899e-05
prevalence O 1 0.9947288632392883
is O 0 0.00021680723875761032
not O 0 5.5906457419041544e-05
well O 0 0.00011144747259095311
known O 0 0.0008144430466927588
. O 0 0.00025549533893354237

We O 0 0.0006105210050009191
searched O 0 0.002033061580732465
for O 0 3.930418461095542e-05
such O 0 5.0507929699961096e-05
germline O 1 0.8323168158531189
mutations O 0 0.0008437462383881211
in O 0 9.861826401902363e-05
48 O 0 0.0032613782677799463
French O 0 0.06047787889838219
melanoma B-Disease 1 1.0
- O 1 0.9457733631134033
prone O 1 0.9342688918113708
families O 0 0.0003069428203161806
selected O 0 0.00022704055299982429
according O 0 7.900367927504703e-05
to O 0 2.5674899006844498e-05
two O 0 2.4673960069776513e-05
major O 0 0.001538122072815895
criteria O 0 0.0018124887719750404
families O 0 0.00016263076395262033
with O 0 5.816699194838293e-05
at O 0 0.000598028302192688
least O 0 0.00012416436220519245
three O 0 4.3284766434226185e-05
affected O 0 0.0017661636229604483
members O 0 0.00018581196491140872
( O 0 0.0006129348184913397
n O 0 0.006793025881052017
= O 0 0.007435924839228392
20 O 0 0.0008510549669153988
) O 0 0.00017186019977089018
or O 0 0.00021453131921589375
families O 0 0.00011375451140338555
with O 0 4.8118698032340035e-05
two O 0 9.155447332886979e-05
affected O 0 0.004042118322104216
members O 0 9.970292740035802e-05
, O 0 7.09670057403855e-05
one O 0 2.8405245757312514e-05
of O 0 6.846059932286153e-06
them O 0 3.947765799239278e-05
affected O 0 0.003007344901561737
before O 0 0.00022872528643347323
the O 0 6.77072093822062e-05
age O 0 0.00020532694179564714
of O 0 1.2391131349431816e-05
50 O 0 0.00075457280036062
( O 0 0.0006700110388919711
n O 0 0.00641989428550005
= O 0 0.008332018740475178
28 O 0 0.0021954714320600033
) O 0 0.00011771427671192214
, O 0 5.202722968533635e-05
and O 0 2.8571947041200474e-05
one O 0 4.395354335429147e-05
additional O 0 0.00037259788950905204
minor O 0 0.10678965598344803
criterion O 0 0.050390325486660004
. O 0 0.00042374696931801736

Sixteen O 0 0.002359648235142231
different O 0 8.116390381474048e-05
p16 O 1 0.6876939535140991
germline O 1 0.9479590058326721
mutations O 0 0.0017033605836331844
were O 0 3.4826949558919296e-05
found O 0 0.00016199651872739196
in O 0 0.00011720611655618995
21 O 0 0.0007995626074261963
families O 0 0.0001248020416824147
, O 0 6.277529610088095e-05
while O 0 8.77135171322152e-05
one O 0 0.00021601490152534097
germline O 1 0.8316959738731384
mutation O 0 0.0025292914360761642
, O 0 0.00039307240513153374
Arg24His O 1 0.9815917015075684
, O 0 0.00020325384684838355
was O 0 0.0008961918065324426
detected O 0 0.002410362008959055
in O 0 5.2899027650710195e-05
the O 0 0.0003125588991679251
CDK4 O 1 0.9975600242614746
gene O 0 0.0037885047495365143
. O 0 0.0003734775527846068

The O 0 0.0001192473791888915
frequency O 0 9.369664621772245e-05
of O 0 3.0093855457380414e-05
p16 O 0 0.09708985686302185
gene O 0 0.001686481642536819
mutation O 0 0.0006919417064636946
in O 0 3.105585346929729e-05
our O 0 0.00015721574891358614
sample O 0 0.0001925793767441064
( O 0 0.00031504977960139513
44 O 0 0.0006095407879911363
% O 0 8.010220335563645e-05
) O 0 0.00014027958968654275
is O 0 9.513663098914549e-05
among O 0 2.6434265237185173e-05
the O 0 9.118817979469895e-05
highest O 0 0.0040721409022808075
rates O 0 0.0007973964093253016
yet O 0 0.0007221278501674533
reported O 0 0.0012928309151902795
and O 0 6.740468234056607e-05
the O 0 0.0003604968951549381
CDK4 O 1 0.9975666999816895
mutation O 0 0.001484022126533091
is O 0 6.926462810952216e-05
the O 0 4.260787318344228e-05
second O 0 0.0002887335722334683
mutation O 0 0.001600686926394701
detected O 0 0.0026022098027169704
in O 0 4.1219627746613696e-05
this O 0 2.8140075301053002e-05
gene O 0 0.0010003409115597606
worldwide O 0 0.0011332952417433262
. O 0 0.0003846617182716727

In O 0 0.0005970385391265154
summary O 0 0.0016417836304754019
, O 0 0.00015142698248382658
our O 0 0.0003726760915014893
results O 0 0.0006279527442529798
show O 0 0.0004352015967015177
frequent O 0 0.002436206443235278
involvement O 0 0.0023824628442525864
of O 0 8.553602128813509e-06
the O 0 0.00020352007413748652
p16 O 1 0.7571209073066711
gene O 0 0.0022668270394206047
in O 0 0.000770371058024466
familial B-Disease 1 0.9999994039535522
melanoma I-Disease 1 1.0
and O 0 0.0004930327413603663
confirm O 0 0.0015124039491638541
the O 0 4.651537165045738e-05
role O 0 0.0003938848967663944
of O 0 1.1088915016443934e-05
the O 0 0.00031676527578383684
CDK4 O 1 0.9963249564170837
gene O 0 0.00074945850064978
as O 0 0.00014344714873004705
a O 0 0.004818244371563196
melanoma B-Disease 1 1.0
- O 0 0.050888579338788986
predisposing O 0 0.25615689158439636
gene O 0 0.0018866108730435371
. O 0 0.00010420905164210126
. O 0 0.0002611679083202034

Progression O 0 0.4420776963233948
of O 0 0.00010036904131993651
somatic O 0 0.070745088160038
CTG O 1 0.9969239830970764
repeat O 0 0.012394309975206852
length O 0 0.0004968607681803405
heterogeneity O 0 0.004200745839625597
in O 0 3.8303154724417254e-05
the O 0 0.0001281008735531941
blood O 1 0.8807334899902344
cells O 0 0.0019911921117454767
of O 0 0.00022557629563380033
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999997615814209
. O 0 0.0008464575512334704

The O 0 0.00015622407954651862
genetic O 0 0.00031152807059697807
basis O 0 6.921958993189037e-05
of O 0 0.0002624384069349617
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.7337621450424194
DM B-Disease 1 1.0
) O 0 0.0005605189362540841
is O 0 7.124636613298208e-05
the O 0 2.7901849534828216e-05
expansion O 0 0.00035084423143416643
of O 0 9.631832654122263e-06
an O 0 0.000785491953138262
unstable O 1 0.9995712637901306
CTG O 1 0.9984428286552429
repeat O 0 0.01328334491699934
in O 0 8.316364255733788e-05
the O 0 0.00010932151781162247
34 O 0 0.0008984780288301408
UTR O 0 0.018216779455542564
of O 0 1.1265095963608474e-05
the O 0 0.0005959287518635392
DM B-Disease 1 0.999998927116394
protein O 0 0.0009650697465986013
kinase O 0 0.005844971165060997
gene O 0 0.0004990215529687703
on O 0 0.00011966702004428953
chromosome O 0 0.0019196869106963277
19 O 0 0.001202225685119629
. O 0 0.00025341816945001483

One O 0 0.00014172698138281703
of O 0 8.455128408968449e-06
the O 0 0.00014990611816756427
principal O 0 0.0019985989201813936
features O 0 0.0001040812348946929
of O 0 1.9844037524308078e-05
the O 0 0.002110502915456891
DM B-Disease 1 0.9999998807907104
mutation O 0 0.003115920815616846
is O 0 0.0001293384557357058
an O 0 0.00014865124830976129
extraordinarily O 0 0.17425261437892914
high O 0 0.002244136994704604
level O 0 0.0008736381423659623
of O 0 3.686286436277442e-05
somatic O 1 0.7820478677749634
mosaicism O 1 0.9995399713516235
, O 0 0.0003475701960269362
due O 0 0.0006056709098629653
to O 0 3.332603591843508e-05
an O 0 0.00013974730973131955
extremely O 0 0.011127515695989132
high O 0 0.00358246685937047
degree O 0 0.0012528784573078156
of O 0 3.802404899033718e-05
somatic O 0 0.031989678740501404
instability O 0 0.011164135299623013
both O 0 9.3434689915739e-05
within O 0 7.096362242009491e-05
and O 0 4.389573950902559e-05
between O 0 7.022654608590528e-05
different O 0 4.676965909311548e-05
tissues O 0 0.4851846396923065
. O 0 0.0005572809022851288

This O 0 0.00047912707668729126
instability O 0 0.015239931643009186
appears O 0 0.003380668116733432
to O 0 5.704657087335363e-05
be O 0 6.0991456848569214e-05
biased O 0 0.003216492012143135
towards O 0 0.0003981174377258867
further O 0 0.0001988269796129316
expansion O 0 0.0008641930762678385
and O 0 5.2206643886165693e-05
continuous O 0 0.0013644852442666888
throughout O 0 0.00015854655066505075
the O 0 8.798125054454431e-05
life O 0 0.0002104624145431444
of O 0 6.036447757651331e-06
an O 0 0.00014153143274597824
individual O 0 0.00026704760966822505
, O 0 0.00015927750791888684
features O 0 0.00021340699458960444
that O 0 5.779939237982035e-05
could O 0 0.00011772179277613759
be O 0 2.9104638088028878e-05
associated O 0 4.9973972636507824e-05
with O 0 1.2378941391943954e-05
the O 0 0.0001386748772347346
progressive O 0 0.027498766779899597
nature O 0 0.0009427960612811148
of O 0 1.860021620814223e-05
the O 0 0.0016303546726703644
disease O 1 0.9999998807907104
. O 0 0.0006115588475950062

Although O 0 0.00041391028207726777
increasing O 0 0.00026695162523537874
measured O 0 0.0008618966676294804
allele O 0 0.0025092759169638157
size O 0 0.0006115174037404358
between O 0 0.0011886530555784702
patients O 1 0.9999884366989136
clearly O 0 0.0020690441597253084
correlates O 0 0.0027360464446246624
with O 0 2.0889714505756274e-05
an O 0 0.00010636413935571909
increased O 0 0.0010630488395690918
severity O 1 0.9994403719902039
of O 0 0.0002499438123777509
symptoms O 1 0.9999991655349731
and O 0 0.0001012659995467402
an O 0 0.00017108325846493244
earlier O 0 0.0006780207622796297
age O 0 0.00032757807639427483
of O 0 5.250691538094543e-05
onset O 1 0.9999749660491943
, O 0 0.00014770898269489408
this O 0 2.8999136702623218e-05
correlation O 0 0.0014444818953052163
is O 0 0.0001273046073038131
not O 0 2.96509333566064e-05
precise O 0 0.00029726754291914403
and O 0 4.965786138200201e-05
measured O 0 0.0008060144609771669
allele O 0 0.003419543383643031
length O 0 0.000887744827196002
cannot O 0 0.0006137361633591354
be O 0 1.9454548237263225e-05
used O 0 2.0537028831313364e-05
as O 0 2.4128576114890166e-05
an O 0 5.1784587412839755e-05
accurate O 0 0.0012250544968992472
predictor O 0 0.01510670781135559
of O 0 1.5422039723489434e-05
age O 0 0.00046344639849849045
of O 0 7.412202830892056e-05
onset O 1 0.9999740123748779
. O 0 0.001107551041059196

In O 0 0.0002777061890810728
order O 0 4.823645213036798e-05
to O 0 2.757584661594592e-05
further O 0 0.000120597418572288
characterize O 0 0.010429808869957924
the O 0 0.0001315236440859735
dynamics O 0 0.014148549176752567
of O 0 0.0006182562210597098
DM B-Disease 1 1.0
CTG O 1 0.9995679259300232
repeat O 0 0.04676474630832672
somatic O 0 0.02421807497739792
instability O 0 0.014730274677276611
, O 0 0.00018693738093134016
we O 0 0.00010011038830270991
have O 0 4.409325629239902e-05
studied O 0 0.0005577954580076039
repeat O 0 0.0038890475407242775
length O 0 0.00024849080364219844
changes O 0 7.486043614335358e-05
over O 0 2.973262598970905e-05
time O 0 4.951766095473431e-05
in O 0 0.0002484282595105469
111 O 1 0.9920295476913452
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999985694885254
with O 0 0.00014053478662390262
varying O 0 0.002214697888121009
clinical O 1 0.9999983310699463
severity O 1 0.9997788071632385
and O 0 0.0011543934233486652
CTG O 1 0.9984139204025269
repeat O 0 0.009578959085047245
size O 0 0.0001351547980448231
over O 0 4.547781281871721e-05
time O 0 2.5981276849051937e-05
intervals O 0 0.00013299145211931318
of O 0 1.4342715076054446e-05
1 O 0 0.001743650995194912
- O 0 0.0033115223050117493
7 O 0 0.0006673723109997809
years O 0 0.000396417744923383
. O 0 0.0002359559730393812

We O 0 0.00041087635327130556
have O 0 3.415348328417167e-05
found O 0 3.922768519259989e-05
a O 0 8.518289541825652e-05
direct O 0 0.0002356016921112314
progression O 0 0.04673302546143532
of O 0 9.809342373046093e-06
the O 0 9.410890925209969e-05
size O 0 0.0004759538860525936
heterogeneity O 0 0.00833574216812849
over O 0 9.355630754726008e-05
time O 0 9.030087676364928e-05
related O 0 0.0004709314671345055
to O 0 0.00010541590017965063
initial O 0 0.005596146918833256
CTG O 1 0.9976022839546204
repeat O 0 0.01137020718306303
size O 0 0.00024182209745049477
and O 0 4.7099474613787606e-05
the O 0 6.204198143677786e-05
time O 0 9.980717732105404e-05
interval O 0 0.0011123932199552655
and O 0 9.203627269016579e-05
always O 0 0.0005129370838403702
biased O 0 0.0035952692851424217
towards O 0 0.00036480161361396313
further O 0 0.00019983352103736252
expansion O 0 0.0023747480008751154
. O 0 0.000340142723871395

Attempts O 0 0.001261783647350967
to O 0 5.9320838772691786e-05
mathematically O 0 0.0015269904397428036
model O 0 0.0003347866586409509
the O 0 0.00015830695338081568
dynamics O 0 0.013649900443851948
have O 0 0.00011487946903798729
proved O 0 0.004444364923983812
only O 0 9.479956497671083e-05
partially O 0 0.012701367028057575
successful O 0 0.0022134927567094564
suggesting O 0 0.001459937309846282
that O 0 1.0541318260948174e-05
individual O 0 5.000199962523766e-05
specific O 0 0.00023273630358744413
genetic O 0 0.00454539293423295
and O 0 0.0010950795840471983
/ O 1 0.9900890588760376
or O 0 0.0005656745051965117
environmental O 0 0.00409097271040082
factors O 0 0.0002631288953125477
also O 0 6.577294698217884e-05
play O 0 3.582557837944478e-05
a O 0 0.0001122376270359382
role O 0 0.0009646266116760671
in O 0 0.0003009808424394578
somatic O 0 0.11770571768283844
mosaicism O 1 0.9990099668502808
. O 0 0.00023615089594386518
. O 0 0.0002774505119305104

Aspartylglucosaminuria B-Disease 1 0.9955174326896667
among O 0 0.0005217437283135951
Palestinian O 0 0.007998990826308727
Arabs O 0 0.004342946689575911
. O 0 0.00042941878200508654

Aspartylglucosaminuria B-Disease 1 0.9997357726097107
( O 0 0.011542453430593014
AGU B-Disease 1 0.9999960660934448
) O 0 0.0003677025670185685
is O 0 9.967953519662842e-05
a O 0 0.0004165161226410419
rare O 0 0.03099929913878441
disorder B-Disease 1 0.999994158744812
of I-Disease 0 0.0001048546691890806
glycoprotein I-Disease 1 0.9987125396728516
metabolism I-Disease 1 0.9975776076316833
caused O 0 0.0055490960367023945
by O 0 4.367772999103181e-05
the O 0 0.0005444461712613702
deficiency B-Disease 1 0.9999957084655762
of I-Disease 0 9.593375580152497e-06
the I-Disease 0 0.00015075472765602171
lysosomal I-Disease 1 0.9978318810462952
enzyme I-Disease 0 0.012108287774026394
aspartylglucosaminidase I-Disease 1 0.9885121583938599
( O 0 0.002034392673522234
AGA O 1 0.9990323781967163
) O 0 0.0004431525303516537
. O 0 0.0002401942911092192

AGU B-Disease 1 0.9999992847442627
is O 0 0.0027903984300792217
inherited O 1 0.9075743556022644
as O 0 0.00019581617380026728
an O 0 0.000734877772629261
autosomal O 1 0.9999344348907471
recessive O 1 0.9999042749404907
trait O 1 0.9800351858139038
and O 0 0.00037684745620936155
occurs O 0 0.0006141311605460942
with O 0 3.5185385058866814e-05
a O 0 0.0004642112471628934
high O 0 0.001278278767131269
frequency O 0 0.0001468513219151646
in O 0 9.655555186327547e-05
Finland O 0 0.0009863022714853287
because O 0 0.00011528132745297626
of O 0 9.292335562349763e-06
a O 0 0.0007805984350852668
founder O 0 0.011282716877758503
effect O 0 0.0015501183224841952
. O 0 0.0003890102670993656

While O 0 0.0005125445313751698
very O 0 0.0007522469968535006
few O 0 0.0012941436143592
patients O 1 0.9999704360961914
with O 0 0.0006848781486041844
AGU B-Disease 1 0.9999994039535522
have O 0 0.00017891789320856333
been O 0 0.00024270793073810637
reported O 0 0.0007621013792231679
from O 0 4.913298471365124e-05
non O 0 0.0022303902078419924
- O 0 0.0031609779689460993
Finnish O 0 0.0038016291800886393
origin O 0 6.259089423110709e-05
, O 0 0.00020966828742530197
we O 0 0.0014610904036089778
diagnosed O 1 0.9999998807907104
the O 0 0.0012039507273584604
disorder O 1 0.9999990463256836
in O 0 0.0006851073121652007
8 O 0 0.004902459681034088
patients O 1 0.9999449253082275
originating O 0 0.0009695366607047617
from O 0 0.00014959969848860055
3 O 0 0.0010312923695892096
unrelated O 0 0.004535493906587362
families O 0 0.0002716579183470458
, O 0 0.0001049448037520051
all O 0 4.336996062193066e-05
Palestinian O 0 0.0067787920124828815
Arabs O 0 0.0015957459108904004
from O 0 4.256457759765908e-05
the O 0 6.33244781056419e-05
region O 0 0.0005639921873807907
of O 0 3.060706876567565e-05
Jerusalem O 0 0.020282180979847908
. O 0 0.0004018840263597667

The O 0 0.002234759973362088
clinical O 1 0.9999963045120239
diagnosis O 1 0.9999991655349731
of O 0 0.0005366588593460619
AGU B-Disease 1 0.9999998807907104
is O 0 0.0009937130380421877
often O 0 0.0003185347595717758
difficult O 0 0.0031080669723451138
, O 0 0.00012872855586465448
in O 0 5.147646152181551e-05
particular O 0 0.0001476916513638571
early O 0 0.00029511915636248887
in O 0 6.015241160639562e-05
the O 0 0.00011771854042308405
course O 0 0.0030021213460713625
of O 0 1.9110248103970662e-05
the O 0 0.0016449177637696266
disease O 1 1.0
, O 0 0.0001471903087804094
and O 0 2.515690357540734e-05
most O 0 1.6691024939063936e-05
of O 0 7.516468940593768e-06
the O 0 0.0007064752280712128
patients O 1 0.9999996423721313
are O 0 0.0003516804426908493
diagnosed O 1 1.0
after O 0 0.0007717347471043468
the O 0 7.730038487352431e-05
age O 0 0.0002517809334676713
of O 0 1.7039204976754263e-05
5 O 0 0.0008285807562060654
years O 0 0.0006322182016447186
. O 0 0.00023026794951874763

However O 0 0.0011499089887365699
, O 0 0.0002274810685776174
since O 0 0.0005477434024214745
these O 0 0.00012775466893799603
patients O 1 0.9999696016311646
excrete O 0 0.41265496611595154
early O 0 0.0001723413442960009
large O 0 2.5953466320061125e-05
amounts O 0 8.413006435148418e-05
of O 0 2.1552337784669362e-05
aspartylglucosamine O 1 0.9464873671531677
in O 0 0.000277189799817279
urine O 0 0.01263120211660862
, O 0 0.00018406991148367524
biochemical O 0 0.010976823046803474
screening O 0 0.004837268032133579
is O 0 0.00011264764907537028
easy O 0 0.00036568965879268944
by O 0 4.293818710721098e-05
urine O 0 0.025713365525007248
chromatography O 1 0.6890780925750732
. O 0 0.00024076842237263918
. O 0 0.0003062988689634949

Detection O 0 0.008945264853537083
of O 0 3.4360575227765366e-05
heterozygous O 0 0.002496086759492755
carriers O 0 0.001524854451417923
of O 0 1.711029835860245e-05
the O 0 0.0011469043092802167
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9986540079116821
telangiectasia I-Disease 1 0.9999704360961914
( O 0 0.001807528198696673
ATM O 0 0.02070814184844494
) O 0 0.00018432247452437878
gene O 0 0.000589728238992393
by O 0 9.061417222255841e-05
G2 O 1 0.999788224697113
phase O 0 0.01660824939608574
chromosomal O 0 0.01649566926062107
radiosensitivity O 0 0.041604913771152496
of O 0 8.613426325609908e-05
peripheral O 1 0.999995231628418
blood O 1 0.999834418296814
lymphocytes O 1 0.9995111227035522
. O 0 0.0007193388883024454

In O 0 0.002710694447159767
ataxia B-Disease 1 0.9999991655349731
- I-Disease 1 0.9969242215156555
telangiectasia I-Disease 1 0.9999783039093018
( O 0 0.0022852590773254633
A B-Disease 1 0.9997681975364685
- I-Disease 1 0.99973064661026
T I-Disease 1 0.9999969005584717
) O 0 0.0014813526067882776
patients O 1 0.9999699592590332
, O 0 0.00014773811562918127
mutations O 0 0.000505093194078654
in O 0 2.8459799068514258e-05
a O 0 0.00016228282765951008
single O 0 0.0002971807844005525
gene O 0 0.0015549613162875175
, O 0 0.00020009014406241477
ATM O 0 0.01230549719184637
, O 0 0.00010901181667577475
result O 0 0.00019650613830890507
in O 0 9.613083966542035e-05
an O 0 0.00211447780020535
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
that O 0 0.0004770049126818776
embraces O 0 0.009477741084992886
a O 0 0.00020590036001522094
variety O 0 0.00016648585733491927
of O 0 5.357137706596404e-05
clinical O 1 0.9999773502349854
features O 0 0.0004335727426223457
and O 0 0.0002721017226576805
manifests O 1 0.924740195274353
extreme O 0 0.02594452165067196
radiosensitivity O 0 0.3916003704071045
and O 0 6.28148191026412e-05
a O 0 0.00016670013428665698
strong O 0 0.0004911583382636309
pre O 0 0.014448761940002441
- O 0 0.007185694295912981
disposition O 0 0.02137051150202751
to O 0 0.0005764375673606992
malignancy B-Disease 1 0.9999678134918213
. O 0 0.0005434678751043975

Heterozygotes O 0 0.20044459402561188
for O 0 0.00019980152137577534
the O 0 0.00024761902750469744
ATM O 0 0.02247043326497078
gene O 0 0.0010552367893978953
have O 0 3.673904575407505e-05
no O 0 0.00010666284651961178
clinical O 1 0.9218984842300415
expression O 0 0.0001416962913936004
of O 0 3.301455217297189e-05
A B-Disease 1 0.9992478489875793
- I-Disease 1 0.9988009929656982
T I-Disease 1 0.9999946355819702
but O 0 0.000318967824568972
may O 0 0.0010708571644499898
be O 0 0.0008235457353293896
cancer B-Disease 1 0.9999998807907104
prone O 0 0.255037784576416
with O 0 5.788687849417329e-05
a O 0 0.0003859156568069011
moderate O 0 0.004047218710184097
increase O 0 0.00023174607485998422
in O 0 6.252938328543678e-05
in O 0 0.00012220162898302078
vitro O 0 0.008374249562621117
radiosensitivity O 1 0.8790155649185181
. O 0 0.0005164204048924148

We O 0 0.0004425678343977779
performed O 0 0.0006965409265831113
a O 0 0.0007089508580975235
blind O 1 0.8916267156600952
chromosomal O 0 0.007938624359667301
analysis O 0 0.00039315971662290394
on O 0 0.0010421377373859286
G2 O 1 0.9999676942825317
- O 0 0.011827751994132996
phase O 0 0.015700753778219223
lymphocytes O 1 0.8081881999969482
from O 0 6.297039362834767e-05
7 O 0 0.0004869925032835454
unrelated O 0 0.00481601245701313
A B-Disease 1 0.9983545541763306
- I-Disease 1 0.9997405409812927
T I-Disease 1 0.9999994039535522
patients O 1 0.9999809265136719
, O 0 0.00016579609655309469
13 O 0 0.0007948008133098483
obligate O 0 0.050537656992673874
A B-Disease 1 0.9928569793701172
- I-Disease 1 0.9960674047470093
T I-Disease 1 0.9999819993972778
heterozygotes O 1 0.9151150584220886
( O 0 0.00043428567005321383
parents O 0 0.00012500367301981896
of O 0 1.0772191672003828e-05
the O 0 0.0012169964611530304
patients O 1 0.9999969005584717
) O 0 0.0003010623622685671
, O 0 8.594957762397826e-05
and O 0 8.681994950165972e-05
14 O 0 0.000589077128097415
normal O 0 0.0013285010354593396
controls O 0 0.0012343480484560132
following O 0 0.001373482751660049
X O 0 0.03304693475365639
- O 0 0.004205802921205759
irradiation O 0 0.009030924178659916
with O 0 8.45287722768262e-05
1 O 0 0.0026224362663924694
Gy O 1 0.8123661875724792
in O 0 6.009760181768797e-05
order O 0 4.140807141084224e-05
to O 0 5.217518628342077e-05
evaluate O 0 0.006596008315682411
this O 0 5.309107655193657e-05
cytogenetic O 0 0.07907090336084366
method O 0 0.0002707993844524026
as O 0 8.580871508456767e-05
a O 0 0.0002010808530030772
tool O 0 0.0029772508423775434
for O 0 0.00011906398867722601
detection O 0 0.002643296495079994
of O 0 2.5809793442022055e-05
ATM O 0 0.03705807775259018
carriers O 0 0.01573280431330204
. O 0 0.0004498980997595936

Both O 0 0.0010569249279797077
A B-Disease 1 0.9956067204475403
- I-Disease 1 0.9976703524589539
T I-Disease 1 0.9999762773513794
homozygotes O 1 0.987808346748352
and O 0 0.00046338365064002573
heterozygotes O 0 0.3987325429916382
showed O 0 0.0011196561390534043
significantly O 0 0.0013245984446257353
increased O 0 9.75172224570997e-05
levels O 0 0.0005599152646027505
of O 0 3.6709981941385195e-05
radiation O 1 0.9999608993530273
- O 1 0.5988447070121765
induced O 1 0.998665452003479
chromatid O 1 0.9997541308403015
damage O 0 0.35815489292144775
relative O 0 0.0002576283586677164
to O 0 2.0075305656064302e-05
that O 0 6.431464498746209e-06
of O 0 7.504621407861123e-06
normal O 0 0.0022499302867799997
controls O 0 0.002130085602402687
. O 0 0.0004799402377102524

These O 0 6.670704169664532e-05
results O 0 0.00031967743416316807
show O 0 0.00012873444939032197
that O 0 2.2342068405123428e-05
the O 0 0.00034998703631572425
G2 O 1 0.999953031539917
- O 0 0.0116852642968297
phase O 0 0.010963588953018188
chromosomal O 0 0.03076356090605259
radiosensitivity O 1 0.7376841902732849
assay O 0 0.00678795762360096
can O 0 7.651244231965393e-05
be O 0 1.755551784299314e-05
used O 0 1.5917648852337152e-05
for O 0 1.4450600247073453e-05
the O 0 2.440027856209781e-05
detection O 0 0.001276215654797852
of O 0 2.2882770281285048e-05
A B-Disease 1 0.9988532066345215
- I-Disease 1 0.9981707334518433
T I-Disease 1 0.9999752044677734
heterozygotes O 1 0.6841270327568054
. O 0 0.000488319608848542

In O 0 0.0005567247280851007
combination O 0 0.003040175186470151
with O 0 0.0001099960645660758
molecular O 0 0.0031088741961866617
genetic O 0 0.0013803106267005205
analyses O 0 0.001182336243800819
, O 0 0.00011935830116271973
this O 0 7.571766764158383e-05
test O 0 0.002348143607378006
may O 0 0.000382265483494848
be O 0 7.066784746712074e-06
of O 0 1.5999520428522374e-06
value O 0 4.7151650505838916e-05
in O 0 4.5918262912891805e-05
studies O 0 0.00019554805476218462
of O 0 2.9906916097388603e-05
familial B-Disease 1 0.9999510049819946
and I-Disease 0 0.0008648801012896001
sporadic I-Disease 1 0.8494457602500916
cancers I-Disease 1 0.999976634979248
aimed O 0 0.0023710059467703104
at O 0 0.0006493079126812518
determination O 0 0.0016660080291330814
of O 0 7.994416591827758e-06
the O 0 7.999000081326813e-05
potential O 0 0.0008404178661294281
involvement O 0 0.0023817308247089386
of O 0 1.7383987142238766e-05
ATM O 0 0.025543147698044777
mutations O 0 0.0026236074045300484
in O 0 0.0007417068700306118
tumor B-Disease 1 0.9999995231628418
risk O 1 0.7556226849555969
or O 0 0.000365711486665532
development O 0 0.0015814383514225483
. O 0 0.00012786666047759354
. O 0 0.00022529902344103903

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.999563992023468
telangiectasia I-Disease 1 0.9999865293502808
: O 0 0.000670764537062496
identification O 0 0.0003312290646135807
and O 0 5.391824743128382e-05
detection O 0 0.003145291469991207
of O 0 3.82479302061256e-05
founder O 0 0.08296550065279007
- O 0 0.005090787541121244
effect O 0 0.0006620358326472342
mutations O 0 0.0005499696126207709
in O 0 5.00991809531115e-05
the O 0 0.00015179994807112962
ATM O 0 0.022539639845490456
gene O 0 0.0009364371653646231
in O 0 4.7309251385740936e-05
ethnic O 0 6.642951484536752e-05
populations O 0 0.0006492157117463648
. O 0 0.00039710296550765634

To O 0 0.00017057795776054263
facilitate O 0 0.0008398423087783158
the O 0 9.711317397886887e-05
evaluation O 0 0.0065131960436701775
of O 0 3.3084583265008405e-05
ATM O 0 0.44813311100006104
heterozygotes O 1 0.6220689415931702
for O 0 0.00021617415768560022
susceptibility O 0 0.03734983876347542
to O 0 7.523177191615105e-05
other O 0 0.0001437929313397035
diseases O 1 0.9999995231628418
, O 0 5.3822845075046644e-05
such O 0 3.644564640126191e-05
as O 0 0.01372004859149456
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0002555031387601048
we O 0 0.00011197786807315424
have O 0 4.0100847400026396e-05
attempted O 0 0.0004884717636741698
to O 0 2.7380307074054144e-05
define O 0 0.0008410916198045015
the O 0 9.707309800432995e-05
most O 0 0.00017038352962117642
common O 0 0.0017779768677428365
mutations O 0 0.0011821114458143711
and O 0 2.6521534891799092e-05
their O 0 7.412227205350064e-06
frequencies O 0 0.00012079699808964506
in O 0 0.0005371217848733068
ataxia B-Disease 1 0.9999991655349731
- I-Disease 1 0.9825071692466736
telangiectasia I-Disease 1 0.9999340772628784
( O 0 0.0021936262492090464
A B-Disease 1 0.9988170862197876
- I-Disease 1 0.997003972530365
T I-Disease 1 0.9999713897705078
) O 0 0.0009049428044818342
homozygotes O 1 0.7446413040161133
from O 0 9.247913112631068e-05
10 O 0 0.00010988976282533258
ethnic O 0 5.403055911301635e-05
populations O 0 0.000463692907942459
. O 0 0.0003573778667487204

Both O 0 0.00042245673830620944
genomic O 0 0.00470585934817791
mutations O 0 0.0013875430449843407
and O 0 3.765777000808157e-05
their O 0 1.9703513316926546e-05
effects O 0 0.0018311894964426756
on O 0 0.00014298417954705656
cDNA O 0 0.0014741941122338176
were O 0 4.9101694457931444e-05
characterized O 0 0.016842560842633247
. O 0 0.0005363533273339272

Protein O 0 0.004823729861527681
- O 0 0.0071357316337525845
truncation O 0 0.016438914462924004
testing O 0 0.001216947683133185
of O 0 4.148797870584531e-06
the O 0 4.8649868404027075e-05
entire O 0 0.0016849618405103683
ATM O 0 0.01180388405919075
cDNA O 0 0.005172118544578552
detected O 0 0.010164747945964336
92 O 0 0.01360263954848051
( O 0 0.0005634854314848781
66 O 0 0.0055313860066235065
% O 0 8.909656025934964e-05
) O 0 0.0003219275386072695
truncating O 0 0.10544037073850632
mutations O 0 0.0014784341910853982
in O 0 0.0001206567685585469
140 O 0 0.0019322782754898071
mutant O 0 0.005428881850093603
alleles O 0 0.004573321435600519
screened O 0 0.007158544845879078
. O 0 0.0004467348335310817

The O 0 0.0009546689107082784
haplotyping O 0 0.3751513957977295
of O 0 0.00018473398813512176
patients O 1 0.9999866485595703
with O 0 7.123291288735345e-05
identical O 0 0.0011560159036889672
mutations O 0 0.002609817311167717
indicates O 0 0.0015584032516926527
that O 0 2.4805209250189364e-05
almost O 0 6.76426716381684e-05
all O 0 3.983336682722438e-06
of O 0 3.1182482871372486e-06
these O 0 1.0417595149192493e-05
represent O 0 0.00021770667808596045
common O 0 0.0013579877559095621
ancestry O 0 0.00037435555714182556
and O 0 6.882020534249023e-05
that O 0 3.0063278245506808e-05
very O 0 0.00029273107065819204
few O 0 0.0003003464953508228
spontaneously O 0 0.020111368969082832
recurring O 1 0.953011155128479
ATM O 0 0.04746951162815094
mutations O 0 0.002802728209644556
exist O 0 0.0004400207253638655
. O 0 0.0002887327573262155

Assays O 0 0.005234564188867807
requiring O 0 0.002037630882114172
minimal O 0 0.0013196133077144623
amounts O 0 0.00010281424329150468
of O 0 1.6569794752285816e-05
genomic O 0 0.0032913193572312593
DNA O 0 0.000885044748429209
were O 0 2.281060915265698e-05
designed O 0 0.00027956627309322357
to O 0 2.5374572942382656e-05
allow O 0 0.00014527943858411163
rapid O 0 0.007435618434101343
screening O 0 0.0037547461688518524
for O 0 9.79205287876539e-05
common O 0 0.0006541446200571954
ethnic O 0 0.00020791873976122588
mutations O 0 0.003322610864415765
. O 0 0.00037115957820788026

These O 0 7.266380998771638e-05
rapid O 0 0.006684464402496815
assays O 0 0.0027697812765836716
detected O 0 0.006525225471705198
mutations O 0 0.0008528221515007317
in O 0 0.00013330709771253169
76 O 0 0.003375842235982418
% O 0 2.118868360412307e-05
of O 0 1.5728710422990844e-05
Costa O 0 0.013980811461806297
Rican O 0 0.014024361036717892
patients O 1 0.9999639987945557
( O 0 0.0007793704862706363
3 O 0 0.000990786706097424
) O 0 0.00011794764577643946
, O 0 6.472341920016333e-05
50 O 0 9.451677033212036e-05
% O 0 1.0844922144315206e-05
of O 0 1.9444569261395372e-05
Norwegian O 0 0.02251049317419529
patients O 1 0.9999853372573853
( O 0 0.0009914959082379937
1 O 0 0.0016924645751714706
) O 0 0.00013374598347581923
, O 0 6.03566259087529e-05
25 O 0 0.00010179675882682204
% O 0 1.0861213013413362e-05
of O 0 2.916712583100889e-05
Polish O 1 0.9961994290351868
patients O 1 0.9999985694885254
( O 0 0.0010452867718413472
4 O 0 0.001756812329404056
) O 0 0.00018122962501365691
, O 0 9.334403875982389e-05
and O 0 8.745494415052235e-05
14 O 0 0.00027162241167388856
% O 0 1.1250784154981375e-05
of O 0 2.1171757907723077e-05
Italian O 0 0.10924322158098221
patients O 1 0.9999985694885254
( O 0 0.001014816458337009
1 O 0 0.0016599169466644526
) O 0 0.00014335470041260123
, O 0 6.398441473720595e-05
as O 0 7.050709973555058e-05
well O 0 6.548305827891454e-05
as O 0 0.00014722540799994022
in O 0 0.0003373440995346755
patients O 1 0.9996911287307739
of O 0 8.249456732301041e-05
Amish O 0 0.2957311272621155
/ O 0 0.4676416218280792
Mennonite O 0 0.030742162838578224
and O 0 0.0002724121150095016
Irish O 0 0.0022364938631653786
English O 0 0.0007118717767298222
backgrounds O 0 0.001819933415390551
. O 0 0.0005246593500487506

Additional O 0 0.0009866002947092056
mutations O 0 0.0008687289082445204
were O 0 1.6898919056984596e-05
observed O 0 0.00016171546303667128
in O 0 6.070828385418281e-05
Japanese O 0 0.0008286039810627699
, O 0 0.00024139639572240412
Utah O 0 0.005544259212911129
Mormon O 0 0.0016422126209363341
, O 0 0.00010420040780445561
and O 0 0.00010222807759419084
African O 0 0.0018675730098038912
American O 0 0.003961652982980013
patients O 1 0.9999862909317017
. O 0 0.0004600356915034354

These O 0 5.053462155046873e-05
assays O 0 0.0005825439584441483
should O 0 0.00010109812137670815
facilitate O 0 0.0009202429791912436
screening O 0 0.003013963345438242
for O 0 0.00039340605144388974
A B-Disease 1 0.9961941242218018
- I-Disease 1 0.9946626424789429
T I-Disease 1 0.9999556541442871
heterozygotes O 0 0.14251156151294708
in O 0 7.125397678464651e-05
the O 0 7.054946763673797e-05
populations O 0 0.0002518284600228071
studied O 0 0.0011048880405724049
. O 0 0.00010873712017200887
. O 0 0.00024152481637429446

The O 0 0.0010197919327765703
von B-Disease 1 0.9788642525672913
Hippel I-Disease 1 0.9999651908874512
- I-Disease 1 0.9982043504714966
Lindau I-Disease 1 0.999990701675415
tumor I-Disease 1 0.9999727010726929
suppressor O 0 0.04230343550443649
gene O 0 0.0008413983159698546
is O 0 9.181378845823929e-05
required O 0 0.00013802608009427786
for O 0 9.680567018222064e-05
cell O 0 0.0018068838398903608
cycle O 0 0.0013034522999078035
exit O 0 0.005163643043488264
upon O 0 0.0007264453452080488
serum O 1 0.9891751408576965
withdrawal O 0 0.01325886882841587
. O 0 0.0003590332344174385

The O 0 0.0005276634474284947
inactivation O 0 0.01781964674592018
of O 0 1.250292370968964e-05
the O 0 0.00033592767431400716
von B-Disease 1 0.9136471152305603
Hippel I-Disease 1 0.9998427629470825
- I-Disease 0 0.2813580632209778
Lindau I-Disease 1 0.9997439980506897
( I-Disease 0 0.00266055203974247
VHL I-Disease 1 0.999974250793457
) I-Disease 0 0.00240611145272851
tumor I-Disease 1 0.999998927116394
suppressor O 1 0.935522735118866
gene O 0 0.009097614325582981
predisposes O 1 0.9991563558578491
affected O 0 0.002544848481193185
individuals O 0 3.4026212233584374e-05
to O 0 1.5861143765505403e-05
the O 0 0.0001269200147362426
human O 1 0.9410496950149536
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.00020203483290970325
is O 0 0.00013686984311789274
associated O 0 9.302503895014524e-05
with O 0 9.87108433037065e-05
sporadic B-Disease 1 0.9952343106269836
renal I-Disease 1 1.0
cell I-Disease 1 0.999146580696106
carcinomas I-Disease 1 0.9999997615814209
( O 0 0.006203516852110624
RCC B-Disease 1 0.9999997615814209
) O 0 0.0005345784593373537
and O 0 0.00042580522131174803
brain B-Disease 1 0.9999850988388062
hemangioblastomas I-Disease 1 0.9880467653274536
. O 0 0.0004895246238447726

VHL O 1 0.9992478489875793
- O 0 0.012862548232078552
negative O 0 0.003264796221628785
786 O 1 0.9431353807449341
- O 0 0.012158763594925404
0 O 0 0.00469245994463563
RCC B-Disease 1 0.9999637603759766
cells O 0 0.001972261583432555
are O 0 2.8159965950180776e-05
tumorigenic O 0 0.142849862575531
in O 0 0.0003833209921140224
nude O 0 0.13852781057357788
mice O 0 0.00868562888354063
which O 0 4.490237552090548e-05
is O 0 0.000151812972035259
suppressed O 0 0.0013722117291763425
by O 0 1.0856843800866045e-05
the O 0 9.275229967897758e-05
reintroduction O 0 0.01353976409882307
of O 0 0.00013381714234128594
VHL B-Disease 1 0.999910831451416
. O 0 0.0013333979295566678

Remarkably O 0 0.21117658913135529
, O 0 0.00025601719971746206
this O 0 4.921372965327464e-05
occurs O 0 0.000625971588306129
without O 0 0.00013750455400440842
affecting O 0 0.003148261923342943
the O 0 0.0001156069411081262
growth O 0 0.0009913500398397446
rate O 0 0.00023139017866924405
and O 0 0.00012190901907160878
cell O 0 0.0038156535010784864
cycle O 0 0.0014081218978390098
profile O 0 0.0012388048926368356
of O 0 7.2302423177461606e-06
these O 0 2.0847823179792613e-05
cells O 0 0.0011105482699349523
in O 0 7.566475687781349e-05
culture O 0 0.0007869880646467209
. O 0 0.0003832759102806449

The O 0 0.001772583811543882
786 O 1 0.8859267234802246
- O 0 0.006388562265783548
0 O 0 0.0008015201310627162
cell O 0 0.0013303672894835472
line O 0 0.0005744920927099884
, O 0 6.644528912147507e-05
like O 0 0.00019394076662138104
many O 0 0.000411382905440405
cancer B-Disease 1 1.0
cells O 0 0.006685025990009308
, O 0 0.0002813521714415401
fails O 0 0.015391861088573933
to O 0 5.8267920394428074e-05
exit O 0 0.00310496031306684
the O 0 7.84851799835451e-05
cell O 0 0.0014476466458290815
cycle O 0 0.0008352676522918046
upon O 0 0.0007825155043974519
serum O 1 0.9791983366012573
withdrawal O 0 0.013252831995487213
. O 0 0.0004046388203278184

Here O 0 0.0011836133198812604
, O 0 0.00012704012624453753
it O 0 8.078123209998012e-05
is O 0 0.00014295734581537545
shown O 0 0.00021882777218706906
that O 0 2.180646697524935e-05
reintroduction O 0 0.0022453900892287493
of O 0 3.3875448934850283e-06
the O 0 7.673852087464184e-05
wild O 0 0.0006526426295749843
- O 0 0.009044940583407879
type O 0 0.017167259007692337
VHL B-Disease 1 0.9998180270195007
gene O 0 0.003888146486133337
restores O 0 0.009107675403356552
the O 0 3.410554563743062e-05
ability O 0 0.0006209502462297678
of O 0 7.315564289456233e-05
VHL O 1 0.9999973773956299
- O 1 0.6996214389801025
negative O 0 0.03740952908992767
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cells O 0 0.0020490814931690693
to O 0 5.7818695495370775e-05
exit O 0 0.002906310372054577
the O 0 8.754924783715978e-05
cell O 0 0.0014097755774855614
cycle O 0 0.0007584828417748213
and O 0 0.00013873266289010644
enter O 0 0.007173104677349329
G0 O 1 0.9999498128890991
/ O 0 0.2632380425930023
quiescence O 0 0.053419142961502075
in O 0 0.0001684849412413314
low O 0 0.005091908387839794
serum O 1 0.9821494221687317
. O 0 0.0005077795940451324

Both O 0 0.002432770561426878
VHL O 1 0.9997747540473938
- O 0 0.009285951964557171
positive O 0 0.001446075621061027
and O 0 0.000556263024918735
VHL O 1 0.9999630451202393
- O 0 0.024894213303923607
negative O 0 0.006360769737511873
RCC B-Disease 1 0.9999932050704956
cells O 0 0.005390866193920374
exit O 0 0.004283836577087641
the O 0 9.186388342641294e-05
cell O 0 0.0017679593292996287
cycle O 0 0.0005255994037725031
by O 0 3.08109556499403e-05
contact O 0 0.0023190637584775686
inhibition O 0 0.0069543542340397835
. O 0 0.0005567138432525098

The O 0 0.0009239919018000364
cyclin O 0 0.2598773241043091
- O 0 0.0031441375613212585
dependent O 0 0.0018295968184247613
kinase O 0 0.015345398336648941
inhibitor O 0 0.04834611713886261
, O 0 0.0004532543825916946
p27 O 1 0.9348745942115784
, O 0 0.000299579172860831
accumulates O 0 0.04318428039550781
upon O 0 0.0009564113570377231
serum O 1 0.9931706190109253
withdrawal O 0 0.011902992613613605
, O 0 6.628827395616099e-05
only O 0 1.806182444852311e-05
in O 0 2.6045754566439427e-05
the O 0 4.8156802222365513e-05
presence O 0 0.00039718925836496055
of O 0 0.0001210013942909427
VHL B-Disease 1 0.9999772310256958
, O 0 0.0003692647151183337
as O 0 0.00011798487685155123
a O 0 0.0001916458859341219
result O 0 0.00014153317897580564
of O 0 5.067641723144334e-06
the O 0 9.302752005169168e-05
stabilization O 0 0.015874745324254036
of O 0 5.907793365622638e-06
the O 0 7.214418292278424e-05
protein O 0 0.0007790453382767737
. O 0 0.0003331234329380095

We O 0 0.0006122329505160451
propose O 0 0.0017797753680497408
that O 0 1.5060324585647322e-05
the O 0 3.5973200283478945e-05
loss O 0 0.001353093539364636
of O 0 1.3469235454977024e-05
wild O 0 0.000999813200905919
- O 0 0.022829098626971245
type O 0 0.04750565439462662
VHL B-Disease 1 0.9999369382858276
gene O 0 0.0028054602444171906
results O 0 0.0002950088819488883
in O 0 2.730937922024168e-05
a O 0 0.00014348419790621847
specific O 0 0.00024198908067774028
cellular O 0 0.020826753228902817
defect O 1 0.9977055191993713
in O 0 0.0005430512828752398
serum O 1 0.9966365098953247
- O 0 0.004086910746991634
dependent O 0 0.0013379505835473537
growth O 0 0.0007587369182147086
control O 0 0.0007386234356090426
, O 0 8.050807809922844e-05
which O 0 3.106983785983175e-05
may O 0 0.0007856580778025091
initiate O 0 0.036558784544467926
tumor B-Disease 1 0.9999823570251465
formation O 0 0.01952756568789482
. O 0 0.0004743016615975648

This O 0 0.0002596449921838939
is O 0 0.0004970014560967684
corrected O 0 0.015373235568404198
by O 0 1.5804249414941296e-05
the O 0 5.987028271192685e-05
reintroduction O 0 0.00427002040669322
of O 0 1.0785061022033915e-05
wild O 0 0.0007597491494379938
- O 0 0.0116376718506217
type O 0 0.0340067595243454
VHL B-Disease 1 0.999954104423523
, O 0 0.0016546028200536966
implicating O 1 0.9971559047698975
VHL B-Disease 1 0.999883770942688
as O 0 0.00020575575763359666
the O 0 0.00013002860941924155
first O 0 0.0007850443944334984
tumor B-Disease 1 0.9999876022338867
suppressor O 0 0.02979767508804798
involved O 0 0.0004102139500901103
in O 0 2.4475510144839063e-05
the O 0 3.9195634599309415e-05
regulation O 0 0.0002775700995698571
of O 0 1.926504774019122e-05
cell O 0 0.004907428752630949
cycle O 0 0.0030698312912136316
exit O 0 0.011408724822103977
, O 0 0.00010383519838796929
which O 0 2.5608163923607208e-05
is O 0 8.18002808955498e-05
consistent O 0 0.000846521754283458
with O 0 2.2892527340445668e-05
its O 0 0.00021252148144412786
gatekeeper O 1 0.9812580347061157
function O 0 0.00040412769885733724
in O 0 0.00010866952652577311
the O 0 0.0009781348053365946
kidney O 1 1.0
. O 0 0.0002802852541208267
. O 0 0.00026315374998375773

Piebaldism B-Disease 1 0.9998579025268555
with O 0 0.0036415206268429756
deafness B-Disease 1 1.0
: O 0 0.0009317007497884333
molecular O 0 0.0013254930963739753
evidence O 0 9.844933083513752e-05
for O 0 4.9618814955465496e-05
an O 0 0.00028161812224425375
expanded O 0 0.04536805674433708
syndrome O 1 1.0
. O 0 0.0008586387266404927

In O 0 0.00045238935854285955
a O 0 0.0007053295848891139
South O 0 0.0019673709757626057
African O 0 0.0018777336226776242
girl O 0 0.009355858899652958
of O 0 6.845615280326456e-05
Xhosa O 1 0.9973752498626709
stock O 0 0.010235609486699104
with O 0 0.0004471433348953724
severe O 1 0.9999926090240479
piebaldism B-Disease 1 0.9992432594299316
and O 0 0.0006927569047547877
profound O 1 0.9999785423278809
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.0007672917563468218
identified O 0 0.0004144367703702301
a O 0 0.0001729776558931917
novel O 0 0.0010428469395264983
missense O 0 0.005588684696704149
substitution O 0 0.0004176619986537844
at O 0 0.00031804622267372906
a O 0 0.00019517958571668714
highly O 0 0.0009164332877844572
conserved O 0 0.00024875206872820854
residue O 0 0.0043286834843456745
in O 0 3.26342269545421e-05
the O 0 6.87135907355696e-05
intracellular O 0 0.008463118225336075
kinase O 0 0.003625379642471671
domain O 0 7.575811468996108e-05
of O 0 5.804105967399664e-06
the O 0 0.0004260496352799237
KIT O 1 0.9977845549583435
proto O 1 0.9856611490249634
- O 0 0.0268767811357975
oncogene O 1 0.931928813457489
, O 0 0.0004996472271159291
R796G O 0 0.04226086288690567
. O 0 0.0004559797525871545

Though O 0 0.004377109929919243
auditory B-Disease 1 0.9967801570892334
anomalies I-Disease 1 0.8299921751022339
have O 0 6.340254185488448e-05
been O 0 8.46005350467749e-05
observed O 0 0.00017118277901317924
in O 0 9.255341865355149e-05
mice O 0 0.0031236899085342884
with O 0 5.644219709211029e-05
dominant O 0 0.01493906881660223
white O 0 0.25500908493995667
spotting O 1 0.9986329674720764
( O 0 0.006670728325843811
W O 1 0.9990689158439636
) O 0 0.0002812902384903282
due O 0 0.000657964323181659
to O 0 0.00023377845354843885
KIT O 1 0.9989553689956665
mutations O 0 0.006186367012560368
, O 0 0.0014449250884354115
deafness B-Disease 1 1.0
is O 0 0.0005119633278809488
not O 0 6.84923943481408e-05
typical O 0 0.0007143336115404963
in O 0 0.00013477796164806932
human O 0 0.00197616801597178
piebaldism B-Disease 1 0.963731050491333
. O 0 0.0006033550598658621

Thus O 0 0.0006547109223902225
, O 0 6.121771730249748e-05
the O 0 6.426620529964566e-05
occurrence O 0 0.005373215768486261
of O 0 0.0002722223289310932
sensorineural B-Disease 1 0.9999998807907104
deafness I-Disease 1 1.0
in O 0 0.00047518187784589827
this O 0 0.00021386043226812035
patient O 1 0.9992628693580627
extends O 0 0.011782405897974968
considerably O 0 0.0032313126139342785
the O 0 8.860480011207983e-05
phenotypic O 0 0.005555359646677971
range O 0 0.0003672681632451713
of O 0 3.396908869035542e-05
piebaldism B-Disease 1 0.9925464987754822
due O 0 0.0014006596757099032
to O 0 0.00022630464809481055
KIT O 1 0.983299970626831
gene O 0 0.0019168904982507229
mutation O 0 0.0009847726905718446
in O 0 0.00010202444536844268
humans O 0 0.0014723142376169562
and O 0 0.0003370800113771111
tightens O 0 0.4155215620994568
the O 0 0.0005830967565998435
clinical O 1 0.9989169836044312
similarity O 0 0.0013373220572248101
between O 0 0.0005409200675785542
piebaldism B-Disease 1 0.98593670129776
and O 0 4.838673703488894e-05
the O 0 1.9383138351258822e-05
various O 0 1.0558844223851338e-05
forms O 0 0.0004674510273616761
of O 0 0.0004020975320599973
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0004498341877479106
. O 0 0.0003398921398911625

Cycloheximide O 1 0.7985743284225464
facilitates O 0 0.011583531275391579
the O 0 9.566590597387403e-05
identification O 0 0.0001846991217462346
of O 0 2.415758353890851e-05
aberrant O 0 0.09229172766208649
transcripts O 0 0.0016822234028950334
resulting O 0 0.0005067182355560362
from O 0 3.625325916800648e-05
a O 0 0.0003270291490480304
novel O 0 0.0018116348655894399
splice O 0 0.05437794700264931
- O 0 0.007621805649250746
site O 0 0.0011536567471921444
mutation O 0 0.0007604992133565247
in O 0 0.00016144785331562161
COL17A1 O 1 0.9967013001441956
in O 0 8.372734009753913e-05
a O 0 0.0005306852981448174
patient O 1 0.999561607837677
with O 0 0.0002677060547284782
generalized O 1 0.9995080232620239
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9999994039535522
bullosa I-Disease 1 0.9999940395355225
. O 0 0.002975975861772895

Patients O 1 0.9999580383300781
with O 0 0.00040055689169093966
generalized O 1 0.9996335506439209
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999947547912598
often O 0 0.0012251168955117464
show O 0 0.0005543797742575407
decreased O 0 0.0029913480393588543
expression O 0 0.00014394601748790592
of O 0 3.074204141739756e-05
type O 1 0.9930064678192139
XVII O 1 0.9999984502792358
collagen O 1 0.999784529209137
, O 0 0.0001401937479386106
a O 0 0.00028181259403936565
transmembrane O 0 0.007499030325561762
hemidesmosomal O 0 0.0181642547249794
protein O 0 8.974101365311071e-05
encoded O 0 2.542500624258537e-05
by O 0 7.026197999948636e-05
COL17A1 O 1 0.9946498274803162
. O 0 0.0005157712730579078

This O 0 0.0001805476495064795
report O 0 0.00030077859992161393
documents O 0 9.193145524477586e-05
a O 0 0.0002795689506456256
novel O 0 0.001735973753966391
splice O 0 0.045083656907081604
- O 0 0.006673838477581739
site O 0 0.001527407206594944
mutation O 0 0.0009165414958260953
in O 0 0.0002004644338740036
COL17A1 O 1 0.9902837872505188
in O 0 9.927543578669429e-05
a O 0 0.0006264643161557615
patient O 1 0.9989475607872009
with O 0 0.0002528408367652446
generalized O 1 0.9993267059326172
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999995231628418
bullosa I-Disease 1 0.9999909400939941
, O 0 0.0012479547876864672
and O 0 0.00017372425645589828
applies O 0 0.001213260693475604
a O 0 0.0003511917602736503
new O 0 0.00018974435806740075
methodology O 0 0.0032683266326785088
to O 0 7.137829379644245e-05
define O 0 0.0017058775993064046
and O 0 0.00012453646922949702
characterize O 0 0.013727088458836079
the O 0 8.251793042290956e-05
resulting O 0 0.0005448636366054416
mRNA O 0 0.0004607165465131402
splice O 0 0.014525022357702255
variants O 0 0.0014552632346749306
. O 0 0.00042003951966762543

Mutational O 0 0.16473937034606934
analysis O 0 0.0003393763327039778
of O 0 5.250045796856284e-05
COL17A1 O 1 0.9959096908569336
identified O 0 0.0006587938405573368
a O 0 0.00043145069503225386
maternally O 0 0.045207563787698746
inherited O 1 0.9933557510375977
G O 1 0.7026434540748596
- O 0 0.004875554703176022
to O 0 0.0003546843072399497
- O 0 0.035304732620716095
T O 1 0.9964001178741455
transversion O 0 0.08009219914674759
at O 0 0.0005328303086571395
the O 0 0.00025274348445236683
- O 0 0.0019572703167796135
1 O 0 0.0001962893147720024
position O 0 0.00018451077630743384
of O 0 1.4686310350953136e-05
exon O 0 0.026081359013915062
32 O 0 0.0014836787013337016
. O 0 0.00024727339041419327

This O 0 0.00031096191378310323
acceptor O 0 0.08609100431203842
splice O 0 0.0670202299952507
- O 0 0.00906505435705185
site O 0 0.0014841330703347921
mutation O 0 0.0007053985609672964
led O 0 0.00014648881915491074
to O 0 2.3577833417220972e-05
the O 0 7.582589751109481e-05
formation O 0 0.003115999046713114
of O 0 3.065865894313902e-05
aberrant O 0 0.0846908837556839
transcripts O 0 0.0020933402702212334
present O 0 0.00013303851301316172
at O 0 0.0006417781114578247
extremely O 0 0.00570360803976655
low O 0 0.0043900408782064915
levels O 0 0.004855182487517595
. O 0 0.0003431484801694751

Based O 0 0.00043144903611391783
on O 0 8.827353303786367e-05
our O 0 0.00013448193203657866
recent O 0 0.0002494736108928919
finding O 0 0.0005599967553280294
that O 0 9.920739830704406e-05
cycloheximide O 1 0.9745000004768372
stabilized O 1 0.9755728840827942
mutant O 0 0.014544188044965267
COL17A1 O 1 0.9376728534698486
transcripts O 0 0.00147647422272712
in O 0 0.00020784602384082973
keratinocytes O 0 0.31751468777656555
homozygous O 0 0.001994743011891842
for O 0 9.908903302857652e-05
a O 0 0.0014248703373596072
frameshift O 1 0.9798398613929749
mutation O 0 0.003997241612523794
, O 0 9.697511268313974e-05
the O 0 7.118810754036531e-05
effects O 0 0.0010271770879626274
of O 0 1.1450920283095911e-05
the O 0 0.00030275050085037947
splice O 0 0.07185804843902588
- O 0 0.00777386873960495
site O 0 0.001351096318103373
mutation O 0 0.0004394715651869774
on O 0 5.616503767669201e-05
splicing O 0 0.0008140280260704458
of O 0 7.356685091508552e-05
COL17A1 O 1 0.9945992231369019
transcripts O 0 0.001700994442217052
were O 0 1.558438816573471e-05
determined O 0 0.00021833321079611778
using O 0 4.7925808758009225e-05
reverse O 0 0.004822969902306795
transcriptase O 0 0.01902090013027191
polymerase O 0 0.0039015773218125105
chain O 0 0.0018431813223287463
reaction O 0 0.0001764021726557985
of O 0 4.583954250847455e-06
total O 0 6.201832002261654e-05
RNA O 0 0.0012653085868805647
from O 0 0.0001995520869968459
keratinocytes O 0 0.1422097533941269
incubated O 0 0.004084380809217691
for O 0 0.00024785238201729953
2 O 0 0.0009665944962762296
. O 0 0.0003093969717156142

5 O 0 0.0031555944588035345
h O 0 0.01158832386136055
in O 0 6.187223334563896e-05
the O 0 9.199870692100376e-05
presence O 0 0.0006012225057929754
or O 0 0.0002311030839337036
absence O 0 0.0009870053036138415
of O 0 1.5021108993096277e-05
10 O 0 0.0005774424644187093
microg O 0 0.4931057095527649
cycloheximide O 0 0.1850167065858841
per O 0 0.0004758357536047697
ml O 0 0.07709372788667679
. O 0 0.00048507857718504965

Using O 0 0.000157641145051457
this O 0 3.7883615732425824e-05
approach O 0 0.001304855803027749
, O 0 8.707580855116248e-05
an O 0 0.0002817701897583902
abnormally O 1 0.9754329323768616
spliced O 0 0.01306112390011549
transcript O 0 0.01094647217541933
was O 0 0.0008066499722190201
identified O 0 0.00019061150669585913
that O 0 8.150691428454593e-06
contains O 0 1.4913016457285266e-05
an O 0 4.824450297746807e-05
extra O 0 0.00047056845505721867
264 O 0 0.0068062422797083855
bases O 0 0.00043553466093726456
upstream O 0 0.0020014236215502024
from O 0 0.00010991103772539645
exon O 0 0.020058216527104378
32 O 0 0.0007954202010296285
, O 0 7.78562534833327e-05
resulting O 0 0.0004165868158452213
in O 0 9.569674875820056e-05
a O 0 0.0012807752937078476
premature O 1 0.9926477670669556
termination O 1 0.5458095669746399
codon O 0 0.01036851853132248
27 O 0 0.0037625066470354795
bp O 0 0.037787724286317825
downstream O 0 0.002223450457677245
from O 0 3.482947431621142e-05
the O 0 0.0001353431143797934
cryptic O 0 0.04840091988444328
splice O 0 0.04526729881763458
site O 0 0.004817469511181116
. O 0 0.000336070719640702

Three O 0 0.00014287039812188596
other O 0 5.979519119136967e-05
splice O 0 0.025368163362145424
variants O 0 0.0018864116864278913
, O 0 0.00011967294994974509
including O 0 3.4700671676546335e-05
one O 0 5.783054803032428e-05
derived O 0 6.663405656581745e-05
from O 0 3.080713941017166e-05
the O 0 9.787402814254165e-05
skipping O 0 0.0089456457644701
of O 0 4.112563328817487e-05
exon O 0 0.033436741679906845
32 O 0 0.0012240845244377851
, O 0 8.367712871404365e-05
were O 0 2.304634290339891e-05
also O 0 0.00015891478687990457
identified O 0 0.0009014953393489122
. O 0 0.0002179717121180147

These O 0 8.433200127910823e-05
results O 0 0.0004041442007292062
indicate O 0 0.0002681034675333649
the O 0 5.975820022285916e-05
usefulness O 0 0.021028561517596245
of O 0 7.907234248705208e-05
cycloheximide O 1 0.9996970891952515
treatment O 1 0.9997938275337219
in O 0 0.00013437400048132986
evaluating O 0 0.0075432914309203625
the O 0 0.00017399000353179872
abnormal O 0 0.009390803053975105
processing O 0 0.0001984375703614205
of O 0 6.945815584913362e-06
mRNA O 0 0.0002340259961783886
due O 0 0.00041901631630025804
to O 0 8.25047172838822e-05
splice O 0 0.029250368475914
- O 0 0.006025614682585001
site O 0 0.0012671102304011583
mutations O 0 0.00097410794114694
, O 0 0.00014229610678739846
because O 0 0.0006957405712455511
( O 0 0.0005959906266070902
i O 0 0.0022155768238008022
) O 0 0.0001396994775859639
aberrant O 0 0.009673969820141792
splicing O 0 0.0009337073424831033
often O 0 8.167291525751352e-05
generates O 0 0.000591074291151017
a O 0 0.0009444210445508361
premature O 1 0.9745046496391296
termination O 0 0.17052926123142242
codon O 0 0.007067027036100626
, O 0 0.00031739589758217335
( O 0 0.0007363972836174071
ii O 0 0.07854879647493362
) O 0 0.00016484696243423969
transcripts O 0 0.0008643807959742844
with O 0 0.00016311997023876756
premature O 1 0.9975554347038269
termination O 1 0.9876573085784912
codons O 0 0.006318093743175268
can O 0 0.00011242734035477042
occur O 0 0.00021220583585090935
at O 0 0.00035580116673372686
low O 0 0.002717592054978013
or O 0 0.0009754442726261914
undetectable O 1 0.997366726398468
levels O 0 0.004169148858636618
due O 0 0.0006146933301351964
to O 0 8.889592572813854e-05
nonsense O 0 0.01058744266629219
- O 0 0.002250306075438857
mediated O 0 0.0035042157396674156
mRNA O 0 0.0002643336192704737
decay O 0 0.002356521785259247
, O 0 0.000158182461746037
and O 0 0.0002535080420784652
( O 0 0.0012764392886310816
iii O 0 0.06314748525619507
) O 0 0.0001243994920514524
the O 0 6.958650919841602e-05
levels O 0 0.0011543470900505781
of O 0 7.308804015337955e-06
these O 0 1.9846345821861178e-05
transcripts O 0 0.001212532282806933
can O 0 3.2492993341293186e-05
be O 0 1.2826776583096944e-05
increased O 0 0.0001135912534664385
by O 0 5.4791315051261336e-05
cycloheximide O 1 0.9163804650306702
. O 0 0.0005438642110675573

A O 0 0.0053285569883883
deletion O 0 0.012054800987243652
mutation O 0 0.0021979836747050285
in O 0 0.00040089437970891595
COL17A1 O 1 0.9949637651443481
in O 0 0.00011533332144608721
five O 0 9.993279672926292e-05
Austrian O 0 0.002628448186442256
families O 0 0.00013012335693929344
with O 0 0.00019090506248176098
generalized O 1 0.9995217323303223
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9999996423721313
bullosa I-Disease 1 0.9999736547470093
represents O 0 0.005553425755351782
propagation O 0 0.0006283412803895772
of O 0 8.780979442235548e-06
an O 0 0.00020207838679198176
ancestral O 0 0.006135573145002127
allele O 0 0.009515184909105301
. O 0 0.00048728406545706093

Patients O 1 0.9999634027481079
with O 0 0.0003484440967440605
generalized O 1 0.9992484450340271
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999943971633911
, O 0 0.0005816246848553419
a O 0 0.0002987594634760171
usually O 0 0.0001751951058395207
nonlethal O 0 0.02322789840400219
form O 0 0.00015209174307528883
of O 0 9.429971396457404e-05
junctional B-Disease 1 0.9999923706054688
epidermolysis I-Disease 1 0.9999986886978149
bullosa I-Disease 1 0.9999773502349854
, O 0 0.00044482049997895956
have O 0 7.11151587893255e-05
generalized O 0 0.011764219962060452
blistering B-Disease 1 0.990136444568634
, O 0 0.0018093375256285071
nail B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
, O 0 0.0037678114604204893
patchy B-Disease 1 0.9999960660934448
alopecia I-Disease 1 1.0
, O 0 0.001486287685111165
and O 0 0.0023203459568321705
dental B-Disease 1 1.0
abnormalities I-Disease 1 0.9999735355377197
. O 0 0.0006389011978171766

Skin B-Disease 1 0.9999998807907104
fragility I-Disease 1 0.9998379945755005
in O 0 0.00038972400943748653
most O 0 0.0002560520952101797
cases O 0 0.0015319904778152704
is O 0 0.00030850977054797113
due O 0 0.0006543170311488211
to O 0 4.7424437070731074e-05
mutations O 0 0.0003072541148867458
in O 0 1.5475059626623988e-05
the O 0 3.50055233866442e-05
gene O 0 0.00041787902591750026
encoding O 0 0.0006092299590818584
type O 0 0.07425663620233536
XVII O 1 0.9999903440475464
collagen O 1 0.9999227523803711
( O 0 0.003623225726187229
COL17A1 O 1 0.999231219291687
) O 0 0.00047889238339848816
. O 0 0.00024969299556687474

Recently O 0 0.016893867403268814
, O 0 0.00018103999900631607
we O 0 0.00011945394362555817
reported O 0 0.0008492019260302186
five O 0 5.0704060413409024e-05
Austrian O 0 0.00205021258443594
families O 0 0.00010594111518003047
with O 0 0.00019518367480486631
generalized O 1 0.9996471405029297
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.999994158744812
who O 0 0.001826989697292447
share O 0 0.0001228788896696642
the O 0 5.01467366120778e-05
same O 0 0.0002424014819553122
COL17A1 O 1 0.9983006119728088
mutation O 0 0.0031371433287858963
. O 0 0.0002990225038956851

Affected O 0 0.016388190910220146
individuals O 0 0.00019211335165891796
in O 0 8.442638500127941e-05
three O 0 4.0487790101906285e-05
families O 0 6.484574259957299e-05
are O 0 1.4989468581916299e-05
homozygous O 0 0.0021468030754476786
for O 0 0.00037597009213641286
4003delTC O 1 0.9043315052986145
, O 0 0.00033327683922834694
whereas O 0 0.0007108040736056864
those O 0 3.724054113263264e-05
in O 0 5.41065564902965e-05
two O 0 2.5193541659973562e-05
others O 0 0.00015774100029375404
are O 0 3.1118292099563405e-05
compound O 0 0.019606705754995346
heterozygotes O 0 0.47753405570983887
. O 0 0.0005130807985551655

To O 0 0.0002903579152189195
determine O 0 0.000413326924899593
if O 0 9.903178579406813e-05
the O 0 5.2641680667875335e-05
occurrence O 0 0.003505461849272251
of O 0 5.5999622418312356e-05
4003delTC O 1 0.6301978826522827
in O 0 0.00010186005965806544
these O 0 2.9469336368492804e-05
unrelated O 0 0.0043170154094696045
families O 0 0.00030913809314370155
signifies O 0 0.007442572619765997
propagation O 0 0.0005328247207216918
of O 0 9.61392743192846e-06
an O 0 0.00019240575784351677
ancestral O 0 0.004727489780634642
allele O 0 0.00404326431453228
or O 0 0.0002825007541105151
a O 0 0.000967916043009609
mutational O 1 0.9750363230705261
hot O 0 0.036976706236600876
spot O 0 0.008902965113520622
, O 0 0.00035327282967045903
haplotypes O 0 0.008561101742088795
were O 0 3.920984090655111e-05
determined O 0 0.0006188625702634454
for O 0 8.296609303215519e-05
polymorphisms O 0 0.0012880794238299131
both O 0 4.72361316496972e-05
within O 0 6.17625264567323e-05
and O 0 0.000270548538537696
flanking O 1 0.9855090975761414
COL17A1 O 1 0.9993088245391846
. O 0 0.0009547753725200891

Five O 0 0.0013938386691734195
intragenic O 0 0.099840447306633
polymorphisms O 0 0.0029439639765769243
were O 0 2.8446964279282838e-05
chosen O 0 0.00011977638496318832
based O 0 4.836680818698369e-05
on O 0 6.291492900345474e-05
their O 0 6.927638605702668e-05
informativeness O 1 0.9273073673248291
. O 0 0.0004965934786014259

One O 0 0.00012235554459039122
of O 0 6.1146729422034696e-06
these O 0 1.5730855011497624e-05
, O 0 0.00010350087541155517
not O 0 0.00010032321006292477
previously O 0 0.0009498106082901359
reported O 0 0.001773020951077342
, O 0 0.00013703019067179412
was O 0 0.0015646524261683226
2988 O 0 0.09568443149328232
A O 0 0.004646691028028727
or O 0 0.0009057800052687526
C O 0 0.02560655027627945
that O 0 3.5531134926714e-05
introduces O 0 0.0011337174801155925
a O 0 0.0001467312395107001
new O 0 9.538880112813786e-05
restriction O 0 0.0003283456608187407
site O 0 0.0007365548517554998
for O 0 0.00022341101430356503
Eco0109 O 0 0.36898863315582275
I O 0 0.016780178993940353
. O 0 0.00029321989859454334

All O 0 0.00010721922444645315
the O 0 0.0003349928592797369
4003delTC O 0 0.11519051343202591
alleles O 0 0.003031795844435692
showed O 0 0.0007668659090995789
the O 0 6.823065632488579e-05
same O 0 0.00020217667042743415
haplotype O 0 0.0207096915692091
for O 0 5.777085243607871e-05
these O 0 1.0134493095392827e-05
five O 0 0.00012568532838486135
polymorphic O 0 0.041721947491168976
markers O 0 0.014023469761013985
. O 0 0.00041182449785992503

Fourteen O 0 0.008797531016170979
microsatellite O 0 0.05687704682350159
polymorphisms O 0 0.0038977949880063534
were O 0 3.1627132557332516e-05
selected O 0 0.00014904669660609215
based O 0 5.35295985173434e-05
on O 0 6.581887282663956e-05
their O 0 6.208778358995914e-05
high O 0 0.009551528841257095
heterozygosity O 1 0.9167830348014832
and O 0 4.606747825164348e-05
their O 0 1.8102866306435317e-05
location O 0 0.00025803226162679493
within O 0 0.00016426094225607812
10q23 O 0 0.0664365366101265
- O 0 0.009265001863241196
q25 O 0 0.04229893162846565
near O 0 0.008090170100331306
COL17A1 O 1 0.9894814491271973
. O 0 0.0005476335063576698

Three O 0 0.00015271079610101879
families O 0 0.00010895913146669045
shared O 0 0.0005429744487628341
microsatellite O 0 0.04661817476153374
polymorphisms O 0 0.007300907745957375
covering O 0 0.010098553262650967
at O 0 0.0009398050606250763
most O 0 0.00033533989335410297
19 O 0 0.002435887698084116
cM O 0 0.006980470381677151
, O 0 0.0002458767266944051
whereas O 0 0.0009155719308182597
the O 0 0.00012920497101731598
others O 0 0.00020391595899127424
shared O 0 0.0002131505898432806
smaller O 0 0.00013110629515722394
regions O 0 0.00032409236882813275
consistent O 0 0.0028529830742627382
with O 0 0.00015478668501600623
cross O 0 0.010353738442063332
- O 0 0.0026276472490280867
over O 0 6.894606485730037e-05
events O 0 0.00012721482198685408
during O 0 0.0003952619736082852
passage O 0 0.00026504223933443427
of O 0 4.97146947964211e-06
this O 0 3.534202915034257e-05
mutation O 0 0.0006462516030296683
through O 0 5.579673597821966e-05
several O 0 4.068984344485216e-05
generations O 0 0.0009085831115953624
. O 0 0.0003177437756676227

These O 0 0.00010982817912008613
results O 0 0.0005174006801098585
indicate O 0 0.00059674889780581
that O 0 9.52774498728104e-05
4003delTC O 0 0.11439935117959976
occurs O 0 0.0003503038315102458
on O 0 4.584523776429705e-05
a O 0 0.0001407502859365195
single O 0 0.0002580201835371554
ancestral O 0 0.004512283485382795
allele O 0 0.007734070532023907
. O 0 0.00019066712411586195
. O 0 0.00035412964643910527

The O 0 0.001566489925608039
haptoglobin O 1 0.992434024810791
- O 0 0.010301710106432438
gene O 0 0.0012019667774438858
deletion O 0 0.0036190401297062635
responsible O 0 0.002160583855584264
for O 0 0.00041916448390111327
anhaptoglobinemia B-Disease 1 0.9704763293266296
. O 0 0.0005742621142417192

We O 0 0.0004375368298497051
have O 0 3.489826121949591e-05
found O 0 6.598339678021148e-05
an O 0 9.580887126503512e-05
allelic O 0 0.022819582372903824
deletion O 0 0.001700898981653154
of O 0 1.0797707545862067e-05
the O 0 0.0005161133594810963
haptoglobin O 1 0.9994507431983948
( O 0 0.0022916977759450674
Hp O 1 0.9067022800445557
) O 0 0.00029266439378261566
gene O 0 0.00038771555409766734
from O 0 1.7067990484065376e-05
an O 0 4.259081106283702e-05
individual O 0 0.00010535981709836051
with O 0 0.00020368276454973966
anhaptoglobinemia B-Disease 1 0.9946010112762451
. O 0 0.0006965501816011965

The O 0 0.0022949185222387314
Hp O 0 0.29794538021087646
gene O 0 0.0027888650074601173
cluster O 0 0.004616946913301945
consists O 0 0.00013329654757399112
of O 0 1.6465655789943412e-05
coding O 0 0.00552167184650898
regions O 0 0.00015281247033271939
of O 0 7.0632004280923866e-06
the O 0 0.00015518037253059447
alpha O 0 0.0035836107563227415
chain O 0 0.002417177427560091
and O 0 0.00010599113738862798
beta O 0 0.0044500986114144325
chain O 0 0.00042590609518811107
of O 0 5.061599949840456e-06
the O 0 0.00023498610244132578
haptoglobin O 1 0.991529107093811
gene O 0 0.005910475272685289
( O 0 0.001311972620896995
Hp O 0 0.2188776284456253
) O 0 0.00013558618957176805
and O 0 2.1268489945214242e-05
of O 0 4.745819296658738e-06
the O 0 0.00015285272093024105
alpha O 0 0.00289277546107769
chain O 0 0.002300629857927561
and O 0 8.979477570392191e-05
beta O 0 0.003446522867307067
chain O 0 0.00039610706153325737
of O 0 6.11620680501801e-06
the O 0 0.00034773777588270605
haptoglobin O 1 0.9957423806190491
- O 0 0.0070418985560536385
related O 0 0.0013498289044946432
gene O 0 0.0033520699944347143
( O 0 0.0014884014381095767
Hpr O 1 0.9970588684082031
) O 0 0.0005710533005185425
, O 0 0.00013331268564797938
in O 0 0.00012164031795691699
tandem O 0 0.006013910751789808
from O 0 4.5209890231490135e-05
the O 0 0.00014416937483474612
5 O 0 0.001026236917823553
side O 0 0.004398769699037075
. O 0 0.0003946760843973607

Southern O 0 0.014083514921367168
blot O 1 0.96041339635849
and O 0 0.0004233639920130372
PCR O 0 0.015570309944450855
analyses O 0 0.0016094621969386935
have O 0 0.0001056397013599053
indicated O 0 0.001256481627933681
that O 0 1.267288280359935e-05
the O 0 3.5162505810149014e-05
individual O 0 8.874363993527368e-05
with O 0 0.00014704244676977396
anhaptoglobinemia B-Disease 1 0.9934993982315063
was O 0 0.001319268369115889
homozygous O 0 0.0011421632952988148
for O 0 4.301515218685381e-05
the O 0 0.00013102930097375065
gene O 0 0.0024930466897785664
deletion O 0 0.004587666597217321
and O 0 4.77035682706628e-05
that O 0 2.066523848043289e-05
the O 0 0.00011243022890994325
gene O 0 0.001902786549180746
deletion O 0 0.006339636631309986
was O 0 0.0008023672271519899
included O 0 7.957763591548428e-05
at O 0 0.0005221081082709134
least O 0 0.00011999015259789303
from O 0 3.63916733476799e-05
the O 0 0.00017725145153235644
promoter O 0 0.024523286148905754
region O 0 0.0008656464051455259
of O 0 4.469449777388945e-05
Hp O 1 0.5993154048919678
to O 0 0.0003932901890948415
Hpr O 1 0.9871839880943298
alpha O 0 0.0021205067168921232
but O 0 5.366049299482256e-05
not O 0 2.697423769859597e-05
to O 0 0.0001146880240412429
Hpr O 1 0.9825563430786133
beta O 0 0.02197202667593956
( O 0 0.0010092719458043575
Hpdel O 1 0.9333661794662476
) O 0 0.00031504168873652816
. O 0 0.000251771358307451

In O 0 0.0005441785324364901
addition O 0 0.00043868759530596435
, O 0 0.00015983112098183483
we O 0 0.0001297204871661961
found O 0 9.317719377577305e-05
seven O 0 6.880538421683013e-05
individuals O 0 6.941882747923955e-05
with O 0 0.00013957057672087103
hypohaptoglobinemia B-Disease 1 0.9879734516143799
in O 0 0.00017146179743576795
three O 0 6.624681554967538e-05
families O 0 0.00020682477043010294
, O 0 0.0001345717319054529
and O 0 8.740409248275682e-05
the O 0 0.0002615012926980853
genotypes O 0 0.019935565069317818
of O 0 1.1786193681473378e-05
six O 0 6.444989412557334e-05
of O 0 6.793864940846106e-06
the O 0 0.00010803730401676148
seven O 0 0.00014476226351689547
individuals O 0 6.02232976234518e-05
were O 0 1.7978270989260636e-05
found O 0 6.54619507258758e-05
to O 0 3.494002157822251e-05
be O 0 0.0002192143292631954
Hp2 O 1 0.9975284934043884
/ O 1 0.9486861228942871
Hpdel O 1 0.9653793573379517
. O 0 0.0006084779743105173

The O 0 0.0017924527637660503
phenotypes O 0 0.030711082741618156
and O 0 0.0005756880855187774
genotypes O 0 0.0622512586414814
in O 0 0.00011146861652377993
one O 0 2.8531487259897403e-05
of O 0 4.772397915075999e-06
these O 0 1.151097512774868e-05
three O 0 3.501386891002767e-05
families O 0 0.0001508948189439252
showed O 0 0.00086148118134588
the O 0 0.00016664214490447193
father O 0 0.0009257190395146608
to O 0 6.2426901422441e-05
be O 0 0.0001752475945977494
hypohaptoglobinemic B-Disease 1 0.8348290920257568
( O 0 0.0009987547527998686
Hp2 O 1 0.8529090881347656
) O 0 0.00026073495973832905
and O 0 0.0003837334515992552
Hp2 O 1 0.9987297654151917
/ O 1 0.9006982445716858
Hpdel O 1 0.9421791434288025
, O 0 0.00015838607214391232
the O 0 0.00012050511577399448
mother O 0 0.0012141918996348977
to O 0 4.1287414205726236e-05
be O 0 0.00012174953008070588
Hp2 O 1 0.6734483242034912
- O 0 0.002524623181670904
1 O 0 0.0005467677256092429
and O 0 0.0003209735150448978
Hp1 O 1 0.9989750385284424
/ O 1 0.945039689540863
Hp2 O 1 0.9159862995147705
, O 0 0.00012309043086133897
one O 0 2.3435459297616035e-05
of O 0 4.032647211715812e-06
the O 0 6.447884516092017e-05
two O 0 3.475584526313469e-05
children O 0 0.00024231598945334554
to O 0 4.2320436477893963e-05
be O 0 0.00013085898535791785
hypohaptoglobinemic B-Disease 0 0.45201677083969116
( O 0 0.0007262351573444903
Hp2 O 1 0.8759633898735046
) O 0 0.00023180330754257739
and O 0 0.0003200607607141137
Hp2 O 1 0.9991936087608337
/ O 1 0.9527466297149658
Hpdel O 1 0.9552233219146729
, O 0 0.00016582454554736614
and O 0 3.9219565223902464e-05
the O 0 6.789658073103055e-05
other O 0 3.521499456837773e-05
child O 0 0.0015290086157619953
to O 0 4.1438561311224476e-05
be O 0 0.00011583115701796487
Hp1 O 1 0.6727228760719299
and O 0 0.0004079546488355845
Hp1 O 1 0.9995797276496887
/ O 1 0.991569995880127
Hpdel O 1 0.9813320636749268
, O 0 0.00012060775770805776
showing O 0 0.0006235359469428658
an O 0 0.00020721064356621355
anomalous O 0 0.13768215477466583
inheritance O 0 0.0030056971590965986
of O 0 8.531394269084558e-05
Hp O 1 0.9750565886497498
phenotypes O 0 0.017104795202612877
in O 0 0.00011587602057261392
the O 0 0.00016651061014272273
child O 0 0.0031680974643677473
with O 0 0.00015675110626034439
Hp1 O 1 0.9894078969955444
. O 0 0.0005952277570031583

The O 0 0.002954771276563406
Hp2 O 1 0.998717188835144
/ O 1 0.9835273623466492
Hpdel O 1 0.8311850428581238
individuals O 0 0.00014429810107685626
had O 0 0.00020078693341929466
an O 0 7.661824201932177e-05
extremely O 0 0.004347824025899172
low O 0 0.0016473248833790421
level O 0 0.0008641313179396093
of O 0 3.2788771932246163e-05
Hp O 1 0.8222026228904724
( O 0 0.000639874953776598
mean O 0 0.005555451847612858
+ O 0 0.13804571330547333
/ O 0 0.055947862565517426
- O 0 0.010174688883125782
SD O 0 0.4835590422153473
= O 0 0.0030062447767704725
0 O 0 0.000742980744689703
. O 0 0.00019995357433799654
049 O 1 0.9866140484809875
+ O 0 0.11584273725748062
/ O 0 0.027603590860962868
- O 0 0.0021087443456053734
0 O 0 0.0004993539187125862
. O 0 0.0001382211339659989
043 O 1 0.8807389736175537
mg O 1 0.9931570887565613
/ O 0 0.26383864879608154
ml O 0 0.08366017043590546
; O 0 0.00026296041323803365
n O 0 0.004050450399518013
= O 0 0.0048581319861114025
6 O 0 0.0013538727071136236
) O 0 0.00010335264232708141
, O 0 6.498552829725668e-05
compared O 0 0.00023873761529102921
with O 0 2.3739330572425388e-05
the O 0 0.00016521818179171532
level O 0 0.0039058176334947348
( O 0 0.0003405236348044127
1 O 0 0.0007078062044456601
. O 0 7.845554500818253e-05
64 O 0 0.001938367378897965
+ O 0 0.05123499408364296
/ O 0 0.030570579692721367
- O 0 0.0020870864391326904
1 O 0 0.0004845171351917088
. O 0 0.00019068075926043093
07 O 1 0.9693079590797424
mg O 1 0.9957870841026306
/ O 0 0.4427216053009033
ml O 0 0.08026135712862015
) O 0 0.00010636870138114318
obtained O 0 9.780441905604675e-05
from O 0 4.684353189077228e-05
52 O 0 0.0031441631726920605
healthy O 0 0.03548368066549301
volunteers O 0 0.006591713987290859
having O 0 0.002970441011711955
phenotype O 0 0.2512022852897644
Hp2 O 1 0.8282310962677002
, O 0 0.0001869871048256755
whereas O 0 0.000631336763035506
the O 0 0.00038110805326141417
serum O 1 0.9969358444213867
Hp O 0 0.08223473280668259
level O 0 0.0005722235655412078
of O 0 3.817095148406224e-06
an O 0 4.989743683836423e-05
individual O 0 0.00011247707880102098
with O 0 0.000289438059553504
Hp1 O 1 0.9997671246528625
/ O 1 0.9724761843681335
Hpdel O 1 0.9796015024185181
was O 0 0.0012458955170586705
0 O 0 0.0008325072703883052
. O 0 0.00017073679191526026

50 O 0 0.0062201605178415775
mg O 1 0.9932756423950195
/ O 1 0.7815077304840088
ml O 0 0.13839706778526306
, O 0 0.00014734716387465596
which O 0 2.917572419391945e-05
was O 0 0.00028528584516607225
approximately O 0 9.762348054209724e-05
half O 0 4.337261270848103e-05
the O 0 4.265088136889972e-05
level O 0 0.0008928924216888845
of O 0 4.2284209484932944e-05
Hp O 0 0.2079295665025711
in O 0 0.00017883960390463471
control O 0 0.0024701792281121016
sera O 0 0.039528023451566696
from O 0 5.4061889386503026e-05
the O 0 0.0002742388751357794
Hp1 O 1 0.9580734968185425
phenotype O 0 0.06529345363378525
( O 0 0.00046065880451351404
1 O 0 0.000749017286580056
. O 0 0.00011812492448370904
26 O 0 0.0024120216257870197
+ O 0 0.05698367580771446
/ O 0 0.028276212513446808
- O 0 0.0020395051687955856
0 O 0 0.0002937705721706152
. O 0 3.992931669927202e-05
33 O 0 0.0025583214592188597
mg O 1 0.9868244528770447
/ O 0 0.13482128083705902
ml O 0 0.09173763543367386
; O 0 0.00023884416441433132
n O 0 0.003701248439028859
= O 0 0.0051495591178536415
9 O 0 0.0011736875167116523
) O 0 8.031912875594571e-05
, O 0 3.848670166917145e-05
showing O 0 0.00041483165114186704
a O 0 0.0005140513530932367
gene O 0 0.0035165022127330303
- O 0 0.007879571989178658
dosage O 1 0.9417745471000671
effect O 0 0.0015182639472186565
. O 0 0.00026900734519585967

The O 0 0.00024389447935391217
other O 0 7.361021562246606e-05
allele O 0 0.01043784897774458
( O 0 0.001831339905038476
Hp2 O 1 0.701714038848877
) O 0 6.746988947270438e-05
of O 0 4.508455731411232e-06
individuals O 0 0.00010413623385829851
with O 0 0.0003393907391000539
Hp2 O 1 0.999882698059082
/ O 1 0.9944443106651306
Hpdel O 1 0.9907360672950745
was O 0 0.0014609942445531487
found O 0 0.00013619883975479752
to O 0 3.988406388089061e-05
have O 0 3.461969390627928e-05
, O 0 4.360011371318251e-05
in O 0 2.8198932341183536e-05
all O 0 1.8463850210537203e-05
exons O 0 0.0039572035893797874
, O 0 0.0001358527661068365
no O 0 0.00016472283459734172
mutation O 0 0.0009722209651954472
, O 0 3.854326860164292e-05
by O 0 1.7589232811587863e-05
DNA O 0 0.0006162910140119493
sequencing O 0 0.0007889592670835555
. O 0 0.00032336622825823724

On O 0 0.00030886559397913516
the O 0 4.4069718569517136e-05
basis O 0 2.142994162568357e-05
of O 0 6.390476755768759e-06
the O 0 0.0001050951104843989
present O 0 0.0003173378063365817
study O 0 0.0010341238230466843
, O 0 6.219931674422696e-05
the O 0 4.3862095481017604e-05
mechanism O 0 0.0006758820381946862
of O 0 4.4359301682561636e-05
anhaptoglobinemia B-Disease 1 0.9780220985412598
and O 0 5.807498746435158e-05
the O 0 4.489488492254168e-05
mechanism O 0 0.0005981805734336376
of O 0 3.6115678085479885e-05
anomalous O 0 0.4322449564933777
inheritance O 0 0.00304370722733438
of O 0 0.00010480989294592291
Hp O 1 0.9871345162391663
phenotypes O 0 0.013154767453670502
were O 0 3.8392932765418664e-05
well O 0 0.00014552359061781317
explained O 0 0.0027653882279992104
. O 0 0.0002859412634279579

However O 0 0.0008179924916476011
, O 0 7.173530320869759e-05
the O 0 4.357193029136397e-05
mechanism O 0 0.0005075163207948208
of O 0 4.329541479819454e-05
hypohaptoglobinemia B-Disease 1 0.9687355756759644
remains O 0 0.0053452737629413605
unknown O 0 0.001944296876899898

ATM O 0 0.04152008518576622
mutations O 0 0.0024828999303281307
and O 0 0.00015950549277476966
phenotypes O 0 0.019694089889526367
in O 0 0.0014359840424731374
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9991933703422546
telangiectasia I-Disease 1 0.9999496936798096
families O 0 0.0005651841056533158
in O 0 0.00011716186418198049
the O 0 0.00026066339341923594
British O 0 0.004397128708660603
Isles O 0 0.018352456390857697
: O 0 0.0001359996385872364
expression O 0 0.00017201201990246773
of O 0 2.2095600797911175e-05
mutant O 0 0.005029670894145966
ATM O 0 0.008744594641029835
and O 0 4.902085129288025e-05
the O 0 0.0001142595792771317
risk O 0 0.04282036051154137
of O 0 0.0002685988147277385
leukemia B-Disease 1 1.0
, O 0 0.07879945635795593
lymphoma B-Disease 1 1.0
, O 0 0.001119461958296597
and O 0 0.006082633975893259
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0005678117158822715

We O 0 0.0006060349405743182
report O 0 0.0002595375699456781
the O 0 3.665953045128845e-05
spectrum O 0 0.001254624337889254
of O 0 2.67846007773187e-05
59 O 0 0.0062165712006390095
ATM O 0 0.010444702580571175
mutations O 0 0.0006908173090778291
observed O 0 0.00030531748780049384
in O 0 0.00046343269059434533
ataxia B-Disease 1 0.9999992847442627
- I-Disease 1 0.9952120780944824
telangiectasia I-Disease 1 0.9999591112136841
( O 0 0.002456840593367815
A B-Disease 1 0.9986940026283264
- I-Disease 1 0.9987578392028809
T I-Disease 1 0.9999910593032837
) O 0 0.0010265082819387317
patients O 1 0.9998201727867126
in O 0 7.196320075308904e-05
the O 0 0.00017135294910985976
British O 0 0.004568066913634539
Isles O 0 0.029275044798851013
. O 0 0.0006349098403006792

Of O 0 0.00010327334166504443
51 O 0 0.00840962864458561
ATM O 0 0.03949898108839989
mutations O 0 0.0035649710334837437
identified O 0 0.0006773291388526559
in O 0 7.159329834394157e-05
families O 0 0.00011296906450297683
native O 0 9.513000986771658e-05
to O 0 4.339337829151191e-05
the O 0 0.00019344229076523334
British O 0 0.0033810632303357124
Isles O 0 0.025917286053299904
, O 0 0.00032324998755939305
11 O 0 0.0007651583873666823
were O 0 5.997027983539738e-05
founder O 0 0.013101126067340374
mutations O 0 0.002048796508461237
, O 0 0.0001298063580179587
and O 0 6.785535515518859e-05
2 O 0 0.0001422659697709605
of O 0 3.793455789491418e-06
these O 0 2.2964113668422215e-05
11 O 0 0.0012739233206957579
conferred O 0 0.06801718473434448
a O 0 0.0021362495608627796
milder O 1 0.9958463311195374
clinical O 1 0.9999582767486572
phenotype O 0 0.044169362634420395
with O 0 2.76646351267118e-05
respect O 0 0.00018798965902533382
to O 0 4.628465831046924e-05
both O 0 0.0003893057000823319
cerebellar B-Disease 1 0.9999996423721313
degeneration I-Disease 1 1.0
and O 0 0.00033427696325816214
cellular O 0 0.004968076013028622
features O 0 0.0004953413736075163
. O 0 0.0003868925559800118

We O 0 0.0009492862154729664
report O 0 0.000512911647092551
, O 0 4.4095064367866144e-05
in O 0 3.6803885450353846e-05
two O 0 7.504031964344904e-05
A B-Disease 1 0.9965432286262512
- I-Disease 1 0.9936823844909668
T I-Disease 1 0.9999250173568726
families O 0 0.00018004669982474297
, O 0 4.335292396717705e-05
an O 0 9.785200381884351e-05
ATM O 0 0.015106176026165485
mutation O 0 0.0029777975287288427
( O 0 0.0006455883267335594
7271T O 0 0.10096686333417892
- O 0 0.013041108846664429
- O 0 0.00895691942423582
> O 0 0.020316079258918762
G O 0 0.03114698827266693
) O 0 0.00018296139023732394
that O 0 6.427759944926947e-05
may O 0 0.0005053026252426207
be O 0 2.767922887869645e-05
associated O 0 4.1068607970373705e-05
with O 0 5.973967290628934e-06
an O 0 4.634268407244235e-05
increased O 0 0.0004716138355433941
risk O 1 0.7028205990791321
of O 0 0.00031976585160009563
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.00018578536401037127
both O 0 0.00033467684988863766
homozygotes O 1 0.9945046305656433
and O 0 0.000551288016140461
heterozygotes O 1 0.8897228837013245
( O 0 0.00043084402568638325
relative O 0 0.0009306263527832925
risk O 0 0.061009179800748825
12 O 0 0.0007149932207539678
. O 0 0.0001022501164698042
7 O 0 0.0009584373910911381
; O 0 0.0004003747599199414
P O 1 0.5620200634002686
= O 0 0.010641660541296005
. O 0 0.0007016590097919106
0025 O 1 0.9822744131088257
) O 0 0.0005451316246762872
, O 0 0.0001084442701539956
although O 0 8.481879922328517e-05
there O 0 1.7588259652256966e-05
is O 0 4.0571976569481194e-05
a O 0 0.00013468123506754637
less O 0 0.0008512779604643583
severe O 1 0.9999886751174927
A B-Disease 1 0.9998486042022705
- I-Disease 1 0.9995953440666199
T I-Disease 1 0.9999803304672241
phenotype O 0 0.044474877417087555
in O 0 4.355590135673992e-05
terms O 0 4.267561962478794e-05
of O 0 3.839139026240446e-06
the O 0 7.24083001841791e-05
degree O 0 0.0013071730500087142
of O 0 0.00010641576955094934
cerebellar B-Disease 1 0.9999997615814209
degeneration I-Disease 1 1.0
. O 0 0.0014033995103091002

This O 0 0.00016557144408579916
mutation O 0 0.0018679010681807995
( O 0 0.0005841354723088443
7271T O 0 0.09501858800649643
- O 0 0.012717713601887226
- O 0 0.010796226561069489
> O 0 0.02383524738252163
G O 0 0.03387318179011345
) O 0 0.0001078560235328041
also O 0 3.7382902519311756e-05
allows O 0 4.0673938201507553e-05
expression O 0 8.119719859678298e-05
of O 0 8.936856829677708e-06
full O 0 0.0007831338443793356
- O 0 0.0019193815533071756
length O 0 0.00028919035685248673
ATM O 0 0.006317537277936935
protein O 0 0.0003113288548775017
at O 0 0.00036310998257249594
a O 0 0.0003310086904093623
level O 0 0.001779514248482883
comparable O 0 0.0015360775869339705
with O 0 3.2632080547045916e-05
that O 0 5.0310787628404796e-05
in O 0 0.00019019012688659132
unaffected O 0 0.323311984539032
individuals O 0 0.00039951212238520384
. O 0 0.0004272405058145523

In O 0 0.0004356255813036114
addition O 0 0.000325105560477823
, O 0 9.71359622781165e-05
we O 0 4.604582500178367e-05
have O 0 1.59740520757623e-05
studied O 0 0.00034575670724734664
18 O 0 0.0005086016026325524
A B-Disease 1 0.9966926574707031
- I-Disease 1 0.9997236132621765
T I-Disease 1 0.9999994039535522
patients O 1 0.9999804496765137
, O 0 0.00010253668733639643
in O 0 8.095335215330124e-05
15 O 0 0.0002192205865867436
families O 0 6.86293569742702e-05
, O 0 9.932344255503267e-05
who O 0 0.0006568515091203153
developed O 1 0.9895086288452148
leukemia B-Disease 1 1.0
, O 0 0.01987183652818203
lymphoma B-Disease 1 1.0
, O 0 0.0016718171536922455
preleukemic O 1 0.9995414018630981
T O 1 0.9998534917831421
- O 0 0.006939048878848553
cell O 0 0.0026525421999394894
proliferation O 0 0.01749483123421669
, O 0 0.000409617816330865
or O 0 0.08752276748418808
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.0005154661484993994
mostly O 0 9.836936806095764e-05
in O 0 0.0002614474215079099
childhood O 1 0.9983773231506348
. O 0 0.0006422002334147692

A O 0 0.0034601271618157625
wide O 0 0.0006849669734947383
variety O 0 0.00017354480223730206
of O 0 2.8665697755059227e-05
ATM O 0 0.05616989731788635
mutation O 0 0.002701043849810958
types O 0 0.0005541684222407639
, O 0 0.000125823455164209
including O 0 0.00013131185551173985
missense O 0 0.01927264593541622
mutations O 0 0.0013873641146346927
and O 0 9.44654893828556e-05
in O 0 0.0002863354457076639
- O 0 0.005350384395569563
frame O 0 0.004940717946738005
deletions O 0 0.003143106587231159
, O 0 8.296609303215519e-05
were O 0 2.1019628547946922e-05
seen O 0 0.0004821687762159854
in O 0 6.563321949215606e-05
these O 0 0.0001275618706131354
patients O 1 0.9999884366989136
. O 0 0.00048497109673917294

We O 0 0.0006752247572876513
also O 0 0.0001580615498824045
show O 0 0.00019419575983192772
that O 0 2.723115358094219e-05
25 O 0 5.6680226407479495e-05
% O 0 3.326075102449977e-06
of O 0 2.8487615963967983e-06
all O 0 5.6066844990709797e-05
A B-Disease 1 0.998853325843811
- I-Disease 1 0.9996442794799805
T I-Disease 1 0.9999972581863403
patients O 1 0.9997817873954773
carried O 0 0.00022742165310773998
in O 0 0.00014772462600376457
- O 0 0.0042875525541603565
frame O 0 0.004634061828255653
deletions O 0 0.004468588624149561
or O 0 0.000855255697388202
missense O 0 0.032336894422769547
mutations O 0 0.0027144737541675568
, O 0 8.901910041458905e-05
many O 0 1.3638133168569766e-05
of O 0 1.1416386769269593e-05
which O 0 4.8174624680541456e-05
were O 0 2.5907229428412393e-05
also O 0 9.409222548129037e-05
associated O 0 8.250746759586036e-05
with O 0 1.0113955795532092e-05
expression O 0 0.00013892474817112088
of O 0 1.277555293199839e-05
mutant O 0 0.003817179938778281
ATM O 0 0.009813801385462284
protein O 0 0.0008529306505806744
. O 0 0.00036520505091175437

The O 0 0.0009215003228746355
DMPK O 1 0.986017644405365
gene O 0 0.0007247815374284983
of O 0 3.926646240870468e-05
severely O 1 0.9999918937683105
affected O 1 0.9989959597587585
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999997615814209
is O 0 0.0017303440254181623
hypermethylated O 1 0.9841719269752502
proximal O 1 0.9935757517814636
to O 0 5.957714165560901e-05
the O 0 6.0341662901919335e-05
largely O 0 0.0004501977819018066
expanded O 0 0.003917965572327375
CTG O 1 0.9964775443077087
repeat O 0 0.023644952103495598
. O 0 0.0005229585221968591

Using O 0 0.00043889720109291375
methylation O 0 0.0016158433863893151
- O 0 0.0029351499397307634
sensitive O 0 0.0027133577968925238
restriction O 0 0.0003941183094866574
enzymes O 0 0.0003635760222095996
, O 0 0.00010533248860156164
we O 0 0.00014433360775001347
characterized O 0 0.004755125846713781
the O 0 0.00013200270768720657
methylation O 0 0.0007786563946865499
pattern O 0 0.002103353152051568
on O 0 0.00016139830404426903
the O 0 0.0001176462828880176
5 O 0 0.0005068414029665291
side O 0 0.0006471903179772198
of O 0 1.0313109669368714e-05
the O 0 0.0006736326613463461
CTG O 1 0.9984920024871826
repeat O 0 0.011838200502097607
in O 0 0.000120343996968586
the O 0 0.00035817016032524407
DMPK O 1 0.9961458444595337
gene O 0 0.0005085504963062704
of O 0 9.57960855885176e-06
normal O 0 0.001422210014425218
individuals O 0 6.425382889574394e-05
and O 0 4.673323201132007e-05
of O 0 7.387730875052512e-05
patients O 1 0.9999995231628418
affected O 0 0.010175034403800964
with O 0 0.0017389165004715323
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.0010272414656355977
showing O 0 0.001500659273006022
expansions O 0 0.0018302553799003363
of O 0 7.3200135375373065e-06
the O 0 0.00014921305410098284
repetitive O 0 0.0656643733382225
sequence O 0 0.00022739519772585481
. O 0 0.00026756213628686965

The O 0 0.0006543578929267824
gene O 0 0.0017057460499927402
segment O 0 0.0028368534985929728
analyzed O 0 0.0006663301028311253
corresponds O 0 0.0002482843119651079
to O 0 1.654602965572849e-05
the O 0 8.214743138523772e-05
genomic O 0 0.008149269036948681
SacI O 1 0.9727548360824585
- O 0 0.008025859482586384
HindIII O 0 0.04410902410745621
fragment O 0 0.0013369022635743022
carrying O 0 0.00035004428355023265
exons O 0 0.005072056315839291
11 O 0 0.0019693372305482626
- O 0 0.003205963410437107
15 O 0 0.0004128642030991614
. O 0 0.00016872641572263092

There O 0 0.000308476883219555
is O 0 0.00023528115707449615
constitutive O 0 0.021831458434462547
methylation O 0 0.0012802958954125643
in O 0 0.00033900910057127476
intron O 1 0.9176133871078491
12 O 0 0.0010915611637756228
at O 0 0.00029064257978461683
restriction O 0 0.00018971235840581357
sites O 0 6.939830927876756e-05
of O 0 2.3814225642126985e-05
SacII O 1 0.9494090676307678
and O 0 0.00035292914253659546
HhaI O 1 0.5873026251792908
, O 0 0.0001891493593575433
localized O 0 0.011144044809043407
1 O 0 0.0011757274623960257
, O 0 0.0002551725192461163
159 O 0 0.017380215227603912
- O 0 0.003580237738788128
1 O 0 0.0006606415845453739
, O 0 0.00016869585670065135
232 O 0 0.013956877402961254
bp O 0 0.03188684210181236
upstream O 0 0.0009820389095693827
of O 0 1.1305313819320872e-05
the O 0 0.0006511937244795263
CTG O 1 0.9987881779670715
repeat O 0 0.03035862185060978
, O 0 0.0002920675906352699
whereas O 0 0.0010653218487277627
most O 0 0.0002072742790915072
, O 0 0.0002527266042307019
if O 0 0.00029853766318410635
not O 0 4.3754229409387335e-05
all O 0 9.023498932947405e-06
, O 0 2.7841777409776114e-05
of O 0 3.765866722460487e-06
the O 0 5.2822309953626245e-05
other O 0 1.127793984778691e-05
sites O 0 8.742610225453973e-05
of O 0 2.8288788598729298e-05
SacII O 1 0.9882319569587708
, O 0 0.0008545396849513054
HhaI O 1 0.9353198409080505
, O 0 0.0003040810988750309
and O 0 0.0002893950149882585
HpaII O 1 0.6530057191848755
in O 0 7.595609349664301e-05
this O 0 3.027906859642826e-05
region O 0 0.0009301742538809776
are O 0 5.139415952726267e-05
unmethylated O 0 0.19985657930374146
, O 0 0.0002221329923486337
in O 0 0.00016465297085233033
normal O 0 0.002724743913859129
individuals O 0 9.55461073317565e-05
and O 0 3.078963345615193e-05
most O 0 2.9630071367137134e-05
of O 0 1.4826741789875086e-05
the O 0 0.001215314376167953
patients O 1 0.9999974966049194
. O 0 0.0004788234073203057

In O 0 0.00014081070548854768
a O 0 7.249313784996048e-05
number O 0 7.648134669580031e-06
of O 0 1.5171843187999912e-05
young O 0 0.004957256373018026
and O 0 0.0010916367173194885
severely O 1 0.9999979734420776
affected O 1 0.9954776167869568
patients O 1 0.9999988079071045
, O 0 0.00024897485855035484
however O 0 0.00015749543672427535
, O 0 6.593648140551522e-05
complete O 0 0.0003412771038711071
methylation O 0 0.00010280269634677097
of O 0 2.911982392106438e-06
these O 0 6.826957360317465e-06
restriction O 0 0.0002684882201720029
sites O 0 0.0002078257966786623
was O 0 0.0003934459818992764
found O 0 6.9515808718279e-05
in O 0 2.505562770238612e-05
the O 0 0.00011190825898665935
mutated O 0 0.009196734987199306
allele O 0 0.007817234843969345
. O 0 0.0006187282269820571

In O 0 0.00018933627870865166
most O 0 3.30669863615185e-05
of O 0 1.0018621651397552e-05
these O 0 0.0001421448978362605
patients O 1 0.9999963045120239
, O 0 7.52435444155708e-05
the O 0 0.00011726145021384582
onset O 1 0.9989911913871765
of O 0 2.2283467842498794e-05
the O 0 0.0020146211609244347
disease O 1 1.0
was O 1 0.9668833017349243
congenital O 1 1.0
. O 0 0.0011465996503829956

Preliminary O 0 0.001994594931602478
in O 0 0.0003955292049795389
vivo O 0 0.03180169686675072
footprinting O 1 0.9937047362327576
data O 0 6.47530541755259e-05
gave O 0 0.000174891363712959
evidence O 0 6.659365317318588e-05
for O 0 4.922696825815365e-05
protein O 0 0.000726452621165663
- O 0 0.003426785347983241
DNA O 0 0.000890206778421998
contact O 0 0.0009081512689590454
in O 0 8.853233157424256e-05
normal O 0 0.0013556887861341238
genes O 0 0.0001840265467762947
at O 0 0.00045091609354130924
an O 0 0.00037817974225617945
Sp1 O 1 0.9943060278892517
consensus O 0 0.0006771742482669652
binding O 0 0.000325086060911417
site O 0 0.000574712990783155
upstream O 0 0.0006590179982595146
of O 0 1.0762702913780231e-05
the O 0 0.0007107181008905172
CTG O 1 0.9994012117385864
repeat O 0 0.017264148220419884
and O 0 8.744551450945437e-05
for O 0 7.723178714513779e-05
a O 0 0.00022356123372446746
significant O 0 0.00039728335104882717
reduction O 0 0.0012055925326421857
of O 0 4.725892722490244e-06
this O 0 1.2891245205537416e-05
interaction O 0 0.00013971066800877452
in O 0 8.612645615357906e-05
cells O 0 0.0007452210411429405
with O 0 2.7914729798794724e-05
a O 0 0.0010833111591637135
hypermethylated O 1 0.9951203465461731
DMPK O 1 0.9970270991325378
gene O 0 0.0023539785761386156
. O 0 9.739344386616722e-05
. O 0 0.00020671456877607852

The O 0 0.005521746817976236
hemochromatosis B-Disease 1 0.9999998807907104
gene O 0 0.004805990494787693
product O 0 0.001557369134388864
complexes O 0 0.0030910170171409845
with O 0 2.658650919329375e-05
the O 0 0.000252185040153563
transferrin O 1 0.9815354347229004
receptor O 0 0.0058477758429944515
and O 0 0.00019786416669376194
lowers O 0 0.07657778263092041
its O 0 6.344645953504369e-05
affinity O 0 0.0011470546014606953
for O 0 0.00011569581693038344
ligand O 0 0.0053261821158230305
binding O 0 0.000794660416431725
. O 0 0.00034344845334999263

We O 0 0.0014006242854520679
recently O 0 0.004292595665901899
reported O 0 0.0008705087820999324
the O 0 4.220770642859861e-05
positional O 0 0.00402671005576849
cloning O 0 0.0012535982532426715
of O 0 4.814279691345291e-06
a O 0 0.00026706670178100467
candidate O 0 0.0009039961732923985
gene O 0 0.0012526081409305334
for O 0 0.0009692965541034937
hereditary B-Disease 1 0.9999997615814209
hemochromatosis I-Disease 1 1.0
called O 1 0.646869957447052
HFE O 1 0.9999748468399048
. O 0 0.001398227410390973

The O 0 0.0007538236095570028
gene O 0 0.0015428478363901377
product O 0 0.0009862083243206143
, O 0 9.217372280545533e-05
a O 0 0.00015850240015424788
member O 0 0.00010186510917264968
of O 0 4.274795173841994e-06
the O 0 0.00014325289521366358
major O 0 0.007471420336514711
histocompatibility O 1 0.9999841451644897
complex O 0 0.020779289305210114
class O 0 0.01061286311596632
I O 0 0.40011677145957947
- O 0 0.004142284393310547
like O 0 0.00019885295478161424
family O 0 0.0004838455643039197
, O 0 0.00024148776719812304
was O 0 0.0008134550298564136
found O 0 8.642922330182046e-05
to O 0 1.3361794117372483e-05
have O 0 1.2798418538295664e-05
a O 0 0.0001900384231703356
mutation O 0 0.0012628391850739717
, O 0 0.0005672126426361501
Cys O 1 0.9978085160255432
- O 0 0.008510394021868706
282 O 0 0.03073757141828537
- O 0 0.007482963614165783
- O 0 0.0076343524269759655
> O 0 0.02419949322938919
Tyr O 1 0.9977986216545105
( O 0 0.0011989400954917073
C282Y O 0 0.05534641817212105
) O 0 0.00024943723110482097
, O 0 8.132086804835126e-05
in O 0 0.00010663722059689462
85 O 0 0.0013360774610191584
% O 0 2.066847082460299e-05
of O 0 2.9231703592813574e-05
patient O 1 0.9995638728141785
chromosomes O 0 0.0009485381888225675
. O 0 0.0003785687731578946

This O 0 0.00021084907348267734
mutation O 0 0.0018649882404133677
eliminates O 0 0.009124645963311195
the O 0 9.176214371109381e-05
ability O 0 0.0012399748666211963
of O 0 8.754890586715192e-05
HFE O 1 0.9998564720153809
to O 0 0.00025213745539076626
associate O 0 0.004981371108442545
with O 0 0.0001583532866789028
beta2 O 1 0.9882985353469849
- O 0 0.016900204122066498
microglobulin O 1 0.888745903968811
( O 0 0.0007783907349221408
beta2m O 0 0.42447417974472046
) O 0 0.00014330455451272428
and O 0 9.173520084004849e-05
prevents O 0 0.022525079548358917
cell O 0 0.004675076808780432
- O 0 0.003534215036779642
surface O 0 0.002986613195389509
expression O 0 0.001109275734052062
. O 0 0.0003246564883738756

A O 0 0.0028597137425094843
second O 0 0.0003744406276382506
mutation O 0 0.0009950745152309537
that O 0 3.834814197034575e-05
has O 0 0.0001240906276507303
no O 0 4.598013038048521e-05
effect O 0 0.00030556588899344206
on O 0 0.0002477385278325528
beta2m O 1 0.9846293926239014
association O 0 0.03124985843896866
, O 0 0.000831682700663805
H63D O 1 0.9990559220314026
, O 0 0.0003611993743106723
was O 0 0.000944300030823797
found O 0 0.00011101715790573508
in O 0 3.3319327485514805e-05
eight O 0 4.353401163825765e-05
out O 0 1.6232226698775776e-05
of O 0 8.782050826994237e-06
nine O 0 0.0010845528449863195
patients O 1 0.999954342842102
heterozygous O 0 0.0016907614190131426
for O 0 7.023438229225576e-05
the O 0 0.00019717054965440184
C282Y O 0 0.05663754418492317
mutant O 0 0.008870181627571583
. O 0 0.0004052719159517437

In O 0 0.00037254320341162384
this O 0 7.555486808996648e-05
report O 0 0.0007318973657675087
, O 0 9.664075332693756e-05
we O 0 6.78028300171718e-05
demonstrate O 0 0.0006528784288093448
in O 0 8.519768744008616e-05
cultured O 0 0.021670803427696228
293 O 0 0.10880228132009506
cells O 0 0.007199784275144339
overexpressing O 1 0.9590800404548645
wild O 0 0.0016110260039567947
- O 0 0.006517436821013689
type O 0 0.0037308838218450546
or O 0 0.0006013846141286194
mutant O 0 0.011454064399003983
HFE O 1 0.9901665449142456
proteins O 0 6.937415309948847e-05
that O 0 1.920697104651481e-05
both O 0 2.0824831153731793e-05
the O 0 9.407212201040238e-05
wild O 0 0.0006795941153541207
- O 0 0.005782014224678278
type O 0 0.00406316202133894
and O 0 0.000508718891069293
H63D O 1 0.9991523027420044
HFE O 1 0.9938534498214722
proteins O 0 0.0001789680536603555
form O 0 0.0006279989029280841
stable O 0 0.022888757288455963
complexes O 0 0.0028652152977883816
with O 0 2.3072861949913204e-05
the O 0 0.00018694149912334979
transferrin O 1 0.9809008240699768
receptor O 0 0.01196335256099701
( O 0 0.0015448917401954532
TfR O 1 0.9976455569267273
) O 0 0.0004887685063295066
. O 0 0.0003059818991459906

The O 0 0.0008116230019368231
C282Y O 0 0.04007523134350777
mutation O 0 0.0019648056477308273
nearly O 0 0.0011641085147857666
completely O 0 0.006672691088169813
prevents O 0 0.010236614383757114
the O 0 0.0001167307491414249
association O 0 0.0016996880294755101
of O 0 6.506431418529246e-06
the O 0 0.0001612983032828197
mutant O 0 0.009382976219058037
HFE O 1 0.9849506616592407
protein O 0 0.00023813154257368296
with O 0 4.0293700294569135e-05
the O 0 0.0005149062490090728
TfR O 1 0.9988722205162048
. O 0 0.0007438240572810173

Studies O 0 0.0013772431993857026
on O 0 0.0002438623778289184
cell O 0 0.0040855794213712215
- O 0 0.0037134152371436357
associated O 0 0.0006645483081229031
transferrin O 1 0.7241799235343933
at O 0 0.001198723097331822
37 O 0 0.002137218602001667
degrees O 0 0.003803757019340992
C O 0 0.022606899961829185
suggest O 0 0.00025640070089139044
that O 0 1.3977613889437634e-05
the O 0 0.00013143059914000332
overexpressed O 0 0.39902928471565247
wild O 0 0.0012218514457345009
- O 0 0.006428742315620184
type O 0 0.009568143635988235
HFE O 1 0.9954628348350525
protein O 0 0.0005831606104038656
decreases O 0 0.0012140092439949512
the O 0 3.462028689682484e-05
affinity O 0 0.00039731990545988083
of O 0 8.544438060198445e-06
the O 0 0.00040339541737921536
TfR O 1 0.997624933719635
for O 0 0.0006044941255822778
transferrin O 1 0.9893179535865784
. O 0 0.0007050970452837646

The O 0 0.001905173296108842
overexpressed O 1 0.9516029953956604
H63D O 1 0.9809422492980957
protein O 0 0.001061529852449894
does O 0 0.0003815499076154083
not O 0 3.5572636988945305e-05
have O 0 1.3715529348701239e-05
this O 0 1.2822801181755494e-05
effect O 0 0.0005071593914180994
, O 0 0.00010327510244678706
providing O 0 0.0011239091400057077
the O 0 4.896086102235131e-05
first O 0 4.707262633019127e-05
direct O 0 0.00010416880832053721
evidence O 0 0.0001376962463837117
for O 0 6.292958278208971e-05
a O 0 0.0002853152109310031
functional O 0 0.0038829506374895573
consequence O 0 0.002419551834464073
of O 0 1.5259254723787308e-05
the O 0 0.0004578125081025064
H63D O 1 0.9984403252601624
mutation O 0 0.004039780702441931
. O 0 0.0003461687592789531

Addition O 0 0.0002435203641653061
of O 0 1.707035153231118e-05
soluble O 0 0.1754963994026184
wild O 0 0.0013327134074643254
- O 0 0.02389906905591488
type O 1 0.6413599252700806
HFE O 1 0.9999858140945435
/ O 1 0.9879917502403259
beta2m O 1 0.7548685669898987
heterodimers O 0 0.12595270574092865
to O 0 0.00016106991097331047
cultured O 0 0.014127600006759167
cells O 0 0.0028955689631402493
also O 0 0.00019710324704647064
decreased O 0 0.004615395795553923
the O 0 0.00013958469207864255
apparent O 0 0.0040711890906095505
affinity O 0 0.0009316705400124192
of O 0 1.5681844161008485e-05
the O 0 0.00044203404104337096
TfR O 1 0.9890897870063782
for O 0 8.908721792977303e-05
its O 0 0.00012022356531815603
ligand O 0 0.006270487327128649
under O 0 0.0005400139489211142
steady O 0 0.012525171972811222
- O 0 0.003686255309730768
state O 0 0.0001791210233932361
conditions O 0 0.002985576866194606
, O 0 7.38126618671231e-05
both O 0 5.224668711889535e-05
in O 0 0.00017259524611290544
293 O 0 0.046792395412921906
cells O 0 0.001465400098823011
and O 0 5.5855507525848225e-05
in O 0 0.0002778865455184132
HeLa O 1 0.9957789182662964
cells O 0 0.0031078278552740812
. O 0 0.00020837780903093517

Furthermore O 0 0.007044466212391853
, O 0 0.00023928612063173205
at O 0 0.0007527918787673116
4 O 0 0.0011407530400902033
degrees O 0 0.004052871372550726
C O 0 0.025590021163225174
, O 0 5.7380591897526756e-05
the O 0 5.539132689591497e-05
added O 0 0.0006730147870257497
soluble O 0 0.024760549888014793
complex O 0 0.0017476010834798217
of O 0 0.00020379855413921177
HFE O 1 0.9999939203262329
/ O 1 0.977233350276947
beta2m O 0 0.12324613332748413
inhibited O 0 0.007725081406533718
binding O 0 0.00010638532694429159
of O 0 1.8334358173888177e-05
transferrin O 1 0.8653149604797363
to O 0 0.0003258524520788342
HeLa O 1 0.9925757646560669
cell O 0 0.006428538355976343
TfR O 1 0.9684029817581177
in O 0 7.003245991654694e-05
a O 0 0.00034281593980267644
concentration O 0 0.0088539719581604
- O 0 0.002798192435875535
dependent O 0 0.0010696783429011703
manner O 0 0.001647310913540423
. O 0 0.0005135221290402114

Scatchard O 0 0.046009499579668045
plots O 0 0.0005973117076791823
of O 0 8.44756777951261e-06
these O 0 1.0054754966404289e-05
data O 0 7.098365313140675e-05
indicate O 0 0.000262322835624218
that O 0 1.3948557352705393e-05
the O 0 7.993235340109095e-05
added O 0 0.001406421884894371
heterodimer O 0 0.09283372014760971
substantially O 0 0.012041984125971794
reduced O 0 0.0007609957829117775
the O 0 4.19060634158086e-05
affinity O 0 0.0008296800078824162
of O 0 5.050591062172316e-05
TfR O 1 0.9983541965484619
for O 0 0.0007169664604589343
transferrin O 1 0.9868506193161011
. O 0 0.0005307943210937083

These O 0 6.161627970868722e-05
results O 0 0.00029093868215568364
establish O 0 0.0005736105958931148
a O 0 0.0003349057224113494
molecular O 0 0.0036017182283103466
link O 0 0.009751388803124428
between O 0 0.0007403595373034477
HFE O 1 0.9995228052139282
and O 0 9.205856622429565e-05
a O 0 0.00015531892131548375
key O 0 0.000374181370716542
protein O 0 0.00018661521608009934
involved O 0 0.0003868771018460393
in O 0 0.00020191966905258596
iron O 1 0.9464436173439026
transport O 0 0.008452361449599266
, O 0 0.00025648775044828653
the O 0 0.0007968335412442684
TfR O 1 0.9991315007209778
, O 0 0.00034790404606610537
and O 0 7.746944174868986e-05
raise O 0 0.0005823913379572332
the O 0 7.133563485695049e-05
possibility O 0 0.0010460319463163614
that O 0 5.505361332325265e-05
alterations O 0 0.002818305278196931
in O 0 3.6365170672070235e-05
this O 0 2.486903940734919e-05
regulatory O 0 0.003753956640139222
mechanism O 0 0.0024764295667409897
may O 0 0.0006419698474928737
play O 0 3.594278314267285e-05
a O 0 0.0001113362523028627
role O 0 0.0006561485934071243
in O 0 7.247060420922935e-05
the O 0 0.00031867422512732446
pathogenesis O 1 0.9999675750732422
of O 0 0.0007245136657729745
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.0015328038716688752
. O 0 0.0004760042647831142

Genomic O 0 0.00305130984634161
organization O 0 0.00045071839122101665
of O 0 1.2845200217270758e-05
the O 0 0.0010441968915984035
UBE3A O 1 0.9999644756317139
/ O 1 0.9944169521331787
E6 O 1 0.9987963438034058
- O 0 0.03683904558420181
AP O 0 0.011218792758882046
gene O 0 0.0008578430279158056
and O 0 9.203328954754397e-05
related O 0 0.0019394728587940335
pseudogenes O 0 0.03472747653722763
. O 0 0.0005323460209183395

The O 0 0.001484643085859716
UBE3A O 1 0.9495328664779663
gene O 0 0.0008037326624616981
encodes O 0 0.00043524825014173985
the O 0 0.0003179264604113996
E6 O 1 0.9928938746452332
- O 0 0.014433003030717373
AP O 0 0.007776922080665827
ubiquitin O 0 0.007065384183079004
- O 0 0.0012180842459201813
protein O 0 0.0002685035578906536
ligase O 0 0.0051435865461826324
and O 0 0.00014414188626687974
has O 0 0.0006971682305447757
recently O 0 0.002217952162027359
been O 0 9.283219696953893e-05
shown O 0 8.622376481071115e-05
to O 0 1.134692138293758e-05
be O 0 4.3447871576063335e-05
mutated O 0 0.008463054895401001
in O 0 0.004448459949344397
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999997615814209
who O 0 0.0011542217107489705
lack O 0 0.006964912638068199
15q11 O 1 0.9516335725784302
- O 0 0.013148218393325806
q13 O 0 0.031668804585933685
deletions O 0 0.002270074561238289
or O 0 0.0002274615253554657
chromosome O 0 0.001470424816943705
15 O 0 0.0008688167436048388
paternal O 0 0.03442852571606636
uniparental B-Disease 1 0.9999798536300659
disomy I-Disease 1 0.9965862035751343
. O 0 0.0009175224113278091

Previous O 0 0.005554556380957365
UBE3A O 1 0.9835531711578369
cDNA O 0 0.003922894597053528
analysis O 0 0.0003876935807056725
has O 0 0.00026847541448660195
shown O 0 0.0002859922533389181
a O 0 0.00024538958678022027
coding O 0 0.004109627101570368
region O 0 0.0004152824985794723
of O 0 1.1774756785598584e-05
approximately O 0 0.0004839327884837985
2 O 0 0.001005926518701017
. O 0 0.0002722646459005773

6 O 0 0.004597401712089777
kb O 0 0.012961695902049541
and O 0 7.36527654225938e-05
a O 0 0.0005978026310913265
3 O 0 0.0015367197338491678
- O 0 0.005851724650710821
untranslated O 0 0.049181532114744186
region O 0 0.00348468404263258
( O 0 0.000771607446949929
UTR O 0 0.11949064582586288
) O 0 9.78377356659621e-05
of O 0 2.650049646035768e-05
< O 0 0.04389398545026779
50 O 0 0.0013371448731049895
bp O 0 0.0616692379117012
, O 0 0.00024879234842956066
whereas O 0 0.0010911250719800591
Northern O 0 0.000806731462944299
analysis O 0 0.00030017158132977784
has O 0 0.0002694429422263056
indicated O 0 0.0006389070185832679
mRNA O 0 8.166699262801558e-05
sizes O 0 5.0712089432636276e-05
of O 0 1.3747954653808847e-05
5 O 0 0.001331276842392981
- O 0 0.0038109985180199146
8 O 0 0.0009607248939573765
kb O 0 0.01950893923640251
. O 0 0.00036223605275154114

We O 0 0.00036327497218735516
have O 0 2.913307434937451e-05
analyzed O 0 0.0003835500101558864
additional O 0 0.0001668076147325337
cDNA O 0 0.0038633872754871845
clones O 0 0.005969856400042772
and O 0 5.577343836193904e-05
provide O 0 0.00032414120505563915
evidence O 0 7.950831059133634e-05
for O 0 2.842513822542969e-05
an O 0 5.534090814762749e-05
additional O 0 0.0002517183020245284
0 O 0 0.0009030547807924449
. O 0 0.00023245955526363105

5 O 0 0.00147421529982239
kb O 0 0.0058766682632267475
of O 0 2.6389534468762577e-05
5 O 0 0.0016050044214352965
- O 0 0.006107861641794443
UTR O 0 0.061879225075244904
and O 0 0.00024382377159781754
> O 0 0.008256719447672367
2 O 0 0.00044173459173180163
kb O 0 0.0037026728969067335
of O 0 2.292136377946008e-05
3 O 0 0.0018543862970545888
- O 0 0.007125381380319595
UTR O 0 0.13683998584747314
. O 0 0.0004026298993267119

We O 0 0.0004006466188002378
have O 0 3.1999137718230486e-05
established O 0 0.00010643606947269291
the O 0 4.2090618080692366e-05
genomic O 0 0.0017390025313943624
organization O 0 0.0012253853492438793
of O 0 9.756745566846803e-05
UBE3A O 1 0.9984523057937622
and O 0 6.840290734544396e-05
the O 0 2.4231836505350657e-05
sequence O 0 1.7845886759459972e-05
of O 0 2.560103530413471e-05
intron O 1 0.9852291941642761
- O 0 0.013055108487606049
exon O 0 0.025233816355466843
borders O 0 0.0030359120573848486
. O 0 0.00047497739433310926

We O 0 0.0005473851342685521
have O 0 4.0252107282867655e-05
also O 0 4.867288225796074e-05
mapped O 0 0.0007518675411120057
two O 0 9.23530024010688e-06
highly O 0 0.0010663956636562943
homologous O 0 0.003185502951964736
processed O 0 0.0011070783948525786
pseudogenes O 0 0.02771110273897648
, O 0 0.0008678783779032528
UBE3AP1 O 1 0.9933465719223022
and O 0 0.0009026284678839147
UBE3AP2 O 1 0.9952736496925354
, O 0 0.00013091265282128006
to O 0 3.5710148949874565e-05
chromosomes O 0 0.0001571917673572898
2 O 0 0.00044425009400583804
and O 0 0.00011578766134334728
21 O 0 0.0012891157530248165
, O 0 0.00018262430967297405
respectively O 0 0.0006023276946507394
, O 0 0.0001134537742473185
and O 0 6.083485277486034e-05
determined O 0 0.00044362168409861624
their O 0 2.0561054043355398e-05
genomic O 0 0.0025200359523296356
organization O 0 0.0026816560421139
. O 0 0.00040737344534136355

These O 0 0.00011269470996921882
results O 0 0.0005492917262017727
will O 0 6.470033258665353e-05
form O 0 8.633796096546575e-05
the O 0 3.2564406865276396e-05
basis O 0 4.2144118197029456e-05
for O 0 6.735809438396245e-05
studies O 0 0.00019278842955827713
of O 0 1.0613906852086075e-05
mutation O 0 0.001088645774871111
and O 0 9.138281893683597e-05
imprinting O 0 0.02635609172284603
of O 0 0.00013283836597111076
UBE3A O 1 0.9998058676719666
. O 0 0.0012921994784846902

Mutation O 0 0.007216986268758774
spectrum O 0 0.0050631556659936905
and O 0 0.00044115472701378167
genotype O 1 0.8563799262046814
- O 0 0.012233839370310307
phenotype O 0 0.013240665197372437
analyses O 0 0.0010177643271163106
in O 0 0.0007346498314291239
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999998807907104
and O 0 0.0006727563450112939
Bannayan B-Disease 1 0.999951958656311
- I-Disease 1 0.9997420907020569
Zonana I-Disease 1 0.9999977350234985
syndrome I-Disease 1 1.0
, O 0 0.0002616130223032087
two O 0 0.0002317628386663273
hamartoma B-Disease 1 0.9999879598617554
syndromes I-Disease 1 0.9999810457229614
with O 0 0.000913230876903981
germline O 1 0.9994558691978455
PTEN O 1 0.9999165534973145
mutation O 0 0.007064875215291977
. O 0 0.0003765007422771305

The O 0 0.0033219573087990284
tumour B-Disease 1 0.9999995231628418
suppressor O 1 0.965743899345398
gene O 0 0.015178266912698746
PTEN O 1 0.9997419714927673
, O 0 0.00018887505575548857
which O 0 1.4837958588032052e-05
maps O 0 0.00016815977869555354
to O 0 8.983604493550956e-05
10q23 O 0 0.03697318211197853
. O 0 0.0003489277441985905

3 O 0 0.0010711157228797674
and O 0 5.037738083046861e-05
encodes O 0 0.00044610671466216445
a O 0 0.0002702046767808497
403 O 0 0.00636655930429697
amino O 0 0.00015289481962099671
acid O 0 0.003247713204473257
dual O 0 0.0017887521535158157
specificity O 0 0.0024253292940557003
phosphatase O 0 0.09095335006713867
( O 0 0.00018582152551971376
protein O 0 0.0005540947313420475
tyrosine O 0 0.011923961341381073
phosphatase O 1 0.770828127861023
; O 0 0.0005607000784948468
PTPase O 1 0.9676885008811951
) O 0 0.00025880365865305066
, O 0 0.00014187488704919815
was O 0 0.0012046820484101772
shown O 0 0.0009410684579052031
recently O 0 0.0015144834760576487
to O 0 2.042610321950633e-05
play O 0 3.284754347987473e-05
a O 0 0.00020303418568801135
broad O 0 0.003563475329428911
role O 0 0.0015626320382580161
in O 0 0.00025088281836360693
human O 0 0.009658404625952244
malignancy B-Disease 1 0.9999908208847046
. O 0 0.0007852292037568986

Somatic O 1 0.9520102739334106
PTEN O 1 0.9998301267623901
deletions O 0 0.007418637163937092
and O 0 0.0001416911545675248
mutations O 0 0.00043303827987983823
were O 0 7.030881079117535e-06
observed O 0 8.47729534143582e-05
in O 0 9.181835048366338e-05
sporadic B-Disease 0 0.07714936137199402
breast I-Disease 1 1.0
, I-Disease 0 0.001298542832955718
brain I-Disease 1 0.9999995231628418
, I-Disease 0 0.005816793534904718
prostate I-Disease 1 1.0
and I-Disease 0 0.4406946301460266
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.006071262992918491
lines O 0 0.0004625316651072353
and O 0 3.453237877693027e-05
in O 0 4.008716132375412e-05
several O 0 4.928577982354909e-05
primary O 0 0.03185722976922989
tumours B-Disease 1 0.9999996423721313
such O 0 5.134027742315084e-05
as O 0 0.0019722438883036375
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9838041663169861
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.8065967559814453
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.0010427762754261494

In O 0 0.00038638795376755297
addition O 0 0.000518293643835932
, O 0 0.0010747909545898438
PTEN O 1 0.9999034404754639
was O 0 0.0020644611213356256
identified O 0 0.0003805333690252155
as O 0 5.88297079957556e-05
the O 0 9.1843910922762e-05
susceptibility O 0 0.02961307018995285
gene O 0 0.0005085022421553731
for O 0 8.349388372153044e-05
two O 0 0.0003409301280044019
hamartoma B-Disease 1 0.9999996423721313
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
( O 0 0.0013634214410558343
CD B-Disease 0 0.010631353594362736
; O 0 0.0007551321177743375
MIM O 1 0.9998670816421509
158350 O 0 0.1872975379228592
) O 0 0.00019119397620670497
and O 0 0.00021443214791361243
Bannayan B-Disease 1 0.9966564178466797
- I-Disease 0 0.04839937761425972
Zonana I-Disease 1 0.9990529417991638
( I-Disease 0 0.0019208109006285667
BZS I-Disease 1 0.9298319220542908
) I-Disease 0 0.00031238788506016135
or I-Disease 0 0.0006613078294321895
Ruvalcaba I-Disease 1 0.9992200136184692
- I-Disease 0 0.038451045751571655
Riley I-Disease 1 0.986077070236206
- I-Disease 0 0.39647623896598816
Smith I-Disease 1 0.9922202229499817
syndrome I-Disease 1 0.9999998807907104
( O 0 0.007577413693070412
MIM O 1 0.9999613761901855
153480 O 1 0.9484381079673767
) O 0 0.0006065816851332784
. O 0 0.00030519498977810144

Constitutive O 0 0.13671758770942688
DNA O 0 0.0019955539610236883
from O 0 0.00011627272033365443
37 O 0 0.0017507249722257257
CD B-Disease 0 0.002615774516016245
families O 0 0.00014239097072277218
and O 0 9.184758528135717e-05
seven O 0 0.0005793179734610021
BZS B-Disease 1 0.9616080522537231
families O 0 0.00025556504260748625
was O 0 0.0006465624319389462
screened O 0 0.0021044083405286074
for O 0 0.0005468601593747735
germline O 1 0.9985394477844238
PTEN O 1 0.9998447895050049
mutations O 0 0.004284327384084463
. O 0 0.00041087379213422537

PTEN O 1 0.999068558216095
mutations O 0 0.0039840200915932655
were O 0 5.732594581786543e-05
identified O 0 0.0003465166373644024
in O 0 4.625077053788118e-05
30 O 0 0.00014674215344712138
of O 0 1.2868618796346709e-05
37 O 0 0.003080221125856042
( O 0 0.0006177750765345991
81 O 0 0.008537635207176208
% O 0 0.00012595500447787344
) O 0 0.0002199420559918508
CD B-Disease 0 0.0028956406749784946
families O 0 0.0002149596402887255
, O 0 0.00012413524382282048
including O 0 0.00012451318616513163
missense O 0 0.013202927075326443
and O 0 0.00020941333787050098
nonsense O 0 0.009716199710965157
point O 0 0.0008652303949929774
mutations O 0 0.001528257387690246
, O 0 0.00016749950009398162
deletions O 0 0.0022194236516952515
, O 0 0.00016005852376110852
insertions O 0 0.004512775223702192
, O 0 0.00011603966413531452
a O 0 0.0008892819751054049
deletion O 0 0.039267316460609436
/ O 0 0.06575633585453033
insertion O 0 0.009959440678358078
and O 0 0.00017611160001251847
splice O 0 0.025943784043192863
site O 0 0.002775286789983511
mutations O 0 0.0016461005434393883
. O 0 0.00022565698600374162

These O 0 0.00015831207565497607
mutations O 0 0.0010002886410802603
were O 0 1.772819996403996e-05
scattered O 0 0.00013076818140689284
over O 0 4.3427080527180806e-05
the O 0 6.14386226516217e-05
entire O 0 0.0011954893125221133
length O 0 0.00038590485928580165
of O 0 0.00010408461821498349
PTEN O 1 0.9999518394470215
, O 0 0.0002458987873978913
with O 0 3.325635043438524e-05
the O 0 9.309141023550183e-05
exception O 0 0.00048431786126457155
of O 0 5.102013346913736e-06
the O 0 8.397969213547185e-05
first O 0 0.00014022772666066885
, O 0 0.00011843756510643288
fourth O 0 0.0008692025439813733
and O 0 0.00010459493205416948
last O 0 0.000997416558675468
exons O 0 0.0069686672650277615
. O 0 0.00033756447373889387

A O 0 0.005564236547797918
hot O 0 0.013139261864125729
spot O 0 0.005187325645238161
for O 0 0.0007070780266076326
PTEN O 1 0.9990925788879395
mutation O 0 0.0018389987526461482
in O 0 0.0001525732659501955
CD B-Disease 0 0.0034866021014750004
was O 0 0.0007224696455523372
identified O 0 0.00034563025110401213
in O 0 9.17079159989953e-05
exon O 0 0.014645744115114212
5 O 0 0.00021452251530718058
that O 0 1.0220009244221728e-05
contains O 0 2.8016285796184093e-05
the O 0 0.00015274110774043947
PTPase O 1 0.9366092681884766
core O 0 0.005209019873291254
motif O 0 0.004134828690439463
, O 0 0.000103349972050637
with O 0 3.540807665558532e-05
13 O 0 0.0003127195523120463
of O 0 1.329514998360537e-05
30 O 0 0.0009872339433059096
( O 0 0.0003739458625204861
43 O 0 0.001501358114182949
% O 0 9.199300257023424e-05
) O 0 0.00020600897551048547
CD B-Disease 0 0.004289169330149889
mutations O 0 0.0012635791208595037
identified O 0 0.00024346090503968298
in O 0 3.058623042306863e-05
this O 0 4.187913873465732e-05
exon O 0 0.0282436516135931
. O 0 0.0004208264290355146

Seven O 0 0.0002807216951623559
of O 0 2.3133805370889604e-05
30 O 0 0.0015283942921087146
( O 0 0.0006454382091760635
23 O 0 0.0019098796183243394
% O 0 6.691774615319446e-05
) O 0 6.136378215160221e-05
were O 0 7.467113391612656e-06
within O 0 3.1997336918720976e-05
the O 0 0.00011047961743315682
core O 0 0.006706305779516697
motif O 0 0.005843386519700289
, O 0 0.00012141295155743137
the O 0 0.00015366243314929307
majority O 0 0.00035477339406497777
( O 0 0.00022827716020401567
five O 0 3.417313200770877e-05
of O 0 8.867792530509178e-06
seven O 0 0.00020860981021542102
) O 0 4.234958396409638e-05
of O 0 4.865749360760674e-06
which O 0 3.065635246457532e-05
were O 0 5.348744889488444e-05
missense O 0 0.01759464293718338
mutations O 0 0.002612828044220805
, O 0 0.0002974166418425739
possibly O 0 0.0022012428380548954
pointing O 0 0.0017188589554280043
to O 0 3.3444306609453633e-05
the O 0 5.166033952264115e-05
functional O 0 0.0017689334927126765
significance O 0 0.00026678162976168096
of O 0 9.031988156493753e-06
this O 0 5.7688826927915215e-05
region O 0 0.0019581702072173357
. O 0 0.00035426049726083875

Germline O 1 0.9988370537757874
PTEN O 1 0.9993970394134521
mutations O 0 0.0034511741250753403
were O 0 4.15194226661697e-05
identified O 0 0.0002331987489014864
in O 0 2.454748027957976e-05
four O 0 1.1425318007241003e-05
of O 0 6.408693934645271e-06
seven O 0 0.0003025392652489245
( O 0 0.0005994238890707493
57 O 0 0.004315884783864021
% O 0 0.00015107450599316508
) O 0 0.0005546247703023255
BZS B-Disease 1 0.9192266464233398
families O 0 0.0004983297549188137
studied O 0 0.0015351444017142057
. O 0 0.0003342403215356171

Interestingly O 0 0.05690852552652359
, O 0 0.0002667269727680832
none O 0 0.0001820408651838079
of O 0 4.2169094740529545e-06
these O 0 1.868655272119213e-05
mutations O 0 0.0010552643798291683
was O 0 0.00035303199547342956
observed O 0 0.00013252015924081206
in O 0 3.3239608455915004e-05
the O 0 0.00016076119209174067
PTPase O 1 0.8425140380859375
core O 0 0.006468724925071001
motif O 0 0.007767541334033012
. O 0 0.00045396614586934447

It O 0 0.0004980951198376715
is O 0 0.00021974123956169933
also O 0 0.00012331223115324974
worthy O 0 0.0022694093640893698
of O 0 1.2109277122362982e-05
note O 0 0.0002183273754781112
that O 0 1.1995568456768524e-05
a O 0 0.00011515321239130571
single O 0 0.00020783551735803485
nonsense O 0 0.006680638529360294
point O 0 0.0007767021306790411
mutation O 0 0.002057685749605298
, O 0 0.0002884718996938318
R233X O 0 0.0404650941491127
, O 0 0.00016463067731820047
was O 0 0.00038647232577204704
observed O 0 0.00016092529403977096
in O 0 3.954035128117539e-05
the O 0 0.0002644150226842612
germline O 1 0.8093880414962769
DNA O 0 0.0008137731929309666
from O 0 3.267228385084309e-05
two O 0 3.443641617195681e-05
unrelated O 0 0.004756815731525421
CD B-Disease 0 0.003883207216858864
families O 0 0.0001758737926138565
and O 0 9.548472735332325e-05
one O 0 0.0005343851516954601
BZS B-Disease 1 0.9866609573364258
family O 0 0.0016806313069537282
. O 0 0.0004637950623873621

Genotype O 1 0.971913754940033
- O 0 0.034822214394807816
phenotype O 0 0.03759148344397545
studies O 0 0.0005591190420091152
were O 0 2.1843225113116205e-05
not O 0 6.056788333808072e-05
performed O 0 0.0004665344604291022
on O 0 4.318622450227849e-05
this O 0 9.535309800412506e-06
small O 0 4.797931615030393e-05
group O 0 0.00011498708045110106
of O 0 4.643381544156e-05
BZS B-Disease 1 0.9800538420677185
families O 0 0.0006830898346379399
. O 0 0.00041008650441654027

However O 0 0.0010078874183818698
, O 0 0.0004544887342490256
genotype O 0 0.14476323127746582
- O 0 0.014921746216714382
phenotype O 0 0.01972295716404915
analysis O 0 0.0005581529112532735
inthe O 0 0.048569630831480026
group O 0 0.00021962643950246274
of O 0 2.409394619462546e-05
CD B-Disease 0 0.00551216397434473
families O 0 0.0004073672171216458
revealed O 0 0.0029781628400087357
two O 0 2.341453182452824e-05
possible O 0 0.00022416359570343047
associations O 0 0.0004363141779322177
worthy O 0 0.003945468459278345
of O 0 2.018967643380165e-05
follow O 0 0.000715007889084518
- O 0 0.0018993907142430544
up O 0 5.1902748964494094e-05
in O 0 4.171392720309086e-05
independent O 0 0.00014108905452303588
analyses O 0 0.0015380694530904293
. O 0 0.0003682571987155825

The O 0 0.0004065089742653072
first O 0 0.00023271277314051986
was O 0 0.000723823148291558
an O 0 0.00029729530797339976
association O 0 0.015097536146640778
noted O 0 0.0007843811181373894
in O 0 5.770467396359891e-05
the O 0 4.882852954324335e-05
group O 0 6.214417953742668e-05
of O 0 7.803450898791198e-06
CD B-Disease 0 0.002399632940068841
families O 0 0.0002051152114290744
with O 0 0.0009984690696001053
breast B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
. O 0 0.0009466142510063946

A O 0 0.0037235445342957973
correlation O 0 0.0024102013558149338
was O 0 0.0006662405212409794
observed O 0 0.00014175170508679003
between O 0 4.18580966652371e-05
the O 0 0.0001472557196393609
presence O 0 0.0033341581001877785
/ O 0 0.06066150590777397
absence O 0 0.0011732298880815506
of O 0 1.299098767049145e-05
a O 0 0.0019111033761873841
PTEN O 1 0.9998630285263062
mutation O 0 0.0015945171471685171
and O 0 2.6705078198574483e-05
the O 0 5.4316496971296147e-05
type O 0 0.002395609160885215
of O 0 0.00013921130448579788
breast O 1 0.9999998807907104
involvement O 1 0.6893208622932434
( O 0 0.0011648378567770123
unaffected O 1 0.9796145558357239
versus O 1 0.6937199234962463
benign O 1 0.9999730587005615
versus O 1 0.9982969164848328
malignant O 1 0.9999998807907104
) O 0 0.0008200117736123502
. O 0 0.00033891384373418987

Specifically O 0 0.0018135553691536188
and O 0 5.919109389651567e-05
more O 0 2.9834163797204383e-05
directly O 0 0.00027467901236377656
, O 0 0.0001120233500842005
an O 0 0.0004129268054384738
association O 0 0.04211951792240143
was O 0 0.0016122842207551003
also O 0 0.0001131793178501539
observed O 0 0.0001334273983957246
between O 0 2.0377210603328422e-05
the O 0 2.5080633349716663e-05
presence O 0 6.02988620812539e-05
of O 0 5.401543603511527e-06
a O 0 0.0012135497527197003
PTEN O 1 0.9999746084213257
mutation O 0 0.006260968744754791
and O 0 0.00291330274194479
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0008572130464017391

Secondly O 0 0.048295337706804276
, O 0 0.00032994631328620017
there O 0 0.00011188477947143838
appeared O 0 0.0007713333470746875
to O 0 2.704373218875844e-05
be O 0 2.5426605134271085e-05
an O 0 0.0001541292149340734
interdependent O 1 0.9194430708885193
association O 0 0.015128370374441147
between O 0 0.0003865508479066193
mutations O 0 0.0017919973470270634
upstream O 0 0.00276898848824203
and O 0 4.767600694322027e-05
within O 0 5.2135597798042e-05
the O 0 0.0003058704605791718
PTPase O 1 0.9632121920585632
core O 0 0.0062426552176475525
motif O 0 0.0040655252523720264
, O 0 9.767394658410922e-05
the O 0 7.783198088873178e-05
core O 0 0.003250885521993041
motif O 0 0.0016258934047073126
containing O 0 5.7598073908593506e-05
the O 0 3.2722509786253795e-05
majority O 0 7.143196125980467e-05
of O 0 3.0546303605660796e-05
missense O 0 0.02693476714193821
mutations O 0 0.0026001560036092997
, O 0 0.00013890037371311337
and O 0 6.0033104091417044e-05
the O 0 0.00013222316920291632
involvement O 0 0.003125243354588747
of O 0 6.948737791390158e-06
all O 0 2.9928571166237816e-05
major O 0 0.003049644874408841
organ O 1 0.6089487671852112
systems O 0 0.031745389103889465
( O 0 0.0004870003613177687
central O 0 0.0012237814953550696
nervous O 1 0.9929463267326355
system O 0 0.003736756509169936
, O 0 0.0010066359536722302
thyroid O 1 1.0
, O 0 0.004497278016060591
breast O 1 1.0
, O 0 0.0033215403091162443
skin O 1 1.0
and O 0 0.011727456003427505
gastrointestinal O 1 1.0
tract O 1 0.9999994039535522
) O 0 0.0007167431176640093
. O 0 0.00036566838389262557

However O 0 0.000945274019613862
, O 0 7.722205918980762e-05
these O 0 1.1437713510531466e-05
observations O 0 0.0005567801999859512
would O 0 0.00010140243830392137
need O 0 0.0003602550132200122
to O 0 4.2123429011553526e-05
be O 0 6.522964395117015e-05
confirmed O 0 0.0005781488143838942
by O 0 1.271804103453178e-05
studying O 0 0.00030750667792744935
a O 0 0.00010400712199043483
larger O 0 6.27291010459885e-05
number O 0 5.292584319249727e-06
of O 0 1.3041956663073506e-05
CD B-Disease 0 0.004458073992282152
families O 0 0.00035264965845271945
. O 0 0.0003484851331450045

Molecular O 0 0.3265911042690277
defects O 1 0.9997727274894714
leading O 0 0.0009736884967423975
to O 0 3.1213847250910476e-05
human O 0 0.0002764753589872271
complement B-Disease 0 0.004239912144839764
component I-Disease 1 0.9963240623474121
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.00018305038975086063
an O 0 0.000270628253929317
African O 0 0.002949435031041503
- O 0 0.004538845736533403
American O 0 0.0005172014934942126
family O 0 0.0006769425817765296
. O 0 0.00044557463843375444

Complement B-Disease 0 0.01350317895412445
component I-Disease 1 0.9965379238128662
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.0045987986959517
C6D B-Disease 1 0.99924635887146
) O 0 0.000722516153473407
was O 0 0.004672887269407511
diagnosed O 1 0.9999990463256836
in O 0 8.57380437082611e-05
a O 0 0.00036305407411418855
16 O 0 0.0011243321932852268
- O 0 0.0024223709478974342
year O 0 0.0006362124113366008
- O 0 0.002310463460162282
old O 0 0.001232051639817655
African O 0 0.001334999455139041
- O 0 0.0026461791712790728
American O 0 0.0003449866489972919
male O 0 0.0014876489294692874
with O 0 0.0019070947309955955
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 0.9999998807907104
. O 0 0.001315908506512642

The O 0 0.004104879684746265
patients O 1 0.999995231628418
father O 0 0.0023420425131917
and O 0 8.012520265765488e-05
two O 0 3.816886237473227e-05
brothers O 0 0.001090221107006073
also O 0 0.0002730239648371935
had O 0 0.001198893296532333
C6D B-Disease 1 0.9974529147148132
, O 0 0.00013629550812765956
but O 0 5.615084228338674e-05
gave O 0 0.00019203331612516195
no O 0 4.252250801073387e-05
history O 0 0.00014753907453268766
of O 0 0.00011253276898059994
meningitis B-Disease 1 1.0
or O 0 0.00041547612636350095
other O 0 0.0001560201490065083
neisserial B-Disease 1 0.9999581575393677
infection I-Disease 1 0.999997615814209
. O 0 0.0006529592792503536

By O 0 7.547435961896554e-05
using O 0 0.00018294360779691488
exon O 0 0.022857246920466423
- O 0 0.0011772345751523972
specific O 0 8.001891546882689e-05
polymerase O 0 0.0021781879477202892
chain O 0 0.0030539333820343018
reaction O 0 0.0017773049185052514
( O 0 0.000851878838147968
PCR O 0 0.032875582575798035
) O 0 0.0011417379137128592
/ O 0 0.018815450370311737
single O 0 0.0005401631933636963
- O 0 0.0038384099025279284
strand O 0 0.0029253545217216015
conformation O 0 0.0022460566833615303
polymorphism O 0 0.0011361440410837531
as O 0 0.00011718923633452505
a O 0 0.0004685377061832696
screening O 0 0.005784638226032257
step O 0 0.001004839432425797
and O 0 1.9982990124844946e-05
nucleotide O 0 4.9567166570341215e-05
sequencing O 0 0.00010628494783304632
of O 0 1.089004672394367e-05
target O 0 0.0008593294769525528
exons O 0 0.005454758182168007
, O 0 0.00012021989823551849
we O 0 7.701600407017395e-05
determined O 0 0.0003191013529431075
that O 0 1.689509917923715e-05
the O 0 0.00010768173524411395
proband O 0 0.07088681310415268
was O 0 0.0005199963925406337
a O 0 0.00028493624995462596
compound O 0 0.0067194560542702675
heterozygote O 0 0.017918813973665237
for O 0 7.972392631927505e-05
two O 0 0.00017074751667678356
C6 O 1 0.9999241828918457
gene O 0 0.00446205073967576
mutations O 0 0.0019090034766122699
. O 0 0.00027617000159807503

The O 0 0.0003753616474568844
first O 0 0.00022935228480491787
, O 0 0.0002644160413183272
1195delC O 0 0.054695483297109604
located O 0 0.0010789548978209496
in O 0 0.0001702111039776355
exon O 0 0.02540670707821846
7 O 0 0.0009160871850326657
, O 0 8.632437675260007e-05
is O 0 9.449035860598087e-05
a O 0 0.0002723284997045994
novel O 0 0.0013193945633247495
mutation O 0 0.0015518773579970002
, O 0 7.553239265689626e-05
while O 0 5.950497870799154e-05
the O 0 5.731212149839848e-05
second O 0 0.00029112849733792245
, O 0 0.000190349601325579
1936delG O 0 0.038011182099580765
in O 0 0.00021207757527008653
exon O 0 0.02217782475054264
12 O 0 0.0006421880098059773
, O 0 0.00010233049397356808
has O 0 0.00024231136194430292
been O 0 0.00014764207298867404
described O 0 0.0008175323018804193
before O 0 0.00022259922116063535
to O 0 9.925981430569664e-05
cause O 0 0.03528093546628952
C6D B-Disease 1 0.9981641173362732
in O 0 0.00010698739060899243
an O 0 0.00022725430608261377
unrelated O 0 0.008356308564543724
African O 0 0.00317679182626307
- O 0 0.003952616360038519
American O 0 0.0002491752675268799
individual O 0 0.0002515302039682865
. O 0 0.00041273649549111724

Both O 0 0.00042970009963028133
mutations O 0 0.0014264528872445226
result O 0 0.00042169183143414557
in O 0 0.0002962422149721533
premature O 1 0.9993942975997925
termination O 1 0.9835538864135742
codons O 0 0.00921240821480751
and O 0 0.0005962725263088942
C6 O 1 0.9999269247055054
null O 0 0.02767271362245083
alleles O 0 0.004857814405113459
. O 0 0.00040614022873342037

Allele O 0 0.02832571417093277
- O 0 0.003866738174110651
specific O 0 0.00029617585823871195
PCR O 0 0.014207317493855953
indicated O 0 0.0019571136217564344
that O 0 2.598313585622236e-05
the O 0 0.00013659097021445632
probands O 0 0.06782406568527222
two O 0 8.206264465115964e-05
brothers O 0 0.001396847190335393
also O 0 0.00038808092358522117
inherited O 1 0.8031412363052368
the O 0 0.00040539694600738585
1195delC O 1 0.5661584138870239
mutation O 0 0.001322435331530869
from O 0 2.833171129168477e-05
their O 0 4.069275382789783e-05
heterozygous O 0 0.005735122598707676
mother O 0 0.0029455421026796103
and O 0 9.61099358391948e-05
the O 0 0.0003332562046125531
1936delG O 0 0.12042753398418427
mutation O 0 0.001001617289148271
from O 0 2.43620561377611e-05
their O 0 4.277899279259145e-05
homozygous O 0 0.006107933819293976
father O 0 0.002364807529374957
. O 0 0.0001286441256524995
. O 0 0.00028651271713897586

PAX6 O 1 0.9995730519294739
mutations O 0 0.009187051095068455
reviewed O 0 0.004922482185065746
. O 0 0.00030984534532763064

Mutations O 0 0.009367878548800945
in O 0 0.0005949841579422355
PAX6 O 1 0.9996362924575806
are O 0 4.355183045845479e-05
responsible O 0 0.0017006057314574718
for O 0 0.0002358610654482618
human O 0 0.0039902422577142715
aniridia B-Disease 1 0.9997174143791199
and O 0 0.0001542745012557134
have O 0 4.1148778109345585e-05
also O 0 5.2443163440329954e-05
been O 0 7.903193909442052e-05
found O 0 8.048950257943943e-05
in O 0 0.00019697511743288487
patients O 1 0.9999942779541016
with O 0 0.0002980553254019469
Peters B-Disease 1 0.9999951124191284
anomaly I-Disease 1 0.9998472929000854
, O 0 0.0004731005465146154
with O 0 0.005683031398802996
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.0003576416929718107
with O 0 0.00020828899869229645
autosomal B-Disease 1 0.9998294115066528
dominant I-Disease 1 0.9945593476295471
keratitis I-Disease 1 0.9999960660934448
, O 0 0.0004241167625878006
and O 0 8.293381688417867e-05
with O 0 0.00021655994351021945
isolated B-Disease 1 0.9682552218437195
foveal I-Disease 1 0.9999816417694092
hypoplasia I-Disease 1 0.9999983310699463
. O 0 0.0014598191482946277

No O 0 0.000772889528889209
locus O 0 0.00505726458504796
other O 0 2.5233597625629045e-05
than O 0 8.862373215379193e-05
chromosome O 0 0.002342218765988946
11p13 O 0 0.03108260966837406
has O 0 0.0005086621968075633
been O 0 0.00043332198401913047
implicated O 0 0.0631287470459938
in O 0 0.0004857925814576447
aniridia B-Disease 1 0.9994065761566162
, O 0 0.000503231945913285
and O 0 0.0005865092971362174
PAX6 O 1 0.9999055862426758
is O 0 0.000610950926784426
clearly O 0 0.0009647838305681944
the O 0 0.00010333913087379187
major O 0 0.0018765809945762157
, O 0 0.00017540839326102287
if O 0 0.00015821428678464144
not O 0 2.568626223364845e-05
only O 0 1.768962829373777e-05
, O 0 9.716339263832197e-05
gene O 0 0.0013818403240293264
responsible O 0 0.004533468745648861
. O 0 0.00044268599594943225

Twenty O 0 0.006113580893725157
- O 0 0.0019109270069748163
eight O 0 6.830030906712636e-05
percent O 0 9.181187488138676e-05
of O 0 1.0552310413913801e-05
identified O 0 0.002436109120026231
PAX6 O 1 0.9998024106025696
mutations O 0 0.0017331484705209732
are O 0 7.0517577114515e-05
C O 1 0.9449630379676819
- O 0 0.037846315652132034
T O 1 0.9867469072341919
changes O 0 0.00033985762274824083
at O 0 0.0012352418852970004
CpG O 0 0.046560291200876236
dinucleotides O 1 0.5912774205207825
, O 0 0.00023606556351296604
20 O 0 0.0001839206088334322
% O 0 1.6565449186600745e-05
are O 0 1.3901097190682776e-05
splicing O 0 0.0028853747062385082
errors O 0 0.007243478670716286
, O 0 0.00016737624537199736
and O 0 3.843869126285426e-05
more O 0 2.5746541723492555e-05
than O 0 6.141952326288447e-05
30 O 0 0.000291774224024266
% O 0 1.803490704332944e-05
are O 0 2.014198253164068e-05
deletion O 0 0.005136340390890837
or O 0 0.000274942081887275
insertion O 0 0.010065910406410694
events O 0 0.000456319801742211
. O 0 0.0004463180957827717

There O 0 0.00020627469348255545
is O 0 0.0001769726222846657
a O 0 0.0007053995504975319
noticeably O 0 0.1345697045326233
elevated O 1 0.973457932472229
level O 0 0.0008276177104562521
of O 0 1.4282056326919701e-05
mutation O 0 0.0011007876601070166
in O 0 8.02139620645903e-05
the O 0 0.00017011277668643743
paired O 0 0.0037253438495099545
domain O 0 0.0005470252363011241
compared O 0 0.0004497869813349098
with O 0 2.9098171580699272e-05
the O 0 0.0001107046555262059
rest O 0 0.0003290981112513691
of O 0 6.720281817251816e-06
the O 0 0.0001649694750085473
gene O 0 0.0021293009631335735
. O 0 0.00031163738458417356

Increased O 0 0.001583841978572309
mutation O 0 0.0010610162280499935
in O 0 7.819555321475491e-05
the O 0 0.00017506585572846234
homeodomain O 0 0.11662707477807999
is O 0 0.00027371750911697745
accounted O 0 0.00042646611109375954
for O 0 3.3373202313669026e-05
by O 0 1.245761177415261e-05
the O 0 0.00026170379715040326
hypermutable O 1 0.9606167674064636
CpG O 0 0.03807676583528519
dinucleotide O 0 0.04372671619057655
in O 0 0.00018490318325348198
codon O 0 0.004856439772993326
240 O 0 0.005560569930821657
. O 0 0.0004157261282671243

Very O 0 0.0012204661034047604
nearly O 0 0.0004796315624844283
all O 0 4.810153768630698e-05
mutations O 0 0.002006376627832651
appear O 0 0.0007828309899196029
to O 0 0.00012941777822561562
cause O 0 0.01594509370625019
loss O 0 0.0021403292194008827
of O 0 5.1245865506643895e-06
function O 0 0.0001878688926808536
of O 0 7.925655154394917e-06
the O 0 0.00020863645477220416
mutant O 0 0.0070717353373765945
allele O 0 0.005310496781021357
, O 0 0.00016786149353720248
and O 0 4.6890727389836684e-05
more O 0 2.343704727536533e-05
than O 0 6.145408406155184e-05
80 O 0 0.00042936112731695175
% O 0 1.6185143977054395e-05
of O 0 1.4662127796327695e-05
exonic O 0 0.08137593418359756
substitutions O 0 0.0009949237573891878
result O 0 0.00031273835338652134
in O 0 0.00013849118840880692
nonsense O 0 0.018001165241003036
codons O 0 0.009210057556629181
. O 0 0.0004074280441273004

In O 0 0.0003000476863235235
a O 0 0.0003620692004915327
gene O 0 0.0005051590851508081
with O 0 1.78057343873661e-05
such O 0 4.821732363780029e-05
extraordinarily O 1 0.9524482488632202
high O 0 0.0021612802520394325
sequence O 0 8.101087587419897e-05
conservation O 0 0.002300569787621498
throughout O 0 0.00010945054236799479
evolution O 0 0.00033965776674449444
, O 0 6.78947035339661e-05
there O 0 3.420880238991231e-05
are O 0 2.5035562430275604e-05
presumed O 0 0.009399966336786747
undiscovered O 0 0.2834838032722473
missense O 0 0.0370945930480957
mutations O 0 0.002504208590835333
, O 0 6.793473585275933e-05
these O 0 8.477897608827334e-06
are O 0 1.728175084281247e-05
hypothesized O 0 0.005734203848987818
to O 0 3.580044358386658e-05
exist O 0 8.262800838565454e-05
in O 0 5.715537190553732e-05
as O 0 0.00031425425549969077
- O 0 0.0045026978477835655
yet O 0 0.0010080717038363218
unidentified O 0 0.020727569237351418
phenotypes O 0 0.015339075587689877
. O 0 0.00016415321442764252
. O 0 0.00023753015557304025

Genetic O 0 0.008700467646121979
heterogeneity O 0 0.02025507390499115
and O 0 0.0002856954815797508
penetrance O 1 0.689824104309082
analysis O 0 0.0001029621998895891
of O 0 9.267175300919916e-06
the O 0 0.00043050944805145264
BRCA1 O 1 0.9998264908790588
and O 0 0.0006214997265487909
BRCA2 O 1 0.9992069602012634
genes O 0 0.0005397270433604717
in O 0 0.0014620812144130468
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0008417804492637515
. O 0 0.00036727081169374287

The O 0 0.11967729777097702
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9734700918197632
Consortium O 0 0.014967923052608967
. O 0 0.0003786131856031716

The O 0 0.00012497566058300436
contribution O 0 0.0007927898550406098
of O 0 7.342024036915973e-05
BRCA1 O 1 0.9999788999557495
and O 0 0.0008909640600904822
BRCA2 O 1 0.9999778270721436
to O 0 0.001547117717564106
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.0029107192531228065
assessed O 0 0.006340531166642904
by O 0 4.2331179429311305e-05
linkage O 0 0.011040647514164448
and O 0 9.969484381144866e-05
mutation O 0 0.0009438710403628647
analysis O 0 0.00020944408606737852
in O 0 0.00027085281908512115
237 O 0 0.033083416521549225
families O 0 0.0002049068280030042
, O 0 5.811176743009128e-05
each O 0 1.2102245818823576e-05
with O 0 2.6858884666580707e-05
at O 0 0.0002850672462955117
least O 0 5.180582229513675e-05
four O 0 2.848711665137671e-05
cases O 0 0.0004859759646933526
of O 0 0.00020342481730040163
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 3.655538966995664e-05
collected O 0 1.1464425369922537e-05
by O 0 2.357578523515258e-05
the O 0 0.0038871970027685165
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.961275577545166
Consortium O 0 0.013340101577341557
. O 0 0.0003406642354093492

Families O 0 0.0008399010985158384
were O 0 3.152586577925831e-05
included O 0 4.9634338211035356e-05
without O 0 0.00010466556705068797
regard O 0 0.00038128497544676065
to O 0 1.3838097402185667e-05
the O 0 3.61611382686533e-05
occurrence O 0 0.003719651373103261
of O 0 0.0001459589839214459
ovarian B-Disease 1 1.0
or I-Disease 0 0.0009134692372754216
other I-Disease 0 0.0003250141453463584
cancers I-Disease 1 0.9999980926513672
. O 0 0.0005623748293146491

Overall O 0 0.012048431672155857
, O 0 0.0017802073853090405
disease O 1 0.9999994039535522
was O 0 0.0023059784434735775
linked O 0 0.006275520194321871
to O 0 0.00028412981191650033
BRCA1 O 1 0.9977349042892456
in O 0 0.00011735651787603274
an O 0 0.00014682248001918197
estimated O 0 0.0007870282861404121
52 O 0 0.0014569694176316261
% O 0 1.2609735676960554e-05
of O 0 6.991865120653529e-06
families O 0 0.0002480788971297443
, O 0 0.00023880088701844215
to O 0 0.0005485074943862855
BRCA2 O 1 0.9985673427581787
in O 0 0.00026465763221494853
32 O 0 0.0006082500913180411
% O 0 2.3165950551629066e-05
of O 0 1.3686888451047707e-05
families O 0 0.00024029507767409086
, O 0 0.00011749391705961898
and O 0 6.111167749622837e-05
to O 0 8.339482155861333e-05
neither O 0 0.002252316800877452
gene O 0 0.0007703959126956761
in O 0 0.00013465771917253733
16 O 0 0.00052629568381235
% O 0 6.993509305175394e-05
( O 0 0.0003125430957879871
95 O 0 0.001251195790246129
% O 0 4.064260792802088e-05
confidence O 0 0.002551116282120347
interval O 0 0.007233873009681702
[ O 0 0.04399259015917778
CI O 1 0.9999070167541504
] O 0 0.018554052338004112
6 O 0 0.0012997831217944622
% O 0 0.00011158475535921752
- O 0 0.003481334075331688
28 O 0 0.0010638412786647677
% O 0 6.014030805090442e-05
) O 0 0.00015007719048298895
, O 0 0.00013518006016965955
suggesting O 0 0.00249662296846509
other O 0 8.617624553153291e-05
predisposition O 1 0.9930860996246338
genes O 0 0.0006669812719337642
. O 0 0.0003380964044481516

The O 0 0.0005003234255127609
majority O 0 0.0005533437361009419
( O 0 0.0006432679365389049
81 O 0 0.0049380152486264706
% O 0 2.3963468265719712e-05
) O 0 1.486274049966596e-05
of O 0 5.450307526189135e-06
the O 0 0.0016084372764453292
breast B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00032135992660187185
were O 0 2.4676925022504292e-05
due O 0 0.0007031597779132426
to O 0 0.0002955803647637367
BRCA1 O 1 0.9997679591178894
, O 0 0.00011650301166810095
with O 0 3.510153328534216e-05
most O 0 0.0001829128887038678
others O 0 0.000688420026563108
( O 0 0.0004109787696506828
14 O 0 0.0006786277517676353
% O 0 6.728625885443762e-05
) O 0 0.0001593040651641786
due O 0 0.0010790557134896517
to O 0 0.0005815155454911292
BRCA2 O 1 0.9997966885566711
. O 0 0.000683861318975687

Conversely O 0 0.042119141668081284
, O 0 0.00017421063967049122
the O 0 5.29819299117662e-05
majority O 0 6.054495315765962e-05
of O 0 9.568396308168303e-06
families O 0 9.225083340425044e-05
with O 0 5.412477548816241e-05
male B-Disease 0 0.0011792245786637068
and I-Disease 0 0.0004969337023794651
female I-Disease 1 0.9720083475112915
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 6.034235411789268e-05
due O 0 0.0008872146136127412
to O 0 0.0004848807875532657
BRCA2 O 1 0.99982750415802
( O 0 0.0010266801109537482
76 O 0 0.010065768845379353
% O 0 0.0001131312019424513
) O 0 0.00024092545208986849
. O 0 0.00026983421412296593

The O 0 0.0003003651218023151
largest O 0 0.0009603743674233556
proportion O 0 0.0011264311615377665
( O 0 0.0007917880429886281
67 O 0 0.0043965778313577175
% O 0 8.3245373389218e-05
) O 0 6.716201460221782e-05
of O 0 1.009973948384868e-05
families O 0 0.0002279995969729498
due O 0 0.0008074154611676931
to O 0 3.33214265992865e-05
other O 0 1.981041714316234e-05
genes O 0 0.00027119001606479287
was O 0 0.0009723506518639624
found O 0 0.00018456848920322955
in O 0 6.183311779750511e-05
families O 0 7.310166984098032e-05
with O 0 2.603115535748657e-05
four O 0 5.657599831465632e-05
or O 0 9.534914715914056e-05
five O 0 3.756007208721712e-05
cases O 0 0.0002568023919593543
of O 0 3.667809869511984e-05
female O 1 0.9934489130973816
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.00016541585500817746
. O 0 0.00021584318892564625

These O 0 9.736920037539676e-05
estimates O 0 0.0005964459269307554
were O 0 3.0465656891465187e-05
not O 0 0.00014298484893515706
substantially O 0 0.012764222919940948
affected O 0 0.0022989530116319656
either O 0 0.00010136068158317357
by O 0 1.5306623026845045e-05
changing O 0 0.0006603942601941526
the O 0 0.000259525200817734
assumed O 0 0.016948644071817398
penetrance O 1 0.9489004015922546
model O 0 0.0016627032309770584
for O 0 0.0010388062801212072
BRCA1 O 1 0.9998165965080261
or O 0 0.0003090767713729292
by O 0 2.2115920728538185e-05
including O 0 5.223438347456977e-05
or O 0 0.0004504821263253689
excluding O 0 0.005479809828102589
BRCA1 O 1 0.9985950589179993
mutation O 0 0.0017319103935733438
data O 0 0.0001458475599065423
. O 0 0.0002755251480266452

Among O 0 0.00018143246416002512
those O 0 4.523499228525907e-05
families O 0 0.00021031255892012268
with O 0 0.0006107474328018725
disease O 1 1.0
due O 0 0.003537497716024518
to O 0 0.0005106082535348833
BRCA1 O 1 0.9997263550758362
that O 0 7.18876181053929e-05
were O 0 4.054992677993141e-05
tested O 0 0.003762118751183152
by O 0 9.00071427167859e-06
one O 0 1.3766939446213655e-05
of O 0 4.204861852485919e-06
the O 0 0.00014043030387256294
standard O 0 0.0036026497837156057
screening O 0 0.005480303894728422
methods O 0 0.0005380866350606084
, O 0 0.00027341285021975636
mutations O 0 0.0010452847927808762
were O 0 3.433243909967132e-05
detected O 0 0.002833507489413023
in O 0 3.840348290395923e-05
the O 0 6.643154483754188e-05
coding O 0 0.005693627987056971
sequence O 0 9.760895045474172e-05
or O 0 0.0002922296989709139
splice O 0 0.01124639343470335
sites O 0 0.00013688448234461248
in O 0 3.0404939025174826e-05
an O 0 0.00010252201900584623
estimated O 0 0.0009692558669485152
63 O 0 0.004809015430510044
% O 0 8.424326370004565e-05
( O 0 0.0004126535204704851
95 O 0 0.003303257282823324
% O 0 0.00038803729694336653
CI O 1 0.9991979002952576
51 O 0 0.00725932652130723
% O 0 0.0001827530504669994
- O 0 0.005124152172356844
77 O 0 0.0045525748282670975
% O 0 9.045264596352354e-05
) O 0 0.00023885647533461452
. O 0 0.00029119206010363996

The O 0 0.0004029436386190355
estimated O 0 0.0011089282343164086
sensitivity O 0 0.010447714477777481
was O 0 0.0006637984770350158
identical O 0 0.00011439977970439941
for O 0 4.09282511100173e-05
direct O 0 0.00012233734014444053
sequencing O 0 0.0004650789487641305
and O 0 4.435485607245937e-05
other O 0 2.0516043150564656e-05
techniques O 0 0.0012657425832003355
. O 0 0.00044601529953069985

The O 0 0.0010138071374967694
penetrance O 1 0.6951866149902344
of O 0 0.00032428125268779695
BRCA2 O 1 0.999596893787384
was O 0 0.0013522806111723185
estimated O 0 0.0002112837537424639
by O 0 2.1522679162444547e-05
maximizing O 0 0.009402472525835037
the O 0 0.0005895068170502782
LOD O 1 0.9965888261795044
score O 0 0.00020273686095606536
in O 0 0.000651740119792521
BRCA2 O 1 0.9998732805252075
- O 0 0.015894215553998947
mutation O 0 0.0018802053527906537
families O 0 0.00014248864317778498
, O 0 4.717058618552983e-05
over O 0 4.216936576995067e-05
all O 0 1.7015901903505437e-05
possible O 0 0.0007101037190295756
penetrance O 1 0.7727181315422058
functions O 0 0.0006573043065145612
. O 0 0.00045816480997018516

The O 0 0.00016524811508134007
estimated O 0 0.00036641379119828343
cumulative O 0 0.003587819170206785
risk O 0 0.05407964065670967
of O 0 0.00027531900559552014
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 0 0.002234873129054904
28 O 0 0.0010347822681069374
% O 0 4.6391065552597865e-05
( O 0 0.0002663460618350655
95 O 0 0.003217436606064439
% O 0 0.00040264910785481334
CI O 1 0.9997997879981995
9 O 0 0.0028650984168052673
% O 0 0.00012981229519937187
- O 0 0.002436752198264003
44 O 0 0.00039235191070474684
% O 0 4.828961391467601e-05
) O 0 6.811981438659132e-05
by O 0 2.5313571313745342e-05
age O 0 0.0006921879248693585
50 O 0 0.000511611346155405
years O 0 0.00042543886229395866
and O 0 0.00013637467054650187
84 O 0 0.006309544201940298
% O 0 9.58139862632379e-05
( O 0 0.00035786558873951435
95 O 0 0.003205762477591634
% O 0 0.00034903991036117077
CI O 1 0.9993228912353516
43 O 0 0.003681407542899251
% O 0 0.00013814956764690578
- O 0 0.0032925554551184177
95 O 0 0.0014917970402166247
% O 0 4.651550261769444e-05
) O 0 6.489721272373572e-05
by O 0 2.514073821657803e-05
age O 0 0.0008116714307107031
70 O 0 0.001136744860559702
years O 0 0.0006662785890512168
. O 0 0.00026551089831627905

The O 0 0.0010183131089434028
corresponding O 1 0.6249153017997742
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9364233613014221
were O 0 5.0308535719523206e-05
0 O 0 0.0007773693068884313
. O 0 0.00017970128101296723

4 O 0 0.001771943410858512
% O 0 9.713410690892488e-05
( O 0 0.0003782037238124758
95 O 0 0.0031820449512451887
% O 0 0.00040323720895685256
CI O 1 0.9989401698112488
0 O 0 0.0018471559742465615
% O 0 0.00011168459604959935
- O 0 0.0024889991618692875
1 O 0 0.000512438069563359
% O 0 4.862528294324875e-05
) O 0 7.283356535481289e-05
by O 0 3.4333519579377025e-05
age O 0 0.0007181132677942514
50 O 0 0.0004754051915369928
years O 0 0.0004311608208809048
and O 0 0.0001321767776971683
27 O 0 0.0014317516470327973
% O 0 5.81912936468143e-05
( O 0 0.0003657866036519408
95 O 0 0.0032411569263786077
% O 0 0.0003565839142538607
CI O 1 0.9989057779312134
0 O 0 0.0018086881609633565
% O 0 0.00011900679237442091
- O 0 0.003129108576104045
47 O 0 0.0012566202785819769
% O 0 5.2887280617142096e-05
) O 0 7.141138485167176e-05
by O 0 2.7393471100367606e-05
age O 0 0.0007897173636592925
70 O 0 0.001363080576993525
years O 0 0.0006641224608756602
. O 0 0.00028367966297082603

The O 0 0.0006185657111927867
lifetime O 1 0.9667642116546631
risk O 1 0.8231669664382935
of O 0 0.0004673686053138226
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.003666574601083994
similar O 0 5.384107134887017e-05
to O 0 2.6348141545895487e-05
the O 0 0.00011982757860096171
risk O 0 0.17262078821659088
in O 0 0.0009041994344443083
BRCA1 O 1 0.999980092048645
carriers O 0 0.022540990263223648
, O 0 0.0002241259498987347
but O 0 9.028779459185898e-05
there O 0 3.5134082281729206e-05
was O 0 0.00017630279762670398
some O 0 1.253744267160073e-05
suggestion O 0 0.00063166837207973
of O 0 5.316461738402722e-06
a O 0 0.0005410175654105842
lower O 0 0.009970814920961857
risk O 1 0.635398805141449
in O 0 0.000918313511647284
BRCA2 O 1 0.9997543692588806
carriers O 0 0.032205674797296524
< O 0 0.03233366459608078
50 O 0 0.00031355576356872916
years O 0 0.00010735979594755918
of O 0 1.1554109732969664e-05
age O 0 0.001373457838781178
. O 0 0.00038450516876764596

Eye B-Disease 1 0.9999257326126099
movement I-Disease 0 0.007947642356157303
abnormalities I-Disease 1 0.9972072243690491
correlate O 0 0.005646658595651388
with O 0 8.52539305924438e-05
genotype O 0 0.06858755648136139
in O 0 0.00034225985291413963
autosomal O 1 0.9989701509475708
dominant O 1 0.9925044775009155
cerebellar B-Disease 1 0.9999997615814209
ataxia I-Disease 1 0.9999997615814209
type I-Disease 1 0.9996562004089355
I I-Disease 1 0.9859857559204102
. O 0 0.00046997403842397034

We O 0 0.00051448168233037
compared O 0 0.001115952036343515
horizontal O 0 0.018884960561990738
eye O 1 0.998995840549469
movements O 0 0.0008146441541612148
( O 0 0.0008055153302848339
visually O 0 0.13564731180667877
guided O 0 0.03652138635516167
saccades O 1 0.9988765120506287
, O 0 0.0009656358161009848
antisaccades O 1 0.7258298397064209
, O 0 0.0001697248953860253
and O 0 0.00011092720524175093
smooth O 0 0.022490723058581352
pursuit O 0 0.032362449914216995
) O 0 0.00013387904618866742
in O 0 7.814053242327645e-05
control O 0 0.0012407350586727262
subjects O 0 0.0041067469865083694
( O 0 0.0008116830722428858
n O 0 0.005611840169876814
= O 0 0.00618337094783783
14 O 0 0.001074348809197545
) O 0 0.0002791779406834394
and O 0 0.000534481427166611
patients O 1 0.9999790191650391
with O 0 2.3240785594680347e-05
three O 0 1.9030023395316675e-05
forms O 0 0.00013288293848745525
of O 0 4.398595410748385e-05
autosomal O 1 0.9987926483154297
dominant O 1 0.940249502658844
cerebellar B-Disease 1 0.9999974966049194
ataxias I-Disease 1 0.9997884631156921
type I-Disease 1 0.9629746675491333
I I-Disease 1 0.9915544390678406
spinocerebellar B-Disease 1 0.9999921321868896
ataxias I-Disease 1 0.9759304523468018
1 I-Disease 0 0.0009477300918661058
and I-Disease 0 0.00010695862874854356
2 I-Disease 0 0.0009540870087221265
( O 0 0.0006441329605877399
SCA1 B-Disease 1 0.9908910393714905
, O 0 0.0003885077021550387
n O 0 0.004285720642656088
= O 0 0.005262658465653658
11 O 0 0.0012101993197575212
; O 0 0.00022316089598461986
SCA2 B-Disease 1 0.9677693247795105
, O 0 0.00029064147383905947
n O 0 0.0029300495516508818
= O 0 0.0024381503462791443
10 O 0 0.00019733076624106616
) O 0 9.87257226370275e-05
and O 0 0.0003727855219040066
SCA3 B-Disease 1 0.9999945163726807
/ O 1 0.9584698677062988
Machado B-Disease 1 0.8024128079414368
- I-Disease 0 0.049693308770656586
Joseph I-Disease 0 0.4294833242893219
disease I-Disease 1 0.9999997615814209
( O 0 0.0027892617508769035
MJD B-Disease 1 0.999985933303833
) O 0 0.0005674087442457676
( O 0 0.0005307565443217754
n O 0 0.004593078978359699
= O 0 0.005371989216655493
16 O 0 0.0009565864456817508
) O 0 0.00019774252723436803
. O 0 0.00026024351245723665

In O 0 0.002226421842351556
SCA1 B-Disease 1 0.9884385466575623
, O 0 0.00038927883724682033
saccade O 0 0.0646083727478981
amplitude O 0 0.0007751490920782089
was O 0 0.0011302523780614138
significantly O 0 0.002732084132730961
increased O 0 0.00026714307023212314
, O 0 6.537798617500812e-05
resulting O 0 0.0006062342436052859
in O 0 0.0002940115227829665
hypermetria B-Disease 1 0.9731227159500122
. O 0 0.00046969723189249635

The O 0 0.00060786068206653
smooth O 0 0.01438857614994049
pursuit O 0 0.015507259406149387
gain O 0 0.0023607744369655848
was O 0 0.0018561787437647581
decreased O 0 0.015512356534600258
. O 0 0.0004350570379756391

In O 0 0.0015886477194726467
SCA2 B-Disease 1 0.9876204133033752
, O 0 0.00039861456025391817
saccade O 0 0.08370845019817352
velocity O 0 0.002257446525618434
was O 0 0.0019877892918884754
markedly O 0 0.05968046560883522
decreased O 0 0.02101713977754116
. O 0 0.0004102653474546969

The O 0 0.0001956879423232749
percentage O 0 0.0001889673003461212
of O 0 1.2362529560050461e-05
errors O 0 0.0050684604793787
in O 0 0.00034248240990564227
antisaccades O 1 0.9869059920310974
was O 0 0.0010888437973335385
greatly O 0 0.0026444660034030676
increased O 0 0.00022057900787331164
and O 0 6.300024688243866e-05
was O 0 0.0006574991857632995
significantly O 0 0.0020416073966771364
correlated O 0 0.0014532322529703379
with O 0 6.267002754611894e-05
age O 0 0.0018352990737184882
at O 0 0.026540342718362808
disease O 1 1.0
onset O 1 0.999964714050293
. O 0 0.0010980027727782726

In O 0 0.0005390630103647709
addition O 0 0.0002836450294125825
, O 0 8.793855522526428e-05
a O 0 0.0002151966909877956
correlation O 0 0.0012903694296255708
between O 0 0.0002199420559918508
smooth O 0 0.03346173092722893
pursuit O 0 0.030497759580612183
gain O 0 0.0015773477498441935
and O 0 4.2465737351449206e-05
the O 0 2.5688712412375025e-05
number O 0 8.252181032730732e-06
of O 0 4.259771594661288e-05
trinucleotide O 1 0.98097163438797
repeats O 0 0.008128025569021702
was O 0 0.0012628163676708937
found O 0 0.00032192107755690813
. O 0 0.0002115219976985827

In O 0 0.00293817394413054
SCA3 B-Disease 1 0.999914288520813
, O 0 0.0012050982331857085
gaze B-Disease 1 0.5056745409965515
- I-Disease 0 0.01983189955353737
evoked I-Disease 0 0.05044475570321083
nystagmus I-Disease 1 0.9996201992034912
was O 0 0.001859588548541069
often O 0 0.00012122069165343419
present O 0 8.37484112707898e-05
as O 0 0.00019412740948610008
was O 0 0.0022874255664646626
saccade O 1 0.9439265131950378
hypometria O 0 0.10435590147972107
and O 0 0.0001475016470067203
smooth O 0 0.013071620836853981
pursuit O 0 0.015615243464708328
gain O 0 0.002114299451932311
was O 0 0.0019756481051445007
markedly O 0 0.12435770779848099
decreased O 0 0.021487558260560036
. O 0 0.0003938247973565012

Three O 0 0.0002933568903245032
major O 0 0.001583424280397594
criteria O 0 0.002167744329199195
, O 0 0.00021508839563466609
saccade O 0 0.10622028261423111
amplitude O 0 0.0008703438215889037
, O 0 0.000332049501594156
saccade O 0 0.2319789081811905
velocity O 0 0.0019372956594452262
, O 0 8.675870049046353e-05
and O 0 3.418897176743485e-05
presence O 0 0.0001437921164324507
of O 0 3.1894913263386115e-05
gaze B-Disease 1 0.9526126384735107
- I-Disease 0 0.020249415189027786
evoked I-Disease 0 0.07186521589756012
nystagmus I-Disease 1 0.999238133430481
, O 0 0.0002388124994467944
permitted O 0 0.00027148055960424244
the O 0 0.00018532644025981426
correct O 0 0.014676840975880623
assignment O 0 0.01255597174167633
of O 0 1.9081800928688608e-05
90 O 0 0.0005100724520161748
% O 0 1.6224767023231834e-05
of O 0 1.2495556802605279e-05
the O 0 0.0006202381337061524
SCA1 B-Disease 1 0.9982976317405701
, O 0 0.0002535747771617025
90 O 0 0.00034354455419816077
% O 0 1.1280769285804126e-05
of O 0 8.235970199166331e-06
the O 0 0.0006602728390134871
SCA2 B-Disease 1 0.9995781779289246
, O 0 0.0003503671323414892
and O 0 0.0001534779294161126
93 O 0 0.00462858472019434
% O 0 1.5662149962736294e-05
of O 0 1.1168106539116707e-05
the O 0 0.001079039415344596
patients O 1 0.9999961853027344
with O 0 0.000396790390368551
SCA3 B-Disease 1 0.9999779462814331
to O 0 4.8017762310337275e-05
their O 0 2.315194797120057e-05
genetically O 0 0.0015774830244481564
confirmed O 0 0.007461183704435825
patient O 1 0.9995765089988708
group O 0 0.0003542068006936461
and O 0 9.353667701361701e-05
, O 0 0.00012267868441995233
therefore O 0 0.0003805016167461872
, O 0 0.0002101249701809138
may O 0 0.0010006474331021309
help O 0 0.001779321115463972
orient O 0 0.2509079873561859
diagnoses O 1 0.9972600936889648
of O 0 8.726542728254572e-05
SCA1 B-Disease 1 0.9998451471328735
, O 0 0.001055375556461513
SCA2 B-Disease 1 0.9980463981628418
, O 0 0.00039957993431016803
and O 0 0.0004301053995732218
SCA3 B-Disease 1 0.999935507774353
at O 0 0.0011542844586074352
early O 0 0.0011167246848344803
clinical O 1 0.9982630610466003
stages O 0 0.0011448265286162496
of O 0 1.9166771380696446e-05
the O 0 0.0015376645606011152
diseases O 1 1.0
. O 0 0.00019681255798786879
. O 0 0.00024732318706810474

Genetic O 0 0.0016948581906035542
basis O 0 6.506004865514114e-05
and O 0 3.95004462916404e-05
molecular O 0 0.001086689531803131
mechanism O 0 0.0019931423012167215
for O 0 0.004531616345047951
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.0017464301781728864

Ventricular B-Disease 1 0.9999951124191284
fibrillation I-Disease 1 0.9999983310699463
causes O 0 0.046271950006484985
more O 0 4.950004586135037e-05
than O 0 8.215715934056789e-05
300 O 0 0.0007963803363963962
, O 0 0.00020736026635859162
000 O 0 0.008104460313916206
sudden O 0 0.09646276384592056
deaths O 0 0.004921585787087679
each O 0 2.777669760689605e-05
year O 0 0.00024536295677535236
in O 0 5.53794416191522e-05
the O 0 0.00035952971666119993
USA O 0 0.02713969349861145
alone O 0 0.0024091009981930256
. O 0 0.000250629847869277

In O 0 0.0004639595572371036
approximately O 0 0.0008496997179463506
5 O 0 0.0018138386076316237
- O 0 0.0028367103077471256
12 O 0 0.0001996110804611817
% O 0 7.807998372300062e-06
of O 0 5.460603915707907e-06
these O 0 3.21830011671409e-05
cases O 0 0.001523922779597342
, O 0 5.8343710406916216e-05
there O 0 1.6733227312215604e-05
are O 0 7.508874205086613e-06
no O 0 0.00023208040511235595
demonstrable O 1 0.9998632669448853
cardiac O 1 0.9999982118606567
or O 0 0.00101949751842767
non O 0 0.1766228824853897
- O 1 0.9995712637901306
cardiac O 1 0.9999996423721313
causes O 0 0.07435687631368637
to O 0 4.78452566312626e-05
account O 0 6.781939009670168e-05
for O 0 8.842838724376634e-05
the O 0 0.00018499135330785066
episode O 0 0.0026363322976976633
, O 0 8.491291373502463e-05
which O 0 1.5629873814759776e-05
is O 0 5.503859938471578e-05
therefore O 0 0.00018005460151471198
classified O 0 0.01011295523494482
as O 0 0.0036701334174722433
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 0.011182980611920357
IVF B-Disease 1 0.9999538660049438
) O 0 0.0005255823489278555
. O 0 0.00028077178285457194

A O 0 0.0021919894497841597
distinct O 0 0.0004898230545222759
group O 0 0.00036244819057174027
of O 0 0.000245932285906747
IVF B-Disease 1 0.9999992847442627
patients O 1 0.9999973773956299
has O 0 0.0007262842846103013
been O 0 0.0001717475097393617
found O 0 7.981262024259195e-05
to O 0 1.5799156244611368e-05
present O 0 3.0487803087453358e-05
with O 0 1.8289096260559745e-05
a O 0 0.00041392940329387784
characteristic O 0 0.011672759428620338
electrocardiographic O 1 0.996136486530304
pattern O 0 0.010092944838106632
. O 0 0.00045836225035600364

Because O 0 0.0007561352103948593
of O 0 8.250575774582103e-06
the O 0 5.186608177609742e-05
small O 0 5.608902938547544e-05
size O 0 6.996818410698324e-05
of O 0 6.8899626057827845e-06
most O 0 0.00017020980885718018
pedigrees O 0 0.005448515061289072
and O 0 4.731962690129876e-05
the O 0 0.00013064192899037153
high O 0 0.006035905331373215
incidence O 1 0.9975997805595398
of O 0 6.474873225670308e-05
sudden B-Disease 1 0.9984252452850342
death I-Disease 0 0.0056642708368599415
, O 0 0.00014442364044953138
however O 0 0.00013796107668895274
, O 0 0.00010935561294900253
molecular O 0 0.0020096583757549524
genetic O 0 0.0008625058690086007
studies O 0 0.0003860926954075694
of O 0 6.911484524607658e-05
IVF B-Disease 1 0.9999480247497559
have O 0 7.213235221570358e-05
not O 0 4.353737676865421e-05
yet O 0 0.00020772615971509367
been O 0 0.00013815089187119156
done O 0 0.0010138631332665682
. O 0 0.0002155593829229474

Because O 0 0.011491524055600166
IVF B-Disease 1 0.9999769926071167
causes O 1 0.9997121691703796
cardiac O 1 0.9999997615814209
rhythm O 1 0.8577340245246887
disturbance O 1 0.9876186847686768
, O 0 0.00022765420726500452
we O 0 0.00021913739328738302
investigated O 0 0.007465588394552469
whether O 0 0.0007700736750848591
malfunction O 0 0.2403777688741684
of O 0 1.4217359421309084e-05
ion O 0 0.0035210703499615192
channels O 0 0.0006209360435605049
could O 0 0.00038367585511878133
cause O 0 0.013399435207247734
the O 0 0.0006565217627212405
disorder O 1 0.9999990463256836
by O 0 5.8758509112522006e-05
studying O 0 0.0009022373124025762
mutations O 0 0.0005610373918898404
in O 0 4.169264866504818e-05
the O 0 0.00028766723698936403
cardiac O 1 0.9999916553497314
sodium O 0 0.00852467305958271
channel O 0 0.0021243917290121317
gene O 0 0.004104423336684704
SCN5A O 1 0.9946529865264893
. O 0 0.0005259381723590195

We O 0 0.0006223396048881114
have O 0 5.694069841410965e-05
now O 0 0.00028058956377208233
identified O 0 0.0002483598073013127
a O 0 0.0002847841533366591
missense O 0 0.009936409071087837
mutation O 0 0.0012014295207336545
, O 0 8.66168484208174e-05
a O 0 0.0005493587232194841
splice O 0 0.05626213550567627
- O 0 0.009742745198309422
donor O 0 0.0074022989720106125
mutation O 0 0.0018974473932757974
, O 0 8.940302359405905e-05
and O 0 6.993916031206027e-05
a O 0 0.001251336419954896
frameshift O 1 0.937079668045044
mutation O 0 0.0018226078245788813
in O 0 7.509358692914248e-05
the O 0 0.00013040158955845982
coding O 0 0.007338587194681168
region O 0 0.0010513958986848593
of O 0 5.59462423552759e-05
SCN5A O 1 0.9918769598007202
in O 0 0.0002260648470837623
three O 0 0.0003177165053784847
IVF B-Disease 1 0.9994468092918396
families O 0 0.0005177600542083383
. O 0 0.0003316249349154532

We O 0 0.0004291082441341132
show O 0 0.00015408029139507562
that O 0 1.5987723600119352e-05
sodium O 0 0.0011698745656758547
channels O 0 8.379219798371196e-05
with O 0 1.6837804651004262e-05
the O 0 0.00021249594283290207
missense O 0 0.02415434829890728
mutation O 0 0.0067976671271026134
recover O 1 0.5814898610115051
from O 0 0.00022084542433731258
inactivation O 0 0.11634009331464767
more O 0 0.00010760248551378027
rapidly O 0 0.0031403854954987764
than O 0 7.438975444529206e-05
normal O 0 0.0012562524061650038
and O 0 3.4805663744919e-05
that O 0 2.3665550543228164e-05
the O 0 0.00023269349185284227
frameshift O 1 0.9618428945541382
mutation O 0 0.0036725960671901703
causes O 0 0.007696724031120539
the O 0 0.00014041208487469703
sodium O 0 0.004570556338876486
channel O 0 0.0005191751988604665
to O 0 2.312324068043381e-05
be O 0 3.8974238123046234e-05
non O 0 0.0013265457237139344
- O 0 0.0029212194494903088
functional O 0 0.004490739665925503
. O 0 0.000365843647159636

Our O 0 0.0011243695626035333
results O 0 0.00043491876567713916
indicate O 0 0.00024568787193857133
that O 0 2.5234439817722887e-05
mutations O 0 0.0007092535961419344
in O 0 0.00038154589128680527
cardiac O 1 0.9999916553497314
ion O 0 0.02108500711619854
- O 0 0.00450943736359477
channel O 0 0.000564909481909126
genes O 0 7.343340257648379e-05
contribute O 0 0.0009674264001660049
to O 0 2.1777892470709048e-05
the O 0 7.453938451362774e-05
risk O 0 0.007951568812131882
of O 0 4.2344014218542725e-05
developing O 0 0.4782971739768982
IVF B-Disease 1 0.999828577041626
. O 0 0.00030294829048216343
. O 0 0.0002725643862504512

Molecular O 0 0.008984792046248913
heterogeneity O 0 0.017629055306315422
in O 0 0.0007795573328621686
mucopolysaccharidosis B-Disease 1 0.9949926733970642
IVA I-Disease 1 0.998629093170166
in O 0 0.0002582340675871819
Australia O 0 0.0004582901601679623
and O 0 0.00010203826968790963
Northern O 0 0.001719651510939002
Ireland O 0 0.0011356150498613715
: O 0 0.00019267744210083038
nine O 0 0.00017920095706358552
novel O 0 0.0012198607437312603
mutations O 0 0.0012768313754349947
including O 0 0.00014781112258788198
T312S O 0 0.13397924602031708
, O 0 0.00011394796456443146
a O 0 0.00024282366211991757
common O 0 0.0008712951093912125
allele O 0 0.002955012721940875
that O 0 7.916219328762963e-05
confers O 0 0.03745463490486145
a O 0 0.0017779598711058497
mild O 1 0.9998800754547119
phenotype O 1 0.9023253321647644
. O 0 0.0006387833273038268

Mucopolysaccharidosis B-Disease 1 0.9978225231170654
IVA I-Disease 1 0.9997156262397766
( O 0 0.004212670493870974
MPS B-Disease 1 0.9957519769668579
IVA I-Disease 1 0.9999918937683105
) O 0 0.00020277553994674236
is O 0 9.589569526724517e-05
an O 0 0.00027307108393870294
autosomal B-Disease 1 0.9998188614845276
recessive I-Disease 1 0.9999722242355347
lysosomal I-Disease 1 0.9999983310699463
storage I-Disease 1 0.9999144077301025
disorder I-Disease 1 1.0
caused O 0 0.036795757710933685
by O 0 3.446178379817866e-05
a O 0 0.0009321199031546712
genetic B-Disease 1 0.9076244235038757
defect I-Disease 1 0.9999343156814575
in O 0 0.00046934187412261963
N O 0 0.019730303436517715
- O 0 0.007188824005424976
acetylgalactosamine O 0 0.11444994062185287
- O 0 0.0029771069530397654
6 O 0 0.0014542926801368594
- O 0 0.008703481405973434
sulfate O 1 0.9983526468276978
sulfatase O 1 0.9993077516555786
( O 0 0.003052063984796405
GALNS O 1 0.9982652068138123
) O 0 0.00043254756019450724
. O 0 0.00026773512945510447

Previous O 0 0.001304018311202526
studies O 0 0.0004461220232769847
of O 0 6.588694668607786e-05
patients O 1 0.9999501705169678
from O 0 7.571701280539855e-05
a O 0 0.0006170759443193674
British O 0 0.0037768788170069456
- O 0 0.0044867536053061485
Irish O 0 0.0007482525543309748
population O 0 3.6694931623060256e-05
showed O 0 0.0005127033800818026
that O 0 2.3968039386090823e-05
the O 0 0.00016000740288291126
I113F O 0 0.07103231549263
mutation O 0 0.0018485772889107466
is O 0 8.447349682683125e-05
the O 0 4.33534623880405e-05
most O 0 6.037171260686591e-05
common O 0 0.0004295162216294557
single O 0 0.00026552253984846175
mutation O 0 0.0018320479430258274
among O 0 0.0005937556270509958
MPS B-Disease 1 0.9995813965797424
IVA I-Disease 1 1.0
patients O 1 0.9999963045120239
and O 0 8.712731505511329e-05
produces O 0 0.0014041641261428595
a O 0 0.002161552431061864
severe O 1 0.9999988079071045
clinical O 1 0.9999995231628418
phenotype O 1 0.9922670722007751
. O 0 0.0005316667957231402

We O 0 0.0005800590733997524
studied O 0 0.0007708938210271299
mutations O 0 0.00048217084258794785
in O 0 4.623718268703669e-05
the O 0 0.00025296187959611416
GALNS O 1 0.9940899014472961
gene O 0 0.0007279330748133361
from O 0 3.6581863241735846e-05
23 O 0 0.0007401151233352721
additional O 0 0.0009057929273694754
MPS B-Disease 1 0.997927188873291
IVA I-Disease 1 0.9999997615814209
patients O 1 0.9999954700469971
( O 0 0.000734189001377672
15 O 0 0.00042239815229550004
from O 0 7.00805030646734e-05
Australia O 0 0.0004508571873884648
, O 0 0.00015677472401876003
8 O 0 0.00044656152022071183
from O 0 7.637139060534537e-05
Northern O 0 0.001792085007764399
Ireland O 0 0.0014976640231907368
) O 0 0.00011040632671210915
, O 0 3.189050403307192e-05
with O 0 1.848682586569339e-05
various O 0 0.0001324374316027388
clinical O 1 0.999998927116394
phenotypes O 1 0.9850073456764221
( O 0 0.002294885693117976
severe O 1 0.9999939203262329
, O 0 0.000404233462177217
16 O 0 0.0010891944402828813
cases O 0 0.0010971998563036323
; O 0 0.00011575520329643041
intermediate O 0 0.03026842139661312
, O 0 0.000188888720003888
4 O 0 0.0008659116574563086
cases O 0 0.0015680723590776324
; O 0 0.0003104991919826716
mild O 1 0.9998100399971008
, O 0 0.0003760657855309546
3 O 0 0.0011375248432159424
cases O 0 0.0015968233346939087
) O 0 0.00026106429868377745
. O 0 0.0003117443702649325

We O 0 0.0005875936476513743
found O 0 0.00012743881961796433
two O 0 2.570596188888885e-05
common O 0 0.001095031970180571
mutations O 0 0.0013212078483775258
that O 0 2.3031183445709758e-05
together O 0 3.7292462366167456e-05
accounted O 0 0.0007950322469696403
for O 0 0.0001261404831893742
32 O 0 0.00037814045208506286
% O 0 1.1800027095887344e-05
of O 0 6.48990499030333e-06
the O 0 0.00017442605167161673
44 O 0 0.0013438534224405885
unrelated O 0 0.004509608261287212
alleles O 0 0.0025914006400853395
in O 0 0.00016304253949783742
these O 0 0.00017773022409528494
patients O 1 0.9999712705612183
. O 0 0.0004651724884752184

One O 0 0.00027491769287735224
is O 0 0.00015689631982240826
the O 0 0.00017938012024387717
T312S O 0 0.045972730964422226
mutation O 0 0.0013885344378650188
, O 0 7.401156472042203e-05
a O 0 0.0002898263046517968
novel O 0 0.001136243692599237
mutation O 0 0.0009570312686264515
found O 0 7.845090294722468e-05
exclusively O 0 0.0002782667288556695
in O 0 0.0004397644952405244
milder O 1 0.9986310601234436
patients O 1 0.9999939203262329
. O 0 0.0005524439038708806

The O 0 0.00034904186031781137
other O 0 2.661020334926434e-05
is O 0 0.00012093989789718762
the O 0 0.00010205607395619154
previously O 0 0.0010267754551023245
described O 0 0.002343488158658147
I113F O 0 0.01689852401614189
that O 0 3.4680258977459744e-05
produces O 0 0.0011936817318201065
a O 0 0.0018405468435958028
severe O 1 0.9999626874923706
phenotype O 1 0.9760545492172241
. O 0 0.0006186058162711561

The O 0 0.0012908788630738854
I113F O 0 0.0547998808324337
and O 0 0.0002691574627533555
T312S O 0 0.035192690789699554
mutations O 0 0.000928027555346489
accounted O 0 0.0007112526218406856
for O 0 0.0001989716838579625
8 O 0 0.0011318997712805867
( O 0 0.0003135342267341912
18 O 0 0.0003878730349242687
% O 0 5.2266721468186006e-05
) O 0 0.00014796257892157882
and O 0 0.00018109766824636608
6 O 0 0.0030176551081240177
( O 0 0.000525017618201673
14 O 0 0.0006712416070513427
% O 0 4.6119432226987556e-05
) O 0 4.351795359980315e-05
of O 0 1.2787657396984287e-05
44 O 0 0.0011808049166575074
unrelated O 0 0.00625227065756917
alleles O 0 0.004666969645768404
, O 0 0.0002660607860889286
respectively O 0 0.0009388698381371796
. O 0 0.0004140756500419229

The O 0 0.00029019516659900546
relatively O 0 0.0015020931605249643
high O 0 0.004595146048814058
residual O 0 0.07370204478502274
GALNS O 1 0.9939832091331482
activity O 0 0.0007042079814709723
seen O 0 0.0009441057336516678
when O 0 9.667153062764555e-05
the O 0 9.427938493900001e-05
T312S O 0 0.027124211192131042
mutant O 0 0.002618686994537711
cDNA O 0 0.0025614663027226925
is O 0 0.00045469499309547246
overexpressed O 0 0.049611497670412064
in O 0 0.0001574735069880262
mutant O 0 0.004143586382269859
cells O 0 0.001269314787350595
provides O 0 0.0005086399032734334
an O 0 6.758032395737246e-05
explanation O 0 0.0006447004270739853
for O 0 7.67126985010691e-05
the O 0 0.0003676897322293371
mild O 1 0.999976396560669
phenotype O 1 0.9948181509971619
in O 0 0.0009234938188455999
patients O 1 0.9999639987945557
with O 0 3.2375333830714226e-05
this O 0 4.525056283455342e-05
mutation O 0 0.0020190770737826824
. O 0 0.000283708272036165

The O 0 0.00034453015541657805
distribution O 0 0.00016587830032221973
and O 0 6.223373202374205e-05
relative O 0 0.00010922492947429419
frequencies O 0 3.222913801437244e-05
of O 0 7.5727330113295466e-06
the O 0 0.00024854246294125915
I113F O 0 0.04974959045648575
and O 0 0.00026282251928932965
T312S O 0 0.06316821277141571
mutations O 0 0.0011243363842368126
in O 0 0.00012383116700220853
Australia O 0 0.00048565876204520464
corresponded O 0 0.0016181961400434375
to O 0 3.0369930755114183e-05
those O 0 2.1328225557226688e-05
observed O 0 0.0002680947945918888
in O 0 0.00017690261302050203
Northern O 0 0.002303283428773284
Ireland O 0 0.0013765495968982577
and O 0 7.265688327606767e-05
are O 0 9.21256923902547e-06
unique O 0 0.00018315197667106986
to O 0 2.7621796107268892e-05
these O 0 4.604590685630683e-06
two O 0 1.7311489500571042e-05
populations O 0 0.0002589414070826024
, O 0 0.00016880496696103364
suggesting O 0 0.002104187849909067
that O 0 3.3060616260627285e-05
both O 0 9.71074405242689e-05
mutations O 0 0.0010392795084044337
were O 0 3.497769284876995e-05
probably O 0 0.0007133817998692393
introduced O 0 0.00016707948816474527
to O 0 5.051872358308174e-05
Australia O 0 0.000246344628976658
by O 0 2.999219941557385e-05
Irish O 0 0.0013754579704254866
migrants O 0 0.0003121919871773571
during O 0 0.0003382561553735286
the O 0 5.973198858555406e-05
19th O 0 0.00046008703066036105
century O 0 0.00035416189348325133
. O 0 0.0002840471570380032

Haplotype O 0 0.07502242177724838
analysis O 0 0.00039476147503592074
using O 0 0.00024914368987083435
6 O 0 0.00312191154807806
RFLPs O 0 0.1696951985359192
provides O 0 0.0009499969310127199
additional O 0 5.7830715377349406e-05
data O 0 3.172337164869532e-05
that O 0 1.870110099844169e-05
the O 0 0.00012447210610844195
I113F O 0 0.05886262655258179
mutation O 0 0.0013099461793899536
originated O 0 0.0003473399847280234
from O 0 3.566325540305115e-05
a O 0 0.0003076099092140794
common O 0 0.0013308002380654216
ancestor O 0 0.001909569720737636
. O 0 0.00039951878716237843

The O 0 0.0003679069923236966
other O 0 7.454421574948356e-05
9 O 0 0.0016255758237093687
novel O 0 0.0014386257389560342
mutations O 0 0.0016103305388242006
identified O 0 0.00037895783316344023
in O 0 5.551310823648237e-05
these O 0 5.867776781087741e-05
23 O 0 0.007802448235452175
patients O 1 0.9999629259109497
were O 0 1.7220532754436135e-05
each O 0 8.917658306017984e-06
limited O 0 0.00023776263697072864
to O 0 2.2859037926536985e-05
a O 0 0.00016938829503487796
single O 0 0.00023267861979547888
family O 0 0.0007147149299271405
. O 0 0.00040805561002343893

These O 0 3.6771925806533545e-05
data O 0 6.440793367801234e-05
provide O 0 0.0002951984934043139
further O 0 0.00012068829528288916
evidence O 0 9.135825530393049e-05
for O 0 7.754113175906241e-05
extensive O 0 0.00545839685946703
allelic O 0 0.06564449518918991
heterogeneity O 0 0.023961979895830154
in O 0 0.000741027994081378
MPS B-Disease 1 0.976738452911377
IVA I-Disease 1 0.9999529123306274
in O 0 0.0005319330957718194
British O 0 0.005948841106146574
- O 0 0.06444312632083893
Irish O 0 0.017816433683037758
patients O 1 0.9999829530715942
and O 0 0.0001534621260361746
provide O 0 0.0006241662777028978
evidence O 0 0.0001951673039002344
for O 0 5.9034948208136484e-05
their O 0 3.672237289720215e-05
transmission O 0 0.004554691258817911
to O 0 7.021120109129697e-05
Australia O 0 0.00021195346198510379
by O 0 4.2656251025618985e-05
British O 0 0.0038705396000295877
- O 0 0.0069338553585112095
Irish O 0 0.0013819349696859717
migrants O 0 0.0003977185406256467
. O 0 0.00010172242764383554
. O 0 0.0002475260407663882

Identification O 0 0.00045370825682766736
of O 0 2.356578261242248e-05
constitutional O 0 0.002962147118523717
WT1 O 1 0.9997578263282776
mutations O 0 0.0040290094912052155
, O 0 0.0001375445572193712
in O 0 0.00031860373564995825
patients O 1 0.9999825954437256
with O 0 0.00015109925880096853
isolated O 1 0.994545578956604
diffuse B-Disease 1 0.9999979734420776
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.0007324143662117422
and O 0 4.267105759936385e-05
analysis O 0 0.00012272897583898157
of O 0 7.12185210431926e-05
genotype O 1 0.9981241822242737
/ O 1 0.985325276851654
phenotype O 0 0.05597833916544914
correlations O 0 0.0015508728101849556
by O 0 1.0908671356446575e-05
use O 0 2.16527496377239e-05
of O 0 5.371948645915836e-06
a O 0 0.0005573175149038434
computerized O 0 0.034715764224529266
mutation O 0 0.0023214444518089294
database O 0 0.0010524949757382274
. O 0 0.00026419703499414027

Constitutional O 0 0.0014551086351275444
mutations O 0 0.0004985976847819984
of O 0 1.2507192877819762e-05
the O 0 0.0005288391257636249
WT1 O 1 0.9993085861206055
gene O 0 0.001088371966034174
, O 0 3.8586957089137286e-05
encoding O 0 0.00016132199380081147
a O 0 0.0007173580816015601
zinc O 1 0.9672755002975464
- O 0 0.005536852870136499
finger O 0 0.011897990480065346
transcription O 0 0.000830023200251162
factor O 0 0.0011057936353608966
involved O 0 0.0011746783275157213
in O 0 0.0015972417313605547
renal O 1 1.0
and O 0 0.0024135445710271597
gonadal O 1 0.9999263286590576
development O 0 0.004495677538216114
, O 0 0.00011471155448816717
are O 0 1.0621885849104729e-05
found O 0 5.610427615465596e-05
in O 0 3.541158730513416e-05
most O 0 0.0002804480609484017
patients O 1 0.9999784231185913
with O 0 0.00028966221725568175
Denys B-Disease 1 0.9999769926071167
- I-Disease 1 0.9977604150772095
Drash I-Disease 1 0.9999456405639648
syndrome I-Disease 1 1.0
( O 0 0.008677622303366661
DDS B-Disease 1 0.9999998807907104
) O 0 0.0003706587594933808
, O 0 0.00013586936984211206
or O 0 0.00139764288906008
diffuse B-Disease 1 0.9999939203262329
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 0.055459585040807724
DMS B-Disease 1 0.9999974966049194
) O 0 0.0003375259111635387
associated O 0 0.0001632606436032802
with O 0 0.0001272787485504523
pseudohermaphroditism B-Disease 1 0.9999693632125854
and O 0 0.0007129170116968453
/ O 1 0.9732745885848999
or O 0 0.0030125209596008062
Wilms B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999985694885254
( O 0 0.003630295628681779
WT B-Disease 1 0.9997510313987732
) O 0 0.00048222625628113747
. O 0 0.0002665962965693325

Most O 0 0.0005446058348752558
mutations O 0 0.002779780188575387
in O 0 0.0019288118928670883
DDS B-Disease 1 1.0
patients O 1 0.9999923706054688
lie O 0 0.006072526797652245
in O 0 0.00018961488967761397
exon O 0 0.023674940690398216
8 O 0 0.0008153197122737765
or O 0 0.00024318417126778513
exon O 0 0.014255200512707233
9 O 0 0.0005818636855110526
, O 0 4.4189106120029464e-05
encoding O 0 0.000519075954798609
zinc O 0 0.3933258354663849
finger O 0 0.1507425457239151
2 O 0 0.0013475854648277164
or O 0 0.0006499468581750989
zinc O 1 0.9822105169296265
finger O 1 0.8003463745117188
3 O 0 0.001513715018518269
, O 0 0.0001750107912812382
respectively O 0 0.00035259118885733187
, O 0 4.5733930164715275e-05
with O 0 2.1116589778102934e-05
a O 0 0.0006020011496730149
hot O 0 0.016532495617866516
spot O 0 0.009922964498400688
( O 0 0.00077678362140432
R394W O 0 0.031232323497533798
) O 0 0.00010569198639132082
in O 0 0.00011802021617768332
exon O 0 0.028202462941408157
9 O 0 0.002010470489040017
. O 0 0.00028180747176520526

We O 0 0.0003205704560969025
analyzed O 0 0.0005068646278232336
a O 0 9.417668479727581e-05
series O 0 6.0766433307435364e-05
of O 0 2.0382107322802767e-05
24 O 0 0.0026593098882585764
patients O 1 0.9999550580978394
, O 0 8.675224671605974e-05
10 O 0 0.0001061180664692074
with O 0 0.00010122410458279774
isolated B-Disease 1 0.9406117796897888
DMS I-Disease 1 0.9999979734420776
( O 0 0.00608800956979394
IDMS B-Disease 1 0.9999891519546509
) O 0 0.0004124142287764698
, O 0 0.00012502465688157827
10 O 0 0.00027288313140161335
with O 0 0.0003882816818077117
DDS B-Disease 1 0.9999997615814209
, O 0 0.00026155015802942216
and O 0 6.0573143855435774e-05
4 O 0 0.00040720729157328606
with O 0 0.0002376842312514782
urogenital B-Disease 1 0.9999988079071045
abnormalities I-Disease 1 0.9999896287918091
and O 0 0.001441340777091682
/ O 1 0.9966825842857361
or O 0 0.002391632879152894
WT B-Disease 1 0.9994681477546692
. O 0 0.0008749418775551021

We O 0 0.001105854636989534
report O 0 0.0025136792100965977
WT1 O 1 0.9955233335494995
heterozygous O 0 0.0043615433387458324
mutations O 0 0.0007548162830062211
in O 0 0.00016903334471862763
16 O 0 0.0034446497447788715
patients O 1 0.9999948740005493
, O 0 0.00017481364193372428
4 O 0 0.00024399772519245744
of O 0 1.1571466529858299e-05
whom O 0 0.0012174550211057067
presented O 0 0.0010617494117468596
with O 0 0.0005283292848616838
IDMS B-Disease 1 0.9999938011169434
. O 0 0.0012183788930997252

One O 0 0.00043862953316420317
male O 0 0.0006303819245658815
and O 0 5.1752103900071234e-05
two O 0 7.906562677817419e-05
female O 0 0.022106926888227463
IDMS B-Disease 1 0.9999996423721313
patients O 1 0.999996542930603
with O 0 0.0006171223940327764
WT1 O 1 0.9999819993972778
mutations O 0 0.03846369683742523
underwent O 1 0.9999929666519165
normal O 0 0.015316477045416832
puberty O 1 0.9767903089523315
. O 0 0.0005547794280573726

Two O 0 0.0002840715169440955
mutations O 0 0.002569054253399372
associated O 0 0.0006989327375777066
with O 0 0.0005054986686445773
IDMS B-Disease 1 0.9999580383300781
are O 0 1.424524907633895e-05
different O 0 3.9482729334849864e-06
from O 0 1.6027244782890193e-05
those O 0 2.773297092062421e-05
described O 0 0.0024325898848474026
in O 0 0.0021464782766997814
DDS B-Disease 1 1.0
patients O 1 0.9999947547912598
. O 0 0.0005811303853988647

No O 0 0.0046361214481294155
WT1 O 1 0.9981620907783508
mutations O 0 0.0024086677003651857
were O 0 3.5718803701456636e-05
detected O 0 0.002146934624761343
in O 0 2.8132588340668008e-05
the O 0 5.17447006131988e-05
six O 0 0.0002170326915802434
other O 0 0.00043560564517974854
IDMS B-Disease 1 0.9999998807907104
patients O 1 0.9999983310699463
, O 0 0.0002831759338732809
suggesting O 0 0.0021836513187736273
genetic O 0 0.0008374413009732962
heterogeneity O 0 0.0034956878516823053
of O 0 2.0385898096719757e-05
this O 0 0.0005458278465084732
disease O 1 0.9999996423721313
. O 0 0.0005058428505435586

We O 0 0.0005985854659229517
analyzed O 0 0.00558254262432456
genotype O 1 0.6301633715629578
/ O 1 0.8188356757164001
phenotype O 0 0.07085277885198593
correlations O 0 0.006603720597922802
, O 0 0.00014197990822140127
on O 0 6.997973105171695e-05
the O 0 3.616220783442259e-05
basis O 0 2.6058274670504034e-05
of O 0 5.911287644266849e-06
the O 0 9.75093207671307e-05
constitution O 0 0.00012246293772477657
of O 0 1.4308750905911438e-05
a O 0 0.0021027305629104376
WT1 O 1 0.999032735824585
mutation O 0 0.0014056655345484614
database O 0 0.00023554421204607934
of O 0 3.2871168514247984e-05
84 O 0 0.02515372447669506
germ O 1 0.9998424053192139
- O 0 0.012587343342602253
line O 0 0.0021354721393436193
mutations O 0 0.0011864207917824388
, O 0 7.107089913915843e-05
to O 0 5.067254096502438e-05
compare O 0 0.000929382280446589
the O 0 3.8950194721110165e-05
distribution O 0 0.00010538996866671368
and O 0 0.00011715973232639953
type O 0 0.002238609129562974
of O 0 3.886619379045442e-05
mutations O 0 0.0031699331011623144
, O 0 0.00011412587628001347
according O 0 5.54304824618157e-05
to O 0 2.047134330496192e-05
the O 0 6.077530269976705e-05
different O 0 0.00013672583736479282
symptoms O 1 0.9999978542327881
. O 0 0.0008143298327922821

This O 0 0.0002435017959214747
demonstrated O 0 0.007098948583006859
( O 0 0.000544087728485465
1 O 0 0.0011779244523495436
) O 0 0.00011234952398808673
the O 0 0.00013455004955176264
association O 0 0.0065853470005095005
between O 0 0.0002017699443968013
mutations O 0 0.0007842481136322021
in O 0 9.924751066137105e-05
exons O 0 0.004789813421666622
8 O 0 0.0006084396736696362
and O 0 0.00010541026858845726
9 O 0 0.0014668116346001625
and O 0 0.0007445778464898467
DMS B-Disease 1 0.999988317489624
; O 0 0.00042465602746233344
( O 0 0.00039775477489456534
2 O 0 0.0007496735779568553
) O 0 0.00014079474203754216
among O 0 0.0003194714954588562
patients O 1 0.9999725818634033
with O 0 0.0008764521335251629
DMS B-Disease 1 0.9999932050704956
, O 0 0.00017203333845827729
a O 0 0.00014713614655192941
higher O 0 0.0001388211821904406
frequency O 0 4.1907660488504916e-05
of O 0 1.5538400475634262e-05
exon O 0 0.02803875133395195
8 O 0 0.0007552749593742192
mutations O 0 0.0005616912967525423
among O 0 7.665711746085435e-05
46 O 0 0.002918435027822852
, O 0 0.0014620658475905657
XY O 1 0.9999244213104248
patients O 1 0.9999701976776123
with O 0 0.00011225047637708485
female O 0 0.0024761066306382418
phenotype O 0 0.023632701486349106
than O 0 4.561493551591411e-05
among O 0 6.65819679852575e-05
46 O 0 0.0028919766191393137
, O 0 0.001226747059263289
XY O 1 0.9999232292175293
patients O 1 0.9999712705612183
with O 0 0.00011086798622272909
sexual O 0 0.0026620402932167053
ambiguity O 0 0.005101325921714306
or O 0 0.0011260311584919691
male O 0 0.005121369380503893
phenotype O 1 0.925494909286499
; O 0 0.0002530219790060073
and O 0 0.00019900070037692785
( O 0 0.0006358271930366755
3 O 0 0.0006907326751388609
) O 0 5.651388346450403e-05
statistically O 0 0.0003566105442587286
significant O 0 0.00017529536853544414
evidence O 0 0.0001404719369020313
that O 0 3.377666143933311e-05
mutations O 0 0.000576455146074295
in O 0 0.00010592171747703105
exons O 0 0.007418900728225708
8 O 0 0.0009362105629406869
and O 0 0.000122458950500004
9 O 0 0.0010370081290602684
preferentially O 0 0.002727313432842493
affect O 0 0.0006832157960161567
amino O 0 9.047895582625642e-05
acids O 0 9.558602323522791e-05
with O 0 9.104059245146345e-06
different O 0 4.0778645598038565e-06
functions O 0 0.00018662054208107293
. O 0 0.00014602957526221871
. O 0 0.0002856894861906767

The O 0 0.0018953777616843581
185delAG O 1 0.9813856482505798
BRCA1 O 1 0.9986574649810791
mutation O 0 0.0041028838604688644
originated O 0 0.0009123185300268233
before O 0 0.00020929316815454513
the O 0 6.795714580221102e-05
dispersion O 0 0.0037538299802690744
of O 0 1.907848854898475e-05
Jews O 0 0.0004681318823713809
in O 0 9.895418770611286e-05
the O 0 0.00011118856491521001
diaspora O 0 0.0006313478806987405
and O 0 0.00010517271584831178
is O 0 0.00013607836444862187
not O 0 3.604727316997014e-05
limited O 0 0.0004049077979288995
to O 0 0.00013487438263837248
Ashkenazim O 1 0.9282598495483398
. O 0 0.0005206306232139468

The O 0 0.000813590653706342
185delAG O 0 0.07639956474304199
mutation O 0 0.002461573574692011
in O 0 0.00048012216575443745
BRCA1 O 1 0.9996122717857361
is O 0 0.0006262368406169116
detected O 0 0.004067689646035433
in O 0 0.0001325245830230415
Ashkenazi O 0 0.1443602591753006
Jews O 0 0.00015732327301520854
both O 0 2.9835873647243716e-05
in O 0 0.0003230734437238425
familial B-Disease 1 0.9999996423721313
breast I-Disease 1 1.0
and I-Disease 1 0.9989295601844788
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00017618248239159584
in O 0 5.662630792357959e-05
the O 0 6.861025758553296e-05
general O 0 0.0005611550877802074
population O 0 5.7870769524015486e-05
. O 0 0.00025752471992745996

All O 0 0.0003937935980502516
tested O 0 0.0420934297144413
Ashkenazi O 1 0.7960666418075562
mutation O 0 0.00435022683814168
carriers O 0 0.00435142545029521
share O 0 0.00016749950009398162
the O 0 5.464521746034734e-05
same O 0 0.00012727899593301117
allelic O 0 0.03209134563803673
pattern O 0 0.004490831401199102
at O 0 0.0007806140929460526
the O 0 0.0006512930267490447
BRCA1 O 1 0.999769389629364
locus O 0 0.030923036858439445
. O 0 0.0007471395656466484

Our O 0 0.0009894665563479066
previous O 0 0.0005000636447221041
study O 0 0.000852603989187628
showed O 0 0.0005054452340118587
that O 0 2.2800018996349536e-05
this O 0 5.6105775001924485e-05
Ashkenazi O 1 0.5741741061210632
mutation O 0 0.0023263986222445965
also O 0 0.00021154219575691968
occurs O 0 0.0006840268615633249
in O 0 0.00012812481145374477
Iraqi O 0 0.0020836645271629095
Jews O 0 0.0001743997709127143
with O 0 2.3216551198856905e-05
a O 0 0.0002764139208011329
similar O 0 0.00039937449037097394
allelic O 0 0.06856171786785126
pattern O 0 0.010697748512029648
. O 0 0.000629246816970408

We O 0 0.0004865159571636468
extended O 0 0.0003844531311187893
our O 0 0.00010257765825372189
analysis O 0 7.83163559390232e-05
to O 0 2.4967683202703483e-05
other O 0 2.9237111448310316e-05
non O 0 0.003939792513847351
- O 0 0.010618507862091064
Ashkenazi O 0 0.06251583248376846
subsets O 0 0.002252819249406457
354 O 0 0.01038702018558979
of O 0 1.5078304386406671e-05
Moroccan O 0 0.0016391573008149862
origin O 0 7.867490785429254e-05
, O 0 0.00017104801372624934
200 O 0 0.001227566390298307
Yemenites O 1 0.8771339058876038
and O 0 0.00014946852752473205
150 O 0 0.0004466428654268384
Iranian O 0 0.0005109127378091216
Jews O 0 0.0005144995520822704
. O 0 0.00026063431869260967

Heteroduplex O 1 0.5081497430801392
analysis O 0 0.0003669647267088294
complemented O 0 0.0024041139986366034
by O 0 1.5330082533182576e-05
direct O 0 8.32658406579867e-05
DNA O 0 0.0002197944704676047
sequencing O 0 0.00012740357487928122
of O 0 2.259473330923356e-05
abnormally O 1 0.9802990555763245
migrating O 0 0.002958826720714569
bands O 0 0.0003867537307087332
were O 0 4.369959424366243e-05
employed O 0 0.0020296114962548018
. O 0 0.0003670472651720047

Four O 0 0.00012672579032368958
of O 0 1.263822014152538e-05
Moroccan O 0 0.0016319777350872755
origin O 0 0.00011566141620278358
( O 0 0.0004128158325329423
1 O 0 0.0010782091412693262
. O 0 0.0001046742545440793
1 O 0 0.0005847758729942143
% O 0 5.2980012696934864e-05
) O 0 0.00011411020386731252
and O 0 5.616059206658974e-05
none O 0 0.0001945475087268278
of O 0 8.441108548140619e-06
the O 0 0.0005569606437347829
Yemenites O 1 0.9953064322471619
or O 0 0.0007034010486677289
Iranians O 0 0.001738954451866448
was O 0 0.0005550613277591765
a O 0 0.00022154668113216758
carrier O 0 0.0041489931754767895
of O 0 1.0278440640831832e-05
the O 0 0.00024655048036947846
185delAG O 0 0.24663469195365906
mutation O 0 0.0035536738578230143
. O 0 0.00033477001124992967

BRCA1 O 1 0.9987872242927551
allelic O 0 0.09753157943487167
patterns O 0 0.001031592022627592
were O 0 4.798731970367953e-05
determined O 0 0.0008326515671797097
for O 0 6.648692215094343e-05
four O 0 1.633742795092985e-05
of O 0 4.053769771417137e-06
these O 0 1.3031911294092424e-05
individuals O 0 6.59987490507774e-05
and O 0 4.281352084944956e-05
for O 0 9.568862878950313e-05
12 O 0 0.00020899003720842302
additional O 0 0.00015437338151969016
non O 0 0.0034310023766011
- O 0 0.013475424610078335
Ashkenazi O 1 0.6694326400756836
185delAG O 0 0.12316784262657166
mutation O 0 0.001982355723157525
carriers O 0 0.003674016799777746
who O 0 0.0006051734671927989
had O 0 0.012359943240880966
breast B-Disease 1 1.0
/ I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0008441869867965579

Six O 0 0.001436936086975038
non O 0 0.007671251893043518
- O 0 0.01906532235443592
Ashkenazi O 0 0.1364082247018814
individuals O 0 0.0001226088497787714
shared O 0 0.00023877678904682398
the O 0 0.00020608617342077196
common O 0 0.008123095147311687
Ashkenazi O 1 0.997863233089447
haplotype O 1 0.766520082950592
, O 0 0.00022086816898081452
four O 0 6.673860480077565e-05
had O 0 0.0002418336080154404
a O 0 0.00019736126705538481
closely O 0 0.00041153369238600135
related O 0 0.0011836562771350145
pattern O 0 0.004210634622722864
, O 0 0.00013907848915550858
and O 0 6.779222167097032e-05
the O 0 0.00019110430730506778
rest O 0 0.0024501674342900515
( O 0 0.0005568828782998025
n O 0 0.004730238579213619
= O 0 0.005380710121244192
6 O 0 0.0010583291295915842
) O 0 7.057168113533407e-05
displayed O 0 0.0003475705161690712
a O 0 0.0002965536550618708
distinct O 0 0.0024322057142853737
BRCA1 O 1 0.99953293800354
allelic O 0 0.4549468159675598
pattern O 0 0.015645256265997887
. O 0 0.0007681099814362824

We O 0 0.000517729262355715
conclude O 0 0.0022650707978755236
that O 0 1.900519782793708e-05
the O 0 0.00017895510245580226
185delAG O 1 0.9919022917747498
BRCA1 O 1 0.9992444515228271
mutation O 0 0.002393999369814992
occurs O 0 0.0004568934964481741
in O 0 3.4493408747948706e-05
some O 0 4.697872282122262e-05
non O 0 0.007132901344448328
- O 0 0.028195733204483986
Ashkenazi O 0 0.21902348101139069
populations O 0 0.0005986944888718426
at O 0 0.0005445168353617191
rates O 0 0.00041893962770700455
comparable O 0 0.0008232746622525156
with O 0 1.5304960470530204e-05
that O 0 2.0303343262639828e-05
of O 0 3.0240371415857226e-05
Ashkenazim O 1 0.964783787727356
. O 0 0.0007435923325829208

The O 0 0.00019433427951298654
majority O 0 7.52928463043645e-05
of O 0 1.5475916370633058e-05
Jewish O 0 0.0027793387416750193
185delAG O 1 0.6915559768676758
mutation O 0 0.003962849732488394
carriers O 0 0.0043640583753585815
have O 0 3.566604573279619e-05
a O 0 0.0002731319982558489
common O 0 0.0022233426570892334
allelic O 0 0.19613616168498993
pattern O 0 0.007601505145430565
, O 0 0.00020344210497569293
supporting O 0 0.0011966548627242446
the O 0 0.0003360896371304989
founder O 0 0.011671660467982292
effect O 0 0.0009315293864347041
notion O 0 0.0015764455311000347
, O 0 0.00021293971803970635
but O 0 0.00013984607357997447
dating O 0 0.0006499910959973931
the O 0 9.90748594631441e-05
mutations O 0 0.00059760786825791
origin O 0 1.869154402811546e-05
to O 0 2.2075844753999263e-05
an O 0 0.00010344808106310666
earlier O 0 0.00035224948078393936
date O 0 0.00011139508569613099
than O 0 3.8967471482465044e-05
currently O 0 0.00022479455219581723
estimated O 0 0.0005542762228287756
. O 0 0.0001948185235960409

However O 0 0.0010655390797182918
, O 0 6.874274549772963e-05
the O 0 3.290202948846854e-05
different O 0 1.8778302546706982e-05
allelic O 0 0.0344536267220974
pattern O 0 0.0047838687896728516
at O 0 0.0009614381706342101
the O 0 0.0009456596453674138
BRCA1 O 1 0.999884843826294
locus O 0 0.019766367971897125
even O 0 0.00017313174612354487
in O 0 3.222471059416421e-05
some O 0 2.2927353711565956e-05
Jewish O 0 0.0013414646964520216
mutation O 0 0.003836610820144415
carriers O 0 0.011489483527839184
, O 0 0.00029246159829199314
might O 0 0.0005046970909461379
suggest O 0 0.0001959560759132728
that O 0 1.2725029591820203e-05
the O 0 7.007729436736554e-05
mutation O 0 0.001405975897796452
arose O 0 0.0011048517189919949
independently O 0 0.00021922998712398112
. O 0 8.845258707879111e-05
. O 0 0.00025878247106447816

Crystal O 0 0.04094235971570015
structure O 0 0.0005767144612036645
of O 0 2.006933391385246e-05
the O 0 0.0009931419044733047
hemochromatosis B-Disease 1 0.9999998807907104
protein O 0 0.013143060728907585
HFE O 1 0.9997342228889465
and O 0 0.0003161477216053754
characterization O 0 0.005513779819011688
of O 0 6.474455858551664e-06
its O 0 5.135065657668747e-05
interaction O 0 0.00017550027405377477
with O 0 0.00010779310832731426
transferrin O 1 0.9764140248298645
receptor O 0 0.008934677578508854
. O 0 0.00037267321022227407

HFE O 1 0.9977097511291504
is O 0 0.000810508499853313
an O 0 0.0007694018422625959
MHC O 1 0.9985201954841614
- O 0 0.00502136442810297
related O 0 0.000330263574142009
protein O 0 0.00014209543587639928
that O 0 1.7593260054127313e-05
is O 0 7.03720870660618e-05
mutated O 0 0.0007646435406059027
in O 0 2.300865889992565e-05
the O 0 0.00017361779464408755
iron B-Disease 1 0.9999395608901978
- I-Disease 1 0.9998651742935181
overload I-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.0034920384641736746

HFE O 1 0.9917375445365906
binds O 0 0.007258955389261246
to O 0 0.00022666830045636743
transferrin O 1 0.8529840111732483
receptor O 0 0.013694655150175095
( O 0 0.0015320240054279566
TfR O 1 0.9970557689666748
) O 0 0.00023523313575424254
and O 0 8.232206891989335e-05
reduces O 0 0.005676123779267073
its O 0 5.939669063081965e-05
affinity O 0 0.0011255195131525397
for O 0 0.0003059387090615928
iron O 1 0.9563937783241272
- O 0 0.0033863182179629803
loaded O 0 0.0012473203241825104
transferrin O 1 0.7676209211349487
, O 0 0.0005111558130010962
implicating O 1 0.9875797629356384
HFE O 1 0.9997662901878357
in O 0 0.0007898685871623456
iron O 1 0.9985387325286865
metabolism O 1 0.85279381275177
. O 0 0.0005596595001406968

The O 0 0.0006868846248835325
2 O 0 0.001377567183226347
. O 0 0.0003295099886599928

6 O 0 0.002576317172497511
A O 0 0.0029071730095893145
crystal O 0 0.027478637173771858
structure O 0 0.00134254340082407
of O 0 0.00010801298776641488
HFE O 1 0.9999345541000366
reveals O 0 0.011442801915109158
the O 0 6.81449455441907e-05
locations O 0 0.00012278612121008337
of O 0 0.00014442061365116388
hemochromatosis B-Disease 1 1.0
mutations O 0 0.004626732785254717
and O 0 0.00016510825662408024
a O 0 0.0015442254953086376
patch O 1 0.9999303817749023
of O 0 8.988730405690148e-05
histidines O 1 0.9795524477958679
that O 0 6.197314360179007e-05
could O 0 6.679221405647695e-05
be O 0 2.2758242266718298e-05
involved O 0 0.00021838735847268254
in O 0 0.00023391490685753524
pH O 1 0.8229690194129944
- O 0 0.0037661546375602484
dependent O 0 0.0009388439357280731
interactions O 0 0.0005371933802962303
. O 0 0.00036317939520813525

We O 0 0.0003431023797020316
also O 0 7.005043153185397e-05
demonstrate O 0 0.0006836978136561811
that O 0 6.777438102290034e-05
soluble O 1 0.9810689091682434
TfR O 1 0.9978684186935425
and O 0 0.001093594473786652
HFE O 1 0.9995284080505371
bind O 0 0.007600231561809778
tightly O 0 0.0013978692004457116
at O 0 0.0004141699755564332
the O 0 9.201204375131056e-05
basic O 0 0.0028193723410367966
pH O 0 0.022693373262882233
of O 0 1.2439555575838313e-05
the O 0 0.00019997912750113755
cell O 0 0.004648321308195591
surface O 0 0.0073243072256445885
, O 0 0.00018986561917699873
but O 0 8.33655649330467e-05
not O 0 4.9550155381439254e-05
at O 0 0.00024817403755150735
the O 0 0.00021846566232852638
acidic O 1 0.8338482975959778
pH O 0 0.03892510011792183
of O 0 3.2226616895059124e-05
intracellular O 0 0.01995581015944481
vesicles O 0 0.04057195782661438
. O 0 0.0007977687637321651

TfR O 1 0.9982481002807617
HFE O 1 0.9984177350997925
stoichiometry O 0 0.07208459824323654
( O 0 0.0010502267396077514
2 O 0 0.0007233924698084593
1 O 0 0.0006148046813905239
) O 0 8.606127084931359e-05
differs O 0 0.0012594603467732668
from O 0 0.00020965987641829997
TfR O 1 0.9955937266349792
transferrin O 1 0.9531420469284058
stoichiometry O 0 0.03907524794340134
( O 0 0.0008841024246066809
2 O 0 0.0013512186706066132
2 O 0 0.0012312463950365782
) O 0 0.0001635074004298076
, O 0 0.00014221797755453736
implying O 0 0.004125315696001053
a O 0 9.179330663755536e-05
different O 0 4.42376040155068e-06
mode O 0 0.00023271188547369093
of O 0 6.091345312597696e-06
binding O 0 0.0005147433839738369
for O 0 0.0007294887327589095
HFE O 1 0.9997302889823914
and O 0 0.0006078548613004386
transferrin O 1 0.9638689160346985
to O 0 0.0006011719815433025
TfR O 1 0.9971158504486084
, O 0 0.0001917467889143154
consistent O 0 0.0010675478260964155
with O 0 2.096479329338763e-05
our O 0 0.00019836115825455636
demonstration O 0 0.001365863485261798
that O 0 0.0001540422672405839
HFE O 1 0.9995355606079102
, O 0 0.0007854319992475212
transferrin O 1 0.9655368328094482
, O 0 0.0002780031063593924
and O 0 0.00027271980070509017
TfR O 1 0.9926396608352661
form O 0 0.00029382240609265864
a O 0 0.00034772715298458934
ternary O 0 0.017768211662769318
complex O 0 0.0077176569029688835
. O 0 0.0005546839092858136

Identification O 0 0.0007080356008373201
of O 0 1.4998834558355156e-05
three O 0 0.00010206377191934735
novel O 0 0.002000014530494809
mutations O 0 0.0013178273802623153
and O 0 6.495485285995528e-05
a O 0 0.00031319097615778446
high O 0 0.0006708525470457971
frequency O 0 4.582447581924498e-05
of O 0 5.716776286135428e-06
the O 0 0.00021122898033354431
Arg778Leu O 1 0.9586671590805054
mutation O 0 0.0012220970820635557
in O 0 0.0001559460797579959
Korean O 0 0.09164946526288986
patients O 1 0.9999901056289673
with O 0 0.0005744649679400027
Wilson B-Disease 1 0.9999428987503052
disease I-Disease 1 0.9999996423721313
. O 0 0.0006018055719323456

Four O 0 0.00041863901424221694
mutations O 0 0.0029926167335361242
- O 0 0.008751756511628628
- O 0 0.00589000154286623
R778L O 0 0.027805600315332413
, O 0 0.0002709236287046224
A874V O 0 0.03064616583287716
, O 0 0.00030223082285374403
L1083F O 0 0.031200028955936432
, O 0 0.0001724659523461014
and O 0 0.00024681081413291395
2304delC O 1 0.7504217624664307
- O 0 0.004873194731771946
- O 0 0.0008109975606203079
in O 0 2.187672544096131e-05
the O 0 9.442965529160574e-05
copper O 0 0.020436838269233704
- O 0 0.0012991447001695633
transporting O 0 0.0022473467979580164
enzyme O 0 0.0017200350994244218
, O 0 0.00040387737681157887
P O 0 0.22225569188594818
- O 0 0.005755619145929813
type O 0 0.007943268865346909
ATPase O 1 0.9349102973937988
( O 0 0.002648085355758667
ATP7B O 1 0.9970954656600952
) O 0 0.0002687135711312294
, O 0 5.350132778403349e-05
were O 0 1.6559666619286872e-05
identified O 0 0.0002811513259075582
in O 0 0.00015055073890835047
Korean O 0 0.12602396309375763
Patients O 1 0.9999972581863403
with O 0 0.0005185743211768568
Wilson B-Disease 1 0.9999250173568726
disease I-Disease 1 0.9999996423721313
. O 0 0.0005908635794185102

Arg778Leu O 1 0.9149155616760254
, O 0 0.0002068707108264789
the O 0 9.352053166367114e-05
most O 0 0.00014154368545860052
frequently O 0 0.0012157432502135634
reported O 0 0.001282178913243115
mutation O 0 0.00017307185044046491
of O 0 2.852804300346179e-06
this O 0 3.2187301258090883e-05
enzyme O 0 0.0022747826296836138
, O 0 0.00024484601453877985
was O 0 0.0009965825593098998
found O 0 0.00010407697118353099
in O 0 2.9698136131628416e-05
six O 0 3.0967370548751205e-05
of O 0 7.937976988614537e-06
eight O 0 0.0005465405993163586
unrelated O 0 0.35029029846191406
patients O 1 0.9999904632568359
studied O 0 0.001581384101882577
, O 0 6.794840010115877e-05
an O 0 8.219860319513828e-05
allele O 0 0.001073164283297956
frequency O 0 8.052050543483347e-05
of O 0 2.2845593775855377e-05
37 O 0 0.002769659971818328
. O 0 0.0003556573938112706

5 O 0 0.001533027971163392
% O 0 6.053393008187413e-05
, O 0 8.303922368213534e-05
which O 0 4.257911496097222e-05
is O 0 0.0002437254588585347
considerably O 0 0.005730566568672657
higher O 0 0.000366317224688828
than O 0 3.3214477298315614e-05
those O 0 2.7524873075890355e-05
in O 0 5.210333983995952e-05
other O 0 3.1030755053507164e-05
Asian O 0 0.001781779108569026
populations O 0 0.000726585160009563
. O 0 0.0003428829659242183

The O 0 0.00033518645795993507
novel O 0 0.0004943254170939326
single O 0 0.00012692146992776543
nucleotide O 0 0.0005585073377005756
deletion O 0 0.009318147785961628
, O 0 0.0005829522269777954
2304delC O 0 0.34529802203178406
, O 0 0.00025450438261032104
was O 0 0.0006334196659736335
found O 0 9.505556954536587e-05
in O 0 5.589814099948853e-05
one O 0 0.00038797827437520027
patient O 1 0.9998996257781982
. O 0 0.0004899463383480906

Since O 0 0.0010257746325805783
a O 0 0.00021607709641102701
mutation O 0 0.0006200477364473045
at O 0 0.0002433114859741181
cDNA O 0 0.0016742654843255877
nucleotide O 0 0.0016352619277313352
2302 O 1 0.9546465277671814
( O 0 0.0022054454311728477
2302insC O 0 0.42241597175598145
) O 0 0.00036776356864720583
had O 0 0.00046858814312145114
been O 0 0.00027206511003896594
previously O 0 0.0008275560685433447
described O 0 0.0015368082094937563
, O 0 6.892081728437915e-05
this O 0 1.3522378139896318e-05
region O 0 0.0001789301895769313
of O 0 5.968329787719995e-06
the O 0 0.0003660892543848604
ATP7B O 1 0.9999164342880249
gene O 0 0.002906822133809328
may O 0 0.0005180431762710214
be O 0 6.885211041662842e-05
susceptible O 0 0.10993675887584686
to O 0 5.572463487624191e-05
gene O 0 0.001511862501502037
rearrangements O 0 0.03432582691311836
causing O 1 0.9996015429496765
Wilson B-Disease 1 0.9999682903289795
disease I-Disease 1 0.9999997615814209
. O 0 0.0007294914685189724

Disruption O 0 0.011758001521229744
of O 0 2.0158528059255332e-05
splicing O 0 0.0008766233804635704
regulated O 0 0.0005789549904875457
by O 0 2.81243246718077e-05
a O 0 0.0009047811618074775
CUG O 1 0.9880532026290894
- O 0 0.0010464490624144673
binding O 0 0.00013609965390060097
protein O 0 0.0004015252343378961
in O 0 0.0009989128448069096
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0027907220646739006

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.7560842037200928
DM B-Disease 1 1.0
) O 0 0.0008298841421492398
is O 0 0.0002994932292494923
caused O 0 0.0021318658255040646
by O 0 3.412506703170948e-05
a O 0 0.001375095802359283
CTG O 1 0.9796016216278076
expansion O 0 0.001894462271593511
in O 0 8.813173189992085e-05
the O 0 0.0001221204292960465
3 O 0 0.0008429145091213286
untranslated O 0 0.025053231045603752
region O 0 0.0004110608424525708
of O 0 1.9294577214168385e-05
the O 0 0.0016153589822351933
DM B-Disease 1 0.9999998807907104
gene O 0 0.0047734822146594524
. O 0 0.0003822432190645486

One O 0 0.00028197382926009595
model O 0 0.0006900920998305082
of O 0 0.00040563486982136965
DM B-Disease 1 1.0
pathogenesis O 1 0.9999945163726807
suggests O 0 0.004278990440070629
that O 0 9.629284613765776e-05
RNAs O 0 0.011895008385181427
from O 0 2.8883936465717852e-05
the O 0 5.5102253099903464e-05
expanded O 0 0.0007088180864229798
allele O 0 0.001179919927380979
create O 0 0.00011984242883045226
a O 0 0.00028914876747876406
gain O 0 0.0015876920660957694
- O 0 0.0015306052519008517
of O 0 2.9532973712775856e-05
- O 0 0.0033331618178635836
function O 0 0.000618134334217757
mutation O 0 0.0007787484209984541
by O 0 1.9409702872508205e-05
the O 0 0.0001415944570908323
inappropriate O 0 0.007240505423396826
binding O 0 0.00014141258725430816
of O 0 3.7896809317317093e-06
proteins O 0 3.120488690910861e-05
to O 0 5.17214102728758e-05
the O 0 0.0003525177307892591
CUG O 1 0.9979602098464966
repeats O 0 0.012779228389263153
. O 0 0.000416819762904197

Data O 0 0.0005451477481983602
presented O 0 0.0010690453927963972
here O 0 0.00019270757911726832
indicate O 0 0.000277140672551468
that O 0 6.533504802064272e-06
the O 0 1.7616428522160277e-05
conserved O 0 0.00016084124217741191
heterogeneous O 0 0.013171974569559097
nuclear O 0 0.011843027547001839
ribonucleoprotein O 1 0.9960265159606934
, O 0 0.0007964426185935736
CUG O 1 0.9310178756713867
- O 0 0.0008421149686910212
binding O 0 0.00011916826042579487
protein O 0 0.0003703438560478389
( O 0 0.0006962508196011186
CUG O 1 0.9986972212791443
- O 0 0.02742646262049675
BP O 1 0.9601950645446777
) O 0 0.000248763186391443
, O 0 0.0001556207425892353
may O 0 0.0009569975081831217
mediate O 0 0.007863407023251057
the O 0 0.00026559492107480764
trans O 0 0.06539859622716904
- O 0 0.0033398359082639217
dominant O 0 0.0012780677061527967
effect O 0 0.00012540494208224118
of O 0 3.319119969091844e-06
the O 0 8.390173024963588e-05
RNA O 0 0.0029769879765808582
. O 0 0.00041939050424844027

CUG O 1 0.9965988993644714
- O 0 0.055917464196681976
BP O 1 0.9496781826019287
was O 0 0.0010706245666369796
found O 0 7.33846754883416e-05
to O 0 1.90674836630933e-05
bind O 0 0.00044746746425516903
to O 0 1.2206382052681874e-05
the O 0 8.350758434971794e-05
human O 0 0.017421135678887367
cardiac O 1 1.0
troponin O 1 0.9999988079071045
T O 1 0.9995675683021545
( O 0 0.0013880975311622024
cTNT O 0 0.08559361845254898
) O 0 0.00029412677395157516
pre O 0 0.007149860262870789
- O 0 0.0040820809081196785
messenger O 0 0.007627162616699934
RNA O 0 0.0007511355215683579
and O 0 3.7908332160441205e-05
regulate O 0 0.001008312334306538
its O 0 7.124351395759732e-05
alternative O 0 0.0007596060750074685
splicing O 0 0.001921814982779324
. O 0 0.00032041032682172954

Splicing O 0 0.0013374646659940481
of O 0 4.370393435237929e-05
cTNT O 0 0.09111445397138596
was O 0 0.0016231152694672346
disrupted O 0 0.029700087383389473
in O 0 0.0021570974495261908
DM B-Disease 1 1.0
striated O 1 0.9999769926071167
muscle O 1 0.9998356103897095
and O 0 0.00020212019444443285
in O 0 0.0001433454017387703
normal O 0 0.002554763574153185
cells O 0 0.001395827392116189
expressing O 0 0.0011283277999609709
transcripts O 0 0.0005352037260308862
that O 0 2.158553797926288e-05
contain O 0 0.0005052203196100891
CUG O 1 0.9954149723052979
repeats O 0 0.008344154804944992
. O 0 0.00038566687726415694

Altered O 0 0.0039550503715872765
expression O 0 0.0001711067307041958
of O 0 7.5115958679816686e-06
genes O 0 0.00016418124141637236
regulated O 0 0.002307456685230136
posttranscriptionally O 0 0.07121846079826355
by O 0 0.00021623085194732994
CUG O 1 0.9986200332641602
- O 0 0.017989691346883774
BP O 0 0.49916067719459534
therefore O 0 0.00031563089578412473
may O 0 0.00030536582926288247
contribute O 0 0.0025195730850100517
to O 0 0.0010441740741953254
DM B-Disease 1 1.0
pathogenesis O 1 0.9999858140945435
. O 0 0.0003070244856644422
. O 0 0.00030042725848034024

Identification O 0 0.00047740177251398563
of O 0 1.437821083527524e-05
a O 0 0.0006009720964357257
novel O 0 0.0025474424473941326
nonsense O 0 0.019498715177178383
mutation O 0 0.0014999882550910115
and O 0 3.7311390769900754e-05
a O 0 0.00022833113325759768
missense O 0 0.0034085761290043592
substitution O 0 0.0001943936076713726
in O 0 4.969031215296127e-05
the O 0 0.0002814061299432069
vasopressin O 1 0.9965013265609741
- O 0 0.04082438349723816
neurophysin O 1 0.9842609167098999
II O 1 0.9204906225204468
gene O 0 0.0005395543994382024
in O 0 2.522762952139601e-05
two O 0 1.1168617675139103e-05
Spanish O 0 0.00022808373614680022
kindreds O 0 0.02963109128177166
with O 0 0.0002855372440535575
familial B-Disease 1 0.9999897480010986
neurohypophyseal I-Disease 1 0.9999890327453613
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999992847442627
. O 0 0.0018363085109740496

Familial B-Disease 1 0.9999911785125732
neurohypophyseal I-Disease 1 0.9999909400939941
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 0 0.010527098551392555
FNDI B-Disease 1 0.9999864101409912
) O 0 0.00017719499010127038
is O 0 8.00025081844069e-05
an O 0 0.00026478030486032367
autosomal B-Disease 1 0.99989914894104
dominant I-Disease 1 0.9998410940170288
disease I-Disease 1 1.0
caused O 1 0.7504550814628601
by O 0 0.0003888545325025916
deficiency O 1 0.9999997615814209
in O 0 9.04636035556905e-05
the O 0 0.0002902181295212358
antidiuretic O 1 0.9964103102684021
hormone O 1 0.9631033539772034
arginine O 0 0.11086620390415192
vasopressin O 1 0.9782236218452454
( O 0 0.0024298650678247213
AVP O 1 0.9995573163032532
) O 0 4.7676279791630805e-05
encoded O 0 1.0194301466981415e-05
by O 0 1.1292372619209345e-05
the O 0 0.000502631301060319
AVP O 1 0.999945878982544
- O 0 0.01876046136021614
neurophysin O 1 0.9771036505699158
II O 1 0.9967125654220581
( O 0 0.0028238222002983093
AVP O 1 0.9999943971633911
- O 0 0.046672970056533813
NPII O 1 0.9922223687171936
) O 0 0.00018243286467622966
gene O 0 0.0005367255653254688
on O 0 0.0001765682827681303
chromosome O 0 0.0027986837085336447
20p13 O 0 0.03462953492999077
. O 0 0.0003759338869713247

In O 0 0.0003053591353818774
this O 0 5.7009048759937286e-05
study O 0 0.0007614549831487238
, O 0 6.812610808992758e-05
we O 0 6.087176370783709e-05
analyzed O 0 0.0004174713685642928
two O 0 1.2348166819720063e-05
families O 0 6.719776865793392e-05
with O 0 0.00020229970687069
FNDI B-Disease 1 0.9988653659820557
using O 0 5.366504774428904e-05
direct O 0 0.00013447373930830508
automated O 0 0.004872913006693125
fluorescent O 0 0.016278980299830437
, O 0 0.00018127317889593542
solid O 0 0.00618405407294631
phase O 0 0.006534353364259005
, O 0 0.00011372379958629608
single O 0 0.0003221796068828553
- O 0 0.0026192402001470327
stranded O 0 0.002122543752193451
DNA O 0 0.00011592552618822083
sequencing O 0 6.21755316387862e-05
of O 0 1.1680297575367149e-05
PCR O 0 0.017251433804631233
- O 0 0.006947607267647982
amplified O 0 0.014369843527674675
AVP O 1 0.9999421834945679
- O 0 0.031238101422786713
NPII O 1 0.9836421012878418
DNA O 0 0.0019644894637167454
. O 0 0.00024207560636568815

In O 0 0.0001911509461933747
one O 0 2.9286000426509418e-05
of O 0 7.45699389881338e-06
the O 0 0.00017039214435499161
families O 0 0.0003618104092311114
, O 0 0.0002538524568080902
affected O 0 0.002977262483909726
individuals O 0 0.00011294665455352515
presented O 0 0.0005415158811956644
a O 0 0.0005152038065716624
novel O 0 0.0019782406743615866
nonsense O 0 0.014589664526283741
mutation O 0 0.0018377002561464906
in O 0 0.00018682068912312388
exon O 0 0.01789061538875103
3 O 0 0.00019908553804270923
of O 0 5.41666804565466e-06
the O 0 0.00013076793402433395
gene O 0 0.0006895274273119867
, O 0 3.606615064200014e-05
consisting O 0 4.884101144853048e-05
in O 0 7.473674486391246e-05
a O 0 0.0009662450174801052
G O 0 0.04011150449514389
to O 0 0.0005229917587712407
T O 1 0.9912211894989014
transition O 0 0.0027591439429670572
at O 0 0.0006656800978817046
nucleotide O 0 0.0010491057764738798
2101 O 1 0.967678427696228
, O 0 0.00018468749476596713
which O 0 3.612260115914978e-05
produces O 0 0.0006349930190481246
a O 0 0.00028979702619835734
stop O 0 0.0010856154840439558
signal O 0 0.0006401165155693889
in O 0 9.785041766008362e-05
codon O 0 0.0051919883117079735
82 O 0 0.010074600577354431
( O 0 0.001486819121055305
Glu O 1 0.9976264834403992
) O 0 0.0001595827634446323
of O 0 5.5836982937762514e-05
NPII O 1 0.9993314743041992
. O 0 0.0007012715796008706

The O 0 0.002118554664775729
premature O 1 0.9878794550895691
termination O 0 0.374357670545578
eliminates O 0 0.01269024983048439
part O 0 0.00024179003958124667
of O 0 1.264871025341563e-05
the O 0 0.0005470059113577008
C O 1 0.8375635147094727
- O 0 0.010190914385020733
terminal O 0 0.030788395553827286
domain O 0 0.00029161598649807274
of O 0 5.743117435486056e-05
NPII O 1 0.9934934973716736
, O 0 9.660980140324682e-05
including O 0 1.4682486835226882e-05
a O 0 0.0001879599003586918
cysteine O 0 0.002066949848085642
residue O 0 0.006631307769566774
in O 0 0.00012657557090278715
position O 0 0.0021626409143209457
85 O 0 0.004265525843948126
, O 0 0.0001455984020140022
which O 0 4.207954407320358e-05
could O 0 8.949745824793354e-05
be O 0 2.682432568690274e-05
involved O 0 0.0001736182748572901
in O 0 4.410705514601432e-05
the O 0 0.00013086697435937822
correct O 0 0.009359466843307018
folding O 0 0.007126521319150925
of O 0 2.049117028946057e-05
the O 0 0.0006385006126947701
prohormone O 1 0.9990172386169434
. O 0 0.0012356973020359874

In O 0 0.0002799097856041044
the O 0 0.00014259765157476068
second O 0 0.00046992162242531776
family O 0 0.0003914011758752167
, O 0 0.00010076761100208387
a O 0 0.0004705536412075162
G279A O 0 0.021560633555054665
substitution O 0 0.0006721314857713878
at O 0 0.0010726357577368617
position O 0 0.0032232271041721106
- O 0 0.001825678744353354
1 O 0 0.00010868082608794793
of O 0 2.8022268452332355e-06
the O 0 5.972333383397199e-05
signal O 0 0.0019041961058974266
peptide O 0 0.004115805961191654
was O 0 0.0006583011127077043
observed O 0 0.0001894923479994759
in O 0 3.775312870857306e-05
all O 0 2.190259147027973e-05
affected O 0 0.0025122985243797302
individuals O 0 0.00023551277990918607
. O 0 0.00041533910552971065

This O 0 0.0002306777605554089
missense O 0 0.010400066152215004
mutation O 0 0.0012144440552219748
, O 0 0.00012118220911361277
which O 0 0.0001095025145332329
replaces O 1 0.7961758375167847
Ala O 1 0.9994957447052002
with O 0 0.0007085485849529505
Thr O 1 0.9998884201049805
, O 0 0.00024636436137370765
is O 0 0.0002491864433977753
frequent O 0 0.005223128013312817
among O 0 0.0014401444932445884
FNDI B-Disease 1 0.9999992847442627
patients O 1 0.9999934434890747
and O 0 0.00020467427384573966
is O 0 0.00022017097217030823
thought O 0 0.00040671692113392055
to O 0 2.969162233057432e-05
reduce O 0 0.0009987440425902605
the O 0 3.502549589029513e-05
efficiency O 0 0.0008530932245776057
of O 0 2.366947774135042e-05
cleavage O 0 0.06142589449882507
by O 0 7.066891703289002e-05
signal O 0 0.004056124947965145
peptidases O 0 0.10530992597341537
. O 0 0.000251227495027706
. O 0 0.00027446565218269825

Genetic O 0 0.0029466876294463873
heterogeneity O 0 0.004726221784949303
of O 0 8.038564556045458e-05
Saethre B-Disease 1 0.9998608827590942
- I-Disease 1 0.9988935589790344
Chotzen I-Disease 1 0.9999679327011108
syndrome I-Disease 1 1.0
, O 0 0.00030585270724259317
due O 0 0.0008026069845072925
to O 0 0.00011824821558548138
TWIST O 0 0.021981874480843544
and O 0 0.000547825067769736
FGFR O 1 0.9985896944999695
mutations O 0 0.0034980771597474813
. O 0 0.00033116142731159925

Thirty O 0 0.009094731882214546
- O 0 0.0033385201822966337
two O 0 8.010793681023642e-05
unrelated O 0 0.0166554544121027
patients O 1 0.9999008178710938
with O 0 2.0894874978694133e-05
features O 0 5.878339288756251e-05
of O 0 4.194732537143864e-05
Saethre B-Disease 1 0.9999819993972778
- I-Disease 1 0.9985201954841614
Chotzen I-Disease 1 0.9999353885650635
syndrome I-Disease 1 1.0
, O 0 0.00018173943681176752
a O 0 0.00034846473135985434
common O 0 0.0034930328838527203
autosomal B-Disease 1 0.9991918206214905
dominant I-Disease 1 0.6774552464485168
condition I-Disease 1 0.9999203681945801
of O 0 0.0002404146798653528
craniosynostosis B-Disease 1 0.9999997615814209
and O 0 0.007849707268178463
limb B-Disease 1 0.9999991655349731
anomalies I-Disease 1 0.994699239730835
, O 0 0.00016902980860322714
were O 0 2.323983244423289e-05
screened O 0 0.0012041280278936028
for O 0 9.011421207105741e-05
mutations O 0 0.0008678569574840367
in O 0 0.00021367026783991605
TWIST O 0 0.04059114679694176
, O 0 0.0008764416561461985
FGFR2 O 1 0.9983634352684021
, O 0 0.0003683711402118206
and O 0 0.0004028573748655617
FGFR3 O 1 0.998782217502594
. O 0 0.0007989758159965277

Nine O 0 0.001201227423734963
novel O 0 0.0009856442920863628
and O 0 8.964513835962862e-05
three O 0 0.00023258058354258537
recurrent O 1 0.9997153878211975
TWIST O 0 0.22103942930698395
mutations O 0 0.0018832872156053782
were O 0 2.64514128502924e-05
found O 0 0.00011784680100390688
in O 0 7.365459168795496e-05
12 O 0 0.00046907083014957607
families O 0 0.00018166356312576681
. O 0 0.00026696769054979086

Seven O 0 0.0008627584902569652
families O 0 0.00017033253971021622
were O 0 2.1357391233323142e-05
found O 0 8.570796489948407e-05
to O 0 2.0321671399869956e-05
have O 0 2.4882276193238795e-05
the O 0 0.0002483754651620984
FGFR3 O 1 0.9988942742347717
P250R O 0 0.2070751041173935
mutation O 0 0.0020283423364162445
, O 0 9.029656939674169e-05
and O 0 4.536493361229077e-05
one O 0 5.999933637212962e-05
individual O 0 0.00017983840371016413
was O 0 0.0009055565460585058
found O 0 0.00010671860218280926
to O 0 1.846216036938131e-05
have O 0 1.6391642930102535e-05
an O 0 0.0002532418293412775
FGFR2 O 1 0.9976420402526855
VV269 O 0 0.11631200462579727
- O 0 0.0063733262941241264
270 O 0 0.008511294610798359
deletion O 0 0.008095893077552319
. O 0 0.0004086698463652283

To O 0 0.00029421396902762353
date O 0 0.00016429931565653533
, O 0 2.924514228652697e-05
our O 0 0.00013466106611303985
detection O 0 0.003307539504021406
rate O 0 0.0001184365464723669
for O 0 0.00019450541003607213
TWIST O 0 0.047126222401857376
or O 0 0.0020547453314065933
FGFR O 1 0.9974557757377625
mutations O 0 0.002183938166126609
is O 0 0.0002567015471868217
68 O 0 0.0012343927519395947
% O 0 1.1939668183913454e-05
in O 0 3.454364195931703e-05
our O 0 0.0007322286837734282
Saethre B-Disease 1 0.999848484992981
- I-Disease 1 0.9994125366210938
Chotzen I-Disease 1 0.9999951124191284
syndrome I-Disease 1 1.0
patients O 1 0.9999979734420776
, O 0 9.498796862317249e-05
including O 0 1.860035990830511e-05
our O 0 0.00036869593895971775
five O 0 0.0005240246537141502
patients O 1 0.999997615814209
elsewhere O 0 0.0010705165332183242
reported O 0 0.0011336618335917592
with O 0 7.160313543863595e-05
TWIST O 0 0.05897826701402664
mutations O 0 0.0031653980258852243
. O 0 0.0003707076539285481

More O 0 0.00011360046482877806
than O 0 5.7095010561170056e-05
35 O 0 0.0003287691215518862
different O 0 2.079330079141073e-05
TWIST O 0 0.030138803645968437
mutations O 0 0.0017484081909060478
are O 0 2.6258439902449027e-05
now O 0 0.0004636708472389728
known O 0 0.0002545065653976053
in O 0 3.936585198971443e-05
the O 0 6.845654570497572e-05
literature O 0 0.00041308702202513814
. O 0 0.00032920483499765396

The O 0 0.00039544791798107326
most O 0 0.0002729094121605158
common O 0 0.0023564849980175495
phenotypic O 0 0.028004560619592667
features O 0 0.0008706855587661266
, O 0 0.00018672946316655725
present O 0 9.157491149380803e-05
in O 0 4.889507181360386e-05
more O 0 2.157911512767896e-05
than O 0 2.5787776394281536e-05
a O 0 0.00010251332423649728
third O 0 7.516558252973482e-05
of O 0 1.1351294233463705e-05
our O 0 0.002225586213171482
patients O 1 0.9999802112579346
with O 0 0.00012980413157492876
TWIST O 0 0.11703663319349289
mutations O 0 0.0018301524687558413
, O 0 8.902657282305881e-05
are O 0 3.393233782844618e-05
coronal B-Disease 1 0.9332510232925415
synostosis I-Disease 1 0.5035586953163147
, O 0 0.00025881821056827903
brachycephaly B-Disease 0 0.18963056802749634
, O 0 0.00025356991682201624
low B-Disease 0 0.023052111268043518
frontal I-Disease 1 0.9999986886978149
hairline I-Disease 1 1.0
, O 0 0.002857212908565998
facial B-Disease 1 0.9999985694885254
asymmetry I-Disease 1 0.9971899390220642
, O 0 0.0031069547403603792
ptosis B-Disease 1 0.9999994039535522
, O 0 0.0025191432796418667
hypertelorism B-Disease 1 0.9998548030853271
, O 0 0.0005613979301415384
broad B-Disease 0 0.01507131103426218
great I-Disease 0 0.004242205526679754
toes I-Disease 1 0.9980954527854919
, O 0 0.00034400977892801166
and O 0 0.00027275309548713267
clinodactyly B-Disease 1 0.9099721312522888
. O 0 0.0005006039864383638

Significant O 0 0.0025992512237280607
intra O 0 0.18834932148456573
- O 0 0.00989463459700346
and O 0 0.0002530171477701515
interfamilial O 1 0.5342580676078796
phenotypic O 0 0.01681586168706417
variability O 0 0.004976989235728979
is O 0 0.00016402961045969278
present O 0 5.6668766774237156e-05
for O 0 9.491924720350653e-05
either O 0 0.00045518160914070904
TWIST O 0 0.046564098447561264
mutations O 0 0.003413825063034892
or O 0 0.0011982157593593001
FGFR O 1 0.9987026453018188
mutations O 0 0.003980584908276796
. O 0 0.00032131155603565276

The O 0 0.0005893074558116496
overlap O 0 0.003107830649241805
in O 0 0.0004924972890876234
clinical O 1 0.9998852014541626
features O 0 0.0003167985414620489
and O 0 7.249604095704854e-05
the O 0 0.00014310871483758092
presence O 0 0.0007177677471190691
, O 0 0.00010334386024624109
in O 0 5.173181853024289e-05
the O 0 6.5312058723066e-05
same O 0 6.947524525457993e-05
genes O 0 0.00014495399955194443
, O 0 4.054072269354947e-05
of O 0 1.1499541869852692e-05
mutations O 0 0.000626281020231545
for O 0 3.1662922992836684e-05
more O 0 1.2812486602342688e-05
than O 0 5.0312664825469255e-05
one O 0 0.00032571086194366217
craniosynostotic B-Disease 1 0.995208203792572
condition I-Disease 1 0.9986096620559692
- O 0 0.0011971904896199703
such O 0 1.2656239960051607e-05
as O 0 0.00044037066982127726
Saethre B-Disease 1 0.9946065545082092
- I-Disease 0 0.012360955588519573
Chotzen I-Disease 1 0.7115315198898315
, I-Disease 0 0.00040349754272028804
Crouzon I-Disease 1 0.9768241047859192
, I-Disease 0 0.0003658832283690572
and I-Disease 0 0.0012020927388221025
Pfeiffer I-Disease 1 0.9999983310699463
syndromes I-Disease 1 0.9999850988388062
- O 0 0.004250314552336931
support O 0 0.00018530557281337678
the O 0 8.675324352225289e-05
hypothesis O 0 0.0018316017230972648
that O 0 0.00010300286521669477
TWIST O 0 0.033239126205444336
and O 0 0.0004930110881105065
FGFRs O 1 0.681194543838501
are O 0 1.1939053365495056e-05
components O 0 0.00022401531168725342
of O 0 5.408574452303583e-06
the O 0 6.106397631810978e-05
same O 0 0.00013615729403682053
molecular O 0 0.004082484170794487
pathway O 0 0.004360727034509182
involved O 0 0.0003102884511463344
in O 0 2.532192593207583e-05
the O 0 4.1519182559568435e-05
modulation O 0 0.002720309654250741
of O 0 0.0001828989334171638
craniofacial O 1 1.0
and O 0 0.002515906235203147
limb O 1 0.9999910593032837
development O 0 0.0018390686018392444
in O 0 0.00015032038209028542
humans O 0 0.0013241872657090425
. O 0 0.00011894053022842854
. O 0 0.0002456234360579401

Mutation O 0 0.0015318532241508365
analysis O 0 9.272922034142539e-05
of O 0 6.536488945130259e-05
UBE3A O 1 0.9999860525131226
in O 0 0.19751738011837006
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.0007116499473340809

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.004683977924287319
AS B-Disease 0 0.1962713599205017
) O 0 0.00023341453925240785
is O 0 0.00020420625514816493
caused O 0 0.002349283080548048
by O 0 5.8960518799722195e-05
chromosome O 0 0.004767647944390774
15q11 O 0 0.3675861060619354
- O 0 0.010325852781534195
q13 O 0 0.020255882292985916
deletions O 0 0.0008439842495135963
of O 0 1.1954320143559016e-05
maternal O 0 0.006051515694707632
origin O 0 4.2240728362230584e-05
, O 0 7.018965698080137e-05
by O 0 5.972811413812451e-05
paternal O 0 0.0948692336678505
uniparental B-Disease 1 0.9999837875366211
disomy I-Disease 1 0.9991025924682617
( O 0 0.006950680166482925
UPD B-Disease 1 0.9999914169311523
) O 0 0.0005468970048241317
15 O 0 0.0003191311552654952
, O 0 6.596408638870344e-05
by O 0 0.00011083606659667566
imprinting O 1 0.9984368681907654
defects O 1 0.9999843835830688
, O 0 0.000295454723527655
and O 0 6.816886889282614e-05
by O 0 3.360006303410046e-05
mutations O 0 0.0006535812863148749
in O 0 8.240014722105116e-05
the O 0 0.0005132437217980623
UBE3A O 1 0.9997215867042542
gene O 0 0.004433670546859503
. O 0 0.00031394732650369406

UBE3A O 1 0.9079769253730774
encodes O 0 0.0012592682614922523
a O 0 0.00035502377431839705
ubiquitin O 0 0.007633665576577187
- O 0 0.0010588252916932106
protein O 0 0.0002524792798794806
ligase O 0 0.003530102549120784
and O 0 8.467939187539741e-05
shows O 0 0.0009248859714716673
brain O 1 0.9999008178710938
- O 0 0.0032247030176222324
specific O 0 0.00021640410705003887
imprinting O 0 0.0420355424284935
. O 0 0.0005189540097489953

Here O 0 0.0005221519386395812
we O 0 0.00016804292681626976
describe O 0 0.005080354865640402
UBE3A O 1 0.9980879426002502
coding O 0 0.03755329176783562
- O 0 0.006713859271258116
region O 0 0.0017752285348251462
mutations O 0 0.0015489041106775403
detected O 0 0.003385465359315276
by O 0 6.69656801619567e-05
SSCP O 1 0.9341530799865723
analysis O 0 0.00031711309566162527
in O 0 0.00018024389282800257
13 O 0 0.001469197915866971
AS B-Disease 0 0.006192879285663366
individuals O 0 0.0001880983036244288
or O 0 0.00030636164592579007
families O 0 0.00026065122801810503
. O 0 0.00035267474595457315

Two O 0 0.00011857158096972853
identical O 0 0.000589482020586729
de O 0 0.0040121981874108315
novo O 0 0.0202014297246933
5 O 0 0.001449750503525138
- O 0 0.005624264013022184
bp O 0 0.03387828543782234
duplications O 0 0.008775109425187111
in O 0 0.00022418239677790552
exon O 0 0.020072434097528458
16 O 0 0.0004664392617996782
were O 0 2.2871816327096894e-05
found O 0 0.0002008669835049659
. O 0 0.00023606758622918278

Among O 0 0.00021157244918867946
the O 0 7.153680053306744e-05
other O 0 2.877034421544522e-05
11 O 0 0.000567925104405731
unique O 0 0.000663595215883106
mutations O 0 0.002352026291191578
, O 0 0.00017147765902336687
8 O 0 0.0003126191149931401
were O 0 1.2308640179981012e-05
small O 0 0.00011844615073641762
deletions O 0 0.002725126687437296
or O 0 0.00039473228389397264
insertions O 0 0.0081275450065732
predicted O 0 0.0021534122060984373
to O 0 0.00013955899339634925
cause O 0 0.03224236145615578
frameshifts O 1 0.9354405403137207
, O 0 0.0002900490944739431
1 O 0 0.0007023380021564662
was O 0 0.00037709681782871485
a O 0 0.00020206796762067825
mutation O 0 0.00038960238453000784
to O 0 2.6864825485972688e-05
a O 0 0.00023535832588095218
stop O 0 0.0018678255146369338
codon O 0 0.002572162076830864
, O 0 0.0001084495524992235
1 O 0 0.0004484072851482779
was O 0 0.00038538462831638753
a O 0 0.0004962087259627879
missense O 0 0.015774134546518326
mutation O 0 0.0021251775324344635
, O 0 0.0001555278868181631
and O 0 0.0001306950143771246
1 O 0 0.0011764700757339597
was O 0 0.0008457119110971689
predicted O 0 0.00108303502202034
to O 0 5.570136636379175e-05
cause O 0 0.0028678837697952986
insertion O 0 0.003342417534440756
of O 0 1.3080382814223412e-05
an O 0 0.0005268528475426137
isoleucine O 1 0.9670050144195557
in O 0 0.00018728832947090268
the O 0 0.00022580116637982428
hect O 0 0.035001982003450394
domain O 0 0.00015521618479397148
of O 0 9.538712220091838e-06
the O 0 0.0005475347861647606
UBE3A O 1 0.9911665320396423
protein O 0 0.000997797236777842
, O 0 8.457423973595724e-05
which O 0 1.1573717529245187e-05
functions O 0 8.279315807158127e-05
in O 0 0.00018037250265479088
E2 O 0 0.1965535581111908
binding O 0 0.000539814995136112
and O 0 9.253806638298556e-05
ubiquitin O 0 0.00849169585853815
transfer O 0 0.0007927400874905288
. O 0 0.00035070141893811524

Eight O 0 0.00023063775734044611
of O 0 1.0932251825579442e-05
the O 0 0.00020473224867600948
cases O 0 0.001656621228903532
were O 0 0.0001343823387287557
familial O 1 0.9991784691810608
, O 0 0.0002597261918708682
and O 0 7.334801921388134e-05
five O 0 6.141647463664412e-05
were O 0 2.6107825760846026e-05
sporadic O 0 0.004970822483301163
. O 0 0.00036763580283150077

In O 0 0.0003957028384320438
two O 0 0.0001182898340630345
familial O 1 0.9997574687004089
cases O 0 0.0030138532165437937
and O 0 8.58432540553622e-05
one O 0 0.00012847763719037175
sporadic O 0 0.00572736281901598
case O 0 0.0015793872298672795
, O 0 0.0003299686359241605
mosaicism O 1 0.9944981932640076
for O 0 0.0008950363844633102
UBE3A O 1 0.9993140697479248
mutations O 0 0.004351526498794556
was O 0 0.0011886076536029577
detected O 0 0.0033123313914984465
in O 0 6.365432636812329e-05
the O 0 0.0001170049945358187
mother O 0 0.001152124721556902
of O 0 1.3578201105701737e-05
three O 0 0.00022629214799962938
AS B-Disease 0 0.20020827651023865
sons O 0 0.006992687936872244
, O 0 0.00010511696746107191
in O 0 6.585528899449855e-05
the O 0 0.00020320831390563399
maternal O 0 0.02233906090259552
grandfather O 0 0.003409326309338212
of O 0 1.6851588952704333e-05
two O 0 7.096497574821115e-05
AS B-Disease 0 0.010552516207098961
first O 0 0.00034498897730372846
cousins O 0 0.003996056970208883
, O 0 0.00016522291116416454
and O 0 5.804132160847075e-05
in O 0 8.607243944425136e-05
the O 0 0.0001422052300767973
mother O 0 0.0009169914410449564
of O 0 9.208668416249566e-06
an O 0 0.0004773392283823341
AS B-Disease 1 0.9434977173805237
daughter O 0 0.03985520079731941
. O 0 0.00036370151792652905

The O 0 0.00019711170170921832
frequencies O 0 8.571899525122717e-05
with O 0 3.0154351406963542e-05
which O 0 3.0044875529711135e-05
we O 0 0.0001529923902126029
detected O 0 0.0030141135212033987
mutations O 0 0.00041476244223304093
were O 0 3.20860453939531e-05
5 O 0 0.0006437505944631994
( O 0 0.00037614753819070756
14 O 0 0.0005535420496016741
% O 0 3.633109372458421e-05
) O 0 4.026243186672218e-05
of O 0 8.664272172609344e-06
35 O 0 0.0006882445886731148
in O 0 0.00013439168105833232
sporadic O 0 0.007025087717920542
cases O 0 0.001707803108729422
and O 0 0.0001897197653306648
8 O 0 0.001479758066125214
( O 0 0.0003968384116888046
80 O 0 0.0008885072893463075
% O 0 3.9889771869638935e-05
) O 0 3.4186752600362524e-05
of O 0 7.343758170463843e-06
10 O 0 0.0002447773877065629
in O 0 0.00028193299658596516
familial O 1 0.999921441078186
cases O 0 0.00620606355369091
. O 0 0.00020000927906949073
. O 0 0.00034860693267546594

The O 0 0.004963040351867676
hemochromatosis B-Disease 1 0.9999991655349731
845 O 1 0.9929372668266296
G O 1 0.8273745775222778
- O 0 0.013296740129590034
- O 0 0.004834972321987152
> O 0 0.003921824973076582
A O 0 0.0009115981520153582
and O 0 0.00011056392395403236
187 O 0 0.01042619626969099
C O 0 0.0842316746711731
- O 0 0.008458966389298439
- O 0 0.006627712864428759
> O 0 0.01432618498802185
G O 0 0.02731381729245186
mutations O 0 0.0018207081593573093
: O 0 0.000405741244321689
prevalence O 1 0.8155043721199036
in O 0 0.00020170857897028327
non O 0 0.0061757867224514484
- O 0 0.016822222620248795
Caucasian O 0 0.10323107242584229
populations O 0 0.0009569752146489918
. O 0 0.0003885673067998141

Hemochromatosis B-Disease 1 0.9999986886978149
, O 0 0.0008494503563269973
the O 0 0.0010570177109912038
inherited B-Disease 1 0.9999992847442627
disorder I-Disease 1 1.0
of I-Disease 0 0.0001300273579545319
iron I-Disease 1 0.9999257326126099
metabolism I-Disease 1 0.998877227306366
, O 0 0.00031860521994531155
leads O 0 0.0019936594180762768
, O 0 0.00020327806123532355
if O 0 0.001102559152059257
untreated O 1 0.9999761581420898
, O 0 6.175999442348257e-05
to O 0 7.515949255321175e-05
progressive O 1 0.9933806657791138
iron B-Disease 1 0.9999451637268066
overload I-Disease 1 0.9998801946640015
and O 0 0.0007584503036923707
premature B-Disease 1 0.9996155500411987
death I-Disease 0 0.004959846381098032
. O 0 0.00031911596306599677

The O 0 0.00452703470364213
hemochromatosis B-Disease 1 0.9999998807907104
gene O 0 0.009612058289349079
, O 0 0.0012872325023636222
HFE O 1 0.9999456405639648
, O 0 0.000849579053465277
recently O 0 0.004738183692097664
has O 0 0.0004306161717977375
been O 0 0.00027658240287564695
identified O 0 0.0005409267614595592
, O 0 8.59054853208363e-05
and O 0 7.133495819289237e-05
characterization O 0 0.005068626254796982
of O 0 1.0655062396836001e-05
this O 0 6.936403224244714e-05
gene O 0 0.001359789283014834
has O 0 0.00024726183619350195
shown O 0 0.00021426942839752883
that O 0 1.3325080544746015e-05
it O 0 1.8649399862624705e-05
contains O 0 2.743823097262066e-05
two O 0 2.076860619126819e-05
mutations O 0 0.00056017393944785
that O 0 1.8527915017330088e-05
result O 0 0.00011128296318929642
in O 0 3.013081004610285e-05
amino O 0 0.00013944273814558983
acid O 0 0.0033635820727795362
substitutions O 0 0.0008424600819125772
- O 0 0.0013943205121904612
cDNA O 0 0.001718492479994893
nucleotides O 0 0.0020473813638091087
845 O 0 0.14054308831691742
G O 0 0.05945304408669472
- O 0 0.008134000934660435
- O 0 0.00421054707840085
> O 0 0.006408188957720995
A O 0 0.002720683580264449
( O 0 0.0005959804984740913
C282Y O 0 0.0329112745821476
) O 0 9.243064414476976e-05
and O 0 7.872256537666544e-05
187 O 0 0.008655163459479809
C O 0 0.048473458737134933
- O 0 0.00818958692252636
- O 0 0.00626721978187561
> O 0 0.013871433213353157
G O 0 0.03618170693516731
( O 0 0.001334449858404696
H63D O 1 0.9937397241592407
) O 0 0.00038706709165126085
. O 0 0.00024000974372029305

Although O 0 0.009431117214262486
hemochromatosis B-Disease 1 0.9999997615814209
is O 0 0.0009326034924015403
common O 0 0.0010104746324941516
in O 0 0.0002885409921873361
Caucasians O 1 0.9674482941627502
, O 0 0.00028050606488250196
affecting O 0 0.023568131029605865
> O 0 0.04626603052020073
= O 0 0.012038696557283401
1 O 0 0.005825452506542206
/ O 0 0.025258691981434822
300 O 0 0.0005773059674538672
individuals O 0 3.7697154766647145e-05
of O 0 1.2660271750064567e-05
northern O 0 0.0008157102856785059
European O 0 0.0004252446233294904
origin O 0 7.16919603291899e-05
, O 0 0.00012959932792000473
it O 0 0.00010444692452438176
has O 0 0.00027101481100544333
not O 0 6.452461093431339e-05
been O 0 0.00010526782716624439
recognized O 0 0.0005063247517682612
in O 0 3.6769401049241424e-05
other O 0 2.2093114239396527e-05
populations O 0 0.0004471478459890932
. O 0 0.0003300161624792963

The O 0 0.0003481479361653328
present O 0 0.0001396035950165242
study O 0 0.0003622977528721094
used O 0 0.00010258900874760002
PCR O 0 0.004469158593565226
and O 0 7.343858305830508e-05
restriction O 0 0.0008292272104881704
- O 0 0.003736646380275488
enzyme O 0 0.0019471768755465746
digestion O 0 0.012947526760399342
to O 0 6.0415364714572206e-05
analyze O 0 0.0007971943123266101
the O 0 1.9450912077445537e-05
frequency O 0 3.0637820600531995e-05
of O 0 7.111892955435906e-06
the O 0 0.00041031779255717993
845 O 1 0.9521061182022095
G O 0 0.13476218283176422
- O 0 0.008313034661114216
- O 0 0.0032936602365225554
> O 0 0.003556494601070881
A O 0 0.0006931927055120468
and O 0 0.00011256583093199879
187 O 0 0.009318412281572819
C O 0 0.0662585124373436
- O 0 0.007428970653563738
- O 0 0.004347080830484629
> O 0 0.01049046777188778
G O 0 0.015057175420224667
mutations O 0 0.0011782388901337981
in O 0 0.00038674616371281445
HLA O 1 0.9995263814926147
- O 0 0.003255255054682493
typed O 0 0.0008941132691688836
samples O 0 0.00017447560094296932
from O 0 7.229266338981688e-05
non O 0 0.004852763842791319
- O 0 0.011361525394022465
Caucasian O 0 0.03671499714255333
populations O 0 0.00032603516592644155
, O 0 7.892566645750776e-05
comprising O 0 0.00030745830736123025
Australian O 0 0.005744031630456448
Aboriginal O 0 0.010859085246920586
, O 0 0.00023285415954887867
Chinese O 0 0.00034444397897459567
, O 0 0.00017100822879001498
and O 0 0.00017753661086317152
Pacific O 0 0.0075345332734286785
Islanders O 0 0.009479694999754429
. O 0 0.0003964049101341516

Results O 0 0.001440723310224712
showed O 0 0.0004025308880954981
that O 0 1.40320244099712e-05
the O 0 0.00014448328875005245
845 O 1 0.891441285610199
G O 0 0.3688304126262665
- O 0 0.010859818197786808
- O 0 0.005018182564526796
> O 0 0.005221220199018717
A O 0 0.001865506754256785
mutation O 0 0.0023545988369733095
was O 0 0.0005748075200244784
present O 0 7.747180643491447e-05
in O 0 4.458670809981413e-05
these O 0 1.3507967196346726e-05
populations O 0 0.0003296690119896084
( O 0 0.00023900727683212608
allele O 0 0.0015252509620040655
frequency O 0 0.0003385682648513466
0 O 0 0.0008277201559394598
. O 0 7.29752573533915e-05
32 O 0 0.00046060740714892745
% O 0 6.532046245411038e-05
) O 0 0.00017764398944564164
, O 0 0.000140991949592717
and O 0 0.00013212524936534464
, O 0 0.00021888221090193838
furthermore O 0 0.0021514699328690767
, O 0 0.00014005826960783452
it O 0 0.00011520483531057835
was O 0 0.0006556681473739445
always O 0 0.0004010329721495509
seen O 0 0.0004928800044581294
in O 0 8.18417829577811e-05
conjunction O 0 0.003528484608978033
with O 0 0.0005602075252681971
HLA O 1 0.9998183846473694
haplotypes O 0 0.01898856833577156
common O 0 0.0013141562230885029
in O 0 0.000293922406854108
Caucasians O 1 0.8938419222831726
, O 0 0.00013232420315034688
suggesting O 0 0.001408421783708036
that O 0 8.590581273892894e-05
845 O 1 0.8818995356559753
G O 0 0.38209792971611023
- O 0 0.012064379639923573
- O 0 0.00795473251491785
> O 0 0.009966420009732246
A O 0 0.003779685590416193
may O 0 0.0009394801454618573
have O 0 4.0972376154968515e-05
been O 0 9.434342791792005e-05
introduced O 0 6.207937985891476e-05
into O 0 1.8229975466965698e-05
these O 0 5.984014023852069e-06
populations O 0 0.0001226559979841113
by O 0 6.083033076720312e-05
Caucasian O 1 0.9715847373008728
admixture O 0 0.30550941824913025
. O 0 0.0012209824053570628

187 O 0 0.03148240968585014
C O 0 0.09361246228218079
- O 0 0.01109964121133089
- O 0 0.007881298661231995
> O 0 0.017739705741405487
G O 0 0.024714134633541107
was O 0 0.0007952307350933552
present O 0 9.93092471617274e-05
at O 0 0.0002556869003456086
an O 0 9.03566979104653e-05
allele O 0 0.0010620347457006574
frequency O 0 8.71058800839819e-05
of O 0 1.9498957044561394e-05
2 O 0 0.00132943713106215
. O 0 0.0003567797539290041

68 O 0 0.009403773583471775
% O 0 4.887465183855966e-05
in O 0 3.8185320590855554e-05
the O 0 4.626285590347834e-05
two O 0 2.0760169718414545e-05
populations O 0 0.00027663673972710967
analyzed O 0 0.0028095757588744164
( O 0 0.000556066632270813
Australian O 0 0.0034151426516473293
Aboriginal O 0 0.005894135683774948
and O 0 9.260470687877387e-05
Chinese O 0 0.00042778413626365364
) O 0 0.00024231136194430292
. O 0 0.00026273357798345387

In O 0 0.0002534089726395905
the O 0 0.0001525006809970364
Australian O 0 0.0024426451418548822
Aboriginal O 0 0.003647903213277459
samples O 0 0.00031811173539608717
, O 0 0.0001424637739546597
187 O 0 0.008528138510882854
C O 0 0.06821157783269882
- O 0 0.008069269359111786
- O 0 0.006830517202615738
> O 0 0.013490360230207443
G O 0 0.021386533975601196
was O 0 0.0006853181985206902
found O 0 7.833712879801169e-05
to O 0 1.921646253322251e-05
be O 0 3.4274504287168384e-05
associated O 0 0.0001579938834765926
with O 0 0.0002461556578055024
HLA O 1 0.9999135732650757
haplotypes O 0 0.024085475131869316
common O 0 0.0020831094589084387
in O 0 0.0006889808573760092
Caucasians O 1 0.9869763255119324
, O 0 0.0003163762448821217
suggesting O 0 0.0019270784687250853
that O 0 3.598514376790263e-05
it O 0 4.85318923892919e-05
was O 0 0.0003041739109903574
introduced O 0 0.00011290735710645095
by O 0 1.8902961528510787e-05
recent O 0 0.0007856879965402186
admixture O 0 0.045709386467933655
. O 0 0.0008100052364170551

In O 0 0.00016719136328902096
the O 0 5.4125135648064315e-05
Chinese O 0 0.00011081544653279707
samples O 0 0.00016400143795181066
analyzed O 0 0.0008175377151928842
, O 0 0.00014959271356929094
187 O 0 0.0074472445994615555
C O 0 0.059331513941287994
- O 0 0.009282617829740047
- O 0 0.006478318013250828
> O 0 0.014969133771955967
G O 0 0.0206356979906559
was O 0 0.0007322978344745934
present O 0 0.00012991334369871765
in O 0 0.00016113842139020562
association O 0 0.004493087064474821
with O 0 4.2480962292756885e-05
a O 0 0.00026682286988943815
wide O 0 0.0005668144440278411
variety O 0 0.00033125237678177655
of O 0 0.00016609751037321985
HLA O 1 0.9999790191650391
haplotypes O 0 0.03342711180448532
, O 0 0.00015830349002499133
showing O 0 0.0007051047869026661
this O 0 3.8989997847238556e-05
mutation O 0 0.0005336915492080152
to O 0 2.9871829610783607e-05
be O 0 4.216494198772125e-05
widespread O 0 0.0006130405236035585
and O 0 0.00016663673159200698
likely O 0 0.0010430595139041543
to O 0 8.996824180940166e-05
predate O 0 0.009732409380376339
the O 0 3.063410986214876e-05
more O 0 2.325759305676911e-05
genetically O 0 0.0005348766571842134
restricted O 0 0.001806941581889987
845 O 1 0.7476438879966736
G O 0 0.19291141629219055
- O 0 0.010699520818889141
- O 0 0.004615443758666515
> O 0 0.005077995825558901
A O 0 0.0016534547321498394
mutation O 0 0.0021635896991938353
. O 0 0.00024693721206858754

Genotype O 1 0.8267897367477417
- O 0 0.01510948222130537
phenotype O 0 0.016471227630972862
correlations O 0 0.002648914000019431
in O 0 0.0007155535276979208
attenuated B-Disease 1 0.9999648332595825
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.999995231628418
. O 0 0.0015278791543096304

Germ O 1 0.9996458292007446
- O 0 0.009824343025684357
line O 0 0.0008300944464281201
mutations O 0 0.00015399303811136633
of O 0 6.100513019191567e-06
the O 0 0.0005805203691124916
tumor B-Disease 1 0.9999973773956299
suppressor O 1 0.8978303074836731
APC O 1 0.9891862273216248
are O 0 5.565235551330261e-05
implicated O 0 0.04069188982248306
in O 0 0.0005752759170718491
attenuated B-Disease 1 0.999954104423523
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999986886978149
( O 0 0.012111174874007702
AAPC B-Disease 1 0.999991774559021
) O 0 0.00033969240030273795
, O 0 5.144868919160217e-05
a O 0 0.00018879403069149703
variant O 0 0.00741915637627244
of O 0 0.0002547184703871608
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.05224126577377319
FAP B-Disease 1 0.9999860525131226
) O 0 0.0009358403622172773
. O 0 0.00033643312053754926

AAPC B-Disease 1 0.9999353885650635
is O 0 0.0010918581392616034
recognized O 0 0.0006521514151245356
by O 0 1.2365325346763711e-05
the O 0 7.346709753619507e-05
occurrence O 0 0.0026244744658470154
of O 0 3.417459811316803e-05
< O 0 0.06182684749364853
100 O 0 0.002431444823741913
colonic B-Disease 1 0.9998987913131714
adenomas I-Disease 1 0.9995834231376648
and O 0 6.017915075062774e-05
a O 0 0.00022401231399271637
later O 0 0.0004370981187094003
onset O 1 0.9999091625213623
of O 0 0.0013976802583783865
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.001392259495332837
age O 0 0.0015463399467989802
> O 0 0.010255713015794754
40 O 0 0.0004956573247909546
years O 0 0.0005470231408253312
) O 0 0.0001604304270585999
. O 0 0.0001842186029534787

The O 0 0.0004737549461424351
aim O 0 0.0016309989150613546
of O 0 8.159463504853193e-06
this O 0 3.535189898684621e-05
study O 0 0.00057290552649647
was O 0 0.0003686915442813188
to O 0 6.040614243829623e-05
assess O 0 0.023553641512989998
genotype O 0 0.15608012676239014
- O 0 0.012889895588159561
phenotype O 0 0.036127883940935135
correlations O 0 0.005478511098772287
in O 0 0.0013266473542898893
AAPC B-Disease 1 0.9999892711639404
families O 0 0.0008661426836624742
. O 0 0.00036764174001291394

By O 0 8.433520997641608e-05
protein O 0 0.0006306935101747513
- O 0 0.0037164080422371626
truncation O 0 0.02787606418132782
test O 0 0.004929101560264826
( O 0 0.0010750674409791827
PTT O 1 0.7363103628158569
) O 0 0.0003324558783788234
assay O 0 0.003377557499334216
, O 0 9.500100713921711e-05
the O 0 9.37689546844922e-05
entire O 0 0.002489713253453374
coding O 0 0.0069870115257799625
region O 0 0.0004851990379393101
of O 0 1.1002526662196033e-05
the O 0 0.00042368657886981964
APC B-Disease 1 0.9974168539047241
gene O 0 0.0033987711649388075
was O 0 0.00114721292629838
screened O 0 0.002285852562636137
in O 0 0.00010683467553462833
affected O 0 0.0017524358117952943
individuals O 0 0.00014777787146158516
from O 0 0.00025445924256928265
11 O 0 0.009924575686454773
AAPC B-Disease 1 0.9999860525131226
kindreds O 1 0.941356360912323
, O 0 0.0002782961819320917
and O 0 4.42546843260061e-05
their O 0 3.169364936184138e-05
phenotypic O 0 0.00967016164213419
differences O 0 0.0012267569545656443
were O 0 0.00011285988875897601
examined O 0 0.02546541951596737
. O 0 0.0003546446969266981

Five O 0 0.0006766019505448639
novel O 0 0.004208072554320097
germ O 1 0.9994101524353027
- O 0 0.014424662105739117
line O 0 0.005643427837640047
APC B-Disease 1 0.9791765213012695
mutations O 0 0.0013791988603770733
were O 0 2.5081639250856824e-05
identified O 0 0.000256584316957742
in O 0 6.123290222603828e-05
seven O 0 0.00034124424564652145
kindreds O 0 0.10741877555847168
. O 0 0.0006034004618413746

Mutations O 0 0.00589943490922451
were O 0 7.675023516640067e-05
located O 0 0.0007133529870770872
in O 0 4.467029430088587e-05
three O 0 1.2261916708666831e-05
different O 0 2.810405703712604e-06
regions O 0 5.1240935135865584e-05
of O 0 7.138475211831974e-06
the O 0 0.0004983280668966472
APC B-Disease 1 0.9944838881492615
gene O 0 0.003968783188611269
( O 0 0.0004817126027774066
1 O 0 0.0013849112438037992
) O 0 0.00011576557153603062
at O 0 0.00029131950577721
the O 0 0.00014100807311479002
5 O 0 0.0006448125932365656
end O 0 0.0009698415524326265
spanning O 0 0.0028230715543031693
exons O 0 0.00530181685462594
4 O 0 0.0007009713444858789
and O 0 0.00011838698264909908
5 O 0 0.0006756579387001693
, O 0 0.00022267735039349645
( O 0 0.00034931086702272296
2 O 0 0.0006414588424377143
) O 0 6.159606709843501e-05
within O 0 9.098380542127416e-05
exon O 0 0.023701969534158707
9 O 0 0.0017237786669284105
, O 0 0.00018262988305650651
and O 0 0.0001826713269110769
( O 0 0.0006350126932375133
3 O 0 0.001018877956084907
) O 0 0.0001306041667703539
at O 0 0.00034040387254208326
the O 0 0.00020222485181875527
3 O 0 0.0016728522023186088
distal O 1 0.9751707315444946
end O 0 0.0007129329023882747
of O 0 6.876145107526099e-06
the O 0 0.00017457612557336688
gene O 0 0.002267588395625353
. O 0 0.00030824841815046966

Variability O 0 0.006702113430947065
in O 0 4.063722008140758e-05
the O 0 1.9516202883096412e-05
number O 0 1.74222732312046e-05
of O 0 0.00034146770485676825
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
was O 0 0.0028534047305583954
most O 0 0.00019063059880863875
apparent O 0 0.0038520540110766888
in O 0 8.210341911762953e-05
individuals O 0 6.376307283062488e-05
with O 0 7.491034921258688e-05
mutations O 0 0.0012974926503375173
in O 0 0.00012526009231805801
region O 0 0.0010853806743398309
1 O 0 0.0005510944174602628
, O 0 9.650721040088683e-05
and O 0 0.00023867364507168531
upper O 1 0.9999175071716309
- O 1 0.9994401335716248
gastrointestinal O 1 0.9999998807907104
manifestations O 1 0.9918163418769836
were O 0 4.7146746510406956e-05
more O 0 0.00014989297778811306
severe O 1 0.9998520612716675
in O 0 0.00011315925803501159
them O 0 4.458926196093671e-05
. O 0 0.0002761220675893128

In O 0 0.0003461492888163775
individuals O 0 0.00010671179188648239
with O 0 8.335070015164092e-05
mutations O 0 0.0014454623451456428
in O 0 0.00011471396283013746
either O 0 0.00029686876223422587
region O 0 0.0016940676141530275
2 O 0 0.0009081348543986678
or O 0 0.0002772902662400156
region O 0 0.0011756204767152667
3 O 0 0.0004940055077895522
, O 0 5.248328307061456e-05
the O 0 5.319948468240909e-05
average O 0 0.0003372606879565865
number O 0 1.1718521818693262e-05
of O 0 6.805416342103854e-05
adenomas B-Disease 1 0.9999417066574097
tended O 0 0.005739305634051561
to O 0 9.934485569829121e-05
be O 0 9.120731556322426e-05
lower O 0 0.001525255385786295
than O 0 4.531508238869719e-05
those O 0 2.6019164579338394e-05
in O 0 5.454389611259103e-05
individuals O 0 5.965827585896477e-05
with O 0 6.616316386498511e-05
mutations O 0 0.0013969414867460728
in O 0 0.0001482291700085625
region O 0 0.0016654640203341842
1 O 0 0.0008808927959762514
, O 0 9.77578092715703e-05
although O 0 0.0002559954591561109
age O 0 0.0008735457668080926
at O 0 0.003755265846848488
diagnosis O 1 0.9999995231628418
was O 0 0.00099388777744025
similar O 0 0.00025654202909208834
. O 0 0.00035155771183781326

In O 0 0.0005726696108467877
all O 0 0.00047498647472821176
AAPC B-Disease 1 0.9999884366989136
kindreds O 0 0.13835211098194122
, O 0 0.00010120942897628993
a O 0 0.00012393748329486698
predominance O 0 0.003711908822879195
of O 0 2.772223342617508e-05
right O 0 0.021644892171025276
- O 1 0.9964584708213806
sided O 1 0.9999854564666748
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
and O 0 0.007187156472355127
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9999960660934448
sparing O 1 0.8776386380195618
was O 0 0.0011311167618259788
observed O 0 0.000522530754096806
. O 0 0.00024986540665850043

No O 0 0.005295546725392342
desmoid B-Disease 1 0.9994235038757324
tumors I-Disease 1 0.999997615814209
were O 0 5.9432608395582065e-05
found O 0 7.854394789319485e-05
in O 0 3.554418435669504e-05
these O 0 3.6092162190470845e-05
kindreds O 0 0.1669529527425766
. O 0 0.000613198266364634

Our O 0 0.0006439605494961143
data O 0 0.00012532604159787297
suggest O 0 0.0004608191375155002
that O 0 4.65642697236035e-05
, O 0 0.00020697369473055005
in O 0 0.0009729734738357365
AAPC B-Disease 1 0.9999904632568359
families O 0 0.0006356984376907349
, O 0 6.827074685133994e-05
the O 0 3.932848267140798e-05
location O 0 0.0001022469878080301
of O 0 6.817770099587506e-06
the O 0 0.0005155909457243979
APC B-Disease 1 0.9996814727783203
mutation O 0 0.0093814292922616
may O 0 0.0019178567454218864
partially O 0 0.011594443581998348
predict O 0 0.0010497337207198143
specific O 0 0.00011766960960812867
phenotypic O 0 0.008507697843015194
expression O 0 0.0019330850336700678
. O 0 0.0005395739572122693

This O 0 0.00018914142856374383
should O 0 0.0002543724258430302
help O 0 0.00036383068072609603
in O 0 3.0113718821667135e-05
the O 0 4.799056478077546e-05
design O 0 0.0006453216192312539
of O 0 5.080729897599667e-05
tailored O 1 0.9881041646003723
clinical O 1 0.9999982118606567
- O 0 0.18735554814338684
management O 0 0.32289403676986694
protocols O 0 0.009798754006624222
in O 0 3.121357804047875e-05
this O 0 9.959500857803505e-06
subset O 0 0.0008120613056235015
of O 0 0.00019032492127735168
FAP B-Disease 1 0.9999996423721313
patients O 1 0.9999969005584717
. O 0 0.00023815561144147068
. O 0 0.0002483392017893493

Wilms B-Disease 1 0.9999966621398926
' I-Disease 1 0.6935883164405823
tumor I-Disease 1 0.9998156428337097
1 O 0 0.0012277874629944563
and O 0 0.0002713281137403101
Dax O 1 0.996131420135498
- O 0 0.00396182993426919
1 O 0 0.0005173390381969512
modulate O 0 0.008019303902983665
the O 0 0.00020094016508664936
orphan O 0 0.30043160915374756
nuclear O 0 0.005226674024015665
receptor O 0 0.024433022364974022
SF O 1 0.9996179342269897
- O 0 0.0033148759976029396
1 O 0 0.0003448349016252905
in O 0 7.426111551467329e-05
sex O 0 0.001122591900639236
- O 0 0.0017463336698710918
specific O 0 0.00013599847443401814
gene O 0 0.000980863464064896
expression O 0 0.0010413725394755602
. O 0 0.0003710242745000869

Products O 0 0.0017267910297960043
of O 0 5.5012413213262334e-05
steroidogenic O 1 0.9930824041366577
factor O 0 0.002963211853057146
1 O 0 0.0019659344106912613
( O 0 0.001334005151875317
SF O 1 0.9997170567512512
- O 0 0.003079504007473588
1 O 0 0.00045346617116592824
) O 0 7.802519394317642e-05
and O 0 0.00047433513100259006
Wilms B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999802112579346
1 O 0 0.0035709841176867485
( O 0 0.0022045737132430077
WT1 O 1 0.9995242357254028
) O 0 0.00020960471010766923
genes O 0 6.780043622711673e-05
are O 0 5.2175819291733205e-06
essential O 0 0.0008523916476406157
for O 0 0.00021145548089407384
mammalian O 0 0.014587348327040672
gonadogenesis O 1 0.7664626240730286
prior O 0 0.000516161322593689
to O 0 5.7858738728100434e-05
sexual O 0 0.0015471780207008123
differentiation O 0 0.0062996940687298775
. O 0 0.0004470197600312531

In O 0 0.0005894394125789404
males O 0 0.001960177207365632
, O 0 0.0015306926798075438
SF O 1 0.9998947381973267
- O 0 0.00968853197991848
1 O 0 0.0009630736894905567
participates O 0 0.007168046664446592
in O 0 0.00012014839012408629
sexual O 0 0.0012317512882873416
development O 0 0.000822733563836664
by O 0 2.1388863387983292e-05
regulating O 0 0.0019245992880314589
expression O 0 0.00011005881970049813
of O 0 3.7833183341717813e-06
the O 0 8.517136302543804e-05
polypeptide O 0 0.012491940520703793
hormone O 1 0.9480232000350952
Mullerian O 1 0.998815655708313
inhibiting O 0 0.07725697010755539
substance O 1 0.9949744939804077
( O 0 0.0034950661938637495
MIS O 1 0.999594509601593
) O 0 0.0006017006235197186
. O 0 0.00025796875706873834

Here O 0 0.0007278974517248571
, O 0 8.287428499897942e-05
we O 0 5.5844011512817815e-05
show O 0 0.00021713576279580593
that O 0 0.00019230303587391973
WT1 O 1 0.9995748400688171
- O 0 0.02254032902419567
KTS O 1 0.965691328048706
isoforms O 0 0.0014192684320732951
associate O 0 0.00534038245677948
and O 0 0.00019162431999575347
synergize O 1 0.989198625087738
with O 0 0.0008985611493699253
SF O 1 0.9999455213546753
- O 0 0.004155490547418594
1 O 0 0.00026025716215372086
to O 0 3.362147253938019e-05
promote O 0 0.001582717290148139
MIS O 1 0.9944958090782166
expression O 0 0.0013937271432951093
. O 0 0.00030982878524810076

In O 0 0.0005038934177719057
contrast O 0 0.002753439825028181
, O 0 0.0014243583427742124
WT1 O 1 0.9997158646583557
missense O 0 0.05259787291288376
mutations O 0 0.0023569625336676836
, O 0 0.00011133604130009189
associated O 0 0.00014646172348875552
with O 0 5.427228825283237e-05
male B-Disease 0 0.002369901165366173
pseudohermaphroditism I-Disease 1 0.9996052384376526
in O 0 0.0009430359932594001
Denys B-Disease 1 0.9999582767486572
- I-Disease 1 0.9980473518371582
Drash I-Disease 1 0.999969482421875
syndrome I-Disease 1 1.0
, O 0 0.0007550540030933917
fail O 0 0.01588933728635311
to O 0 0.0001398946187691763
synergize O 1 0.9846137762069702
with O 0 0.0005719041218981147
SF O 1 0.9999827146530151
- O 0 0.007342169526964426
1 O 0 0.0008940842235460877
. O 0 0.00017742576892487705

Additionally O 0 0.004766189027577639
, O 0 0.00013743889576289803
the O 0 0.00032014166936278343
X O 0 0.06974757462739944
- O 0 0.007991070859134197
linked O 0 0.003928790334612131
, O 0 0.0001289403298869729
candidate O 0 0.0019007209921255708
dosage O 1 0.9959099292755127
- O 0 0.005897260271012783
sensitive O 0 0.005792038980871439
sex O 0 0.0019693849608302116
- O 0 0.005215264856815338
reversal O 0 0.012122487649321556
gene O 0 0.0022871950641274452
, O 0 0.0005845262203365564
Dax O 1 0.9977455735206604
- O 0 0.0068419985473155975
1 O 0 0.0007745269685983658
, O 0 0.00019333185628056526
antagonizes O 0 0.15379583835601807
synergy O 0 0.019682642072439194
between O 0 0.0013179517118260264
SF O 1 0.9998900890350342
- O 0 0.006968528963625431
1 O 0 0.0008700104081071913
and O 0 0.0005374786560423672
WT1 O 1 0.9997860789299011
, O 0 0.0002904237771872431
most O 0 0.00010673326323740184
likely O 0 0.0002848436706699431
through O 0 3.167095565004274e-05
a O 0 5.511644485522993e-05
direct O 0 6.75103729008697e-05
interaction O 0 0.00030802571563981473
with O 0 0.00045502971624955535
SF O 1 0.9999678134918213
- O 0 0.007434932515025139
1 O 0 0.0009569784160703421
. O 0 0.00022772389638703316

We O 0 0.00057555316016078
propose O 0 0.003662664210423827
that O 0 0.0002088593755615875
WT1 O 1 0.9992307424545288
and O 0 0.001174545381218195
Dax O 1 0.9990729093551636
- O 0 0.01155027374625206
1 O 0 0.0013699933188036084
functionally O 0 0.014569468796253204
oppose O 0 0.0005767411785200238
each O 0 1.0619191016303375e-05
other O 0 1.4923330127203371e-05
in O 0 0.00018379086395725608
testis O 1 0.9937257170677185
development O 0 0.0012665916001424193
by O 0 0.0001179910686914809
modulating O 1 0.9861134886741638
SF O 1 0.9999183416366577
- O 0 0.01010336447507143
1 O 0 0.0017231632955372334
- O 0 0.004675657954066992
mediated O 0 0.024875640869140625
transactivation O 0 0.1386803686618805
. O 0 0.00025859501329250634
. O 0 0.00024792924523353577

A O 0 0.0040702130645513535
mouse O 0 0.004059039056301117
model O 0 0.0005468546878546476
for O 0 0.0010365601629018784
Prader B-Disease 1 1.0
- I-Disease 1 0.9999804496765137
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9948539137840271
- O 0 0.03080187365412712
centre O 0 0.008845248259603977
mutations O 0 0.002079981379210949
. O 0 0.0002840796369127929

Imprinting O 0 0.06206071004271507
in O 0 0.00020113374921493232
the O 0 0.00038524577394127846
15q11 O 0 0.2290472835302353
- O 0 0.008955348283052444
q13 O 0 0.01776694506406784
region O 0 0.0005107888136990368
involves O 0 0.0005042181583121419
an O 0 0.00018522044410929084
imprinting O 0 0.19131335616111755
centre O 0 0.027526646852493286
( O 0 0.0024830985348671675
IC O 1 0.9992218017578125
) O 0 0.00039579771691933274
, O 0 0.00011768937110900879
mapping O 0 0.002688628388568759
in O 0 8.385470573557541e-05
part O 0 0.00036119489232078195
to O 0 4.361974060884677e-05
the O 0 0.00017306473455391824
promoter O 0 0.02683192677795887
and O 0 8.057228842517361e-05
first O 0 0.00013744136958848685
exon O 0 0.00810492318123579
of O 0 6.269226287258789e-05
SNRPN O 1 0.9980722665786743
. O 0 0.0005930953193455935

Deletion O 0 0.007061605341732502
of O 0 1.759379665600136e-05
this O 0 0.00017766734526958317
IC O 1 0.997141420841217
abolishes O 0 0.12250048667192459
local O 0 0.0002443628036417067
paternally O 0 0.013323492370545864
derived O 0 0.00022448567324317992
gene O 0 0.00040811451617628336
expression O 0 0.00016163638792932034
and O 0 4.334333061706275e-05
results O 0 0.0004053654265590012
in O 0 0.0007471516728401184
Prader B-Disease 1 1.0
- I-Disease 1 0.9999843835830688
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.018675561994314194
PWS B-Disease 1 0.9999995231628418
) O 0 0.0013415968278422952
. O 0 0.00034582967055030167

We O 0 0.00039629233651794493
have O 0 2.7026429961551912e-05
created O 0 6.927796493982896e-05
two O 0 1.9378590877749957e-05
deletion O 0 0.005779095459729433
mutations O 0 0.0010457588359713554
in O 0 0.00015844468725845218
mice O 0 0.00808856450021267
to O 0 0.00021611254487652332
understand O 0 0.03309045732021332
PWS B-Disease 1 0.9999985694885254
and O 0 0.00013470860722009093
the O 0 4.8663416237104684e-05
mechanism O 0 0.0002956184034701437
of O 0 1.242081452801358e-05
this O 0 0.00013008713722229004
IC O 1 0.9977503418922424
. O 0 0.0007216098019853234

Mice O 0 0.10754630714654922
harbouring O 1 0.9458279609680176
an O 0 0.000802346970885992
intragenic O 1 0.9436870813369751
deletion O 0 0.01167602650821209
in O 0 0.0003411853685975075
Snrpn O 1 0.7850406169891357
are O 0 6.388443580362946e-05
phenotypically O 0 0.1334441751241684
normal O 0 0.003367567900568247
, O 0 0.0001604992721695453
suggesting O 0 0.0019012675620615482
that O 0 4.598245504894294e-05
mutations O 0 0.000518252607434988
of O 0 3.621642099460587e-05
SNRPN O 1 0.9990155696868896
are O 0 1.2417486686899792e-05
not O 0 2.3304261048906483e-05
sufficient O 0 0.00036514727980829775
to O 0 0.00014573508815374225
induce O 1 0.9521514177322388
PWS B-Disease 1 0.9999991655349731
. O 0 0.0014945953153073788

Mice O 0 0.015480831265449524
with O 0 3.208237103535794e-05
a O 0 0.0002189749211538583
larger O 0 0.00031918901368044317
deletion O 0 0.004877870436757803
involving O 0 0.00048185361083596945
both O 0 0.00022857073054183275
Snrpn O 1 0.8724713921546936
and O 0 5.912712367717177e-05
the O 0 0.00036690750857815146
putative O 1 0.994120180606842
PWS O 1 0.9999998807907104
- O 1 0.7266395092010498
IC O 1 0.9931244254112244
lack O 0 0.0021150594111531973
expression O 0 0.00018277532944921404
of O 0 8.310330485983286e-06
the O 0 0.00017303026106674224
imprinted O 0 0.047656141221523285
genes O 0 0.0008476658840663731
Zfp127 O 1 0.524639904499054
( O 0 0.0006333484197966754
mouse O 0 0.00642350222915411
homologue O 0 0.01885293796658516
of O 0 8.518127287970856e-05
ZNF127 O 1 0.9984787106513977
) O 0 0.000536432838998735
, O 0 0.0006295443745329976
Ndn O 1 0.9986018538475037
and O 0 0.0008814167813397944
Ipw O 1 0.991748571395874
, O 0 0.0003242227539885789
and O 0 0.000145863406942226
manifest O 0 0.008653461933135986
several O 0 0.00013001645857002586
phenotypes O 0 0.016923606395721436
common O 0 0.0026840688660740852
to O 0 0.0022175805643200874
PWS B-Disease 1 1.0
infants O 1 0.9997265934944153
. O 0 0.0009472457459196448

These O 0 4.8762547521619126e-05
data O 0 0.00012885073374491185
demonstrate O 0 0.001420558663085103
that O 0 1.774697557266336e-05
both O 0 2.4733186364755966e-05
the O 0 5.146958937984891e-05
position O 0 0.00039912713691592216
of O 0 1.06818906715489e-05
the O 0 0.00047759656445123255
IC O 1 0.9988388419151306
and O 0 0.00014532406930811703
its O 0 0.00015912356320768595
role O 0 0.001518472097814083
in O 0 9.696346387499943e-05
the O 0 8.665469067636877e-05
coordinate O 0 0.0025581049267202616
expression O 0 0.00020848812710028142
of O 0 9.697890163806733e-06
genes O 0 0.0001071715887519531
is O 0 6.526541983475909e-05
conserved O 0 0.0001402416091877967
between O 0 0.00017589845811016858
mouse O 0 0.007524306420236826
and O 0 0.00014347545220516622
human O 0 0.001289195497520268
, O 0 0.00018794502830132842
and O 0 8.213161345338449e-05
indicate O 0 0.000518505577929318
that O 0 2.5566025215084665e-05
the O 0 0.0001138248189818114
mouse O 0 0.005006140097975731
is O 0 0.0001278977724723518
a O 0 0.00021890684729442
suitable O 0 0.003408628050237894
model O 0 0.0011515585938468575
system O 0 0.0013304295716807246
in O 0 8.417203207500279e-05
which O 0 2.8878424927825108e-05
to O 0 5.773307566414587e-05
investigate O 0 0.0026067858561873436
the O 0 0.00010972326708724722
molecular O 0 0.0013619886012747884
mechanisms O 0 0.0004972222959622741
of O 0 3.1968942494131625e-05
imprinting O 0 0.04980991408228874
in O 0 9.966224024537951e-05
this O 0 2.1692556401831098e-05
region O 0 0.00025338339037261903
of O 0 5.235211574472487e-06
the O 0 0.00011855304182972759
genome O 0 0.0030089139472693205
. O 0 0.00011829727736767381
. O 0 0.0002454977366141975

Mutations O 0 0.0013065867824479938
of O 0 6.600465439987602e-06
the O 0 0.0001268169580725953
ATM O 0 0.020175253972411156
gene O 0 0.0015234561869874597
detected O 0 0.0024816475342959166
in O 0 9.771288023330271e-05
Japanese O 0 0.007051635533571243
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999773502349854
telangiectasia I-Disease 1 0.9999997615814209
patients O 1 0.9999990463256836
: O 0 0.00035349270910955966
possible O 0 0.00034340634010732174
preponderance O 0 0.007769530173391104
of O 0 5.812009476358071e-06
the O 0 6.228585698409006e-05
two O 0 6.031807424733415e-05
founder O 0 0.014387737028300762
mutations O 0 0.0035215856041759253
4612del165 O 0 0.037078458815813065
and O 0 0.0003451564407441765
7883del5 O 0 0.17007270455360413
. O 0 0.00045776579645462334

The O 0 0.0005424224655143917
ATM O 0 0.025516243651509285
( O 0 0.001155019155703485
A O 1 0.994337260723114
- O 1 0.993014931678772
T O 1 0.9999505281448364
, O 0 0.0002817080821841955
mutated O 0 0.005239095073193312
) O 0 0.00013029345427639782
gene O 0 0.00037335240631364286
on O 0 7.976179767865688e-05
human O 0 0.0009943703189492226
chromosome O 0 0.005004577804356813
11q22 O 0 0.05845262110233307
. O 0 0.00047977990470826626

3 O 0 0.0029106554575264454
has O 0 0.0010295214597135782
recently O 0 0.0031124758534133434
been O 0 0.00023773498833179474
identified O 0 0.000245409260969609
as O 0 3.5088814911432564e-05
the O 0 6.538932939292863e-05
gene O 0 0.000621932907961309
responsible O 0 0.0007127624121494591
for O 0 3.3812331821536645e-05
the O 0 9.125185169978067e-05
human O 0 0.014441635459661484
recessive B-Disease 1 0.9999960660934448
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9996833801269531
telangiectasia I-Disease 1 0.9999895095825195
( O 0 0.0024363005068153143
A B-Disease 1 0.9991718530654907
- I-Disease 1 0.997753918170929
T I-Disease 1 0.9999737739562988
) O 0 0.00026201241416856647
. O 0 0.00018912427185568959

In O 0 0.00024091675004456192
order O 0 4.371176692075096e-05
to O 0 2.157193375751376e-05
define O 0 0.0004564350820146501
the O 0 4.0831488149706274e-05
types O 0 0.0003815562813542783
of O 0 0.00020742256310768425
disease O 1 1.0
- O 0 0.034501321613788605
causing O 0 0.019116271287202835
ATM O 0 0.011132019571959972
mutations O 0 0.0005175679107196629
in O 0 4.772276588482782e-05
Japanese O 0 0.0015033709350973368
A B-Disease 1 0.9997487664222717
- I-Disease 1 0.9998001456260681
T I-Disease 1 0.9999991655349731
patients O 1 0.9999699592590332
as O 0 0.00013967015547677875
well O 0 7.069203275023028e-05
as O 0 8.569897181587294e-05
to O 0 5.493655407917686e-05
look O 0 0.0005632427637465298
for O 0 8.533119398634881e-05
possible O 0 0.0008622215245850384
mutational O 1 0.7157238721847534
hotspots O 0 0.0364510603249073
, O 0 0.00029642615118063986
reverse O 0 0.006510743871331215
- O 0 0.002207161858677864
transcribed O 0 0.0005514535587280989
RNA O 0 0.0004739200521726161
derived O 0 7.483295485144481e-05
from O 0 7.242611172841862e-05
ten O 0 0.000962015416007489
patients O 1 0.999695897102356
belonging O 0 0.0004690672503784299
to O 0 3.5325720091350377e-05
eight O 0 9.341767872683704e-05
unrelated O 0 0.0022565959952771664
Japanese O 0 0.002726480830460787
A B-Disease 1 0.99905925989151
- I-Disease 1 0.9977070093154907
T I-Disease 1 0.9999557733535767
families O 0 0.0003604418889153749
was O 0 0.0006966411601752043
analyzed O 0 0.000760119641199708
for O 0 8.437237556790933e-05
mutations O 0 0.00034337135730311275
by O 0 6.872919584566262e-06
the O 0 5.670963219017722e-05
restriction O 0 0.0008810766157694161
endonuclease O 0 0.06350918114185333
fingerprinting O 0 0.008686142042279243
method O 0 0.0005845740670338273
. O 0 0.0003224635438527912

As O 0 0.0010322891175746918
has O 0 0.0005801718798466027
been O 0 0.0003176044556312263
reported O 0 0.0010233018547296524
by O 0 3.0455348678515293e-05
others O 0 0.00029757889569737017
, O 0 0.00011582453589653596
mutations O 0 0.0006117208395153284
that O 0 1.7147689504781738e-05
lead O 0 0.00011663827172014862
to O 0 7.319646829273552e-05
exon O 0 0.026768628507852554
skipping O 0 0.024886852130293846
or O 0 0.00064704759279266
premature O 0 0.1367090344429016
protein O 0 0.0009223585948348045
truncation O 0 0.016631487756967545
were O 0 4.6176024625310674e-05
also O 0 0.0001030315543175675
predominant O 0 0.0015245461836457253
in O 0 0.00010710609058151022
our O 0 0.0008165610488504171
mutants O 0 0.012189480476081371
. O 0 0.00038039227365516126

Six O 0 0.000360831938451156
different O 0 2.536867032176815e-05
mutations O 0 0.0008133232477121055
were O 0 2.949222289316822e-05
identified O 0 0.0003456207341514528
on O 0 6.929190567461774e-05
12 O 0 9.013037924887612e-05
of O 0 4.128742602915736e-06
the O 0 0.00011234630073886365
16 O 0 0.0009726834832690656
alleles O 0 0.004229269921779633
examined O 0 0.02142287790775299
. O 0 0.0003209227288607508

Four O 0 0.00023841325310058892
were O 0 3.671802915050648e-05
deletions O 0 0.0015936298295855522
involving O 0 0.00042106720502488315
a O 0 0.00043878259020857513
loss O 0 0.0017914299387484789
of O 0 6.911805485287914e-06
a O 0 0.00022370197984855622
single O 0 0.0003735624486580491
exon O 0 0.028692428022623062
exon O 0 0.02586277574300766
7 O 0 0.0011713849380612373
, O 0 0.0002257133455714211
exon O 0 0.01916465163230896
16 O 0 0.0008597603882662952
, O 0 0.00018350823665969074
exon O 0 0.019802546128630638
33 O 0 0.002022581407800317
or O 0 0.0003628263948485255
exon O 0 0.024297848343849182
35 O 0 0.0019454685971140862
. O 0 0.0003274465852882713

The O 0 0.0005244121421128511
others O 0 0.0002283197973156348
were O 0 1.3465138181345537e-05
minute O 0 0.00018803623970597982
deletions O 0 0.0021107702050358057
, O 0 0.00028810856747440994
4649delA O 0 0.06389443576335907
in O 0 0.00028390364605002105
exon O 0 0.025675561279058456
33 O 0 0.002063207095488906
and O 0 0.0001329425285803154
7883del5 O 0 0.021799346432089806
in O 0 0.0002531201462261379
exon O 0 0.025977587327361107
55 O 0 0.003616402857005596
. O 0 0.0003029061190318316

The O 0 0.0009979491587728262
mutations O 0 0.004613945726305246
4612del165 O 0 0.054853495210409164
and O 0 0.0003315199865028262
7883del5 O 0 0.03249429538846016
were O 0 3.8023903471184894e-05
found O 0 8.294520375784487e-05
in O 0 2.2944414013181813e-05
more O 0 1.2531382708402816e-05
than O 0 3.443339664954692e-05
two O 0 3.8088212022557855e-05
unrelated O 0 0.004302850924432278
families O 0 0.00038299959851428866
; O 0 0.00014495621144305915
44 O 0 0.0007688663899898529
% O 0 0.00011449471639934927
( O 0 0.00042139209108427167
7 O 0 0.00046659624786116183
of O 0 1.959258588613011e-05
16 O 0 0.0006975558935664594
) O 0 3.720699533005245e-05
of O 0 4.565386916510761e-06
the O 0 0.0002050757029792294
mutant O 0 0.006969785783439875
alleles O 0 0.0028570934664458036
had O 0 0.0002799466310534626
one O 0 1.5788582459208556e-05
of O 0 2.583882633189205e-06
the O 0 5.9188496379647404e-05
two O 0 5.496737503563054e-05
mutations O 0 0.002030999632552266
. O 0 0.0003252329770475626

The O 0 0.0015296230558305979
4612del165 O 0 0.07327042520046234
mutations O 0 0.001810755580663681
in O 0 6.0167210904182866e-05
three O 0 2.584188405307941e-05
different O 0 8.887993317330256e-06
families O 0 7.997093780431896e-05
were O 0 1.0396117431810126e-05
all O 0 1.1165146133862436e-05
ascribed O 0 0.0018048005877062678
to O 0 2.3902070097392425e-05
the O 0 7.853870192775503e-05
same O 0 0.0007916009053587914
T O 1 0.9993605017662048
- O 0 0.00924764946103096
- O 0 0.004434266593307257
> O 0 0.004013406578451395
A O 0 0.0006559788598679006
substitution O 0 0.00023193616652861238
at O 0 0.0002860871027223766
the O 0 0.00012698503269348294
splice O 0 0.02211342751979828
donor O 0 0.007287248503416777
site O 0 0.001485910383053124
in O 0 0.0002546815958339721
intron O 1 0.9042789340019226
33 O 0 0.0050735026597976685
. O 0 0.00039483941509388387

Microsatellite O 0 0.2093411386013031
genotyping O 0 0.05362134054303169
around O 0 0.00014734617434442043
the O 0 0.00018301756063010544
ATM O 0 0.032353296875953674
locus O 0 0.015685800462961197
also O 0 0.00027614471036940813
indicated O 0 0.0012963319895789027
that O 0 1.820424586185254e-05
a O 0 0.00033686798997223377
common O 0 0.0030671327840536833
haplotype O 1 0.7792192697525024
was O 0 0.0008216818096116185
shared O 0 0.0001693705125944689
by O 0 1.4470169844571501e-05
the O 0 0.00011861207167385146
mutant O 0 0.004325604531913996
alleles O 0 0.001515625393949449
in O 0 6.230777216842398e-05
both O 0 0.00012986107321921736
mutations O 0 0.00271501112729311
. O 0 0.00035568009479902685

This O 0 0.00023745454382151365
suggests O 0 0.0007462166831828654
that O 0 1.2495986084104516e-05
these O 0 6.4027317421277985e-06
two O 0 5.289459295454435e-05
founder O 0 0.0450030118227005
mutations O 0 0.00292169745080173
may O 0 0.0004834896535612643
be O 0 2.9888953577028587e-05
predominant O 0 0.0007252185605466366
among O 0 5.195449557504617e-05
Japanese O 0 0.0010126695269718766
ATM O 0 0.02226708084344864
mutant O 0 0.006976535078138113
alleles O 0 0.0035834440495818853
. O 0 0.0004387871886137873

W474C O 0 0.029778631404042244
amino O 0 0.0004759307485073805
acid O 0 0.005628559272736311
substitution O 0 0.0016371632227674127
affects O 0 0.027470555156469345
early O 0 0.0001724588655633852
processing O 0 0.00012241341755725443
of O 0 5.452028744912241e-06
the O 0 7.678837573621422e-05
alpha O 0 0.0015673177549615502
- O 0 0.0003770447219721973
subunit O 0 0.00011992496001766995
of O 0 1.6422967746620998e-05
beta O 0 0.014686483889818192
- O 0 0.006061841268092394
hexosaminidase O 0 0.04448307678103447
A O 0 0.0011127764591947198
and O 0 6.406202010111883e-05
is O 0 0.00014402030501514673
associated O 0 0.00021497705893125385
with O 0 0.00037101280759088695
subacute O 1 0.9999996423721313
G B-Disease 1 0.9855029582977295
( I-Disease 0 0.0029062649700790644
M2 I-Disease 1 0.999037504196167
) I-Disease 0 0.0008786621619947255
gangliosidosis I-Disease 0 0.3308839797973633
. O 0 0.000593637116253376

Mutations O 0 0.003490658476948738
in O 0 0.00012137661542510614
the O 0 0.0006801299750804901
HEXA O 1 0.9995469450950623
gene O 0 0.0019029657123610377
, O 0 4.227058161632158e-05
encoding O 0 9.463202877668664e-05
the O 0 7.62788113206625e-05
alpha O 0 0.0012957549188286066
- O 0 0.0003487970388960093
subunit O 0 0.00012651715951506048
of O 0 1.0405401553725824e-05
beta O 0 0.01199833583086729
- O 0 0.00451413169503212
hexosaminidase O 0 0.04246193543076515
A O 0 0.0030140795279294252
( O 0 0.0006879048887640238
Hex O 0 0.028304627165198326
A O 0 0.004105643834918737
) O 0 0.00014217972056940198
, O 0 5.15414540132042e-05
that O 0 2.714822767302394e-05
abolish O 0 0.0038253481034189463
Hex O 0 0.0057189613580703735
A O 0 0.0005885007558390498
enzyme O 0 0.0011413334868848324
activity O 0 0.0010911915451288223
cause O 1 0.9988356232643127
Tay B-Disease 1 1.0
- I-Disease 1 0.9998643398284912
Sachs I-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999998807907104
( O 0 0.003507544519379735
TSD B-Disease 1 0.99996018409729
) O 0 0.0003422287991270423
, O 0 0.0001339947630185634
the O 0 0.0005876410286873579
fatal O 1 0.9999939203262329
infantile B-Disease 1 0.9999678134918213
form I-Disease 0 0.000546062015928328
of I-Disease 0 7.659405673621222e-05
G I-Disease 1 0.9015907049179077
( I-Disease 0 0.0020567949395626783
M2 I-Disease 1 0.9979335069656372
) I-Disease 0 0.0006543940398842096
gangliosidosis I-Disease 0 0.12628310918807983
, I-Disease 0 0.0002653823175933212
Type I-Disease 0 0.006551241967827082
1 I-Disease 0 0.0014895314816385508
. O 0 0.00032158184330910444

Less O 0 0.003527661319822073
severe O 1 0.9999097585678101
, O 0 0.001982592511922121
subacute O 1 0.9999998807907104
( O 0 0.004589191172271967
juvenile O 1 0.9999006986618042
- O 0 0.3130776882171631
onset O 1 0.9998354911804199
) O 0 0.000507031858433038
and O 0 0.0008996858960017562
chronic O 1 1.0
( O 0 0.0018829726614058018
adult O 0 0.016495730727910995
- O 1 0.7163015604019165
onset O 1 0.9999016523361206
) O 0 0.00031951902201399207
variants O 0 0.0006039252039045095
are O 0 2.240544017695356e-05
characterized O 0 0.00555678503587842
by O 0 2.72273628070252e-05
a O 0 0.00039250380359590054
broad O 0 0.006054223980754614
spectrum O 0 0.0036320085637271404
of O 0 0.00014303738134913146
clinical O 1 0.9999992847442627
manifestations O 1 0.9969244599342346
and O 0 0.00013527290138881654
are O 0 1.6223188140429556e-05
associated O 0 0.00013986928388476372
with O 0 3.828113403869793e-05
residual O 0 0.010923723690211773
levels O 0 0.001035227905958891
of O 0 1.3661889170180075e-05
Hex O 0 0.012392372824251652
A O 0 0.001063804724253714
enzyme O 0 0.0012664864771068096
activity O 0 0.0005051037878729403
. O 0 0.0002879100211430341

We O 0 0.00039987752097658813
identified O 0 0.00044262479059398174
a O 0 0.0008654645644128323
1422 O 1 0.9970256686210632
G O 0 0.23875410854816437
- O 0 0.012619788758456707
- O 0 0.007602921687066555
> O 0 0.01306636817753315
C O 0 0.018998999148607254
( O 0 0.0001713841629680246
amino O 0 0.00023619885905645788
acid O 0 0.01298125647008419
W474C O 0 0.049499742686748505
) O 0 7.428208482451737e-05
substitution O 0 0.00015193084254860878
in O 0 3.964985080529004e-05
the O 0 4.6872573875589296e-05
first O 0 7.369000377366319e-05
position O 0 0.0003819114062935114
of O 0 1.9944438463426195e-05
exon O 0 0.025866927579045296
13 O 0 0.0005620048032142222
of O 0 3.2711188396206126e-05
HEXA O 1 0.9943207502365112
of O 0 1.9713663277798332e-05
a O 0 0.000515415973495692
non O 0 0.003457707352936268
- O 0 0.004566460382193327
Jewish O 0 0.0013110545696690679
proband O 0 0.3536466956138611
who O 0 0.0008625222253613174
manifested O 0 0.03000694327056408
a O 0 0.0019831829704344273
subacute O 1 0.9999885559082031
variant O 0 0.0175209641456604
of O 0 0.00010027280950453132
G B-Disease 1 0.6990311145782471
( I-Disease 0 0.0019518908811733127
M2 I-Disease 1 0.9991666078567505
) I-Disease 0 0.0008243520860560238
gangliosidosis I-Disease 1 0.8426269292831421
. O 0 0.00037096222513355315

On O 0 0.00024861402926035225
the O 0 0.00010190397733822465
second O 0 0.0007289390196092427
maternally O 0 0.11651379615068436
inherited O 1 0.9945585131645203
allele O 0 0.0085131311789155
, O 0 0.00013975462934467942
we O 0 7.24553974578157e-05
identified O 0 0.00014318803732749075
the O 0 9.133926505455747e-05
common O 0 0.04246410354971886
infantile O 1 1.0
disease O 1 1.0
- O 0 0.0457516685128212
causing O 0 0.02336711809039116
4 O 0 0.0015177064342424273
- O 0 0.00471740635111928
bp O 0 0.031579870730638504
insertion O 0 0.012728070840239525
, O 0 0.0007553891045972705
+ O 0 0.104416124522686
TATC O 1 0.9953505992889404
1278 O 1 0.9869402050971985
, O 0 0.0002019885869231075
in O 0 0.00018209120025858283
exon O 0 0.025682158768177032
11 O 0 0.001550036366097629
. O 0 0.000246883777435869

Pulse O 0 0.08252756297588348
- O 0 0.00973737332969904
chase O 0 0.004355430603027344
analysis O 0 0.0001363513874821365
using O 0 0.00021430355263873935
proband O 1 0.950865626335144
fibroblasts O 0 0.21005670726299286
revealed O 0 0.0029220529831945896
that O 0 1.6515807146788575e-05
the O 0 9.356076770927757e-05
W474C O 0 0.034580979496240616
- O 0 0.0007945754914544523
containing O 0 5.532945579034276e-05
alpha O 0 0.0010062878718599677
- O 0 0.0008119023405015469
subunit O 0 0.0005441198591142893
precursor O 0 0.0057530030608177185
was O 0 0.0005983104929327965
normally O 0 0.0004020956112071872
synthesized O 0 0.0005515965167433023
, O 0 7.437451859004796e-05
but O 0 5.796123150503263e-05
not O 0 5.240106474957429e-05
phosphorylated O 0 0.007060983218252659
or O 0 0.00024354728520847857
secreted O 0 0.002444207202643156
, O 0 7.57461239118129e-05
and O 0 4.072648880537599e-05
the O 0 0.00012777246593032032
mature O 0 0.023922443389892578
lysosomal O 1 0.9907864928245544
alpha O 0 0.004969784989953041
- O 0 0.0016995043260976672
subunit O 0 0.0005447051953524351
was O 0 0.0004998229560442269
not O 0 9.47697481024079e-05
detected O 0 0.004860823042690754
. O 0 0.0002724058576859534

When O 0 0.0007283980376087129
the O 0 0.00018119820742867887
W474C O 0 0.02895684912800789
- O 0 0.0008418967481702566
containing O 0 6.918250437593088e-05
alpha O 0 0.0013374360278248787
- O 0 0.0011406607227399945
subunit O 0 0.0008318109903484583
was O 0 0.0018204862717539072
transiently O 0 0.1253143548965454
co O 0 0.01685287430882454
- O 0 0.0017527303425595164
expressed O 0 8.169566717697307e-05
with O 0 1.417624116584193e-05
the O 0 0.0001273416419280693
beta O 0 0.007325340528041124
- O 0 0.0005550086498260498
subunit O 0 0.0001349551894236356
to O 0 1.8413877114653587e-05
produce O 0 0.00013049488188698888
Hex O 0 0.013018638826906681
A O 0 0.002858224092051387
( O 0 0.0006707824650220573
alphabeta O 0 0.39899176359176636
) O 0 0.00023417867487296462
in O 0 0.0004379460006020963
COS O 1 0.9991999268531799
- O 0 0.007376759313046932
7 O 0 0.0008321607601828873
cells O 0 0.0008377968915738165
, O 0 4.1564264392945915e-05
the O 0 8.673851698404178e-05
mature O 0 0.00766203785315156
alpha O 0 0.003024120582267642
- O 0 0.0015471684746444225
subunit O 0 0.0008671716204844415
was O 0 0.0006403032457455993
present O 0 0.0001220608246512711
, O 0 8.856746717356145e-05
but O 0 5.953358777333051e-05
its O 0 9.235363540938124e-05
level O 0 0.0023433039896190166
was O 0 0.0007417740416713059
much O 0 0.00025249875034205616
lower O 0 0.001329588470980525
than O 0 2.917817073466722e-05
that O 0 1.481861272623064e-05
from O 0 3.02148619084619e-05
normal O 0 0.0014756028540432453
alpha O 0 0.002912903670221567
- O 0 0.0021938213612884283
subunit O 0 0.0023576051462441683
transfections O 0 0.11999928951263428
, O 0 0.00021232823200989515
although O 0 0.0001519056677352637
higher O 0 0.00018426991300657392
than O 0 3.4722950658760965e-05
in O 0 5.37362284376286e-05
those O 0 6.996565207373351e-05
cells O 0 0.0027536230627447367
transfected O 0 0.026366442441940308
with O 0 2.022193257289473e-05
an O 0 8.971978968475014e-05
alpha O 0 0.0022881655022501945
- O 0 0.0012677923077717423
subunit O 0 0.0005708595854230225
associated O 0 0.0002775378234218806
with O 0 0.00046298757661134005
infantile O 1 0.9999980926513672
TSD B-Disease 1 0.9999712705612183
. O 0 0.0018814292270690203

Furthermore O 0 0.006560810375958681
, O 0 0.00013033943832851946
the O 0 0.00011535059456946328
precursor O 0 0.007312792353332043
level O 0 0.0005711800768040121
of O 0 5.72222052142024e-06
the O 0 0.00014929502503946424
W474C O 0 0.03944765031337738
alpha O 0 0.002807316370308399
- O 0 0.0015307639259845018
subunit O 0 0.0006870989454910159
was O 0 0.0007134341867640615
found O 0 0.00013830380339641124
to O 0 5.743527799495496e-05
accumulate O 0 0.007007281295955181
in O 0 6.639112689299509e-05
comparison O 0 0.0002500307746231556
to O 0 1.7055999705917202e-05
the O 0 3.7208097637631e-05
normal O 0 0.00154229742474854
alpha O 0 0.0017940676771104336
- O 0 0.0009996144799515605
subunit O 0 0.0006936262361705303
precursor O 0 0.009505015797913074
levels O 0 0.004140860866755247
. O 0 0.0003421453293412924

We O 0 0.0004391595721244812
conclude O 0 0.0015163524076342583
that O 0 1.874302324722521e-05
the O 0 0.00020449071598704904
1422 O 1 0.9984697699546814
G O 1 0.5073007941246033
- O 0 0.01652391441166401
- O 0 0.010014563798904419
> O 0 0.01525665819644928
C O 0 0.02457091584801674
mutation O 0 0.000821187102701515
is O 0 6.834161467850208e-05
the O 0 4.6110064431559294e-05
cause O 0 0.0016038516769185662
of O 0 1.7472806575824507e-05
Hex B-Disease 0 0.030998149886727333
A I-Disease 0 0.011388042941689491
enzyme I-Disease 1 0.9986793398857117
deficiency I-Disease 1 1.0
in O 0 0.0002604795736260712
the O 0 0.0003768329042941332
proband O 1 0.9723686575889587
. O 0 0.0005645030760206282

The O 0 0.0004532777238637209
resulting O 0 0.0019018594175577164
W474C O 0 0.022860560566186905
substitution O 0 0.0009428266785107553
clearly O 0 0.0025533013977110386
interferes O 0 0.0350775346159935
with O 0 6.445468898164108e-05
alpha O 0 0.0025061890482902527
- O 0 0.001107572577893734
subunit O 0 0.0004440020420588553
processing O 0 0.0005720782792195678
, O 0 0.00015912145317997783
but O 0 0.00010734669194789603
because O 0 0.00014473992632701993
the O 0 5.971877908450551e-05
base O 0 0.001518041710369289
substitution O 0 0.00183607148937881
falls O 0 0.03621801733970642
at O 0 0.0003678708744700998
the O 0 4.347742287791334e-05
first O 0 6.555466097779572e-05
position O 0 0.00029641823493875563
of O 0 2.1408104657894e-05
exon O 0 0.029271237552165985
13 O 0 0.0010003776988014579
, O 0 0.0001701656583463773
aberrant O 0 0.025859016925096512
splicing O 0 0.003453303361311555
may O 0 0.0007443048525601625
also O 0 5.673441046383232e-05
contribute O 0 0.0010574391344562173
to O 0 9.609087283024564e-05
Hex B-Disease 0 0.033548351377248764
A I-Disease 0 0.022162754088640213
deficiency I-Disease 1 0.9999990463256836
in O 0 0.00014918403758201748
this O 0 8.63343448145315e-05
proband O 1 0.9063153266906738
. O 0 0.00015526192146353424
. O 0 0.00019811921811196953

Two O 0 0.00016457228048238903
frequent O 0 0.005893571302294731
missense O 0 0.02158224768936634
mutations O 0 0.003302572760730982
in O 0 0.0012735314667224884
Pendred B-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
. O 0 0.0016322402516379952

Pendred B-Disease 1 0.9999990463256836
syndrome I-Disease 1 1.0
is O 0 0.0008385085384361446
an O 0 0.0022991958539932966
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9988300204277039
by O 0 0.00018806708976626396
early O 0 0.006228174548596144
childhood O 1 0.9999986886978149
deafness B-Disease 1 1.0
and O 0 0.13980664312839508
goiter B-Disease 1 1.0
. O 0 0.001570726279169321

A O 0 0.003175809048116207
century O 0 0.00033148995134979486
after O 0 0.00036690087290480733
its O 0 6.587148527614772e-05
recognition O 0 0.0008360416977666318
as O 0 0.000303108332445845
a O 0 0.004679245408624411
syndrome O 1 1.0
by O 0 0.0002933613723143935
Vaughan O 1 0.9945606589317322
Pendred O 1 0.9844523668289185
, O 0 0.0002229892270406708
the O 0 0.0007739330758340657
disease O 1 0.9999996423721313
gene O 0 0.006027317605912685
( O 0 0.0018237532349303365
PDS O 1 0.9999525547027588
) O 0 0.00039114663377404213
was O 0 0.0005519883707165718
mapped O 0 0.001448493218049407
to O 0 7.51927582314238e-05
chromosome O 0 0.0024663119111210108
7q22 O 0 0.06600194424390793
- O 0 0.010146274231374264
q31 O 0 0.04039217531681061
. O 0 0.00033293484011664987

1 O 0 0.0024421829730272293
and O 0 0.0002632257528603077
, O 0 0.00041505592525936663
recently O 0 0.004668145440518856
, O 0 7.432133861584589e-05
found O 0 3.637807094492018e-05
to O 0 6.956196557439398e-06
encode O 0 6.634936289628968e-05
a O 0 0.00029093812918290496
putative O 0 0.043165288865566254
sulfate O 1 0.9995934367179871
transporter O 1 0.9960267543792725
. O 0 0.0007204540888778865

We O 0 0.0005658799782395363
performed O 0 0.0007867083768360317
mutation O 0 0.00028710716287605464
analysis O 0 3.052105603273958e-05
of O 0 6.522423063870519e-06
the O 0 0.0006140329060144722
PDS B-Disease 1 0.999970555305481
gene O 0 0.0035968138836324215
in O 0 0.0005533511284738779
patients O 1 0.9999663829803467
from O 0 0.00020491504983510822
14 O 0 0.0016504364321008325
Pendred B-Disease 1 0.9275359511375427
families O 0 0.00021354724594857544
originating O 0 0.0006985731888562441
from O 0 7.123481918824837e-05
seven O 0 7.547868153778836e-05
countries O 0 2.264776048832573e-05
and O 0 8.02990616648458e-05
identified O 0 0.0003554447030182928
all O 0 2.3404218154610135e-05
mutations O 0 0.0015125336358323693
. O 0 0.00023431627778336406

The O 0 0.0007468644180335104
mutations O 0 0.0010109165450558066
include O 0 8.735509618418291e-05
three O 0 2.8471389668993652e-05
single O 0 0.00021471628861036152
base O 0 0.0018969940720126033
deletions O 0 0.002046160167083144
, O 0 7.233955693664029e-05
one O 0 9.581161430105567e-05
splice O 0 0.018910454586148262
site O 0 0.001923300907947123
mutation O 0 0.0008619516738690436
and O 0 6.392361683538184e-05
10 O 0 0.0004248507902957499
missense O 0 0.015391160733997822
mutations O 0 0.002690692665055394
. O 0 0.00035398537875153124

One O 0 0.0005589759675785899
missense O 0 0.01826483942568302
mutation O 0 0.005441777408123016
( O 0 0.0012760435929521918
L236P O 0 0.12573885917663574
) O 0 0.00035894804750569165
was O 0 0.0006801279960200191
found O 0 0.00011451733735157177
in O 0 3.941393515560776e-05
a O 0 0.00031694109202362597
homozygous O 0 0.001934941508807242
state O 0 6.350807234412059e-05
in O 0 7.474423182429746e-05
two O 0 0.000102956713817548
consanguineous O 1 0.6201756596565247
families O 0 0.0003536056028679013
and O 0 7.857152377255261e-05
in O 0 7.857474702177569e-05
a O 0 0.0004140262899454683
heterozygous O 0 0.0014810148859396577
state O 0 3.9373851905111223e-05
in O 0 2.204218617407605e-05
five O 0 3.1457362638320774e-05
additional O 0 0.0001944243849720806
non O 0 0.005338544957339764
- O 0 0.016314992681145668
consanguineous O 0 0.22714932262897491
families O 0 0.0005014664493501186
. O 0 0.00040647212881594896

Another O 0 0.002143979538232088
missense O 0 0.023541655391454697
mutation O 0 0.005552075337618589
( O 0 0.0011060412507504225
T416P O 0 0.08663685619831085
) O 0 0.00030295841861516237
was O 0 0.0006761968834325671
found O 0 9.767050505615771e-05
in O 0 4.381351755000651e-05
a O 0 0.00033009290928021073
homozygous O 0 0.00223323586396873
state O 0 8.914431964512914e-05
in O 0 7.436415762640536e-05
one O 0 0.00013132924505043775
family O 0 0.00037525035440921783
and O 0 7.966115663293749e-05
in O 0 8.03568254923448e-05
a O 0 0.0004970815498381853
heterozygous O 0 0.0018975584534928203
state O 0 6.733786722179502e-05
in O 0 4.8292560677509755e-05
four O 0 5.435686762211844e-05
families O 0 0.0002029087918344885
. O 0 0.0003516420256346464

Pendred B-Disease 1 0.9971867203712463
patients O 1 0.9998276233673096
in O 0 0.00010626761650200933
three O 0 6.535828288178891e-05
non O 0 0.006377660669386387
- O 0 0.01993292011320591
consanguineous O 1 0.6279894709587097
families O 0 0.00021297240164130926
were O 0 1.8793170966091566e-05
shown O 0 0.0001898880727821961
to O 0 2.725552076299209e-05
be O 0 5.735105150961317e-05
compound O 0 0.00938404444605112
heterozygotes O 0 0.06067434325814247
for O 0 0.0002995663380715996
L236P O 0 0.04435666650533676
and O 0 0.00031583503005094826
T416P O 0 0.06853935122489929
. O 0 0.0004819156019948423

In O 0 0.0002443264238536358
total O 0 0.00014730375551152974
, O 0 0.00013852948904968798
one O 0 0.00010239686525892466
or O 0 0.0001201910272357054
both O 0 1.8635513697518036e-05
of O 0 5.790096565760905e-06
these O 0 2.2193798940861598e-05
mutations O 0 0.0010572618339210749
were O 0 2.3888856958365068e-05
found O 0 0.0001088369099306874
in O 0 3.6341039958642796e-05
nine O 0 4.956929478794336e-05
of O 0 6.546540134877432e-06
the O 0 0.00016998565115500242
14 O 0 0.000716031005140394
families O 0 0.00013890753325540572
analyzed O 0 0.0021713594906032085
. O 0 0.0003161094500683248

The O 0 0.00019819026056211442
identification O 0 0.00014698160521220416
of O 0 9.377012247568928e-06
two O 0 7.996910426300019e-05
frequent O 0 0.032501254230737686
PDS B-Disease 1 0.9998501539230347
mutations O 0 0.0016584218246862292
will O 0 3.554991417331621e-05
facilitate O 0 0.000442506221588701
the O 0 0.00010820565512403846
molecular O 0 0.04844113066792488
diagnosis O 1 0.9999992847442627
of O 0 0.00034568196861073375
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 0 0.0013713195221498609

Insertional O 0 0.23547635972499847
mutation O 0 0.001359101734124124
by O 0 5.51808116142638e-05
transposable O 0 0.06894631683826447
element O 0 0.0027811499312520027
, O 0 0.0006962479092180729
L1 O 1 0.9953842759132385
, O 0 0.0001141119355452247
in O 0 7.232962525449693e-05
the O 0 0.0007900364580564201
DMD B-Disease 1 0.9999996423721313
gene O 0 0.001601150375790894
results O 0 0.0002757858601398766
in O 0 0.00018879871640820056
X B-Disease 0 0.35767433047294617
- I-Disease 0 0.08011738210916519
linked I-Disease 1 0.9618163108825684
dilated I-Disease 1 0.9999983310699463
cardiomyopathy I-Disease 1 1.0
. O 0 0.0022098622284829617

X B-Disease 1 0.5538667440414429
- I-Disease 0 0.10077184438705444
linked I-Disease 1 0.9509838819503784
dilated I-Disease 1 0.9999966621398926
cardiomyopathy I-Disease 1 1.0
( O 0 0.008243018761277199
XLDCM B-Disease 1 0.9993864297866821
) O 0 0.0002872462500818074
is O 0 0.0001996737119043246
a O 0 0.0011366847902536392
clinical O 1 0.999769389629364
phenotype O 0 0.02829732559621334
of O 0 4.651244307751767e-05
dystrophinopathy B-Disease 1 0.9790351390838623
which O 0 6.562646012753248e-05
is O 0 0.00021855189697816968
characterized O 0 0.011361301876604557
by O 0 0.00014666382048744708
preferential O 1 0.9756839871406555
myocardial B-Disease 1 1.0
involvement I-Disease 0 0.04880274459719658
without O 0 0.00011437130888225511
any O 0 6.460526492446661e-05
overt O 0 0.02140277810394764
clinical O 1 0.9999747276306152
signs O 0 0.004797777626663446
of O 0 0.0002009942108998075
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.0025451509281992912

To O 0 0.0002904520370066166
date O 0 0.00017339394253212959
, O 0 2.4815217329887673e-05
several O 0 1.2761282050632872e-05
mutations O 0 0.00026010311557911336
in O 0 4.353314216132276e-05
the O 0 0.0009157398017123342
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 0.14152096211910248
, O 0 0.004190358333289623
DMD O 1 1.0
, O 0 0.00045893850619904697
have O 0 6.529747770400718e-05
been O 0 0.00016103798407129943
identified O 0 0.0003830903151538223
in O 0 0.0003104358329437673
patients O 1 0.9999876022338867
with O 0 0.0003296209033578634
XLDCM B-Disease 1 0.9996812343597412
, O 0 0.00022855022689327598
but O 0 6.695456977467984e-05
a O 0 0.00023735991271678358
pathogenic O 0 0.005300809163600206
correlation O 0 0.0004541877133306116
of O 0 7.949985047162045e-06
these O 0 4.9271679017692804e-05
cardiospecific O 1 0.9464302659034729
mutations O 0 0.0030001639388501644
in O 0 0.0008013838087208569
DMD O 1 0.9999997615814209
with O 0 0.00015068001812323928
the O 0 0.0008125926833599806
XLDCM B-Disease 1 0.9998875856399536
phenotype O 0 0.4879467189311981
has O 0 0.0005322311189956963
remained O 0 0.0009162190253846347
to O 0 2.7674213924910873e-05
be O 0 6.95977287250571e-05
elucidated O 0 0.05777741223573685
. O 0 0.00028251580079086125

We O 0 0.0011436962522566319
report O 0 0.0006642791558988392
here O 0 5.556162795983255e-05
the O 0 2.331412906642072e-05
identification O 0 7.210126204881817e-05
of O 0 4.9119762479676865e-06
a O 0 0.0002268313110107556
unique O 0 0.0008005828130990267
de O 0 0.005338308867067099
novo O 0 0.03757262974977493
L1 O 0 0.35004764795303345
insertion O 0 0.005309067200869322
in O 0 6.692201714031398e-05
the O 0 0.00019750621868297458
muscle O 1 0.9951750040054321
exon O 0 0.0333259142935276
1 O 0 0.001423159148544073
in O 0 0.0008424423867836595
DMD O 1 0.9999991655349731
in O 0 0.00032632530201226473
three O 0 0.00034103612415492535
XLDCM B-Disease 1 0.999954104423523
patients O 1 0.9999679327011108
from O 0 5.466574657475576e-05
two O 0 3.55524207407143e-05
unrelated O 0 0.0029712568502873182
Japanese O 0 0.0012537642614915967
families O 0 0.0002885470457840711
. O 0 0.0003019692958332598

The O 0 0.0005062026903033257
insertion O 0 0.011434281244874
was O 0 0.0010530584258958697
a O 0 0.000622581981588155
5 O 0 0.0013035713927820325
- O 0 0.004634865093976259
truncated O 0 0.01575349271297455
form O 0 0.00014319486217573285
of O 0 1.8112503312295303e-05
human O 0 0.002947162603959441
L1 O 1 0.9586939215660095
inversely O 0 0.002953068818897009
integrated O 0 0.005680418107658625
in O 0 0.00012456686818040907
the O 0 0.0002267668751301244
5 O 0 0.0017786913085728884
- O 0 0.005464613437652588
untranslated O 0 0.02904953993856907
region O 0 0.0006290663732215762
in O 0 6.580644549103454e-05
the O 0 0.0003086757205892354
muscle O 1 0.999366819858551
exon O 0 0.05830618366599083
1 O 0 0.0017233879771083593
, O 0 0.00014136215031612664
which O 0 4.570872988551855e-05
affected O 0 0.0011748148826882243
the O 0 8.449202141491696e-05
transcription O 0 0.0008577310363762081
or O 0 0.00018837364041246474
the O 0 6.151588604552671e-05
stability O 0 0.0013007461093366146
of O 0 1.0568313882686198e-05
the O 0 0.00030134289409033954
muscle O 1 0.9858454465866089
form O 0 0.00033959138090722263
of O 0 7.868038665037602e-05
dystrophin O 1 0.9995825886726379
transcripts O 0 0.0031339076813310385
but O 0 6.995283911237493e-05
not O 0 1.26159666251624e-05
that O 0 2.9200693916209275e-06
of O 0 3.2183793337026145e-06
the O 0 0.0004410491674207151
brain O 1 0.9999926090240479
or O 0 0.0013378614094108343
Purkinje O 1 0.9995239973068237
cell O 0 0.003697497770190239
form O 0 0.0006175519083626568
, O 0 0.00033648620592430234
probably O 0 0.00171089346986264
due O 0 0.00043050781823694706
to O 0 2.1173251298023388e-05
its O 0 4.11170840379782e-05
unique O 0 0.00029174116207286716
site O 0 0.0005364908138290048
of O 0 1.1509658179420512e-05
integration O 0 0.0032513493206351995
. O 0 0.0004922593361698091

We O 0 0.0008892017649486661
speculate O 0 0.0029048584401607513
that O 0 1.1382925549696665e-05
this O 0 9.824959306570236e-06
insertion O 0 0.0017355160089209676
of O 0 7.387428922811523e-06
an O 0 0.00027242250507697463
L1 O 1 0.9759621024131775
sequence O 0 0.0002692090056370944
in O 0 0.0010334659600630403
DMD O 1 1.0
is O 0 0.0009658138151280582
responsible O 0 0.00267698778770864
for O 0 6.422821752494201e-05
some O 0 8.856442946125753e-06
of O 0 3.736411372301518e-06
the O 0 3.336798181408085e-05
population O 0 1.0984044820361305e-05
of O 0 1.461855208617635e-05
Japanese O 0 0.005850442685186863
patients O 1 0.9999935626983643
with O 0 0.0002927466994151473
XLDCM B-Disease 1 0.9998899698257446
. O 0 0.00022002427431289107
. O 0 0.00020640887669287622

Severe O 1 0.9999580383300781
early O 0 0.0041151694022119045
- O 1 0.9885409474372864
onset O 1 0.999996542930603
obesity B-Disease 1 1.0
, O 0 0.004292453173547983
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.0017789840931072831
red O 1 0.9986270666122437
hair O 1 0.9999876022338867
pigmentation O 1 0.9999946355819702
caused O 0 0.04579322785139084
by O 0 0.00045457063242793083
POMC O 1 0.9998530149459839
mutations O 0 0.0023879113141447306
in O 0 0.00014848577848169953
humans O 0 0.001609750441275537
. O 0 0.00031007020152173936

Sequential O 0 0.005295267794281244
cleavage O 0 0.013338420540094376
of O 0 7.774392543069553e-06
the O 0 6.661035877186805e-05
precursor O 0 0.004162666853517294
protein O 0 0.0005658878362737596
pre O 0 0.008742040954530239
- O 0 0.004963102284818888
pro O 0 0.010918437503278255
- O 0 0.010681092739105225
opiomelanocortin O 1 0.764217734336853
( O 0 0.0022015634458512068
POMC O 1 0.9966282248497009
) O 0 0.00015392758359666914
generates O 0 0.00041870324639603496
the O 0 0.00021490226208698004
melanocortin O 1 0.9858328104019165
peptides O 0 0.00741950748488307
adrenocorticotrophin O 1 0.9505387544631958
( O 0 0.0021171134430915117
ACTH O 1 0.9992254972457886
) O 0 0.0002899266255553812
, O 0 0.0002620403829496354
melanocyte O 1 0.994120180606842
- O 0 0.007529517635703087
stimulating O 0 0.4251871407032013
hormones O 0 0.034876104444265366
( O 0 0.003113499842584133
MSH O 1 0.9999682903289795
) O 0 0.00040401823935098946
alpha O 0 0.0016785173211246729
, O 0 0.00013024028157815337
beta O 0 0.0034943989012390375
and O 0 6.566113734152168e-05
gamma O 0 0.0029418012127280235
as O 0 5.256843724055216e-05
well O 0 3.3799886296037585e-05
as O 0 3.988824755651876e-05
the O 0 0.00010400345490779728
opioid O 1 0.9467939734458923
- O 0 0.0021233398001641035
receptor O 0 0.001813420676626265
ligand O 0 0.006597467698156834
beta O 0 0.013732732273638248
- O 0 0.010348496958613396
endorphin O 1 0.9747188687324524
. O 0 0.00042177847353741527

While O 0 0.00045086751924827695
a O 0 0.00021315261255949736
few O 0 0.00011670503590721637
cases O 0 0.00028194644255563617
of O 0 4.026731039630249e-05
isolated O 1 0.9952239394187927
ACTH B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999998807907104
have O 0 0.00012475895346142352
been O 0 0.00038242805749177933
reported O 0 0.0036201593466103077
( O 0 0.002348370384424925
OMIM O 1 0.9999185800552368
201400 O 1 0.9617658257484436
) O 0 0.0002461319381836802
, O 0 9.723086259327829e-05
an O 0 0.000883998756762594
inherited O 1 0.9999688863754272
POMC O 1 0.9999988079071045
defect O 1 0.999776303768158
has O 0 0.0008431820897385478
not O 0 8.408828580286354e-05
been O 0 0.00015300785889849067
described O 0 0.001066594268195331
so O 0 0.0001754528930177912
far O 0 0.0003344242286402732
. O 0 0.00025697165983729064

Recent O 0 0.0023704003542661667
studies O 0 0.0006031725206412375
in O 0 0.00011579979036469012
animal O 0 0.002706782193854451
models O 0 0.0011027214350178838
elucidated O 0 0.02911541238427162
a O 0 0.00022777405683882535
central O 0 0.00015264689864125103
role O 0 0.000363600644050166
of O 0 2.4192859200411476e-05
alpha O 0 0.013156920671463013
- O 0 0.055876296013593674
MSH O 1 0.9998559951782227
in O 0 9.981488983612508e-05
the O 0 4.3560467020142823e-05
regulation O 0 0.0002612359239719808
of O 0 9.397565918334294e-06
food O 0 0.0008144927560351789
intake O 0 0.005303426180034876
by O 0 1.0946064321615268e-05
activation O 0 0.000458852737210691
of O 0 8.123671250359621e-06
the O 0 0.0004960345104336739
brain O 1 0.9999402761459351
melanocortin O 1 0.9963287711143494
- O 0 0.00457204133272171
4 O 0 0.000603280495852232
- O 0 0.0015795339131727815
receptor O 0 0.003509615082293749
( O 0 0.0013434540014714003
MC4 O 1 0.9999402761459351
- O 0 0.027101827785372734
R O 0 0.06552884727716446
; O 0 0.00027355446945875883
refs O 0 0.052053358405828476
3 O 0 0.0017036368371918797
- O 0 0.0028908560052514076
5 O 0 0.000512290105689317
) O 0 5.490806506713852e-05
and O 0 2.0571093045873567e-05
the O 0 5.560360659728758e-05
linkage O 0 0.006400815211236477
of O 0 3.2687770726624876e-05
human O 0 0.013563692569732666
obesity B-Disease 1 0.9999990463256836
to O 0 0.00024986587231978774
chromosome O 0 0.001277378760278225
2 O 0 0.00031816872069612145
in O 0 4.692194488598034e-05
close O 0 0.0005971079808659852
proximity O 0 0.0008883548434823751
to O 0 7.622449629707262e-05
the O 0 0.0007429073448292911
POMC O 1 0.9997962117195129
locus O 0 0.03236297890543938
, O 0 0.0002917959645856172
led O 0 0.0002920091210398823
to O 0 2.7423920982982963e-05
the O 0 4.396167423692532e-05
proposal O 0 0.0003832753573078662
of O 0 4.73412956125685e-06
an O 0 0.0001835696748457849
association O 0 0.0061847553588449955
of O 0 9.864393359748647e-05
POMC O 1 0.9999576807022095
with O 0 0.0003188021364621818
human O 0 0.02782478928565979
obesity B-Disease 1 0.9999997615814209
. O 0 0.0013266816968098283

The O 0 0.00028205718263052404
dual O 0 0.0014456394128501415
role O 0 0.0005551684298552573
of O 0 2.336942452529911e-05
alpha O 0 0.011439462192356586
- O 0 0.030643682926893234
MSH O 1 0.9997243285179138
in O 0 0.00014060635294299573
regulating O 0 0.004023119807243347
food O 0 0.0012409933842718601
intake O 0 0.01066398061811924
and O 0 0.00024709972785785794
influencing O 0 0.062130406498909
hair O 1 0.9999480247497559
pigmentation O 1 0.999964714050293
predicts O 0 0.023248722776770592
that O 0 4.513394378591329e-05
the O 0 0.0001897458132589236
phenotype O 0 0.08677338063716888
associated O 0 0.00020324086653999984
with O 0 4.009759868495166e-05
a O 0 0.0014555645175278187
defect O 1 0.999010443687439
in O 0 0.0006582759669981897
POMC O 1 0.9996691942214966
function O 0 0.0011259897146373987
would O 0 0.00024261418730020523
include O 0 0.0008021535468287766
obesity B-Disease 1 0.9999996423721313
, O 0 0.00031449494417756796
alteration O 0 0.01710646227002144
in O 0 0.0005501678097061813
pigmentation O 1 0.9999914169311523
and O 0 0.004275164101272821
ACTH B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999998807907104
. O 0 0.0013359020231291652

The O 0 0.00043376669054850936
observation O 0 0.006057335063815117
of O 0 2.1553816623054445e-05
these O 0 0.00020279522868804634
symptoms O 1 0.9999871253967285
in O 0 0.00019886258814949542
two O 0 9.740105451783165e-05
probands O 1 0.972396731376648
prompted O 0 0.004770365543663502
us O 0 0.0007174777565523982
to O 0 3.482688407530077e-05
search O 0 0.00020228233188390732
for O 0 7.731254299869761e-05
mutations O 0 0.00048475043149665
within O 0 6.03348744334653e-05
their O 0 0.00016855518333613873
POMC O 1 0.9994621872901917
genes O 0 0.000700965931173414
. O 0 0.00038181038689799607

Patient O 1 0.9998841285705566
1 O 0 0.0021976849529892206
was O 0 0.0006391216302290559
found O 0 7.997902139322832e-05
to O 0 1.4132033356872853e-05
be O 0 1.977544161491096e-05
a O 0 0.0002799196809064597
compound O 0 0.009698414243757725
heterozygote O 0 0.02789967693388462
for O 0 7.111339073162526e-05
two O 0 2.3022728782962076e-05
mutations O 0 0.0006080437451601028
in O 0 0.00011106119200121611
exon O 0 0.02336999960243702
3 O 0 0.0013136669294908643
( O 0 0.0005485325818881392
G7013T O 0 0.07310621440410614
, O 0 0.0009068326326087117
C7133delta O 1 0.9938156604766846
) O 0 0.00017023902910295874
which O 0 2.3658241843804717e-05
interfere O 0 0.0017781646456569433
with O 0 9.5402310762438e-06
appropriate O 0 0.00020483339903876185
synthesis O 0 0.00045809929724782705
of O 0 4.429766704561189e-05
ACTH O 1 0.9997226595878601
and O 0 0.0002501106937415898
alpha O 0 0.008108561858534813
- O 0 0.04799685999751091
MSH O 1 0.9999138116836548
. O 0 0.0007884259102866054

Patient O 1 0.9995854496955872
2 O 0 0.0011486236471682787
was O 0 0.0005456187063828111
homozygous O 0 0.0006979628815315664
for O 0 2.6578451070236042e-05
a O 0 0.0001652903447393328
mutation O 0 0.0006105192587710917
in O 0 0.0001248841726919636
exon O 0 0.02422034740447998
2 O 0 0.0015092717949301004
( O 0 0.0005676150904037058
C3804A O 0 0.040275804698467255
) O 0 0.00019237327796872705
which O 0 0.00013105978723615408
abolishes O 1 0.9148240089416504
POMC O 1 0.9977405071258545
translation O 0 0.001772639574483037
. O 0 0.00044945612899027765

These O 0 0.00011592994269449264
findings O 0 0.001150472555309534
represent O 0 7.675183587707579e-05
the O 0 3.921892857761122e-05
first O 0 3.821219797828235e-05
examples O 0 5.867110303370282e-05
of O 0 1.0892518730543088e-05
a O 0 0.001796809257939458
genetic B-Disease 1 0.9959313273429871
defect I-Disease 1 0.999883770942688
within O 0 0.00024040047719608992
the O 0 0.0009854495292529464
POMC O 1 0.9998804330825806
gene O 0 0.0013574393233284354
and O 0 3.979717439506203e-05
define O 0 0.0009414980886504054
a O 0 0.0004783706390298903
new O 0 0.0015232176519930363
monogenic B-Disease 1 0.9999884366989136
endocrine I-Disease 1 0.9999991655349731
disorder I-Disease 1 0.9999979734420776
resulting O 0 0.0013877380406484008
in O 0 0.00012462031736504287
early O 0 0.0009939190931618214
- O 1 0.9796969294548035
onset O 1 0.9999980926513672
obesity B-Disease 1 1.0
, O 0 0.003888966515660286
adrenal B-Disease 1 0.9999998807907104
insufficiency I-Disease 1 0.9999998807907104
and O 0 0.0018605465302243829
red O 1 0.9978238344192505
hair O 1 0.9999827146530151
pigmentation O 1 0.9999927282333374
. O 0 0.00048383313696831465
. O 0 0.000310491188429296

A O 0 0.00378889380954206
European O 0 0.0012389228213578463
multicenter O 1 0.7160361409187317
study O 0 0.0003928311343770474
of O 0 6.234129978111014e-05
phenylalanine B-Disease 1 0.9999793767929077
hydroxylase I-Disease 1 0.9999849796295166
deficiency I-Disease 1 1.0
: O 0 0.0008765569073148072
classification O 0 0.005610860884189606
of O 0 2.2612752218265086e-05
105 O 0 0.004128186963498592
mutations O 0 0.0008414420881308615
and O 0 3.896936686942354e-05
a O 0 0.00024020711134653538
general O 0 0.000629735179245472
system O 0 0.001128568546846509
for O 0 0.0003024268080480397
genotype O 0 0.0722142830491066
- O 0 0.0022433525882661343
based O 0 5.772514487034641e-05
prediction O 0 0.0018805006984621286
of O 0 3.497866418911144e-05
metabolic O 1 0.9993557333946228
phenotype O 1 0.8443189859390259
. O 0 0.0007291290094144642

Phenylketonuria B-Disease 1 0.9999953508377075
( O 0 0.013614417985081673
PKU B-Disease 1 0.9999990463256836
) O 0 0.0005369763821363449
and O 0 0.0003702697285916656
mild B-Disease 1 0.9999860525131226
hyperphenylalaninemia I-Disease 1 0.999996542930603
( O 0 0.0077985734678804874
MHP B-Disease 1 0.9999994039535522
) O 0 0.0005930608604103327
are O 0 0.00013854639837518334
allelic B-Disease 1 0.9987024068832397
disorders I-Disease 1 0.9999998807907104
caused O 0 0.02988690696656704
by O 0 5.687666271114722e-05
mutations O 0 0.0006383385043591261
in O 0 2.050594957836438e-05
the O 0 3.7181460356805474e-05
gene O 0 0.0004220514092594385
encoding O 0 0.0008521240088157356
phenylalanine O 0 0.4699196517467499
hydroxylase O 1 0.9674522280693054
( O 0 0.004375808872282505
PAH O 1 0.9999986886978149
) O 0 0.0006943464395590127
. O 0 0.00023680338927078992

Previous O 0 0.002234164858236909
studies O 0 0.0009940568124875426
have O 0 5.854172559338622e-05
suggested O 0 0.0003139910113532096
that O 0 7.2964903665706515e-06
the O 0 2.276473242091015e-05
highly O 0 0.0014163642190396786
variable O 0 0.002756733214482665
metabolic O 1 0.9987195730209351
phenotypes O 0 0.05294007435441017
of O 0 0.0006426986656151712
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
correlate O 0 0.030943170189857483
with O 0 0.0013110358268022537
PAH O 1 0.9999998807907104
genotypes O 0 0.44500088691711426
. O 0 0.0005986516480334103

We O 0 0.0005752465804107487
identified O 0 0.0003153001016471535
both O 0 0.00011057341907871887
causative O 1 0.6060922145843506
mutations O 0 0.003166335402056575
in O 0 0.0007473257137462497
686 O 1 0.9990354776382446
patients O 1 0.9999337196350098
from O 0 6.596238381462172e-05
seven O 0 0.00011242079926887527
European O 0 0.00047441924107261
centers O 0 0.003171151038259268
. O 0 0.0005136827821843326

On O 0 0.000303081440506503
the O 0 3.060689414269291e-05
basis O 0 2.0397352272993885e-05
of O 0 3.817976448772242e-06
the O 0 0.00010256651876261458
phenotypic O 0 0.007429761346429586
characteristics O 0 0.0006568246753886342
of O 0 4.405626896186732e-05
297 O 1 0.6586032509803772
functionally O 1 0.995185911655426
hemizygous O 1 0.999430239200592
patients O 1 0.9999606609344482
, O 0 0.0001827439700718969
105 O 0 0.0009110555402003229
of O 0 8.405915650655515e-06
the O 0 0.00018519216973800212
mutations O 0 0.0012367548188194633
were O 0 2.9017783162998967e-05
assigned O 0 0.0008009955054149032
to O 0 2.120435055985581e-05
one O 0 1.0967066373268608e-05
of O 0 2.972867150674574e-06
four O 0 3.186654794262722e-05
arbitrary O 0 0.000354843883542344
phenotype O 0 0.21300217509269714
categories O 0 0.0021819325629621744
. O 0 0.00048063567373901606

We O 0 0.0006949654780328274
proposed O 0 0.0008938295650295913
and O 0 0.00015527747746091336
tested O 0 0.007134623359888792
a O 0 0.000194378022570163
simple O 0 0.0003430676879361272
model O 0 0.00036326440749689937
for O 0 9.318643424194306e-05
correlation O 0 0.0013026560191065073
between O 0 0.00026528086164034903
genotype O 0 0.04538208618760109
and O 0 0.0001819575554691255
phenotypic O 0 0.01574193499982357
outcome O 0 0.0027963758911937475
. O 0 0.0004533058381639421

The O 0 0.00041708193020895123
observed O 0 0.001685013179667294
phenotype O 0 0.03283274546265602
matched O 0 0.0013804229674860835
the O 0 0.00016309322381857783
predicted O 0 0.006573192309588194
phenotype O 0 0.030021632090210915
in O 0 0.0002276173181599006
79 O 0 0.004760564770549536
% O 0 1.7825985196395777e-05
of O 0 8.53798701427877e-06
the O 0 0.00031398440478369594
cases O 0 0.003058652626350522
, O 0 0.0001664531446294859
and O 0 5.712877828045748e-05
in O 0 4.799358794116415e-05
only O 0 3.221380393370055e-05
5 O 0 0.00016717702965252101
of O 0 2.7126645363750868e-05
184 O 0 0.12970541417598724
patients O 1 0.9999841451644897
was O 0 0.0006652944139204919
the O 0 9.156757005257532e-05
observed O 0 0.0009087546495720744
phenotype O 0 0.012447302229702473
more O 0 3.122501220786944e-05
than O 0 6.01924657530617e-05
one O 0 0.00011528067261679098
category O 0 0.0008401696686632931
away O 0 0.00016217764641623944
from O 0 2.6310954126529396e-05
that O 0 2.83400895568775e-05
expected O 0 0.0005406344425864518
. O 0 0.00022337162226904184

Among O 0 0.00022861978504806757
the O 0 0.0001242894504684955
seven O 0 0.00029109572642482817
contributing O 0 0.004207192920148373
centers O 0 0.001507436390966177
, O 0 6.70670997351408e-05
the O 0 5.3379524615593255e-05
proportion O 0 0.00035604037111625075
of O 0 0.00011285428627161309
patients O 1 0.9999953508377075
for O 0 0.00024335602938663214
whom O 0 0.0007652470376342535
the O 0 0.00011212776007596403
observed O 0 0.0013240596745163202
phenotype O 0 0.08014719188213348
did O 0 0.00044763594632968307
not O 0 3.211910734535195e-05
match O 0 0.00013593236508313566
the O 0 0.00010748989006970078
predicted O 0 0.00445198779925704
phenotype O 0 0.027619479224085808
was O 0 0.0012085806811228395
4 O 0 0.0005392423481680453
% O 0 9.332285117125139e-05
- O 0 0.0030515738762915134
23 O 0 0.0009971789550036192
% O 0 0.00011555889795999974
( O 0 0.0015050246147438884
P O 1 0.8410443067550659
< O 0 0.06399670243263245
. O 0 0.00058651965809986
0001 O 1 0.7537329792976379
) O 0 0.0005032406188547611
, O 0 0.00020499438687693328
suggesting O 0 0.0028181038796901703
that O 0 3.853944508591667e-05
differences O 0 0.0004061417712364346
in O 0 4.247723700245842e-05
methods O 0 0.00015510951925534755
used O 0 7.762969471514225e-05
for O 0 0.00012448255438357592
mutation O 0 0.0023617148399353027
detection O 0 0.021692778915166855
or O 0 0.0018074146937578917
phenotype O 1 0.9908294677734375
classification O 1 0.8247427940368652
may O 0 0.0008800848736427724
account O 0 5.6763634347589687e-05
for O 0 3.2471190934302285e-05
a O 0 8.15550156403333e-05
considerable O 0 0.00019956541655119509
proportion O 0 0.00017965742154046893
of O 0 4.407589585753158e-05
genotype O 1 0.942834198474884
- O 0 0.049957260489463806
phenotype O 0 0.06887838244438171
inconsistencies O 0 0.014404218643903732
. O 0 0.000492048158776015

Our O 0 0.0003944631898775697
data O 0 7.324889884330332e-05
indicate O 0 0.00022949707636144012
that O 0 2.87575603579171e-05
the O 0 0.0007407204830087721
PAH O 1 0.9999998807907104
- O 0 0.01397156435996294
mutation O 0 0.0024835639633238316
genotype O 0 0.016399770975112915
is O 0 9.63255442911759e-05
the O 0 4.246833123033866e-05
main O 0 0.0005152524681761861
determinant O 0 0.009001726284623146
of O 0 6.674420728813857e-05
metabolic O 1 0.9992958307266235
phenotype O 0 0.20625893771648407
in O 0 0.00012921432789880782
most O 0 0.0005450713797472417
patients O 1 0.9999986886978149
with O 0 0.004408030770719051
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0010620406828820705

In O 0 0.0003033144457731396
the O 0 0.00010561693488853052
present O 0 0.00022298796102404594
study O 0 0.000783280935138464
, O 0 5.382941890275106e-05
the O 0 6.935080455150455e-05
classification O 0 0.0046957978047430515
of O 0 4.532079037744552e-05
105 O 0 0.09235422313213348
PAH O 1 0.9999998807907104
mutations O 0 0.0057706222869455814
may O 0 0.00042511854553595185
allow O 0 6.148174725240096e-05
the O 0 4.385987631394528e-05
prediction O 0 0.0021395599469542503
of O 0 5.556601990974741e-06
the O 0 0.00014466317952610552
biochemical O 0 0.02967838943004608
phenotype O 0 0.050465915352106094
in O 0 0.00031059866887517273
> O 0 0.013850478455424309
10 O 0 0.00037485314533114433
, O 0 0.0002480013354215771
000 O 0 0.00778275215998292
genotypes O 0 0.07048548012971878
, O 0 0.0002824021503329277
which O 0 7.740417640889063e-05
may O 0 0.00036330943112261593
be O 0 1.8505983462091535e-05
useful O 0 0.00028852419927716255
for O 0 6.150286208139732e-05
the O 0 0.00018205441301688552
management O 0 0.042933475226163864
of O 0 0.00010448278044350445
hyperphenylalaninemia B-Disease 1 0.9999434947967529
in O 0 0.0006536167347803712
newborns O 1 0.9968798160552979
. O 0 0.0004551746242213994

Somatic O 0 0.029685121029615402
instability O 0 0.00392213836312294
of O 0 2.4235949240392074e-05
the O 0 0.0007531289011240005
CTG O 1 0.998011589050293
repeat O 0 0.013751734048128128
in O 0 0.00018693222955334932
mice O 0 0.003299667499959469
transgenic O 0 0.000967590429354459
for O 0 9.515523561276495e-05
the O 0 0.001353959902189672
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.016395602375268936
is O 0 0.0007489581475965679
age O 0 0.0007823745836503804
dependent O 0 0.0017315716249868274
but O 0 0.00010848182864720002
not O 0 6.440289143938571e-05
correlated O 0 0.0017695068381726742
to O 0 2.122383375535719e-05
the O 0 4.492893276619725e-05
relative O 0 0.0006268829456530511
intertissue O 0 0.0570935495197773
transcription O 0 0.0014600041322410107
levels O 0 0.0038070541340857744
and O 0 0.0004903782391920686
proliferative O 1 0.9999747276306152
capacities O 0 0.046915676444768906
. O 0 0.0007438508910126984

A O 0 0.013751442544162273
( O 0 0.0031394928228110075
CTG O 1 0.9929282069206238
) O 0 0.0008290391997434199
nexpansion O 0 0.03877950832247734
in O 0 7.406338409055024e-05
the O 0 0.00015472235099878162
3 O 0 0.0013173881452530622
- O 0 0.005318233277648687
untranslated O 0 0.0458139032125473
region O 0 0.0033785963896661997
( O 0 0.0007225855952128768
UTR O 0 0.10421573370695114
) O 0 4.2089894122909755e-05
of O 0 5.57216571905883e-06
the O 0 0.0005729319527745247
DM O 1 0.999998927116394
protein O 0 0.0013668830506503582
kinase O 0 0.01221412606537342
gene O 0 0.0027046320028603077
( O 0 0.0009964340133592486
DMPK O 1 0.9952449202537537
) O 0 0.0001380571338813752
is O 0 6.931140524102375e-05
responsible O 0 0.0010732372757047415
for O 0 0.00043576848111115396
causing O 1 0.999500036239624
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.5908253192901611
DM B-Disease 1 1.0
) O 0 0.0015049980720505118
. O 0 0.0004252514918334782

Major O 0 0.015706103295087814
instability O 0 0.017099536955356598
, O 0 0.0001540518132969737
with O 0 3.8456139009213075e-05
very O 0 0.00032014655880630016
large O 0 0.0002000405511353165
expansions O 0 0.005535324569791555
between O 0 0.0001159786042990163
generations O 0 0.000551101693417877
and O 0 0.0001199416583403945
high O 0 0.0019585981499403715
levels O 0 0.0013758738059550524
of O 0 3.76949246856384e-05
somatic O 0 0.07016415894031525
mosaicism O 1 0.9985520243644714
, O 0 0.00022692950733471662
is O 0 0.00014751106209587306
observed O 0 0.00040740318945609033
in O 0 0.00042330691940151155
patients O 1 0.9999899864196777
. O 0 0.0004436259332578629

There O 0 0.00024190600379370153
is O 0 0.00011986675235675648
a O 0 0.00021892815129831433
good O 0 0.0010356392012909055
correlation O 0 0.001062131836079061
between O 0 0.0001861146156443283
repeat O 0 0.008002960123121738
size O 0 0.0005220847087912261
( O 0 0.0003259180230088532
at O 0 0.0003494011180009693
least O 0 0.00014110222400631756
in O 0 0.0002039118844550103
leucocytes O 1 0.929606556892395
) O 0 0.0004238164401613176
, O 0 0.0006724178674630821
clinical O 1 0.9999892711639404
severity O 1 0.9997177720069885
and O 0 0.00014564700541086495
age O 0 0.0003225259715691209
of O 0 6.0333608416840434e-05
onset O 1 0.9999452829360962
. O 0 0.0008902657427825034

The O 0 0.0025227172300219536
trinucleotide O 1 0.9683162569999695
repeat O 0 0.016404971480369568
instability O 0 0.006278722546994686
mechanisms O 0 0.0012646279064938426
involved O 0 0.0014399141073226929
in O 0 0.0013425556244328618
DM B-Disease 1 1.0
and O 0 0.0001579758245497942
other O 0 5.9775244153570384e-05
human O 0 0.021044639870524406
genetic B-Disease 1 0.9998915195465088
diseases I-Disease 1 1.0
are O 0 6.26175751676783e-05
unknown O 0 0.000782535586040467
. O 0 0.0002742441138252616

We O 0 0.0006412668735720217
studied O 0 0.0010959368664771318
somatic O 0 0.007095756474882364
instability O 0 0.0029553272761404514
by O 0 2.35192637774162e-05
measuring O 0 0.004450555425137281
the O 0 0.0015836548991501331
CTG O 1 0.9967273473739624
repeat O 0 0.019824709743261337
length O 0 0.0009446798358112574
at O 0 0.0004892484284937382
several O 0 6.363738793879747e-05
ages O 0 0.0007675490342080593
in O 0 4.281429573893547e-05
various O 0 2.8230224415892735e-05
tissues O 0 0.008200419135391712
of O 0 2.475477958796546e-05
transgenic O 0 0.006089562084525824
mice O 0 0.0029933424666523933
carrying O 0 0.00024568295339122415
a O 0 0.0006096173892728984
( O 0 0.0015400669071823359
CTG O 1 0.9982717037200928
) O 0 0.001049312180839479
55expansion O 0 0.10477111488580704
surrounded O 0 0.003640309674665332
by O 0 2.8927763196406886e-05
45 O 0 0.00027177968877367675
kb O 0 0.0034944056533277035
of O 0 8.071913725871127e-06
the O 0 0.0003691270831041038
human O 0 0.02799527533352375
DM B-Disease 1 0.9999996423721313
region O 0 0.0028094130102545023
, O 0 4.257326872902922e-05
using O 0 3.597429531509988e-05
small O 0 0.00015783940034452826
- O 0 0.00346867716871202
pool O 0 0.005327614024281502
PCR O 0 0.013881365768611431
. O 0 0.00042311730794608593

These O 0 0.0002315609744982794
mice O 0 0.007694875355809927
have O 0 4.5335742470342666e-05
been O 0 9.903650789055973e-05
shown O 0 0.0002024940331466496
to O 0 3.349384860484861e-05
reproduce O 0 0.0005213668337091804
the O 0 0.00011800896027125418
intergenerational O 0 0.05498974397778511
and O 0 0.0001556367933517322
somatic O 0 0.0074453349225223064
instability O 0 0.002104149665683508
of O 0 1.0225790902040899e-05
the O 0 0.00027108300128020346
55 O 0 0.010693228803575039
CTG O 1 0.9977625608444214
repeat O 0 0.025253551080822945
suggesting O 0 0.0034720762632787228
that O 0 5.965361197013408e-05
surrounding O 0 0.00047073711175471544
sequences O 0 2.439846321067307e-05
and O 0 4.372598777990788e-05
the O 0 0.00011934657959500328
chromatin O 0 0.007109691854566336
environment O 0 0.001963872229680419
are O 0 1.9720959244295955e-05
involved O 0 0.00041306758066639304
in O 0 0.00012557461741380394
instability O 0 0.008275389671325684
mechanisms O 0 0.004424315877258778
. O 0 0.0007266932516358793

As O 0 0.0006219174829311669
observed O 0 0.00027885654708370566
in O 0 2.0604824385372922e-05
some O 0 4.62645812149276e-06
of O 0 5.008210791856982e-06
the O 0 0.00018971017561852932
tissues O 1 0.739159882068634
of O 0 0.0010555005865171552
DM B-Disease 1 1.0
patients O 1 0.9999997615814209
, O 0 0.0001296316913794726
there O 0 3.287552681285888e-05
is O 0 7.764280599076301e-05
a O 0 0.00024195537844207138
tendency O 0 0.0034777792170643806
for O 0 0.00022006371000315994
repeat O 0 0.007246767170727253
length O 0 0.0005242521874606609
and O 0 0.0002674073039088398
somatic O 0 0.04809267818927765
mosaicism O 1 0.9903834462165833
to O 0 8.131388312904164e-05
increase O 0 0.0001344493794022128
with O 0 2.343490268685855e-05
the O 0 9.259702346753329e-05
age O 0 0.00024391632177866995
of O 0 9.76167393673677e-06
the O 0 0.0003012368979398161
mouse O 0 0.011981152929365635
. O 0 0.0004812844272237271

Furthermore O 0 0.009652230888605118
, O 0 0.00016885098011698574
we O 0 9.802216663956642e-05
observed O 0 0.00020824235980398953
no O 0 5.156273255124688e-05
correlation O 0 0.00040614602039568126
between O 0 3.58186116500292e-05
the O 0 9.56828662310727e-05
somatic O 0 0.008664526045322418
mutation O 0 0.0013234219513833523
rate O 0 0.0001670427154749632
and O 0 0.00019980913202743977
tissue O 1 0.99933260679245
proliferation O 0 0.04370427131652832
capacity O 0 0.0031707847956568003
. O 0 0.0003909995430149138

The O 0 0.0006430650246329606
somatic O 0 0.01792212761938572
mutation O 0 0.0023226914927363396
rates O 0 0.00037914031418040395
in O 0 5.727289317292161e-05
different O 0 3.240616206312552e-05
tissues O 0 0.0576288215816021
were O 0 4.43252210970968e-05
also O 0 0.00010080901847686619
not O 0 3.945413845940493e-05
correlated O 0 0.0010556018678471446
to O 0 1.647754652367439e-05
the O 0 3.791708149947226e-05
relative O 0 0.0006199402268975973
inter O 0 0.04159674420952797
- O 0 0.01616889238357544
tissue O 0 0.2391805648803711
difference O 0 0.0006379514234140515
in O 0 6.394373485818505e-05
transcriptional O 0 0.0019338092533871531
levels O 0 0.0007230505580082536
of O 0 4.84694101032801e-06
the O 0 4.6574485168093815e-05
three O 0 3.929263766622171e-05
genes O 0 0.00036915912642143667
( O 0 0.0009380123810842633
DMAHP O 1 0.9976149797439575
, O 0 0.0010591973550617695
DMPK O 1 0.9873220324516296
and O 0 0.0003614366869442165
59 O 0 0.00783225055783987
) O 0 0.00016804020560812205
surrounding O 0 0.0007654294022358954
the O 0 0.00023375039745587856
repeat O 0 0.01648685336112976
. O 0 0.00019174496992491186
. O 0 0.00030943175079301

A O 0 0.004603327717632055
novel O 0 0.0029963436536490917
missense O 0 0.019357167184352875
mutation O 0 0.003103278111666441
in O 0 0.0004964550025761127
patients O 1 0.9999604225158691
from O 0 0.00012350110046099871
a O 0 0.0018138790037482977
retinoblastoma B-Disease 1 0.9999593496322632
pedigree O 0 0.2450769543647766
showing O 0 0.0014464957639575005
only O 0 0.00012335175415500998
mild O 1 0.96219801902771
expression O 0 0.00019454305584076792
of O 0 1.4012151950737461e-05
the O 0 0.0009521127212792635
tumor B-Disease 1 0.9999994039535522
phenotype O 1 0.7681167125701904
. O 0 0.0005160297150723636

We O 0 0.000333790376316756
have O 0 1.70453804457793e-05
used O 0 3.822065264103003e-05
single O 0 0.0001613464264664799
strand O 0 0.0033522234298288822
conformation O 0 0.003130241995677352
polymorphism O 0 0.0013342705788090825
analysis O 0 0.00017664875485934317
to O 0 6.216704787220806e-05
study O 0 0.0004120781959500164
the O 0 0.00010404472413938493
27 O 0 0.0008339702035300434
exons O 0 0.0008806318510323763
of O 0 1.4345218005473725e-05
the O 0 0.001150817726738751
RB1 O 1 0.9999644756317139
gene O 0 0.0018932635430246592
in O 0 7.057490438455716e-05
individuals O 0 6.764513091184199e-05
from O 0 3.7921567127341405e-05
a O 0 0.0003540277248248458
family O 0 0.0007037041941657662
showing O 0 0.0037433907855302095
mild O 1 0.9874676465988159
expression O 0 0.0002621973108034581
of O 0 1.385482755722478e-05
the O 0 0.0009576853481121361
retinoblastoma B-Disease 1 0.9999877214431763
phenotype O 1 0.9149872064590454
. O 0 0.0006981614860706031

In O 0 0.00028567176195792854
this O 0 4.038440602016635e-05
family O 0 0.0004050079733133316
affected O 0 0.0023373321164399385
individuals O 0 0.00029008922865614295
developed O 0 0.3515978157520294
unilateral B-Disease 1 0.9993158578872681
tumors I-Disease 1 1.0
and O 0 0.0002813948376569897
, O 0 9.32559632929042e-05
as O 0 6.430286157410592e-05
a O 0 0.00013018405297771096
result O 0 0.00010154623305425048
of O 0 1.252213587576989e-05
linkage O 0 0.01988019235432148
analysis O 0 0.0005485042929649353
, O 0 0.0003812715585809201
unaffected O 1 0.9075646996498108
mutation O 0 0.004471588879823685
carriers O 0 0.005667685065418482
were O 0 3.267022475483827e-05
also O 0 9.554520511301234e-05
identified O 0 0.0001619619142729789
within O 0 2.4068775019259192e-05
the O 0 0.00018112182442564517
pedigree O 0 0.04548207297921181
. O 0 0.0006577317253686488

A O 0 0.0025806757621467113
single O 0 0.00023495699861086905
band O 0 0.0005768118426203728
shift O 0 0.000868153409101069
using O 0 0.0004213643551338464
SSCP O 1 0.9968235492706299
was O 0 0.0012421131832525134
identified O 0 0.0005106973112560809
in O 0 0.0001373494160361588
exon O 0 0.026277149096131325
21 O 0 0.000944150669965893
which O 0 2.9526550861191936e-05
resulted O 0 0.00046481742174364626
in O 0 4.8484613216714934e-05
a O 0 0.00030548812355846167
missense O 0 0.005690195132046938
mutation O 0 0.0004760307783726603
converting O 0 0.00044053318561054766
a O 0 0.0019063540967181325
cys O 1 0.9976678490638733
- O 0 0.025346148759126663
- O 0 0.013820324093103409
> O 0 0.019420750439167023
arg O 0 0.06519266963005066
at O 0 0.00031319932895712554
nucleotide O 0 0.00018638402980286628
position O 0 0.0012819323455914855
28 O 0 0.0006912347162142396
in O 0 4.315604383009486e-05
the O 0 0.0001988493459066376
exon O 0 0.04340910166501999
. O 0 0.0005329415434971452

The O 0 0.0005799169884994626
mutation O 0 0.0018743476830422878
destroyed O 0 0.002349263522773981
an O 0 0.00013649137690663338
NdeI O 0 0.07668407261371613
restriction O 0 0.0005873386398889124
enzyme O 0 0.0023888293653726578
site O 0 0.0016738669946789742
. O 0 0.00025624476256780326

Analysis O 0 0.000397249823436141
of O 0 1.3853322343493346e-05
all O 0 3.270856905146502e-05
family O 0 0.00037432124372571707
members O 0 5.685410360456444e-05
demonstrated O 0 0.001218289602547884
that O 0 1.5330097085097805e-05
the O 0 8.835118205752224e-05
missense O 0 0.017758285626769066
mutation O 0 0.004416727460920811
co O 0 0.022716782987117767
- O 0 0.005600824020802975
segregated O 0 0.00969582237303257
with O 0 0.0004869613330811262
patients O 1 0.9999988079071045
with O 0 0.0015372816706076264
tumors B-Disease 1 1.0
or O 0 0.0013770621735602617
who O 0 0.0006086345529183745
, O 0 8.021167013794184e-05
as O 0 6.614177982555702e-05
a O 0 0.0001739750587148592
result O 0 0.00017484198906458914
of O 0 1.7545207811053842e-05
linkage O 0 0.019965169951319695
analysis O 0 0.0005442293477244675
had O 0 0.0004570990859065205
been O 0 0.0001464698143536225
predicted O 0 0.0005385268596000969
to O 0 1.3303407286002766e-05
carry O 0 8.758981857681647e-05
the O 0 0.00010658263636287302
predisposing O 0 0.0983976200222969
mutation O 0 0.0032247279305011034
. O 0 0.00030930613866075873

These O 0 6.9925888965372e-05
observations O 0 0.0005089959013275802
point O 0 0.0002944802981801331
to O 0 3.859792559524067e-05
another O 0 0.00012499043077696115
region O 0 0.00021426942839752883
of O 0 1.0034132174041588e-05
the O 0 0.001210020505823195
RB1 O 1 0.9999662637710571
gene O 0 0.0028338416013866663
where O 0 0.00017938559176400304
mutations O 0 0.0005398446228355169
only O 0 2.9931228709756397e-05
modify O 0 0.002041332423686981
the O 0 3.850014036288485e-05
function O 0 0.00012428163609001786
of O 0 6.9869993239990436e-06
the O 0 0.00015749182784929872
gene O 0 0.0013559418730437756
and O 0 6.814780499553308e-05
raise O 0 0.00047840739716775715
important O 0 0.00018819877004716545
questions O 0 0.0004441087075974792
for O 0 0.00022313791851047426
genetic O 0 0.005748112220317125
counseling O 1 0.9880643486976624
in O 0 0.00014703515626024455
families O 0 8.509425242664292e-05
with O 0 2.5562538212398067e-05
these O 0 3.083511546719819e-05
distinctive O 0 0.029961319640278816
phenotypes O 0 0.08034122735261917
. O 0 0.00022587353305425495
. O 0 0.0003059649607166648

Maternal B-Disease 0 0.36269712448120117
disomy I-Disease 1 0.9922502040863037
and O 0 0.0027039276901632547
Prader B-Disease 1 1.0
- I-Disease 1 0.9999823570251465
Willi I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
consistent O 0 0.009072402492165565
with O 0 0.00026883374084718525
gamete O 1 0.8454304933547974
complementation O 1 0.9960107803344727
in O 0 0.0001252443325938657
a O 0 0.00019452895503491163
case O 0 0.00038710248190909624
of O 0 2.790645339700859e-05
familial O 1 0.9995607733726501
translocation O 0 0.09431901574134827
( O 0 0.0010586598655208945
3 O 0 0.0010784987825900316
; O 0 0.00013561101513914764
15 O 0 0.0007026982493698597
) O 0 0.00024355982895940542
( O 0 0.0009014820097945631
p25 O 1 0.7504510879516602
; O 0 0.00043176175677217543
q11 O 0 0.03266213461756706
. O 0 0.00017074002244044095
2 O 0 0.0007201883709058166
) O 0 0.00017412194574717432
. O 0 0.00017691745597403497

Maternal B-Disease 1 0.9930835962295532
uniparental I-Disease 1 0.999935507774353
disomy I-Disease 1 0.9970811009407043
( I-Disease 0 0.00883295014500618
UPD I-Disease 1 0.9999746084213257
) I-Disease 0 0.00045213461271487176
for I-Disease 0 0.00019046288798563182
chromosome I-Disease 0 0.0018212593859061599
15 I-Disease 0 0.00040230972808785737
is O 0 0.00013756541011389345
responsible O 0 0.0014185712207108736
for O 0 7.654937508050352e-05
an O 0 0.00012127387890359387
estimated O 0 0.0005860843230038881
30 O 0 0.00020567492174450308
% O 0 5.7608231145422906e-06
of O 0 4.615863417711807e-06
cases O 0 0.0005525618325918913
of O 0 0.00016707886243239045
Prader B-Disease 1 1.0
- I-Disease 1 0.9999961853027344
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.03349054977297783
PWS B-Disease 1 0.9999998807907104
) O 0 0.0012355054495856166
. O 0 0.00037137922481633723

We O 0 0.0007713446393609047
report O 0 0.0003639047499746084
on O 0 5.192244498175569e-05
an O 0 7.56839508539997e-05
unusual O 0 0.0007400950416922569
case O 0 0.0006255056359805167
of O 0 2.7066695110988803e-05
maternal B-Disease 1 0.7216355800628662
disomy I-Disease 1 0.9896463751792908
15 I-Disease 0 0.0015685061225667596
in O 0 0.0011254734126850963
PWS B-Disease 1 0.9999995231628418
that O 0 0.00010797085997182876
is O 0 0.00010644987924024463
most O 0 4.4012016587657854e-05
consistent O 0 0.0015129772946238518
with O 0 8.157205593306571e-05
adjacent O 0 0.004232516046613455
- O 0 0.003310688305646181
1 O 0 0.0004704988969024271
segregation O 0 0.002227499382570386
of O 0 6.035089427314233e-06
a O 0 0.0007697875844314694
paternal O 0 0.04846243932843208
t O 1 0.9859502911567688
( O 0 0.0005986853502690792
3 O 0 0.000976235547568649
; O 0 8.712698763702065e-05
15 O 0 0.0005104761221446097
) O 0 0.00024849624605849385
( O 0 0.0008437462383881211
p25 O 1 0.8886926174163818
; O 0 0.0005102549912407994
q11 O 0 0.04026176780462265
. O 0 0.0001382857299176976
2 O 0 0.0004001038323622197
) O 0 2.69340343947988e-05
with O 0 1.0829553502844647e-05
simultaneous O 0 0.00060568394837901
maternal O 0 0.32885900139808655
meiotic O 1 0.9960973858833313
nondisjunction O 0 0.40704143047332764
for O 0 0.00029195009847171605
chromosome O 0 0.0020686849020421505
15 O 0 0.0006502033211290836
. O 0 0.00020163704175502062

The O 0 0.0016531306318938732
patient O 1 0.9999175071716309
( O 0 0.0031354748643934727
J O 1 0.9999195337295532
. O 0 0.0005112544749863446
B O 0 0.0797557607293129
. O 0 9.769685129867867e-05
) O 0 5.387270721257664e-05
, O 0 4.5877557568019256e-05
a O 0 0.00031279498944059014
17 O 0 0.0020132113713771105
- O 0 0.003050493076443672
year O 0 0.000951454509049654
- O 0 0.004852445796132088
old O 0 0.0032421904616057873
white O 0 0.009827638976275921
male O 0 0.002432765904814005
with O 0 0.0013948671985417604
PWS B-Disease 1 0.9999998807907104
, O 0 0.0009029218344949186
was O 0 0.0011809825664386153
found O 0 0.00013153578038327396
to O 0 2.1517178538488224e-05
have O 0 2.3551314370706677e-05
47 O 0 0.0004265881434548646
chromosomes O 0 6.202151416800916e-05
with O 0 1.9988232452305965e-05
a O 0 0.0009730496094562113
supernumerary O 1 0.9900587201118469
, O 0 0.0007412454579025507
paternal O 0 0.047377705574035645
der O 1 0.9996360540390015
( O 0 0.0009319644887000322
15 O 0 0.0005953644867986441
) O 0 3.336849113111384e-05
consisting O 0 1.7273099729209207e-05
of O 0 6.358015525620431e-06
the O 0 0.0002195368433604017
short O 0 0.004566495772451162
arm O 1 0.9827026128768921
and O 0 0.0002067945897579193
the O 0 0.0005472750635817647
proximal O 1 0.9995204210281372
long O 0 0.009306640364229679
arm O 0 0.054434988647699356
of O 0 4.4150907342555e-05
chromosome O 0 0.0018810647306963801
15 O 0 0.0004416684387251735
, O 0 9.870416397461668e-05
and O 0 0.0002322109939996153
distal O 1 0.999001681804657
chromosome O 0 0.02309586852788925
arm O 1 0.9968198537826538
3p O 1 0.9906449317932129
. O 0 0.0011361971264705062

The O 0 0.003189519513398409
t O 1 0.879336953163147
( O 0 0.0008172391098923981
3 O 0 0.001022735028527677
; O 0 0.0001330004452029243
15 O 0 0.0007059691706672311
) O 0 0.00013510607823263854
was O 0 0.00046545505756512284
present O 0 7.64669239288196e-05
in O 0 3.8009980926290154e-05
the O 0 5.6366727221757174e-05
balanced O 0 0.0012143307831138372
state O 0 8.088722097454593e-05
in O 0 8.591818186687306e-05
the O 0 0.0008674050914123654
patients O 1 0.9999970197677612
father O 0 0.0020443450193852186
and O 0 8.683477062731981e-05
a O 0 0.00093814916908741
sister O 0 0.005252071190625429
. O 0 0.0005603774334304035

Fluorescent O 0 0.04447432979941368
in O 0 0.0003980688634328544
situ O 0 0.03509414568543434
hybridization O 0 0.00038012798177078366
analysis O 0 0.00019219284877181053
demonstrated O 0 0.0017513484926894307
that O 0 5.8176978200208396e-05
the O 0 0.0009497453575022519
PWS B-Disease 1 0.9999984502792358
critical O 0 0.03250042349100113
region O 0 0.0042343949899077415
resided O 0 0.004889338742941618
on O 0 7.011700654402375e-05
the O 0 9.509019582765177e-05
derivative O 0 0.007177904713898897
chromosome O 0 0.0026814700104296207
3 O 0 0.0005005519487895072
and O 0 4.635577352019027e-05
that O 0 2.784358184726443e-05
there O 0 4.629736940842122e-05
was O 0 0.0004213993379380554
no O 0 7.911502325441688e-05
deletion O 0 0.0013994703767821193
of O 0 2.1334308257792145e-05
the O 0 0.0020493834745138884
PWS B-Disease 1 0.9999966621398926
region O 0 0.0035885146353393793
on O 0 0.0001240034616785124
the O 0 9.32132825255394e-05
normal O 0 0.0013259073020890355
pair O 0 0.0001783466141205281
of O 0 3.0215207516448572e-05
15s O 1 0.5917297601699829
present O 0 0.0003851247893180698
in O 0 0.0008443450788035989
J O 1 0.9996397495269775
. O 0 0.000632742652669549

B O 1 0.65592360496521
. O 0 0.0006996911251917481

Methylation O 0 0.0017055090283975005
analysis O 0 0.00028504981310106814
at O 0 0.0007290776702575386
exon O 0 0.009045128710567951
alpha O 0 0.0003157717874273658
of O 0 2.8687672966043465e-06
the O 0 4.001271372544579e-05
small O 0 0.00018657217151485384
nuclear O 0 0.008772239089012146
ribonucleoprotein O 1 0.9965231418609619
- O 0 0.004561601672321558
associated O 0 0.0003736832004506141
polypeptide O 0 0.009392311796545982
N O 0 0.02513488382101059
( O 0 0.0017696787836030126
SNRPN O 1 0.9958529472351074
) O 0 0.0003725604328792542
gene O 0 0.001097323140129447
showed O 0 0.0007040435448288918
a O 0 0.00031957810278981924
pattern O 0 0.0018426409224048257
characteristic O 0 0.0009609743719920516
of O 0 8.99226597539382e-06
only O 0 3.55030206264928e-05
the O 0 0.00012088237417628989
maternal O 0 0.013024951331317425
chromosome O 0 0.0020626874174922705
15 O 0 0.0007022797944955528
in O 0 0.000492811668664217
J O 1 0.9995538592338562
. O 0 0.0006987256347201765

B O 1 0.843214213848114
. O 0 0.0009182530920952559

Maternal B-Disease 1 0.8226033449172974
disomy I-Disease 1 0.9888203740119934
was O 0 0.002412419533357024
confirmed O 0 0.0010267641628161073
by O 0 1.940947913681157e-05
polymerase O 0 0.0031958974432200193
chain O 0 0.0025087171234190464
reaction O 0 0.00039959215791895986
analysis O 0 9.734014020068571e-05
of O 0 3.235046096961014e-05
microsatellite O 0 0.05788843706250191
repeats O 0 0.0041729845106601715
at O 0 0.0002622628235258162
the O 0 0.00010003271017922089
gamma O 0 0.009958622045814991
- O 0 0.0038747023791074753
aminobutyric O 0 0.030872108414769173
acid O 0 0.005435515195131302
receptor O 0 0.003939627669751644
beta3 O 0 0.039321452379226685
subunit O 0 0.0032684928737580776
( O 0 0.0014695421559736133
GABRB3 O 1 0.9954460859298706
) O 0 0.0005448184092529118
locus O 0 0.014301548711955547
. O 0 0.0004376651195343584

A O 0 0.01880755089223385
niece O 1 0.8357885479927063
( O 0 0.002454785630106926
B O 1 0.9588009715080261
. O 0 0.0005173690733499825
B O 0 0.33822160959243774
. O 0 0.00016261650307569653
) O 0 7.394884596578777e-05
with O 0 3.094076964771375e-05
45 O 0 0.0003190237912349403
chromosomes O 0 0.0001820875477278605
and O 0 5.579684875556268e-05
the O 0 0.00014123496657703072
derivative O 0 0.007311165798455477
3 O 0 0.0006361259729601443
but O 0 7.667057070648298e-05
without O 0 0.0001083396709873341
the O 0 0.00044371982221491635
der O 1 0.996338963508606
( O 0 0.000699761847499758
15 O 0 0.000735159614123404
) O 0 0.0001315957633778453
demonstrated O 0 0.0018404725706204772
a O 0 0.0008399270591326058
phenotype O 0 0.058486342430114746
consistent O 0 0.00260395766235888
with O 0 4.8763151426101103e-05
that O 0 7.220791303552687e-05
reported O 0 0.0010907977120950818
for O 0 0.0001084556570276618
haploinsufficiency O 0 0.034770071506500244
of O 0 6.351582851493731e-05
distal O 1 0.9985699653625488
3 O 0 0.005007527768611908
p O 0 0.020532093942165375
. O 0 0.00039418291999027133

Uniparental B-Disease 1 0.9999988079071045
disomy I-Disease 1 0.9992167949676514
associated O 0 0.000947799242567271
with O 0 9.630478598410264e-05
unbalanced O 1 0.9147986173629761
segregation O 0 0.008788283914327621
of O 0 2.969604065583553e-05
non O 0 0.00630977051332593
- O 0 0.025479977950453758
Robertsonian O 1 0.9811456799507141
translocations O 0 0.025260714814066887
has O 0 0.0005945201264694333
been O 0 0.00038253358798101544
reported O 0 0.0020150544587522745
previously O 0 0.0007215328514575958
but O 0 0.0001426316302968189
has O 0 0.00022817010176368058
not O 0 5.1862669351976365e-05
, O 0 3.6421912227524444e-05
to O 0 2.2340960640576668e-05
our O 0 0.00015774733037687838
knowledge O 0 0.0014177541015669703
, O 0 0.00012245522520970553
been O 0 0.00010453759750816971
observed O 0 0.00010401992039987817
in O 0 3.20091494359076e-05
a O 0 0.0002214444539276883
case O 0 0.0010931743308901787
of O 0 0.0001809202367439866
PWS B-Disease 1 0.9999997615814209
. O 0 0.0017292737029492855

Furthermore O 0 0.00920511968433857
, O 0 0.00025059544714167714
our O 0 0.00047201753477565944
findings O 0 0.00142580212559551
are O 0 6.425235824281117e-06
best O 0 0.0001227156608365476
interpreted O 0 0.00015534144768025726
as O 0 9.16458448045887e-05
true O 0 0.0009592687129043043
gamete O 0 0.08453603088855743
complementation O 1 0.9802355766296387
resulting O 0 0.0016989081632345915
in O 0 0.0003404819290153682
maternal B-Disease 1 0.9753257632255554
UPD I-Disease 1 0.9999939203262329
15 I-Disease 0 0.00435007456690073
and O 0 0.0018930834485217929
PWS B-Disease 1 0.9999979734420776

Schwartz B-Disease 1 0.9961307048797607
- I-Disease 1 0.9453093409538269
Jampel I-Disease 1 0.9998251795768738
syndrome I-Disease 1 1.0
type I-Disease 0 0.007774075027555227
2 I-Disease 0 0.0006043331231921911
and O 0 0.00018889846978709102
Stuve B-Disease 1 0.9998077750205994
- I-Disease 1 0.998354971408844
Wiedemann I-Disease 1 0.9999895095825195
syndrome I-Disease 1 1.0
: O 0 0.00036603110493160784
a O 0 0.00033219289616681635
case O 0 0.0007131530437618494
for O 0 9.87148960120976e-05
" O 0 0.0005611561355181038
lumping O 0 0.03931402042508125
" O 0 0.0009632458677515388
. O 0 0.0002834001206792891

Recent O 0 0.003028667299076915
studies O 0 0.0008635460981167853
demonstrated O 0 0.002062293002381921
the O 0 8.063162385951728e-05
existence O 0 0.00036270468262955546
of O 0 8.835133485263214e-06
a O 0 0.00034838728606700897
genetically O 0 0.0006791298510506749
distinct O 0 0.0004914248129352927
, O 0 0.0001988501171581447
usually O 0 0.00023252559185493737
lethal O 0 0.004612225107848644
form O 0 4.319092113291845e-05
of O 0 5.646910267387284e-06
the O 0 0.000277152779744938
Schwartz B-Disease 1 0.9996665716171265
- I-Disease 1 0.9869654178619385
Jampel I-Disease 1 0.9999185800552368
syndrome I-Disease 1 1.0
( O 0 0.008225136436522007
SJS B-Disease 1 0.9999954700469971
) O 0 0.0002109626802848652
of O 0 9.079415758606046e-05
myotonia B-Disease 1 0.9999958276748657
and O 0 0.0031417140271514654
skeletal B-Disease 1 0.9999992847442627
dysplasia I-Disease 1 0.9999998807907104
, O 0 0.0003845315659418702
which O 0 3.5392818972468376e-05
we O 0 0.00018828814791049808
called O 0 0.005412174388766289
SJS B-Disease 1 0.9999821186065674
type I-Disease 0 0.011764030903577805
2 I-Disease 0 0.0013351311208680272
. O 0 0.0002614289987832308

This O 0 0.0013536722399294376
disorder O 1 0.9999923706054688
is O 0 0.00035213466617278755
reminiscent O 0 0.0011502550914883614
of O 0 1.4067799384065438e-05
another O 0 0.0007176800863817334
rare O 0 0.054990578442811966
condition O 1 0.9993316531181335
, O 0 7.826857472537085e-05
the O 0 0.00022565505059901625
Stuve B-Disease 1 0.9998235106468201
- I-Disease 1 0.9987857937812805
Wiedemann I-Disease 1 0.9999946355819702
syndrome I-Disease 1 1.0
( O 0 0.005915340036153793
SWS B-Disease 1 0.9999551773071289
) O 0 0.0003744452551472932
, O 0 8.270384569186717e-05
which O 0 2.9622782676597126e-05
comprises O 0 0.0009220510255545378
campomelia B-Disease 1 0.5148095488548279
at O 0 0.0005813525640405715
birth O 0 0.0009400360868312418
with O 0 0.00042763244709931314
skeletal B-Disease 1 0.9999995231628418
dysplasia I-Disease 1 1.0
, O 0 0.00449898187071085
contractures B-Disease 1 0.9999808073043823
, O 0 0.0003727520816028118
and O 0 9.427624172531068e-05
early B-Disease 0 0.0007904506637714803
death I-Disease 0 0.002626902423799038
. O 0 0.00027936752303503454

To O 0 0.0002581193402875215
test O 0 0.0008014471968635917
for O 0 8.77344427863136e-05
possible O 0 0.000717251852620393
nosologic O 1 0.6127820014953613
identity O 0 0.00040854696999303997
between O 0 0.0001448744151275605
these O 0 0.00023082559346221387
disorders O 1 0.9999998807907104
, O 0 0.00041607205639593303
we O 0 0.00021470279898494482
reviewed O 0 0.0011059221578761935
the O 0 5.9772966778837144e-05
literature O 0 0.0001331580861005932
and O 0 5.8301829994888976e-05
obtained O 0 0.0002492287312634289
a O 0 0.00046765690785832703
follow O 0 0.0006026262999512255
- O 0 0.0008831206941977143
up O 0 1.830633482313715e-05
of O 0 2.0327786387497326e-06
the O 0 3.559081596904434e-05
only O 0 2.7761761884903535e-05
two O 0 5.3265066526364535e-05
surviving O 0 0.024022599682211876
patients O 1 0.999964714050293
, O 0 9.922130993800238e-05
one O 0 0.00010074570309370756
with O 0 0.0005050070467405021
SJS B-Disease 1 0.9999915361404419
type I-Disease 0 0.015049101784825325
2 I-Disease 0 0.0013731687795370817
at O 0 0.0008554008090868592
age O 0 0.0007736064144410193
10 O 0 0.00026449296274222434
years O 0 0.0001700313441688195
and O 0 3.7127530958969146e-05
another O 0 0.00026907710707746446
with O 0 0.0003754492790903896
SWS B-Disease 1 0.9999405145645142
at O 0 0.00232980540022254
age O 0 0.0013360584853217006
7 O 0 0.0009842747822403908
years O 0 0.0005271662957966328
. O 0 0.00022620713571086526

Patients O 1 0.999990701675415
reported O 0 0.002170929918065667
as O 0 0.00013801554450765252
having O 0 0.0016496526077389717
either O 0 0.004881982691586018
neonatal O 1 1.0
SJS B-Disease 1 0.9999995231628418
or O 0 0.009248257614672184
SWS B-Disease 1 0.9996930360794067
presented O 0 0.0008966086315922439
a O 0 0.00019057297322433442
combination O 0 0.0006429130444303155
of O 0 7.987922799657099e-06
a O 0 0.0008660201565362513
severe O 1 0.999985933303833
, O 0 0.0008687728550285101
prenatal O 1 0.9999994039535522
- O 1 0.9999032020568848
onset O 1 0.9999998807907104
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.0019356849370524287
with O 0 0.001768902293406427
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999816417694092
contractures I-Disease 1 0.9999998807907104
, O 0 0.01518747303634882
respiratory O 1 1.0
and O 0 0.00047947795246727765
feeding O 0 0.09396125376224518
difficulties O 0 0.30930066108703613
, O 0 0.0003453908138908446
tendency O 0 0.01017970871180296
to O 0 0.0007061649230308831
hyperthermia B-Disease 1 0.9999938011169434
, O 0 0.00024280374054796994
and O 0 0.00014775812451262027
frequent O 0 0.009299111552536488
death O 0 0.0031721037812530994
in O 0 0.0002874267811421305
infancy O 0 0.28909966349601746
) O 0 4.992904359824024e-05
with O 0 8.147148037096485e-06
a O 0 0.0001467518013669178
distinct O 0 0.0007882970967330039
campomelic B-Disease 1 0.9996008276939392
- I-Disease 1 0.960793673992157
metaphyseal I-Disease 1 0.9996953010559082
skeletal I-Disease 1 0.999994158744812
dysplasia I-Disease 1 0.9999991655349731
. O 0 0.0015897192060947418

The O 0 0.0002266194933326915
similarity O 0 0.00027703074738383293
of O 0 1.4057742191653233e-05
the O 0 0.0005415037740021944
clinical O 1 0.9999865293502808
and O 0 0.0006301890825852752
radiographic O 1 0.9999639987945557
findings O 0 0.006801802199333906
is O 0 0.00018462480511516333
so O 0 0.00010830372775672004
extensive O 0 0.001406154129654169
that O 0 5.872265319339931e-05
these O 0 0.00014393340097740293
disorders O 1 0.9999998807907104
appear O 0 0.0012988890521228313
to O 0 2.6972413252224214e-05
be O 0 1.585660720593296e-05
a O 0 8.297598833451048e-05
single O 0 0.00018225186795461923
entity O 0 0.0054375058971345425
. O 0 0.0004989737062714994

The O 0 0.000695017515681684
follow O 0 0.001108621945604682
- O 0 0.0024131631944328547
up O 0 0.00012252085434738547
observation O 0 0.0030384650453925133
of O 0 8.490600521326996e-06
an O 0 0.00011870123125845566
identical O 0 0.00030511844670400023
and O 0 4.593175617628731e-05
unique O 0 0.00025543273659422994
pattern O 0 0.0014770382549613714
of O 0 6.382598076015711e-05
progressive O 1 0.9999880790710449
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9999997615814209
in O 0 0.0002124910824932158
the O 0 0.00017504017159808427
two O 0 0.00024613828281871974
patients O 1 0.9999924898147583
( O 0 0.0002313402947038412
one O 0 0.00011406406702008098
with O 0 0.0006123883067630231
SJS B-Disease 1 0.9999955892562866
type I-Disease 0 0.013236315920948982
2 I-Disease 0 0.0007165737915784121
, O 0 6.723552360199392e-05
one O 0 5.671428152709268e-05
with O 0 0.00035974380443803966
SWS B-Disease 1 0.9999163150787354
) O 0 0.0006419139099307358
surviving O 0 0.0054835425689816475
beyond O 0 0.006609534844756126
infancy O 0 0.4425850510597229
adds O 0 0.003065330907702446
to O 0 4.16349976148922e-05
the O 0 6.889276846777648e-05
evidence O 0 0.0001638070389162749
in O 0 3.9692793507128954e-05
favor O 0 6.381508865160868e-05
of O 0 1.4415089026442729e-05
identity O 0 0.000963448139373213
. O 0 0.0004107580753043294

The O 0 0.0003290773893240839
hypothesis O 0 0.0024022667203098536
that O 0 0.0003497812431305647
SWS B-Disease 1 0.9998489618301392
and O 0 0.0028268247842788696
SJS B-Disease 1 0.9999938011169434
type I-Disease 0 0.011921490542590618
2 I-Disease 0 0.00044754164991900325
are O 0 7.239708793349564e-06
the O 0 9.434828098164871e-05
same O 0 0.0009420117712579668
disorder O 1 0.9999983310699463
should O 0 0.00033867385354824364
be O 0 3.7963032809784636e-05
testable O 0 0.0011268004309386015
by O 0 2.1608440874842927e-05
molecular O 0 0.0011227877112105489
methods O 0 0.00046620721695944667
. O 0 0.00015347148291766644
. O 0 0.0002942768333014101

A O 0 0.004898888058960438
mouse O 0 0.00449121929705143
model O 0 0.00025689933681860566
of O 0 7.83507275627926e-05
severe O 1 0.9999995231628418
von B-Disease 1 0.9999994039535522
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.005494110286235809
defects O 1 0.9999411106109619
in O 0 0.0008454596973024309
hemostasis O 1 0.999997615814209
and O 0 0.00472222687676549
thrombosis B-Disease 1 1.0
. O 0 0.00107447465416044

von B-Disease 1 0.9629903435707092
Willebrand I-Disease 1 0.9998887777328491
factor I-Disease 0 0.006984484847635031
( I-Disease 0 0.0016599108930677176
vWf I-Disease 1 0.9985482096672058
) I-Disease 0 0.005385004449635744
deficiency I-Disease 1 1.0
causes O 1 0.9999657869338989
severe O 1 0.9999998807907104
von B-Disease 1 0.9999997615814209
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.0005103073199279606
humans O 0 0.0019083039369434118
. O 0 0.000297750870231539

We O 0 0.00012824655277654529
generated O 0 3.891648884746246e-05
a O 0 0.0003518948797136545
mouse O 0 0.00394970178604126
model O 0 0.00029776617884635925
for O 0 0.00010267925244988874
this O 0 0.00020426350238267332
disease O 1 0.9999964237213135
by O 0 1.5264640751411207e-05
using O 0 8.596268889959902e-05
gene O 0 0.0008580891299061477
targeting O 0 0.0010358997387811542
. O 0 0.0003296388022135943

vWf B-Disease 1 0.9916817545890808
- I-Disease 1 0.6972454786300659
deficient I-Disease 1 0.9998712539672852
mice O 0 0.012591159902513027
appeared O 0 0.0017547030001878738
normal O 0 0.0021702998783439398
at O 0 0.0011342678917571902
birth O 0 0.002073767362162471
; O 0 7.353627006523311e-05
they O 0 1.8929282305180095e-05
were O 0 2.194867374782916e-05
viable O 0 0.004214727785438299
and O 0 0.00017813211889006197
fertile O 0 0.050817470997571945
. O 0 0.0005856594070792198

Neither O 0 0.02670762501657009
vWf O 1 0.9387619495391846
nor O 0 0.02570498175919056
vWf O 1 0.9744647741317749
propolypeptide O 1 0.9673723578453064
( O 0 0.002351481467485428
von B-Disease 1 0.9959976673126221
Willebrand I-Disease 1 0.9999936819076538
antigen O 1 0.999845027923584
II O 1 0.998449444770813
) O 0 0.00014109912444837391
were O 0 1.8413051293464378e-05
detectable O 0 0.0032089301384985447
in O 0 8.515838271705434e-05
plasma O 0 0.016143228858709335
, O 0 0.0005685685900971293
platelets O 1 0.996894121170044
, O 0 0.0002506922755856067
or O 0 0.0005509851034730673
endothelial O 1 0.7284992337226868
cells O 0 0.0003386481839697808
of O 0 2.5594363251002505e-06
the O 0 9.026385669130832e-05
homozygous O 0 0.004346216097474098
mutant O 0 0.006650272756814957
mice O 0 0.009882841259241104
. O 0 0.00028069844120182097

The O 0 0.0007313102250918746
mutant O 0 0.01423769723623991
mice O 0 0.03997707739472389
exhibited O 1 0.6661842465400696
defects O 1 0.9999376535415649
in O 0 0.0006983002531342208
hemostasis O 1 0.9999256134033203
with O 0 6.860927533125505e-05
a O 0 0.00046682090032845736
highly O 0 0.01823371835052967
prolonged O 1 0.9999353885650635
bleeding O 1 0.9999997615814209
time O 0 0.00033009229809977114
and O 0 0.0002470622712280601
spontaneous O 0 0.04883749410510063
bleeding O 1 0.9999970197677612
events O 0 0.00032298691803589463
in O 0 0.00010704443411668763
approximately O 0 0.0002512928913347423
10 O 0 0.0001330612285528332
% O 0 1.750793308019638e-05
of O 0 5.175580736249685e-05
neonates O 1 0.9989945292472839
. O 0 0.000872742966748774

As O 0 0.00030885881278663874
in O 0 6.198106711963192e-05
the O 0 0.00024725007824599743
human O 0 0.13071490824222565
disease O 1 0.9999997615814209
, O 0 0.00011822229134850204
the O 0 0.00013528695853892714
factor O 0 0.00502755306661129
VIII O 1 0.9981393814086914
level O 0 0.002013381803408265
in O 0 7.129291770979762e-05
these O 0 3.7161142245167866e-05
mice O 0 0.007240855135023594
was O 0 0.000867686583660543
reduced O 0 0.0014358775224536657
strongly O 0 0.0005519925034604967
as O 0 0.00011501472909003496
a O 0 0.00022469299437943846
result O 0 0.0001480760402046144
of O 0 6.251962986425497e-06
the O 0 0.00010988493886543438
lack O 0 0.001384510425850749
of O 0 2.2223324776859954e-05
protection O 0 0.0054787443950772285
provided O 0 0.0005660963361151516
by O 0 0.00011626583727775142
vWf O 1 0.9710934162139893
. O 0 0.0006690854206681252

Defective O 1 0.9999873638153076
thrombosis B-Disease 1 0.9999998807907104
in O 0 0.0008130976930260658
mutant O 0 0.011151623912155628
mice O 0 0.013492187485098839
was O 0 0.0009822428692132235
also O 0 0.00013185451098252088
evident O 0 0.0014862190000712872
in O 0 3.750960240722634e-05
an O 0 5.988330303807743e-05
in O 0 8.842433453537524e-05
vivo O 0 0.004141619428992271
model O 0 0.00033842725679278374
of O 0 0.00022634242486674339
vascular B-Disease 1 1.0
injury I-Disease 1 0.999997615814209
. O 0 0.0008103630971163511

In O 0 0.0002486268640495837
this O 0 4.390352842165157e-05
model O 0 0.0005549933994188905
, O 0 9.458915883442387e-05
the O 0 0.0002527112083043903
exteriorized O 1 0.9215129613876343
mesentery O 1 0.9538270235061646
was O 0 0.002728767693042755
superfused O 0 0.07473713159561157
with O 0 0.00040009315125644207
ferric O 1 0.9998677968978882
chloride O 0 0.3273751139640808
and O 0 8.394318865612149e-05
the O 0 7.254271622514352e-05
accumulation O 0 0.004360532853752375
of O 0 4.7628382162656635e-05
fluorescently O 1 0.9879553318023682
labeled O 0 0.13729020953178406
platelets O 1 0.9892414212226868
was O 0 0.0006952443509362638
observed O 0 0.00022637241636402905
by O 0 6.491676322184503e-05
intravital O 0 0.47782495617866516
microscopy O 0 0.030025437474250793
. O 0 0.0005338200135156512

We O 0 0.0008179023279808462
conclude O 0 0.0028581346850842237
that O 0 1.9961680663982406e-05
these O 0 1.4037914297659881e-05
mice O 0 0.002979496493935585
very O 0 0.00021822625421918929
closely O 0 0.0006804531440138817
mimic O 1 0.9974452257156372
severe O 1 0.9999958276748657
human O 0 0.45152977108955383
von B-Disease 1 0.9999991655349731
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0002791302977129817
will O 0 6.792916246922687e-05
be O 0 2.1645812012138776e-05
very O 0 9.826530731515959e-05
useful O 0 0.0005114650120958686
for O 0 0.0001209542024298571
investigating O 0 0.003046096535399556
the O 0 7.707580516580492e-05
role O 0 0.0006537531735375524
of O 0 3.140041371807456e-05
vWf O 1 0.8545683026313782
in O 0 0.00029594526859000325
normal O 0 0.0062392959371209145
physiology O 1 0.996137797832489
and O 0 0.0003263293474446982
in O 0 0.0014406410045921803
disease O 1 0.9999997615814209
models O 0 0.0014451313763856888
. O 0 0.00015491867088712752
. O 0 0.00025668024318292737

Oral O 1 0.9949690699577332
contraceptives O 1 0.9862914681434631
and O 0 6.630041025346145e-05
the O 0 9.002291335491464e-05
risk O 0 0.0442364439368248
of O 0 0.0001858617615653202
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.001285066013224423

Hereditary B-Disease 1 0.9999996423721313
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.999998927116394
Study O 0 0.004150995519012213
Group O 0 0.0005972300423309207
. O 0 0.00024034843954723328

BACKGROUND O 0 0.023942770436406136
Women O 0 0.0017324142390862107
with O 0 6.569395918631926e-05
mutations O 0 0.0008932787459343672
in O 0 4.9074911657953635e-05
either O 0 0.0001570811728015542
the O 0 0.0004676615644712001
BRCA1 O 1 0.9999496936798096
or O 0 0.0005398971261456609
the O 0 0.0007775771664455533
BRCA2 O 1 0.9995788931846619
gene O 0 0.0008162545273080468
have O 0 1.7808451957535e-05
a O 0 0.00013877144374419004
high O 0 0.0021541498135775328
lifetime O 1 0.8432524800300598
risk O 1 0.8289933204650879
of O 0 0.0007090268190950155
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0008623900357633829

Oral O 1 0.9983319640159607
contraceptives O 1 0.9994938373565674
protect O 1 0.732921302318573
against O 0 0.4615914523601532
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.00033315044129267335
general O 0 0.0010426649823784828
, O 0 0.00013659318210557103
but O 0 8.270036778412759e-05
it O 0 5.997794141876511e-05
is O 0 0.00011369464482413605
not O 0 5.968444384052418e-05
known O 0 0.00027895226958207786
whether O 0 0.00015039548452477902
they O 0 1.5210349374683574e-05
also O 0 6.648997077718377e-05
protect O 0 0.0014770861016586423
against O 0 0.00018061170703731477
hereditary B-Disease 1 0.9775410294532776
forms I-Disease 0 0.0013770607765763998
of I-Disease 0 0.001416490995325148
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.000992684392258525

METHODS O 0 0.004800002556294203
We O 0 0.0007913030567578971
enrolled O 0 0.015272811986505985
207 O 0 0.01328718475997448
women O 0 0.0007622673874720931
with O 0 0.0008782728691585362
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0004038099723402411
161 O 0 0.003912678454071283
of O 0 9.743500413605943e-06
their O 0 5.1927989261457697e-05
sisters O 0 0.001399385742843151
as O 0 8.43815432745032e-05
controls O 0 0.00039136651321314275
in O 0 6.866183684905991e-05
a O 0 0.0005517200333997607
case O 0 0.002705375896766782
- O 0 0.003591937944293022
control O 0 0.0010934543097391725
study O 0 0.0011119599221274257
. O 0 0.000281472661299631

All O 0 8.947261812863871e-05
the O 0 0.00046187060070224106
patients O 1 0.9998704195022583
carried O 0 0.00016230635810643435
a O 0 0.00026625263853929937
pathogenic O 0 0.008921387605369091
mutation O 0 0.0009682369418442249
in O 0 0.00010171834583161399
either O 0 0.0011572350049391389
BRCA1 O 1 0.999526858329773
( O 0 0.0011364915408194065
179 O 0 0.023011166602373123
women O 0 0.00174945208709687
) O 0 0.0003644642711151391
or O 0 0.0015147438971325755
BRCA2 O 1 0.9993959665298462
( O 0 0.0014167000772431493
28 O 0 0.0030713945161551237
women O 0 0.001213404000736773
) O 0 0.0002959111297968775
. O 0 0.0002386352134635672

The O 0 0.0008502221317030489
control O 0 0.003585320897400379
women O 0 0.001314943772740662
were O 0 9.007984772324562e-05
enrolled O 0 0.01209178101271391
regardless O 0 0.00045554101234301925
of O 0 1.6367572243325412e-05
whether O 0 0.0006315205246210098
or O 0 0.00022394421102944762
not O 0 5.9726007748395205e-05
they O 0 1.795849675545469e-05
had O 0 0.00018158854800276458
either O 0 0.000154575624037534
mutation O 0 0.0015395156806334853
. O 0 0.0002848455624189228

Lifetime O 0 0.06562598794698715
histories O 0 0.0022862874902784824
of O 0 7.456930325133726e-05
oral O 1 0.9992004036903381
- O 0 0.0614214763045311
contraceptive O 1 0.9942303895950317
use O 0 9.708318975754082e-05
were O 0 1.9569190044421703e-05
obtained O 0 0.00015645513485651463
by O 0 5.2677332860184833e-05
interview O 0 0.007976984605193138
or O 0 0.00019584698020480573
by O 0 1.7564127119840123e-05
written O 0 4.505129618337378e-05
questionnaire O 0 0.00287335435859859
and O 0 6.036077320459299e-05
were O 0 2.389943074376788e-05
compared O 0 0.0006510870298370719
between O 0 0.0009229533025063574
patients O 1 0.9999972581863403
and O 0 0.00020358529582154006
control O 0 0.003154313424602151
women O 0 0.0014506879961118102
, O 0 0.00021894692326895893
after O 0 0.0009341446566395462
adjustment O 0 0.00327338557690382
for O 0 9.437924018129706e-05
year O 0 0.00020171031064819545
of O 0 9.26674147194717e-06
birth O 0 0.001067961798980832
and O 0 0.00013591123570222408
parity O 0 0.02800258807837963
. O 0 0.0004905433161184192

RESULTS O 0 0.0031433722469955683
The O 0 0.00012945949856657535
adjusted O 0 0.0023436429910361767
odds O 0 0.005827626679092646
ratio O 0 0.0025665101129561663
for O 0 0.08157289773225784
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.0006202321965247393
with O 0 1.747517308103852e-05
any O 0 2.793635576381348e-05
past O 0 5.0353657570667565e-05
use O 0 1.7556103557581082e-05
of O 0 1.7160875358968042e-05
oral O 1 0.9956936836242676
contraceptives O 1 0.9980966448783875
was O 0 0.0019117183983325958
0 O 0 0.0012015890097245574
. O 0 0.00024300499353557825

5 O 0 0.002901939209550619
( O 0 0.0003877136914525181
95 O 0 0.0018117469735443592
percent O 0 0.0004378241137601435
confidence O 0 0.0018411207711324096
interval O 0 0.0014222287572920322
, O 0 0.00015829215408302844
0 O 0 0.0006490269443020225
. O 0 3.966611620853655e-05
3 O 0 0.00018236294272355735
to O 0 5.198041253606789e-05
0 O 0 0.0005755774909630418
. O 0 6.963391206227243e-05
8 O 0 0.0006258729263208807
) O 0 0.00016290826897602528
. O 0 0.0002098824770655483

The O 0 0.0019851953256875277
risk O 0 0.35894718766212463
decreased O 0 0.008266272954642773
with O 0 3.744195419130847e-05
increasing O 0 0.0002667912922333926
duration O 0 0.0014426528941839933
of O 0 1.2005432836303953e-05
use O 0 0.00039608118822798133
( O 0 0.0010229884646832943
P O 0 0.04563574120402336
for O 0 0.0002105971216224134
trend O 0 0.0024236098397523165
, O 0 0.00028641411336138844
< O 0 0.024954281747341156
0 O 0 0.0011801616055890918
. O 0 0.0002421857207082212
001 O 0 0.2369634360074997
) O 0 0.0002123211743310094
; O 0 3.056953210034408e-05
use O 0 3.791599738178775e-05
for O 0 9.965054778149351e-05
six O 0 0.00015111194807104766
or O 0 0.00012107675865991041
more O 0 4.921748404740356e-05
years O 0 0.000531967612914741
was O 0 0.0009025803883560002
associated O 0 0.00013226098963059485
with O 0 2.181695163017139e-05
a O 0 0.0003936764842364937
60 O 0 0.000711557106114924
percent O 0 0.000561737862881273
reduction O 0 0.0032910986337810755
in O 0 0.0002566026814747602
risk O 0 0.4823002815246582
. O 0 0.0003988148528151214

Oral O 1 0.9932827949523926
- O 0 0.013543153181672096
contraceptive O 1 0.9157463908195496
use O 0 0.0002600416191853583
protected O 0 0.014491595327854156
against O 0 0.033585235476493835
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.00012117457663407549
for O 0 8.419251389568672e-05
carriers O 0 0.0011225021444261074
of O 0 6.945359018573072e-06
the O 0 0.0004574098566081375
BRCA1 O 1 0.9995878338813782
mutation O 0 0.004953216761350632
( O 0 0.00044968456495553255
odds O 0 0.009616502560675144
ratio O 0 0.0018188960384577513
, O 0 0.0001802789483917877
0 O 0 0.0007845250656828284
. O 0 6.693720206385478e-05
5 O 0 0.0003564244834706187
; O 0 5.1969607739010826e-05
95 O 0 0.001107458141632378
percent O 0 0.0003622048534452915
confidence O 0 0.0016757764387875795
interval O 0 0.001397214364260435
, O 0 0.00011893711780430749
0 O 0 0.00050456722965464
. O 0 3.659337744466029e-05
3 O 0 0.00018758820078801364
to O 0 5.2227354899514467e-05
0 O 0 0.0006939324084669352
. O 0 9.125306678470224e-05
9 O 0 0.0010513027664273977
) O 0 7.520766666857526e-05
and O 0 3.0364226404344663e-05
for O 0 8.16006722743623e-05
carriers O 0 0.001667570206336677
of O 0 1.1390265171939973e-05
the O 0 0.0005684542702510953
BRCA2 O 1 0.9997178912162781
mutation O 0 0.00438274908810854
( O 0 0.0004348683578427881
odds O 0 0.01041723694652319
ratio O 0 0.0017105318838730454
, O 0 0.0001938627247000113
0 O 0 0.00097899348475039
. O 0 7.459996413672343e-05
4 O 0 0.0005295558949001133
; O 0 7.739191642031074e-05
95 O 0 0.0013905345695093274
percent O 0 0.00032580646802671254
confidence O 0 0.001645407872274518
interval O 0 0.0018066386692225933
, O 0 0.0001996461214730516
0 O 0 0.0006849721539765596
. O 0 4.794263077201322e-05
2 O 0 0.000216572530916892
to O 0 5.7718985772226006e-05
1 O 0 0.0005195564008317888
. O 0 7.293921225937083e-05
1 O 0 0.0009018242708407342
) O 0 0.000160848576342687
. O 0 0.0002184944023611024

CONCLUSIONS O 0 0.03314099460840225
Oral O 1 0.9974996447563171
- O 0 0.02863788604736328
contraceptive O 1 0.9954431056976318
use O 0 0.0002169579965993762
may O 0 0.0004162168188486248
reduce O 0 0.0013370182132348418
the O 0 0.00012133240670664236
risk O 1 0.8792182207107544
of O 0 0.000822764472104609
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.00030621857149526477
women O 0 0.00040229325531981885
with O 0 7.469193224096671e-05
pathogenic O 0 0.01853547804057598
mutations O 0 0.000835073587950319
in O 0 6.076516001485288e-05
the O 0 0.00043700227979570627
BRCA1 O 1 0.9998598098754883
or O 0 0.0036223598290234804
BRCA2 O 1 0.9991815686225891
gene O 0 0.01024390198290348

A O 0 0.004202293697744608
Japanese O 0 0.001523256883956492
family O 0 0.0007581662503071129
with O 0 0.0005889726453460753
adrenoleukodystrophy B-Disease 1 0.9999992847442627
with O 0 0.00015721694217063487
a O 0 0.0007405380601994693
codon O 0 0.007439860142767429
291 O 0 0.03185993805527687
deletion O 0 0.009001484140753746
: O 0 0.00023558823158964515
a O 0 0.0008762525394558907
clinical O 1 0.9998966455459595
, O 0 0.0002950133930426091
biochemical O 0 0.022410694509744644
, O 0 0.0006587881362065673
pathological O 1 0.9998483657836914
, O 0 0.00026229233480989933
and O 0 0.00012049017095705494
genetic O 0 0.002588848117738962
report O 0 0.001045013079419732
. O 0 0.00028649112209677696

We O 0 0.0005307500250637531
report O 0 0.0002664250205270946
a O 0 0.0001386632357025519
Japanese O 0 0.0006466949707828462
family O 0 0.0005078887334093451
with O 0 0.001144721987657249
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.05961889773607254
ALD B-Disease 1 1.0
) O 0 0.0002688263193704188
with O 0 1.8623966752784327e-05
a O 0 0.00012484547914937139
three O 0 2.98969625873724e-05
base O 0 0.0011365836253389716
pair O 0 0.0007253495277836919
deletion O 0 0.011375922709703445
( O 0 0.0010845486540347338
delGAG O 1 0.7656662464141846
291 O 0 0.03849932923913002
) O 0 0.0001338604197371751
in O 0 8.960051491158083e-05
the O 0 0.0012951442040503025
ALD B-Disease 1 1.0
gene O 0 0.0075185252353549
. O 0 0.0003761095576919615

A O 0 0.003465218236669898
variety O 0 0.00030164761119522154
of O 0 4.358107253210619e-05
phenotypes O 0 0.013873266987502575
were O 0 2.7226504244026728e-05
observed O 0 0.00011652988905552775
within O 0 3.0466846510535106e-05
this O 0 3.528534944052808e-05
family O 0 0.000552518991753459
. O 0 0.0003655182081274688

While O 0 0.0004312496166676283
the O 0 0.0003850060165859759
proband O 1 0.9789193868637085
( O 0 0.0019322865409776568
patient O 1 0.9991201758384705
1 O 0 0.0017202766612172127
) O 0 0.00015870564675424248
was O 0 0.0006458301795646548
classified O 0 0.003676861058920622
as O 0 0.00011019481462426484
having O 0 0.000478303903946653
a O 0 0.0003303315315861255
rare O 0 0.0038072599563747644
intermediate O 0 0.021088290959596634
type O 0 0.0015137078007683158
of O 0 2.9357195671764202e-05
adult O 0 0.01921594887971878
cerebral O 1 0.9999984502792358
and O 0 0.0008999303681775928
cerebello O 1 0.9997372031211853
- O 1 0.9894824028015137
brain O 1 0.9998980760574341
stem O 0 0.010447205044329166
forms O 0 0.0004239669651724398
, O 0 0.00012767869338858873
his O 0 0.0010672509670257568
younger O 0 0.0058042206801474094
brother O 0 0.003984748851507902
( O 0 0.001114769373089075
patient O 1 0.9997625946998596
2 O 0 0.0011042283149436116
) O 0 0.00010340812150388956
and O 0 0.00017057405784726143
nephew O 1 0.6520016193389893
( O 0 0.0014809929998591542
patient O 1 0.9997572302818298
3 O 0 0.0007046617683954537
) O 0 7.026050298009068e-05
had O 0 0.00022418455046135932
a O 0 0.001166368369013071
childhood O 1 0.99998939037323
ALD B-Disease 1 1.0
type O 1 0.8906714916229248
. O 0 0.0008696804870851338

Another O 0 0.005200866609811783
nephew O 0 0.08646540343761444
( O 0 0.0019469488179311156
patient O 1 0.9996079802513123
4 O 0 0.0009843929437920451
) O 0 5.5442484153900295e-05
of O 0 2.691549525479786e-05
patient O 1 0.9997926354408264
1 O 0 0.0013934021117165685
was O 0 0.0009971034014597535
classified O 0 0.00364380469545722
as O 0 9.861563739832491e-05
having O 0 0.0005377231282182038
an O 0 0.0002942543651442975
adolescent O 1 0.9995099306106567
form O 0 0.0011102553689852357
. O 0 0.0005097329267300665

The O 0 0.0008592533995397389
tau O 0 0.030631249770522118
level O 0 0.0009580849437043071
in O 0 6.54412287985906e-05
the O 0 0.00040598769555799663
cerebrospinal O 1 0.9998655319213867
fluid O 1 0.9941932559013367
( O 0 0.004835378844290972
CSF O 1 0.9999358654022217
) O 0 0.00040651438757777214
in O 0 0.00033854146022349596
patient O 1 0.9995904564857483
1 O 0 0.0012065368937328458
was O 0 0.0005168032948859036
as O 0 0.00011325337982270867
high O 0 0.0006923790206201375
as O 0 2.503718678781297e-05
that O 0 9.154136932920665e-06
of O 0 2.986501931445673e-05
patients O 1 0.9999983310699463
with O 0 0.002989725675433874
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0017620415892452002
AD B-Disease 0 0.030326738953590393
) O 0 0.0003061365569010377
. O 0 0.00023585859162267298

His O 0 0.0031566321849823
brain O 1 0.9985829591751099
magnetic O 0 0.0012186121894046664
resonance O 0 0.008866806514561176
image O 0 0.025476492941379547
( O 0 0.0025788843631744385
MRI O 1 0.9999657869338989
) O 0 0.00048187014181166887
showed O 0 0.0027906293980777264
abnormalities B-Disease 1 0.9605409502983093
in I-Disease 0 4.498616908676922e-05
the I-Disease 0 0.00010595283674774691
bilateral I-Disease 0 0.15073612332344055
cerebellar I-Disease 1 0.9999923706054688
hemispheres I-Disease 1 0.9957746863365173
and O 0 0.0012277592904865742
brain O 1 0.9999991655349731
stem O 0 0.24157893657684326
, O 0 0.00012387368769850582
but O 0 6.0165148170199245e-05
not O 0 2.2304304366116412e-05
in O 0 5.351673826226033e-05
the O 0 0.0007932214066386223
cerebral O 1 0.9999995231628418
white O 0 0.4730347990989685
matter O 0 0.0020709922537207603
, O 0 0.00013568448775913566
where O 0 9.152942220680416e-05
marked O 0 0.0005512780044227839
reductions O 0 0.0016618334921076894
of O 0 8.646409696666524e-06
the O 0 0.0006285515264607966
cerebral O 1 0.9999997615814209
blood O 1 0.9665998816490173
flow O 0 0.0021116924472153187
and O 0 0.0001756457204464823
oxygen O 0 0.07172639667987823
metabolism O 0 0.03833356872200966
were O 0 3.416189065319486e-05
clearly O 0 0.0005399161018431187
demonstrated O 0 0.000924997846595943
by O 0 3.948044468415901e-05
positron O 0 0.07775049656629562
emission O 0 0.01006421446800232
tomography O 0 0.08758536726236343
( O 0 0.0021235509775578976
PET O 1 0.9942994117736816
) O 0 0.0003505217900965363
. O 0 0.00024498446146026254

In O 0 0.0031404481269419193
patients O 1 0.9998862743377686
2 O 0 0.0008457046351395547
and O 0 7.792154065100476e-05
3 O 0 0.0003377014654688537
, O 0 4.848761818720959e-05
the O 0 0.00013762128946837038
autopsy O 0 0.35268285870552063
findings O 0 0.0016542170196771622
showed O 0 0.0012359833344817162
massive O 0 0.01740778610110283
demyelination B-Disease 1 0.9999899864196777
of I-Disease 0 6.775720248697326e-05
the I-Disease 0 0.0022250376641750336
cerebral I-Disease 1 0.9999998807907104
white I-Disease 0 0.0525975376367569
matter I-Disease 0 0.0006873302045278251
with O 0 4.199391696602106e-05
sparing O 0 0.010869411751627922
of O 0 1.075336604117183e-05
the O 0 0.0004126688581891358
U O 1 0.9943363070487976
- O 0 0.015453441999852657
fibers O 1 0.7506067156791687
, O 0 9.836036042543128e-05
compatible O 0 0.000451655185315758
with O 0 1.2162271559645887e-05
the O 0 6.244369433261454e-05
findings O 0 0.0009158999309875071
of O 0 9.531696559861302e-05
childhood O 1 0.9999949932098389
ALD B-Disease 1 1.0
. O 0 0.0021571938414126635

Oleic O 0 0.49951237440109253
and O 0 0.0005545216845348477
erucic O 1 0.9830185174942017
acids O 0 0.0024396309163421392
( O 0 0.0009856453398242593
Lorenzos O 0 0.3690565526485443
Oil O 0 0.003081653732806444
) O 0 6.949579255888239e-05
were O 0 2.0421291992533952e-05
administered O 0 0.007429332938045263
to O 0 0.0003442885063122958
patients O 1 0.9999611377716064
1 O 0 0.0008179335854947567
and O 0 0.00010292501247022301
4 O 0 0.0005471323966048658
, O 0 5.2719849918503314e-05
but O 0 5.406240597949363e-05
sufficient O 0 0.0010210225591436028
effectiveness O 0 0.19280914962291718
was O 0 0.0005096532986499369
not O 0 4.560479646897875e-05
obtained O 0 0.00020425864204298705
. O 0 0.0001969976583495736

The O 0 0.00071435741847381
findings O 0 0.002015620470046997
in O 0 7.296391413547099e-05
this O 0 4.1451959987170994e-05
family O 0 0.000501176924444735
suggest O 0 0.0009819486876949668
that O 0 0.00013372249668464065
delGAG291 O 0 0.057004790753126144
is O 0 0.00012817246897611767
part O 0 0.00011327066749799997
of O 0 5.007045729144011e-06
the O 0 0.0001399953616783023
cause O 0 0.0063625359907746315
of O 0 3.849727727356367e-05
Japanese O 0 0.03761276230216026
ALD B-Disease 1 0.9999998807907104
with O 0 0.00030418086680583656
phenotypic O 0 0.012306217104196548
variations O 0 0.0005590833607129753
. O 0 0.00043386180186644197

Moreover O 0 0.01393995713442564
, O 0 0.00021224323427304626
although O 0 0.00010396598372608423
the O 0 3.826445754384622e-05
scale O 0 0.0002890382311306894
of O 0 7.447613370459294e-06
the O 0 0.0001631423510843888
study O 0 0.0009666450787335634
is O 0 0.00017727375961840153
limited O 0 0.0005579965654760599
, O 0 6.784306606277823e-05
there O 0 2.6949761377181858e-05
is O 0 6.112222763476893e-05
a O 0 0.0001492620212957263
possibility O 0 0.0010496415197849274
that O 0 8.55337202665396e-05
PET O 1 0.906380832195282
can O 0 0.00010766983177745715
detect O 0 0.005377505905926228
an O 0 0.00066659867297858
insidious B-Disease 1 0.9998787641525269
lesion I-Disease 1 0.9999967813491821
which O 0 0.00010515305621083826
is O 0 0.0002907052403315902
undetectable O 1 0.6943026185035706
by O 0 2.3292128389584832e-05
computed O 0 0.004229054320603609
tomogram O 1 0.8783612251281738
( O 0 0.003728169482201338
CT O 1 0.9999852180480957
) O 0 0.0005615052068606019
or O 0 0.001245520543307066
MRI O 1 0.9999099969863892
analysis O 0 0.0005927294259890914
, O 0 0.00011877889483002946
and O 0 4.7449226258322597e-05
that O 0 2.0069008314749226e-05
the O 0 4.362007894087583e-05
higher O 0 0.00047463865485042334
level O 0 0.0007933491724543273
of O 0 2.6526031433604658e-05
tau O 0 0.03578142449259758
reflects O 0 0.0006237433990463614
the O 0 2.4151548132067546e-05
process O 0 4.716635521617718e-05
of O 0 2.2687925593345426e-05
neuronal B-Disease 1 0.992713987827301
degeneration I-Disease 1 1.0
in O 0 0.006857958622276783
ALD B-Disease 1 1.0
. O 0 0.0018545310012996197

Lorenzos O 1 0.5583601593971252
Oil O 0 0.0042567006312310696
should O 0 0.00022142713714856654
be O 0 2.2479256585938856e-05
given O 0 3.8139387470437214e-05
in O 0 2.7062149456469342e-05
the O 0 8.87233400135301e-05
early O 0 0.0007280871504917741
stage O 0 0.0029730559326708317
. O 0 0.0001383261987939477
. O 0 0.00022576672199647874

Nonsense O 0 0.04491012170910835
mutation O 0 0.0023799322079867125
in O 0 0.0001848169631557539
exon O 0 0.012684397399425507
4 O 0 0.00019077114120591432
of O 0 5.6333183238166384e-06
human O 0 0.0010096055921167135
complement O 0 0.014792312867939472
C9 O 1 0.9998588562011719
gene O 0 0.0018512081587687135
is O 0 9.92157292785123e-05
the O 0 5.990529098198749e-05
major O 0 0.0012080116430297494
cause O 0 0.0016563358949497342
of O 0 9.62458761932794e-06
Japanese O 0 0.0017007597489282489
complement B-Disease 0 0.39957234263420105
C9 I-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999998807907104
. O 0 0.001064920099452138

Deficiency B-Disease 1 0.999995231628418
of I-Disease 0 3.703304537339136e-05
the I-Disease 0 0.00016877404414117336
ninth I-Disease 0 0.007062246557325125
component I-Disease 0 0.0012966962531208992
of I-Disease 0 1.0490291970199905e-05
human I-Disease 0 0.0008575120009481907
complement I-Disease 0 0.006860349327325821
( O 0 0.00303946016356349
C9 O 1 0.9999406337738037
) O 0 0.00022734746744390577
is O 0 4.7794088459340855e-05
the O 0 2.7591022444539703e-05
most O 0 8.885347779141739e-05
common O 0 0.0037554032169282436
complement B-Disease 1 0.9998410940170288
deficiency I-Disease 1 1.0
in O 0 0.00034016784047707915
Japan O 0 0.001110632554627955
but O 0 0.0001548392465338111
is O 0 0.0002550312492530793
rare O 0 0.0021308620925992727
in O 0 5.115461681270972e-05
other O 0 1.4575622117263265e-05
countries O 0 5.45825096196495e-05
. O 0 0.00034325517481192946

We O 0 0.0005202459869906306
studied O 0 0.00032186953467316926
the O 0 3.3480882848380134e-05
molecular O 0 0.00044481756049208343
basis O 0 5.702145062969066e-05
of O 0 0.0001677018153714016
C9 B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999986886978149
in O 0 0.00010844675125554204
four O 0 5.8384390285937116e-05
Japanese O 0 0.004346793983131647
C9 B-Disease 1 0.9999974966049194
- I-Disease 1 0.9989007711410522
deficient I-Disease 1 0.9999971389770508
patients O 1 0.9999926090240479
who O 0 0.0005639096489176154
had O 0 0.0011866597924381495
suffered O 1 0.9999978542327881
from O 0 0.0023319919127970934
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 0.9999998807907104
. O 0 0.0010343396570533514

Direct O 0 0.00023133103968575597
sequencing O 0 0.00018154944700654596
of O 0 1.4697856386192143e-05
amplified O 0 0.008420323953032494
C9 O 1 0.9982933402061462
cDNA O 0 0.0031779080163687468
and O 0 8.239471935667098e-05
DNA O 0 0.0008129210327751935
revealed O 0 0.001381913316436112
a O 0 0.00015996590082067996
nonsense O 0 0.004315644968301058
substitution O 0 0.000934004143346101
( O 0 0.0008107036701403558
CGA O 1 0.6315319538116455
- O 0 0.015927722677588463
- O 0 0.01118389330804348
> O 0 0.024924863129854202
TGA O 1 0.9895740151405334
) O 0 0.00019744237943086773
at O 0 0.0003830005007330328
codon O 0 0.0024427776224911213
95 O 0 0.0011959060793742537
in O 0 0.00010092771844938397
exon O 0 0.014859829097986221
4 O 0 0.0002940227568615228
in O 0 2.4941147785284556e-05
the O 0 9.337626397609711e-05
four O 0 0.0005261607584543526
C9 B-Disease 1 0.9999827146530151
- I-Disease 1 0.7505472302436829
deficient I-Disease 1 0.999575674533844
individuals O 0 0.0002837388892658055
. O 0 0.00032346791704185307

An O 0 0.0007319070282392204
allele O 0 0.007069543469697237
- O 0 0.001920081558637321
specific O 0 0.00012412779324222356
polymerase O 0 0.004959914833307266
chain O 0 0.0050709061324596405
reaction O 0 0.0018290342995896935
system O 0 0.002428603358566761
designed O 0 0.0010175054194405675
to O 0 0.00010034895240096375
detect O 0 0.005335063673555851
exclusively O 0 0.0001855483278632164
only O 0 1.6212115951930173e-05
one O 0 1.269646963919513e-05
of O 0 3.9226988519658335e-06
the O 0 0.0001303630560869351
normal O 0 0.0029129288159310818
and O 0 0.00016771270020399243
mutant O 0 0.005848796106874943
alleles O 0 0.003188695991411805
indicated O 0 0.0020114376675337553
that O 0 1.208024605148239e-05
all O 0 6.59197985442006e-06
the O 0 0.00010412054689368233
four O 0 0.0003736568323802203
patients O 1 0.9998502731323242
were O 0 3.4969554690178484e-05
homozygous O 0 0.0008361309301108122
for O 0 3.715784987434745e-05
the O 0 9.055421833181754e-05
mutation O 0 0.0010779030853882432
in O 0 0.00017019615916069597
exon O 0 0.027326012030243874
4 O 0 0.0007017485913820565
and O 0 4.827008888241835e-05
that O 0 1.9353883544681594e-05
the O 0 5.3017814934719354e-05
parents O 0 0.00019788304052781314
of O 0 4.48332357336767e-05
patient O 1 0.9997794032096863
2 O 0 0.0005036614602431655
were O 0 3.330237086629495e-05
heterozygous O 0 0.0019391387468203902
. O 0 0.0002918883110396564

The O 0 0.000535408325958997
common O 0 0.0013911804417148232
mutation O 0 0.0017297081649303436
at O 0 0.0006289005978032947
codon O 0 0.0032174200750887394
95 O 0 0.0019210879690945148
in O 0 0.00022632212494499981
exon O 0 0.02964896336197853
4 O 0 0.001011742278933525
might O 0 0.0002946299791801721
be O 0 2.5274975996580906e-05
responsible O 0 0.0005178504507057369
for O 0 5.0258950068382546e-05
most O 0 0.0001504769898019731
Japanese O 0 0.01615401729941368
C9 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999998807907104
. O 0 0.000400978431571275
. O 0 0.00025598204229027033

BRCA1 O 1 0.9922502636909485
required O 0 0.0005620752344839275
for O 0 8.610494842287153e-05
transcription O 0 0.002289346419274807
- O 0 0.0044621434062719345
coupled O 0 0.0046542370691895485
repair O 1 0.9912534356117249
of O 0 3.435182952671312e-05
oxidative O 0 0.3497871458530426
DNA O 0 0.005233400035649538
damage O 1 0.9170261025428772
. O 0 0.00044554995838552713

The O 0 0.002733792643994093
breast B-Disease 1 1.0
and I-Disease 1 0.8279190063476562
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9935197234153748
gene O 0 0.003581850789487362
BRCA1 O 1 0.9881232380867004
encodes O 0 0.0010687127942219377
a O 0 0.000695885973982513
zinc O 0 0.43772411346435547
finger O 0 0.018102502450346947
protein O 0 0.00013357072020880878
of O 0 8.123748557409272e-06
unknown O 0 0.00034067899105139077
function O 0 0.0011165288742631674
. O 0 0.00036683690268546343

Association O 0 0.007383452728390694
of O 0 1.4739373909833375e-05
the O 0 0.0002823873364832252
BRCA1 O 1 0.9871750473976135
protein O 0 0.00012658558262046427
with O 0 1.2081767636118457e-05
the O 0 9.179295739158988e-05
DNA O 0 0.0024843390565365553
repair O 1 0.9988699555397034
protein O 0 0.004283555783331394
Rad51 O 1 0.9988114833831787
and O 0 0.0002238333981949836
changes O 0 0.0002045328583335504
in O 0 4.1302300815004855e-05
the O 0 5.460781176225282e-05
phosphorylation O 0 0.00018190396076533943
and O 0 5.4509899200638756e-05
cellular O 0 0.0020317642483860254
localization O 0 0.0014353496953845024
of O 0 3.968408691434888e-06
the O 0 5.479706669575535e-05
protein O 0 0.0005083514843136072
after O 0 0.0009400804992765188
exposure O 0 0.06377236545085907
to O 0 0.0001228821638505906
DNA O 0 0.0032844715751707554
- O 0 0.008860930800437927
damaging O 0 0.10494279861450195
agents O 0 0.0015298882499337196
are O 0 1.1107310456281994e-05
consistent O 0 0.0008491185726597905
with O 0 1.4735650438524317e-05
a O 0 0.00020836848125327379
role O 0 0.001175334327854216
for O 0 0.0005285529186949134
BRCA1 O 1 0.9998939037322998
in O 0 0.00030088413041085005
DNA O 0 0.005437387619167566
repair O 1 0.9997100234031677
. O 0 0.0008043410489335656

Here O 0 0.0008629891090095043
, O 0 9.301128739025444e-05
it O 0 3.7279591197147965e-05
is O 0 7.677812391193584e-05
shown O 0 0.00017248897347599268
that O 0 4.1136419895337895e-05
mouse O 0 0.0059142448008060455
embryonic O 0 0.022385522723197937
stem O 0 0.03565937653183937
cells O 0 0.012101035565137863
deficient B-Disease 1 0.999925971031189
in I-Disease 0 0.0007552832248620689
BRCA1 I-Disease 1 0.9997771382331848
are O 0 0.00016503756341990083
defective O 1 0.9986047148704529
in O 0 0.00014201077283360064
the O 0 0.00011044486018363386
ability O 0 0.000993883004412055
to O 0 2.396376476099249e-05
carry O 0 6.355776713462546e-05
out O 0 2.8800262953154743e-05
transcription O 0 0.001404337934218347
- O 0 0.004143913276493549
coupled O 0 0.0049599409103393555
repair O 1 0.9917565584182739
of O 0 4.349384471424855e-05
oxidative O 1 0.6391273736953735
DNA O 0 0.007581566926091909
damage O 1 0.995389461517334
, O 0 0.00014956646191421896
and O 0 6.73457034281455e-05
are O 0 3.0150153179420158e-05
hypersensitive O 1 0.9944055080413818
to O 0 0.00020077737281098962
ionizing O 1 0.9864532351493835
radiation O 1 0.818655252456665
and O 0 5.4869335144758224e-05
hydrogen O 0 0.0015918940771371126
peroxide O 0 0.3420124053955078
. O 0 0.0004290378710720688

These O 0 6.281781679717824e-05
results O 0 0.0004335969570092857
suggest O 0 0.0005259776953607798
that O 0 0.00020644273899961263
BRCA1 O 1 0.9996551275253296
participates O 0 0.02131875790655613
, O 0 0.0001938435307238251
directly O 0 0.0003311841865070164
or O 0 0.0002949686604551971
indirectly O 0 0.003688757074996829
, O 0 6.733491318300366e-05
in O 0 5.224350024946034e-05
transcription O 0 0.0020255674608051777
- O 0 0.0049899579025805
coupled O 0 0.0041722883470356464
repair O 1 0.9952390193939209
of O 0 3.5725748602999374e-05
oxidative O 1 0.8235432505607605
DNA O 0 0.006011733785271645
damage O 1 0.9163070917129517
. O 0 0.00014234171248972416
. O 0 0.00024207792012020946

Truncation O 0 0.09722457081079483
mutations O 0 0.002044187393039465
in O 0 8.306773088406771e-05
the O 0 0.0001832106790971011
transactivation O 0 0.1263802945613861
region O 0 0.0013473019935190678
of O 0 8.249574602814391e-05
PAX6 O 1 0.9999672174453735
result O 0 0.000915923563297838
in O 0 0.0001840669137891382
dominant O 0 0.00863700918853283
- O 0 0.006116896402090788
negative O 0 0.001800274709239602
mutants O 0 0.010745239444077015
. O 0 0.00042151022353209555

PAX6 O 1 0.997857391834259
is O 0 0.0002732994908001274
a O 0 0.0001128828153014183
transcription O 0 0.0003209594578947872
factor O 0 0.0003186100802849978
with O 0 1.349742160527967e-05
two O 0 2.438618139422033e-05
DNA O 0 0.0012549052480608225
- O 0 0.0013893520226702094
binding O 0 0.00036578081198967993
domains O 0 0.0023976259399205446
( O 0 0.0006215132889337838
paired O 0 0.005883260164409876
box O 0 0.0035152260679751635
and O 0 0.00026978712412528694
homeobox O 1 0.9859766960144043
) O 0 8.547314791940153e-05
and O 0 2.3921087631606497e-05
a O 0 0.00036210851976647973
proline O 0 0.048074234277009964
- O 0 0.003830117406323552
serine O 0 0.007955839857459068
- O 0 0.004549543838948011
threonine O 0 0.04554382339119911
( O 0 0.002206353470683098
PST O 1 0.9963370561599731
) O 0 0.0007127345888875425
- O 0 0.0032114507630467415
rich O 0 0.0016283862059935927
transactivation O 0 0.0895339697599411
domain O 0 0.0016320102149620652
. O 0 0.0004195370711386204

PAX6 O 1 0.9998995065689087
regulates O 1 0.9802672863006592
eye O 1 0.9996980428695679
development O 0 0.0031412451062351465
in O 0 0.00019431058899499476
animals O 0 0.0003910083032678813
ranging O 0 0.0008826672565191984
from O 0 0.00012373272329568863
jellyfish O 0 0.003020379226654768
to O 0 3.635095345089212e-05
Drosophila O 0 0.000936684722546488
to O 0 5.1226812502136454e-05
humans O 0 0.0008715446456335485
. O 0 0.00027713223244063556

Heterozygous O 0 0.012443691492080688
mutations O 0 0.0008358799386769533
in O 0 4.959984289598651e-05
the O 0 0.00013129744911566377
human O 0 0.005790418945252895
PAX6 O 1 0.9999396800994873
gene O 0 0.00235789455473423
result O 0 0.00026562786661088467
in O 0 3.6410001484910026e-05
various O 0 3.9723050576867536e-05
phenotypes O 0 0.019798602908849716
, O 0 0.0001788585213944316
including O 0 0.0002679917961359024
aniridia B-Disease 1 0.9999674558639526
, O 0 0.0013358809519559145
Peters B-Disease 1 0.9999539852142334
anomaly I-Disease 1 0.9991872906684875
, O 0 0.0008225394994951785
autosomal B-Disease 1 0.9984638690948486
dominant I-Disease 1 0.9868448972702026
keratitis I-Disease 1 0.9999982118606567
, O 0 0.0005730512784793973
and O 0 0.0005874147755093873
familial B-Disease 1 0.9999953508377075
foveal I-Disease 1 0.9999704360961914
dysplasia I-Disease 1 0.9999997615814209
. O 0 0.0014868275029584765

It O 0 0.0005885849823243916
is O 0 0.00027330341981723905
believed O 0 0.0005032334011048079
that O 0 1.185724340757588e-05
the O 0 5.741873974329792e-05
mutated O 0 0.003717393847182393
allele O 0 0.0017602014122530818
of O 0 6.33166273473762e-05
PAX6 O 1 0.9985502362251282
produces O 0 0.0015421638963744044
an O 0 0.00015493817045353353
inactive O 0 0.023373300209641457
protein O 0 0.0004366732609923929
and O 0 0.00031705774017609656
aniridia B-Disease 1 0.999900221824646
is O 0 0.0008557221153751016
caused O 0 0.005910553969442844
due O 0 0.000789581099525094
to O 0 0.0001347712823189795
genetic O 0 0.0036417802330106497
haploinsufficiency O 1 0.9754359722137451
. O 0 0.0005438569933176041

However O 0 0.0007792695541866124
, O 0 9.986896475311369e-05
several O 0 6.655061588389799e-05
truncation O 0 0.03989698365330696
mutations O 0 0.002203908748924732
have O 0 6.111669063102454e-05
been O 0 0.00011801166692748666
found O 0 6.713621405651793e-05
to O 0 2.1163137716939673e-05
occur O 0 0.0001219413461512886
in O 0 5.767947732238099e-05
the O 0 0.0004275725223124027
C O 1 0.6909716129302979
- O 0 0.008106104098260403
terminal O 0 0.027209976688027382
half O 0 5.4666477808495983e-05
of O 0 4.090756920049898e-05
PAX6 O 1 0.9999829530715942
in O 0 0.0017676943680271506
patients O 1 0.9999923706054688
with O 0 0.00027662405045703053
Aniridia B-Disease 1 0.999659538269043
resulting O 0 0.0011922994162887335
in O 0 7.422571070492268e-05
mutant O 0 0.001045537181198597
proteins O 0 2.780317299766466e-05
that O 0 2.4655144443386234e-05
retain O 0 0.001180094201117754
the O 0 0.00015243700181599706
DNA O 0 0.0019138175994157791
- O 0 0.0018617972964420915
binding O 0 0.00045260548358783126
domains O 0 0.0015376490773633122
but O 0 0.0001569129090057686
have O 0 5.903224882786162e-05
lost O 0 0.0007231422350741923
most O 0 1.78835034603253e-05
of O 0 3.5865482459485065e-06
the O 0 0.00018559540330898017
transactivation O 0 0.158051997423172
domain O 0 0.0018817775417119265
. O 0 0.0004897165927104652

It O 0 0.0004430327971931547
is O 0 0.00013674084038939327
not O 0 4.6426379412878305e-05
clear O 0 0.0003377038810867816
whether O 0 0.00011007140710717067
such O 0 3.0180995963746682e-05
mutants O 0 0.012589452788233757
really O 0 0.0041812751442193985
behave O 0 0.007262396160513163
as O 0 0.00022206417634151876
loss O 0 0.007376327179372311
- O 0 0.0012520422460511327
of O 0 1.787606925063301e-05
- O 0 0.0029080884996801615
function O 0 0.0007765134796500206
mutants O 0 0.004502519965171814
as O 0 0.00012931416858918965
predicted O 0 0.0014807130210101604
by O 0 7.991330494405702e-05
haploinsufficiency O 1 0.7172860503196716
. O 0 0.0004964048857800663

Contrary O 0 0.0026020612567663193
to O 0 4.1695508116390556e-05
this O 0 2.1570596800302155e-05
theory O 0 0.0002493330975994468
, O 0 6.107935769250616e-05
our O 0 0.0001529953005956486
data O 0 0.00010131835733773187
showed O 0 0.0005758184706792235
that O 0 1.548503860249184e-05
these O 0 1.1604752216953784e-05
mutants O 0 0.002838843734934926
are O 0 1.393970160279423e-05
dominant O 0 0.004288399126380682
- O 0 0.0026417558547109365
negative O 0 0.0004136525094509125
in O 0 0.0002351367293158546
transient O 0 0.3950066864490509
transfection O 1 0.9539519548416138
assays O 0 0.0022161798551678658
when O 0 0.0002039515384240076
they O 0 1.6369336663046852e-05
are O 0 1.0518632734601852e-05
coexpressed O 0 0.02502446249127388
with O 0 5.53612808289472e-05
wild O 0 0.0009225158137269318
- O 0 0.011148502118885517
type O 0 0.022601356729865074
PAX6 O 1 0.9997844099998474
. O 0 0.0012039284920319915

We O 0 0.00036580473533831537
found O 0 6.991781992837787e-05
that O 0 1.0827664482349064e-05
the O 0 7.9976802226156e-05
dominant O 0 0.010438011959195137
- O 0 0.0063596186228096485
negative O 0 0.0011263744672760367
effects O 0 0.003944709897041321
result O 0 0.0003347148303873837
from O 0 3.456176636973396e-05
the O 0 0.00010648480383679271
enhanced O 0 0.009545683860778809
DNA O 0 0.0007242456777021289
binding O 0 0.00019399475422687829
ability O 0 0.0004523561801761389
of O 0 6.239645244932035e-06
these O 0 3.4548913390608504e-05
mutants O 0 0.009978501126170158
. O 0 0.0003545499057509005

Kinetic O 0 0.0018521405290812254
studies O 0 0.00021908601047471166
of O 0 8.35314131109044e-06
binding O 0 0.0005439348169602454
and O 0 0.00026002153754234314
dissociation O 0 0.19005930423736572
revealed O 0 0.0030760380905121565
that O 0 1.2395740668580402e-05
various O 0 2.5964063752326183e-05
truncation O 0 0.03603745624423027
mutants O 0 0.00807809829711914
have O 0 8.806720870779827e-05
3 O 0 0.0006741532124578953
- O 0 0.0027227583341300488
5 O 0 0.0007503136293962598
- O 0 0.0016746418550610542
fold O 0 0.0013171329628676176
higher O 0 0.0002478717651683837
affinity O 0 0.000687415711581707
to O 0 1.9361081285751425e-05
various O 0 2.4523171305190772e-05
DNA O 0 0.0017039143713191152
- O 0 0.0015192891005426645
binding O 0 0.0002105786552419886
sites O 0 0.0001722546003293246
when O 0 0.00010717772238422185
compared O 0 0.00017460243543609977
with O 0 1.4742453458893578e-05
the O 0 0.0001059370770235546
wild O 0 0.0008962237625382841
- O 0 0.012492646463215351
type O 0 0.02004074864089489
PAX6 O 1 0.9994961023330688
. O 0 0.0011692707194015384

These O 0 9.411949577042833e-05
results O 0 0.0004136578645557165
provide O 0 0.00037010895903222263
a O 0 0.00036710326094180346
new O 0 0.0002774491731543094
insight O 0 0.007469995878636837
into O 0 5.062042691861279e-05
the O 0 3.913035470759496e-05
role O 0 0.0004353997064754367
of O 0 2.5534738597343676e-05
mutant O 0 0.021208930760622025
PAX6 O 1 0.9996713399887085
in O 0 0.000758388836402446
causing O 1 0.814833402633667
aniridia B-Disease 1 0.9998664855957031
. O 0 0.00032259023282676935
. O 0 0.00027024149312637746

Reversal O 0 0.026326313614845276
of O 0 0.00034115201560780406
severe O 1 0.9999998807907104
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.0015222744550555944
excellent O 1 0.7377918362617493
neuropsychologic O 1 0.8471913933753967
outcome O 0 0.0007284765015356243
in O 0 7.885712693678215e-05
very B-Disease 0 0.0007193282363004982
- I-Disease 0 0.003161981701850891
long I-Disease 0 0.0017348306719213724
- I-Disease 0 0.0017131998902186751
chain I-Disease 0 0.00180139415897429
acyl I-Disease 0 0.01308072917163372
- I-Disease 0 0.004243785515427589
coenzyme I-Disease 0 0.020840255543589592
A I-Disease 0 0.02744142897427082
dehydrogenase I-Disease 1 0.9996002316474915
deficiency I-Disease 1 0.9999996423721313
. O 0 0.0011631082743406296

Very B-Disease 0 0.003632662817835808
- I-Disease 0 0.005124679766595364
long I-Disease 0 0.0021970700472593307
- I-Disease 0 0.0021413411013782024
chain I-Disease 0 0.0021166198421269655
acyl I-Disease 0 0.013683811761438847
- I-Disease 0 0.003069366794079542
coenzyme I-Disease 0 0.010274559259414673
A I-Disease 0 0.005920395255088806
dehydrogenase I-Disease 1 0.9029490351676941
( I-Disease 0 0.0025628837756812572
VLCAD I-Disease 1 0.9996945858001709
) I-Disease 0 0.002767795929685235
deficiency I-Disease 1 0.9999996423721313
is O 0 0.0004096160701010376
a O 0 0.0013327294727787375
disorder O 1 0.9999868869781494
of O 0 4.540223744697869e-05
fatty O 1 0.6271545886993408
acid O 0 0.016275504603981972
beta O 0 0.00687751779332757
oxidation O 0 0.0013471595011651516
that O 0 9.961977048078552e-05
reportedly O 0 0.005549429915845394
has O 0 0.0003007992636412382
high O 0 0.0009232765296474099
rates O 0 0.00016725021123420447
of O 0 3.373744766577147e-05
morbidity O 1 0.9998530149459839
and O 0 0.0004888072144240141
mortality O 1 0.997947633266449
. O 0 0.0003876135451719165

We O 0 0.00042221316834911704
describe O 0 0.0005279527977108955
the O 0 3.272797403042205e-05
outcome O 0 0.00015231408178806305
of O 0 4.8018259803939145e-06
a O 0 0.00039290604763664305
5 O 0 0.0008983899024315178
- O 0 0.002345069544389844
year O 0 0.0007156520150601864
- O 0 0.00288922106847167
old O 0 0.0024892217479646206
girl O 0 0.014324448071420193
with O 0 0.000836321385577321
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
who O 0 0.001500223996117711
was O 0 0.0006083518383093178
first O 0 0.00013329539797268808
seen O 0 0.0009114107233472168
at O 0 0.0005165868205949664
5 O 0 0.00027516341651789844
months O 0 0.00019248756871093065
of O 0 5.160958153282991e-06
age O 0 0.00042495387606322765
with O 0 0.0004271163197699934
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 0.06293407082557678
hepatomegaly B-Disease 1 1.0
, O 0 0.07693253457546234
encephalopathy B-Disease 1 1.0
, O 0 0.0008406613487750292
and O 0 0.0005982201546430588
hypotonia B-Disease 1 0.9998667240142822
. O 0 0.0010043971706181765

Biochemical O 0 0.03745328634977341
studies O 0 0.004066710360348225
indicated O 1 0.9434271454811096
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
caused O 0 0.013186980970203876
by O 0 3.451657175901346e-05
a O 0 0.0004235601518303156
stable O 0 0.01599002443253994
yet O 0 0.0007932093576528132
inactive O 0 0.03274938464164734
enzyme O 0 0.0033910886850208044
. O 0 0.0003349286853335798

Molecular O 0 0.005237253848463297
genetic O 0 0.0005480481195263565
analysis O 0 6.831399514339864e-05
of O 0 1.5314624761231244e-05
her O 0 0.0028342052828520536
VLCAD O 1 0.9991368651390076
gene O 0 0.0028711745981127024
revealed O 0 0.003228395711630583
a O 0 0.0006818595575168729
T1372C O 0 0.10199123620986938
( O 0 0.0008910210453905165
F458L O 0 0.04591457545757294
) O 0 0.0002933904470410198
missense O 0 0.006828817073255777
mutation O 0 0.0009253090829588473
and O 0 7.878873293520883e-05
a O 0 0.002093894174322486
1668 O 1 0.9986374974250793
ACAG O 1 0.9992461204528809
1669 O 1 0.9650298953056335
splice O 0 0.04090527445077896
site O 0 0.0030731409788131714
mutation O 0 0.002253633923828602
. O 0 0.000313765078317374

After O 0 0.004176774062216282
initial O 0 0.0038425400853157043
treatment O 1 0.9982503056526184
with O 0 0.00012159416655777022
intravenous O 1 0.9982011318206787
glucose O 0 0.021678674966096878
and O 0 0.0005510473856702447
carnitine O 1 0.9997949004173279
, O 0 0.00029425829416140914
the O 0 0.0005094133666716516
patient O 1 0.999695897102356
has O 0 0.0006057284190319479
thrived O 0 0.009130105376243591
on O 0 6.810740887885913e-05
a O 0 0.000262414658209309
low O 0 0.0036187577061355114
- O 0 0.003746137721464038
fat O 0 0.006111915223300457
diet O 0 0.004634634125977755
supplemented O 0 0.0008966855239123106
with O 0 3.488295624265447e-05
medium O 0 0.0033850667532533407
- O 0 0.0046619088388979435
chain O 0 0.0053129661828279495
triglyceride O 0 0.2960648536682129
oil O 0 0.0025222136173397303
and O 0 0.0003593415895011276
carnitine O 1 0.999584972858429
and O 0 0.00020702641631942242
avoidance O 0 0.1392107456922531
of O 0 5.845698615303263e-05
fasting O 0 0.029939889907836914
. O 0 0.0004304282192606479

Her O 0 0.024863025173544884
ventricular O 1 0.9999967813491821
hypertrophy O 1 0.9999878406524658
resolved O 0 0.01977885141968727
significantly O 0 0.004926403518766165
over O 0 0.00020284940546844155
1 O 0 0.0008524033473804593
year O 0 0.00040268502198159695
, O 0 0.00012309607700444758
and O 0 0.0003438130661379546
cognitively O 1 0.9980093836784363
, O 0 0.0004741127195302397
she O 0 0.0006746754515916109
is O 0 0.00010434618161525577
in O 0 5.333628359949216e-05
the O 0 0.0001450864801881835
superior O 0 0.019076554104685783
range O 0 0.0008113052463158965
for O 0 0.00023705822241026908
age O 0 0.0012314614141359925
. O 0 0.0004565904091577977

Clinical O 1 0.9993249177932739
recognition O 0 0.002228478668257594
of O 0 0.00030308839632198215
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.0005762228392995894
important O 0 0.0004458172479644418
because O 0 0.000350394839188084
it O 0 4.326783891883679e-05
is O 0 4.3264954001642764e-05
one O 0 9.752890036907047e-06
of O 0 2.2290362267085584e-06
the O 0 6.260623194975778e-05
few O 0 0.0002326553367311135
directly O 0 0.0026554930955171585
treatable O 1 0.9999997615814209
causes O 1 0.7991868257522583
of O 0 0.00036219603498466313
cardiomyopathy B-Disease 1 1.0
in O 0 0.00095699931262061
children O 0 0.0014308419777080417
. O 0 0.00014358617772813886
. O 0 0.00027583527844399214

Cloning O 0 0.005434298887848854
of O 0 1.5047360648168251e-05
a O 0 0.0003942179318983108
novel O 0 0.0007008550455793738
member O 0 0.00010037651372840628
of O 0 3.6039384667674312e-06
the O 0 8.737409370951355e-05
low O 0 0.003066438715904951
- O 0 0.0024558252189308405
density O 0 0.0009556773002259433
lipoprotein O 1 0.9998668432235718
receptor O 0 0.010323240421712399
family O 0 0.0008609711076132953
. O 0 0.0003633286105468869

A O 0 0.0035570492036640644
gene O 0 0.000571652315557003
encoding O 0 0.0001559790689498186
a O 0 0.0002220262831542641
novel O 0 0.0008371808216907084
transmembrane O 0 0.005066145211458206
protein O 0 0.0007903944933786988
was O 0 0.0009193316218443215
identified O 0 0.00024812479387037456
by O 0 8.197682291211095e-06
DNA O 0 0.0001545097620692104
sequence O 0 7.949629434733652e-06
analysis O 0 2.7762449462898076e-05
within O 0 2.1073779862490483e-05
the O 0 0.00011736134183593094
insulin B-Disease 1 0.9961340427398682
- I-Disease 0 0.15927733480930328
dependent I-Disease 1 0.7295244932174683
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.007204281631857157
IDDM B-Disease 1 0.9989890456199646
) O 0 0.0005632824613712728
locus O 0 0.021063121035695076
IDDM4 O 1 0.9867215156555176
on O 0 0.0003889702202286571
chromosome O 0 0.002527062315493822
11q13 O 0 0.03815047815442085
. O 0 0.00040309381438419223

Based O 0 0.00034548103576526046
on O 0 0.00010697678953874856
its O 0 0.00021092648967169225
chromosomal O 0 0.014962460845708847
position O 0 0.0015264119720086455
, O 0 0.00010791631211759523
this O 0 3.372557694092393e-05
gene O 0 0.0007396913133561611
is O 0 6.815222150180489e-05
a O 0 0.000159316070494242
candidate O 0 0.0004050069837830961
for O 0 0.00011476449435576797
conferring O 0 0.1006896048784256
susceptibility O 1 0.9794517755508423
to O 0 0.0013871559640392661
diabetes B-Disease 1 1.0
. O 0 0.0008984686573967338

The O 0 0.000504653318785131
gene O 0 0.0012706152629107237
, O 0 0.00013361302262637764
termed O 0 0.016383104026317596
low O 0 0.0032772524282336235
- O 0 0.0021933841053396463
density O 0 0.0006565091898664832
lipoprotein O 1 0.9992850422859192
receptor O 0 0.003889008890837431
related O 0 0.0005540340789593756
protein O 0 0.0006154630682431161
5 O 0 0.001311315456405282
( O 0 0.001190723036415875
LRP5 O 1 0.9964854717254639
) O 0 0.00021373628987930715
, O 0 4.342525789979845e-05
encodes O 0 0.00023632320517208427
a O 0 8.853857434587553e-05
protein O 0 0.00011993823136435822
of O 0 2.470546678523533e-05
1615 O 0 0.04265216365456581
amino O 0 0.00013640835823025554
acids O 0 0.00015575256838928908
that O 0 9.790520380192902e-06
contains O 0 2.1378749806899577e-05
conserved O 0 0.00013027159729972482
modules O 0 0.0007866548257879913
which O 0 1.2477134077926166e-05
are O 0 3.283646719864919e-06
characteristic O 0 0.0002592674863990396
of O 0 4.107425411348231e-06
the O 0 9.225928079104051e-05
low O 0 0.0028249702882021666
- O 0 0.0027258184272795916
density O 0 0.0011554197408258915
lipoprotein O 1 0.9999837875366211
( O 0 0.004952074959874153
LDL O 1 0.9999973773956299
) O 0 0.0006204057135619223
receptor O 0 0.005166990682482719
family O 0 0.0006743739359080791
. O 0 0.0003560353070497513

These O 0 6.013486927258782e-05
modules O 0 0.0008596042753197253
include O 0 9.509074152447283e-05
a O 0 0.00030056879040785134
putative O 0 0.00671509699895978
signal O 0 0.0009627545368857682
peptide O 0 0.0009383967844769359
for O 0 3.3100994187407196e-05
protein O 0 0.0001233213988598436
export O 0 0.00021756287605967373
, O 0 6.294925697147846e-05
four O 0 8.891305333236232e-05
epidermal O 1 0.9969164133071899
growth O 0 0.0013734368840232491
factor O 0 0.00266644055955112
( O 0 0.0011837092461064458
EGF O 1 0.993743360042572
) O 0 0.0003498567675705999
repeats O 0 0.0023538260720670223
with O 0 4.949320646119304e-05
associated O 0 0.00033358807559125125
spacer O 0 0.020790690556168556
domains O 0 0.0010635423241183162
, O 0 0.00010281729191774502
three O 0 0.0002138284035027027
LDL O 1 0.9999939203262329
- O 0 0.01050702203065157
receptor O 0 0.008644349873065948
( O 0 0.0014140879502519965
LDLR O 1 0.9963942170143127
) O 0 0.00036759214708581567
repeats O 0 0.002338504185900092
, O 0 5.123858863953501e-05
a O 0 0.00011530111078172922
single O 0 0.00013789399235974997
transmembrane O 0 0.00830517616122961
spanning O 0 0.003693558042868972
domain O 0 0.0007545487605966628
, O 0 9.62399790296331e-05
and O 0 4.375840217107907e-05
a O 0 0.00027088276692666113
cytoplasmic O 0 0.004511861130595207
domain O 0 0.0011819323990494013
. O 0 0.00036848351010121405

The O 0 8.258137677330524e-05
encoded O 0 3.21165680361446e-05
protein O 0 0.0001984909613383934
has O 0 0.00010032100544776767
a O 0 9.139815665548667e-05
unique O 0 0.0002118027477990836
organization O 0 0.0007008701213635504
of O 0 5.514829535968602e-05
EGF O 1 0.9981391429901123
and O 0 0.0008863346301950514
LDLR O 1 0.9989746809005737
repeats O 0 0.011420712806284428
; O 0 0.0001113314792746678
therefore O 0 0.0003751434269361198
, O 0 0.00042019167449325323
LRP5 O 1 0.9974483251571655
likely O 0 0.000980655080638826
represents O 0 0.0007974686450324953
a O 0 0.0002559624845162034
new O 0 0.00013124238466843963
category O 0 0.00031267391750589013
of O 0 1.1109026672784239e-05
the O 0 0.0005481974803842604
LDLR O 1 0.9996004700660706
family O 0 0.0011593303643167019
. O 0 0.0003371504135429859

Both O 0 0.00036815874045714736
human O 0 0.000990837230347097
and O 0 0.0004413667193148285
mouse O 0 0.045584987848997116
LRP5 O 1 0.9986162185668945
cDNAs O 1 0.8006084561347961
have O 0 0.000155667366925627
been O 0 0.00030279954080469906
isolated O 0 0.00305846962146461
and O 0 2.6820081984624267e-05
the O 0 2.9720577003899962e-05
encoded O 0 8.448130392935127e-05
mature O 0 0.0031514870934188366
proteins O 0 4.3866111809620634e-05
are O 0 1.4905551324773114e-05
95 O 0 0.0009832035284489393
% O 0 3.3075564715545624e-05
identical O 0 0.0003014472022186965
, O 0 0.00013067819236312062
indicating O 0 0.001745725399814546
a O 0 0.0004971497692167759
high O 0 0.001906014047563076
degree O 0 0.0006066706846468151
of O 0 8.814456123218406e-06
evolutionary O 0 0.0015163510106503963
conservation O 0 0.007281442638486624
. O 0 0.00012304092524573207
. O 0 0.0002257682353956625

The O 0 0.0018652047729119658
APC B-Disease 1 0.955205500125885
variants O 0 0.0035435371100902557
I1307K O 0 0.03486926481127739
and O 0 0.00014601301518268883
E1317Q O 0 0.012036239728331566
are O 0 1.4556465430359822e-05
associated O 0 0.0003191341820638627
with O 0 0.003441639244556427
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0004748549545183778
but O 0 0.00012384580622892827
not O 0 3.743120760191232e-05
always O 0 0.00011551162606338039
with O 0 1.4041850590729155e-05
a O 0 0.0003033855464309454
family O 0 0.00038768822560086846
history O 0 0.0006270634476095438
. O 0 0.00034673899062909186

Classical O 0 0.028275737538933754
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.02543046325445175
FAP B-Disease 1 0.9999485015869141
) O 0 0.0002584663452580571
is O 0 8.522353164153174e-05
a O 0 0.0003098409215454012
high O 0 0.006119801662862301
- O 0 0.2627039849758148
penetrance O 1 0.9991891980171204
autosomal B-Disease 1 0.9997360110282898
dominant I-Disease 1 0.999237060546875
disease I-Disease 1 0.9999998807907104
that O 0 0.00045720499474555254
predisposes O 1 0.9985722303390503
to O 0 6.675706390524283e-05
hundreds O 0 0.00012966457870788872
or O 0 8.007951691979542e-05
thousands O 0 0.000233686194405891
of O 0 0.00041827201494015753
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.14710544049739838
carcinoma I-Disease 1 1.0
and O 0 0.00026058536604978144
that O 0 4.79743757750839e-05
results O 0 0.00027018817490898073
from O 0 8.43696398078464e-05
truncating O 0 0.11755964159965515
mutations O 0 0.0008758035255596042
in O 0 6.121410115156323e-05
the O 0 0.00033402277040295303
APC B-Disease 1 0.9979634284973145
gene O 0 0.0036536166444420815
. O 0 0.00034224058617837727

A O 0 0.003659602953121066
variant O 0 0.0077989487908780575
of O 0 0.00011583380546653643
FAP B-Disease 1 0.9999825954437256
is O 0 0.004160408396273851
attenuated B-Disease 1 0.9998863935470581
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.9999853372573853
, O 0 0.00029717455618083477
which O 0 3.0427274396060966e-05
results O 0 0.0003420388384256512
from O 0 0.00020215893164277077
germ O 1 0.999656081199646
- O 0 0.007410891819745302
line O 0 0.0015786731382831931
mutations O 0 0.0005824723630212247
in O 0 5.6653530918993056e-05
the O 0 0.00014289190585259348
5 O 0 0.0006258788052946329
and O 0 9.632242290535942e-05
3 O 0 0.00020460656378418207
regions O 0 5.581195728154853e-05
of O 0 7.517572612414369e-06
the O 0 0.0005129932542331517
APC B-Disease 1 0.9977725148200989
gene O 0 0.0039678653702139854
. O 0 0.00036609882954508066

Attenuated B-Disease 1 0.99997878074646
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
patients O 1 0.9999988079071045
have O 0 8.206507482100278e-05
" O 0 0.000195748420082964
multiple O 0 0.0024557961151003838
" O 0 0.1318962275981903
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999994039535522
( O 0 0.0010747909545898438
typically O 0 0.00022477333550341427
fewer O 0 0.0002584047324489802
than O 0 5.4241081670625135e-05
100 O 0 0.0002682893828023225
) O 0 6.132495036581531e-05
without O 0 5.180582229513675e-05
the O 0 0.0001287205668631941
florid O 1 0.9830991625785828
phenotype O 0 0.02136828377842903
of O 0 3.151140481350012e-05
classical O 0 0.004270263481885195
FAP B-Disease 1 0.9999581575393677
. O 0 0.0011704463977366686

Another O 0 0.0009737487998791039
group O 0 0.0002507675380911678
of O 0 7.25140271242708e-05
patients O 1 0.9999891519546509
with O 0 0.000160194409545511
multiple O 0 0.017022522166371346
adenomas B-Disease 1 0.9999876022338867
has O 0 0.0004933730815537274
no O 0 0.00010780585580505431
mutations O 0 0.00041627875179983675
in O 0 5.6033914006548e-05
the O 0 0.0004541608504951
APC B-Disease 1 0.9997531771659851
gene O 0 0.0028476216830313206
, O 0 0.0001266781910089776
and O 0 6.137935270089656e-05
their O 0 0.0001133352707256563
phenotype O 0 0.3542052209377289
probably O 0 0.001459666294977069
results O 0 0.00018131935212295502
from O 0 2.0120998669881374e-05
variation O 0 0.0001442246575606987
at O 0 0.00043350603664293885
a O 0 0.0005412749014794827
locus O 0 0.018920863047242165
, O 0 0.0003919896262232214
or O 0 0.0006654377793893218
loci O 0 0.010418211109936237
, O 0 0.00019234081264585257
elsewhere O 0 0.00033346566488035023
in O 0 3.4845787013182417e-05
the O 0 0.00010225518781226128
genome O 0 0.00379876047372818
. O 0 0.00033122114837169647

Recently O 0 0.019029488787055016
, O 0 0.0001851688721217215
however O 0 0.00011397567868698388
, O 0 4.8233094275929034e-05
a O 0 0.00035520692472346127
missense O 0 0.011676891706883907
variant O 0 0.007681128103286028
of O 0 0.00013189173478167504
APC B-Disease 1 0.9989834427833557
( O 0 0.0025284881703555584
I1307K O 0 0.18054574728012085
) O 0 0.00027928472263738513
was O 0 0.0005867746658623219
described O 0 0.000831233395729214
that O 0 2.8036918592988513e-05
confers O 0 0.008927849121391773
an O 0 5.1333714509382844e-05
increased O 0 0.0005451093311421573
risk O 1 0.919846773147583
of O 0 0.0012192983413115144
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0002995966060552746
including O 0 0.00011664316843962297
multiple O 0 0.010619735345244408
adenomas B-Disease 1 0.9999719858169556
, O 0 0.0003465058980509639
in O 0 0.00035541856777854264
Ashkenazim O 1 0.9671711325645447
. O 0 0.0007250979542732239

We O 0 0.00051194301340729
have O 0 3.7842382880626246e-05
studied O 0 0.0001672562793828547
a O 0 4.559853550745174e-05
set O 0 1.4314934560388792e-05
of O 0 1.8410293705528602e-05
164 O 0 0.05882396548986435
patients O 1 0.9999808073043823
with O 0 0.00022302434081211686
multiple O 1 0.9997802376747131
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.005705458577722311
/ I-Disease 1 0.999338686466217
or I-Disease 0 0.0060234046541154385
carcinoma I-Disease 1 1.0
and O 0 0.0002796841145027429
analyzed O 0 0.0028336721006780863
codons O 0 0.008816633373498917
1263 O 1 0.9437331557273865
- O 0 0.017928481101989746
1377 O 1 0.9355676174163818
( O 0 0.0009395727538503706
exon O 0 0.03274906054139137
15G O 0 0.06669683754444122
) O 0 4.817260196432471e-05
of O 0 4.476204139791662e-06
the O 0 0.0002421718672849238
APC B-Disease 1 0.9848769903182983
gene O 0 0.0014908412704244256
for O 0 0.00045197815052233636
germ O 1 0.9991956353187561
- O 0 0.008020023815333843
line O 0 0.0013517951592803001
variants O 0 0.0010706995381042361
. O 0 0.00031747063621878624

Three O 0 0.0017086148727685213
patients O 1 0.9997648596763611
with O 0 5.11359357915353e-05
the O 0 0.0002824285184033215
I1307K O 0 0.054702721536159515
allele O 0 0.004240803420543671
were O 0 6.728222069796175e-05
detected O 0 0.003389947582036257
, O 0 3.267081774538383e-05
each O 0 1.0497287803445943e-05
of O 0 3.112491322099231e-05
Ashkenazi O 1 0.9767107367515564
descent O 0 0.005024188198149204
. O 0 0.0006483972538262606

Four O 0 0.0017932316986843944
patients O 1 0.9994732737541199
had O 0 0.0004248522163834423
a O 0 0.0010848235106095672
germ O 1 0.9994387030601501
- O 0 0.007294579409062862
line O 0 0.002488809870555997
E1317Q O 0 0.040355246514081955
missense O 0 0.015998460352420807
variant O 0 0.006901703309267759
of O 0 9.417543333256617e-05
APC O 1 0.9973487854003906
that O 0 0.00014809299318585545
was O 0 0.0007498243357986212
not O 0 5.9610272728605196e-05
present O 0 8.943312423070893e-05
in O 0 0.00012355350190773606
controls O 0 0.002095399424433708
; O 0 8.916267688618973e-05
one O 0 2.8394628316164017e-05
of O 0 6.2720700952922925e-06
these O 0 1.552055255160667e-05
individuals O 0 0.0001548498694319278
had O 0 0.00034869133378379047
an O 0 0.00010943843517452478
unusually O 0 0.004933565855026245
large O 0 4.990095840184949e-05
number O 0 1.0948214367090259e-05
of O 0 4.05351966037415e-05
metaplastic B-Disease 1 0.9970220923423767
polyps I-Disease 1 0.9858712553977966
of I-Disease 0 1.592833905306179e-05
the I-Disease 0 0.0003532433765940368
colorectum I-Disease 1 0.9470621943473816
. O 0 0.00046922286855988204

There O 0 0.0002103663282468915
is O 0 8.306219388032332e-05
increasing O 0 0.00020673347171396017
evidence O 0 0.00011541639833012596
that O 0 2.25067760766251e-05
there O 0 4.888705370831303e-05
exist O 0 0.0008439392549917102
germ O 1 0.9995463490486145
- O 0 0.004173259250819683
line O 0 0.0005026638973504305
variants O 0 0.0001315758127020672
of O 0 6.661774932581466e-06
the O 0 0.00045841647079214454
APC B-Disease 1 0.9989356398582458
gene O 0 0.0021677890326827765
that O 0 7.806970097590238e-05
predispose O 0 0.032894596457481384
to O 0 1.539229924674146e-05
the O 0 1.8736767742666416e-05
development O 0 0.00029606439056806266
of O 0 4.829873068956658e-05
multiple O 1 0.9999035596847534
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.37647053599357605
carcinoma I-Disease 1 1.0
, O 0 0.0005140441935509443
but O 0 8.652967517264187e-05
without O 0 6.233161548152566e-05
the O 0 0.00014000938972458243
florid O 1 0.9857975840568542
phenotype O 0 0.02042260952293873
of O 0 2.7313362807035446e-05
classical O 0 0.004070889670401812
FAP B-Disease 1 0.9999556541442871
, O 0 0.0003699005173984915
and O 0 6.145161751192063e-05
possibly O 0 0.00023441726807504892
with O 0 9.949401828635018e-06
importance O 0 0.0020328930113464594
for O 1 0.871566116809845
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9707769751548767
in O 0 8.575072570238262e-05
the O 0 6.616795872105286e-05
general O 0 0.0005483574932441115
population O 0 5.169576979824342e-05
. O 0 9.892012894852087e-05
. O 0 0.00025838823057711124

Genomic O 0 0.002099329372867942
structure O 0 0.00021654569718521088
of O 0 3.7993791011103895e-06
the O 0 0.0001658927067182958
human O 1 0.9000436067581177
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999990463256836
diarrhea I-Disease 1 1.0
( O 0 0.03443825617432594
CLD B-Disease 1 0.999997615814209
) O 0 0.0008010142482817173
gene O 0 0.0020170623902231455
. O 0 0.00028223366825841367

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999977350234985
diarrhea I-Disease 1 1.0
( O 0 0.1677270382642746
CLD B-Disease 1 0.9999995231628418
) O 0 0.0009193868609145284
is O 0 0.00039459989056922495
caused O 0 0.0028003889601677656
by O 0 4.023023575427942e-05
mutations O 0 0.000803327769972384
in O 0 4.9468333600088954e-05
a O 0 0.0002178979484597221
gene O 0 0.0003655953914858401
which O 0 9.8460250228527e-06
encodes O 0 0.00038829169352538884
an O 0 0.0005593147361651063
intestinal O 1 0.9999995231628418
anion O 1 0.9986156225204468
transporter O 1 0.9983548521995544
. O 0 0.0011210237862542272

We O 0 0.0009118284215219319
report O 0 0.0004273070953786373
here O 0 5.021377728553489e-05
the O 0 4.1781007894314826e-05
complete O 0 0.0005591369117610157
genomic O 0 0.0010749829234555364
organization O 0 0.00030095272813923657
of O 0 7.99706958787283e-06
the O 0 0.00021378642122726887
human O 0 0.008347097784280777
CLD B-Disease 1 0.999984860420227
gene O 0 0.0021722051315009594
which O 0 6.96930947015062e-05
spans O 0 0.00815344974398613
approximately O 0 0.001074684434570372
39kb O 0 0.4605329930782318
, O 0 0.00016794410475995392
and O 0 0.00010338674474041909
comprises O 0 0.0008787316037341952
21 O 0 0.0014303132193163037
exons O 0 0.007387521676719189
. O 0 0.00036618925514630973

All O 0 0.0003809503687079996
exon O 0 0.09814003854990005
/ O 0 0.04319678246974945
intron O 0 0.0815865769982338
boundaries O 0 0.0002048556343652308
conform O 0 0.0012089526280760765
to O 0 5.7659017329569906e-05
the O 0 0.0006590456468984485
GT O 1 0.9995105266571045
/ O 1 0.9922391176223755
AG O 1 0.9995418787002563
rule O 0 0.0010614393977448344
. O 0 0.00035357862361706793

An O 0 0.0001960618537850678
analysis O 0 8.728531975066289e-05
of O 0 1.0515193025639746e-05
the O 0 0.0002484022406861186
putative O 0 0.031292807310819626
promoter O 0 0.02315039560198784
region O 0 0.0005495519726537168
sequence O 0 3.8664387830067426e-05
shows O 0 9.531297109788284e-05
a O 0 0.0007072290172800422
putative O 0 0.12460491061210632
TATA O 1 0.9998812675476074
box O 0 0.006802349351346493
and O 0 0.00016170728486031294
predicts O 0 0.007464708760380745
multiple O 0 0.0003319595707580447
transcription O 0 0.0005369558930397034
factor O 0 0.0007442075875587761
binding O 0 0.00041700334986671805
sites O 0 0.0004095877811778337
. O 0 0.0002616200072225183

The O 0 0.000371813919628039
genomic O 0 0.0030504886526614428
structure O 0 0.0025197984650731087
was O 0 0.0009315658244304359
determined O 0 0.0006561957998201251
using O 0 8.481022086925805e-05
DNA O 0 0.0005720910849049687
from O 0 1.8243385056848638e-05
several O 0 1.5182135030045174e-05
sources O 0 7.670012564631179e-05
including O 0 2.6206631446257234e-05
multiple O 0 0.0006991659174673259
large O 0 0.0004666630120482296
- O 0 0.010282815434038639
insert O 0 0.036536965519189835
libaries O 0 0.047301046550273895
and O 0 6.274609040701762e-05
genomic O 0 0.0011342921061441302
DNA O 0 0.0005767183611169457
from O 0 0.00011537985847098753
Finnish O 1 0.9946293234825134
CLD B-Disease 1 0.9999996423721313
patients O 1 0.9999752044677734
and O 0 0.0001878635084722191
controls O 0 0.002120198216289282
. O 0 0.000381980964448303

Exon O 0 0.10725333541631699
- O 0 0.004119216464459896
specific O 0 0.00024270074209198356
primers O 0 0.015593722462654114
developed O 0 0.0018399338005110621
in O 0 5.6016710004769266e-05
this O 0 1.9510900528985076e-05
study O 0 0.00025077018653973937
will O 0 3.103093331446871e-05
facilitate O 0 0.001007271115668118
mutation O 0 0.0014223325997591019
screening O 0 0.002307870425283909
studies O 0 0.00027672218857333064
of O 0 4.2802945245057344e-05
patients O 1 0.9999979734420776
with O 0 9.216871694661677e-05
the O 0 0.001344085088931024
disease O 1 0.9999997615814209
. O 0 0.0006245904951356351

Genomic O 0 0.001168372342363
sequencing O 0 0.00013244475121609867
of O 0 1.1674093912006356e-05
a O 0 0.001983911031857133
BAC O 1 0.9993923902511597
clone O 1 0.9695197939872742
H O 1 0.9998019337654114
_ O 0 0.003533596871420741
RG364P16 O 0 0.062461867928504944
revealed O 0 0.003020422300323844
the O 0 5.304795558913611e-05
presence O 0 0.00011423061368986964
of O 0 7.87560384196695e-06
another O 0 0.00036178657319396734
, O 0 0.00011752607679227367
highly O 0 0.0019545943941920996
homologous O 0 0.003994846250861883
gene O 0 0.0008410195005126297
3 O 0 0.00014390032447408885
of O 0 1.3104642675898504e-05
the O 0 0.0014492160407826304
CLD B-Disease 1 0.9999909400939941
gene O 0 0.004100252874195576
, O 0 8.213341061491519e-05
with O 0 1.5997835362213664e-05
a O 0 0.00018158114107791334
similar O 0 0.0001499201316619292
genomic O 0 0.0022287247702479362
structure O 0 0.0025611482560634613
, O 0 0.00022215544595383108
recently O 0 0.0019770346116274595
identified O 0 0.00019693643844220787
as O 0 6.733311602147296e-05
the O 0 0.0007014551083557308
Pendred B-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
gene O 0 0.012354676611721516
( O 0 0.002180794021114707
PDS B-Disease 1 0.9999480247497559
) O 0 0.0004917127080261707
. O 0 0.00011450739111751318
. O 0 0.00021200679475441575

The O 0 0.0015950895613059402
APCI1307K O 1 0.9986735582351685
allele O 0 0.02126988209784031
and O 0 0.0030622680205851793
cancer B-Disease 1 1.0
risk O 0 0.17400126159191132
in O 0 7.62146883062087e-05
a O 0 0.0004003873618785292
community O 0 0.0011896934593096375
- O 0 0.00192785554099828
based O 0 5.209181472309865e-05
study O 0 0.00019195898494217545
of O 0 2.539074375818018e-05
Ashkenazi O 1 0.9831159710884094
Jews O 0 0.0015964858466759324
. O 0 0.00047688098857179284

Mutations O 0 0.007476178463548422
in O 0 0.00044652773067355156
APC O 1 0.9938575625419617
are O 0 8.052343036979437e-05
classically O 1 0.7624130845069885
associated O 0 0.0005614081164821982
with O 0 0.0006713395123369992
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.03344281390309334
FAP B-Disease 1 0.9999721050262451
) O 0 0.0002682676713448018
, O 0 3.815437594312243e-05
a O 0 0.0002507178287487477
highly O 0 0.0278150774538517
penetrant O 1 0.9999897480010986
autosomal B-Disease 1 0.9999974966049194
dominant I-Disease 1 0.9998959302902222
disorder I-Disease 1 1.0
characterized O 1 0.9982615113258362
by O 0 0.00024512421805411577
multiple O 1 0.9975827932357788
intestinal O 1 1.0
polyps B-Disease 1 0.9999852180480957
and O 0 0.00024849435430951416
, O 0 0.00023969690664671361
without O 0 0.0013087625848129392
surgical O 1 0.9999978542327881
intervention O 0 0.0076356022618710995
, O 0 4.602935950970277e-05
the O 0 2.7598123779171146e-05
development O 0 0.0011697208974510431
of O 0 0.0007208146271295846
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.003941376693546772
CRC B-Disease 1 0.9996411800384521
) O 0 0.0003961144248023629
. O 0 0.0002019864768953994

APC B-Disease 1 0.9778427481651306
is O 0 0.0006181090138852596
a O 0 0.0032734894193708897
tumour O 1 0.9999998807907104
- O 0 0.026362458243966103
suppressor O 0 0.02316795289516449
gene O 0 0.0008375502657145262
, O 0 5.8655161410570145e-05
and O 0 9.160984336631373e-05
somatic O 0 0.011846906505525112
loss O 0 0.008603939786553383
occurs O 0 0.0015745642594993114
in O 0 0.001004237332381308
tumours B-Disease 1 0.9999998807907104
. O 0 0.0006976224249228835

The O 0 0.003179938765242696
germline O 1 0.9965255856513977
T O 1 0.9984418749809265
- O 0 0.003209064481779933
to O 0 8.565436291974038e-05
- O 0 0.0021542110480368137
A O 0 0.002036534482613206
transversion O 0 0.07294386625289917
responsible O 0 0.001895097317174077
for O 0 0.00011340738274157047
the O 0 0.0004759933508466929
APC O 1 0.9911473393440247
I1307K O 0 0.040640939027071
allele O 0 0.0021485548932105303
converts O 0 0.00025685655418783426
the O 0 0.00012723871623165905
wild O 0 0.0005882596014998853
- O 0 0.002248393837362528
type O 0 0.0006148354150354862
sequence O 0 1.750556293700356e-05
to O 0 2.5345598260173574e-05
a O 0 0.0008175323018804193
homopolymer O 1 0.9982359409332275
tract O 1 0.9999778270721436
( O 0 0.004892272409051657
A8 O 1 0.999964714050293
) O 0 0.00023727233929093927
that O 0 3.612232467276044e-05
is O 0 0.00021256424952298403
genetically O 0 0.001997276907786727
unstable O 1 0.9972410202026367
and O 0 0.000365335465176031
prone O 1 0.6120636463165283
to O 0 0.00017579435370862484
somatic O 0 0.011387012898921967
mutation O 0 0.002933439565822482
. O 0 0.00029065506532788277

The O 0 0.0009069523657672107
I1307K O 0 0.04702183976769447
allele O 0 0.005866027902811766
was O 0 0.0010817323345690966
found O 0 0.00016543714446015656
in O 0 0.00010529212886467576
6 O 0 0.0012889403151348233
. O 0 0.00031519311596639454

1 O 0 0.0010499986819922924
% O 0 2.940577905974351e-05
of O 0 4.5287732064025477e-05
unselected O 1 0.9872972965240479
Ashkenazi O 1 0.9839316010475159
Jews O 0 0.0009418381378054619
and O 0 0.0001271853398066014
higher O 0 0.0007749544456601143
proportions O 0 0.004921617917716503
of O 0 0.00010205850412603468
Ashkenazim O 1 0.9406086206436157
with O 0 0.0002386611158726737
family O 0 0.0007730051293037832
or O 0 0.00028891314286738634
personal O 0 0.0010015190346166492
histories O 0 0.0032636639662086964
of O 0 0.00014876271598041058
CRC B-Disease 1 0.9998339414596558
( O 0 0.002490536542609334
ref O 1 0.7842242121696472
. O 0 0.0001310480438405648
2 O 0 0.0006065319175831974
) O 0 0.0001339250011369586
. O 0 0.00018774246564134955

To O 0 0.00031334420782513916
evaluate O 0 0.005011387635022402
the O 0 4.117472781217657e-05
role O 0 0.0004295944527257234
of O 0 2.901022890000604e-05
I1307K O 1 0.7490971088409424
in O 0 0.0016315706307068467
cancer B-Disease 1 0.9999998807907104
, O 0 0.00018802942940965295
we O 0 0.00019596709171310067
genotyped O 0 0.06773827970027924
5 O 0 0.0007812699768692255
, O 0 0.0004961054073646665
081 O 1 0.9883018136024475
Ashkenazi O 1 0.5453084111213684
volunteers O 0 0.0039535705000162125
in O 0 5.407210119301453e-05
a O 0 0.0002648684603627771
community O 0 0.0006541034672409296
survey O 0 0.0013372233370319009
. O 0 0.0003354922810103744

Risk O 0 0.028468945994973183
of O 0 6.988763198023662e-05
developing O 1 0.9997549653053284
colorectal B-Disease 1 1.0
, I-Disease 0 0.007357629481703043
breast I-Disease 1 1.0
and I-Disease 0 0.00027011067140847445
other I-Disease 0 0.00018482384621165693
cancers I-Disease 1 0.9999749660491943
were O 0 4.286879629944451e-05
compared O 0 0.0004842931521125138
between O 0 0.00031413082615472376
genotyped O 1 0.9889001846313477
I1307K O 0 0.13249222934246063
carriers O 0 0.007810218725353479
and O 0 0.00015188552788458765
non O 0 0.004784002900123596
- O 0 0.0057228184305131435
carriers O 0 0.0029505486600100994
and O 0 2.0540201148833148e-05
their O 0 1.5718154827482067e-05
first O 0 0.00031559544731862843
- O 0 0.004683489445596933
degree O 0 0.0022524686064571142
relatives O 0 0.0010414905846118927
. O 0 0.00027858445537276566

Sperm O 0 0.0017246617935597897
DNA O 0 0.00038878628402017057
analysis O 0 8.020463428692892e-05
in O 0 0.0001038492628140375
a O 0 0.002529412042349577
Friedreich B-Disease 1 0.9999759197235107
ataxia I-Disease 1 0.9999929666519165
premutation O 1 0.999083399772644
carrier O 0 0.2524341344833374
suggests O 0 0.0016970557626336813
both O 0 0.00016004218196030706
meiotic O 0 0.4545329213142395
and O 0 0.00013160154048819095
mitotic O 0 0.012522377073764801
expansion O 0 0.0011024815030395985
in O 0 7.951786392368376e-05
the O 0 0.0003342890995554626
FRDA B-Disease 1 0.9967425465583801
gene O 0 0.0029361003544181585
. O 0 0.0003121137560810894

Friedreich B-Disease 1 0.9999603033065796
ataxia I-Disease 1 0.9999728202819824
is O 0 0.002185680205002427
usually O 0 0.00056331732776016
caused O 0 0.0020878349896520376
by O 0 1.4130038834991865e-05
an O 0 4.6054650738369673e-05
expansion O 0 0.0004809924867004156
of O 0 1.3122877135174349e-05
a O 0 0.00152586551848799
GAA O 0 0.31050920486450195
trinucleotide O 1 0.9452752470970154
repeat O 0 0.008943028748035431
in O 0 0.00023079218226484954
intron O 0 0.09325137734413147
1 O 0 0.00027290082653053105
of O 0 6.421866601158399e-06
the O 0 0.00035097505315206945
FRDA B-Disease 1 0.9986997842788696
gene O 0 0.0032283866312354803
. O 0 0.00028453776030801237

Occasionally O 0 0.006342262029647827
, O 0 0.00012688430433627218
a O 0 0.0003598230250645429
fully O 0 0.0029200008139014244
expanded O 0 0.0010282736038789153
allele O 0 0.003542133141309023
has O 0 0.0003713387413881719
been O 0 0.000157662492711097
found O 0 0.0001012203429127112
to O 0 5.2189818234182894e-05
arise O 0 0.0017815633909776807
from O 0 4.359869853942655e-05
a O 0 0.0004313585814088583
premutation O 0 0.02884332649409771
of O 0 1.1342332982167136e-05
100 O 0 0.00019311151118017733
or O 0 0.00013135455083101988
less O 0 0.0006718176882714033
triplet O 1 0.5122898817062378
repeats O 0 0.014700698666274548
. O 0 0.0005310708656907082

We O 0 0.0006497572758235037
have O 0 7.929479033919051e-05
examined O 0 0.0028781562577933073
the O 0 5.0006718083750457e-05
sperm O 0 0.0002491481718607247
DNA O 0 0.0001526848936919123
of O 0 6.335620582831325e-06
a O 0 0.0011272372212260962
premutation O 1 0.991248607635498
carrier O 0 0.07448869198560715
. O 0 0.0006327414303086698

This O 0 0.0003418577543925494
mans O 0 0.024654285982251167
leucocyte O 0 0.09210671484470367
DNA O 0 0.001519122626632452
showed O 0 0.0006750324391759932
one O 0 0.00010842627671081573
normal O 0 0.0022295687813311815
allele O 0 0.002617989666759968
and O 0 6.917901191627607e-05
one O 0 5.616883936454542e-05
allele O 0 0.0006038181600160897
of O 0 1.1009128684236202e-05
approximately O 0 0.00037342161522246897
100 O 0 0.0005878129159100354
repeats O 0 0.007064527366310358
. O 0 0.00043176300823688507

His O 0 0.001576166250742972
sperm O 0 0.0010527230333536863
showed O 0 0.000611431838478893
an O 0 0.00010097586346091703
expanded O 0 0.0011063308920711279
allele O 0 0.0023002284578979015
in O 0 0.00011177857231814414
a O 0 0.00039293154259212315
tight O 0 0.0026914223562926054
range O 0 0.000826811243314296
centering O 0 0.005084603559225798
on O 0 8.317110041389242e-05
a O 0 9.811511699808761e-05
size O 0 5.8501263993093744e-05
of O 0 9.82164237939287e-06
approximately O 0 0.0013772774254903197
320 O 0 0.05621059983968735
trinucleotide O 1 0.9492659568786621
repeats O 0 0.013317764736711979
. O 0 0.00040946988156065345

His O 0 0.004357883706688881
affected O 0 0.016726255416870117
son O 0 0.01214953325688839
has O 0 0.0004994695773348212
repeat O 0 0.0038258901331573725
sizes O 0 0.00018899755377788097
of O 0 6.309337913990021e-05
1040 O 1 0.9886513948440552
and O 0 0.0005653246771544218
540 O 0 0.05191494897007942
. O 0 0.0005695589352399111

These O 0 3.4704313293332234e-05
data O 0 9.928301005857065e-05
suggest O 0 0.00039308887789957225
that O 0 3.0322182283271104e-05
expansion O 0 0.0015017068944871426
occurs O 0 0.000577858998440206
in O 0 7.361471216427162e-05
two O 0 3.9600425225216895e-05
stages O 0 0.002500873291864991
, O 0 7.235017255879939e-05
the O 0 4.8910744226304814e-05
first O 0 0.00011465948773548007
during O 0 0.0011911586625501513
meiosis O 0 0.01608971878886223
followed O 0 0.0001509834692114964
by O 0 1.1006997738149948e-05
a O 0 0.00013982020027469844
second O 0 0.0002826825948432088
mitotic O 0 0.015475970692932606
expansion O 0 0.003050203202292323
. O 0 0.0003252714523114264

We O 0 0.0008036400540731847
also O 0 0.0001440102787455544
show O 0 0.00018206237291451544
that O 0 1.5763640476507135e-05
in O 0 2.5231191102648154e-05
all O 0 1.6412415789091028e-05
informative O 0 0.008335771039128304
carrier O 0 0.03337564319372177
father O 0 0.0018630233826115727
to O 0 0.00013154205225873739
affected O 0 0.005892587825655937
child O 0 0.008174317888915539
transmissions O 0 0.005586062092334032
, O 0 7.839257159503177e-05
with O 0 2.3262828108272515e-05
the O 0 9.716635395307094e-05
notable O 0 0.0003497387224342674
exception O 0 0.0006797329988330603
of O 0 1.6549342035432346e-05
the O 0 0.0005831375601701438
premutation O 1 0.9821709394454956
carrier O 0 0.030955061316490173
, O 0 8.604059257777408e-05
the O 0 5.255641008261591e-05
expansion O 0 0.0008171082590706646
size O 0 0.0002963260922115296
decreases O 0 0.0042484225705266
. O 0 0.00013489420234691352
. O 0 0.0002584700414445251

The O 0 0.0009009985369630158
R496H O 0 0.028566040098667145
mutation O 0 0.0005752290016971529
of O 0 1.9273795260232873e-05
arylsulfatase O 1 0.7451912760734558
A O 0 0.002450254512950778
does O 0 0.0005181508604437113
not O 0 0.00015431216161232442
cause O 1 0.6916191577911377
metachromatic B-Disease 1 0.9999727010726929
leukodystrophy I-Disease 1 0.9999983310699463
. O 0 0.0017950569745153189

Deficiency B-Disease 1 0.9999951124191284
of I-Disease 0 0.00011224211630178615
arylsulfatase I-Disease 1 0.9512856602668762
A I-Disease 0 0.008369951508939266
( O 0 0.00197163550183177
ARSA O 1 0.9996299743652344
) O 0 0.0002120745339198038
enzyme O 0 0.0010795718990266323
activity O 0 0.0008701219921931624
causes O 1 0.9858909845352173
metachromatic B-Disease 1 0.9999732971191406
leukodystrophy I-Disease 1 0.9999996423721313
( O 0 0.016331085935235023
MLD B-Disease 1 0.9999960660934448
) O 0 0.0009976911824196577
. O 0 0.0003860332362819463

A O 0 0.0009970435639843345
number O 0 1.6282428987324238e-05
of O 0 6.138918979559094e-05
ARSA O 1 0.9998564720153809
gene O 0 0.0035022981464862823
mutations O 0 0.0013514631427824497
responsible O 0 0.0036412817426025867
for O 0 0.001396208768710494
MLD B-Disease 1 0.9999985694885254
have O 0 0.00016764552856329829
been O 0 0.00021984978229738772
identified O 0 0.0006421549478545785
. O 0 0.0001883513614302501

Recently O 0 0.011527030728757381
, O 0 0.0001092436577891931
the O 0 0.00013082216901239008
R496H O 0 0.028342636302113533
mutation O 0 0.001122101442888379
of O 0 8.497212547808886e-05
ARSA O 1 0.9999178647994995
was O 0 0.001979293767362833
proposed O 0 0.00033681164495646954
to O 0 1.534230977995321e-05
be O 0 1.3843680790159851e-05
a O 0 0.00013286380271892995
cause O 0 0.003354250220581889
of O 0 0.0001423786161467433
MLD B-Disease 1 0.999997615814209
( O 0 0.0037461339961737394
Draghia O 1 0.9924458861351013
et O 0 0.056839343160390854
al O 0 0.012341121211647987
. O 0 0.00013331929221749306
, O 0 0.00022179968073032796
1997 O 0 0.006402246188372374
) O 0 0.00018785169231705368
. O 0 0.00019654700008686632

We O 0 0.0005501206032931805
have O 0 8.714908472029492e-05
investigated O 0 0.003434774000197649
the O 0 0.00022926414385437965
R496H O 0 0.05888514593243599
mutation O 0 0.001844913698732853
and O 0 7.678764086449519e-05
found O 0 0.00010172067413805053
this O 0 2.5393239411641844e-05
mutation O 0 0.0010371808893978596
at O 0 0.0003636465407907963
a O 0 0.0002969672787003219
relatively O 0 0.0009973467094823718
high O 0 0.001308787614107132
frequency O 0 0.00016084827075246722
in O 0 6.768486491637304e-05
an O 0 0.00016254362708423287
African O 0 0.0007918145274743438
American O 0 0.00031822366872802377
population O 0 8.766519749769941e-05
( O 0 0.0006512278923764825
f O 0 0.008438406512141228
= O 0 0.004848519340157509
0 O 0 0.0008669245289638638
. O 0 0.00016369868535548449
09 O 0 0.04528023302555084
, O 0 0.00032292839023284614
n O 0 0.00412322860211134
= O 0 0.006261622067540884
61 O 0 0.006154079921543598
subjects O 0 0.0029075131751596928
) O 0 0.00031641547684557736
. O 0 0.00026952745974995196

The O 0 0.0028620006050914526
ARSA O 1 0.9984343647956848
enzyme O 0 0.005648798309266567
activity O 0 0.0005536169628612697
in O 0 0.0001477820915170014
subjects O 0 0.0014616268454119563
with O 0 5.8159228501608595e-05
and O 0 8.005226845853031e-05
without O 0 0.00015806742885615677
the O 0 0.00020995832164771855
R496H O 0 0.058109767735004425
mutation O 0 0.002610452938824892
was O 0 0.0010421506594866514
determined O 0 0.001151491655036807
and O 0 6.791996565880254e-05
found O 0 8.905748109100387e-05
to O 0 2.2018128220224753e-05
be O 0 3.4387685445835814e-05
normal O 0 0.0014180835569277406
. O 0 0.00023942739062476903

It O 0 0.00035161536652594805
is O 0 0.00019049050752073526
therefore O 0 0.00035964694689027965
concluded O 0 0.004183078184723854
that O 0 1.3290638889884576e-05
the O 0 9.054731344804168e-05
R496H O 0 0.03206105902791023
mutation O 0 0.0012061760062351823
of O 0 0.0001224699371960014
ARSA O 1 0.9999160766601562
does O 0 0.0015255166217684746
not O 0 7.674005610169843e-05
negatively O 0 0.0012446261243894696
influence O 0 5.526654058485292e-05
the O 0 4.1562678234186023e-05
activity O 0 0.00024021900026127696
of O 0 8.55498801684007e-05
ARSA O 1 0.9999548196792603
and O 0 0.00023041488020680845
is O 0 0.00014419302169699222
not O 0 2.6022913516499102e-05
a O 0 0.0002209922531619668
cause O 0 0.005236493889242411
of O 0 0.00022785289911553264
MLD B-Disease 1 0.9999958276748657

Down O 0 0.010857411660254002
- O 0 0.0012749307788908482
regulation O 0 0.0001185702349175699
of O 0 9.408273399458267e-06
transmembrane O 0 0.02469591051340103
carbonic O 1 0.9988130331039429
anhydrases O 1 0.9970217347145081
in O 0 0.0027690778952091932
renal B-Disease 1 1.0
cell I-Disease 1 0.9998883008956909
carcinoma I-Disease 1 1.0
cell O 0 0.004079342819750309
lines O 0 0.00026173153310082853
by O 0 2.146954466297757e-05
wild O 0 0.00048550625797361135
- O 0 0.005720116198062897
type O 0 0.008259257301688194
von B-Disease 1 0.9808295965194702
Hippel I-Disease 1 0.999894380569458
- I-Disease 0 0.40683111548423767
Lindau I-Disease 1 0.9994325041770935
transgenes O 0 0.260897696018219
. O 0 0.0006659129285253584

To O 0 0.00041248733759857714
discover O 0 0.0030001765117049217
genes O 0 0.00012209633132442832
involved O 0 0.00032964383717626333
in O 0 0.0002656785072758794
von B-Disease 1 0.9440581202507019
Hippel I-Disease 1 0.9999452829360962
- I-Disease 1 0.6602955460548401
Lindau I-Disease 1 0.9997424483299255
( O 0 0.0031598107889294624
VHL B-Disease 1 0.999923825263977
) O 0 0.0011063267011195421
- O 0 0.008284065872430801
mediated O 0 0.05020026117563248
carcinogenesis O 1 0.9996745586395264
, O 0 0.0001383971975883469
we O 0 0.00011959470430156216
used O 0 0.0015181002672761679
renal B-Disease 1 1.0
cell I-Disease 1 0.9994328618049622
carcinoma I-Disease 1 1.0
cell O 0 0.0069953142665326595
lines O 0 0.0015781921101734042
stably O 0 0.04229774326086044
transfected O 0 0.03363831341266632
with O 0 5.8661429648054764e-05
wild O 0 0.0007836781442165375
- O 0 0.010691397823393345
type O 0 0.04203501343727112
VHL O 1 0.9999595880508423
- O 0 0.012680037878453732
expressing O 0 0.005630518775433302
transgenes O 0 0.21372906863689423
. O 0 0.0005194066325202584

Large O 0 0.000739992770832032
- O 0 0.0017592968652024865
scale O 0 0.0005989588098600507
RNA O 0 0.0015531479148194194
differential O 0 0.005345073062926531
display O 0 0.001167542184703052
technology O 0 0.0037928300444036722
applied O 0 0.0008731825510039926
to O 0 2.8724971343763173e-05
these O 0 1.859432813944295e-05
cell O 0 0.002517524641007185
lines O 0 0.0006640952778980136
identified O 0 0.0004417897143866867
several O 0 5.1123599405400455e-05
differentially O 0 0.011598912999033928
expressed O 0 0.00032885404652915895
genes O 0 0.00010714216477936134
, O 0 3.1996147299651057e-05
including O 0 1.2910265468235593e-05
an O 0 0.00010759982251329347
alpha O 0 0.005204763729125261
carbonic O 1 0.9507418274879456
anhydrase O 1 0.9885905385017395
gene O 0 0.0028891274705529213
, O 0 0.0003914177359547466
termed O 0 0.14340554177761078
CA12 O 1 0.996025562286377
. O 0 0.0008456893265247345

The O 0 0.00016600490198470652
deduced O 0 0.0008621853776276112
protein O 0 0.0001324289623880759
sequence O 0 5.9954611060675234e-05
was O 0 0.000666281150188297
classified O 0 0.0028358150739222765
as O 0 5.934720684308559e-05
a O 0 0.000184122211067006
one O 0 0.00018265322432853281
- O 0 0.0032418810296803713
pass O 0 0.0012176490854471922
transmembrane O 0 0.017963575199246407
CA O 0 0.047154128551483154
possessing O 0 0.001405457966029644
an O 0 0.0001853172288974747
apparently O 0 0.003625362878665328
intact O 0 0.005636394489556551
catalytic O 0 0.0030858139507472515
domain O 0 0.0003122276975773275
in O 0 3.70578418369405e-05
the O 0 0.00010218343959422782
extracellular O 0 0.010550638660788536
CA O 1 0.7046048641204834
module O 0 0.02199408784508705
. O 0 0.00042978243436664343

Reintroduced O 0 0.022018255665898323
wild O 0 0.0014994449447840452
- O 0 0.011591635644435883
type O 0 0.02148451656103134
VHL B-Disease 1 0.9997826218605042
strongly O 0 0.003881484968587756
inhibited O 0 0.015982361510396004
the O 0 0.00015448132762685418
overexpression O 0 0.004648133646696806
of O 0 1.1704405551427044e-05
the O 0 0.0003633593150880188
CA12 O 1 0.9965246319770813
gene O 0 0.0005503311986103654
in O 0 3.043000106117688e-05
the O 0 0.00027562366449274123
parental O 1 0.9991235136985779
renal B-Disease 1 1.0
cell I-Disease 1 0.9999114274978638
carcinoma I-Disease 1 1.0
cell O 0 0.013023481704294682
lines O 0 0.0015270087169483304
. O 0 0.00035422822111286223

Similar O 0 0.0007435741717927158
results O 0 0.0004347556096035987
were O 0 2.453945307934191e-05
obtained O 0 0.0002823281101882458
with O 0 0.00036642985651269555
CA9 O 1 0.9998723268508911
, O 0 0.00016031452105380595
encoding O 0 0.0002906389709096402
another O 0 0.0006246038828976452
transmembrane O 0 0.02501962147653103
CA O 0 0.03328532353043556
with O 0 1.905012504721526e-05
an O 0 0.00011544038716237992
intact O 0 0.005798470228910446
catalytic O 0 0.00533402431756258
domain O 0 0.0014034262858331203
. O 0 0.00045561831211671233

Although O 0 0.0005211015231907368
both O 0 2.9055050617898814e-05
domains O 0 0.0002745258389040828
of O 0 1.0782634490169585e-05
the O 0 0.0005123061710037291
VHL B-Disease 1 0.9992831349372864
protein O 0 0.0008559250854887068
contribute O 0 0.0016719104023650289
to O 0 3.0382503609871492e-05
regulation O 0 0.0002740013296715915
of O 0 4.460907803149894e-05
CA12 O 1 0.9979222416877747
expression O 0 0.001028229482471943
, O 0 0.00010869232937693596
the O 0 0.0001438979961676523
elongin O 0 0.07053101062774658
binding O 0 0.0004076607583556324
domain O 0 0.0004750978550873697
alone O 0 0.0009660752257332206
could O 0 0.00011528813047334552
effectively O 0 0.002664330182597041
regulate O 0 0.015788139775395393
CA9 O 1 0.9996235370635986
expression O 0 0.002871556906029582
. O 0 0.0005244143540039659

We O 0 0.0011013876646757126
mapped O 0 0.013415361754596233
CA12 O 1 0.9932030439376831
and O 0 0.0017388518899679184
CA9 O 1 0.9997277855873108
loci O 0 0.012098332867026329
to O 0 0.00012438003614079207
chromosome O 0 0.0011657075956463814
bands O 0 0.0009252174058929086
15q22 O 0 0.03254403546452522
and O 0 0.00034028798108920455
17q21 O 0 0.059686802327632904
. O 0 0.0004577911167871207

2 O 0 0.002411763183772564
respectively O 0 0.0007393808919005096
, O 0 0.00017590618517715484
regions O 0 0.0009151419508270919
prone O 0 0.05126901715993881
to O 0 7.130468293325976e-05
amplification O 0 0.0014526585582643747
in O 0 4.523046300164424e-05
some O 0 4.358664227765985e-05
human O 0 0.007496362552046776
cancers B-Disease 1 0.9999957084655762
. O 0 0.0007085736142471433

Additional O 0 0.0006865714676678181
experiments O 0 0.0007375546847470105
are O 0 1.1330398592690472e-05
needed O 0 0.0005724685615859926
to O 0 2.2446502043749206e-05
define O 0 0.0003907949139829725
the O 0 4.354842167231254e-05
role O 0 0.0008340690983459353
of O 0 0.00010828328231582418
CA O 1 0.9991509914398193
IX O 1 0.9998921155929565
and O 0 0.0010809256928041577
CA O 1 0.9946708083152771
XII O 1 0.9989637136459351
enzymes O 0 0.0002896696678362787
in O 0 3.874950562021695e-05
the O 0 4.098034696653485e-05
regulation O 0 0.0003916824352927506
of O 0 3.5541303077479824e-05
pH O 0 0.28607916831970215
in O 0 8.76311823958531e-05
the O 0 0.00011394274770282209
extracellular O 0 0.00782601349055767
microenvironment O 0 0.37226176261901855
and O 0 6.872445374028757e-05
its O 0 5.1851988246198744e-05
potential O 0 0.0005887066945433617
impact O 0 0.001892539206892252
on O 0 0.0014029225567355752
cancer B-Disease 1 0.9999997615814209
cell O 0 0.0031474586576223373
growth O 0 0.0008588702767156065
. O 0 0.0001915099855978042

A O 0 0.002634207019582391
gene O 0 0.0004408923559822142
encoding O 0 0.00010776577255455777
a O 0 0.00011969338083872572
transmembrane O 0 0.002697285497561097
protein O 0 0.0003395503154024482
is O 0 0.0001624900323804468
mutated O 0 0.003351340303197503
in O 0 0.0002916924422606826
patients O 1 0.999998927116394
with O 0 0.0026906749699264765
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.036720287054777145
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999998807907104
( O 0 0.059219956398010254
Wolfram B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
) O 0 0.0009394657681696117
. O 0 0.00028389989165589213

Wolfram B-Disease 1 0.9999984502792358
syndrome I-Disease 1 1.0
( O 0 0.021306710317730904
WFS B-Disease 1 0.9999961853027344
; O 0 0.0037661935202777386
OMIM O 1 0.9999581575393677
222300 O 1 0.8851784467697144
) O 0 0.0001381730253342539
is O 0 9.617584146326408e-05
an O 0 0.0005538877448998392
autosomal B-Disease 1 0.9999868869781494
recessive I-Disease 1 0.9999988079071045
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
defined O 0 0.0022082205396145582
by O 0 0.00013609991583507508
young O 0 0.006258353125303984
- O 0 0.014045443385839462
onset O 1 0.9995561242103577
non O 0 0.00823297444730997
- O 0 0.042839664965867996
immune O 1 0.9998544454574585
insulin B-Disease 1 0.9989810585975647
- I-Disease 0 0.1977510303258896
dependent I-Disease 1 0.7994313836097717
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.0016793131362646818
progressive O 1 0.9999608993530273
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999984502792358
. O 0 0.0011773074511438608

Linkage O 0 0.030512535944581032
to O 0 0.00013173413753975183
markers O 0 0.0029093478806316853
on O 0 0.0002766535908449441
chromosome O 0 0.0066538588143885136
4p O 1 0.9975233674049377
was O 0 0.002987104468047619
confirmed O 0 0.001463495078496635
in O 0 4.34518042311538e-05
five O 0 6.916429992998019e-05
families O 0 0.00019037937454413623
. O 0 0.00029316116706468165

On O 0 0.00015150265244301409
the O 0 2.2056065063225105e-05
basis O 0 2.44164330069907e-05
of O 0 2.3630596842849627e-05
meiotic O 1 0.9986041188240051
recombinants O 1 0.9979524612426758
and O 0 0.0035558221861720085
disease O 1 0.9999998807907104
- O 0 0.01676899380981922
associated O 0 0.0006517898291349411
haplotypes O 0 0.008238637819886208
, O 0 0.00015736602654214948
the O 0 0.0007451496785506606
WFS B-Disease 1 0.9999736547470093
gene O 0 0.002142657758668065
was O 0 0.00043661793461069465
localized O 0 0.003251602640375495
to O 0 8.38914857013151e-05
a O 0 0.0025006092619150877
BAC O 1 0.9997972846031189
/ O 1 0.968745768070221
P1 O 1 0.9964454770088196
contig O 0 0.02719184383749962
of O 0 7.74613545218017e-06
less O 0 0.00012009271449642256
than O 0 8.134134986903518e-05
250 O 0 0.0018119901651516557
kb O 0 0.024726219475269318
. O 0 0.0005388855352066457

Mutations O 0 0.0033250467386096716
in O 0 8.780675125308335e-05
a O 0 0.0003456490230746567
novel O 0 0.0020828063134104013
gene O 0 0.0043970076367259026
( O 0 0.0015245003160089254
WFS1 O 1 0.993067741394043
) O 0 0.0001080297734006308
encoding O 0 0.0001715075777610764
a O 0 0.00034673072514124215
putative O 0 0.007966364733874798
transmembrane O 0 0.00579034723341465
protein O 0 0.0004843642527703196
were O 0 3.164408917655237e-05
found O 0 0.00010053399455500767
in O 0 2.7914518796023913e-05
all O 0 1.9085549865849316e-05
affected O 0 0.0015446373727172613
individuals O 0 9.922546450980008e-05
in O 0 0.00018664333038032055
six O 0 0.0019203154370188713
WFS B-Disease 1 0.9999873638153076
families O 0 0.0007323766476474702
, O 0 0.00015414657536894083
and O 0 5.5952859838726e-05
these O 0 2.2007778170518577e-05
mutations O 0 0.0007665411103516817
were O 0 1.317514124821173e-05
associated O 0 9.632261208025739e-05
with O 0 4.8630940000293776e-05
the O 0 0.0019427745137363672
disease O 1 1.0
phenotype O 1 0.9881316423416138
. O 0 0.0006711331661790609

WFS1 O 1 0.995558500289917
appears O 0 0.005447584670037031
to O 0 3.53327595803421e-05
function O 0 0.00027965291519649327
in O 0 0.00010948831913992763
survival O 0 0.01128034945577383
of O 0 2.614450204418972e-05
islet O 0 0.12885452806949615
beta O 0 0.030569588765501976
- O 0 0.0051450710743665695
cells O 0 0.0009685848490335047
and O 0 7.184730930021033e-05
neurons O 0 0.011601516045629978
. O 0 9.677659545559436e-05
. O 0 0.0001668189070187509

Stable O 0 0.02849557250738144
interaction O 0 0.0004098385397810489
between O 0 7.810231909388676e-05
the O 0 5.998721098876558e-05
products O 0 0.00026738742599263787
of O 0 1.1479382010293193e-05
the O 0 0.0006579746841453016
BRCA1 O 1 0.9999793767929077
and O 0 0.0019909513648599386
BRCA2 O 1 0.9999887943267822
tumor B-Disease 1 0.9999452829360962
suppressor O 0 0.01580551080405712
genes O 0 9.982858318835497e-05
in O 0 7.513570017181337e-05
mitotic O 0 0.012942974455654621
and O 0 0.000321697152685374
meiotic O 1 0.9906953573226929
cells O 0 0.005457796156406403
. O 0 0.00032033154275268316

BRCA1 O 1 0.9996082186698914
and O 0 0.0027591618709266186
BRCA2 O 1 0.9973059892654419
account O 0 0.00016577253700233996
for O 0 6.958942685741931e-05
most O 0 7.375855057034642e-05
cases O 0 0.0003149464901071042
of O 0 1.927680932567455e-05
familial O 1 0.9999157190322876
, O 0 0.0003305218124296516
early O 0 0.002511067083105445
onset O 1 0.9999986886978149
breast B-Disease 1 1.0
and I-Disease 0 0.0030333788599818945
/ I-Disease 1 0.9999481439590454
or I-Disease 1 0.9826160669326782
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00013424082135315984
encode O 0 0.00018184447253588587
products O 0 0.00044880920904688537
that O 0 1.4742270650458522e-05
each O 0 1.3346600098884664e-05
interact O 0 0.0008606569608673453
with O 0 0.00013514950114767998
hRAD51 O 1 0.7219673991203308
. O 0 0.0005459428648464382

Results O 0 0.0019176870118826628
presented O 0 0.0006190994754433632
here O 0 0.00011028679000446573
show O 0 0.0003138081810902804
that O 0 0.0002354288153583184
BRCA1 O 1 0.99974125623703
and O 0 0.0013784188777208328
BRCA2 O 1 0.9991936087608337
coexist O 0 0.003534285118803382
in O 0 7.268473564181477e-05
a O 0 0.0003257086791563779
biochemical O 0 0.01160133071243763
complex O 0 0.0047908383421599865
and O 0 0.0002872596960514784
colocalize O 1 0.5417770147323608
in O 0 0.0004281406872905791
subnuclear O 1 0.7346451878547668
foci O 0 0.029008377343416214
in O 0 0.0002471562474966049
somatic O 0 0.018540939316153526
cells O 0 0.002349907997995615
and O 0 4.649461334338412e-05
on O 0 5.678269008058123e-05
the O 0 5.973609222564846e-05
axial O 0 0.005493531934916973
elements O 0 4.402872218634002e-05
of O 0 1.986134157050401e-05
developing O 0 0.021213138476014137
synaptonemal O 1 0.9898237586021423
complexes O 0 0.019819235429167747
. O 0 0.00048652105033397675

Like O 0 0.0038329437375068665
BRCA1 O 1 0.9992873072624207
and O 0 0.0013149180449545383
RAD51 O 1 0.9999446868896484
, O 0 0.0027498675044625998
BRCA2 O 1 0.9992882609367371
relocates O 0 0.07942108064889908
to O 0 0.0007748599746264517
PCNA O 1 0.9993069171905518
+ O 0 0.03224823996424675
replication O 0 0.001850256696343422
sites O 0 0.00022620974050369114
following O 0 0.0003731296746991575
exposure O 0 0.025289738550782204
of O 0 6.959659367566928e-05
S O 1 0.9766031503677368
phase O 0 0.008460951037704945
cells O 0 0.001003159792162478
to O 0 0.00013562472304329276
hydroxyurea O 1 0.9988486766815186
or O 0 0.0011621308512985706
UV O 1 0.9996347427368164
irradiation O 0 0.048484381288290024
. O 0 0.0004109325527679175

Thus O 0 0.0017065289430320263
, O 0 0.0011550246272236109
BRCA1 O 1 0.9997099041938782
and O 0 0.002067423891276121
BRCA2 O 1 0.9988234639167786
participate O 0 0.001905699260532856
, O 0 8.338558836840093e-05
together O 0 2.3643897293368354e-05
, O 0 5.811094160890207e-05
in O 0 5.501771374838427e-05
a O 0 0.0006622955552302301
pathway O 0 0.015695706009864807
( O 0 0.0013779372675344348
s O 0 0.05232587456703186
) O 0 0.00016180785314645618
associated O 0 9.1237758169882e-05
with O 0 1.0217017916147597e-05
the O 0 3.934806591132656e-05
activation O 0 0.0008463269332423806
of O 0 1.5125209756661206e-05
double O 0 0.002681842539459467
- O 0 0.004851064179092646
strand O 0 0.0043103452771902084
break O 0 0.003676066640764475
repair O 1 0.9995748400688171
and O 0 0.001130800461396575
/ O 0 0.1064736470580101
or O 0 0.00029235793044790626
homologous O 0 0.005152910947799683
recombination O 0 0.004483656957745552
. O 0 0.00039254967123270035

Dysfunction O 1 0.9997267127037048
of O 0 3.150644988636486e-05
this O 0 0.00012525914644356817
pathway O 0 0.011344588361680508
may O 0 0.0006096384022384882
be O 0 3.055679189856164e-05
a O 0 0.000172558386111632
general O 0 0.0008448512526229024
phenomenon O 0 0.0018675046740099788
in O 0 4.5462420530384406e-05
the O 0 3.40882470482029e-05
majority O 0 3.86331339541357e-05
of O 0 6.9327793426054996e-06
cases O 0 0.0004740594304166734
of O 0 7.222182466648519e-05
hereditary B-Disease 1 0.9999970197677612
breast I-Disease 1 1.0
and I-Disease 0 0.004382419865578413
/ I-Disease 1 0.9999616146087646
or I-Disease 1 0.9922961592674255
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00033027390600182116
. O 0 0.00023942282132338732

A O 0 0.005864437203854322
novel O 0 0.0041024163365364075
Arg362Ser O 0 0.39383724331855774
mutation O 0 0.0007780571468174458
in O 0 3.962184564443305e-05
the O 0 0.00015318667283281684
sterol O 0 0.4826102554798126
27 O 0 0.006476710084825754
- O 0 0.009324217215180397
hydroxylase O 0 0.17415209114551544
gene O 0 0.0032574401702731848
( O 0 0.0013873826246708632
CYP27 O 1 0.998146653175354
) O 0 0.00034155946923419833
: O 0 7.751570228720084e-05
its O 0 6.752800982212648e-05
effects O 0 0.0020147955510765314
on O 0 0.00019539226195774972
pre O 0 0.004016999155282974
- O 0 0.0005069206818006933
mRNA O 0 8.398562204092741e-05
splicing O 0 0.000307601090753451
and O 0 4.601426189765334e-05
enzyme O 0 0.0012798667885363102
activity O 0 0.00046596021275036037
. O 0 0.00029171360074542463

A O 0 0.007300462573766708
novel O 0 0.004688310902565718
C O 0 0.02364150434732437
to O 0 4.140048986300826e-05
A O 0 0.0010724191088229418
mutation O 0 0.00046017474960535765
in O 0 3.500278398860246e-05
the O 0 0.00013982995005790144
sterol O 1 0.8233993649482727
27 O 0 0.007297121454030275
- O 0 0.010509519837796688
hydroxylase O 0 0.25525331497192383
gene O 0 0.0027925490867346525
( O 0 0.0011363097000867128
CYP27 O 1 0.9985734224319458
) O 0 0.0003641874354798347
was O 0 0.0005284693324938416
identified O 0 0.00012517996947281063
by O 0 7.257980087160831e-06
sequencing O 0 0.0005728336982429028
amplified O 0 0.006943354848772287
CYP27 O 1 0.9378297924995422
gene O 0 0.0012116993311792612
products O 0 0.00042860169196501374
from O 0 3.0802439141552895e-05
a O 0 0.000602384505327791
patient O 1 0.9995498061180115
with O 0 0.0002901708066929132
cerebrotendinous B-Disease 1 0.9999648332595825
xanthomatosis I-Disease 1 0.9998922348022461
( O 0 0.0052614458836615086
CTX B-Disease 1 0.9999866485595703
) O 0 0.0009210618445649743
. O 0 0.0003119120665360242

The O 0 0.000609770359005779
mutation O 0 0.001979389926418662
changed O 0 0.0008855361375026405
the O 0 0.00016241194680333138
adrenodoxin O 0 0.09918444603681564
cofactor O 0 0.04053930193185806
binding O 0 0.001549349632114172
residue O 0 0.020031550899147987
362Arg O 0 0.05425834655761719
to O 0 0.00026123516727238894
362Ser O 0 0.12797442078590393
( O 0 0.001243532751686871
CGT O 1 0.9827309250831604
362Arg O 1 0.6724918484687805
to O 0 0.001032059546560049
AGT O 1 0.9999988079071045
362Ser O 1 0.9386386275291443
) O 0 0.0003203037194907665
, O 0 7.065678801154718e-05
and O 0 6.612853758269921e-05
was O 0 0.0006123821367509663
responsible O 0 0.0027178556192666292
for O 0 0.000873140525072813
deficiency O 1 0.9999992847442627
in O 0 0.000102116224297788
the O 0 0.00025178934447467327
sterol O 1 0.9275333881378174
27 O 0 0.00823279656469822
- O 0 0.00899622030556202
hydroxylase O 0 0.08325741440057755
activity O 0 0.0004878854670096189
, O 0 0.00011945542792091146
as O 0 0.00019648665329441428
confirmed O 0 0.0007697358960285783
by O 0 5.5668861023150384e-06
expression O 0 5.9584130212897435e-05
of O 0 8.720309779164381e-06
mutant O 0 0.0019071437418460846
cDNA O 0 0.0017946382286027074
into O 0 0.0004227969911880791
COS O 1 0.9959250688552856
- O 0 0.004712232854217291
1 O 0 0.0008501135744154453
cells O 0 0.0016235187649726868
. O 0 0.00018896044639404863

Quantitative O 0 0.004739195108413696
analysis O 0 0.0005428295116871595
showed O 0 0.0006825727759860456
that O 0 1.3354545444599353e-05
the O 0 2.081780075968709e-05
expression O 0 0.00019760643772315234
of O 0 4.2220548493787646e-05
CYP27 O 1 0.9900387525558472
gene O 0 0.0003925896598957479
mRNA O 0 9.67864616541192e-05
in O 0 4.064857785124332e-05
the O 0 0.00022430084936786443
patient O 1 0.9940347075462341
represented O 0 0.0005333333392627537
52 O 0 0.0052117579616606236
. O 0 0.00033371784957125783

5 O 0 0.000712035340256989
% O 0 1.0435751391923986e-05
of O 0 3.486680498099304e-06
the O 0 0.00012701227387879044
normal O 0 0.003776649245992303
level O 0 0.004780405201017857
. O 0 0.0004642595013137907

As O 0 0.0003292578330729157
the O 0 0.00021427229512482882
mutation O 0 0.0021969382651150227
occurred O 0 0.00123067875392735
at O 0 0.0002525748568587005
the O 0 7.830560207366943e-05
penultimate O 0 0.01046007964760065
nucleotide O 0 0.00010117469355463982
of O 0 2.2700349290971644e-05
exon O 0 0.03548159822821617
6 O 0 0.0035099016968160868
( O 0 0.0006596438470296562
- O 0 0.002024530665948987
2 O 0 0.00021900412684772164
position O 0 0.0001973989128600806
of O 0 1.5789968529134057e-05
exon O 0 0.02717815898358822
6 O 0 0.003311260836198926
- O 0 0.0066551752388477325
intron O 0 0.24235473573207855
6 O 0 0.002551449928432703
splice O 0 0.022526027634739876
site O 0 0.002075344789773226
) O 0 3.2801028282847255e-05
of O 0 4.900811745756073e-06
the O 0 0.00019958823395427316
gene O 0 0.00197248300537467
, O 0 0.00012306991266086698
we O 0 0.00011897468357346952
hypothesized O 0 0.0033670333214104176
that O 0 1.475470435252646e-05
the O 0 0.00010810088133439422
mutation O 0 0.0034228533040732145
may O 0 0.0019411202520132065
partially O 0 0.011350407265126705
affect O 0 0.0008096278179436922
the O 0 5.580121069215238e-05
normal O 0 0.0008154432871378958
splicing O 0 0.0006542615010403097
efficiency O 0 0.0017531301127746701
in O 0 0.0002236840664409101
exon O 0 0.02864949032664299
6 O 0 0.0011941407574340701
and O 0 0.00013382110046222806
cause O 0 0.006448508705943823
alternative O 0 0.0012415465898811817
splicing O 0 0.0029642684385180473
elsewhere O 0 0.0007227026508189738
, O 0 8.138044358929619e-05
which O 0 2.9014796382398345e-05
resulted O 0 0.0008710190886631608
in O 0 0.0001779437152436003
decreased O 0 0.01594863459467888
transcript O 0 0.004340052604675293
in O 0 6.266142008826137e-05
the O 0 0.00034560789936222136
patient O 1 0.9998855590820312
. O 0 0.00039792581810615957

Transfection O 0 0.2272748202085495
of O 0 9.85392980510369e-05
constructed O 0 0.007651414256542921
minigenes O 1 0.8207038044929504
, O 0 0.00019348235218785703
with O 0 4.634825745597482e-05
or O 0 0.00014219357399269938
without O 0 8.592924859840423e-05
the O 0 7.613957131979987e-05
mutation O 0 0.0010763678001239896
, O 0 0.00012149565736763179
into O 0 0.000463692907942459
COS O 1 0.9991188645362854
- O 0 0.00579435657709837
1 O 0 0.0009741130052134395
cells O 0 0.0014357406180351973
confirmed O 0 0.0006577505264431238
that O 0 1.1281662409601267e-05
the O 0 8.857489592628554e-05
mutant O 0 0.007082267198711634
minigene O 0 0.44439178705215454
was O 0 0.0013426218647509813
responsible O 0 0.0016608410514891148
for O 0 7.253116928040981e-05
a O 0 0.00017650228983256966
mRNA O 0 0.00026272557443007827
species O 0 7.224897126434371e-05
alternatively O 0 0.0018981185276061296
spliced O 0 0.001582649420015514
at O 0 0.00034003928885795176
an O 0 0.00026049200096167624
activated O 0 0.049259819090366364
cryptic O 0 0.03030472621321678
5 O 0 0.0008540131384506822
splice O 0 0.019505077973008156
site O 0 0.002755116205662489
88 O 0 0.007645146921277046
bp O 0 0.040581878274679184
upstream O 0 0.002596182283014059
from O 0 4.508421989157796e-05
the O 0 0.00010588496661512181
3 O 0 0.00047495681792497635
end O 0 0.00034749912447296083
of O 0 1.8230635760119185e-05
exon O 0 0.03698531538248062
6 O 0 0.002201514085754752
. O 0 0.0003685789415612817

Our O 0 0.0006126848165877163
data O 0 9.784398571355268e-05
suggest O 0 0.00031718716491013765
that O 0 1.5699337382102385e-05
the O 0 0.00015409410116262734
C O 0 0.02137422375380993
to O 0 5.0135924539063126e-05
A O 0 0.001760064042173326
mutation O 0 0.0010023678187280893
at O 0 0.0002508010366000235
the O 0 9.250779839931056e-05
penultimate O 0 0.01687464863061905
nucleotide O 0 0.00010505634418223053
of O 0 1.962246824405156e-05
exon O 0 0.020101934671401978
6 O 0 0.00039918493712320924
of O 0 7.547715540567879e-06
the O 0 0.00034761131973937154
CYP27 O 1 0.998749852180481
gene O 0 0.0007336235139518976
not O 0 2.4915996618801728e-05
only O 0 3.5504101106198505e-05
causes O 0 0.016734082251787186
the O 0 0.0009827323956415057
deficiency B-Disease 1 0.9999997615814209
in I-Disease 0 0.00012046616029692814
the I-Disease 0 0.000258288491750136
sterol I-Disease 1 0.9566072821617126
27 I-Disease 0 0.007052443455904722
- I-Disease 0 0.00869782269001007
hydroxylase I-Disease 0 0.06386729329824448
activity I-Disease 0 0.0005662631010636687
, O 0 0.00011569273192435503
but O 0 0.00014908108278177679
also O 0 0.00023759243777021766
partially O 0 0.012866816483438015
leads O 0 0.00098900287412107
to O 0 3.406484756851569e-05
alternative O 0 0.0008554754895158112
pre O 0 0.004096031654626131
- O 0 0.000529022712726146
mRNA O 0 7.622078555868939e-05
splicing O 0 0.0001285202888539061
of O 0 5.953151685389457e-06
the O 0 0.00015860580606386065
gene O 0 0.0024027088657021523
. O 0 0.0003351851482875645

To O 0 0.00026738207088783383
our O 0 0.0002754500601440668
knowledge O 0 0.0015545387286692858
, O 0 9.180591587210074e-05
this O 0 2.0635108739952557e-05
is O 0 8.835210610413924e-05
the O 0 6.288121949182823e-05
first O 0 0.00013434403808787465
report O 0 0.0005200222949497402
regarding O 0 0.0004998544463887811
effects O 0 0.0035114362835884094
on O 0 0.00027339201187714934
pre O 0 0.005220202729105949
- O 0 0.0005586074548773468
mRNA O 0 6.731333996867761e-05
splicing O 0 0.0001321509334957227
of O 0 6.521384420921095e-06
a O 0 0.0003228643618058413
mutation O 0 0.001282677287235856
at O 0 0.0005848165019415319
the O 0 0.00027840392431244254
- O 0 0.002903940621763468
2 O 0 0.0002028428134508431
position O 0 0.00015256206097546965
of O 0 4.57154237665236e-06
a O 0 0.00032646438921801746
5 O 0 0.0006608457188121974
splice O 0 0.0210467167198658
site O 0 0.0028007167857140303
. O 0 0.0002667621010914445

ATM O 0 0.07845165580511093
germline O 0 0.4038410484790802
mutations O 0 0.001117148669436574
in O 0 0.00011495859507704154
classical O 0 0.004658606369048357
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999908208847046
telangiectasia I-Disease 1 0.9999998807907104
patients O 1 0.9999954700469971
in O 0 0.0001335532870143652
the O 0 0.00011189598444616422
Dutch O 0 0.0012316041393205523
population O 0 7.583075057482347e-05
. O 0 0.00031404042965732515

Germline O 1 0.9612349271774292
mutations O 0 0.0021538014989346266
in O 0 7.908388215582818e-05
the O 0 0.00017519327229820192
ATM O 0 0.016634507104754448
gene O 0 0.0006685557309538126
are O 0 6.722795205860166e-06
responsible O 0 0.0006552790873683989
for O 0 8.36899780551903e-05
the O 0 0.0011640983866527677
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999316930770874
telangiectasia I-Disease 1 0.9999951124191284
( O 0 0.0030529582872986794
A B-Disease 1 0.9992033839225769
- I-Disease 1 0.9961256384849548
T I-Disease 1 0.999962568283081
) O 0 0.0003638546331785619
. O 0 0.00025627287686802447

In O 0 0.00040163169614970684
our O 0 0.0005337431794032454
study O 0 0.0012444999301806092
, O 0 9.397449321113527e-05
we O 0 7.422061753459275e-05
have O 0 2.086106724163983e-05
determined O 0 0.00032025095424614847
the O 0 7.522889791289344e-05
ATM O 0 0.011357327923178673
mutation O 0 0.0009603596990928054
spectrum O 0 0.0014073671773076057
in O 0 7.484836532967165e-05
19 O 0 0.0004268419579602778
classical O 0 0.0006022444576956332
A B-Disease 1 0.9990975856781006
- I-Disease 1 0.9999094009399414
T I-Disease 1 0.9999997615814209
patients O 1 0.9999946355819702
, O 0 8.746578532736748e-05
including O 0 1.8747348804026842e-05
some O 0 3.065614873776212e-05
immigrant O 0 0.0005043345154263079
populations O 0 0.0003782233688980341
, O 0 0.0001362502807751298
as O 0 0.00014706936781294644
well O 0 0.0001236461685039103
as O 0 0.0001367161748930812
12 O 0 0.00015204490046016872
of O 0 8.28041993372608e-06
Dutch O 0 0.0007075731409713626
ethnic O 0 4.9524271162226796e-05
origin O 0 8.070062176557258e-05
. O 0 0.00030090194195508957

Both O 0 7.526464469265193e-05
the O 0 3.6201501643517986e-05
protein O 0 0.000475849024951458
truncation O 0 0.030259106308221817
test O 0 0.005792384967207909
( O 0 0.0010354607366025448
PTT O 1 0.8775033354759216
) O 0 0.00011371112486813217
and O 0 1.4176429431245197e-05
the O 0 4.1401435737498105e-05
restriction O 0 0.0008696222212165594
endonuclease O 1 0.6190089583396912
fingerprinting O 0 0.08043675124645233
( O 0 0.003081665374338627
REF O 1 0.9817366600036621
) O 0 0.00014483046834357083
method O 0 0.0001165289941127412
were O 0 1.6292477084789425e-05
used O 0 0.00011349349369993433
and O 0 5.997005064273253e-05
compared O 0 0.0003872211091220379
for O 0 4.8096680984599516e-05
their O 0 2.3598078769282438e-05
detection O 0 0.006800915580242872
efficiency O 0 0.0036116745322942734
, O 0 0.0002566379262134433
identifying O 0 0.011687345802783966
76 O 0 0.011371494270861149
% O 0 6.333825149340555e-05
and O 0 8.711717964615673e-05
60 O 0 0.00027566569042392075
% O 0 1.277347018913133e-05
of O 0 5.765439254901139e-06
the O 0 0.00018013360386248678
mutations O 0 0.002281361259520054
, O 0 0.00018850118794944137
respectively O 0 0.0009952812688425183
. O 0 0.0003495562414173037

Most O 0 0.003892347915098071
patients O 1 0.9999144077301025
were O 0 3.7624238757416606e-05
found O 0 6.54120376566425e-05
to O 0 2.1087389541207813e-05
be O 0 5.124508970766328e-05
compound O 0 0.007470967713743448
heterozygote O 0 0.06816349178552628
. O 0 0.0004134524497203529

Seventeen O 0 0.011160420253872871
mutations O 0 0.001422050059773028
were O 0 2.2615686248173006e-05
distinct O 0 0.00021883549925405532
, O 0 6.139434117358178e-05
of O 0 9.781513654161245e-06
which O 0 5.401175076258369e-05
10 O 0 0.00012866916949860752
were O 0 1.6982588931568898e-05
not O 0 0.00010326781921321526
reported O 0 0.0014937998494133353
previously O 0 0.0009233979508280754
. O 0 0.00026842067018151283

Mutations O 0 0.0038644757587462664
are O 0 1.6067524484242313e-05
small O 0 0.00013014892465434968
deletions O 0 0.0026884519029408693
or O 0 0.00028569356072694063
point O 0 0.0007346729980781674
mutations O 0 0.0013180871028453112
frequently O 0 0.0009328634478151798
affecting O 0 0.008292127400636673
splice O 0 0.02816275879740715
sites O 0 0.0007548896828666329
. O 0 0.00033199030440300703

Moreover O 0 0.008868571370840073
, O 0 0.00014716839359607548
a O 0 0.000446623278548941
16 O 0 0.0010555705521255732
. O 0 0.00027794961351901293

7 O 0 0.005180419888347387
- O 0 0.006173811852931976
kb O 0 0.012187620624899864
genomic O 0 0.0020604676101356745
deletion O 0 0.0018566260114312172
of O 0 1.1275616998318583e-05
the O 0 0.0001712637604214251
3 O 0 0.0006795455701649189
end O 0 0.00037776483804918826
of O 0 6.095895969338017e-06
the O 0 0.00023392695584334433
gene O 0 0.0019205714343115687
, O 0 0.00012468166823964566
most O 0 0.00010160222882404923
likely O 0 0.0003960738249588758
a O 0 0.00013853450946044177
result O 0 0.00012660985521506518
of O 0 9.868944289337378e-06
recombination O 0 0.001219309982843697
between O 0 7.760800508549437e-05
two O 0 5.3744173783343285e-05
LINE O 0 0.004246183671057224
elements O 0 0.00014497611846309155
, O 0 0.00022280329721979797
was O 0 0.0011199451982975006
identified O 0 0.0009249441209249198
. O 0 0.00022430963872466236

The O 0 0.00034162410884164274
most O 0 0.00016447942471131682
frequently O 0 0.0009692808380350471
found O 0 0.0003618031332734972
mutation O 0 0.0017857456114143133
, O 0 0.0001384015631629154
identified O 0 0.0003174621379002929
in O 0 3.2396150345448405e-05
three O 0 3.733224730240181e-05
unrelated O 0 0.002649380126968026
Turkish O 0 0.005378949921578169
A B-Disease 1 0.998615026473999
- I-Disease 1 0.998650848865509
T I-Disease 1 0.999976396560669
individuals O 0 0.0003286334394942969
, O 0 0.00023095439246390015
was O 0 0.0013387957587838173
previously O 0 0.000730794679839164
described O 0 0.0004938492202199996
to O 0 1.4979736988607328e-05
be O 0 1.022688411467243e-05
a O 0 0.00010164290870307013
Turkish O 0 0.00204084487631917
A B-Disease 1 0.9929218888282776
- I-Disease 1 0.9946934580802917
T I-Disease 1 0.9999719858169556
founder O 0 0.01699443720281124
mutation O 0 0.002357656601816416
. O 0 0.000279176834737882

The O 0 0.00023180793505162
presence O 0 0.00016733889060560614
of O 0 1.1242900654906407e-05
a O 0 0.0012275056215003133
founder O 0 0.025305235758423805
mutation O 0 0.0021954982075840235
among O 0 8.208000508602709e-05
relatively O 0 0.0006354137440212071
small O 0 7.900714263087139e-05
ethnic O 0 3.8173046050360426e-05
population O 0 3.382684735697694e-05
groups O 0 2.7963860702584498e-05
in O 0 0.0001407031959388405
Western O 0 0.0014147465117275715
Europe O 0 0.0014242795296013355
could O 0 0.0002154046669602394
indicate O 0 0.00042729752021841705
a O 0 0.0004620357067324221
high O 0 0.003183100838214159
carrier O 0 0.011390975676476955
frequency O 0 0.0001334824919467792
in O 0 3.451170050539076e-05
such O 0 1.8769102098303847e-05
communities O 0 0.00039880990516394377
. O 0 0.000272773380856961

In O 0 0.0026255708653479815
patients O 1 0.9995959401130676
of O 0 2.0340201444923878e-05
Dutch O 0 0.0010516383918002248
ethnic O 0 7.007622480159625e-05
origin O 0 6.95144190103747e-05
, O 0 0.000127280451124534
however O 0 0.00018019559502135962
, O 0 7.578491204185411e-05
no O 0 9.401329589309171e-05
significant O 0 0.0006203874363563955
founder O 0 0.007165541872382164
effect O 0 0.0007907836115919054
could O 0 0.00013765569019597024
be O 0 4.907037509838119e-05
identified O 0 0.00048812039312906563
. O 0 0.00013499765191227198

The O 0 0.00042739853961393237
observed O 0 0.0008896213257685304
genetic O 0 0.0018077380955219269
heterogeneity O 0 0.008723754435777664
including O 0 4.3036576244048774e-05
the O 0 6.38615238131024e-05
relative O 0 0.0003386722528375685
high O 0 0.0008375527104362845
percentage O 0 0.00013410417886916548
of O 0 1.686681389401201e-05
splice O 0 0.1621934324502945
- O 0 0.009939505718648434
site O 0 0.0016991016454994678
mutations O 0 0.0008818291244097054
had O 0 0.0001831251138355583
no O 0 5.630881787510589e-05
reflection O 0 0.002007202012464404
on O 0 0.00011373845336493105
the O 0 0.00032930774614214897
phenotype O 0 0.18817953765392303
. O 0 0.0005038285162299871

All O 0 0.0004931078874506056
patients O 1 0.999796450138092
manifested O 0 0.024959081783890724
classical O 0 0.0014907731674611568
A B-Disease 1 0.9987142086029053
- I-Disease 1 0.9972113966941833
T I-Disease 1 0.9999018907546997
and O 0 8.349547715624794e-05
increased O 0 0.0003666793927550316
cellular O 0 0.004347980488091707
radioresistant O 0 0.05339506268501282
DNA O 0 0.0006623488734476268
synthesis O 0 0.0012457834091037512
. O 0 0.00033155447454191744

Determination O 0 0.006541423965245485
of O 0 1.361645627184771e-05
the O 0 8.806913683656603e-05
genomic O 0 0.0011714770225808024
structure O 0 0.0004999545053578913
of O 0 1.2752947441185825e-05
the O 0 0.0006722397520206869
COL4A4 O 1 0.9992425441741943
gene O 0 0.0008281960035674274
and O 0 1.6155348930624314e-05
of O 0 7.555651336588198e-06
novel O 0 0.0018053760286420584
mutations O 0 0.005524541717022657
causing O 1 0.9979901313781738
autosomal B-Disease 1 0.9999954700469971
recessive I-Disease 1 0.9999996423721313
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.002755449153482914

Autosomal B-Disease 1 0.9999889135360718
recessive I-Disease 1 0.9999977350234985
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0007355303969234228
a O 0 0.0011119106784462929
progressive O 1 0.9947518706321716
hematuric B-Disease 1 0.9998375177383423
glomerulonephritis I-Disease 1 0.9999991655349731
characterized O 1 0.828384280204773
by O 0 0.00042125771869905293
glomerular B-Disease 1 0.9999953508377075
basement I-Disease 1 0.9993492960929871
membrane I-Disease 1 0.6950079202651978
abnormalities I-Disease 1 0.9996968507766724
and O 0 0.00020633962412830442
associated O 0 0.00021436609677039087
with O 0 3.7773083022329956e-05
mutations O 0 0.0009685119730420411
in O 0 6.615325401071459e-05
either O 0 0.0002257878368254751
the O 0 0.00039157323772087693
COL4A3 O 1 0.9989712238311768
or O 0 0.00044579236418940127
the O 0 0.0004882991197519004
COL4A4 O 1 0.9981479644775391
gene O 0 0.0015408986946567893
, O 0 5.022618279326707e-05
which O 0 6.41651649857522e-06
encode O 0 6.385087181115523e-05
the O 0 0.00012309066369198263
alpha3 O 0 0.41504546999931335
and O 0 0.00027193620917387307
alpha4 O 1 0.9957531690597534
type O 0 0.4971458613872528
IV O 1 0.9999752044677734
collagen O 1 0.9999113082885742
chains O 0 0.00757620157673955
, O 0 0.0002943166473414749
respectively O 0 0.0007902248180471361
. O 0 0.00031358355772681534

To O 0 0.00028743280563503504
date O 0 0.00031543447403237224
, O 0 0.00019277521641924977
mutation O 0 0.0018636352615430951
screening O 0 0.0033680591732263565
in O 0 4.5305445382837206e-05
the O 0 3.916805871995166e-05
two O 0 1.823378261178732e-05
genes O 0 0.0001769916998455301
has O 0 0.0004699323617387563
been O 0 0.0005906479200348258
hampered O 1 0.9840145707130432
by O 0 2.2340749637805857e-05
the O 0 7.368536898866296e-05
lack O 0 0.0008790428400970995
of O 0 1.3658228454005439e-05
genomic O 0 0.002564881229773164
structure O 0 0.001779516926035285
information O 0 0.0003653713793028146
. O 0 0.00033381619141437113

We O 0 0.0010924184462055564
report O 0 0.0005090420017950237
here O 0 5.9059726481791586e-05
the O 0 5.3649131587008014e-05
complete O 0 0.0007611153996549547
characterization O 0 0.005111259873956442
of O 0 1.1314179573673755e-05
the O 0 0.00012549033272080123
48 O 0 0.0008912162738852203
exons O 0 0.0010238386457785964
of O 0 1.0861151167773642e-05
the O 0 0.0004963982501067221
COL4A4 O 1 0.998377799987793
gene O 0 0.0014268977101892233
, O 0 8.10758865554817e-05
a O 0 0.0003620633215177804
comprehensive O 0 0.02407882921397686
gene O 0 0.0025348460767418146
screen O 0 0.001785188214853406
, O 0 0.0001109250879380852
and O 0 3.894666951964609e-05
the O 0 8.546034950995818e-05
subsequent O 0 0.0005669737583957613
detection O 0 0.001982863061130047
of O 0 1.0967903108394239e-05
10 O 0 0.00022023245401214808
novel O 0 0.0005340793286450207
mutations O 0 0.0005012184847146273
in O 0 9.456022235099226e-05
eight O 0 0.0016725590685382485
patients O 1 1.0
diagnosed O 1 1.0
with O 0 0.0007077184855006635
autosomal B-Disease 1 0.999997615814209
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0021002315916121006

Furthermore O 0 0.007684811018407345
, O 0 0.00013873544230591506
we O 0 9.70606051851064e-05
identified O 0 0.00021175143774598837
a O 0 0.00019253953360021114
glycine O 0 0.0035116400104016066
to O 0 6.0984824813203886e-05
alanine O 0 0.008997001685202122
substitution O 0 0.00033486515167169273
in O 0 6.55497788102366e-05
the O 0 0.0003225269028916955
collagenous O 1 0.9980480670928955
domain O 0 0.0009048320353031158
that O 0 6.504112388938665e-05
is O 0 0.00038165354635566473
apparently O 0 0.0028556187171489
silent O 0 0.00376149476505816
in O 0 7.775631820550188e-05
the O 0 0.00014405202819034457
heterozygous O 0 0.004599353298544884
carriers O 0 0.007693178951740265
, O 0 0.00012832178617827594
in O 0 0.00016109617718029767
11 O 0 0.0013394743436947465
. O 0 0.0003331697953399271

5 O 0 0.0011269614333286881
% O 0 2.4653261789353564e-05
of O 0 5.918868282606127e-06
all O 0 3.5986446164315566e-05
control O 0 0.001605637022294104
individuals O 0 0.0002918070531450212
, O 0 0.00020160686108283699
and O 0 7.95912928879261e-05
in O 0 7.894817827036604e-05
one O 0 8.04258233984001e-05
control O 0 0.0005590047803707421
individual O 0 0.00014859017392154783
homozygous O 0 0.0013395929709076881
for O 0 3.679282599478029e-05
this O 0 2.3237285859067924e-05
glycine O 0 0.004142673686146736
substitution O 0 0.000709777232259512
. O 0 0.0003487907233648002

There O 0 0.0004350398376118392
has O 0 0.0003654868633020669
been O 0 0.00012972592958249152
no O 0 5.035115827922709e-05
previous O 0 9.781412518350407e-05
finding O 0 0.0002086619206238538
of O 0 5.233779120317195e-06
a O 0 0.00034077937016263604
glycine O 0 0.00614579115062952
substitution O 0 0.00041519245132803917
that O 0 4.086007902515121e-05
is O 0 0.00015573685232084244
not O 0 6.312201730906963e-05
associated O 0 8.643450564704835e-05
with O 0 1.921678995131515e-05
any O 0 0.00010649597970768809
obvious O 0 0.011329947970807552
phenotype O 0 0.062196552753448486
in O 0 0.00019263300055172294
homozygous O 0 0.0032461362425237894
individuals O 0 0.0002514599764253944
. O 0 0.00038140019751153886

Founder O 1 0.9489860534667969
BRCA1 O 1 0.999713122844696
and O 0 0.0009837123798206449
BRCA2 O 1 0.9982343912124634
mutations O 0 0.000700675358530134
in O 0 6.246216071303934e-05
French O 0 0.0015944032929837704
Canadian O 1 0.5177215933799744
breast B-Disease 1 1.0
and I-Disease 1 0.991192638874054
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0011274757562205195
. O 0 0.00033290148712694645

We O 0 0.0006160240736790001
have O 0 7.587370055262e-05
identified O 0 0.00028246897272765636
four O 0 2.8289761758060195e-05
mutations O 0 0.00023189259809441864
in O 0 7.822479346941691e-06
each O 0 2.757535867203842e-06
of O 0 7.298154287127545e-06
the O 0 0.002954681171104312
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 0 0.019955342635512352
susceptibility O 0 0.031465619802474976
genes O 0 0.0002615571138449013
, O 0 0.0005126510513946414
BRCA1 O 1 0.9998194575309753
and O 0 0.0008122021099552512
BRCA2 O 1 0.999786913394928
, O 0 8.281685586553067e-05
in O 0 5.372336454456672e-05
French O 0 0.0015559714520350099
Canadian O 1 0.9585820436477661
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.2016030251979828
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0004540565423667431
from O 0 0.00013932379079051316
Quebec O 0 0.015273330733180046
. O 0 0.00044471281580626965

To O 0 0.00041763909393921494
identify O 0 0.0027523424942046404
founder O 0 0.015606713481247425
effects O 0 0.0060616545379161835
, O 0 0.0001763606269378215
we O 0 0.00016247561143245548
examined O 0 0.004516251385211945
independently O 0 0.0002245282958028838
ascertained O 0 0.011083757504820824
French O 0 0.004906050395220518
Canadian O 0 0.18668748438358307
cancer B-Disease 1 0.9999996423721313
families O 0 0.0002892154734581709
for O 0 5.827497807331383e-05
the O 0 2.8794001991627738e-05
distribution O 0 2.5563100280123763e-05
of O 0 5.117211912875064e-06
these O 0 1.211952530866256e-05
eight O 0 0.00023358686303254217
mutations O 0 0.0020283705089241266
. O 0 0.00031643116381019354

Mutations O 0 0.004581952001899481
were O 0 4.0706534491619095e-05
found O 0 0.00010030598059529439
in O 0 5.536915341508575e-05
41 O 0 0.0005777461919933558
of O 0 1.91455619642511e-05
97 O 0 0.008521917276084423
families O 0 0.00033968727802857757
. O 0 0.000350090122083202

Six O 0 0.0002345773536944762
of O 0 1.3636376934300642e-05
eight O 0 0.00017287246009800583
mutations O 0 0.0006524659693241119
were O 0 1.7111962733906694e-05
observed O 0 0.00021260212815832347
at O 0 0.0003008382918778807
least O 0 0.0002011959149967879
twice O 0 0.0017449260922148824
. O 0 0.00026511147734709084

The O 0 0.002798166126012802
BRCA1 O 1 0.9998477697372437
C4446T O 0 0.15312233567237854
mutation O 0 0.0025406372733414173
was O 0 0.0003555070434231311
the O 0 3.8434111047536135e-05
most O 0 0.00010232659406028688
common O 0 0.0012934623518958688
mutation O 0 0.0024808011949062347
found O 0 0.0002173623797716573
, O 0 6.260718510020524e-05
followed O 0 9.007495100377128e-05
by O 0 1.9161087038810365e-05
the O 0 0.0007302235462702811
BRCA2 O 1 0.9999221563339233
8765delAG O 1 0.9645283222198486
mutation O 0 0.0038782968185842037
. O 0 0.00038398944889195263

Together O 0 0.00021559925517067313
, O 0 9.045738988788798e-05
these O 0 1.817406518966891e-05
mutations O 0 0.0008326366078108549
were O 0 2.014077290368732e-05
found O 0 0.00011985487799393013
in O 0 7.449702388839796e-05
28 O 0 0.0005663796910084784
of O 0 2.0525123545667157e-05
41 O 0 0.0030181400943547487
families O 0 0.00020051642786711454
identified O 0 0.0003799046389758587
to O 0 1.8664539311430417e-05
have O 0 1.748233989928849e-05
a O 0 0.00024722085800021887
mutation O 0 0.0019802323076874018
. O 0 0.0003429218486417085

The O 0 0.0007964698597788811
odds O 0 0.005910766310989857
of O 0 2.0412217054399662e-05
detection O 0 0.0020815380848944187
of O 0 3.117820142506389e-06
any O 0 1.0597905202303082e-05
of O 0 3.826206921075936e-06
the O 0 0.00010376018326496705
four O 0 0.0002997080737259239
BRCA1 O 1 0.9992313385009766
mutations O 0 0.0029839009512215853
was O 0 0.00099665904417634
18 O 0 0.0005012332112528384
. O 0 0.00022514740703627467

7x O 1 0.992119550704956
greater O 0 0.0009444751194678247
if O 0 0.00021733087487518787
one O 0 2.695328112167772e-05
or O 0 4.259015986463055e-05
more O 0 2.14363190025324e-05
cases O 0 0.0009765741415321827
of O 0 0.0006816392415203154
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 7.564246334368363e-05
also O 0 6.281290552578866e-05
present O 0 3.238570934627205e-05
in O 0 3.393016959307715e-05
the O 0 0.00011066561273764819
family O 0 0.0008008986478671432
. O 0 0.00040403290768153965

The O 0 0.0009016370750032365
odds O 0 0.0055260141380131245
of O 0 2.0120287445024587e-05
detection O 0 0.0022814329713582993
of O 0 3.89036858905456e-06
any O 0 1.1475484825496096e-05
of O 0 3.5524831218936015e-06
the O 0 0.0001027705438900739
four O 0 0.0003232031303923577
BRCA2 O 1 0.9990825653076172
mutations O 0 0.0026274570263922215
was O 0 0.0009072267566807568
5 O 0 0.0006233547464944422
. O 0 0.00023008292191661894

3x O 1 0.9341118931770325
greater O 0 0.001052516046911478
if O 0 0.0002685517247300595
there O 0 1.98758534679655e-05
were O 0 8.86805537447799e-06
at O 0 0.00011829863069579005
least O 0 4.6938774175941944e-05
five O 0 3.763335553230718e-05
cases O 0 0.0005872541223652661
of O 0 0.00023179291747510433
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.00013863916683476418
the O 0 0.00012124092609155923
family O 0 0.0008532452047802508
. O 0 0.0003917518479283899

Interestingly O 0 0.031806282699108124
, O 0 5.881984543520957e-05
the O 0 1.8556949726189487e-05
presence O 0 5.947779573034495e-05
of O 0 1.1830315088445786e-05
a O 0 0.05875541269779205
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 0 0.008460231125354767
< O 0 0.03685374930500984
36 O 0 0.0007745203911326826
years O 0 0.00011484485730761662
of O 0 1.1232526958337985e-05
age O 0 0.001073647872544825
was O 0 0.001135096768848598
strongly O 0 0.0009478172869421542
predictive O 0 0.005386299919337034
of O 0 1.4624701179855037e-05
the O 0 8.910249744076282e-05
presence O 0 0.00014323501090984792
of O 0 4.16975308326073e-06
any O 0 1.4843830285826698e-05
of O 0 3.3782855552999536e-06
the O 0 6.972586561460048e-05
eight O 0 0.0002307151589775458
mutations O 0 0.001611395855434239
screened O 0 0.004112363792955875
. O 0 0.0002715506707318127

Carriers O 0 0.008543029427528381
of O 0 1.1521485248522367e-05
the O 0 9.740105451783165e-05
same O 0 0.00017768108227755874
mutation O 0 0.0022737656254321337
, O 0 0.0001214661097037606
from O 0 3.500211823848076e-05
different O 0 1.2845200217270758e-05
families O 0 0.00017074069182854146
, O 0 0.0001037122929119505
shared O 0 0.0004006284580100328
similar O 0 0.0005369174759835005
haplotypes O 0 0.020961251109838486
, O 0 0.00019694979710038751
indicating O 0 0.0012269843136891723
that O 0 2.477771158737596e-05
the O 0 0.00013252875942271203
mutant O 0 0.005541627295315266
alleles O 0 0.0020907351281493902
were O 0 4.87067736685276e-05
likely O 0 0.0004137554788030684
to O 0 3.091738835792057e-05
be O 0 2.7351759854354896e-05
identical O 0 8.459173841401935e-05
by O 0 1.8092061509378254e-05
descent O 0 0.0003704250557348132
for O 0 9.350618347525597e-05
a O 0 0.0004990950110368431
mutation O 0 0.0010660361731424928
in O 0 6.933917029527947e-05
the O 0 0.00020011533342767507
founder O 0 0.007220899220556021
population O 0 9.502637840341777e-05
. O 0 0.0003961352340411395

The O 0 0.00019363495812285691
identification O 0 0.0001898288755910471
of O 0 2.9743427148787305e-05
common O 0 0.019363727420568466
BRCA1 O 1 0.9999803304672241
and O 0 0.0019158461363986135
BRCA2 O 1 0.9997990727424622
mutations O 0 0.0013090786524116993
will O 0 4.1509600123390555e-05
facilitate O 0 0.000879388302564621
carrier O 0 0.00856503751128912
detection O 0 0.0021145199425518513
in O 0 4.675989112001844e-05
French O 0 0.0012106501962989569
Canadian O 1 0.9566949009895325
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.15783657133579254
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0008808877901174128
. O 0 0.0003146787639707327

Are O 0 0.0002550178614910692
Dp71 O 1 0.7405682802200317
and O 0 0.00046778886462561786
Dp140 O 1 0.9535291790962219
brain O 1 0.9997852444648743
dystrophin O 1 0.9866340160369873
isoforms O 0 0.0009386814781464636
related O 0 0.000399653275962919
to O 0 7.863395876483992e-05
cognitive B-Disease 1 0.9987165927886963
impairment I-Disease 1 0.999998927116394
in O 0 0.002738100476562977
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9111148715019226

Molecular O 0 0.011748181656002998
study O 0 0.0014598219422623515
and O 0 0.00022756958787795156
neuropsychological O 1 0.6540014147758484
analysis O 0 0.00017097560339607298
were O 0 1.5005330169515219e-05
performed O 0 0.00029394260491244495
concurrently O 0 0.0008875334169715643
on O 0 0.00017611730436328799
49 O 0 0.006920333951711655
patients O 1 0.999958872795105
with O 0 0.0007973295287229121
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.7226092219352722
DMD B-Disease 1 1.0
) O 0 0.0005087096942588687
in O 0 4.4533164327731356e-05
order O 0 3.476220808806829e-05
to O 0 3.5614517400972545e-05
find O 0 0.0001875819289125502
a O 0 0.00015928632637951523
molecular O 0 0.0010850845137611032
explanation O 0 0.000618098652921617
for O 0 5.5919041187735274e-05
the O 0 0.00019377921125851572
cognitive B-Disease 1 0.9977453351020813
impairment I-Disease 1 0.9998952150344849
observed O 0 0.0005052000633440912
in O 0 0.00016937391774263233
most O 0 0.002952128415927291
DMD B-Disease 1 1.0
patients O 1 0.9999978542327881
. O 0 0.0005952391074970365

Complete O 0 0.0008576738182455301
analysis O 0 6.307267904048786e-05
of O 0 7.5160819505981635e-06
the O 0 0.0004904191591776907
dystrophin O 1 0.9994449019432068
gene O 0 0.004392463248223066
was O 0 0.0011821576626971364
performed O 0 0.0007032161229290068
to O 0 4.0817478293320164e-05
define O 0 0.0006162232020869851
the O 0 7.167083822423592e-05
localization O 0 0.002823759103193879
of O 0 2.758626033028122e-05
deletions O 0 0.0038693593814969063
and O 0 0.0001933506573550403
duplications O 0 0.009335282258689404
in O 0 7.731785444775596e-05
relation O 0 0.00038668347406201065
to O 0 2.9177921533118933e-05
the O 0 8.067837916314602e-05
different O 0 0.0002572464582044631
DMD B-Disease 1 0.9999998807907104
promoters O 0 0.10927721858024597
. O 0 0.0006778521346859634

Qualitative O 0 0.0037521824706345797
analysis O 0 0.0001166921210824512
of O 0 1.038123809848912e-05
the O 0 0.0005230789538472891
Dp71 O 1 0.9847450852394104
transcript O 0 0.014046882279217243
and O 0 0.000106520346889738
testing O 0 0.0020818787161260843
for O 0 4.231454659020528e-05
the O 0 3.576733797672205e-05
specific O 0 7.315954280784354e-05
first O 0 0.00014552900393027812
exon O 0 0.01054772175848484
of O 0 2.6997247914550826e-05
Dp140 O 0 0.030522871762514114
were O 0 2.2632515538134612e-05
also O 0 4.739106589113362e-05
carried O 0 0.00010260191629640758
out O 0 9.018220589496195e-05
. O 0 0.00022854589042253792

Neuropsychological O 1 0.7848093509674072
analysis O 0 0.0009742230176925659
assessed O 0 0.01284019649028778
verbal O 0 0.01318376138806343
and O 0 0.00045826309360563755
visuospatial O 1 0.998441755771637
intelligence O 0 0.01451035588979721
, O 0 0.00042504401062615216
verbal O 0 0.024166395887732506
memory O 0 0.07117336243391037
, O 0 0.00021351243776734918
and O 0 0.00012702267849817872
reading O 0 0.004030402284115553
skills O 0 0.014855475164949894
. O 0 0.0005976432003080845

Comparison O 0 0.001123537658713758
of O 0 2.152686647605151e-05
molecular O 0 0.003334823762997985
and O 0 0.0002496972738299519
psychometric O 1 0.99136883020401
findings O 0 0.004423744976520538
demonstrated O 0 0.002366398461163044
that O 0 5.1158960559405386e-05
deletions O 0 0.0015219547785818577
and O 0 0.0001247584878001362
duplications O 0 0.009044068865478039
that O 0 3.6387787986313924e-05
were O 0 2.515076266718097e-05
localized O 0 0.006652153562754393
in O 0 0.00011819657811429352
the O 0 0.00028988049598410726
distal O 1 0.9933070540428162
part O 0 0.000595302670262754
of O 0 1.542661448183935e-05
the O 0 0.00022256336524151266
gene O 0 0.0022354512475430965
seemed O 0 0.0019478794420138001
to O 0 2.161747033824213e-05
be O 0 2.8913809728692286e-05
preferentially O 0 0.002163209021091461
associated O 0 0.00011659247684292495
with O 0 0.00010322114394512028
cognitive B-Disease 1 0.9995635151863098
impairment I-Disease 1 0.9999958276748657
. O 0 0.000837565865367651

Two O 0 0.0002568241907283664
altered O 0 0.006272300146520138
Dp71 O 0 0.1312997043132782
transcripts O 0 0.0015219366177916527
and O 0 3.8646325265290216e-05
two O 0 3.464426481514238e-05
deleted O 0 0.0030964419711381197
Dp140 O 0 0.017788296565413475
DNA O 0 0.00023289636010304093
sequences O 0 1.4045333045942243e-05
were O 0 8.8782689999789e-06
found O 0 5.057473390479572e-05
in O 0 4.2893821955658495e-05
four O 0 0.00018249201821163297
patients O 1 0.9999876022338867
with O 0 0.0006538096349686384
severe O 1 0.9999998807907104
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.9999997615814209
. O 0 0.0013493550941348076

These O 0 0.0001846734230639413
findings O 0 0.0031297660898417234
suggest O 0 0.00038665547617711127
that O 0 1.0394213859399315e-05
some O 0 7.836920303816441e-06
sequences O 0 3.1061837944434956e-05
located O 0 0.0005641477764584124
in O 0 7.439748878823593e-05
the O 0 0.0002822793903760612
distal O 1 0.9866116046905518
part O 0 0.000506916840095073
of O 0 9.65892195381457e-06
the O 0 0.0002659030433278531
gene O 0 0.001979907974600792
and O 0 0.00011656133574433625
, O 0 0.00010736880358308554
in O 0 6.411623326130211e-05
particular O 0 0.00018653320148587227
, O 0 0.00017880977247841656
some O 0 0.0003557576274033636
DMD B-Disease 1 0.9999977350234985
isoforms O 0 0.0008772191358730197
expressed O 0 0.00022441722103394568
in O 0 9.855189273366705e-05
the O 0 0.0007310056826099753
brain O 1 0.9999974966049194
may O 0 0.0010282422881573439
be O 0 3.7969763070577756e-05
related O 0 0.00014590959472116083
to O 0 1.995781531149987e-05
the O 0 0.00017129039042629302
cognitive B-Disease 1 0.9996391534805298
impairment I-Disease 1 0.9999945163726807
associated O 0 0.001304463716223836
with O 0 0.0010226054582744837
DMD B-Disease 1 1.0
. O 0 0.0005131776561029255
. O 0 0.0003504399210214615

I1307K O 1 0.6828742623329163
APC O 1 0.9875332117080688
and O 0 0.0005882231635041535
hMLH1 O 0 0.096767358481884
mutations O 0 0.0009999312460422516
in O 0 4.820707181352191e-05
a O 0 0.0003776733938138932
non O 0 0.003052403684705496
- O 0 0.003167734481394291
Jewish O 0 0.0003748027666006237
family O 0 0.00012211845023557544
with O 0 8.216044079745188e-05
hereditary B-Disease 1 0.9997146725654602
non I-Disease 1 0.9988414645195007
- I-Disease 1 0.9999970197677612
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0010133754694834352

We O 0 0.00027167811640538275
describe O 0 0.0005921365809626877
a O 0 0.0002549906203057617
French O 0 0.0012832669308409095
Canadian O 0 0.0037434373516589403
hereditary B-Disease 1 0.9986610412597656
non I-Disease 1 0.9956579208374023
- I-Disease 1 0.9999935626983643
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.014563309028744698
HNPCC B-Disease 1 0.9999995231628418
) O 0 0.0014585769968107343
kindred O 1 0.9771388173103333
which O 0 5.7903995184460655e-05
carries O 0 0.00045027778833173215
a O 0 0.00024598176241852343
novel O 0 0.0017260301392525434
truncating O 0 0.3630598485469818
mutation O 0 0.002251973608508706
in O 0 0.0002898699895013124
hMLH1 O 0 0.37795308232307434
. O 0 0.0005108508630655706

Interestingly O 0 0.035720936954021454
, O 0 0.00018975378770846874
the O 0 0.000323642510920763
I1307K O 0 0.18305233120918274
APC O 1 0.9707266092300415
polymorphism O 0 0.003993313293904066
, O 0 0.0001267101033590734
associated O 0 6.765156285837293e-05
with O 0 8.49505522637628e-06
an O 0 5.593045352725312e-05
increased O 0 0.0006072896649129689
risk O 1 0.9672539830207825
of O 0 0.0014086563605815172
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.000471121835289523
is O 0 0.00021313187608029693
also O 0 6.530340033350512e-05
present O 0 4.8756643082015216e-05
in O 0 3.955588908866048e-05
this O 0 3.7133722798898816e-05
family O 0 0.0005376370390877128
. O 0 0.0004153804911766201

The O 0 0.0007621547556482255
I1307K O 0 0.044655732810497284
polymorphism O 0 0.003198816906660795
has O 0 0.000482193601783365
previously O 0 0.0003702084650285542
only O 0 3.952462793677114e-05
been O 0 0.0001344165502814576
identified O 0 0.000189248938113451
in O 0 1.701510882412549e-05
individuals O 0 1.8739305232884362e-05
of O 0 1.4405331967282109e-05
self O 0 0.08071280270814896
- O 0 0.049386605620384216
reported O 0 0.0043794079683721066
Ashkenazi O 0 0.10195259004831314
Jewish O 0 0.0017135408706963062
origins O 0 0.001896149362437427
. O 0 0.0003733589837793261

In O 0 0.0004992594476789236
addition O 0 0.00044274592073634267
, O 0 0.00012635078746825457
in O 0 7.493435259675607e-05
this O 0 4.9548551032785326e-05
family O 0 0.000496094289701432
, O 0 0.00018080761947203428
there O 0 0.00011569229536689818
appears O 0 0.0024131082464009523
to O 0 4.4443815568229184e-05
be O 0 4.3610762077150866e-05
no O 0 8.660346065880731e-05
relationship O 0 0.0012962494511157274
between O 0 8.309340773848817e-05
the O 0 0.0001996997743844986
I1307K O 0 0.04950723424553871
polymorphism O 0 0.0015414752997457981
and O 0 3.972543709096499e-05
the O 0 5.277296440908685e-05
presence O 0 0.0003561049234122038
or O 0 0.00023512370535172522
absence O 0 0.0032746708020567894
of O 0 0.00022295904636848718
cancer B-Disease 1 1.0
. O 0 0.00022903627541381866
. O 0 0.0002854006306733936

Identification O 0 0.00048353898455388844
of O 0 1.2114729543100111e-05
a O 0 0.0003436646074987948
novel O 0 0.0009248419082723558
mutation O 0 0.00032525655115023255
of O 0 6.88690806782688e-06
the O 0 0.00025883130729198456
CPO O 0 0.11023988574743271
gene O 0 0.0006106165237724781
in O 0 4.1622057324275374e-05
a O 0 0.0003304707643110305
Japanese O 0 0.0037063227500766516
hereditary B-Disease 1 0.9990739822387695
coproporphyria I-Disease 1 0.9982317090034485
family O 0 0.0016039167530834675
. O 0 0.0004248955228831619

Hereditary B-Disease 1 0.9992671608924866
coproporphyria I-Disease 1 0.9985536932945251
( O 0 0.004787395242601633
HCP B-Disease 1 0.9998857975006104
) O 0 0.00020439637592062354
is O 0 0.0001104014809243381
an O 0 0.0003809741756413132
autosomal B-Disease 1 0.9999189376831055
dominant I-Disease 1 0.9994791150093079
disease I-Disease 1 1.0
characterized O 0 0.13182996213436127
by O 0 8.335499296663329e-05
a O 0 0.002517251530662179
deficiency B-Disease 1 0.9999974966049194
of I-Disease 0 0.00010308638593414798
coproporphyrinogen I-Disease 1 0.9969924688339233
oxidase I-Disease 0 0.1396985799074173
( O 0 0.0013446803204715252
CPO O 0 0.15826407074928284
) O 0 0.0003822192084044218
caused O 0 0.0018654284067451954
by O 0 1.8211885617347434e-05
a O 0 0.0002757574256975204
mutation O 0 0.0008727657259441912
in O 0 7.173079939093441e-05
the O 0 0.0002779520000331104
CPO O 0 0.1728205680847168
gene O 0 0.0028608685825020075
. O 0 0.0002657788572832942

Only O 0 0.0002946139720734209
11 O 0 0.0006240246584638953
mutations O 0 0.00021192898566368967
of O 0 3.869573902193224e-06
the O 0 0.0001181023835670203
gene O 0 0.0008954527438618243
have O 0 4.151118628215045e-05
been O 0 0.00019110321591142565
reported O 0 0.001716297585517168
in O 0 0.0007174818892963231
HCP B-Disease 1 0.9999967813491821
patients O 1 0.9999920129776001
. O 0 0.0007292599766515195

We O 0 0.000665076426230371
report O 0 0.0004457010072655976
another O 0 0.0002321746724192053
mutation O 0 0.0006544944480992854
in O 0 4.538184657576494e-05
a O 0 0.0002862328547053039
Japanese O 0 0.0014253569534048438
family O 0 0.001141570508480072
. O 0 0.0005454903584904969

Polymerase O 0 0.011202418245375156
chain O 0 0.005090822000056505
reaction O 0 0.0019072871655225754
- O 0 0.0025770326610654593
single O 0 0.00022100150818005204
strand O 0 0.004367855377495289
conformational O 0 0.0026741677429527044
polymorphism O 0 0.0012019622372463346
and O 0 2.795047839754261e-05
direct O 0 6.619377381866798e-05
sequence O 0 3.6618515878217295e-05
analyses O 0 0.0006436757976189256
demonstrated O 0 0.0026254106778651476
a O 0 0.000930385198444128
C O 0 0.03999931737780571
to O 0 0.0002617789141368121
T O 1 0.5679340362548828
substitution O 0 0.00025572002050466835
in O 0 8.797705959295854e-05
exon O 0 0.01106721255928278
1 O 0 0.00021181648480705917
of O 0 6.130104793555802e-06
the O 0 0.00024928292259573936
CPO O 0 0.07545734196901321
gene O 0 0.0008079165127128363
at O 0 0.00024367224250454456
nucleotide O 0 0.00019054426229558885
position O 0 0.0018557230941951275
85 O 0 0.003948143217712641
, O 0 0.00014391048171091825
which O 0 5.946118471911177e-05
lies O 0 0.0021674104500561953
in O 0 6.507010402856395e-05
the O 0 0.0001870020932983607
putative O 0 0.028944527730345726
presequence O 0 0.07643526047468185
for O 0 0.00010471259884070605
targeting O 0 0.00044402320054359734
to O 0 6.835778913227841e-05
mitochondria O 0 0.0023106762673705816
. O 0 0.00030278399935923517

This O 0 0.00021779886446893215
mutation O 0 0.0008801796939224005
changes O 0 9.47825683397241e-05
the O 0 8.026752766454592e-05
codon O 0 0.0016446891240775585
for O 0 0.00011216102575417608
glutamine O 0 0.0038609420880675316
to O 0 3.764031862374395e-05
a O 0 0.000348841305822134
termination O 0 0.04252848029136658
codon O 0 0.0020806887187063694
at O 0 0.00019798475841525942
amino O 0 0.00020541467529255897
acid O 0 0.006699688732624054
position O 0 0.0025311089120805264
29 O 0 0.0035579244140535593
. O 0 0.0002868415031116456

MaeI O 0 0.12619467079639435
restriction O 0 0.0007529354770667851
analysis O 0 0.0002847114228643477
showed O 0 0.0005815285257995129
two O 0 1.3316112926986534e-05
other O 0 2.4739932996453717e-05
carriers O 0 0.0036561915185302496
in O 0 7.185163121903315e-05
the O 0 0.00015447204350493848
family O 0 0.0008051001932471991
. O 0 0.0004082507221028209

The O 0 0.0023807177785784006
C O 1 0.9658594131469727
- O 0 0.3152303993701935
T O 1 0.9923481941223145
mutation O 0 0.001600921736098826
is O 0 0.00014497888332698494
located O 0 0.00032772767008282244
within O 0 3.9496488170698285e-05
a O 0 0.00044681873987428844
recently O 0 0.003071588696911931
proposed O 0 0.0004793865664396435
putative O 0 0.0032186296302825212
alternative O 0 0.0003143094072584063
translation O 0 0.00023971428163349628
initiation O 0 0.0034202346578240395
codon O 0 0.009323805570602417
( O 0 0.002111690351739526
TIC O 1 0.9998470544815063
- O 0 0.00785567332059145
1 O 0 0.0010682945139706135
) O 0 7.794042176101357e-05
, O 0 6.9296860601753e-05
supporting O 0 0.001350624836049974
that O 0 0.0004167277947999537
TIC O 1 0.9999178647994995
- O 0 0.004515610635280609
1 O 0 0.00038009975105524063
is O 0 5.81558961130213e-05
the O 0 7.610777538502589e-05
real O 0 0.00280880113132298
TIC O 1 0.998708963394165
rather O 0 0.00041483622044324875
than O 0 0.0006054700934328139
TIC O 1 0.9998213648796082
- O 0 0.008237219415605068
2 O 0 0.0006420882418751717
. O 0 8.22585861897096e-05
. O 0 0.00019509550475049764

Human B-Disease 0 0.0010691160568967462
complement I-Disease 0 0.0028748740442097187
factor I-Disease 0 0.0616627037525177
H I-Disease 1 0.999997615814209
deficiency I-Disease 1 0.9999998807907104
associated O 0 0.0017935843206942081
with O 0 0.0037998235784471035
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0019505826057866216

This O 0 0.00017937022494152188
study O 0 0.0006652095471508801
reports O 0 0.00021030935749877244
on O 0 7.626258593518287e-05
six O 0 0.00013018937897868454
cases O 0 0.0006625467212870717
of O 0 0.00014892223407514393
deficiency B-Disease 1 1.0
in I-Disease 0 0.00011251302203163505
the I-Disease 0 5.3165957069722936e-05
human I-Disease 0 0.00025596446357667446
complement I-Disease 0 0.0008898663800209761
regulatory I-Disease 0 0.0018922475865110755
protein I-Disease 0 0.0009078377042897046
Factor I-Disease 0 0.00899294763803482
H I-Disease 1 0.9996724128723145
( O 0 0.0037213903851807117
FH O 1 0.9998370409011841
) O 0 0.00016748033522162586
in O 0 1.5768180674058385e-05
the O 0 9.67060805123765e-06
context O 0 4.704031380242668e-05
of O 0 1.617275302123744e-05
an O 0 0.019142882898449898
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0014577270485460758

Five O 0 0.00014764038496650755
of O 0 9.498914550931659e-06
the O 0 0.00017891994502861053
cases O 0 0.0009930742671713233
were O 0 1.7191425286000594e-05
observed O 0 0.0001660866109887138
in O 0 4.818390516447835e-05
children O 0 0.0003088988596573472
presenting O 0 0.007075098343193531
with O 0 0.0038868244737386703
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.3453748822212219
HUS B-Disease 1 0.9999998807907104
) O 0 0.001178508042357862
. O 0 0.00035358298919163644

Two O 0 3.1770661735208705e-05
of O 0 6.271472102525877e-06
the O 0 0.00015215178427752107
children O 0 0.0008228743099607527
exhibited O 0 0.010104184970259666
a O 0 0.002467657905071974
homozygous O 1 0.6988610625267029
deficiency O 1 0.9999997615814209
characterized O 0 0.03039395809173584
by O 0 4.322684617363848e-05
the O 0 0.00010580381785985082
absence O 0 0.0008798333583399653
of O 0 5.781615982414223e-06
the O 0 0.00018930379883386195
150 O 0 0.0027475617825984955
- O 0 0.008373838849365711
kD O 0 0.06496242433786392
form O 0 8.474053902318701e-05
of O 0 2.460323776176665e-05
Factor O 0 0.01953909359872341
H O 1 0.998553454875946
and O 0 0.00010310683137504384
the O 0 0.00010091559670399874
presence O 0 0.000514043727889657
, O 0 0.00016084981325548142
upon O 0 0.0006823450676165521
immunoblotting O 0 0.12869033217430115
, O 0 3.223054955014959e-05
of O 0 4.058961167174857e-06
the O 0 0.0001418322790414095
42 O 0 0.004499451722949743
- O 0 0.007872302085161209
kD O 0 0.34837982058525085
Factor O 0 0.00806121714413166
H O 1 0.9897866249084473
- O 0 0.001261507160961628
like O 0 5.549416164285503e-05
protein O 0 0.00026989259640686214
1 O 0 0.0012656543403863907
( O 0 0.0013685235753655434
FHL O 1 0.9975495934486389
- O 0 0.00641181506216526
1 O 0 0.0007408723467960954
) O 0 6.580945773748681e-05
and O 0 5.013932241126895e-05
other O 0 0.0001761455205269158
FH O 1 0.9999569654464722
- O 0 0.004401585552841425
related O 0 0.0005555087700486183
protein O 0 0.0010108259739354253
( O 0 0.0012038493296131492
FHR O 1 0.9989575147628784
) O 0 0.00025239260867238045
bands O 0 0.00048091821372509
. O 0 0.00030914516537450254

Southern O 0 0.011629846878349781
blot O 1 0.9193792939186096
and O 0 0.0001866118109319359
PCR O 0 0.004104794468730688
analysis O 0 5.203932960284874e-05
of O 0 4.712189365818631e-06
DNA O 0 0.00016174308257177472
of O 0 5.04109766552574e-06
one O 0 0.0001855750597314909
patient O 1 0.9997996687889099
with O 0 0.00028424791526049376
homozygous O 0 0.385747492313385
deficiency O 1 0.9999997615814209
ruled O 0 0.0045594885013997555
out O 0 6.635757745243609e-05
the O 0 4.144512422499247e-05
presence O 0 0.00010598648805171251
of O 0 4.982784957974218e-06
a O 0 0.00016534457972738892
large O 0 0.00011351070861564949
deletion O 0 0.0020293903071433306
of O 0 1.5460987924598157e-05
the O 0 0.0008530086488462985
FH O 1 0.9999207258224487
gene O 0 0.0011203241301700473
as O 0 7.468836702173576e-05
the O 0 0.0001411568809999153
underlying O 1 0.9771839380264282
defect O 1 0.9993568062782288
for O 0 0.00025317908148281276
the O 0 0.001556467148475349
deficiency O 1 0.9999998807907104
. O 0 0.0010457648895680904

The O 0 0.00026431470178067684
other O 0 2.8135860702604987e-05
four O 0 6.769300671294332e-05
children O 0 0.00034236456849612296
presented O 0 0.0004095784097444266
with O 0 0.00018787174485623837
heterozygous O 0 0.2107561230659485
deficiency O 1 0.9999997615814209
and O 0 0.00029198575066402555
exhibited O 0 0.00914157833904028
a O 0 0.0009166044765152037
normal O 0 0.006262992974370718
immunoblotting O 0 0.09668512642383575
pattern O 0 0.0007460175547748804
of O 0 3.2556024507357506e-06
proteins O 0 1.7615975593798794e-05
of O 0 1.5304551197914407e-05
the O 0 0.001242464524693787
FH O 1 0.9999850988388062
family O 0 0.0017059905221685767
. O 0 0.0004133883921895176

Factor B-Disease 0 0.3364774286746979
H I-Disease 1 0.9999853372573853
deficiency I-Disease 1 0.9999991655349731
is O 0 0.00011400231596780941
the O 0 3.2777199521660805e-05
only O 0 0.00010233867942588404
complement B-Disease 1 0.9996609687805176
deficiency I-Disease 1 1.0
associated O 0 0.0013847292866557837
with O 0 0.0007457651663571596
HUS B-Disease 1 0.9999996423721313
. O 0 0.0011878262739628553

These O 0 4.807164441444911e-05
observations O 0 0.00038307037902995944
suggest O 0 0.000304465793306008
a O 0 0.00018487566558178514
role O 0 0.0018191463313996792
for O 0 0.001464681699872017
FH O 1 0.999984622001648
and O 0 0.0015646375250071287
/ O 1 0.9402217864990234
or O 0 0.0023095908109098673
FH O 1 0.9997187256813049
receptors O 0 0.0023011346347630024
in O 0 5.7641205785330385e-05
the O 0 0.00024303997633978724
pathogenesis O 1 0.9999842643737793
of O 0 0.0006559419562108815
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.0008133999072015285
. O 0 0.0003464768233243376

Further O 0 0.0004006324743386358
evidence O 0 9.981583571061492e-05
for O 0 3.624523742473684e-05
a O 0 0.00011462931433925405
major O 0 0.0006726254941895604
ancient O 0 0.0006300248787738383
mutation O 0 0.014399385079741478
underlying O 1 0.9999675750732422
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 0.0013779753353446722
linkage O 0 0.45034804940223694
disequilibrium O 1 0.9841795563697815
studies O 0 0.0007539618527516723
in O 0 4.953758616466075e-05
the O 0 7.290242501767352e-05
Japanese O 0 0.0007984053809195757
population O 0 8.623116445960477e-05
. O 0 0.0003494514094199985

The O 0 0.007198492530733347
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 0.20749618113040924
DM B-Disease 1 1.0
) O 0 0.0005765270907431841
mutation O 0 0.0007147499709390104
is O 0 0.0001126193892559968
an O 0 0.0003527161024976522
unstable O 1 0.9986314177513123
( O 0 0.004037526901811361
CTG O 1 0.998337984085083
) O 0 0.0009081170428544283
n O 0 0.004059570841491222
repeat O 0 0.011007505469024181
, O 0 0.00014219396689441055
present O 0 0.00013362958270590752
at O 0 0.0003371242491994053
a O 0 0.0001669653138378635
copy O 0 0.0002737099421210587
number O 0 4.378406174510019e-06
of O 0 1.1909259228559677e-05
5 O 0 0.0015096399001777172
- O 0 0.004052338190376759
37 O 0 0.0013267487520352006
repeats O 0 0.0026153603103011847
on O 0 0.00012825755402445793
normal O 0 0.0010397756705060601
chromosomes O 0 0.00016218723612837493
but O 0 5.504012369783595e-05
amplified O 0 0.0007154894410632551
to O 0 5.899353345739655e-05
50 O 0 0.0005066146259196103
- O 0 0.0035671228542923927
3000 O 0 0.015629570931196213
copies O 0 0.0002312567230546847
on O 0 0.0011422683019191027
DM B-Disease 1 0.9999985694885254
chromosomes O 0 0.0012868979247286916
. O 0 0.0003914836561307311

Previous O 0 0.002738591516390443
findings O 0 0.0032395520247519016
in O 0 0.00021867592295166105
Caucasian O 0 0.03268955647945404
populations O 0 0.000119308679131791
of O 0 1.9749621060327627e-05
a O 0 0.009660554118454456
DM B-Disease 1 1.0
founder O 0 0.08961019665002823
chromosome O 0 0.0018198236357420683
raise O 0 0.0006958230515010655
a O 0 0.000267584080575034
question O 0 0.00034970001433975995
about O 0 6.403301085811108e-05
the O 0 9.350796608487144e-05
molecular O 0 0.0018735986668616533
events O 0 0.00012179969053249806
involved O 0 0.0003421110741328448
in O 0 3.5978278901893646e-05
the O 0 6.675070471828803e-05
expansion O 0 0.002564772730693221
mutation O 0 0.0024078793358057737
. O 0 0.00026294085546396673

To O 0 0.00037003401666879654
investigate O 0 0.003673376515507698
whether O 0 0.00027315126499161124
a O 0 0.0004074850876349956
founder O 0 0.007947462610900402
chromosome O 0 0.0009023073362186551
for O 0 0.00014508675667457283
the O 0 0.0014082150300964713
DM B-Disease 1 0.9999998807907104
mutation O 0 0.005731482990086079
exists O 0 0.0007593167247250676
in O 0 4.82533396279905e-05
the O 0 8.095998782664537e-05
Japanese O 0 0.0007859606994315982
population O 0 6.216622568899766e-05
, O 0 0.00016469834372401237
we O 0 0.00023594946833327413
genotyped O 0 0.03719208389520645
families O 0 9.39450110308826e-05
using O 0 0.00012188553955638781
polymorphic O 0 0.028418080881237984
markers O 0 0.007146327290683985
near O 0 0.0019317155238240957
the O 0 0.0003637665358837694
( O 0 0.0019511026330292225
CTG O 1 0.9945647716522217
) O 0 0.0006345658330246806
n O 0 0.003372772829607129
repeat O 0 0.008842481300234795
region O 0 0.0012505988124758005
and O 0 0.0001178196253022179
constructed O 0 0.004449807107448578
haplotypes O 0 0.018964042887091637
. O 0 0.0003672765742521733

Six O 0 0.00026286765933036804
different O 0 1.7771126294974238e-05
haplotypes O 0 0.005550101399421692
were O 0 3.9256876334547997e-05
found O 0 0.0003964529314544052
and O 0 0.0010669865878298879
DM B-Disease 1 0.9999998807907104
alleles O 0 0.004298563115298748
were O 0 3.408291740925051e-05
always O 0 0.0006740587996318936
haplotype O 0 0.0460398904979229
A O 0 0.0036010376643389463
. O 0 0.00047371338587254286

To O 0 0.00018299560179002583
find O 0 0.0002163822209695354
an O 0 2.9362850909819826e-05
origin O 0 8.431704372924287e-06
of O 0 5.598874395218445e-06
the O 0 0.0003997418680228293
( O 0 0.003040640614926815
CTG O 1 0.9972884654998779
) O 0 0.0007393935811705887
n O 0 0.004021171946078539
repeat O 0 0.013617259450256824
mutation O 0 0.0017770309932529926
and O 0 9.022616723086685e-05
to O 0 9.465901530347764e-05
investigate O 0 0.0023207985796034336
the O 0 5.5022646847646683e-05
mechanism O 0 0.00032293793628923595
of O 0 7.436625764967175e-06
the O 0 0.00011075766815338284
expansion O 0 0.0028293472714722157
mutation O 0 0.0012117944424971938
in O 0 6.157609459478408e-05
the O 0 7.566187559859827e-05
Japanese O 0 0.0005582391750067472
population O 0 2.8880382160423324e-05
we O 0 6.854250386822969e-05
have O 0 2.9563576390501112e-05
studied O 0 0.0004889239789918065
90 O 0 0.0014185685431584716
Japanese O 0 0.00921392161399126
DM B-Disease 1 0.9999985694885254
families O 0 0.0005923464777879417
comprising O 0 0.0005238765152171254
190 O 0 0.007522400934249163
affected O 0 0.004137285519391298
and O 0 0.00015103243640623987
130 O 0 0.0036920811980962753
unaffected O 0 0.05166257917881012
members O 0 0.0001879276242107153
. O 0 0.00023791618878021836

The O 0 0.0007404956850223243
results O 0 0.0008438837248831987
suggest O 0 0.00044284953037276864
that O 0 1.9634186173789203e-05
a O 0 0.0001801925100153312
few O 0 0.00016893151041585952
common O 0 0.001102813403122127
ancestral O 0 0.005521174054592848
mutations O 0 0.0016485771629959345
in O 0 0.00012486535706557333
both O 0 0.0003503380576148629
Caucasian O 1 0.9778797030448914
and O 0 0.00025879775057546794
Japanese O 0 0.001279716845601797
populations O 0 0.0003415007086005062
have O 0 4.494779568631202e-05
originated O 0 0.00016957185289356858
by O 0 8.88079284777632e-06
expansion O 0 0.00023689214140176773
of O 0 5.308112122293096e-06
an O 0 0.0001674372178968042
ancestral O 0 0.007091243285685778
n O 0 0.006336465012282133
= O 0 0.004473962355405092
5 O 0 0.0004495306930039078
repeat O 0 0.002957497490569949
to O 0 0.00010372504766564816
n O 0 0.0033254639711230993
= O 0 0.0050629014149308205
19 O 0 0.001527856569737196
- O 0 0.0020756034646183252
37 O 0 0.0008114181691780686
copies O 0 0.000205846008611843
. O 0 0.00025329398340545595

These O 0 3.7801404687343165e-05
data O 0 6.598112668143585e-05
support O 0 0.00039630307583138347
multistep O 0 0.031082740053534508
models O 0 0.000450814695795998
of O 0 4.746452395920642e-05
triplet O 1 0.8932533264160156
repeat O 0 0.014768468216061592
expansion O 0 0.0014807019615545869
that O 0 2.767849036899861e-05
have O 0 1.619952126930002e-05
been O 0 3.658946661744267e-05
proposed O 0 0.00014272905536927283
for O 0 7.981079397723079e-05
both O 0 0.0010119477519765496
DM B-Disease 1 1.0
and O 0 0.0013402118347585201
Friedreichs B-Disease 1 0.9994779229164124
ataxia I-Disease 1 0.9999481439590454
. O 0 0.0004229773476254195
. O 0 0.0003373201470822096

The O 0 0.0001815890718717128
molecular O 0 0.0006585590308532119
basis O 0 9.914969996316358e-05
of O 0 0.00028313195798546076
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.00024886283790692687
the O 0 0.00019444775534793735
western O 0 0.0016540343640372157
Cape O 0 0.022199012339115143
, O 0 0.00026860955404117703
South O 0 0.0015916615957394242
Africa O 0 0.0018282457021996379
. O 0 0.000258769141510129

Deficiency B-Disease 1 0.9999973773956299
of I-Disease 0 2.7035041057388298e-05
the I-Disease 0 0.00013451065751723945
sixth I-Disease 0 0.002303789835423231
component I-Disease 0 0.0009980405448004603
of I-Disease 0 8.536439963791054e-06
human I-Disease 0 0.0007332841050811112
complement I-Disease 0 0.006222642492502928
( O 0 0.0025976889301091433
C6 O 1 0.999976634979248
) O 0 0.000549117976333946
has O 0 0.0005562723381444812
been O 0 0.00033038039691746235
reported O 0 0.0010313610546290874
in O 0 3.713383193826303e-05
a O 0 8.101706043817103e-05
number O 0 5.546960437641246e-06
of O 0 7.156559149734676e-06
families O 0 0.0001108611177187413
from O 0 3.689975346787833e-05
the O 0 0.0001426085364073515
western O 0 0.0019341872539371252
Cape O 0 0.022598128765821457
, O 0 0.00034948455868288875
South O 0 0.0015741669340059161
Africa O 0 0.001569933257997036
. O 0 0.0002565410395618528

Meningococcal B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999998807907104
is O 0 0.0019473788561299443
endemic O 0 0.020271766930818558
in O 0 0.00015949209046084434
the O 0 0.000402071833377704
Cape O 0 0.015194998122751713
and O 0 6.22603838564828e-05
almost O 0 0.00010258627298753709
all O 0 9.75480543274898e-06
pedigrees O 0 0.0010980635415762663
of O 0 1.2693142707576044e-05
total O 0 0.0015714323380962014
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.005242443643510342
C6Q0 O 1 0.9995651841163635
) O 0 0.00019439509196672589
have O 0 2.1117113647051156e-05
been O 0 9.202319051837549e-05
ascertained O 0 0.004488248378038406
because O 0 9.503235924057662e-05
of O 0 5.476875230669975e-05
recurrent O 1 0.9999996423721313
disease O 1 1.0
. O 0 0.0010176319628953934

We O 0 0.0004741014272440225
have O 0 4.6122160711092874e-05
sequenced O 0 0.0005470759933814406
the O 0 3.0303797757369466e-05
expressed O 0 0.00013835100980941206
exons O 0 0.0008515979861840606
of O 0 1.1722121598722879e-05
the O 0 0.0006547908415086567
C6 O 1 0.9999743700027466
gene O 0 0.0016467840177938342
from O 0 5.6323955504922196e-05
selected O 0 0.0003203734231647104
cases O 0 0.0006443315651267767
and O 0 4.602505941875279e-05
have O 0 2.8053129426552914e-05
found O 0 5.86138412472792e-05
three O 0 4.135996277909726e-05
molecular O 0 0.014630152843892574
defects O 1 0.9999161958694458
leading O 0 0.0008486114093102515
to O 0 8.128489571390674e-05
total O 0 0.0008369750576093793
deficiency O 1 1.0
879delG O 1 0.9867923259735107
, O 0 0.00020364683587104082
which O 0 3.1268398743122816e-05
is O 0 0.00011294450087007135
the O 0 0.0001526534470031038
common O 0 0.005457351449877024
defect O 1 0.9989560842514038
in O 0 0.0002072058996418491
the O 0 0.0003236233606003225
Cape O 0 0.018420761451125145
and O 0 0.00018436164828017354
hitherto O 0 0.016512611880898476
unreported O 0 0.012612816877663136
, O 0 0.0002477456000633538
and O 0 0.0002845374692697078
1195delC O 1 0.9159839153289795
and O 0 0.0004907291731797159
1936delG O 1 0.6446062326431274
, O 0 0.00016390108794439584
which O 0 2.698849311855156e-05
have O 0 2.813773971865885e-05
been O 0 0.00013316606055013835
previously O 0 0.0005368463462218642
reported O 0 0.0009275254560634494
in O 0 0.00013340194709599018
African O 0 0.002000741893425584
- O 0 0.006220569834113121
Americans O 0 0.000822296948172152
. O 0 0.00029104025452397764

We O 0 0.0006819316768087447
also O 0 0.00010885309893637896
show O 0 0.00012981478357687593
that O 0 1.8278948118677363e-05
the O 0 0.00011958443792536855
879delG O 1 0.5254238843917847
and O 0 0.0006102752522565424
1195delC O 1 0.9978576302528381
defects O 1 0.9996776580810547
are O 0 1.7715625290293247e-05
associated O 0 0.00010876935994019732
with O 0 8.196018461603671e-05
characteristic O 1 0.9912840127944946
C6 O 1 0.9999998807907104
/ O 1 0.9992989301681519
C7 O 1 0.9998313188552856
region O 0 0.005669104401022196
DNA O 0 0.0025275335647165775
marker O 0 0.016038022935390472
haplotypes O 0 0.012842953205108643
, O 0 0.00014932591875549406
although O 0 9.561721526551992e-05
small O 0 4.436124800122343e-05
variations O 0 8.69841969688423e-05
were O 0 2.2168671421241015e-05
observed O 0 0.0006152716232463717
. O 0 0.00029197821277193725

The O 0 0.002019886625930667
1936delG O 1 0.9923743605613708
defect O 1 0.9982542395591736
was O 0 0.0010053853038698435
observed O 0 0.00021159341849852353
only O 0 3.915118213626556e-05
once O 0 0.0005250375252217054
in O 0 6.574107828782871e-05
the O 0 0.00028714415384456515
Cape O 0 0.022419989109039307
, O 0 0.00014209951041266322
but O 0 5.561611760640517e-05
its O 0 0.00011745348456315696
associated O 0 0.0006910282536409795
haplotype O 0 0.03456971049308777
could O 0 0.00012286013225093484
be O 0 3.145664231851697e-05
deduced O 0 0.0018253225134685636
. O 0 0.0001851912820711732

The O 0 0.0002024216519203037
data O 0 7.805212953826413e-05
from O 0 4.1854385926853865e-05
the O 0 0.00016064365627244115
haplotypes O 0 0.011784431524574757
indicate O 0 0.0004216303932480514
that O 0 9.836039680521935e-06
these O 0 4.125342002225807e-06
three O 0 7.585939601995051e-05
molecular O 0 0.02377321571111679
defects O 1 0.9994440674781799
account O 0 0.00016124754620250314
for O 0 0.00018854576046578586
the O 0 0.0007628137827850878
defects O 1 0.9998419284820557
in O 0 8.478079689666629e-05
all O 0 1.825302570068743e-05
the O 0 0.00022230589820537716
38 O 0 0.0042050923220813274
unrelated O 0 0.02119433507323265
C6Q0 O 1 0.9981897473335266
individuals O 0 0.0002545067691244185
we O 0 0.00012249936116859317
have O 0 3.039270632143598e-05
studied O 0 0.0002879759413190186
from O 0 3.384153023944236e-05
the O 0 0.00027292556478641927
Cape O 0 0.027106424793601036
. O 0 0.0003639835340436548

We O 0 0.00043777943938039243
have O 0 3.497516081552021e-05
also O 0 4.3284766434226185e-05
observed O 0 0.0001317635178565979
the O 0 0.00015922312741167843
879delG O 1 0.9523312449455261
defect O 1 0.964677631855011
in O 0 4.427714156918228e-05
two O 0 4.526696284301579e-05
Dutch O 0 0.01600659266114235
C6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9983421564102173
deficient I-Disease 1 0.9999979734420776
kindreds O 1 0.5890741348266602
, O 0 0.00019134463218506426
but O 0 9.535132994642481e-05
the O 0 0.0002970607310999185
879delG O 1 0.9859356880187988
defect O 1 0.9924682974815369
in O 0 0.00013963872333988547
the O 0 0.0003873509122058749
Cape O 0 0.03163772076368332
probably O 0 0.0025363750755786896
did O 0 0.000320463499519974
not O 0 3.4404183679725975e-05
come O 0 4.0589849959360436e-05
from O 0 1.693465128482785e-05
The O 0 0.00015707909187767655
Netherlands O 0 0.0015657165786251426
. O 0 0.00012120450992370024
. O 0 0.00022441678447648883

Complement B-Disease 1 0.9826799631118774
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.000491109152790159
seven O 0 9.964750643121079e-05
further O 0 0.0003483550972305238
molecular O 0 0.0462559349834919
defects O 1 0.9999567270278931
and O 0 7.018938777036965e-05
their O 0 4.0513594285584986e-05
associated O 0 0.0004847042146138847
marker O 0 0.016609035432338715
haplotypes O 0 0.015454603359103203
. O 0 0.00035842572106048465

Seven O 0 0.0002453428169246763
further O 0 7.395202555926517e-05
molecular O 0 0.0004637004167307168
bases O 0 0.00023827962286304682
of O 0 0.00023570864868815988
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.00014310026017483324
described O 0 0.00362811959348619
. O 0 0.00040796821122057736

All O 0 3.9850230677984655e-05
these O 0 1.4328278666653205e-05
new O 0 0.00039399039815180004
molecular O 0 0.02600407414138317
defects O 1 0.9994792342185974
involve O 0 0.0016766979824751616
single O 0 0.00043711226317100227
- O 0 0.0014454438351094723
nucleotide O 0 0.00011297703895252198
events O 0 0.00016401427274104208
, O 0 0.00020239944569766521
deletions O 0 0.0022758133709430695
and O 0 9.41612379392609e-05
substitutions O 0 0.0008101676357910037
, O 0 4.856781743001193e-05
some O 0 6.100664450059412e-06
of O 0 8.627186616649851e-06
which O 0 9.968390804715455e-05
alter O 0 0.01719336397945881
splice O 0 0.02103135734796524
sites O 0 0.0004294535901863128
, O 0 0.0001213121649925597
and O 0 9.683521784609184e-05
others O 0 0.0005050902836956084
codons O 0 0.005752899684011936
. O 0 0.0003648739366326481

They O 0 7.934394670883194e-05
are O 0 5.431203135231044e-06
distributed O 0 6.187228427734226e-05
along O 0 0.00011221815657336265
the O 0 0.0004694552917499095
C7 O 1 0.9999452829360962
gene O 0 0.003284148871898651
, O 0 0.00012698878708761185
but O 0 6.173719884827733e-05
predominantly O 0 0.0001056723267538473
towards O 0 0.00022814683325123042
the O 0 0.00016100909851957113
3 O 0 0.0008707834058441222
end O 0 0.00198390893638134
. O 0 0.00035058092908002436

All O 0 6.292333273449913e-05
were O 0 2.0718536688946187e-05
found O 0 9.381887502968311e-05
in O 0 9.00461818673648e-05
compound O 0 0.011440477333962917
heterozygous O 0 0.002856637118384242
individuals O 0 0.00022773322416469455
. O 0 0.00036275185993872583

The O 0 0.0041130357421934605
C6 O 1 0.999995231628418
/ O 1 0.9981877207756042
C7 O 1 0.9998782873153687
marker O 0 0.030176369473338127
haplotypes O 0 0.01098140049725771
associated O 0 0.00017599257989786565
with O 0 5.0203962018713355e-05
most O 0 0.0012509670341387391
C7 B-Disease 1 0.9999982118606567
defects I-Disease 1 0.9999161958694458
are O 0 5.996764593874104e-05
tabulated O 0 0.0018935645930469036
. O 0 0.00013631914043799043
. O 0 0.0002394602634012699

A O 0 0.007237338926643133
genome O 0 0.006283235270529985
- O 0 0.0023219173308461905
wide O 0 0.00031772375223226845
search O 0 0.00020325559307821095
for O 0 0.00013727921759709716
chromosomal O 0 0.01957961544394493
loci O 0 0.015894422307610512
linked O 0 0.009227513335645199
to O 0 0.000607985770329833
mental O 1 0.9999997615814209
health O 1 0.9999942779541016
wellness O 1 0.9999644756317139
in O 0 0.00021102523896843195
relatives O 0 0.0005540472338907421
at O 0 0.0004712974769063294
high O 0 0.0038324925117194653
risk O 1 0.9135961532592773
for O 0 0.003344302298501134
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
among O 0 0.00020058563677594066
the O 0 0.00021036471298430115
Old O 0 0.00278603401966393
Order O 0 0.0002980610297527164
Amish O 0 0.013627423904836178
. O 0 0.00034342307480983436

Bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
( O 0 0.008446936495602131
BPAD B-Disease 1 0.9999994039535522
; O 0 0.003280696226283908
manic B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999791383743286
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999997615814209
) O 0 0.0004563178226817399
is O 0 0.000211937673157081
characterized O 0 0.005428819451481104
by O 0 3.0427740057348274e-05
episodes O 0 0.0004242040740791708
of O 0 6.954963464522734e-05
mania B-Disease 1 0.999988317489624
and O 0 0.0012777195079252124
/ O 1 0.9914449453353882
or O 0 0.0026881424710154533
hypomania B-Disease 1 0.9999421834945679
interspersed O 0 0.0026201133150607347
with O 0 4.439053373062052e-05
periods O 0 0.000720767246093601
of O 0 0.00010172340262215585
depression B-Disease 1 0.9999983310699463
. O 0 0.0008226202335208654

Compelling O 0 0.006733405869454145
evidence O 0 0.00041502920794300735
supports O 0 0.00180965440813452
a O 0 0.00015792070189490914
significant O 0 0.0002866670838557184
genetic O 0 0.000805246876552701
component O 0 0.0028901880141347647
in O 0 5.9998077631462365e-05
the O 0 0.00015549497038591653
susceptibility O 0 0.15155255794525146
to O 0 0.000253401231020689
develop O 1 0.9921432733535767
BPAD B-Disease 1 0.9999802112579346
. O 0 0.0007719730492681265

To O 0 0.00036449587787501514
date O 0 0.00035467787529341877
, O 0 0.00013268642942421138
however O 0 0.00021217566973064095
, O 0 0.00020312964625190943
linkage O 0 0.020130828022956848
studies O 0 0.000516486179549247
have O 0 3.1241394026437774e-05
attempted O 0 0.00034480172325856984
only O 0 1.0243828910461161e-05
to O 0 3.796013697865419e-05
identify O 0 0.0015429938212037086
chromosomal O 0 0.02440982311964035
loci O 0 0.009179288521409035
that O 0 0.0001284783793380484
cause O 0 0.010838132351636887
or O 0 0.00017447429127059877
increase O 0 0.00014144655142445117
the O 0 0.00012341811088845134
risk O 0 0.01149293314665556
of O 0 4.3901683966396376e-05
developing O 0 0.4537253677845001
BPAD B-Disease 1 0.999982476234436
. O 0 0.0009271419839933515

To O 0 0.00018926410120911896
determine O 0 0.0003922574978787452
whether O 0 0.0001740359584800899
there O 0 3.659833237179555e-05
could O 0 0.00011054432980017737
be O 0 0.00010572273458819836
protective O 1 0.9825339913368225
alleles O 0 0.00230618380010128
that O 0 7.796555291861296e-05
prevent O 0 0.0038336357101798058
or O 0 0.0002547787153162062
reduce O 0 0.003700217930600047
the O 0 0.00019880724721588194
risk O 0 0.015626490116119385
of O 0 5.174055331735872e-05
developing O 1 0.944499671459198
BPAD B-Disease 1 0.9999943971633911
, O 0 0.0002973656228277832
similar O 0 9.818558464758098e-05
to O 0 3.450081203482114e-05
what O 0 9.980975301004946e-05
is O 0 6.739272794220597e-05
observed O 0 0.0001371428807033226
in O 0 4.6914832637412474e-05
other O 0 0.00016972844605334103
genetic B-Disease 1 0.9999592304229736
disorders I-Disease 1 1.0
, O 0 0.0003455953556112945
we O 0 0.00018194089352618903
used O 0 0.0012267808197066188
mental O 1 0.9999998807907104
health O 1 0.9999923706054688
wellness O 1 0.9999825954437256
( O 0 0.0004009193798992783
absence O 0 0.0009444142924621701
of O 0 1.7370264686178416e-05
any O 0 0.001651217695325613
psychiatric B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
) O 0 0.00034083283389918506
as O 0 0.00012822038843296468
the O 0 0.00019313546363264322
phenotype O 0 0.024634813889861107
in O 0 6.940227467566729e-05
our O 0 0.0003585290687624365
genome O 0 0.004915979690849781
- O 0 0.003739173524081707
wide O 0 0.001309752929955721
linkage O 0 0.03758177533745766
scan O 0 0.02800017036497593
of O 0 6.038923856976908e-06
several O 0 2.5549503334332258e-05
large O 0 0.00034641323145478964
multigeneration O 1 0.980432391166687
Old O 0 0.003113982267677784
Order O 0 0.0002356603363296017
Amish O 0 0.011001336388289928
pedigrees O 0 0.01018314529210329
exhibiting O 0 0.010073002427816391
an O 0 0.00024201211635954678
extremely O 0 0.019572222605347633
high O 0 0.00992185901850462
incidence O 1 0.9976556301116943
of O 0 0.0002353062736801803
BPAD B-Disease 1 0.9999871253967285
. O 0 0.0011234873672947288

We O 0 0.0006043599569238722
have O 0 4.7736608394188806e-05
found O 0 5.184338442631997e-05
strong O 0 6.851820216979831e-05
evidence O 0 9.06098575796932e-05
for O 0 4.153676491114311e-05
a O 0 0.0002577536506578326
locus O 0 0.00912550836801529
on O 0 0.0004489277198445052
chromosome O 0 0.005361838266253471
4p O 1 0.9819477796554565
at O 0 0.001974480925127864
D4S2949 O 0 0.035772375762462616
( O 0 0.0003035684349015355
maximum O 0 0.0010270839557051659
GENEHUNTER O 1 0.9956833124160767
- O 0 0.005073774605989456
PLUS O 0 0.00378610473126173
nonparametric O 0 0.021597011014819145
linkage O 0 0.008352666161954403
score O 0 0.00029973118216730654
= O 0 0.0025309366174042225
4 O 0 0.0005720877670682967
. O 0 0.00015745848941151053
05 O 0 0.44968438148498535
, O 0 0.0007289153872989118
P O 0 0.11019625514745712
= O 0 0.004138858988881111
5 O 0 0.00039689629920758307
. O 0 5.516934106708504e-05
22 O 0 0.0007465684320777655
x O 0 0.0021481988951563835
10 O 0 0.00045623848563991487
( O 0 0.0005078943213447928
- O 0 0.0037287806626409292
4 O 0 0.0008983603911474347
) O 0 0.00016057184257078916
; O 0 0.00018321818788535893
SIBPAL O 1 0.9850644469261169
Pempirical O 0 0.06152770295739174
value O 0 0.00036612749681808054
< O 0 0.020696628838777542
3 O 0 0.000767543853726238
x O 0 0.0017129994230344892
10 O 0 0.0004366986686363816
( O 0 0.0005166555638425052
- O 0 0.004188464488834143
5 O 0 0.0007524552056565881
) O 0 0.000156265203258954
) O 0 0.00010763647151179612
and O 0 0.00011036948126275092
suggestive O 0 0.020271839573979378
evidence O 0 0.00016343196330126375
for O 0 5.310241976985708e-05
a O 0 0.0002739302290137857
locus O 0 0.008726938627660275
on O 0 0.0004555203777272254
chromosome O 0 0.011407245881855488
4q O 1 0.9990909099578857
at O 0 0.0020968622993677855
D4S397 O 0 0.03709980100393295
( O 0 0.00026526922010816634
maximum O 0 0.0010938862105831504
GENEHUNTER O 1 0.9960668683052063
- O 0 0.00566707830876112
PLUS O 0 0.004830054007470608
nonparametric O 0 0.023237476125359535
linkage O 0 0.010172860696911812
score O 0 0.00033097778214141726
= O 0 0.0026136531960219145
3 O 0 0.00046098671737127006
. O 0 8.396097109653056e-05
29 O 0 0.0019001684850081801
, O 0 0.00039770317380316556
P O 0 0.10072919726371765
= O 0 0.0038910021539777517
2 O 0 0.0004541725793387741
. O 0 6.197408947627991e-05
57 O 0 0.002466518199071288
x O 0 0.0023533727508038282
10 O 0 0.0004172690096311271
( O 0 0.0005022457335144281
- O 0 0.0034681730903685093
3 O 0 0.000678092532325536
) O 0 0.00016218259406741709
; O 0 0.0002351196890231222
SIBPAL O 1 0.9696221947669983
Pempirical O 0 0.06429581344127655
value O 0 0.0003123030182905495
< O 0 0.017619306221604347
1 O 0 0.0009787760209292173
x O 0 0.0018977978033944964
10 O 0 0.0003977740998379886
( O 0 0.0005794120952486992
- O 0 0.003992447163909674
3 O 0 0.0007735674153082073
) O 0 0.00011361921497154981
) O 0 4.153878762735985e-05
that O 0 1.2537574548332486e-05
are O 0 1.3079147720418405e-05
linked O 0 0.0036640288308262825
to O 0 0.00034981704084202647
mental O 1 0.9999998807907104
health O 1 0.9999843835830688
wellness O 1 0.9999662637710571
. O 0 0.0008018979569897056

These O 0 0.00016482308274134994
findings O 0 0.0017286802176386118
are O 0 1.4462953913607635e-05
consistent O 0 0.0013213437050580978
with O 0 2.1804929929203354e-05
the O 0 9.553281415719539e-05
hypothesis O 0 0.001311953878030181
that O 0 1.924474236147944e-05
certain O 0 9.540154132992029e-05
alleles O 0 0.0025698484387248755
could O 0 0.0004218273679725826
prevent O 0 0.003656961489468813
or O 0 0.0003588135587051511
modify O 0 0.006879970896989107
the O 0 0.0003878331044688821
clinical O 1 0.9999527931213379
manifestations O 0 0.3546595573425293
of O 0 0.00012696503836195916
BPAD B-Disease 1 0.9999979734420776
and O 0 0.0001146796130342409
perhaps O 0 0.000471541250590235
other O 0 3.78719087166246e-05
related O 0 0.04195060208439827
affective B-Disease 1 0.9999996423721313
disorders I-Disease 1 1.0
. O 0 0.0017190128564834595

Segregation O 0 0.061368126422166824
distortion O 0 0.02885419875383377
in O 0 0.0028057468589395285
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0029364994261413813

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 0.4948439598083496
DM B-Disease 1 1.0
) O 0 0.00036699758493341506
is O 0 0.00010867635864997283
an O 0 0.00032732076942920685
autosomal B-Disease 1 0.9999017715454102
dominant I-Disease 1 0.9996368885040283
disease I-Disease 1 1.0
which O 0 0.00017666089115664363
, O 0 9.876036347122863e-05
in O 0 5.613023313344456e-05
the O 0 0.0001502773811807856
typical O 0 0.005788350012153387
pedigree O 0 0.05942390114068985
, O 0 0.0001608134771231562
shows O 0 8.590499055571854e-05
a O 0 0.00014160254795569927
three O 0 5.128928387421183e-05
generation O 0 0.0021824652794748545
anticipation O 0 0.006688078865408897
cascade O 0 0.13109739124774933
. O 0 0.0005752163706347346

This O 0 7.757500861771405e-05
results O 0 0.00034130134736187756
in O 0 0.00033352410537190735
infertility B-Disease 1 0.9999994039535522
and O 0 0.11396157741546631
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.03623104467988014
CDM B-Disease 1 0.9999083280563354
) O 0 0.00015566231741104275
with O 0 2.1437301256810315e-05
the O 0 0.00015230884309858084
disappearance O 0 0.005875044036656618
of O 0 0.00022117519984021783
DM B-Disease 1 0.9999998807907104
in O 0 0.00028103665681555867
that O 0 0.0001040558418026194
pedigree O 0 0.022524455562233925
. O 0 0.0003962454793509096

The O 0 0.00018800218822434545
concept O 0 0.00032565524452365935
of O 0 4.5847249566577375e-05
segregation O 0 0.11092684417963028
distortion O 0 0.041581891477108
, O 0 0.0003317682130727917
where O 0 0.00014491943875327706
there O 0 5.1694387366296723e-05
is O 0 0.00023236911511048675
preferential O 0 0.006211694795638323
transmission O 0 0.002284558955579996
of O 0 6.645930170634529e-06
the O 0 6.416271207854152e-05
larger O 0 0.0002621333405841142
allele O 0 0.003250116016715765
at O 0 0.0010079988278448582
the O 0 0.0017706983489915729
DM B-Disease 1 0.9999997615814209
locus O 0 0.04115809500217438
, O 0 0.00037816501571796834
has O 0 0.0003253291069995612
been O 0 0.00011584706953726709
put O 0 0.0002105160237988457
forward O 0 0.00016860675532370806
to O 0 3.140961052849889e-05
explain O 0 0.0016308577032759786
partially O 0 0.005672217812389135
the O 0 0.0001941605587489903
maintenance O 1 0.9906402826309204
of O 0 0.00036384232225827873
DM B-Disease 1 1.0
in O 0 0.00017515936633571982
the O 0 7.20557727618143e-05
population O 0 6.347199814626947e-05
. O 0 0.00033046951284632087

In O 0 0.0002430026652291417
a O 0 0.0002786160621326417
survey O 0 0.0009405852761119604
of O 0 0.00022291079221758991
DM B-Disease 1 0.9999995231628418
in O 0 0.0005043859127908945
Northern O 0 0.00227767089381814
Ireland O 0 0.0014258484588935971
, O 0 0.000259718275628984
59 O 0 0.005871625151485205
pedigrees O 0 0.006786498706787825
were O 0 8.792807784629986e-05
ascertained O 0 0.016857584938406944
. O 0 0.0002696850278880447

Sibships O 1 0.8147836923599243
where O 0 0.00031712668715044856
the O 0 9.36498399823904e-05
status O 0 0.0004411635163705796
of O 0 5.438298558146926e-06
all O 0 1.2027001503156498e-05
the O 0 9.275026968680322e-05
members O 0 0.00013054479495622218
had O 0 0.0005102462600916624
been O 0 0.00026108199381269515
identified O 0 0.00036388859734870493
were O 0 2.831515303114429e-05
examined O 0 0.004546795506030321
to O 0 2.488256177457515e-05
determine O 0 0.00012123249325668439
the O 0 4.6317061787704006e-05
transmission O 0 0.0015929684741422534
of O 0 1.9486897144815885e-05
the O 0 0.0019376403652131557
DM B-Disease 1 1.0
expansion O 0 0.007016345392912626
from O 0 0.00021445564925670624
affected O 0 0.0038132942281663418
parents O 0 0.0002771768777165562
to O 0 2.6063122277264483e-05
their O 0 2.7386495276005007e-05
offspring O 0 0.0017168482299894094
. O 0 0.0003232040908187628

Where O 0 0.00031816266709938645
the O 0 0.00015936227282509208
transmitting O 0 0.062434595078229904
parent O 0 0.02721473015844822
was O 0 0.0018293512985110283
male O 0 0.0012098259758204222
, O 0 0.00025594368344172835
58 O 0 0.00617255037650466
. O 0 0.0003627394326031208

3 O 0 0.0010133389150723815
% O 0 1.89562688319711e-05
of O 0 6.245992153708357e-06
the O 0 0.00019210435857530683
offspring O 0 0.001589408959262073
were O 0 7.376242137979716e-05
affected O 0 0.004599431529641151
, O 0 0.00014971016207709908
and O 0 6.542688061017543e-05
in O 0 6.362361455103382e-05
the O 0 8.07704491307959e-05
case O 0 0.0003027360653504729
of O 0 6.111874427006114e-06
a O 0 0.000540074659511447
female O 0 0.002874126425012946
transmitting O 0 0.3902772068977356
parent O 0 0.024007517844438553
, O 0 0.0005303924554027617
68 O 0 0.006701942533254623
. O 0 0.0002998418058268726

7 O 0 0.0016691659111529589
% O 0 4.0590311982668936e-05
were O 0 3.653466046671383e-05
affected O 0 0.0037455435376614332
. O 0 0.0003702981339301914

Studies O 0 0.0011792711447924376
on O 0 0.0002599551226012409
meiotic O 1 0.9500356912612915
drive O 0 0.00460858317092061
in O 0 0.0016482460778206587
DM B-Disease 1 0.9999998807907104
have O 0 0.00019240427354816347
shown O 0 0.0003877009730786085
increased O 0 0.00031101141939871013
transmission O 0 0.0014860801165923476
of O 0 5.270850124361459e-06
the O 0 3.723148620338179e-05
larger O 0 0.00022804352920502424
allele O 0 0.002908257069066167
at O 0 0.0007364836055785418
the O 0 0.0009693362517282367
DM B-Disease 1 0.9999988079071045
locus O 0 0.012966455891728401
in O 0 0.0002671660331543535
non O 0 0.010176523588597775
- O 1 0.9678319692611694
DM O 1 0.9999996423721313
heterozygotes O 1 0.863470733165741
for O 0 0.0005663710180670023
CTGn O 1 0.9791494011878967
. O 0 0.0006077670841477811

This O 0 0.00013596811913885176
study O 0 0.0005031365435570478
provides O 0 0.0006655608303844929
further O 0 8.332669676747173e-05
evidence O 0 0.00010480879427632317
that O 0 3.6513552913675085e-05
the O 0 0.0009083693730644882
DM B-Disease 1 1.0
expansion O 0 0.006277682259678841
tends O 0 0.003116434905678034
to O 0 4.592685218085535e-05
be O 0 7.602696132380515e-05
transmitted O 0 0.0028870785608887672
preferentially O 0 0.0061202142387628555
. O 0 0.00027825238066725433

Diagnosis O 1 0.9999984502792358
of O 0 0.000652681163046509
hemochromatosis B-Disease 1 1.0
. O 0 0.0020905728451907635

If O 0 0.008166362531483173
untreated O 1 0.9999910593032837
, O 0 0.002691440051421523
hemochromatosis B-Disease 1 1.0
can O 0 0.0014016485074535012
cause O 1 0.9977654218673706
serious O 1 0.9999754428863525
illness O 1 0.9999996423721313
and O 0 0.0002538152039051056
early B-Disease 0 0.0008919740212149918
death I-Disease 0 0.0014287573285400867
, O 0 7.441196794388816e-05
but O 0 0.00010083623783430085
the O 0 0.0005494770593941212
disease O 1 0.9999996423721313
is O 0 0.0003209665010217577
still O 0 0.00043142764479853213
substantially O 0 0.008432148024439812
under O 0 0.0018029551720246673
- O 1 0.9993069171905518
diagnosed O 1 0.9999998807907104
. O 0 0.0004801008617505431

The O 0 0.00045826396672055125
cornerstone O 0 0.043240711092948914
of O 0 3.139628461212851e-05
screening O 0 0.008203468285501003
and O 0 0.000155124012962915
case O 0 0.0014955818187445402
detection O 0 0.004437393508851528
is O 0 5.633733235299587e-05
the O 0 2.644127562234644e-05
measurement O 0 0.00084243796300143
of O 0 4.878012623521499e-05
serum O 1 0.994569718837738
transferrin O 1 0.9315295219421387
saturation O 0 0.025176476687192917
and O 0 7.265763997565955e-05
the O 0 0.00022558898490387946
serum O 1 0.995010495185852
ferritin O 1 0.9819871783256531
level O 0 0.004884246736764908
. O 0 0.0003207899571862072

Once O 0 0.004301213193684816
the O 0 0.0008926874143071473
diagnosis O 1 0.9999982118606567
is O 0 0.0010805008932948112
suspected O 0 0.007651787716895342
, O 0 0.00031950711854733527
physicians O 1 0.8191867470741272
must O 0 0.00010049583943327889
use O 0 0.00014656397979706526
serum O 1 0.9950771927833557
ferritin O 1 0.9930029511451721
levels O 0 0.0032134512439370155
and O 0 0.0003599480842240155
hepatic O 1 0.9999995231628418
iron O 1 0.9986903071403503
stores O 0 0.001106170704588294
on O 0 0.0017085291910916567
liver O 1 0.9999998807907104
biopsy O 1 0.9999927282333374
specimens O 0 0.0035346513614058495
to O 0 0.00022696763335261494
assess O 1 0.8339633345603943
patients O 1 0.9998272061347961
for O 0 3.2782078051241115e-05
the O 0 3.019115683855489e-05
presence O 0 0.00014877518697176129
of O 0 3.39902144332882e-05
iron B-Disease 1 0.9998443126678467
overload I-Disease 1 0.9997941851615906
. O 0 0.0007289317436516285

Liver O 1 0.9999998807907104
biopsy O 1 0.999990701675415
is O 0 0.0006904664332978427
also O 0 8.055230864556506e-05
used O 0 4.9122209020424634e-05
to O 0 2.60831893683644e-05
establish O 0 0.0003610814455896616
the O 0 4.619363971869461e-05
presence O 0 0.0004203481075819582
or O 0 0.00022728419571649283
absence O 0 0.002298454288393259
of O 0 0.00010289880447089672
cirrhosis B-Disease 1 0.9999998807907104
, O 0 0.00022785464534536004
which O 0 3.60831108991988e-05
can O 0 0.00015772867482155561
affect O 0 0.013111241161823273
prognosis O 1 0.9999995231628418
and O 0 0.0005840756930410862
management O 1 0.9883695840835571
. O 0 0.0005918267415836453

A O 0 0.005461411084979773
DNA O 0 0.0018980760360136628
- O 0 0.001333374995738268
based O 0 4.9299171223537996e-05
test O 0 0.0004384267667774111
for O 0 6.759018287993968e-05
the O 0 0.0003945690405089408
HFE O 1 0.9995335340499878
gene O 0 0.001998667139559984
is O 0 0.0001808955566957593
commercially O 0 0.0013165277196094394
available O 0 0.00015102651377674192
, O 0 5.6547469284851104e-05
but O 0 3.451973316259682e-05
its O 0 2.990041502926033e-05
place O 0 5.640270683215931e-05
in O 0 4.407308006193489e-05
the O 0 0.0004634591459762305
diagnosis O 1 0.9999995231628418
of O 0 0.00035720228333957493
hemochromatosis B-Disease 1 1.0
is O 0 0.0011308365501463413
still O 0 0.0004903901717625558
being O 0 0.0004187283921055496
evaluated O 0 0.014318524859845638
. O 0 0.00023310785763897002

Currently O 0 0.0019512362778186798
, O 0 7.903261575847864e-05
the O 0 4.108177017769776e-05
most O 0 5.207149661146104e-05
useful O 0 0.0008709228131920099
role O 0 0.0007471039425581694
for O 0 7.194357021944597e-05
this O 0 3.7407546187750995e-05
test O 0 0.0008340738713741302
is O 0 5.831506132381037e-05
in O 0 2.532636972318869e-05
the O 0 6.426644540624693e-05
detection O 0 0.007072251755744219
of O 0 0.00019878678722307086
hemochromatosis B-Disease 1 1.0
in O 0 0.0004022880457341671
the O 0 0.0001861566852312535
family O 0 0.00033308184356428683
members O 0 6.444411701522768e-05
of O 0 8.820832590572536e-05
patients O 1 0.9999675750732422
with O 0 4.737236668006517e-05
a O 0 0.0005595138645730913
proven O 0 0.07408584654331207
case O 0 0.00040993953007273376
of O 0 1.3003531421418302e-05
the O 0 0.0011179832508787513
disease O 1 0.9999998807907104
. O 0 0.000679441902320832

It O 0 0.00014717696467414498
is O 0 6.158948963275179e-05
crucial O 0 0.001564468489959836
to O 0 0.0006790402112528682
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 0 0.43256399035453796
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.999836802482605
because O 0 0.004270591773092747
phlebotomy O 1 0.9999923706054688
therapy O 1 0.9999922513961792
can O 0 0.000483111449284479
avert O 1 0.9992795586585999
serious O 1 0.9999991655349731
chronic O 1 1.0
disease O 1 1.0
and O 0 0.00021281222871039063
can O 0 7.809881935827434e-05
even O 0 8.519914990756661e-05
lead O 0 0.00010002508497564122
to O 0 3.2253483368549496e-05
normal O 0 0.0015020701102912426
life O 0 0.0014435744378715754
expectancy O 1 0.749997615814209
. O 0 0.00015855378296691924
. O 0 0.00025304805603809655

Prevalence O 0 0.441071093082428
of O 0 2.4598029995104298e-05
the O 0 0.00048036090447567403
I1307K O 1 0.8509030342102051
APC B-Disease 1 0.9944120049476624
gene O 0 0.005022285971790552
variant O 0 0.012807098217308521
in O 0 0.00020619605493266135
Israeli O 0 0.001839359407313168
Jews O 0 0.00015832854842301458
of O 0 4.02006753574824e-06
differing O 0 7.085556717356667e-05
ethnic O 0 2.3760894691804424e-05
origin O 0 2.161239717679564e-05
and O 0 0.00012505720951594412
risk O 1 0.9996935129165649
for O 1 0.8241650462150574
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0009734065388329327

BACKGROUND O 0 0.05744701623916626
& O 1 0.6398090720176697
AIMS O 0 0.05337982997298241
Israeli O 0 0.0023386578541249037
Jews O 0 0.00014224470942281187
of O 0 8.88304475665791e-06
European O 0 0.0006483938777819276
birth O 0 0.0029753041453659534
, O 0 0.0003096891159657389
i O 0 0.0023342452477663755
. O 0 0.00010827233927557245
e O 0 0.0017295763827860355
. O 0 9.39726087381132e-05
, O 0 0.0002571888326201588
Ashkenazim O 0 0.08658261597156525
, O 0 6.608932744711637e-05
have O 0 1.5795885701663792e-05
the O 0 0.00022303793230094016
highest O 1 0.9999279975891113
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9992832541465759
of O 0 1.739707113301847e-05
any O 0 6.624220259254798e-05
Israeli O 0 0.0013073401059955359
ethnic O 0 9.006850450532511e-05
group O 0 0.0005898434319533408
. O 0 0.00042029263568110764

The O 0 0.0011630278313532472
I1307K O 0 0.15622302889823914
APC B-Disease 1 0.983612596988678
gene O 0 0.0038776425644755363
variant O 0 0.014162709936499596
was O 0 0.0010818666778504848
found O 0 0.0001753686083247885
in O 0 0.0001266383333131671
6 O 0 0.0017180870054289699
. O 0 0.00028282872517593205

1 O 0 0.001117824693210423
% O 0 2.4090362785500474e-05
of O 0 1.058903490047669e-05
American O 0 0.0005278027383610606
Jews O 0 0.0005852531758137047
, O 0 0.00014113722136244178
28 O 0 0.00031035003485158086
% O 0 4.238228484609863e-06
of O 0 5.201356088946341e-06
their O 0 0.000568305840715766
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.023482471704483032
, O 0 0.0001332499086856842
but O 0 5.7313431170769036e-05
not O 0 2.7735984986065887e-05
in O 0 5.716943269362673e-05
non O 0 0.002329933689907193
- O 0 0.0037848353385925293
Jews O 0 0.0005591987282969058
. O 0 0.0002520187117625028

We O 0 0.0006447505438700318
assessed O 0 0.005861479789018631
the O 0 0.0003230368020012975
I1307K O 1 0.76910400390625
prevalence O 1 0.9883352518081665
in O 0 0.0002220811293227598
Israeli O 0 0.002217785222455859
Jews O 0 0.00012184023216832429
of O 0 3.923454642063007e-06
differing O 0 9.567046799929813e-05
ethnic O 0 2.6218704078928567e-05
origin O 0 3.243008904973976e-05
and O 0 0.00012725933629553765
risk O 1 0.9992992877960205
for O 0 0.42283955216407776
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0009725666604936123

METHODS O 0 0.005068044178187847
DNA O 0 0.001352334744296968
samples O 0 0.000361768965376541
from O 0 9.080299059860408e-05
500 O 0 0.002156622475013137
unrelated O 0 0.002481373492628336
Jews O 0 0.00018159010505769402
of O 0 1.435993272025371e-05
European O 0 0.000745074765291065
or O 0 0.0007052328437566757
non O 0 0.004427224397659302
- O 0 0.003270589280873537
European O 0 0.0002557754050940275
origin O 0 4.6477940486511216e-05
, O 0 8.846465789247304e-05
with O 0 4.9818136176327243e-05
or O 0 0.00022896466543897986
without O 0 0.00012638152111321688
a O 0 0.00034965237136930227
personal O 0 0.0026656570844352245
and O 0 0.0014282300835475326
/ O 1 0.9788828492164612
or O 0 0.00032132319756783545
family O 0 0.00027807417791336775
history O 0 0.00034595231409184635
of O 0 0.00011652799730654806
neoplasia B-Disease 1 0.9999735355377197
, O 0 0.00040687626460567117
were O 0 4.610992982634343e-05
examined O 0 0.0042279805056750774
for O 0 6.607331306440756e-05
the O 0 0.00021632923744618893
I1307K O 0 0.051340989768505096
variant O 0 0.004739047028124332
by O 0 1.3403055163507815e-05
the O 0 0.00010469362314324826
allele O 0 0.004857638385146856
- O 0 0.0022457176819443703
specific O 0 0.0002739639603532851
oligonucleotide O 0 0.08362526446580887
( O 0 0.0029963068664073944
ASO O 1 0.999446451663971
) O 0 0.00030791619792580605
method O 0 0.00046919830492697656
. O 0 0.0003820875135716051

RESULTS O 0 0.0065762135200202465
In O 0 0.0001509546855231747
persons O 0 0.00045773183228448033
at O 0 0.0003768031019717455
average O 0 0.0016242485726252198
risk O 1 0.9808509349822998
for O 0 0.06623969972133636
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0006873492384329438
I1307K O 0 0.04179326072335243
was O 0 0.0006974542047828436
found O 0 0.00011606589396251366
in O 0 6.143704376881942e-05
5 O 0 0.0005474200006574392
. O 0 0.00020767706155311316

0 O 0 0.0014219784643501043
% O 0 1.6840760508785024e-05
of O 0 8.554890882805921e-06
120 O 0 0.0006068371585570276
European O 0 0.0004947392735630274
and O 0 0.00019433500710874796
1 O 0 0.0017259406158700585
. O 0 0.00033564146724529564

6 O 0 0.0013477458851411939
% O 0 1.6462892745039426e-05
of O 0 1.5133981833059806e-05
188 O 0 0.011228974908590317
non O 0 0.00362158240750432
- O 0 0.002948588225990534
European O 0 0.00047607006854377687
Jews O 0 0.0011054191272705793
( O 0 0.0012571795377880335
P O 0 0.17549534142017365
= O 0 0.004956122487783432
0 O 0 0.0009305030689574778
. O 0 0.00018335363711230457
08 O 0 0.0378650538623333
) O 0 0.0002522146387491375
. O 0 0.00021151575492694974

It O 0 0.0004762050521094352
occurred O 0 0.0010104686953127384
in O 0 0.00010159931116504595
15 O 0 0.0007665191660635173
. O 0 0.0002877766382880509

4 O 0 0.0008341541979461908
% O 0 1.9596174752223305e-05
of O 0 1.5222306501527783e-05
52 O 0 0.005743061192333698
Ashkenazi O 1 0.6119736433029175
Israelis O 0 0.004595892038196325
with O 0 0.0004220942500978708
familial O 1 0.9999992847442627
cancer B-Disease 1 1.0
( O 0 0.0028573190793395042
P O 1 0.9401469826698303
= O 0 0.0059240893460810184
0 O 0 0.0011922619305551052
. O 0 0.0002846376155503094
02 O 1 0.9937173128128052
) O 0 0.00017397689225617796
and O 0 5.147292904439382e-05
was O 0 0.0005483417771756649
not O 0 8.630404045106843e-05
detected O 0 0.0022641681134700775
in O 0 7.797728903824463e-05
51 O 0 0.002772023668512702
non O 0 0.002428749343380332
- O 0 0.0020605784375220537
European O 0 0.0002187403733842075
Jews O 0 0.0003096410073339939
at O 0 0.0009562064078636467
increased O 0 0.022983482107520103
cancer B-Disease 1 1.0
risk O 1 0.9751020669937134
. O 0 0.00041108866571448743

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.999996542930603
occurred O 0 0.01818588748574257
personally O 0 0.10654056817293167
or O 0 0.0002966045285575092
in O 0 5.4343807278200984e-05
the O 0 6.294757622526959e-05
families O 0 5.894753121538088e-05
of O 0 9.629325177229475e-06
13 O 0 0.00032067132997326553
of O 0 1.598499329702463e-05
20 O 0 0.0016492254799231887
Ashkenazi O 1 0.9437210559844971
I1307K O 0 0.3448604345321655
carriers O 0 0.014893919229507446
, O 0 0.00021849981567356735
8 O 0 0.0002518942637834698
of O 0 1.6729638446122408e-05
whom O 0 0.0013775081606581807
also O 0 0.00015731906751170754
had O 0 0.0002761507930699736
a O 0 0.0002309867850271985
personal O 0 0.001190394046716392
or O 0 0.000305018707877025
family O 0 0.00021551703684963286
history O 0 0.00016735804092604667
of O 0 6.986657535890117e-05
noncolonic O 1 0.9989141225814819
neoplasia B-Disease 1 0.9999736547470093
. O 0 0.0009393225773237646

CONCLUSIONS O 0 0.011976356618106365
The O 0 0.00102680129930377
I1307K O 1 0.8500330448150635
APC O 1 0.9969003200531006
variant O 0 0.02516782283782959
may O 0 0.0003754206991288811
represent O 0 5.057309681433253e-05
a O 0 0.0003464238252490759
susceptibility O 1 0.5081620812416077
gene O 0 0.0024160724133253098
for O 0 0.0015723019605502486
colorectal B-Disease 1 1.0
, I-Disease 0 0.0003990475961472839
or I-Disease 0 0.00020614807726815343
other I-Disease 0 5.391331069404259e-05
, I-Disease 0 0.000862618035171181
cancers I-Disease 1 0.9999963045120239
in O 0 0.0005134571110829711
Ashkenazi O 1 0.9810983538627625
Jews O 0 0.000988607294857502
, O 0 0.0001762128813425079
and O 0 0.00018483283929526806
partially O 0 0.016606690362095833
explains O 0 0.0011353360023349524
the O 0 4.935717515763827e-05
higher O 0 0.0011983064468950033
incidence O 1 0.99991774559021
of O 0 0.0016633911291137338
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.00018459824786987156
European O 0 0.0009644741076044738
Israelis O 0 0.008624120615422726
. O 0 0.0003414616803638637

Systematic O 0 0.003884214675053954
analysis O 0 0.00014661683235317469
of O 0 2.715257869567722e-05
coproporphyrinogen O 1 0.9941591024398804
oxidase O 0 0.3668094873428345
gene O 0 0.009202211163938046
defects O 1 0.9996784925460815
in O 0 0.0005769550334662199
hereditary B-Disease 1 0.9991503953933716
coproporphyria I-Disease 1 0.9964642524719238
and O 0 0.0003052214451599866
mutation O 0 0.003931089770048857
update O 0 0.014575330540537834
. O 0 0.0004060588835272938

Hereditary B-Disease 1 0.9988382458686829
coproporphyria I-Disease 1 0.9969800114631653
( O 0 0.00495087169110775
HC B-Disease 1 0.9999991655349731
) O 0 0.00041560185491107404
is O 0 0.00016955455066636205
an O 0 0.0011698071612045169
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 0.9999998807907104
with O 0 0.0010835283901542425
autosomal O 1 0.9990058541297913
dominant O 0 0.061011724174022675
inheritance O 0 0.019734136760234833
caused O 0 0.017819564789533615
by O 0 0.00013484958617482334
deficient B-Disease 1 0.9992607235908508
activity I-Disease 0 0.0001369912934023887
of I-Disease 0 2.585830407042522e-05
coproporphyrinogen I-Disease 1 0.9957719445228577
III I-Disease 1 0.9959685802459717
oxidase I-Disease 0 0.05456593632698059
( O 0 0.0011910166358575225
CPO O 0 0.10035860538482666
) O 0 0.00041105024865828454
. O 0 0.0002597445563878864

Clinical O 1 0.9998525381088257
manifestations O 0 0.04970952868461609
of O 0 3.027652928722091e-05
the O 0 0.0012186863459646702
disease O 1 0.9999998807907104
are O 0 3.602290962589905e-05
characterized O 0 0.06999167054891586
by O 0 0.00025985451065935194
acute O 1 0.9999994039535522
attacks O 0 0.0039358725771307945
of O 0 0.00036691452260129154
neurological B-Disease 1 1.0
dysfunction I-Disease 1 0.9999998807907104
often O 0 0.00162429956253618
precipitated O 1 0.975667417049408
by O 0 0.00011257119331276044
drugs O 0 0.018625544384121895
, O 0 0.000244905095314607
fasting O 0 0.014991873875260353
, O 0 0.00033709866693243384
cyclical O 1 0.9959861636161804
hormonal O 1 0.9890527129173279
changes O 0 0.0008823023526929319
, O 0 0.0004488948325160891
or O 0 0.005633242428302765
infectious B-Disease 1 0.9999998807907104
diseases I-Disease 1 0.9999997615814209
. O 0 0.0010725974570959806

Skin O 1 1.0
photosensitivity O 1 0.9999881982803345
may O 0 0.003174541052430868
also O 0 9.460594446863979e-05
be O 0 3.116262814728543e-05
present O 0 9.726323332870379e-05
. O 0 0.00022902098135091364

The O 0 0.0003681448579300195
seven O 0 0.00026237062411382794
exons O 0 0.0032963459379971027
, O 0 0.0001024603407131508
the O 0 0.0003107618249487132
exon O 0 0.16950275003910065
/ O 0 0.05240819230675697
intron O 0 0.10520488768815994
boundaries O 0 0.00018461706349626184
and O 0 5.1929080655099824e-05
part O 0 0.0002431087923469022
of O 0 1.7809028577175923e-05
3 O 0 0.0006657609483227134
noncoding O 0 0.00783800333738327
sequence O 0 2.3505386707256548e-05
of O 0 8.147194421326276e-06
the O 0 0.00042031711200252175
CPO O 0 0.11155491322278976
gene O 0 0.0012943051988258958
were O 0 3.0382967452169396e-05
systematically O 0 0.0037208846770226955
analyzed O 0 0.00034698485978879035
by O 0 1.048743160936283e-05
an O 0 0.00016619337839074433
exon O 0 0.031209224835038185
- O 0 0.001886799349449575
by O 0 4.755050758831203e-05
- O 0 0.0038071658927947283
exon O 0 0.02157815732061863
denaturing O 0 0.23916171491146088
gradient O 0 0.032582927495241165
gel O 1 0.9921897053718567
electrophoresis O 0 0.4243949353694916
( O 0 0.003920670598745346
DGGE O 1 0.9979895353317261
) O 0 0.0004868147079832852
strategy O 0 0.003814178518950939
followed O 0 0.00011496756633277982
by O 0 6.541385573655134e-06
direct O 0 4.003664798801765e-05
sequencing O 0 0.00017354331794194877
in O 0 4.209937105770223e-05
seven O 0 0.00014654305414296687
unrelated O 0 0.008442265912890434
heterozygous O 0 0.050122518092393875
HC B-Disease 1 0.9999997615814209
patients O 1 0.9999967813491821
from O 0 0.00034684146521613
France O 0 0.0033917976543307304
, O 0 0.0005035126232542098
Holland O 0 0.025214675813913345
, O 0 0.00015258097846526653
and O 0 0.00011966896272497252
Czech O 0 0.005124978721141815
Republic O 0 0.0008521966519765556
. O 0 0.00036929885391145945

Seven O 0 0.0011691538384184241
novel O 0 0.0018757391953840852
mutations O 0 0.0009540306054987013
and O 0 3.707703945110552e-05
two O 0 1.5780455214553513e-05
new O 0 0.00012093851546524093
polymorphisms O 0 0.00210999115370214
were O 0 6.372780626406893e-05
detected O 0 0.0073527805507183075
. O 0 0.0002203261392423883

Among O 0 0.00020843783568125218
these O 0 2.0011579181300476e-05
mutations O 0 0.0004270450153853744
two O 0 9.52732989389915e-06
are O 0 2.0312252672738396e-05
missense O 0 0.01588883064687252
( O 0 0.0008418381330557168
G197W O 0 0.0613706111907959
, O 0 0.0005636304849758744
W427R O 0 0.05108664557337761
) O 0 0.00015766821161378175
, O 0 4.689184424933046e-05
two O 0 1.2951007192896213e-05
are O 0 2.339903949177824e-05
nonsense O 0 0.016807617619633675
( O 0 0.00101303996052593
Q306X O 0 0.07548663020133972
, O 0 0.0005889508756808937
Q385X O 0 0.08162757009267807
) O 0 0.00017034228949341923
, O 0 3.983659189543687e-05
two O 0 8.59834017319372e-06
are O 0 6.494820809166413e-06
small O 0 0.00017289105744566768
deletions O 0 0.006064660847187042
( O 0 0.000886347726918757
662de14bp O 0 0.07325956970453262
; O 0 0.0003458276914898306
1168del3bp O 0 0.04994811490178108
removing O 0 0.00508115766569972
a O 0 0.0005376836634241045
glycine O 0 0.008820888586342335
at O 0 0.0010060555068776011
position O 0 0.0035936401691287756
390 O 0 0.048199430108070374
) O 0 0.00028661952819675207
, O 0 8.494499343214557e-05
and O 0 2.983174636028707e-05
one O 0 3.25269102177117e-05
is O 0 3.8334324926836416e-05
a O 0 0.00010484016092959791
splicing O 0 0.0013487994438037276
mutation O 0 0.002100084675475955
( O 0 0.0008271705592051148
IVS1 O 1 0.9961766004562378
- O 0 0.013765774667263031
15c O 0 0.2948223352432251
- O 0 0.01290902029722929
- O 0 0.00792280025780201
> O 0 0.014357488602399826
g O 0 0.004506510216742754
) O 0 8.409572910750285e-05
which O 0 1.7690708773443475e-05
creates O 0 0.0006531155086122453
a O 0 0.00025767256738618016
new O 0 0.00039240557816810906
acceptor O 0 0.2477559894323349
splice O 0 0.06557904928922653
site O 0 0.004561515059322119
. O 0 0.00038336176658049226

The O 0 0.0012098316801711917
pathological O 1 0.811784565448761
significance O 0 0.0004918890190310776
of O 0 7.567463399027474e-06
the O 0 9.616712486604229e-05
point O 0 0.0010241091949865222
mutations O 0 0.002578137442469597
G197W O 0 0.045099589973688126
, O 0 0.00046148113324306905
W427R O 0 0.03164530172944069
, O 0 0.00012423591397237033
and O 0 3.627366459113546e-05
the O 0 6.955578282941133e-05
in O 0 0.0002107596374116838
- O 0 0.00556689640507102
frame O 0 0.008493799716234207
deletion O 0 0.02181578427553177
390delGly O 0 0.1380896419286728
were O 0 6.215235771378502e-05
assessed O 0 0.00439767399802804
by O 0 1.0788793588289991e-05
their O 0 1.062105548044201e-05
respective O 0 0.0002627455978654325
expression O 0 0.00034316451638005674
in O 0 7.488884875783697e-05
a O 0 0.000343985011568293
prokaryotic O 0 0.0025753078516572714
system O 0 0.000770987884607166
using O 0 0.00016141061496455222
site O 0 0.0028736330568790436
- O 0 0.0028315114323049784
directed O 0 0.00025616856873966753
mutagenesis O 0 0.01601686328649521
. O 0 0.0004055772442370653

These O 0 0.00011902244295924902
mutations O 0 0.0014040792593732476
resulted O 0 0.0009681687224656343
in O 0 8.962983702076599e-05
the O 0 0.00017128794570453465
absence O 0 0.004243413917720318
or O 0 0.00019355355470906943
a O 0 0.00027663540095090866
dramatic O 0 0.0025014111306518316
decrease O 0 0.0015864152228459716
of O 0 3.305330028524622e-05
CPO O 0 0.18414556980133057
activity O 0 0.0008200625889003277
. O 0 0.00027250018320046365

The O 0 0.0002497787354514003
two O 0 4.3891890527447686e-05
polymorphisms O 0 0.0020219425205141306
were O 0 4.983828330296092e-05
localized O 0 0.008758886717259884
in O 0 0.00020486346329562366
noncoding O 0 0.018536999821662903
part O 0 0.00022593123139813542
of O 0 6.087251222197665e-06
the O 0 9.878306445898488e-05
gene O 0 0.0009632564033381641
1 O 0 0.0005764337256550789
) O 0 7.867535896366462e-05
a O 0 0.001235460746102035
C O 1 0.9530077576637268
/ O 0 0.14657244086265564
G O 0 0.02241404913365841
polymorphism O 0 0.0011601997539401054
in O 0 0.00011132584768347442
the O 0 0.00039819919038563967
promotor O 1 0.9724598526954651
region O 0 0.005271510686725378
, O 0 0.0005276192096062005
142 O 0 0.01436709426343441
bp O 0 0.04656417295336723
upstream O 0 0.0012878499692305923
from O 0 1.3161429706087802e-05
the O 0 1.9568462448660284e-05
transcriptional O 0 0.0014121163403615355
initiation O 0 0.0034563278313726187
site O 0 0.002585956361144781
( O 0 0.0006590525154024363
- O 0 0.011105751618742943
142C O 0 0.25086063146591187
/ O 0 0.1116250678896904
G O 0 0.040885843336582184
) O 0 0.0001933089952217415
, O 0 0.00010857010056497529
and O 0 9.124958887696266e-05
2 O 0 0.0007189814932644367
) O 0 8.674794662510976e-05
a O 0 0.0003655074106063694
6 O 0 0.0020226261112838984
bp O 0 0.05117640271782875
deletion O 0 0.004387416411191225
polymorphism O 0 0.0011006580898538232
in O 0 7.551352609880269e-05
the O 0 0.0001496348122600466
3 O 0 0.0009612018475309014
noncoding O 0 0.014926373958587646
part O 0 0.0002249671524623409
of O 0 8.780024472798686e-06
the O 0 0.0003124620416201651
CPO O 0 0.471038818359375
gene O 0 0.0023175019305199385
, O 0 0.0004760670999530703
574 O 0 0.3070087134838104
bp O 0 0.07076501101255417
downstream O 0 0.0018950204830616713
of O 0 1.1585247193579562e-05
the O 0 0.000135753201902844
last O 0 0.00048479242832399905
base O 0 0.00025984435342252254
of O 0 4.09715994464932e-06
the O 0 0.00010817635484272614
normal O 0 0.0043332562781870365
termination O 0 0.06805574148893356
codon O 0 0.01110663078725338
( O 0 0.0011747450334951282
+ O 0 0.06998929381370544
574 O 1 0.8461262583732605
delATTCTT O 0 0.41216015815734863
) O 0 0.00037611942389048636
. O 0 0.00025773694505915046

Five O 0 0.001602860284037888
intragenic O 1 0.9154771566390991
dimorphisms O 1 0.8521422743797302
are O 0 3.2677828130545095e-05
now O 0 0.000393926165997982
well O 0 0.0001977740175789222
characterized O 0 0.011150824837386608
and O 0 0.00012924254406243563
the O 0 0.0001859296316979453
high O 0 0.0021600411273539066
degree O 0 0.000745202589314431
of O 0 2.4538096113246866e-05
allelic O 0 0.08451618254184723
heterogeneity O 0 0.042893655598163605
in O 0 0.0017119883559644222
HC B-Disease 1 0.999997615814209
is O 0 0.0012910732766613364
demonstrated O 0 0.0024705096147954464
with O 0 3.689535515150055e-05
seven O 0 0.00014731104602105916
new O 0 5.850109300808981e-05
different O 0 1.0725201718742028e-05
mutations O 0 0.0004555257910396904
making O 0 9.584652434568852e-05
a O 0 5.220564707997255e-05
total O 0 1.6647927623125724e-05
of O 0 1.0253886102873366e-05
nineteen O 0 0.00866625551134348
CPO O 1 0.987533688545227
gene B-Disease 0 0.0229660514742136
defects I-Disease 1 0.9999375343322754
reported O 0 0.003969193436205387
so O 0 0.000261051143752411
far O 0 0.0003167000540997833
. O 0 7.709403871558607e-05
. O 0 0.00018735100456979126

Coincidence O 0 0.0036669299006462097
of O 0 1.2813708053727169e-05
two O 0 4.245873060426675e-05
novel O 0 0.002047113608568907
arylsulfatase O 0 0.22196480631828308
A O 0 0.002193637890741229
alleles O 0 0.0015272407326847315
and O 0 0.00016679569671396166
mutation O 0 0.006291600875556469
459 O 1 0.9517095685005188
+ O 0 0.15091894567012787
1G O 1 0.9707109332084656
> O 0 0.013670072890818119
A O 0 0.0009606553940102458
within O 0 4.621945845428854e-05
a O 0 0.000311184034217149
family O 0 0.0006145662046037614
with O 0 0.0007342848111875355
metachromatic B-Disease 1 0.9999903440475464
leukodystrophy I-Disease 1 0.9999979734420776
: O 0 0.0008254356798715889
molecular O 0 0.0005613305838778615
basis O 0 2.2627378712059e-05
of O 0 1.2162039638496935e-05
phenotypic O 0 0.028332537040114403
heterogeneity O 0 0.053731419146060944
. O 0 0.0007348574581556022

In O 0 0.0003597052418626845
a O 0 0.0004541301750577986
family O 0 0.00034704015706665814
with O 0 6.919127918081358e-05
three O 0 0.00014195973926689476
siblings O 0 0.0024753024335950613
, O 0 8.159545541275293e-05
one O 0 6.501310417661443e-05
developed O 0 0.0013127613347023726
classical O 0 0.0008673352422192693
late O 0 0.007058592513203621
infantile O 1 0.999998927116394
metachromatic B-Disease 1 0.9999821186065674
leukodystrophy I-Disease 1 0.9999996423721313
( O 0 0.011713502928614616
MLD B-Disease 1 0.9999973773956299
) O 0 0.0011431081220507622
, O 0 0.0008204944897443056
fatal O 1 0.9999498128890991
at O 0 0.0018118160078302026
age O 0 0.001071691862307489
5 O 0 0.0005728983669541776
years O 0 0.00030698615591973066
, O 0 7.727481715846807e-05
with O 0 0.0002018545928876847
deficient O 1 0.9999680519104004
arylsulfatase O 1 0.9821439981460571
A O 0 0.009015633724629879
( O 0 0.002184368437156081
ARSA O 1 0.9991725087165833
) O 0 0.0001643568102736026
activity O 0 0.0001223264989675954
and O 0 5.089429396321066e-05
increased O 0 0.0009921829914674163
galactosylsulfatide O 1 0.9901874661445618
( O 0 0.0029771914705634117
GS O 1 0.9999831914901733
) O 0 0.0007504841778427362
excretion O 0 0.024878336116671562
. O 0 0.00047075553447939456

The O 0 0.00030322829843498766
two O 0 2.709076215978712e-05
other O 0 4.777271533384919e-05
siblings O 0 0.002969557885080576
, O 0 0.00027561551542021334
apparently O 0 0.0034660836681723595
healthy O 0 0.01621430180966854
at O 0 0.000821803230792284
12 O 0 0.0009579358156770468
( O 0 0.0005923075950704515
1 O 0 0.0037990943528711796
/ O 0 0.029111988842487335
2 O 0 0.0008833058527670801
) O 0 0.00010007926903199404
and O 0 9.141471673501655e-05
15 O 0 0.0006651306175626814
years O 0 0.0005189623916521668
, O 0 0.0001725294132484123
respectively O 0 0.0006553792045451701
, O 0 9.21367245609872e-05
and O 0 5.530735506908968e-05
their O 0 6.180894706631079e-05
father O 0 0.002765060868114233
, O 0 0.0002909023314714432
apparently O 0 0.003750869305804372
healthy O 0 0.00940810889005661
as O 0 0.00011751487181754783
well O 0 0.00014283688506111503
, O 0 0.00022723132860846817
presented O 0 0.005680114030838013
ARSA O 1 0.9998520612716675
and O 0 0.0017498602392151952
GS O 1 0.999626874923706
values O 0 6.872301310067996e-05
within O 0 1.5183914911176544e-05
the O 0 2.605842200864572e-05
range O 0 0.00039816886419430375
of O 0 0.0002328175469301641
MLD B-Disease 1 1.0
patients O 1 0.9999977350234985
. O 0 0.00041751351091079414

Mutation O 0 0.011570369824767113
screening O 0 0.004231214057654142
and O 0 3.34591131831985e-05
sequence O 0 5.735619197366759e-05
analysis O 0 0.0004815377469640225
disclosed O 0 0.015752488747239113
the O 0 9.669025166658685e-05
involvement O 0 0.0028481497429311275
of O 0 9.568214409227949e-06
three O 0 5.929205508437008e-05
different O 0 0.00011317522148601711
ARSA O 1 0.9998904466629028
mutations O 0 0.003781826701015234
being O 0 0.0001929311256390065
the O 0 5.212476389715448e-05
molecular O 0 0.0004990322631783783
basis O 0 3.2337258744519204e-05
of O 0 2.5737754185684025e-05
intrafamilial O 1 0.9657427072525024
phenotypic O 0 0.03895355388522148
heterogeneity O 0 0.03805509954690933
. O 0 0.0007475056918337941

The O 0 0.0009214775054715574
late O 0 0.013586948625743389
infantile O 1 0.9999995231628418
patient O 1 0.9999961853027344
inherited O 1 0.9983783960342407
from O 0 0.00017011731688398868
his O 0 0.0008784813107922673
mother O 0 0.0023382818326354027
the O 0 0.0001201415216200985
frequent O 0 0.004437892697751522
0 O 0 0.0016188070876523852
- O 0 0.0029149206820875406
type O 0 0.0028743846341967583
mutation O 0 0.004200264811515808
459 O 1 0.9552710652351379
+ O 0 0.10607151687145233
1G O 1 0.9670416712760925
> O 0 0.021738151088356972
A O 0 0.0026824965607374907
, O 0 0.00016722502186894417
and O 0 6.562045018654317e-05
from O 0 6.870192009955645e-05
his O 0 0.0008842275128699839
father O 0 0.00183400500100106
a O 0 0.00045910850167274475
novel O 0 0.0011191782541573048
, O 0 0.00013178361405152828
single O 0 0.0005540620186366141
basepair O 0 0.140022873878479
microdeletion O 0 0.033994272351264954
of O 0 1.591644831933081e-05
guanine O 0 0.0019298180704936385
at O 0 0.00027191959088668227
nucleotide O 0 0.00015502094174735248
7 O 0 0.00030636368319392204
in O 0 0.00011190825898665935
exon O 0 0.022502390667796135
1 O 0 0.0020052772015333176
( O 0 0.0008774736779741943
7delG O 0 0.10829360038042068
) O 0 0.00037097817403264344
. O 0 0.00022433677804656327

The O 0 0.0003020792792085558
two O 0 0.00020747972303070128
clinically O 1 0.9998821020126343
unaffected O 1 0.6991074681282043
siblings O 0 0.001949386321939528
carried O 0 0.00011525845911819488
the O 0 9.870030771708116e-05
maternal O 0 0.016294633969664574
mutation O 0 0.008412365801632404
459 O 1 0.9589483737945557
+ O 0 0.15612635016441345
1G O 1 0.951485276222229
> O 0 0.02691834606230259
A O 0 0.0028462179470807314
and O 0 0.00013940618373453617
, O 0 9.490069351159036e-05
on O 0 6.038183710188605e-05
their O 0 3.376413224032149e-05
paternal O 0 0.005259407684206963
allele O 0 0.0048390403389930725
, O 0 0.00013854785356670618
a O 0 0.00035511021269485354
novel O 0 0.0013591094175353646
cytosine O 0 0.004563028458505869
to O 0 0.00011643091420410201
thymidine O 0 0.02292843721807003
transition O 0 0.002302424516528845
at O 0 0.0006199301569722593
nucleotide O 0 0.0010836950968950987
2435 O 1 0.8737034797668457
in O 0 0.0005307100946083665
exon O 0 0.03579804301261902
8 O 0 0.0011597410775721073
, O 0 0.00010412769916001707
resulting O 0 0.0003482152824290097
in O 0 2.4776671125437133e-05
substitution O 0 0.0001332105020992458
of O 0 2.4421835405519232e-05
alanine O 0 0.10660863667726517
464 O 0 0.46483322978019714
by O 0 0.0002915715449489653
valine O 1 0.7663231492042542
( O 0 0.0019449280807748437
A464V O 0 0.10576549917459488
) O 0 0.0003740809625014663
. O 0 0.00022685035946778953

The O 0 0.0005167638882994652
fathers O 0 0.002356714801862836
genotype O 0 0.02131981961429119
thus O 0 0.000499277317430824
was O 0 0.0028517460450530052
7delG O 1 0.9876723885536194
/ O 0 0.47738948464393616
A464V O 0 0.05680421367287636
. O 0 0.0005727550596930087

Mutation O 0 0.01359197124838829
A464V O 0 0.036129847168922424
was O 0 0.0006189402192831039
not O 0 4.5619322918355465e-05
found O 0 6.791749910917133e-05
in O 0 7.896083116065711e-05
18 O 0 0.001046862336806953
unrelated O 1 0.8901309370994568
MLD B-Disease 1 0.9999998807907104
patients O 1 0.999997615814209
and O 0 0.0001931045117089525
50 O 0 0.00047495364560745656
controls O 0 0.0016575875924900174
. O 0 0.00039801097591407597

A464V O 0 0.07049582153558731
, O 0 0.00024989162920974195
although O 0 0.00019740757124964148
clearly O 0 0.0019879047758877277
modifying O 0 0.04324346408247948
ARSA O 1 0.9997484087944031
and O 0 0.0023090457543730736
GS O 1 0.999994158744812
levels O 0 0.008060764521360397
, O 0 0.0002892223419621587
apparently O 0 0.0024820275139063597
bears O 0 0.0027567651122808456
little O 0 0.0002328517148271203
significance O 0 0.00044505693949759007
for O 0 0.0003519217134453356
clinical O 1 0.9999426603317261
manifestation O 1 0.8886352777481079
of O 0 0.00023203481396194547
MLD B-Disease 1 0.9999992847442627
, O 0 0.0005211703828535974
mimicking O 0 0.026367872953414917
the O 0 0.0004148567095398903
frequent O 0 0.034894440323114395
ARSA O 1 0.999782383441925
pseudodeficiency O 1 0.8282608985900879
allele O 0 0.012846985831856728
. O 0 0.0006030332879163325

Our O 0 0.0014522679848596454
results O 0 0.0006110281101427972
demonstrate O 0 0.001075098174624145
that O 0 9.897946256387513e-06
in O 0 2.1950056179775856e-05
certain O 0 7.761748565826565e-05
genetic O 0 0.004302680026739836
conditions O 1 0.9826422929763794
MLD B-Disease 1 0.9999991655349731
- O 0 0.03992539644241333
like O 0 0.0020694537088274956
ARSA O 1 0.9994298815727234
and O 0 0.0017668470973148942
GS O 1 0.9998395442962646
values O 0 0.00026053196052089334
need O 0 0.0004570943128783256
not O 0 2.867479997803457e-05
be O 0 2.458137896610424e-05
paralleled O 0 0.0036741422954946756
by O 0 0.0002386033593211323
clinical O 1 0.9999995231628418
disease O 1 0.9999997615814209
, O 0 0.00010637580999173224
a O 0 0.00021911857766099274
finding O 0 0.0007001300691626966
with O 0 0.00017134282097686082
serious O 1 0.9997530579566956
diagnostic O 1 0.9998981952667236
and O 0 0.0005648938240483403
prognostic O 1 0.9993513226509094
implications O 0 0.05907919630408287
. O 0 0.00045262963976711035

Moreover O 0 0.007596380542963743
, O 0 0.0003150891570840031
further O 0 0.001285536796785891
ARSA O 1 0.9990748167037964
alleles O 0 0.009864418767392635
functionally O 0 0.02585381641983986
similar O 0 0.00026548607274889946
to O 0 0.0001943309762282297
A464V O 0 0.08122054487466812
might O 0 0.0006333372439257801
exist O 0 8.969788905233145e-05
which O 0 1.1719863323378377e-05
, O 0 1.9966209947597235e-05
together O 0 1.0958493476209696e-05
with O 0 3.647425546660088e-05
0 O 0 0.0015276508638635278
- O 0 0.004376573022454977
type O 0 0.003214773954823613
mutations O 0 0.0014346950920298696
, O 0 0.00014547047612722963
may O 0 0.0020044471602886915
cause O 1 0.9533945918083191
pathological O 1 0.9999933242797852
ARSA O 1 0.9999864101409912
and O 0 0.0028751473873853683
GS O 1 0.999996542930603
levels O 0 0.0057354215532541275
, O 0 0.00010527124686632305
but O 0 9.367949678562582e-05
not O 0 0.0002132969384547323
clinical O 1 0.9999215602874756
outbreak O 1 0.8992785811424255
of O 0 2.86127942672465e-05
the O 0 0.001425572787411511
disease O 1 0.9999998807907104
. O 0 0.00023677585704717785
. O 0 0.00031861464958637953

Human O 1 0.8117964863777161
MLH1 O 1 0.9999991655349731
deficiency O 1 1.0
predisposes O 1 0.9997861981391907
to O 0 0.001191235613077879
hematological B-Disease 1 0.9999933242797852
malignancy I-Disease 1 0.9999992847442627
and O 0 0.0017237506108358502
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 0 0.24956728518009186
1 I-Disease 0 0.0023224465548992157
. O 0 0.0002570260257925838

Heterozygous O 0 0.04140874743461609
germ O 1 0.9984272718429565
- O 0 0.008240858092904091
line O 0 0.0010371824027970433
mutations O 0 0.00030233224970288575
in O 0 1.8925040421891026e-05
the O 0 9.18032819754444e-05
DNA O 0 0.0033579187002032995
mismatch O 1 0.998138427734375
repair O 1 0.9979246854782104
genes O 0 0.00015640891797374934
lead O 0 0.0001835740404203534
to O 0 0.0001898216432891786
hereditary B-Disease 1 0.9999911785125732
nonpolyposis I-Disease 1 0.9999995231628418
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0011434719199314713

The O 0 0.006157603580504656
disease O 1 0.9999995231628418
susceptibility O 1 0.6543169021606445
of O 0 3.0239418265409768e-05
individuals O 0 0.0003026096965186298
who O 0 0.0008126302855089307
constitutionally O 0 0.007511028554290533
lack O 0 0.0017016244819387794
both O 0 0.00015886886103544384
wild O 0 0.0007510181749239564
- O 0 0.006354112643748522
type O 0 0.003164014546200633
alleles O 0 0.0016224581049755216
is O 0 0.00026547821471467614
unknown O 0 0.0006213794695213437
. O 0 0.00024288638087455183

We O 0 0.000549824966583401
have O 0 4.55747613159474e-05
identified O 0 0.00015796888328623027
three O 0 1.2864152267866302e-05
offspring O 0 0.00018043234013020992
in O 0 4.710401481133886e-05
a O 0 0.0014669724041596055
hereditary B-Disease 1 0.9999966621398926
nonpolyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0020156651735305786
who O 0 0.0009188320254907012
developed O 0 0.21084091067314148
hematological B-Disease 1 0.9999946355819702
malignancy I-Disease 1 0.9999959468841553
at O 0 0.0006665104301646352
a O 0 0.00029461426311172545
very O 0 0.0006186605896800756
early O 0 0.000742719741538167
age O 0 0.0009744053822942078
, O 0 0.00022647733567282557
and O 0 0.00013438478345051408
at O 0 0.00048263827920891345
least O 0 4.9562062486074865e-05
two O 0 3.6288390674599214e-06
of O 0 2.576014367150492e-06
them O 0 1.4852566891931929e-05
displayed O 0 0.0007067075930535793
signs O 0 0.0017739454051479697
of O 0 6.870173092465848e-05
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 0 0.1400054693222046
1 I-Disease 0 0.003911903593689203
( O 0 0.002151216147467494
NF1 B-Disease 1 0.9996645450592041
) O 0 0.0006082552135922015
. O 0 0.00025939481565728784

DNA O 0 0.0008404243271797895
sequence O 0 4.905573223368265e-05
analysis O 0 0.00019788247300311923
and O 0 0.00012702196545433253
allele O 0 0.005981083959341049
- O 0 0.0020868040155619383
specific O 0 0.00010536664922256023
amplification O 0 0.0021740214433521032
in O 0 6.897315324749798e-05
two O 0 3.799153273575939e-05
siblings O 0 0.0021394751965999603
revealed O 0 0.0030650978442281485
a O 0 0.000541859248187393
homozygous O 0 0.009589757770299911
MLH1 O 1 0.9976673126220703
mutation O 0 0.006906015332788229
( O 0 0.0008572727092541754
C676T O 0 0.09604664891958237
- O 0 0.012722197920084
- O 0 0.007711655925959349
> O 0 0.01717274822294712
Arg226Stop O 1 0.7460498213768005
) O 0 0.000285681860987097
. O 0 0.00022633615299127996

Thus O 0 0.00045417624642141163
, O 0 5.806623448734172e-05
a O 0 0.0004311592201702297
homozygous O 0 0.007202879060059786
germ O 1 0.9988818764686584
- O 0 0.012567846104502678
line O 0 0.004641969688236713
MLH1 O 1 0.999508261680603
mutation O 0 0.0020905074197798967
and O 0 0.0001510091096861288
consequent O 1 0.9991756081581116
mismatch O 1 0.9999969005584717
repair O 1 0.9999997615814209
deficiency O 1 1.0
results O 0 0.000646899570710957
in O 0 7.503389497287571e-05
a O 0 0.0014585491735488176
mutator O 1 0.9997610449790955
phenotype O 1 0.9828061461448669
characterized O 0 0.3747420907020569
by O 0 0.0010336865670979023
leukemia B-Disease 1 1.0
and O 0 0.0037002847529947758
/ O 1 0.9997835755348206
or O 0 0.04368859902024269
lymphoma B-Disease 1 1.0
associated O 0 0.0017644066829234362
with O 0 0.000483767653349787
neurofibromatosis B-Disease 1 0.9999997615814209
type I-Disease 0 0.3649584949016571
1 I-Disease 0 0.0017889428418129683
. O 0 0.0001275805989280343
. O 0 0.00021423146245069802

Missense O 0 0.08881227672100067
mutations O 0 0.002279408276081085
in O 0 6.710855814162642e-05
the O 0 4.988526779925451e-05
most O 0 5.188304930925369e-05
ancient O 0 0.00016199836682062596
residues O 0 0.0004117314820177853
of O 0 1.2501039236667566e-05
the O 0 0.0007676287787035108
PAX6 O 1 0.9999361038208008
paired O 0 0.007005954161286354
domain O 0 0.0008863401017151773
underlie O 0 0.02641378715634346
a O 0 0.0001919073984026909
spectrum O 0 0.0009660954819992185
of O 0 4.608993185684085e-05
human O 1 0.9993454813957214
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999998807907104
malformations I-Disease 1 0.9999979734420776
. O 0 0.001347025972791016

Mutations O 0 0.0009459209395572543
of O 0 4.963226274412591e-06
the O 0 0.00010871161066461354
human O 0 0.00536457309499383
PAX6 O 1 0.9999189376831055
gene O 0 0.013014312833547592
underlie O 1 0.9984130859375
aniridia B-Disease 1 0.9999732971191406
( O 0 0.01006975956261158
congenital B-Disease 1 1.0
absence I-Disease 0 0.0036621526814997196
of I-Disease 0 2.4772418328211643e-05
the I-Disease 0 0.0009516720310784876
iris I-Disease 1 0.9999029636383057
) O 0 0.00020683363254647702
, O 0 5.9775469708256423e-05
a O 0 0.00038274514372460544
rare O 0 0.0053935181349515915
dominant O 0 0.03007504530251026
malformation B-Disease 1 0.9998360872268677
of I-Disease 0 4.8335503379348665e-05
the I-Disease 0 0.0011143761221319437
eye I-Disease 1 0.9999674558639526
. O 0 0.0007911873399280012

The O 0 0.00027892840444110334
spectrum O 0 0.0020441727247089148
of O 0 8.676168363308534e-05
PAX6 O 1 0.9999457597732544
mutations O 0 0.004923996515572071
in O 0 0.0008690741378813982
aniridia B-Disease 1 0.9999881982803345
patients O 1 0.999968409538269
is O 0 0.0003866689803544432
highly O 0 0.0029314609710127115
biased O 0 0.011486535891890526
, O 0 0.00017821163055486977
with O 0 7.850672409404069e-05
92 O 0 0.0048674726858735085
% O 0 1.2493054782680701e-05
of O 0 3.987187028542394e-06
all O 0 3.9991282392293215e-05
reported O 0 0.003401876660063863
mutations O 0 0.0012956513091921806
leading O 0 0.0011727678356692195
to O 0 0.0001820467587094754
premature O 0 0.3413223326206207
truncation O 0 0.007334423717111349
of O 0 7.5423331509227864e-06
the O 0 8.932199125410989e-05
protein O 0 0.0010320058790966868
( O 0 0.0004993701004423201
nonsense O 0 0.01083045732229948
, O 0 0.00015959187294356525
splicing O 0 0.0012355372309684753
, O 0 0.00016826658975332975
insertions O 0 0.005819815676659346
and O 0 0.0002041116385953501
deletions O 0 0.004212558269500732
) O 0 0.0001913783635245636
and O 0 9.599507029633969e-05
just O 0 0.0006779038230888546
2 O 0 0.0005228394293226302
% O 0 3.623424709076062e-05
leading O 0 0.000474728672998026
to O 0 1.5281157175195403e-05
substitution O 0 6.246132397791371e-05
of O 0 3.4573567972984165e-06
one O 0 3.039899456780404e-05
amino O 0 0.00011433369945734739
acid O 0 0.0025819120928645134
by O 0 2.9899272703914903e-05
another O 0 0.0006508661317639053
( O 0 0.0009505741181783378
missense O 0 0.024015335366129875
) O 0 0.0004029236442875117
. O 0 0.00032964636920951307

The O 0 0.0004097613273188472
extraordinary O 0 0.0020909311715513468
conservation O 0 0.002088645938783884
of O 0 1.5242338122334331e-05
the O 0 0.00037381681613624096
PAX6 O 1 0.9985879063606262
protein O 0 0.0005672521656379104
at O 0 0.00017705718346405774
the O 0 3.120310066151433e-05
amino O 0 0.00021465530153363943
acid O 0 0.0052602034993469715
level O 0 0.0018183707725256681
amongst O 0 0.0014448767760768533
vertebrates O 0 0.006916440092027187
predicts O 0 0.015844333916902542
that O 0 0.0002183232136303559
pathological O 1 0.9976657629013062
missense O 0 0.03880736976861954
mutations O 0 0.0019476327579468489
should O 0 0.00014456859207712114
in O 0 4.425409497343935e-05
fact O 0 0.0002562306181062013
be O 0 7.670377817703411e-05
common O 0 0.0007266135071404278
even O 0 0.00029544008430093527
though O 0 0.00016244447033386678
they O 0 1.0949311217700597e-05
are O 0 8.653652002976742e-06
hardly O 0 0.002120997291058302
ever O 0 0.0004107666900381446
seen O 0 0.0010101395891979337
in O 0 0.0006830829661339521
aniridia B-Disease 1 0.9999803304672241
patients O 1 0.9999921321868896
. O 0 0.0005968186887912452

This O 0 0.0002550925128161907
indicates O 0 0.0009994907304644585
that O 0 1.882560354715679e-05
there O 0 2.2078707843320444e-05
is O 0 8.52071971166879e-05
a O 0 0.000404682825319469
heavy O 0 0.02128632366657257
ascertainment O 1 0.998494029045105
bias O 0 0.006545091047883034
in O 0 5.497974416357465e-05
the O 0 4.2813928303075954e-05
selection O 0 0.0002539386332500726
of O 0 8.351562428288162e-05
patients O 1 0.9999967813491821
for O 0 0.0010180998360738158
PAX6 O 1 0.9999301433563232
mutation O 0 0.0019739854615181684
analysis O 0 0.00015684604295529425
and O 0 3.7394311220850796e-05
that O 0 1.8915981854661368e-05
the O 0 0.00016282254364341497
missing O 0 0.012257718481123447
PAX6 O 1 0.9994152784347534
missense O 0 0.07200730592012405
mutations O 0 0.0049414001405239105
frequently O 0 0.003060205839574337
may O 0 0.00292497081682086
underlie O 1 0.9825909733772278
phenotypes O 0 0.011267327703535557
distinct O 0 0.0003693072940222919
from O 0 0.0001788858207874
textbook O 1 0.9986353516578674
aniridia B-Disease 1 0.9999179840087891
. O 0 0.0008265174692496657

Here O 0 0.00042383483378216624
we O 0 6.418462726287544e-05
present O 0 5.064949800726026e-05
four O 0 7.508900307584554e-05
novel O 0 0.0045224083587527275
PAX6 O 1 0.9996726512908936
missense O 0 0.06249597668647766
mutations O 0 0.0020970150362700224
, O 0 7.215629011625424e-05
two O 0 1.7847043636720628e-05
in O 0 0.00010173871123697609
association O 0 0.0060754516161978245
with O 0 0.00028260229737497866
atypical O 1 0.9997124075889587
phenotypes O 1 0.5328207015991211
ectopia B-Disease 1 0.9913169145584106
pupillae I-Disease 1 0.9604911804199219
( O 0 0.0009364746510982513
displaced B-Disease 0 0.015686655417084694
pupils I-Disease 0 0.016962403431534767
) O 0 0.0004098772187717259
and O 0 0.0019485951634123921
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999914169311523
( O 0 0.0028198573272675276
searching B-Disease 0 0.011065970174968243
gaze I-Disease 0 0.3367394804954529
) O 0 0.00035070328158326447
, O 0 0.00010607778676785529
and O 0 4.351206007413566e-05
two O 0 2.3516415240010247e-05
in O 0 0.00012819714902434498
association O 0 0.003626385936513543
with O 0 4.219012407702394e-05
more O 0 0.00015495828120037913
recognizable O 0 0.18789838254451752
aniridia B-Disease 1 0.9991017580032349
phenotypes O 0 0.04722611606121063
. O 0 0.0005728252581320703

Strikingly O 0 0.04881056770682335
, O 0 0.00017029972514137626
all O 0 1.2962597793375608e-05
four O 0 4.6659846702823415e-05
mutations O 0 0.0004857784660998732
are O 0 9.08184392756084e-06
located O 0 0.00026235487894155085
within O 0 5.5268708820221946e-05
the O 0 0.0006412229267880321
PAX6 O 1 0.999964714050293
paired O 0 0.010305668227374554
domain O 0 0.0005848190048709512
and O 0 7.559423102065921e-05
affect O 0 0.0011431386228650808
amino O 0 0.0001564014528412372
acids O 0 0.00026417640037834644
which O 0 1.8732549506239593e-05
are O 0 6.148148258944275e-06
highly O 0 0.000499378249514848
conserved O 0 0.000140329371788539
in O 0 4.495336543186568e-05
all O 0 1.872040593298152e-05
known O 0 0.0005112559301778674
paired O 0 0.0016268705949187279
domain O 0 0.00026969044120050967
proteins O 0 0.00011206373892491683
. O 0 0.0003282771212980151

Our O 0 0.001417018473148346
results O 0 0.0004579189990181476
support O 0 0.0001996640203287825
the O 0 0.0001217261960846372
hypothesis O 0 0.0013604084961116314
that O 0 1.7912521798280068e-05
the O 0 6.038368519512005e-05
under O 0 0.00027544162003323436
- O 0 0.0006036714185029268
representation O 0 3.2387655664933845e-05
of O 0 2.0684361516032368e-05
missense O 0 0.02515779435634613
mutations O 0 0.002430887660011649
is O 0 0.00039192166877910495
caused O 0 0.0049710823222994804
by O 0 0.00018963440379593521
ascertainment O 1 0.9997633099555969
bias O 0 0.016350263729691505
and O 0 0.00015342305414378643
suggest O 0 0.0003720771928783506
that O 0 1.0798520634125452e-05
a O 0 8.815710316412151e-05
substantial O 0 0.0005896734073758125
burden O 0 0.011111493222415447
of O 0 0.0001349083468085155
PAX6 B-Disease 1 0.9999992847442627
- I-Disease 1 0.996933102607727
related I-Disease 1 0.5184741616249084
disease I-Disease 1 0.9999998807907104
remains O 0 0.002256362233310938
to O 0 4.658941543311812e-05
be O 0 5.548369153984822e-05
uncovered O 0 0.00439159432426095
. O 0 7.77142122387886e-05
. O 0 0.00016957784828264266

The O 0 0.000761112489271909
chromosomal O 0 0.009824732318520546
order O 0 4.209744292893447e-05
of O 0 6.907601346028969e-06
genes O 0 0.00019254357903264463
controlling O 0 0.003991531208157539
the O 0 0.0003418673586566001
major O 0 0.01314312219619751
histocompatibility O 1 0.9999696016311646
complex O 0 0.00998765230178833
, O 0 0.00043070566607639194
properdin O 1 0.6245890855789185
factor O 0 0.004680556245148182
B O 0 0.38078880310058594
, O 0 0.0003928891965188086
and O 0 0.0007040106575004756
deficiency B-Disease 1 0.9999974966049194
of I-Disease 0 1.7377818949171342e-05
the I-Disease 0 7.471116987289861e-05
second I-Disease 0 0.0001631601044209674
component I-Disease 0 0.0013870560796931386
of I-Disease 0 1.384381357638631e-05
complement I-Disease 0 0.003878665389493108
. O 0 0.0004793198313564062

The O 0 0.0004126243875361979
relationship O 0 0.0009490787633694708
of O 0 6.354124252538895e-06
the O 0 6.824522279202938e-05
genes O 0 0.00023710478853899986
coding O 0 0.00822638999670744
for O 0 0.0009572929702699184
HLA O 1 0.9983888864517212
to O 0 4.967676068190485e-05
those O 0 2.3770458938088268e-05
coding O 0 0.0032786275260150433
for O 0 0.00020525333820842206
properdin O 1 0.5696309804916382
Factor O 0 0.008910860866308212
B O 1 0.6530008912086487
allotypes O 0 0.14815092086791992
and O 0 0.00017215510888490826
for O 0 0.0009436453110538423
deficiency B-Disease 1 0.9999964237213135
of I-Disease 0 9.88618194242008e-06
the I-Disease 0 5.868671723874286e-05
second I-Disease 0 0.00010608041338855401
component I-Disease 0 0.001024110708385706
of I-Disease 0 1.4663582987850532e-05
complement I-Disease 0 0.007180267013609409
( O 0 0.0035663361195474863
C2 O 1 0.9999895095825195
) O 0 0.0005162149318493903
was O 0 0.0007435816805809736
studied O 0 0.0003749062307178974
in O 0 3.501190076349303e-05
families O 0 4.994314076611772e-05
of O 0 4.772499960381538e-05
patients O 1 0.9999992847442627
with O 0 0.0005936840898357332
connective O 1 0.9999997615814209
tissue O 1 0.9999998807907104
disorders O 1 1.0
. O 0 0.0018400450935587287

Patients O 1 0.9999802112579346
were O 0 7.619782263645902e-05
selected O 0 0.00022407129290513694
because O 0 0.00011669123341562226
they O 0 8.003143193491269e-06
were O 0 8.351731594302692e-06
heterozygous O 0 0.0005829661386087537
or O 0 0.00016015775327105075
homozygous O 0 0.00426760409027338
for O 0 0.003234467003494501
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.001822012010961771

12 O 0 0.0010255312081426382
families O 0 8.820858056424186e-05
with O 0 3.443011155468412e-05
15 O 0 0.0006168783293105662
matings O 0 0.03946509212255478
informative O 0 0.013495736755430698
for O 0 0.007385518867522478
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.0001803941559046507
found O 0 0.0002938781399279833
. O 0 0.0001962266251211986

Of O 0 8.647820504847914e-05
57 O 0 0.006484692450612783
informative O 0 0.018109917640686035
meioses O 1 0.5170335173606873
, O 0 0.00012960228195879608
two O 0 1.7599351849639788e-05
crossovers O 0 0.0010291036451235414
were O 0 1.2428718946466688e-05
noted O 0 0.00016331669758073986
between O 0 0.00010234727233182639
the O 0 0.0029785141814500093
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0020801518112421036
and O 0 9.237160702468827e-05
the O 0 0.0007577517535537481
HLA O 1 0.9999872446060181
- O 0 0.03144151344895363
B O 0 0.06390176713466644
gene O 0 0.0009575735894031823
, O 0 3.087480945396237e-05
with O 0 1.2015260836051311e-05
a O 0 0.00013473584840539843
recombinant O 0 0.0013057771138846874
fraction O 0 0.0003200479259248823
of O 0 2.0272966139600612e-05
0 O 0 0.001520153135061264
. O 0 0.00023467803839594126

035 O 1 0.9403016567230225
. O 0 0.0011701342882588506

A O 0 0.011880244128406048
lod O 0 0.14659900963306427
score O 0 7.362208270933479e-05
of O 0 1.0017226486525033e-05
13 O 0 0.00045248560491017997
was O 0 0.00015696050832048059
calculated O 0 0.00011744072253350168
for O 0 6.0358124756021425e-05
linkage O 0 0.022404616698622704
between O 0 0.003347377059981227
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.0040255202911794186
HLA O 1 0.9999881982803345
- O 0 0.05068390443921089
B O 0 0.03860755264759064
at O 0 0.0002783426025416702
a O 0 0.00012503705511335284
maximum O 0 0.0002485026780050248
likelihood O 0 0.0007863935898058116
value O 0 1.5448827980435453e-05
of O 0 2.6792620246851584e-06
the O 0 4.913738666800782e-05
recombinant O 0 0.0015873202355578542
fraction O 0 0.0002339247294003144
of O 0 1.7865213521872647e-05
0 O 0 0.0013093925081193447
. O 0 0.0002734311274252832

04 O 1 0.9768732786178589
. O 0 0.0008589202188886702

18 O 0 0.0011391997104510665
families O 0 0.00012318578956183046
with O 0 6.381185812642798e-05
21 O 0 0.0012674537720158696
informative O 0 0.00690429238602519
matings O 0 0.035259075462818146
for O 0 9.59844546741806e-05
both O 0 0.0001335121487500146
properdin O 0 0.32380610704421997
Factor O 0 0.006387540139257908
B O 0 0.3376862704753876
allotype O 1 0.6519668102264404
and O 0 0.0009239372448064387
HLA O 1 0.9999419450759888
- O 0 0.016954192891716957
B O 0 0.024105804041028023
were O 0 2.272265737701673e-05
found O 0 0.0001790190872270614
. O 0 0.00017941297846846282

Of O 0 0.0001239464763784781
72 O 0 0.008219919167459011
informative O 0 0.014994282275438309
meioses O 0 0.38706275820732117
, O 0 0.0002571039949543774
three O 0 0.00016683769354131073
recombinants O 0 0.17900308966636658
were O 0 4.848378011956811e-05
found O 0 0.00014071875193621963
, O 0 4.546124910120852e-05
giving O 0 0.0002346945839235559
a O 0 0.00013720252900384367
recombinant O 0 0.0013071165885776281
fraction O 0 0.00029815195011906326
of O 0 2.1785328499390744e-05
0 O 0 0.0013835731660947204
. O 0 0.00023576620151288807

042 O 0 0.34323057532310486
. O 0 0.0013004681095480919

A O 0 0.00937462504953146
lod O 0 0.14135240018367767
score O 0 4.370735041447915e-05
of O 0 7.389190614048857e-06
16 O 0 0.0005051600746810436
between O 0 0.0006885532638989389
HLA O 1 0.9999397993087769
- O 0 0.014616121537983418
B O 0 0.028495633974671364
and O 0 0.00012894143583253026
Factor O 0 0.0066431132145226
B O 0 0.4627366065979004
allotypes O 0 0.13866139948368073
was O 0 0.0007777672726660967
calculated O 0 0.0003682982351165265
at O 0 0.00019468019308988005
a O 0 0.0001410984550602734
maximum O 0 0.0002117149269906804
likelihood O 0 0.0009107734076678753
value O 0 2.0240780941094272e-05
of O 0 2.638808382471325e-06
the O 0 4.45619662059471e-05
recombinant O 0 0.0015682261437177658
fraction O 0 0.00031039080931805074
of O 0 1.9223096387577243e-05
0 O 0 0.001399739645421505
. O 0 0.0003248363209422678

04 O 1 0.9787783622741699
. O 0 0.0007009471883065999

A O 0 0.0036560893058776855
crossover O 0 0.002861675340682268
was O 0 0.001266935491003096
shown O 0 0.00037470454117283225
to O 0 3.6074750823900104e-05
have O 0 2.6559193429420702e-05
occurred O 0 0.0002623413747642189
between O 0 2.3810476704966277e-05
genes O 0 4.654483200283721e-05
for O 0 7.854933937778696e-05
Factor O 0 0.004204493016004562
B O 0 0.12728580832481384
and O 0 0.000898706610314548
HLA O 1 0.9999583959579468
- O 0 0.02953805774450302
D O 1 0.5733725428581238
, O 0 5.801984661957249e-05
in O 0 6.282572576310486e-05
which O 0 0.00020280297030694783
HLA O 1 0.9999173879623413
- O 0 0.024538792669773102
D O 1 0.9663198590278625
segregared O 0 0.09292741119861603
with O 0 0.0005294744623824954
HLA O 1 0.9996017813682556
- O 0 0.004947251174598932
A O 0 0.0019127029227092862
and O 0 0.0003008649218827486
B O 0 0.46688225865364075
. O 0 0.00040250748861581087

These O 0 0.0001211672934005037
studies O 0 0.0005968991317786276
suggest O 0 0.00024711998412385583
that O 0 6.982390004850458e-06
the O 0 1.4972624740039464e-05
genes O 0 3.138161628157832e-05
for O 0 5.994134335196577e-05
Factor O 0 0.005335845984518528
B O 1 0.9949262142181396
and O 0 0.004749692510813475
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.061514432076365e-05
located O 0 0.0005503663560375571
outside O 0 9.169235272565857e-05
those O 0 4.801968680112623e-05
for O 0 0.0008259234018623829
HLA O 1 0.999891996383667
, O 0 0.00012391124619171023
that O 0 1.0114584256371018e-05
the O 0 1.7867530914372765e-05
order O 0 1.3842558473697864e-05
of O 0 1.6741798390285112e-05
genese O 1 0.8110220432281494
is O 0 0.0014900144888088107
HLA O 1 0.9982169270515442
- O 0 0.002369847847148776
A O 0 0.0013800278538838029
, O 0 0.0002967677137348801
- O 0 0.0054604425095021725
B O 0 0.03360329195857048
, O 0 0.00030715009779669344
- O 0 0.009339573793113232
D O 1 0.522920548915863
, O 0 0.00010035085870185867
Factor O 0 0.0035388090182095766
B O 1 0.9165242314338684
allotype O 1 0.99636310338974
, O 0 0.007333924062550068
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.00014080278924666345
that O 0 7.156381343520479e-06
the O 0 1.4186464795784559e-05
genes O 0 9.026385669130832e-05
coding O 0 0.009371623396873474
for O 0 0.004222034942358732
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.0004905117093585432
Factor O 0 0.007143552880734205
B O 0 0.0933898389339447
allotypes O 0 0.029172874987125397
are O 0 8.512263775628526e-06
approximately O 0 0.0002498042013030499
3 O 0 0.0010016097221523523
- O 0 0.003200297011062503
- O 0 0.001757722464390099
5 O 0 0.0003618052287492901
centimorgans O 0 0.017364295199513435
from O 0 4.1362131014466286e-05
the O 0 0.00038747722283005714
HLA O 1 0.999661922454834
- O 0 0.0027174444403499365
A O 0 0.0014748660614714026
and O 0 0.00047054176684468985
HLA O 1 0.9999164342880249
- O 0 0.025701673701405525
B O 0 0.11459727585315704
loci O 0 0.008108248002827168
, O 0 8.853655162965879e-05
and O 0 4.044943489134312e-05
that O 0 2.749097802734468e-05
the O 0 0.00010633584315655753
apparent O 0 0.007269622292369604
lack O 0 0.0013281216379255056
of O 0 2.7670994313666597e-05
recombinants O 0 0.0690685287117958
between O 0 3.875859692925587e-05
the O 0 5.980419882689603e-05
Factor O 0 0.00354409241117537
B O 1 0.7109554409980774
gene O 0 0.003666393691673875
and O 0 0.0028774256352335215
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.007290450856089592
suggests O 0 0.001212532282806933
that O 0 1.883056029328145e-05
these O 0 4.9535797188582364e-06
two O 0 2.01113671209896e-05
genes O 0 0.0002773431478999555
lie O 0 0.0032577533274888992
in O 0 7.80656046117656e-05
close O 0 0.0008035397622734308
proximity O 0 0.0008786938851699233
to O 0 3.8189398765098304e-05
one O 0 4.523688767221756e-05
another O 0 0.00041319691808894277
. O 0 0.00032897357596084476

Distribution O 0 0.00023714637791272253
of O 0 6.048511932021938e-05
emerin O 1 0.533806562423706
and O 0 0.0005701925838366151
lamins O 1 0.9741790294647217
in O 0 0.00017150954226963222
the O 0 0.0004199066024739295
heart O 1 0.9999281167984009
and O 0 8.891627658158541e-05
implications O 0 0.00589454360306263
for O 0 0.0005557598196901381
Emery B-Disease 1 0.9998683929443359
- I-Disease 1 0.9972777962684631
Dreifuss I-Disease 1 0.9999996423721313
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
. O 0 0.0023474041372537613

Emerin O 1 0.5337746143341064
is O 0 0.0002668951347004622
a O 0 0.00016375690756831318
nuclear O 0 0.0009064133046194911
membrane O 0 0.0006562849739566445
protein O 0 0.00015408676699735224
which O 0 1.8760923921945505e-05
is O 0 0.00015517385327257216
missing O 0 0.0012807253515347838
or O 0 0.000250745564699173
defective O 1 0.9931935667991638
in O 0 0.00046838988782837987
Emery B-Disease 1 0.9997523427009583
- I-Disease 1 0.9971344470977783
Dreifuss I-Disease 1 0.9999997615814209
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.020862171426415443
EDMD B-Disease 1 0.9999921321868896
) O 0 0.0006709244335070252
. O 0 0.0003175777674186975

It O 0 0.00046429489157162607
is O 0 0.0001285700564039871
one O 0 4.330160663812421e-05
member O 0 8.703115599928424e-05
of O 0 5.914720986766042e-06
a O 0 0.00027165637584403157
family O 0 0.00029591479687951505
of O 0 8.303732465719804e-05
lamina O 1 0.999982476234436
- O 0 0.007032775320112705
associated O 0 7.96314561739564e-05
proteins O 0 1.880860872915946e-05
which O 0 2.7990006856271066e-05
includes O 0 0.0003202729276381433
LAP1 O 1 0.9981617331504822
, O 0 0.000603731197770685
LAP2 O 1 0.9952206015586853
and O 0 0.0004444505029823631
lamin O 1 0.9987002611160278
B O 1 0.8551586866378784
receptor O 0 0.018947871401906013
( O 0 0.0028467741794884205
LBR O 1 0.99994957447052
) O 0 0.0005621599266305566
. O 0 0.00027045930619351566

A O 0 0.0030778066720813513
panel O 0 0.0011846893467009068
of O 0 1.648454235692043e-05
16 O 0 0.0010578306391835213
monoclonal O 0 0.035250697284936905
antibodies O 0 0.02326819859445095
( O 0 0.002411315916106105
mAbs O 1 0.986530065536499
) O 0 0.0005128525081090629
has O 0 0.0003758668899536133
been O 0 0.0001722890738165006
mapped O 0 0.0010339750442653894
to O 0 2.3215488909045234e-05
six O 0 3.54225339833647e-05
specific O 0 4.3295374780427665e-05
sites O 0 6.259608926484361e-05
throughout O 0 5.2424660680117086e-05
the O 0 0.00010504743113415316
emerin O 0 0.038535043597221375
molecule O 0 0.0010722872102633119
using O 0 0.00029093396733514965
phage O 1 0.9149470925331116
- O 0 0.0034183834213763475
displayed O 0 0.0008109597838483751
peptide O 0 0.002888127462938428
libraries O 0 0.0007098232163116336
and O 0 7.888134132372215e-05
has O 0 0.00022066505334805697
been O 0 6.080829189158976e-05
used O 0 4.107056520297192e-05
to O 0 5.897046867175959e-05
localize O 0 0.11511452496051788
emerin O 0 0.09327074885368347
in O 0 0.00013831513933837414
human O 0 0.0009270802256651223
and O 0 0.0006662465166300535
rabbit O 1 0.9990424513816833
heart O 1 0.9999595880508423
. O 0 0.000702440447639674

Several O 0 0.0008758907206356525
mAbs O 0 0.24930769205093384
against O 0 0.00018214502779301256
different O 0 5.7927085435949266e-05
emerin O 1 0.8489651083946228
epitopes O 0 0.07962264120578766
did O 0 0.0005348577396944165
not O 0 7.589896267745644e-05
recognize O 0 0.00471696350723505
intercalated O 0 0.12312372028827667
discs O 0 0.0029968679882586002
in O 0 0.00011540549894561991
the O 0 0.000551655946765095
heart O 1 0.999984622001648
, O 0 0.0002055106742773205
though O 0 0.0001764189946698025
they O 0 3.0252918804762885e-05
recognized O 0 0.0014984880108386278
cardiomyocyte O 0 0.07538369297981262
nuclei O 0 0.0014297337038442492
strongly O 0 0.0009040908771567047
, O 0 7.744706090306863e-05
both O 0 5.897862138226628e-05
at O 0 0.00042793707689270377
the O 0 0.00018684346287045628
rim O 0 0.02864302322268486
and O 0 0.00011228173389099538
in O 0 0.0003496572026051581
intranuclear O 1 0.9645057320594788
spots O 0 0.007125164847820997
or O 0 0.0002427264116704464
channels O 0 0.0006890373770147562
. O 0 0.0003638093767222017

A O 0 0.01425111386924982
polyclonal O 1 0.9593238830566406
rabbit O 1 0.9194433689117432
antiserum O 1 0.9769431352615356
against O 0 0.0019569164142012596
emerin O 1 0.9875090718269348
did O 0 0.0010089892894029617
recognize O 0 0.0018827413441613317
both O 0 5.9267804317642e-05
nuclear O 0 0.0019617313519120216
membrane O 0 0.001933107036165893
and O 0 0.00022296648239716887
intercalated O 1 0.9276041388511658
discs O 0 0.005792135372757912
but O 0 0.00015625476953573525
, O 0 8.954424265539274e-05
after O 0 0.00040960771730169654
affinity O 0 0.0010718554258346558
purification O 0 0.005547164008021355
against O 0 0.00010727158223744482
a O 0 0.0003185344685334712
pure O 0 0.003837337950244546
- O 0 0.009818843565881252
emerin O 0 0.07237037271261215
band O 0 0.0007125973934307694
on O 0 7.89981713751331e-05
a O 0 0.0003446668270044029
western O 0 0.0015308413421735168
blot O 1 0.9955766201019287
, O 0 0.0003504215565044433
it O 0 0.00025207785074599087
stained O 1 0.9900434017181396
only O 0 3.0062590667512268e-05
the O 0 5.643563054036349e-05
nuclear O 0 0.0025412391405552626
membrane O 0 0.003393906634300947
. O 0 0.0003070438397116959

These O 0 8.843732211971655e-05
results O 0 0.0004034029261674732
would O 0 6.93186666467227e-05
not O 0 2.839202898030635e-05
be O 0 2.3446795239578933e-05
expected O 0 0.00021346926223486662
if O 0 0.00037238624645397067
immunostaining O 0 0.48038622736930847
at O 0 0.0015866024186834693
intercalated O 1 0.8877479434013367
discs O 0 0.0039713457226753235
were O 0 3.6008965253131464e-05
due O 0 0.00039373544859699905
to O 0 2.2356369299814105e-05
a O 0 7.817548612365499e-05
product O 0 0.00019250997866038233
of O 0 8.11888457974419e-06
the O 0 0.00033839757088571787
emerin O 1 0.985451340675354
gene O 0 0.0020340674091130495
and O 0 0.00010799228766700253
, O 0 0.00015855439414735883
therefore O 0 0.00033463153522461653
, O 0 7.491120777558535e-05
cast O 0 7.389886013697833e-05
some O 0 1.8379350876784883e-05
doubt O 0 0.000696804840117693
upon O 0 8.403849642490968e-05
the O 0 6.007050251355395e-05
hypothesis O 0 0.0024794775526970625
that O 0 0.00040455051930621266
cardiac B-Disease 1 0.9999998807907104
defects I-Disease 1 0.999992847442627
in O 0 0.0012518567964434624
EDMD B-Disease 1 0.9999927282333374
are O 0 7.808153895894065e-05
caused O 0 0.0028673179913312197
by O 0 3.323035343782976e-05
absence O 0 0.0016855556750670075
of O 0 2.765527278825175e-05
emerin O 1 0.8978453874588013
from O 0 0.000209361023735255
intercalated O 1 0.8950324058532715
discs O 0 0.009453633800148964
. O 0 0.0003965621581301093

Although O 0 0.00301183364354074
emerin O 0 0.12007605284452438
was O 0 0.0007109118159860373
abundant O 0 0.0003568185493350029
in O 0 4.183857890893705e-05
the O 0 7.644119614269584e-05
membranes O 0 0.006340597756206989
of O 0 3.721380926435813e-05
cardiomyocyte O 1 0.9840770959854126
nuclei O 0 0.002364699263125658
, O 0 0.00011319583427393809
it O 0 9.275062620872632e-05
was O 0 0.0007325351471081376
absent O 0 0.002561854897066951
from O 0 2.0977973690605722e-05
many O 0 2.619311271701008e-05
non O 0 0.004112730734050274
- O 0 0.012739777565002441
myocyte O 1 0.9714789390563965
cells O 0 0.001351068029180169
in O 0 6.496284186141565e-05
the O 0 0.0005291003617458045
heart O 1 0.9999858140945435
. O 0 0.0005296715535223484

This O 0 6.644015957135707e-05
distribution O 0 7.484922389267012e-05
of O 0 4.837663072976284e-05
emerin O 1 0.9417605996131897
was O 0 0.0008893173653632402
similar O 0 5.276894080452621e-05
to O 0 1.842392339312937e-05
that O 0 1.1784520211222116e-05
of O 0 3.2802028727019206e-05
lamin O 1 0.9990924596786499
A O 0 0.004352586343884468
, O 0 0.00014805445971433073
a O 0 0.00033839806565083563
candidate O 0 0.0009566429071128368
gene O 0 0.0003597001195885241
for O 0 5.060705734649673e-05
an O 0 0.00021552876569330692
autosomal O 0 0.44496145844459534
form O 0 0.0005522219580598176
of O 0 0.00019375814008526504
EDMD B-Disease 1 0.9999936819076538
. O 0 0.0010854200227186084

In O 0 0.00042373445467092097
contrast O 0 0.002611973090097308
, O 0 0.0016575310146436095
lamin O 1 0.9999055862426758
B1 O 1 0.9999915361404419
was O 0 0.0038044287357479334
absent O 0 0.0062726992182433605
from O 0 0.0001409826654708013
cardiomyocyte O 0 0.06374025344848633
nuclei O 0 0.0013076550094410777
, O 0 0.00011624034232227132
showing O 0 0.0013189787277951837
that O 0 0.00043525113142095506
lamin O 1 0.9998804330825806
B1 O 1 0.9999904632568359
is O 0 0.00036600971361622214
not O 0 3.5453187592793256e-05
essential O 0 0.0006167495739646256
for O 0 7.360684685409069e-05
localization O 0 0.002964167157188058
of O 0 2.357688754273113e-05
emerin O 0 0.062263067811727524
to O 0 4.848378011956811e-05
the O 0 0.00013867752568330616
nuclear O 0 0.01514182984828949
lamina O 1 0.9998635053634644
. O 0 0.0008360042702406645

Lamin O 1 0.9999029636383057
B1 O 1 0.9999783039093018
is O 0 0.0005161687731742859
also O 0 7.454365550074726e-05
almost O 0 0.00017996225506067276
completely O 0 0.0028998469933867455
absent O 0 0.004065756686031818
from O 0 0.0001979594526346773
skeletal O 1 0.9999555349349976
muscle O 1 0.9989609718322754
nuclei O 0 0.0069824205711483955
. O 0 0.0005740360938943923

In O 0 0.003073738422244787
EDMD B-Disease 1 0.9996484518051147
, O 0 0.00014514430949930102
the O 0 3.60430458385963e-05
additional O 0 0.00011239346349611878
absence O 0 0.0012289719888940454
of O 0 9.15652999537997e-05
lamin O 1 0.9999302625656128
B1 O 1 0.9999961853027344
from O 0 0.0009100712486542761
heart O 1 0.9999868869781494
and O 0 0.0008057173690758646
skeletal O 1 0.9999872446060181
muscle O 1 0.9997283816337585
nuclei O 0 0.0025951331481337547
which O 0 0.00010386134090367705
already O 0 0.0010685714660212398
lack O 0 0.008509010076522827
emerin O 1 0.9972692131996155
may O 0 0.001357752364128828
offer O 0 0.0004069235874339938
an O 0 6.398734694812447e-05
alternative O 0 0.0006047580973245203
explanation O 0 0.0006737543735653162
of O 0 1.8176371668232605e-05
why O 0 0.0011900822864845395
these O 0 3.914162880391814e-05
tissues O 0 0.11973722279071808
are O 0 2.896779369621072e-05
particularly O 0 0.0011705836514011025
affected O 0 0.004848997574299574
. O 0 0.0001395131112076342
. O 0 0.00022979376080911607

Genetic O 0 0.001972739351913333
mapping O 0 0.00098386500030756
of O 0 1.0638532330631278e-05
the O 0 0.0003452671808190644
copper B-Disease 1 0.9893150329589844
toxicosis I-Disease 1 0.9997326731681824
locus O 0 0.028736108914017677
in O 0 0.0010460509220138192
Bedlington O 1 0.9990980625152588
terriers O 0 0.46910518407821655
to O 0 0.0003130142285954207
dog O 0 0.025335220620036125
chromosome O 0 0.0020537746604532003
10 O 0 0.0002474278735462576
, O 0 6.493868568213657e-05
in O 0 5.561272701015696e-05
a O 0 0.0004126717976760119
region O 0 0.0026425474788993597
syntenic O 0 0.06911412626504898
to O 0 6.272610335145146e-05
human O 0 0.0004749201179947704
chromosome O 0 0.0014491237234324217
region O 0 0.002343845786526799
2p13 O 0 0.133265882730484
- O 0 0.01152132824063301
p16 O 0 0.06443832814693451
. O 0 0.0004200983385089785

Abnormal O 1 0.9995854496955872
hepatic B-Disease 1 0.9999991655349731
copper I-Disease 1 0.983346700668335
accumulation I-Disease 0 0.033270739018917084
is O 0 0.0003003665478900075
recognized O 0 0.0007293830276466906
as O 0 0.00017787858087103814
an O 0 0.001454744953662157
inherited B-Disease 1 0.9999995231628418
disorder I-Disease 1 1.0
in O 0 0.001059940317645669
man O 0 0.007130845449864864
, O 0 0.0003661566006485373
mouse O 0 0.008485764265060425
, O 0 0.0005314703448675573
rat O 1 0.8574245572090149
and O 0 0.00038995282375253737
dog O 0 0.04548611864447594
. O 0 0.0005487778107635677

The O 0 0.00031117009348236024
major O 0 0.0016162589890882373
cause O 0 0.004816915839910507
of O 0 0.0001107170173781924
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9884592890739441
accumulation I-Disease 0 0.0365019328892231
in O 0 0.0002732953289523721
man O 0 0.0021401389967650175
is O 0 0.00012330940808169544
a O 0 0.0007636261871084571
dysfunctional O 1 0.9959133267402649
ATP7B O 1 0.9989722967147827
gene O 0 0.002494360785931349
, O 0 0.0002542526344768703
causing O 1 0.9935477375984192
Wilson B-Disease 1 0.9999477863311768
disease I-Disease 1 0.9999998807907104
( O 0 0.004465432837605476
WD B-Disease 1 0.9998766183853149
) O 0 0.0005336175672709942
. O 0 0.0002685317595023662

Mutations O 0 0.00519126420840621
in O 0 0.00012127863010391593
the O 0 0.0003948066441807896
ATP7B O 1 0.9765222072601318
genes O 0 0.0002660455647855997
have O 0 3.466564157861285e-05
also O 0 6.75386399962008e-05
been O 0 0.00013023432984482497
demonstrated O 0 0.0014499712269753218
in O 0 0.00015654080198146403
mouse O 0 0.006805075332522392
and O 0 0.0004797627916559577
rat O 1 0.886419415473938
. O 0 0.0004612229822669178

The O 0 0.002195953857153654
ATP7B O 1 0.9944742321968079
gene O 0 0.002904864028096199
has O 0 0.00038451398722827435
been O 0 0.00013605813728645444
excluded O 0 0.0007912073051556945
in O 0 1.91295566764893e-05
the O 0 2.3008877178654075e-05
much O 0 0.00028082853532396257
rarer O 1 0.7963575124740601
human O 0 0.002383550861850381
copper B-Disease 1 0.9993122816085815
overload I-Disease 1 0.9999936819076538
disease O 1 0.9999998807907104
non B-Disease 0 0.008847387507557869
- I-Disease 0 0.012431546114385128
Indian I-Disease 0 0.0027422623243182898
childhood I-Disease 1 0.9999338388442993
cirrhosis I-Disease 1 0.9999998807907104
, O 0 0.0005446335999295115
indicating O 0 0.003165250876918435
genetic O 0 0.0023378056939691305
heterogeneity O 0 0.024805357679724693
. O 0 0.0005836065392941236

By O 0 0.00016037505702115595
investigating O 0 0.0027787124272435904
the O 0 0.0001585132849868387
common O 0 0.004033626522868872
autosomal O 1 0.9996693134307861
recessive O 1 0.9998465776443481
copper B-Disease 1 0.9996067881584167
toxicosis I-Disease 1 0.9999951124191284
( O 0 0.011746005155146122
CT B-Disease 1 0.9999922513961792
) O 0 0.0005009226151742041
in O 0 0.0006405669264495373
Bedlington O 1 0.9992110729217529
terriers O 1 0.8503909111022949
, O 0 0.0002312789874849841
we O 0 9.528698865324259e-05
have O 0 2.6263400286552496e-05
identified O 0 0.00011411629384383559
a O 0 7.618474046466872e-05
new O 0 8.180949225788936e-05
locus O 0 0.004669455345720053
involved O 0 0.00041974170017056167
in O 0 0.00036692258436232805
progressive O 1 0.9999970197677612
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0013111695880070329

We O 0 0.000697089359164238
examined O 0 0.005501238163560629
whether O 0 0.00024431574274785817
the O 0 0.000463781354483217
WD B-Disease 1 0.9997747540473938
gene O 0 0.006909999996423721
ATP7B O 1 0.9920544624328613
was O 0 0.0008929893956519663
also O 0 0.00014141136489342898
causative O 0 0.08546939492225647
for O 0 0.0010011889971792698
CT B-Disease 1 0.9999769926071167
by O 0 6.197350012371317e-05
investigating O 0 0.0035498833749443293
the O 0 0.0003159928019158542
chromosomal O 0 0.045896977186203
co O 0 0.018498029559850693
- O 0 0.0026276118587702513
localization O 0 0.002811393467709422
of O 0 6.865790055599064e-05
ATP7B O 1 0.9985033273696899
and O 0 0.0003691143065225333
C04107 O 0 0.026406720280647278
, O 0 6.479345029219985e-05
using O 0 5.6097105698427185e-05
fluorescence O 0 0.007936942391097546
in O 0 0.00017466821009293199
situ O 0 0.050233397632837296
hybridization O 0 0.001485674176365137
( O 0 0.0004154038615524769
FISH O 0 0.0036044642329216003
) O 0 0.0002553696685936302
. O 0 0.0002378175122430548

C04107 O 0 0.0529521219432354
is O 0 0.00015962019097059965
an O 0 0.00010831756662810221
anonymous O 0 0.0029564376454800367
microsatellite O 0 0.050949662923812866
marker O 0 0.008759358897805214
closely O 0 0.000679372635204345
linked O 0 0.0055501325987279415
to O 0 0.000619924277998507
CT B-Disease 1 0.9999856948852539
. O 0 0.0006365678273141384

However O 0 0.0013145969714969397
, O 0 0.0007410000544041395
BAC O 1 0.997086226940155
clones O 0 0.006973813753575087
containing O 0 0.0005119023262523115
ATP7B O 1 0.9960964322090149
and O 0 0.0002750579733401537
C04107 O 0 0.03472840040922165
mapped O 0 0.0020184768363833427
to O 0 3.813494913629256e-05
the O 0 0.0002067630412057042
canine O 1 0.9765263199806213
chromosome O 0 0.0035267092753201723
regions O 0 0.0013724548043683171
CFA22q11 O 1 0.9739257097244263
and O 0 0.0005159203428775072
CFA10q26 O 1 0.9920824766159058
, O 0 0.00020274885173421353
respectively O 0 0.0004172526823822409
, O 0 0.00011619944416452199
demonstrating O 0 0.00432093208655715
that O 0 0.0003889392246492207
WD B-Disease 1 0.9989275336265564
cannot O 0 0.0006950324168428779
be O 0 4.874357910011895e-05
homologous O 0 0.0019967735279351473
to O 0 0.0006688846042379737
CT B-Disease 1 0.9999603033065796
. O 0 0.0005619097501039505

The O 0 0.0007285653846338391
copper O 0 0.02614670619368553
transport O 0 0.009599283337593079
genes O 0 0.0013330994406715035
CTR1 O 1 0.9960336089134216
and O 0 0.0007901539211161435
CTR2 O 1 0.9967256784439087
were O 0 5.1913630159106106e-05
also O 0 0.00011012799222953618
excluded O 0 0.0012687068665400147
as O 0 5.914359280723147e-05
candidate O 0 0.0004978587385267019
genes O 0 0.00015271765005309135
for O 0 0.0008929328178055584
CT B-Disease 1 0.9999958276748657
since O 0 0.0005979793495498598
they O 0 1.2215790775371715e-05
both O 0 2.8002128601656295e-05
mapped O 0 0.001717915991321206
to O 0 0.00014406218542717397
canine O 1 0.9919931888580322
chromosome O 0 0.0045738122425973415
region O 0 0.004143976606428623
CFA11q22 O 1 0.9283697605133057
. O 0 0.0006236280896700919

2 O 0 0.0039419191889464855
- O 0 0.005169940181076527
22 O 0 0.0009405257296748459
. O 0 0.00024902066797949374

5 O 0 0.0023326887749135494
. O 0 0.00038296577986329794

A O 0 0.0028251102194190025
transcribed O 0 0.000850277952849865
sequence O 0 7.119638758013025e-05
identified O 0 0.0002277818857692182
from O 0 2.5012821424752474e-05
the O 0 0.00015419624105561525
C04107 O 0 0.10096003115177155
- O 0 0.005002066493034363
containing O 0 0.0008619973086751997
BAC O 1 0.9984459280967712
was O 0 0.0010134624317288399
found O 0 0.00010142836254090071
to O 0 2.1552954422077164e-05
be O 0 2.5151073714368977e-05
homologous O 0 0.000730056082829833
to O 0 2.1312953322194517e-05
a O 0 0.00019394594710320234
gene O 0 0.0005360799259506166
expressed O 0 0.00010259644477628171
from O 0 3.004452992172446e-05
human O 0 0.000813343736808747
chromosome O 0 0.004621467553079128
2p13 O 0 0.32750824093818665
- O 0 0.013179376721382141
p16 O 0 0.052775297313928604
, O 0 0.00015022853040136397
a O 0 0.0003241566591896117
region O 0 0.0009264328982681036
devoid O 0 0.002061443403363228
of O 0 4.638036898541031e-06
any O 0 4.4321161112748086e-05
positional O 0 0.005649235099554062
candidate O 0 0.001059798989444971
genes O 0 0.00029457968776114285
. O 0 0.00025294575607404113

Molecular O 0 0.002792119747027755
analysis O 0 7.402327901218086e-05
of O 0 8.24148446554318e-06
the O 0 0.00041601393604651093
APC B-Disease 1 0.994749128818512
gene O 0 0.001464111264795065
in O 0 0.00016378829604946077
205 O 0 0.008482580073177814
families O 0 0.00022259731485974044
: O 0 0.00016787907225079834
extended O 0 0.0019346082117408514
genotype O 0 0.1921221911907196
- O 0 0.014148562215268612
phenotype O 0 0.030652988702058792
correlations O 0 0.005733409430831671
in O 0 0.0009443135932087898
FAP B-Disease 1 0.9999734163284302
and O 0 0.00019517846521921456
evidence O 0 0.00017461206880398095
for O 0 4.0726099541643634e-05
the O 0 4.1129751480184495e-05
role O 0 0.0005235603312030435
of O 0 2.3448270439985208e-05
APC B-Disease 1 0.8628291487693787
amino O 0 0.00021626382658723742
acid O 0 0.004774461500346661
changes O 0 0.0005831950693391263
in O 0 0.01938059739768505
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999430179595947
. O 0 0.0007409090176224709

BACKGROUND O 0 0.07790634036064148
/ O 0 0.1822839230298996
AIMS O 0 0.010432339273393154
The O 0 0.0001026808240567334
development O 0 0.0015258756466209888
of O 0 0.0009628654806874692
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00013613144983537495
a O 0 0.00018943905888590962
variable O 0 0.00035671787918545306
range O 0 0.00018522539176046848
of O 0 3.0075319955358282e-05
extracolonic O 1 0.9890239238739014
manifestations O 1 0.9881474375724792
in O 0 0.001680396031588316
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.0681336373090744
FAP B-Disease 1 0.999992847442627
) O 0 0.0005120406276546419
is O 0 9.272355964640155e-05
the O 0 4.513188105192967e-05
result O 0 8.446656283922493e-05
of O 0 3.671379545266973e-06
the O 0 6.308127922238782e-05
dominant O 0 0.0030018645338714123
inheritance O 0 0.003468697192147374
of O 0 0.0005734346341341734
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999982118606567
( O 0 0.004682471044361591
APC B-Disease 1 0.9990554451942444
) O 0 0.0004775368724949658
gene O 0 0.0016966299153864384
mutations O 0 0.0015622384380549192
. O 0 0.00025311074568890035

In O 0 0.000301220832625404
this O 0 4.155387796345167e-05
study O 0 0.0005459215026348829
, O 0 3.97024086851161e-05
direct O 0 0.00014543191355187446
mutation O 0 0.0004365488130133599
analysis O 0 4.391261245473288e-05
of O 0 7.85768042987911e-06
the O 0 0.0005102683790028095
APC B-Disease 1 0.9990222454071045
gene O 0 0.0026497619692236185
was O 0 0.0006047678762115538
performed O 0 0.0003461753949522972
to O 0 3.9869733882369474e-05
determine O 0 0.0008599560824222863
genotype O 0 0.08494476228952408
- O 0 0.010346162132918835
phenotype O 0 0.01860680989921093
correlations O 0 0.001568828709423542
for O 0 0.00011969954357482493
nine O 0 0.0008094935910776258
extracolonic O 1 0.9732471704483032
manifestations O 0 0.4678056240081787
and O 0 9.968400991056114e-05
to O 0 7.617428491357714e-05
investigate O 0 0.002779676578938961
the O 0 0.00018730259034782648
incidence O 1 0.9901373386383057
of O 0 5.2189618145348504e-05
APC B-Disease 1 0.9980912804603577
mutations O 0 0.0008273550774902105
in O 0 8.928349416237324e-05
non O 0 0.08497460931539536
- O 1 0.9999444484710693
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0010853300336748362

METHODS O 0 0.004546601325273514
The O 0 0.0011567368637770414
APC B-Disease 1 0.9820036292076111
gene O 0 0.0016225003637373447
was O 0 0.00048735702876001596
analysed O 0 0.001267833518795669
in O 0 9.04508342500776e-05
190 O 0 0.006051803007721901
unrelated O 0 0.01442765910178423
FAP B-Disease 1 0.9998563528060913
and O 0 0.0001377722801407799
15 O 0 0.0005562935257330537
non O 0 0.03606661409139633
- O 1 0.9999767541885376
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999862909317017
using O 0 0.0003611612773966044
denaturing O 1 0.9625447392463684
gradient O 0 0.055066145956516266
gel O 1 0.9920846223831177
electrophoresis O 0 0.03038877435028553
, O 0 7.227267633425072e-05
the O 0 3.94506350858137e-05
protein O 0 0.000618418853264302
truncation O 0 0.029441572725772858
test O 0 0.0025455504655838013
, O 0 7.271663343999535e-05
and O 0 2.289318035764154e-05
direct O 0 8.489835454383865e-05
sequencing O 0 0.000684836704749614
. O 0 0.00027470625354908407

RESULTS O 0 0.016314007341861725
Chain O 0 0.01616150513291359
terminating O 0 0.08954522013664246
signals O 0 0.0008000839734449983
were O 0 1.3404536730377004e-05
only O 0 2.447177394060418e-05
identified O 0 0.0005890209577046335
in O 0 0.0002836152561940253
patients O 1 0.9999066591262817
belonging O 0 0.00035281057353131473
to O 0 4.174189962213859e-05
the O 0 0.0004796809225808829
FAP B-Disease 1 0.9999090433120728
group O 0 0.0010085096582770348
( O 0 0.0008108144975267351
105 O 0 0.017956940457224846
patients O 1 0.999962568283081
) O 0 0.00035003191442228854
. O 0 0.00023126114683691412

Amino O 0 0.0012026057811453938
acid O 0 0.006830061785876751
changes O 0 0.00019880005856975913
were O 0 2.3316886654356495e-05
identified O 0 0.00032236179686151445
in O 0 0.00011478694068500772
four O 0 0.00042206645593978465
patients O 1 0.9999841451644897
, O 0 8.869745215633884e-05
three O 0 1.957949461939279e-05
of O 0 1.4829696738161147e-05
whom O 0 0.001453425269573927
belonged O 0 0.0006947233923710883
to O 0 1.8578552044345997e-05
the O 0 6.724123522872105e-05
non O 0 0.004706815350800753
- O 0 0.06407083570957184
FAP O 1 0.9998776912689209
group O 0 0.0004647255118470639
of O 0 0.0007785235648043454
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999992847442627
. O 0 0.0004937563207931817

Genotype O 1 0.9589014649391174
- O 0 0.03589559346437454
phenotype O 0 0.046002574265003204
correlations O 0 0.004549600649625063
identified O 0 0.0005696100415661931
significant O 0 0.000281008513411507
differences O 0 0.0006386053864844143
in O 0 8.53367309900932e-05
the O 0 7.07201543264091e-05
nature O 0 0.00047018975601531565
of O 0 7.955172804940958e-06
certain O 0 0.0003204790991730988
extracolonic O 1 0.9964224100112915
manifestations O 1 0.9954114556312561
in O 0 0.0026483095716685057
FAP B-Disease 1 0.9999991655349731
patients O 1 0.9999510049819946
belonging O 0 0.0005485817673616111
to O 0 2.585307629487943e-05
three O 0 3.531345646479167e-05
mutation O 0 0.0012195899616926908
subgroups O 0 0.0023407982662320137
. O 0 0.00038923803367652

CONCLUSIONS O 0 0.014952590689063072
Extended O 0 0.005538443569093943
genotype O 0 0.195046067237854
- O 0 0.015204306691884995
phenotype O 0 0.027191562578082085
correlations O 0 0.001973881386220455
made O 0 0.00011557541438378394
in O 0 7.36983711249195e-05
this O 0 5.490073453984223e-05
study O 0 0.001697523519396782
may O 0 0.0006561232730746269
have O 0 2.6971874831360765e-05
the O 0 6.216468318598345e-05
potential O 0 0.0005061148549430072
to O 0 2.9502742108888924e-05
determine O 0 0.00011919394455617294
the O 0 2.5147117412416264e-05
most O 0 3.471116360742599e-05
appropriate O 0 0.0006783459102734923
surveillance O 0 0.004411931149661541
and O 0 0.0005733455182053149
prophylactic O 1 0.9999982118606567
treatment O 1 0.9999985694885254
regimens O 1 0.9996800422668457
for O 0 0.0002088740875478834
those O 0 0.00027549834339879453
patients O 1 0.9999921321868896
with O 0 9.53394192038104e-05
mutations O 0 0.0019455298315733671
associated O 0 0.00020359734480734915
with O 0 7.398318848572671e-05
life O 0 0.005091724451631308
threatening O 1 0.9898498058319092
conditions O 0 0.019875723868608475
. O 0 0.0006252761231735349

This O 0 0.00016726585454307497
study O 0 0.000640492478851229
also O 0 7.883021316956729e-05
provided O 0 0.00023417019110638648
evidence O 0 0.00013122960808686912
for O 0 8.165081089828163e-05
the O 0 0.00026637245900928974
pathological O 1 0.9907752871513367
nature O 0 0.0006303194095380604
of O 0 6.3869429141050205e-06
amino O 0 0.00023347775277215987
acid O 0 0.005893015302717686
changes O 0 0.0003743688575923443
in O 0 0.00037986572715453804
APC O 1 0.99221271276474
associated O 0 0.0002840458182618022
with O 0 2.7862814022228122e-05
both O 0 0.0003077489382121712
FAP B-Disease 1 0.999901294708252
and O 0 0.00015716717462055385
non O 0 0.15046986937522888
- O 1 0.9999805688858032
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999996423721313
. O 0 0.00018046522745862603
. O 0 0.0002034312201431021

Inherited B-Disease 1 0.9999992847442627
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.3181002140045166
cancer B-Disease 1 1.0
risk O 0 0.014436259865760803
of O 0 1.0972214113280643e-05
the O 0 0.0004058621416334063
APC O 1 0.9989920258522034
I1307K O 0 0.05875318869948387
polymorphism O 0 0.003921575378626585
. O 0 0.00036727378028444946

Germ O 1 0.9997033476829529
- O 0 0.01206206064671278
line O 0 0.0015287931310012937
and O 0 0.000165398174431175
somatic O 0 0.015506203286349773
truncating O 0 0.08517828583717346
mutations O 0 0.0005074007203802466
of O 0 1.0102619853569195e-05
the O 0 0.00040210134466178715
APC B-Disease 1 0.9975481629371643
gene O 0 0.0008482254925183952
are O 0 8.365059329662472e-06
thought O 0 0.00025209563318639994
to O 0 8.02404319983907e-05
initiate O 1 0.9955646991729736
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999982118606567
formation O 0 0.0950932726264
in O 0 0.0017437022179365158
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.0018225411185994744
sporadic O 1 0.9994058609008789
colorectal O 1 1.0
carcinogenesis O 1 0.9999974966049194
, O 0 0.0005017849616706371
respectively O 0 0.0008749125991016626
. O 0 0.0002838181098923087

Recently O 0 0.008069316856563091
, O 0 0.00010975822806358337
an O 0 0.00034918132587336004
isoleucine O 1 0.9881459474563599
- O 0 0.016455568373203278
- O 0 0.005680291447788477
> O 0 0.007184632588177919
lysine O 0 0.01001738104969263
polymorphism O 0 0.00171274587046355
at O 0 0.001165830297395587
codon O 0 0.014171314425766468
1307 O 1 0.849162220954895
( O 0 0.0013424052158370614
I1307K O 0 0.03182597830891609
) O 0 4.53565880889073e-05
of O 0 4.884974714514101e-06
the O 0 0.0003507633227854967
APC B-Disease 1 0.9948568344116211
gene O 0 0.0022497461177408695
has O 0 0.0003537113079801202
been O 0 0.00014829252904746681
identified O 0 0.00029501167591661215
in O 0 7.834556890884414e-05
6 O 0 0.0010763853788375854
% O 0 0.0001281536533497274
- O 0 0.0032442298252135515
7 O 0 0.00032723936601541936
% O 0 9.73796340986155e-06
of O 0 8.69424366101157e-06
the O 0 0.0003867388586513698
Ashkenazi O 1 0.9215755462646484
Jewish O 0 0.0014561205171048641
population O 0 0.00012558982416521758
. O 0 0.00034966436214745045

To O 0 0.0005365307442843914
assess O 0 0.012307178229093552
the O 0 0.00020236585987731814
risk O 0 0.004732517991214991
of O 0 4.817756234842818e-06
this O 0 3.135947554255836e-05
common O 0 0.003255245741456747
APC B-Disease 1 0.9990801811218262
allelic O 0 0.40354123711586
variant O 1 0.5307339429855347
in O 0 0.004749069921672344
colorectal O 1 1.0
carcinogenesis O 1 0.9999943971633911
, O 0 0.0005575622199103236
we O 0 9.539717575535178e-05
have O 0 1.707111732685007e-05
analyzed O 0 0.00023907357535790652
a O 0 7.527856359956786e-05
large O 0 9.236368350684643e-05
cohort O 0 0.003049073973670602
of O 0 3.160099367960356e-05
unselected O 1 0.9417948126792908
Ashkenazi O 1 0.9578269124031067
Jewish O 0 0.0015139953466132283
subjects O 0 0.0028924013022333384
with O 0 0.0011945581063628197
adenomatous B-Disease 1 0.9999998807907104
polyps I-Disease 1 0.9999673366546631
and O 0 0.0002088143810397014
. O 0 0.0003283353289589286
or O 1 0.5782032608985901
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.0001499187055742368
for O 0 7.408994133584201e-05
the O 0 0.0003332501801196486
APC O 1 0.9969828724861145
I1307K O 0 0.05854473263025284
polymorphism O 0 0.003358483547344804
. O 0 0.00036075367825105786

The O 0 0.0020784293301403522
APC O 1 0.9867749214172363
I1307K O 0 0.070778489112854
allele O 0 0.005822150036692619
was O 0 0.0010960591025650501
identified O 0 0.0004362738982308656
in O 0 9.368932660436258e-05
48 O 0 0.0019020512700080872
( O 0 0.0003628430131357163
10 O 0 0.0003098072484135628
. O 0 5.946878081886098e-05
1 O 0 0.000410045642638579
% O 0 2.8405353077687323e-05
) O 0 5.174795296625234e-05
of O 0 5.1562339649535716e-05
476 O 1 0.9980807304382324
patients O 1 0.9999892711639404
. O 0 0.0005212125834077597

Compared O 0 0.0023916445206850767
with O 0 4.476252797758207e-05
the O 0 9.164164657704532e-05
frequency O 0 0.00021953035320620984
in O 0 6.0396927437977865e-05
two O 0 1.3473139915731736e-05
separate O 0 6.0144269809825346e-05
population O 0 2.914213291660417e-05
control O 0 0.0005010211607441306
groups O 0 2.940297417808324e-05
, O 0 9.238570783054456e-05
the O 0 0.0005721587222069502
APC O 1 0.9973382353782654
I1307K O 0 0.12879523634910583
allele O 0 0.008695409633219242
is O 0 0.00047094677574932575
associated O 0 0.00016338552813977003
with O 0 1.7672902686172165e-05
an O 0 0.00010192584886681288
estimated O 0 0.0005332306609489024
relative O 0 0.0006806110613979399
risk O 0 0.008258211426436901
of O 0 2.5791983716771938e-05
1 O 0 0.0016378351720049977
. O 0 0.0002928578178398311

5 O 0 0.003641157178208232
- O 0 0.0037452583201229572
1 O 0 0.0008049629395827651
. O 0 0.00023304163187276572

7 O 0 0.0026510138995945454
for O 0 0.002230284037068486
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.999971866607666
( O 0 0.001110495999455452
both O 0 0.0004815684224013239
P O 1 0.9417226314544678
= O 0 0.009175235405564308
. O 0 0.0004768916987814009
01 O 1 0.9967321157455444
) O 0 0.00037648066063411534
. O 0 0.00022758127306587994

Furthermore O 0 0.006193086970597506
, O 0 0.00017334369476884604
compared O 0 0.0004939537029713392
with O 0 0.00015962567704264075
noncarriers O 1 0.9878159165382385
, O 0 0.0014565670862793922
APC O 1 0.9986269474029541
I1307K O 0 0.19588468968868256
carriers O 0 0.008637976832687855
had O 0 0.00015861548308748752
increased O 0 4.350591916590929e-05
numbers O 0 8.98190319276182e-06
of O 0 2.6912723114946857e-05
adenomas B-Disease 1 0.9999765157699585
and O 0 0.005850634071975946
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999943971633911
per O 0 0.0008196875569410622
patient O 1 0.9998856782913208
( O 0 0.0016021949704736471
P O 1 0.9806962609291077
= O 0 0.010199615731835365
. O 0 0.00046784040750935674
03 O 1 0.9766923189163208
) O 0 0.00018609529070090503
, O 0 7.264088344527408e-05
as O 0 5.383814641390927e-05
well O 0 6.445708277169615e-05
as O 0 8.659323793835938e-05
a O 0 0.0005398023640736938
younger O 0 0.0026030910667032003
age O 0 0.001454932615160942
at O 0 0.006010029464960098
diagnosis O 1 0.9999996423721313
. O 0 0.00071940035559237

We O 0 0.0005073905922472477
conclude O 0 0.0020569791086018085
that O 0 1.9256453015259467e-05
the O 0 0.00021541924797929823
APC O 1 0.9973697662353516
I1307K O 0 0.12159251421689987
variant O 0 0.01636197231709957
leads O 0 0.0011779367923736572
to O 0 6.885105540277436e-05
increased O 0 0.003259078599512577
adenoma B-Disease 1 0.9999998807907104
formation O 0 0.01983797550201416
and O 0 9.71660774666816e-05
directly O 0 0.00034126947866752744
contributes O 0 0.008097134530544281
to O 0 7.699793059146032e-05
3 O 0 0.0004733935638796538
% O 0 6.682507955702022e-05
- O 0 0.0016324236057698727
4 O 0 0.0001449979463359341
% O 0 4.0502882256987505e-06
of O 0 2.902599817389273e-06
all O 0 5.909499304834753e-05
Ashkenazi O 1 0.9998297691345215
Jewish O 1 0.9993487000465393
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0012131133116781712

The O 0 0.0003068969235755503
estimated O 0 0.0006402721046470106
relative O 0 0.00102860142942518
risk O 0 0.05351829156279564
for O 0 0.0004274317470844835
carriers O 0 0.020625188946723938
may O 0 0.00126524711959064
justify O 0 0.007539363112300634
specific O 0 0.0008659578743390739
clinical O 1 0.9999477863311768
screening O 0 0.004601981490850449
for O 0 9.503000910626724e-05
the O 0 0.00021301466040313244
360 O 0 0.009920818731188774
, O 0 0.00026680249720811844
000 O 0 0.0030898917466402054
Americans O 0 0.00043105578515678644
expected O 0 0.0002668363449629396
to O 0 5.182242239243351e-05
harbor O 0 0.006448084954172373
this O 0 3.9436494262190536e-05
allele O 0 0.0029548779129981995
, O 0 0.00015677083865739405
and O 0 9.932419925462455e-05
genetic O 0 0.0018773135961964726
testing O 0 0.003392023267224431
in O 0 3.512490002322011e-05
the O 0 4.0657185309100896e-05
setting O 0 0.00021116313291713595
of O 0 2.4887307517929003e-05
long O 0 0.007139231543987989
- O 0 0.006557554006576538
term O 0 0.003010147251188755
- O 0 0.0020578308030962944
outcome O 0 0.000519299996085465
studies O 0 0.0003112371196039021
may O 0 0.00022692649508826435
impact O 0 0.0008738871547393501
significantly O 0 0.011235561221837997
on O 0 0.03222409263253212
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9999442100524902
in O 0 6.354939978336915e-05
this O 0 1.2718988728011027e-05
population O 0 3.575574737624265e-05
. O 0 0.0002341300278203562

Localization O 0 0.006723982281982899
of O 0 3.0811195756541565e-05
human O 0 0.0039366427809000015
BRCA1 O 1 0.9986315369606018
and O 0 0.00010109030699823052
its O 0 0.00011776772589655593
loss O 0 0.003517620265483856
in O 0 0.00014935355284251273
high O 0 0.004880442749708891
- O 0 0.0058640483766794205
grade O 0 0.01748703047633171
, O 0 0.00016211767797358334
non B-Disease 0 0.00670201238244772
- I-Disease 1 0.9927092790603638
inherited I-Disease 1 0.999985933303833
breast I-Disease 1 1.0
carcinomas I-Disease 1 0.9999991655349731
. O 0 0.0012021900620311499

Although O 0 0.00042909104377031326
the O 0 5.620966840069741e-05
link O 0 0.001933107036165893
between O 0 6.422454316634685e-05
the O 0 0.0007241357234306633
BRCA1 O 1 0.9999977350234985
tumour B-Disease 1 0.9999998807907104
- O 0 0.014504234306514263
suppressor O 0 0.015389269217848778
gene O 0 0.0009479693253524601
and O 0 0.0002484393771737814
hereditary B-Disease 1 0.9999957084655762
breast I-Disease 1 1.0
and I-Disease 1 0.9959830045700073
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.00047071711742319167
established O 0 0.0003449199430178851
, O 0 6.173278234200552e-05
the O 0 8.67504277266562e-05
role O 0 0.0020121599081903696
, O 0 0.00015617106691934168
if O 0 9.969940583687276e-05
any O 0 2.075589327432681e-05
, O 0 3.254807597841136e-05
of O 0 2.2490254195872694e-05
BRCA1 O 1 0.9997379183769226
in O 0 0.000275960483122617
non B-Disease 0 0.013642583042383194
- I-Disease 1 0.9894410371780396
familial I-Disease 1 0.9999654293060303
cancers I-Disease 1 0.9999979734420776
is O 0 0.0006898014689795673
unclear O 0 0.001475559314712882
. O 0 0.00024778247461654246

BRCA1 O 1 0.9992527365684509
mutations O 0 0.0022996102925390005
are O 0 2.7623165806289762e-05
rare O 0 0.0018239539349451661
in O 0 0.0003147621755488217
sporadic B-Disease 0 0.12939834594726562
cancers I-Disease 1 0.9999957084655762
, O 0 0.0002539105771575123
but O 0 0.00012441491708159447
loss O 0 0.002225549891591072
of O 0 7.61749324738048e-05
BRCA1 O 1 0.9998806715011597
resulting O 0 0.0015447696205228567
from O 0 8.416826312895864e-05
reduced O 0 0.0017989932093769312
expression O 0 0.0007723468588665128
or O 0 0.0003993731224909425
incorrect O 0 0.0044342996552586555
subcellular O 0 0.013254564255475998
localization O 0 0.014868516474962234
is O 0 0.0004306561895646155
postulated O 0 0.0037536267191171646
to O 0 1.4016082786838524e-05
be O 0 6.324753940134542e-06
important O 0 2.6411109502078034e-05
in O 0 4.8276535380864516e-05
non B-Disease 0 0.0038003036752343178
- I-Disease 1 0.9830317497253418
familial I-Disease 1 0.9999978542327881
breast I-Disease 1 1.0
and I-Disease 1 0.894366443157196
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0010707046603783965

Epigenetic O 0 0.038765255361795425
loss O 0 0.018746478483080864
, O 0 0.00027008901815861464
however O 0 0.0002228521479992196
, O 0 0.0001351743849227205
has O 0 0.0003633310552686453
not O 0 0.00010095843026647344
received O 0 0.0009689572616480291
general O 0 0.001174382516182959
acceptance O 0 0.0077593689784407616
due O 0 0.001184582244604826
to O 0 5.8661928051151335e-05
controversy O 0 0.0005457300576381385
regarding O 0 0.00016047358803916723
the O 0 6.217724876478314e-05
subcellular O 0 0.005890917964279652
localization O 0 0.004859542939811945
of O 0 9.462263551540673e-05
BRCA1 O 1 0.9986655712127686
proteins O 0 0.00017307877715211362
, O 0 0.0001294103858526796
reports O 0 0.00015225919196382165
of O 0 8.56079986988334e-06
which O 0 3.819485573330894e-05
have O 0 3.825135718216188e-05
ranged O 0 0.0019512474536895752
from O 0 4.5755521568935364e-05
exclusively O 0 0.00046461191959679127
nuclear O 0 0.0023813850712031126
, O 0 8.670942042954266e-05
to O 0 0.00011397295747883618
conditionally O 0 0.03690604120492935
nuclear O 0 0.0011058126110583544
, O 0 3.8976875657681376e-05
to O 0 4.062195512233302e-05
the O 0 0.0007228759932331741
ER O 1 0.9999885559082031
/ O 1 0.855209231376648
golgi O 1 0.825950026512146
, O 0 0.00017135849338956177
to O 0 6.608459807466716e-05
cytoplasmic O 0 0.005980063695460558
invaginations O 0 0.03521573543548584
into O 0 4.697639087680727e-05
the O 0 7.912709406809881e-05
nucleus O 0 0.007035096641629934
. O 0 0.00035242363810539246

In O 0 0.00032563135027885437
an O 0 0.00014413184544537216
attempt O 0 0.0008258821326307952
to O 0 9.190348646370694e-05
resolve O 0 0.007902706041932106
this O 0 5.690878242603503e-05
issue O 0 0.000588963448535651
, O 0 8.779318886809051e-05
we O 0 6.57149575999938e-05
have O 0 5.342251097317785e-05
comprehensively O 0 0.03503836318850517
characterized O 0 0.014091840013861656
19 O 0 0.002234530169516802
anti O 0 0.013579459860920906
- O 0 0.06504548341035843
BRCA1 O 1 0.9989961981773376
antibodies O 0 0.015642788261175156
. O 0 0.0004016412131022662

These O 0 8.928349416237324e-05
reagents O 0 0.016560621559619904
detect O 0 0.009691080078482628
a O 0 0.0007151798927225173
220 O 0 0.005543468054383993
- O 0 0.007661308627575636
kD O 0 0.0692170113325119
protein O 0 0.0003718988155014813
localized O 0 0.004315089900046587
in O 0 7.371798710664734e-05
discrete O 0 0.0015116609865799546
nuclear O 0 0.005230030044913292
foci O 0 0.020144226029515266
in O 0 9.33423507376574e-05
all O 0 8.031652396311983e-05
epithelial O 1 0.9993763566017151
cell O 0 0.0063280160538852215
lines O 0 0.0008077545207925141
, O 0 5.715264705941081e-05
including O 0 1.3004572792851832e-05
those O 0 1.76947742147604e-05
derived O 0 0.0001657679385971278
from O 0 0.0004711034125648439
breast B-Disease 1 0.9999998807907104
malignancies I-Disease 1 0.9999228715896606
. O 0 0.0009550009272061288

Immunohistochemical O 1 0.9976849555969238
staining O 0 0.2837684154510498
of O 0 8.411963790422305e-05
human O 0 0.023066557943820953
breast O 1 0.9999997615814209
specimens O 0 0.0037797018885612488
also O 0 0.00039621227188035846
revealed O 0 0.013111697509884834
BRCA1 O 1 0.9991171956062317
nuclear O 0 0.004135374445468187
foci O 0 0.03004363179206848
in O 0 0.000615590950474143
benign O 1 0.9999996423721313
breast O 1 1.0
, O 0 0.0036378076765686274
invasive B-Disease 1 0.9999988079071045
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999967813491821
and O 0 0.00026769557734951377
low B-Disease 0 0.012769353576004505
- I-Disease 1 0.9328525066375732
grade I-Disease 1 0.9996563196182251
ductal I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 0.9999974966049194
. O 0 0.0011168699711561203

Conversely O 0 0.03738870471715927
, O 0 0.0009441767469979823
BRCA1 O 1 0.9945712685585022
expression O 0 0.0016103757079690695
was O 0 0.0015889685600996017
reduced O 0 0.0035572214983403683
or O 0 0.000989440712146461
undetectable O 1 0.9880430698394775
in O 0 5.6388991652056575e-05
the O 0 2.1433254005387425e-05
majority O 0 3.805234155151993e-05
of O 0 1.4087857380218338e-05
high O 0 0.008867260068655014
- O 0 0.028708433732390404
grade O 1 0.9555062055587769
, O 0 0.0021606176160275936
ductal B-Disease 1 1.0
carcinomas I-Disease 1 0.9999995231628418
, O 0 0.000442271790234372
suggesting O 0 0.0016405829228460789
that O 0 3.172748620272614e-05
absence O 0 0.0015671498840674758
of O 0 8.728248940315098e-05
BRCA1 O 1 0.9999773502349854
may O 0 0.0019252231577411294
contribute O 0 0.002416140865534544
to O 0 6.125293293735012e-05
the O 0 0.0002555645478423685
pathogenesis O 1 0.9975651502609253
of O 0 6.297741492744535e-06
a O 0 7.100057700881734e-05
significant O 0 7.98884648247622e-05
percentage O 0 9.391768253408372e-05
of O 0 1.9412107576499693e-05
sporadic B-Disease 1 0.9977072477340698
breast I-Disease 1 1.0
cancers I-Disease 1 0.999998927116394
. O 0 0.0003154326986987144
. O 0 0.00031960735213942826

